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investigación pionera y abriera nuevas líneas en las que avanzar en esta disciplina. Una vez 
desarrollados los estudios previstos, los resultados se han dividido en tres bloques: bibliografía, 
metabolómica vegetal y metabolómica clínica. 
 
-Un primer bloque (Bloque A) pone de manifiesto la formación adquirida por la doctoranda en el 
manejo de la información bibliográfica, especialmente orientada a la preparación de la muestra, con 
la publicación de un capítulo de libro sobre extracción asistida por ultrasonidos (US), una revisión 
bibliográfica sobre el uso de los US en metabolómica y otra sobre los contravertidos efectos de los US 
en la actividad enzimática y en los propios biocatalizadores, que constituyen los Capítulos I, II y III, 
respectivamente, de la Memoria de Tesis. La continua actualización de la literatura científica 
mantenida a lo largo de desarrollo de la Tesis ha dado lugar también a otras publicaciones, que se 
recogen en la Memoria como anexos; todas ellas ponen de manifiesto su amplia formación en este 
aspecto. 
 
-El segundo bloque de la Memoria (Bloque B) comienza con el Capítulo IV, que aprovecha la 
experiencia adquirida sobre US para iniciar una línea de investigación sobre la influencia de esta 
energía en los procesos de hidrólisis enzimática. El estudio se centra en la oleuropeína como materia 
prima obtenida de extractos de hojas de olivo para la producción de la correspondiente aglicona. Otra 
línea de investigación de interés se abre en el Capítulo V con la identificación de 123 metabolitos (55 
identificados por primera vez) existentes en los extractos enzimáticos acuosos de la seta comestible 
Agaricus bisporus, ya que esta seta ha mostrado su capacidad de inhibición de la proteasa NS3 del 
virus de la hepatitis C, de ahí el enorme interés de la exhaustiva identificación realizada. Una 
plataforma constituida por un cromatógrafo de líquidos y un detector de masas de tiempo de vuelo 
(LC–QTOF MS/MS) constituye la herramienta analítica más adecuada para este tipo de estudios. De 
no menor interés, dado el incremento en los últimos años del uso farmacológico del cannabis, es la 
investigación que se recoge en el Capítulo VI de la Memoria. Dos plataformas analíticas basada una 
de ellas en un cromatógrafo de gases y un detector de masas de tiempo de vuelo (GC–TOF/MS) y la 
otra en LC–QTOF MS/MS han hecho posible la identificación de 169 compuestos (cannabinoides y 
terpenoides), el estudio de 17 variedades de la planta y la comparación relativa de los compuestos en 
  
función de su desarrollo en invernadero o en campo. Información clave la que proporciona este 
estudio, dado el interés creciente de muchos países en legalizar el uso total o parcial de esta planta. 
 
Los Bloques C y D tienen como común denominador, además de la metabolómica, la muestra clínica 
que se estudia: el sudor.  
 
-En el Bloque C el uso de una plataforma analítica basada en LC y un detector de triple cuadrupolo 
(QqQ) dio lugar al único método de análisis metabolómico dirigido para la cuantificación de 
aminoácidos en sudor (Capítulo VII). El papel clave que tienen estos compuestos en la diagnosis y 
tratamiento de diferentes enfermedades les hace cobrar una especial relevancia en el caso de fluidos 
biológicos relativamente poco explotados, como es el caso del sudor. 
Los desarrollos de análisis metabolómico no dirigidos se focalizaron en el estudio de los 
diferentes tipos de muestreadores y muestras de sudor: muestreo en diferentes partes del cuerpo de 
sudor después de ejercicio moderado comparado con sudor obtenido en reposo mediante muestreo 
pasivo, tal como se recoge en el Capítulo VIII. Las estrategias de derivatización para la conversión de 
los metabolitos en compuestos volátiles suponen una aportación clave en esta investigación. El 
muestreo de sudor seco constituye una novedad digna de destacarse, ya que requirió el estudio de 
diferentes soportes impregnados de diferentes disolventes para la recogida de las muestras y su 
comparación para la selección del conjunto óptimo. El uso de las plataformas GC–MS y LC–MS/MS 
para la identificación de los diferentes metabolitos y la comparación con los existentes en sudor fresco 
permitió delimitar las posibles aplicaciones de cada tipo de sudor, tal como se recoge en el Capítulo 
IX.  
 
-El Bloque D tiene un perfil aplicado, ya que se dedica a la mejora los métodos para abarcar un mayor 
número de metabolitos y, por tanto, dar lugar a un mayor número de posibilidades de aplicación 
(Capítulo X); lo que proporciona una base sólida para la proposición de metabolitos del sudor como 
biomarcadores de cáncer de pulmón (Capítulo XI). El uso de herramientas quimiométricas actuales, 
como el programa PanelomiX, ha permitido obtener dos paneles de metabolitos que reducen tanto el 
número de falsos negativos como de falsos positivos y proporcionan valores de especificidad y de 
sensibilidad del 95%.  
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Resumen 
1. Motivación de la tesis 
La hipótesis que precedió al establecimiento de los objetivos sobre los que se 
planteó la investigación fue la existencia de un gran número de retos en metabolómica 
vegetal y animal de los que se requiere su abordaje. Por tanto, el objetivo básico abarcó 
ambas áreas de la metabolómica: la vegetal y la animal. Los tres pilares en los que se 
soportó la investigación desarrollada fueron el diseño de la plataforma analítica apropiada 
para cada caso, la supervisión por investigadores con reconocida experiencia en 
metabolómica y la formación y capacidad de la doctoranda para aceptar y desarrollar los 
retos planteados. 
 
2. Contenido de la investigación 
La investigación realizada ha implicado: 
-Un estudio en profundidad de la bibliografía relacionada con el trabajo planteado, 
complementado con una actualización continua durante todo el desarrollo de la tesis para 
mantener la investigación en primera línea. Se prestó especial atención a temas 
relacionados con la preparación de la muestra y la metabolómica, incluyendo una 
herramienta comúnmente utilizada por el grupo de investigación al que pertenece la 
doctoranda: los ultrasonidos (US) usados como energía auxiliar para favorecer etapas 
analíticas. De hecho, la extracción asistida por US (USAE) [1], los US y la metabolómica [2] 
y el controvertido efecto de los US en la actividad enzimática [3] han dado lugar a tres 
publicaciones que constituyen la Sección A de la tesis. 
-La hidrólisis de la oleuropeína en extractos de hojas de olivo acelerada por diferentes 
hidrolasas y por la acción de los US (USAEH) [4] (que abre la puerta al complejo mundo 
del binomio enzimas–US), el uso de una plataforma basada en cromatografía líquida y 
espectrometría de masas en tándem (LC–QTOF MS/MS) que proporcionó los datos para 
la identificación tentativa de 123 metabolitos de extractos que habían producido la 
inhibición de la proteasa NS3 del virus de la hepatitis-C [5] constituyen logros plasmados 
en publicaciones. Otro de los logros fue la exhaustiva identificación de los componentes de 
una planta controvertida, Cannabis sativa L., mediante plataformas basadas en 
cromatografía de gases–espectrometría de masas de tiempo de vuelo (GC–TOF/MS) y LC–
QTOF MS/MS [6]. Estas investigaciones, que constituyen la Sección B de la tesis, abren 
nuevas líneas de trabajo en metabolómica vegetal. 
-El exhaustivo estudio de una muestra apenas usada en clínica, el sudor, que ha consistido 
en: (1) el desarrollo de procedimientos para el muestreo y la preparación de la muestra — 
los primeros basados en estimulación de la sudoración mediante ejercicio moderado, 
mediante la forma convencional basada en estimulación química+eléctrica y por disolución 
de sudor seco utilizando soportes sólidos impregnados de los disolventes adecuados. (2) El 
análisis metabolómico de los dos primeros tipos de muestras y su comparación con sudor 
obtenido mediante el último tipo de muestreo [8,9]; todo lo cual forma parte de la Sección 
C. En todos los casos, el análisis no dirigido permitió establecer el perfil del tipo de muestra 
que debe obtenerse dependiendo de los metabolitos de interés (compuestos polares, no 
polares o de polaridad media), que se sometieron a análisis no dirigido para su 
identificación tentativa en todos los tipos de sudor muestreado. 
La Sección C también recoge un estudio sobre muestreo de sudor después de 
ejercicio moderado, en el que se comparó su composición con la de sudor obtenido 
mediante muestreo pasivo utilizando diferentes procedimientos de inducción. Se 
ensayaron diferentes estrategias de preparación de muestra incluyendo estrategias de 
derivatización para obtener instantáneas representativas del metaboloma del sudor, 
especialmente de los metabolitos no polares, como corresponde al uso de una plataforma 
GC–MS [8]. 
Además, en la Sección C, se usaron como muestreadores de sudor seco diferentes 
soportes sólidos impregnados con diferentes disolventes y las composiciones de las 
muestras se compararon entre sí y también con la composición del sudor fresco. Todas las 
muestras se analizaron mediante dos plataformas, GC–MS y LC–MS/MS, y los resultados 
mostraron que el sudor seco es más adecuado para el análisis de los metabolitos de baja 
polaridad, mientras que el sudor fresco es más apropiado para compuestos polares [9]. 
La última de las investigaciones contenidas en la Sección C se refiere a aminoácidos 
existentes en sudor. Estos compuestos son metabolitos claves en la diagnosis y tratamiento 
de diversas enfermedades, como el cáncer, por lo que se determinan en diferentes 
biofluidos. La determinación cuantitativa de estos compuestos en sudor requirió la 
optimización de la preparación de la muestra que, dependiendo de la concentración, puede 
consistir en simple dilución o en microextracción centrífuga en fase sólida (c-SPµE) como 
 etapa previa a la inserción en un cromatógrafo de líquidos conectado a un espectrómetro 
de masas de triple cuadrupolo [7]. 
En los estudios de metabolómica clínica que se recogen en la Sección D se 
compararon diferentes estrategias de preparación de la muestra para la obtención del perfil 
de metabolitos en sudor con el uso de una plataforma GC–TOF/MS en modo de alta 
resolución [10]. La comparación mostró que una etapa de metoximación más sililación tras 
la desproteinización era la opción más adecuada para conocer la situación instantánea del 
metaboloma del sudor. 
También la Sección D recoge el estudio de muestras de sudor procedentes de dos 
cohortes de pacientes de cáncer de pulmón, analizadas mediante LC–QTOF MS/MS para 
configurar paneles de biomarcadores con los que discriminar estos pacientes de fumadores 
como individuos con factor de riesgo [11]. El uso de una herramienta como PanelomiX 
permitió reducir los falsos negativos (95% de especificidad) y los falsos positivos (95% de 
sensibilidad) y la proposición de dos paneles de biomarcadores: uno, con 96.9% de 
especificidad y 83.8% de sensibilidad, compuesto por el monoglicérido MG(22:2), los 
ácidos mucónico, subérico y urocánico y una tetrahexosa; el otro con 81.2% de especificidad 
y el 97.3% de sensibilidad, compuesto por el monoglicérido MG(22:2), los ácidos mucónico, 
nonanodioico y urocánico, y una tetrahexosa. 
 
3.Conclusión 
La investigación realizada ha permitido extraer las siguientes conclusiones: 
-La extensa búsqueda bibliográfica [1–3], ha permitido una evaluación crítica del estado 
actual de los métodos basados en USAE para obtener componentes de plantas/alimentos y 
de los controvertidos efectos de los US en las enzimas y en su acción biocatalítica, pero 
también ha proporcionado pautas para planificar investigación metabolómica de plantas, 
en la que es clave la asistencia de los US. 
-La investigación experimental contenida en esta Memoria de Tesis se orientó al análisis 
metabolómico, tanto dirigido como global, en las áreas vegetal y animal. La diversidad de 
los estudios desarrollados incluye el efecto de la preparación de la muestra en la cobertura 
conseguida en la detección y el efecto favorable de los US en las reacciones enzimáticas. La 
variedad de los estudios realizados también abarca el efecto del muestreo y la preparación 
de la muestra en la eficacia de la detección de componentes del sudor, así como el estudio 
de los cambios en los perfiles de los metabolitos en el sudor humano recogido después de 
estimulación mediante diferentes procedimientos. 
Las conclusiones más destacables de la investigación en metabolómica en el área 
vegetal son: 
 El método basado en USAEH para la obtención de la aglicona de la oleuropeína a 
partir de oleuropeína de extractos de hojas de olivo requiere menos de 20 min para 
la hidrólisis completa, lo que permite una comparación favorable con el método 
tradicional basado en incubación enzimática, que requiere 2 h [4]. 
 El fraccionamiento basado en extracción líquido–líquido secuencial con extractantes 
de diferente polaridad mejora drásticamente la cobertura de la identificación 
tentativa de metabolitos en los extractos enzimáticos acuosos del A. bisporus (123 
metabolitos tentativamente identificados) [5]. 
 Se han identificado 169 compuestos (cannabinoides, terpenoides, lípidos, 
flavonoides, aminoácidos y ácidos orgánicos, entre los más destacables) en extractos 
polares y no polares, obtenidos con la asistencia de US, de 17 cultivos de Cannabis 
sativa L. Las plataformas GC–TOF/MS y LC–QTOF MS/MS maximizan la cobertura 
en la detección de componentes del cannabis, con lo que se ha consiguido identificar 
46 compuestos en los extractos polares y 134 en los no polares [6]. 
En cuanto al efecto del muestreo y de la preparación de la muestra en la detección 
de metabolitos en sudor humano (Sección C), el uso de análisis dirigido y no dirigido 
permitió obtener las siguientes conclusiones: 
 El sudor es una muestra excelente para el análisis cuantitativo del perfil de 
aminoácidos en estudios clínicos, lo que resulta de interés teniendo en cuenta el 
papel biomarcador de estos compuestos. La dilución+c-SPµE ha demostrado ser 
decisiva para disminuir el efecto matriz del sudor humano y hacer así posible la 
cuantificación de aminoácidos mediante LC–MS/MS [7]. 
 El sudor activo, con respecto al sudor pasivo, está enriquecido en algunas familias de 
compuestos claves, tales como ácidos grasos, alcoholes, carbohidratos y aminoácidos 
no proteinogénicos. La LLE con diclorometano y posterior metoximación más 
sililación es la mejor opción entre los protocolos ensayados para obtener mediante 
 GC–MS una instantánea representativa de los compuestos no polares del sudor 
activo [8]. 
 El muestreo de sudor seco es una alternativa para la estandarización de la recogida 
de sudor. El papel impregnado con etanol–PBS en proporción 1:1 (v/v) da lugar a los 
mejores resultados en términos de cobertura de la detección utilizando un análisis 
combinado mediante las plataformas GC–MS y LC–MS/MS. Se han detectado en 
sudor seco familias tales como carnitinas, esfingolípidos y N-acil-aminoácidos, que 
no aparecen o lo hacen a bajísima concentración en sudor fresco [9]. 
Los hallazgos más destacables en la mejora de la cobertura metabolómica del sudor 
para estudios clínicos han sido los siguientes: 
 La optimización de una nueva plataforma basada en GC–MS para el análisis de sudor 
revela la presencia de metabolitos que pueden ser de interés para el estudio de 
diferentes patologías. Es destacable la capacidad de la plataforma para detectar 
azúcares, lípidos y ácidos carboxílicos, familias cuya presencia había resultado 
insignificante cuando se utilizaron plataformas basadas en RMN o en LC–MS [10]. 
 El diseño de dos paneles de cinco metabolitos que incluyen aminoácidos, ácidos 
dicarboxílicos de cadena corta, azúcares y algunos lípidos permite discriminar 
pacientes con cáncer de pulmón del grupo de control con factor de riesgo. Este nuevo 
modelo de predicción es más robusto que el obtenido previamente por nuestro 
grupo, ya que se construyó con dos tandas de muestras recogidas y analizadas con 
una diferencia de tiempo de dos años y por diferentes analistas [11]. 
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Summary 
1. Motivation of the thesis 
The hypothesis that preceded the establishment of the objectives on which the 
research was planned were the existence of a large number of challenges that needed to be 
addressed in both plant and animal metabolomics. Therefore, the basic objective should 
encompass both metabolomics areas, and should be divided into plant and animal 
metabolomics. The three pillars on which the developed research was supported were the 
design of the appropriate analytical platform in each case, the supervision by senior 
researchers with experience in metabolomics, and the training+capability of the PhD 
student to accept and develop the planned challenges. 
 
2. Content of the investigation 
The performed research has involved: 
-An in-depth study of the literature related to the planned work, complemented with a 
continuous updating during the development of the target studies that will keep the 
research in the front line. Especial attention have been paid to sample preparation and 
metabolomics, including a tool commonly used by the PhD student research team: 
ultrasound (US) used as auxiliary energy to favor analytical steps. Thus, US-assisted 
extraction (USAE) [1], US and metabolomics [2] and the controversial effect of US on 
enzymatic activity [3] gave place to three publications that constitute Section A of the 
thesis. 
-The hydrolysis of oleuropein in olive leaf extracts accelerated by different hydrolases and 
by US action (USAEH) [4] (which opens the door to the complex enzymes–US world), and 
the use of a liquid chromatography–time-of-flight tandem mass spectrometry (LC–QTOF 
MS/MS) platform to obtain the data for tentative identification of 123 metabolites in 
extracts that had shown inhibition of the protease NS3 of hepatitis-C virus (HCV) [ 5] 
constitute key achievements. Another achievement was the in-depth identification of the 
components of a controversial plant, Cannabis sativa L., by gas chromatography–time-of-
flight mass spectrometry (GC–TOF/MS) and LC–QTOF MS/MS platforms [6]. All these 
investigations, which constitute Section B of the thesis, open new research lines in plant 
metabolomics. 
-An in-depth study of an almost not used sample in clinical, sweat, has consisted of : (1) the 
development of sampling and sample preparation procedures —the first ones based on 
sweat stimulation of sweat by moderate exercise, by the conventional via based on 
chemical+electrical stimulation and on dissolution of dry sweat by using solid supports 
impregnated with appropriate solvents. (2) The metabolomics analysis of the first two types 
of samples and their comparison with sweat obtained by the last kind of sampling [8,9]; all 
of which is part of Section C. The untargeted analysis in all cases allowed setting the pattern 
of the type of sample to be obtained depending on the metabolites of interest (polar, no 
polar or medium polarity compounds), all which were subjected to untargeted analysis for 
tentative identification in all types of sampled sweat. 
Section C also includes a study on sweat sampling after moderate exercise, in which 
the composition of this biofluid was compared with that of sweat obtained by passive 
sampling using different sweat induction procedures. Different sample preparation 
strategies, including derivatization strategies, were assayed to obtain a representative 
snapshot of sweat metabolome, mainly of no polar metabolites as corresponds to the use of 
a GC–MS platform [8]. Moreover, different solid supports impregnated with different 
solvents were used as dry sweat samplers and the composition of the collected samples was 
compared among them, and also with the composition of fresh sweat. All the samples were 
analyzed by a dual approach, GC–MS and LC–MS/MS, and the results showed that dry 
sweat is better for analysis of low polar metabolites and fresh sweat is more suited for polar 
compounds [9]. 
The last of the research contained in Section C refers to amino acids existing in 
sweat. These compounds are key metabolites in the diagnosis and treatment of several 
diseases such as cancer; therefore, they are determined in common biofluids. Quantitative 
determination of these compounds in sweat has required optimization of the sample 
preparation step which, depending on the concentration, can consist either on simple 
dilution or centrifugal microsolid-phase extraction (c-SPµE) prior to insertion into a liquid 
chromatograph connected to a triple quadrupole mass detector [7]. 
In the clinical metabolomics studies that constitute Section D, different sample 
preparation strategies were compared to obtain the profile of sweat metabolites by a GC–
TOF/MS platform in high resolution mode [10]. The comparison showed that 
 methoxymation plus silylation after deproteination was the most suited option to obtain a 
representative snapshot of sweat metabolome. 
Section D also contains the study of sweat samples, from two cohorts of lung-cancer 
patients, subjected to analysis by LC–QTOF MS/MS to configure biomarker panels to 
discriminate these patients from smokers as risk factor individuals [11]. The use of the 
PanelomiX tool allowed reducing false negatives (95% specificity) and false positives (95% 
sensitivity), and proposing two biomarker panels: one, with 96.9% specificity and 83.8% 
sensitivity, composed by monoglyceride MG(22:2), muconic, suberic and urocanic acids 
and a tetrahexose; and the other with 81.2% specificity and 97.3% sensitivity, and 
composed by monoglyceride MG(22:2), muconic, nonanodioic and urocanic acids, and a 
tetrahexose. 
 
4. Conclusion 
The performed research has allowed to extract the following conclusions: 
-The in-depth bibliographic search [1–3] allows a critical evaluation of the state-of-the-art 
of USAE methods to obtain components from plants/foods, and the controversial effects of 
US on enzymes and their biocatalytic action, but also provides guidelines to plan the 
research on plants through metabolomics helped by US. 
-The experimental research in this Thesis-Book was focused on the use of both targeted and 
untargeted metabolomics analysis for plant and clinical studies. The diversity of the 
developed studies includes the effect of sample preparation on detection coverage, and the 
favorable US effect on enzymatic reactions. The variety of the developed studies also covers 
the effect of both sampling and sample preparation on the efficient detection of sweat 
components, and the study of the changes in the metabolite profiles of human sweat 
collected after different sweat stimulation procedures. 
The most outstanding conclusions from the research devoted to studying the 
metabolomics in the plant field are: 
 The USAEH method to obtain oleuropein aglycon from oleuropein in olive leaf 
extracts requires less than 20 min for complete hydrolysis, which compares 
favorably with the traditional method based on enzymatic incubation, for which 2 h 
are necessary [4]. 
 Fractionation based on sequential liquid–liquid extraction with extractants of 
different polarity drastically improves the tentative identification coverage of 
metabolites in A. bisporus aqueous enzymatic extracts (123 tentatively identified 
metabolites) [5]. 
 A total of 169 compounds (cannabinoids, terpenoids, lipids, flavonoids, amino and 
organic acids, among others) have been identified in polar and no polar extracts 
obtained by US assistance from 17 cultivars of Cannabis sativa L. GC–TOF/MS and 
LC–QTOF MS/MS maximize the detection coverage of Cannabis components, so 46 
compounds were identified in polar extracts and 134 compounds in no polar extracts 
[6]. 
Concerning the effect of sampling and sample preparation on the detection of 
metabolites from human sweat (Section C), untargeted and targeted analysis allowed 
reaching the following conclusions: 
 Sweat is an excellent sample for quantitative profiling analysis of amino acids in 
clinical studies, which is of interest taking into account the biomarker role of these 
compounds. Dilution+c-SPµE has proved to be mandatory to decrease the matrix 
effect of human sweat thus making possible absolute quantitation of amino acids by 
LC–MS/MS [7]. 
 Active sweat, with respect to passive sweat, is enriched in some key families of 
compounds such as fatty acids, alcohols, carbohydrates and no proteinogenic amino 
acids. LLE with dichloromethane with subsequent methoxymation plus silylation is 
the best option among the tested protocols to obtain a representative snapshot of the 
no polar compounds from active sweat by GC–MS [8]. 
 Dry sweat sampling is an alternative to standardize sweat collection. Paper 
impregnated with 1:1 (v/v) ethanol‒PBS provides the best results in terms of 
detection coverage by using a combined approach based on GC–MS and LC–MS/MS 
analysis. Particular families such as carnitines, sphingolipids and N-acyl-amino 
acids detected in dry sweat have not been reported or they do it at very low 
concentration in fresh sweat [9]. 
The most remarkable findings on enhancement of metabolomics coverage of sweat 
for clinical studies have been the following: 
  The optimization of a new GC–MS platform for sweat analysis reveals the presence 
of metabolites that can be of interest for the study of different pathologies. It is 
worthy to remarking the ability of GC–MS to detect sugars, lipids and carboxylic 
acids, families that with previous platforms (NMR and LC–MS) seemed to have 
insignificant presence [10]. 
 The design of two panels of five metabolites including amino acids, short chain 
dicarboxylic acids, sugars and some lipids allow discriminating patients with lung 
cancer from a control group with risk factor. This new prediction model is more 
robust than that obtained previously by our group since it was built with two batches 
of samples collected and analyzed with a shift time of two years and by different 
analysts [11]. 
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Hipótesis y objetivos de la investigación 
 La hipótesis que precedió al establecimiento de los objetivos sobre los que se 
planteó la investigación fue la existencia de un gran número de retos en metabolómica 
vegetal y animal de los que se requiere su abordaje. 
 Tras la presentación de la hipótesis, queda claro que el objetivo básico debe abarcar 
ambas áreas de la metabolómica: la vegetal y la animal. Los tres pilares en los que se 
soportó la investigación desarrollada fueron el diseño de la plataforma analítica apropiada 
para cada caso, la supervisión por investigadores con reconocida experiencia en 
metabolómica y la formación y capacidad de la doctoranda para aceptar y desarrollar los 
retos planteados; todos los cuales dieron lugar a los objetivos específicos, divididos en 4 
secciones. 
  
Sección A: 
El objetivo específico de la Sección A debería ser el primer objetivo de cualquier 
investigación: llevar a cabo un estudio en profundidad de la bibliografía relacionada con el 
trabajo planteado, complementado con una actualización continua durante todo el 
desarrollo de la tesis para mantener la investigación en primera línea. De esta forma, 
además de adiestrarse en la literatura científica, el estudiante aprende a ser crítico con la 
información que maneja, de manera que puede contribuir a la formación de otros 
investigadores publicando su crítica y bien soportada información en revistas científicas 
accesibles. Los temas a los que la estudiante de doctorado ha prestado especial atención 
han estado relacionados con la preparación de la muestra y con la metabolómica, 
incluyendo una herramienta comúnmente utilizada por el grupo de investigación al que ella 
pertenece: los ultrasonidos (US) como energía auxiliar para favorecer etapas analíticas. De 
hecho, la extracción asistida por US es el tema del Capítulo I, los US y la metabolómica se 
discuten en el Capítulo II, mientras que el controvertido efecto de los US en la actividad 
enzimática constituye el Capítulo III. 
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Sección B: 
 Contribuir a la metabolómica vegetal abriendo nuevas líneas de investigación 
claves fue el objetivo específico de la Sección B. La hidrólisis de la oleuropeína en extractos 
de hojas de olivo acelerada por diferentes hidrolasas y por la acción de los US constituye el 
material del Capítulo IV, que abre la puerta al complejo mundo del binomio enzimas–US. 
El Capítulo V contiene el uso de una plataforma basada en cromatografía líquida y 
espectrometría de masas en tándem (LC–QTOF MS/MS) con la que obtener los datos para 
la identificación tentativa de 123 metabolitos, 55 de los cuales fueron identificados por 
primera vez en extractos enzimáticos acuosos de la seta comestible Agaricus bisporus. Los 
extractos habían producido la inhibición de la proteasa NS3 del virus de la hepatitis-C 
(HCV); por tanto, la instantánea que proporciona este estudio es muy prometedora para 
los pacientes con HCV. En la misma línea, la investigación del Capítulo VI puede ser un 
avance clave en medicina, ya que está dedicado a la identificación amplia de los 
componentes de una planta controvertida: Cannabis sativa L. Se identificaron un total de 
169 compuestos en extractos polares y no polares en 17 cultivos de Cannabis sativa L. 
utilizando los datos obtenidos mediante plataformas basadas en cromatografía de gases–
espectrometría de masas de tiempo de vuelo (GC–TOF/MS) y LC–QTOF MS/MS. La 
existencia de patrones comerciales de cannabinoides y terpenoides posibilitó confirmar la 
identificación de un buen número de ellos. Se compararon los contenidos relativos de 
terpenoides y cannabinoides de los mismos cultivares procedentes de invernadero y de 
campo: las diferencias en composición entre ambos tipos de cultivos abren una puerta a un 
cultivo más racional de esta planta en función del uso al que se destine. 
 
Secciones C y D: 
 El objetivo específico común de las Secciones C y D fue un estudio en profundidad 
de una muestra apenas usada en clínica: el sudor. Por tanto, se abordaron procedimientos 
para el muestreo y la preparación de la muestra. Los procedimientos de muestreo se 
basaron en estimulación de la sudoración mediante ejercicio moderado, mediante la forma 
convencional basada en estimulación química+eléctrica y por disolución de sudor seco 
utilizando soportes sólidos impregnados de los disolventes adecuados. El análisis 
metabolómico de los dos primeros tipos de muestras y su comparación con sudor obtenido 
mediante el último tipo de muestreo constituyen los Capítulos VIII y IX, respectivamente. 
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En todos los casos, el análisis no dirigido permitió establecer el perfil del tipo de muestra 
que debe obtenerse dependiendo de los metabolitos de interés (compuestos polares, no 
polares o de polaridad media), todos los cuales se sometieron a análisis no dirigido para su 
identificación tentativa en todos los tipos de sudor muestreado.  
 El muestreo de sudor después de ejercicio moderado proporcionó muestras de 
diferentes partes del cuerpo y su composición se comparó con la de sudor obtenido 
mediante muestreo pasivo utilizando diferentes procedimientos de inducción. Se 
ensayaron diferentes estrategias de derivatización para obtener instantáneas 
representativas del metaboloma del sudor, especialmente de los metabolitos no polares, 
como corresponde al uso de una plataforma GC–MS. El Capítulo VIII refleja los resultados 
de esta investigación. 
 El muestreo de sudor seco constituye una novedad, por lo que se utilizaron como 
muestreadores diferentes soportes sólidos impregnados con diferentes disolventes y las 
composiciones de las muestras se compararon entre sí y también con la composición de 
sudor fresco. Todas las muestras se analizaron mediante dos plataformas, GC–MS y LC–
MS/MS, y los resultados permitieron concluir que el sudor seco es más adecuado para el 
análisis de los metabolitos de baja polaridad, mientras que el sudor fresco es más apropiado 
para compuestos polares, tal como se recoge en el Capítulo IX.  
 La plataforma GC–TOF/MS en modo de alta resolución soportó la comparación de 
diferentes estrategias de preparación de la muestra para la obtención del perfil de 
metabolitos en sudor, entre ellas la metoximación más sililación después de la 
desproteinización fue la opción más adecuada para obtener una instantánea del 
metaboloma del sudor. La identificación tentativa de 66 metabolitos (la mayoría de ellos 
implicados en rutas bioquímicas claves) y las excelentes características del método 
desarrollado abren nuevas posibilidades al uso del sudor como fuente de metabolitos 
biomarcadores de desórdenes específicos. Todos estos logros constituyen el Capítulo X. 
 Muestras de sudor procedentes de dos cohortes de pacientes de cáncer de pulmón 
se sometieron a análisis mediante LC–QTOF MS/MS para configurar paneles de 
biomarcadores con los que discriminar estos pacientes de fumadores como individuos con 
factor de riesgo. El uso de una herramienta como el PanelomiX permitió reducir los falsos 
negativos (95% de especificidad) y los falsos positivos (95% de sensibilidad), y la 
proposición de dos paneles de biomarcadores: uno, con 96.9% de especificidad y 83.8% de 
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sensibilidad, compuesto por el monoglicérido MG(22:2), los ácidos mucónico, subérico y 
urocánico y una tetrahexosa; y el otro con 81.2% de especificidad y el 97.3% de sensibilidad, 
y compuesto por el monoglicérido MG(22:2), los ácidos mucónico, nonanodioico y 
urocánico, y una tetrahexosa. El modelo de predicción así obtenido constituye el Capítulo 
XI. 
 Los aminoácidos son el objetivo específico abordado en el Capítulo VII. Estos 
compuestos son metabolitos claves en la diagnosis y tratamiento de diversas enfermedades, 
como el cáncer; por tanto, se determinan en diferentes biofluidos. La determinación 
cuantitativa de estos compuestos en sudor requirió la optimización de la preparación de la 
muestra, que, dependiendo de la concentración, puede consistir en simple dilución o en 
microextracción centrífuga en fase sólida como etapa previa a la inserción en un 
cromatógrafo de líquidos conectado a un espectrómetro de masas de triple cuadrupolo, tal 
como se detalla en el Capítulo VII. 
 
 El objetivo final de toda Tesis Doctoral debe ser siempre la formación del futuro 
doctor o doctora. En el presente caso, su formación ha incluido también los cursos 
obligatorios de un máster en química. En paralelo con las tareas antes comentadas y la 
investigación recogida en la parte principal de esta Memoria de Tesis, la formación de la 
doctoranda se ha ampliado con el desarrollo de otras actividades, que se resumen a 
continuación como anexos. 
Anexo I: Artículos de revisión sobre temas relacionados con la Tesis, tales como 
emulsificación–extracción asistida por US, extracción asistida por US y derivatización in 
situ e “in medium virtus” evaluación de la química analítica verde. 
Anexo II: Capítulo de libro sobre un tema relacionado con la Tesis, como es el uso 
de las microondas en el campo de las ómicas. 
Anexo III: Experto en Docencia Universitaria, con título propio de la Universidad 
de Córdoba.  
Anexo IV: Artículo de investigación derivado de un Proyecto del Plan de Innovación 
y Buenas Prácticas Docentes (desarrollo de un método para la evaluación de la adquisición 
de competencias y su comparación con el sistema tradicional de evaluación en asignaturas 
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del Grado de Química), que fue el resultado de la colaboración con miembros del 
Departamento de Química Física y Termodinámica Aplicada. 
Anexo V: Codirección del Trabajo Fin de Máster (TFM) de Francisco Martín Loro 
(La orina como muestra clínica para la búsqueda de biomarcadores metabolómicos de 
cáncer de próstata sustitutivos del PSA), desarrollado en la UCO durante el curso 
académico 2017–18. 
Anexo VI: Codirección de los Trabajos Fin de Grado (TFG) de Ismael Ruiz González 
(Caracterización de extractos fenólicos de hoja de olivo para la preparación de 
concentrados purificados con interés nutricional), de Eva Natalia Cárdenas Soria 
(Comparación del espectrómetro de diodos en fila y el de masas conectados a un 
cromatógrafo de líquidos para la cuantificación en orina de metabolitos biomarcadores de 
cáncer de próstata) y de Elvira Cruces Vera (Comparación del perfil metabólico de los 
componentes del sudor en niños, adultos y ancianos), desarrollados en la UCO durante los 
cursos académicos 2018–19, 2017–18 and 2016–17, respectivamente. 
Anexo VII: Comunicaciones orales y en carteles en congresos y reuniones nacionales 
de química analítica. 
Anexo VIII: Comunicaciones orales y en carteles en congresos y reuniones de 
investigadores jóvenes. 
Anexo IX: Comunicaciones orales en congresos de medicina. 
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Hypothesis and objectives of the research 
 The hypothesis that preceded the establishment of the objectives on which the 
research was planned were the existence of a large number of challenges that needed to be 
addressed in both plant and animal metabolomics. 
 After presentation of the hypothesis, it was clear that the basic objective should 
encompass both metabolomics areas, and should be divided into plant and animal 
metabolomics. The three pillars on which the developed research was supported were the 
design of the appropriate analytical platform in each case, the supervision by senior 
researchers with experience in metabolomics, and the training+capability of the PhD 
student to accept and develop the planned challenges; all them giving place to the specific 
objectives divided into 4 sections. 
 
Section A: 
 The specific objective of Section A should always be the first objective of any 
research: to carry out an in depth study of the literature related to the planned work, 
complemented with a continuous updating during the development of the target studies 
that will keep the research in the front line. In this way, in addition to training in literature, 
the PhD student learns to be critical with the information she handles in such a way that 
she can contribute to the training of other researchers by publishing her well supported and 
critical information in accessible journals. The subjects to which the PhD student has paid 
especial attention have been related to sample preparation and metabolomics, including a 
tool commonly used by the research team to which she belongs: ultrasound (US) as 
auxiliary energy to favor analytical steps. Thus, US-assisted extraction is the matter of 
Chapter I, US and metabolomics are discussed in Chapter II, while the controversial effect 
of US on enzymatic activity constitutes Chapter III. 
 
Section B: 
To contribute to plant metabolomics by opening new key research lines was the 
specific objective of Section B. The hydrolysis of oleuropein in olive leaf extracts accelerated 
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by different hydrolases and US action constitutes the matter of Chapter IV, which opens 
the door to the complex enzymes–US world. Chapter V contains the use of a liquid 
chromatography–time-of-flight tandem mass spectrometry (LC–QTOF MS/MS) platform 
to obtain the data for tentative identification of 123 metabolites, 55 of which were identified 
for the first time in aqueous enzymatic extracts of the common edible mushroom Agaricus 
bisporus. The extracts had shown inhibition of the protease NS3 of hepatitis-C virus (HCV); 
therefore, the representative snapshot of the composition of the target extracts thus 
obtained is very promising for HCV patients. In this line, the research in Chapter VI may 
constitute a key advance in medicine as it is devoted to in-depth identification of 
components of a controversial plant: Cannabis sativa L. A total of 169 compounds were 
identified in polar and no polar extracts from 17 cultivars of Cannabis sativa L. using the 
data obtained by gas chromatography–time-of-flight/mass spectrometry (GC–TOF/MS) 
and LC–QTOF MS/MS platforms. A number of commercial standards of cannabinoids, and 
terpenoids allowed confirming their identification. Relative contents of terpenoids and 
cannabinoids in the same cultivars grown in greenhouse and in field were compared: the 
compositional differences between both types of grown conditions open a door for a more 
rational cultivation of this plant as a function of its use. 
 
Sections C and D: 
 Common specific objective of Sections C and D was an in-depth study of an almost 
no used sample: sweat. Therefore, sampling and preparation procedures for this clinical 
sample were afforded. Sampling procedures were based on sweat stimulation by moderate 
exercise, by the conventional via based on chemical+electrical stimulation and on 
dissolution of dry sweat by using solid supports impregnated by appropriate solvents. The 
metabolomics analysis of the first two types of samples and their comparison with sweat 
obtained by the last kind of sampling constitute Chapters VIII and IX, respectively. The 
untargeted analysis in all cases allowed setting the pattern of the type of sample to be 
obtained depending on the metabolites of interest (polar, no polar or medium polarity 
compounds), all which were subjected to untargeted analysis for tentative identification in 
all types of sampled sweat. 
Sweat sampling after moderate exercise provided samples from different parts of 
the body, the composition of which was compared with that of sweat obtained by passive 
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sampling and using different sweat induction procedures. Different sample preparation 
strategies including derivatization were assayed to obtain a representative snapshot of 
sweat metabolome, mainly of no polar metabolites as corresponds to the use of a GC–MS 
platform. Chapter VIII contains this research. 
Sampling dry sweat constitutes a novelty; therefore, different solid supports 
impregnated with different solvents were used as samplers and the composition of the 
collected samples was compared among them, and also with the composition of fresh sweat. 
All the samples were analyzed by a dual approach, GC–MS and LC–MS/MS, and the results 
allowed concluding that dry sweat is better for analysis of low polar metabolites and fresh 
sweat is more suited for polar compounds, as shows Chapter IX.  
The GC–TOF/MS platform in high resolution mode supported the comparison of 
different sample preparation strategies on the profile of sweat metabolites, among which 
methyoxiamination plus silylation after deproteination was the most suited option to 
obtain a representative snapshot of sweat metabolome. The tentative identification of 66 
metabolites (most of them involved in key biochemical pathways), and the excellent 
characteristics of the developed method open new possibilities to the use of sweat as a 
source of metabolite biomarkers of specific disorders. All these achievements constitute 
Chapter X. 
Sweat samples from two cohorts of lung-cancer patients were subjected to analysis 
by LC–QTOF MS/MS looking for proposing biomarkers panels to discriminate these 
patients from smokers as risk factor individuals. The use of the PanelomiX tool allowed 
reducing false negatives (95% specificity) and false positives (95% sensitivity), and 
proposing two biomarkers panels: one, with 96.9% specificity and 83.8% sensitivity, 
composed by monoglyceride MG(22:2), muconic, suberic and urocanic acids, and a 
tetrahexose; and the other with 81.2% specificity and 97.3% sensitivity, and composed by 
the monoglyceride MG(22:2), muconic, nonanedioic and urocanic acids, and a tetrahexose. 
The prediction model thus obtained constitutes Chapter XI.  
 Amino acids are the specific objective afforded in Chapter VII. They are key 
metabolites in the diagnosis and treatment of several diseases as cancer; therefore, they are 
determined in common biofluids. Quantitative determination of these compounds in sweat 
have required optimization of the sample preparation step that can consist either of simple 
dilution or centrifugal microsolid-phase extraction, depending on the concentration of the 
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metabolites, prior to insertion into a liquid chromatograph connected to a triple quad mass 
detector, as shown in Chapter VII. 
 
The final objective of a Doctoral Thesis should be always the formation of the future 
PhD. In the present case her formation has also included the mandatory courses of a master 
on Chemistry. In parallel to the above-mentioned tasks and the research in the main part 
of this Thesis-Book, the training of the PhD student has been improved by development of 
other activities below summarized as annexes: 
Annex I: Review articles on subjects related to the Thesis, as are US-assisted 
emulsification–extraction, US-assisted extraction and in situ derivatization, and the “in 
medium virtus” assessment of green analytical chemistry. 
Annex II: Book chapter on a subject related to the Thesis, as is microwaves in the 
omics field. 
Annex III: Expert in University Teaching, graduating from the University of 
Córdoba. 
Annex IV: Research article from a Project of the Innovation Plan and Good Teaching 
Practices (development of a method for the evaluation of competences acquisition and its 
comparison with the traditional evaluation system in subjects of Chemistry degree), that 
resulted from the collaboration with members of the Department of Physical Chemistry 
and Applied Thermodynamics. 
Annex V: Co-supervision of the Master´s Thesis of Francisco Martín Loro (La orina 
como muestra clínica para la búsqueda de biomarcadores metabolómicos de cáncer de 
próstata sustitutivos del PSA), developed in the UCO during the 2017–18 academic year. 
Annex VI: Co-supervision of the Final Degree Projects (TFG) of Ismael Ruiz Gónzalez 
(Caracterización de extractos fenólicos de hoja de olivo para la preparación de 
concentrados purificados con interés nutricional), Eva Natalia Cárdenas Soria 
(Comparación del espectrómetro de diodos en fila y el de masas conectados a un 
cromatógrafo de líquidos para la cuantificación en orina de metabolitos biomarcadores de 
cáncer de próstata), and Elvira Cruces Vera (Comparación del perfil metabólico de los 
componentes del sudor en niños, adultos y ancianos), developed in the UCO during the 
2018–19, 2017–18 and 2016–17 academic years, respectively. 
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Annex VII: Oral and poster communications in national analytical chemistry 
meetings. 
Annex VIII. Oral and poster communications in young investigators meetings. 
Annex IX. Oral communications in medicine meetings. 
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INTRODUCTION 
An overview of the knowledge acquired by the PhD student on analytical concepts 
and tools training is intended to be shown in this introduction by encompassing: (i) the 
basic aspects on metabolomics, on which the research presented in this Thesis-Book has 
been supported. (ii) The sampling, preliminary and sample preparation steps needed 
before both plant and clinical metabolomics analyses. (iii) The analytical platforms solidly 
supported on mass spectrometry (MS) equipment managed by the PhD student, as support 
for targeted and untargeted analyses. (iv) The chemometric approaches used for treatment 
of the multiple data provided by the analytical platforms she developed. Some of the 
existing gaps in plant and clinical metabolomics have been successfully afforded by the PhD 
student helped by the knowledge and training she acquired, as shows the present Thesis-
Book. All the achievements included in it are supported solidly on the previous experience 
and research developed by the group of which she is a part of, and on a continuous and 
appropriate supervision. 
 
1. Metabolomics 
The “omics of small molecules”, as is also named the youngest of the primary omics, 
constitutes, together with those that preceded it —viz., genomics, transcriptomics and 
proteomics—, the solid support of the present systems biology. Information/discussion on 
metabolomics, as the omics on which the research developed by the PhD student, is 
developed below. 
 
1.1. Definitions of the discipline 
A number of definitions of metabolomics have appeared in the literature since it 
was considered as a new omics. The first time the term metabolome appeared in the 
literature was 1998, once Oliver et al. measured the change in the relative concentrations 
of metabolites as a consequence of overexpression or deletion of a gene [1]. Therefore, the 
metabolome refers to the complete set of small compounds (such as metabolic 
intermediates, hormones and other signaling molecules and secondary metabolites) found 
in a living organism, either animal or plant. It represents the ultimate phenotype of cells, 
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deduced from the perturbation of gene expression and the modulation of protein function, 
as well as environmental cues. 
One year later that the term metabolome was defined, the term metabonomics was 
used by Nicholson et al. [2], who defined it as “quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to physiopathological stimuli or 
genetic modifications”. Then, the term metabolomics was first defined by Fiehn in 2001, as 
“an overall and exhaustive analysis by which all the metabolites in a biological system are 
identified and quantified” [3]. So, both terms, "metabolomics" and "metabonomics", were 
generated almost at the same time to describe the same discipline, but in the plant and 
clinical/pharmaceutical fields, respectively [4,5]. Independently of the differences in the 
name of this omics, a question must be posed from the definitions: may metabolomics be 
considered “a quantitative measurement” or “an analysis”, exhaustive or not? A more 
generic and neutral term “discipline” —or even “science”— seems to be more appropriate 
to support the definition of metabolomics. Therefore, the current definition of 
metabolomics as “the discipline that provides comprehensive and systematic information 
on temporal changes in the profiles of metabolite levels in biofluids and tissues, which can 
arise from control by the host genome, extended genomes and effect of other environmental 
or promoted factors” is adjusted better to the present functions of metabolomics. The use 
of metabolomics in both animal and plant fields is practically accepted at present.  
In the meantime, a number of more or less acceptable definitions of metabolomics 
had been proposed. The definition of metabolomics as “the untargeted measurement of the 
metabolome, which is composed of the complement of small molecules detected in a 
biological sample” [6] deletes from it targeted analysis, which is considered erroneously as 
simple multianalysis. This definition involving only untargeted measurements contrasts 
with that established by the Metabolomics Society as “a newly emerging field of omics 
research concerned with the comprehensive characterization of the small molecule 
metabolites in biological systems” [7]. In this case, metabolomics is not identified as 
analysis or measurement but related to characterization of small molecules that provide an 
overview of both the global biochemical processes and metabolic status related to a 
biological or a cellular system. The involvement of “metabolites characterization” (in 
contrast to genome sequencing) makes glimpse the present practical impossibility of 
comprehensive metabolomics owing to: (i) the enormous chemical diversity of a typical 
metabolome, which requires multiple general approaches for extraction, fractionation and 
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analysis to accommodate variation in solubility, reactivity and other physico-chemical 
properties [8]; (ii) the dynamic range of metabolite concentrations, which can also be huge 
requiring efficient separation strategies to avoid that minor components are not completely 
lost among those that are more abundant; (iii) the spatial distribution, which includes 
specific organs, cell types, sub cellular domains, extracellular spaces and occasionally 
extended beyond the organism to compounds excreted into the environment [9]; (iv) the 
temporal distribution, similarly large with variations ranging across an organism’s lifespan, 
seasonal and circadian rhythms and faster chemical movements and oscillations [10]; and 
(v) the unlike proteomics and transcriptional studies, genomic information cannot be used 
as a constraint for the identification of molecular species. 
As a part of the primary omics, metabolomics has also been defined as “an essential 
component of systems biology, and metabolism studies abound in fields ranging from 
agriculture to the study of human diseases” [11] —where metabonomics had been forgotten 
in dealing with clinical metabolomics studies. One of the most recent definitions of 
metabolomics establishes that “metabolomics is mainly based on the quantitative 
measurement of dynamic metabolic changes of living systems in response to genetic 
modifications or physiological stimuli, including nutrients and drugs [12]. By the global 
study of low molecular weight metabolites (<1500 Da) in biofluids (plasma/serum and 
urine) and tissues, metabolomics assures the characterization of an individual metabolic 
phenotype”. 
In short, metabolomics provides information that would conduct to the whole 
metabolome, which is the quantitative complement of low-molecular weight metabolites 
existing in a biological cell, organism or fluid under a set of physiological conditions or 
perturbations (e.g., pathological states, genetic variations or responses to external stimuli) 
[13]. Nevertheless, when the state, variation or response to an external stimulus can be 
monitored by one metabolite or a family of metabolites, it is also a metabolomics study: a 
targeted metabolomics study. 
 
1.2. Relationship of metabolomics with other great omics 
Omics studies involve measurement of large numbers of parameters —typically 
genes (genomics), mRNA (transcriptomics), proteins (proteomics), or metabolites 
(metabolomics)— in dealing with individual primary omics. 
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Overall and wide information on the dynamics and structure or functions of the 
cells and organisms to understand biology at the system level is obtained by the joint 
application of two or more omics. The combination of the data from the different omics 
constitutes systems biology, which allows a better comprehension of the functioning of a 
biological system. Presently, systems biology is better known as integrative omics [14]. 
The fundamental differences between the traditional central dogma of molecular 
biology, and systems biology (integrative omics) result from the flow of biological 
information they provide, as visualized in the comparison of Fig. 1 with Fig. 2. In the former 
the flow of information is unidirectional —from genes of a cell or organism (viz., DNA) to 
their transcription at mRNA and their translation to proteins, ending with the catalysis of 
metabolic reactions and being finally revealed in the phenotype.  
 
 
Fig. 1. Traditional central dogma of molecular biology. 
 
 
Fig. 2. General scheme of systems biology (omics integration). 
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On the contrary, omics integration allows no only the flow of biological information 
to go from genes to transcripts to proteins to metabolites, but more importantly, this flow 
can also establish bottom-up positive and negative feedback control. Thus, information on 
proteins, transcripts and/or genes by feedback loops (Fig. 2) can be obtained, either overall 
information or up-stream information from an omics located lower in the flow of the 
traditional central dogma of molecular biology. 
 
1.3. Metabolomics subdisciplines 
The vast field of metabolomics makes mandatory division into concrete areas with 
limited content. Among them, distinction must be made among primary metabolomics 
subdisciplines (e.g., lipidomics, nutrimetabolomics or nutritional metabolomics, 
xenometabolomics), and other minor subdisciplines such as pharmacometabolomics, 
environmental metabolomics, cardiometabolomics, secretomics, cosmetobolomics, 
microbial metabolomics and many others that have emerged and will continue emerging 
as a result of the importance acquired by application of metabolomics in new sectors. 
Among primary metabolomics subdisciplines, lipidomics is the most relevant, even 
considered by some authors as a discipline independent of metabolomics (despite it is 
constituted by metabolites). Lipidomics, as other metabolomics subdisciplines, can be 
defined by a simple criterion as “discipline for complete characterization of all lipids in a 
particular type of cell”, or by a wider and more complex criterion as “discipline to obtain 
overall information on all lipids in a biological system with respect to cellular signaling, 
membrane architecture, transcriptional and translational modulation, cell–cell and cell–
protein interactions, and response to environmental changes with time”, both definitions 
excluding targeted lipidomics, despite this strategy is each time more accepted by 
metabolomics researchers. 
Other classification of metabolomics subdisciplines is based on the covered scope, 
which allows division into animal metabolomics (including clinical metabolomics) and 
plant metabolomics. These two areas have been subjects of the research developed by the 
PhD student, the results of which constitutes the main part of this PhD-Book. 
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1.4. Metabolomics strategies 
Metabolomics analysis encompasses different strategies the nature of which 
depends on the objective of the study and previous knowledge of the biological problem 
[15]. The two more common and more widely used strategies in metabolomics are 
untargeted and targeted analyses. 
1.4.1. Untargeted analysis. This is the metabolomics strategy par excellence as it affords 
primarily the qualitative or semiquantitative analysis of the largest possible number of 
metabolites from a diversity of chemical and biological classes contained in a biological 
specimen [16]. Detection of this wide range of metabolites can be done through a single 
analytical platform or a combination of complementary platforms, mainly based on nuclear 
magnetic resonance (NMR) or mass spectrometry (MS), coupled to gas chromatography 
(GC), liquid chromatography (LC) or, less commonly, capillary electrophoresis (CE). In 
these studies, the relative concentrations of the analyzed metabolites are generally 
calculated and their variations between two or more system situations are studied. In 
untargeted approaches, the sample preparation step keeps as simple as possible to obtain 
the widest metabolite coverage. No selective sample pretreatments such as protein 
precipitation for plasma/serum or simple dilution for urine samples (referred to as dilute-
and-shoot) are generally used [17,18]. Besides, the data set obtained by applying these 
strategies is very extensive, so it requires treatments with advanced chemometric 
approaches for conversion into manageable signals and, finally, interpretable results. The 
signals require annotation using either available experimental libraries, structural 
elucidation by in silico fragmentation tools or experimental identification. Thus, this 
strategy allows identification of new metabolites that are involved in metabolic pathways 
and, therefore, the knowledge of them. Untargeted analysis was the most used strategy for 
the research developed and collected in this Thesis-Book. It was selected to obtain as much 
information as possible from the compounds present in plant extracts (Chapters V and VI), 
and in a clinical sample such as sweat with an almost unknown composition (Chapters VIII-
to-X). 
1.4.2. Targeted analysis. This strategy is either a quantitative approach in which 
concentrations are determined or a semiquantitative approach in which relative signals are 
recorded, always referred to few metabolites and/or substrates of metabolic reactions that 
might be associated to common chemical classes or linked to selected metabolic pathways 
[19]. The fact that the number of metabolites involved in this strategy is limited and their 
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nature known, led to researchers to consider studies developed using targeted analysis as 
not pertaining to metabolomics. Nevertheless, this strategy is always applied after 
untargeted analysis that allows knowing the metabolites through which the changes in a 
given organism or in a biological process can be studied. The previous knowledge of the 
metabolites involved in the given process allows selection of the most appropriate 
analytical technique and a selective sample preparation depending on the nature and 
abundance of the target metabolites, enabling a sufficient sample cleanup and 
preconcentration, if required. A mass spectrometer is the detector of choice —particularly 
the triple quadrupole (QqQ) approach— in targeted metabolomics because of its sensitivity. 
These strategy and instrument were selected to develop the studies in Chapters IV and VII 
for the determination of oleuropeine and amino acids, respectively. 
Other strategies less used are as follows: 
1.4.3. Metabolomics fingerprinting. This strategy was defined by Fiehn as a high 
throughput, a fast methodology for analysis of biological samples that provides fingerprints 
for sample classification and screening [20]. Fingerprinting is not focused on particular 
metabolite(s); therefore, it allows the discovery of novel metabolic pathways disturbed by 
the disease or preset stimulus. This approach is frequently used prior to a more 
comprehensive strategy (metabolomics profiling) to find discrimination patterns among 
groups of samples. 
1.4.4. Metabolomics footprinting. This was the term proposed in 2005 by Kell et al. to refer 
to the study of metabolites in extracellular fluids, also known as exometabolome or 
secretome [21]. The purpose of this strategy is mainly to obtain information for 
classification of groups of samples or for screening. 
Both finger- and footprinting strategies are commonly used in cell culture studies 
and their join application in this field is of clear interest as they are highly complementary 
when used in combination.  
The detection techniques involved in finger- and footpringing also depend on the 
chosen strategy. For example, to obtain a metabolomic fingerprint the detection technique 
should allow direct and rapid analysis of the sample. NMR, MS (depending on the 
complexity of the sample) and, to a lesser extent, infrared and Raman spectroscopies are 
mainly used in this context. A separation technique is generally applied in both targeted 
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and untargeted analysis prior to individual detection of the metabolites for their 
quantitation or identification, being GC or LC the most used in this area. 
In dealing with metabolomics coverage, it is always a compromise between quality 
of data and throughput of analysis. Thus, while global metabolic profiling and metabolic 
fingerprinting are tools for large metabolite coverage, the quality of the data is lower than 
in targeted profiling, where the method developed is exclusively optimized for one 
metabolite or few metabolites [22]. However, a large volume of data is required for high 
coverage, which is clearly opposed to high-throughput analysis. 
 
1.5. Current status of metabolomics and some of its pending aspects  
A reflection on the present and future perspectives of metabolomics is convenient 
to be expressed as a final subsection of this section devoted to the youngest of the primary 
omics. 
Of the few thousand metabolites we can currently assign either unambiguously or 
with a high level of confidence, the precise in vivo function of many of them is unknown, 
and even their spatial abundance is not always clearly understood. Nevertheless, it must be 
pointed out that the combination of standard metabolomics approaches with studies of 
wide natural variance and the use of either genome-editing techniques or combinatorial 
transformation potentially offer powerful tools by which the function of an individual 
metabolite can be assigned. 
An aspect that was inconceivable a decade ago is that metabolomics has become an 
essential tool in the elucidation of functional annotation of genes associated with 
metabolism. For this purpose, three major approaches have been used: (i) direct testing of 
candidate genes via the analysis of knock-out mutants; (ii) quantitative trait loci mapping 
of the genes determining the abundance of specific metabolites; and more recently (iii) 
genome-wide association studies of metabolite abundance. 
In addition to the research that details how metabolomics has been used to define 
the way in which the general metabolic landscape changes in response to genetic or 
environmental perturbation [23], an approach to understand metabolite function has 
recently emerged probing metabolite–protein interactions [24,25]. It is commonly 
 Introduction 
 
Page | 27  
performed by the co-elution of metabolites and proteins following the separation of the 
proteins. 
A couple of emergent strategies warrant also a mention here: the use of isotope 
labeling and the development of metabolite imaging techniques. The first approach has 
already been demonstrated to be a powerful way of improving the annotation of plant 
metabolites [26], as well as providing powerful information concerning both the 
elucidation of pathway structures [27] and gene function annotations [28]. Metabolite 
imaging techniques meanwhile provide high or even ultrahigh spatial resolution of 
metabolite abundances [29]; however, to date their coverage is currently relatively limited. 
A vital question is why has the specific function of most plant metabolites not yet 
been characterized? One problem is that their biological properties are largely described 
for a class of compounds rather than for individual metabolites. Furthermore, the 
promiscuity of many enzymes of specialized metabolism (which produce the majority of 
plant metabolites), alongside the general intricacy of most metabolic networks, renders it 
difficult to modify the content of a single metabolite without affecting the others. These 
features of metabolism hence make very difficult to directly assess metabolite function via 
conventional reverse-genetics strategies. For this purpose, more sophisticated approaches, 
in which the kinetic properties of the respective enzymes experience alteration, are likely 
to be required. 
Some of the key questions in metabolomics are as follows: (i) how best do we 
further advance the coverage of the metabolome? (ii) Despite a growing appreciation of the 
importance of interactions between metabolites and other molecular entities, by contrast 
to other systems, very few metabolite receptors have been reported in plants yet. (iii) What 
is the best strategy to dissect the function of individual metabolites? 
 
2. Basic differences between plant and animal metabolomics 
 
2.1. Primary and secondary metabolites 
Before starting with the differences between the metabolomics of the two 
kingdoms, attention must be paid to the difference between primary and secondary 
metabolites, the compilation of which constitutes the metabolome: the final recipient of 
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genetic information. Whereas genes and proteins are mostly involved in unfolding 
information needed for actualization of cellular functional processes, metabolite patterns 
reveal the actual dynamic cellular environment. In general, metabolites are intermediate 
or final products from metabolism, divided into primary and secondary metabolites, which 
constitute the products of molecular pathways disturbed by other omics; therefore, the 
metabolome defines the individual phenotype, by contrast with the transcriptome or the 
proteome. Primary or essential metabolites (e.g., carbohydrates, vitamins, amino acids, 
nucleosides, organic acids) sustain the organism life via normal metabolic processes such 
as respiration or photosynthesis, and are involved directly in the normal growth, 
development and reproduction of the given organism. Secondary or no essential 
metabolites (e.g., phenols, alkaloids, steroids, toxins) are no directly involved in growth, 
development and reproduction, but they have key ecological functions (e.g., to defend 
against predators, parasites or diseases, competition between species or to facilitate the 
processes of reproduction by colors and/or smells). The interaction of both types of 
metabolites (both in animals and plants) is probably one of the most active regulatory 
circuits for balancing environmental pressures on the given system, either biotic or abiotic.  
 
2.2. Definition of plant and animal (or clinical) metabolomics 
Plant metabolomics is the science or discipline devoted to the study of the changes 
produced in a given plant population when subjected to a change caused by evolution, 
stress, genetic modification, etc. This discipline provides information on nutrients and 
vitamins, and genetic engineering of plants to produce more nutrients and vitamins in the 
edible portions of the plant is a key area of plant metabolomics research [30]. In fact, the 
information learned from metabolomics studies in plants has the potential for great impact 
in improving plant response to stress, agricultural efficiency, and food quality. 
Many of the secondary metabolites are also referred to as plant natural products 
and have historically been a key source of lead molecules in drug discovery due to their 
action on many pharmacological targets [31]. Depending on the variety of cultivars 
(different accession), metabolites from the same plant can differ considerably, even if they 
are grown under the same conditions. Their phenotypic plasticity enables plants to 
withstand environmental dynamism, within both short and long time scales, and is 
governed by genes that not only determine the character of an organism, but also the degree 
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of responsiveness of that character to environmental stimuli [32]. Phenotypic plasticity is 
measured by the plant ability to change its growth pattern (morphological traits) and 
function (metabolic traits) as response to changes of environmental pressures through to 
activation or up-regulation of highly specialized metabolic pathways [33]. 
Animal metabolomics is the discipline that studies the metabolic reaction to 
medication, environment and/or diseases. Clinical metabolomics is aimed at evaluating the 
health status of an individual as well as the risk of disease by any of the different metabolic 
analysis of biofluids or tissues, which are influenced by their genetic, epigenetic, 
environmental exposures, diet and behavior. 
The metabolome of an animal organism changes in response to stimuli and 
environmental conditions. This does not happen with its genome or its transcriptome, 
which only change when a genetic mutation occurs, being practically constant throughout 
its life. Diseases affect metabolism and, as a result, produce changes of sufficient duration 
to be detected by measurements of the metabolites [34]. Examples of this ability include 
schizophrenia, depression, Alzheimer's, cardiovascular disease, hypertension, type 2 
diabetes, cancer or Huntington's disease [35]. These diseases are characterized by changes 
(decrease–increase) in the concentration of dozens of metabolites with respect to 
homeostasis. The analysis of the metabolite profile can provide information of these 
pathologies, very useful to combat them. 
 
2.3. Intrinsic differences between animal and plant metabolomics 
Intrinsic, key metabolomics differences between the plant and animal kingdoms 
must be clearly discussed as they establish the characteristics of the steps involved in the 
analytical process used to obtain the required information from the given system. The key 
differences between them are as follows: 
2.3.1. Sessility/motility. The primary and biggest difference between animals and plants is 
the motility of most of the former and sessility of plants, which clearly influence their 
metabolism. Because plants are sessile organisms, they cannot escape from changing 
environmental conditions and/or plant–attacker interactions that adversely affect their 
growth and development (Fig. 3). Therefore, plant survival mostly depends on the initiation 
of complex adaptive responses that involve stress sensing, signal transduction and the 
activation of a number of stress-related genes and metabolites [36]. Central metabolism is 
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involved in the regulation of the various developmental processes that allow plants to 
survive such environmental threats, and the measurement of known primary metabolites 
(e.g., carbohydrates, amino and organic acids) has largely contributed to elucidate how and 
to what extent plant metabolism readjusts to a changing environment [37]. On the other 
hand, the measurement of specific secondary metabolites such as phytohormones (e.g., 
auxins, cytokinins, gibberellins, jasmonates, abscisic and salicylic acids), which are key 
metabolites of signaling and communication between an organism and the abiotic/biotic 
environment, has contributed to improve our current understanding of the plant growth–
defense system [38] (Fig. 3). 
 
 
Fig. 3. Abiotic factors (unfavorable environmental factors) or biotic factors (attack of pathogens, 
parasites, herbivores, etc.) that promote secondary metabolites by plant stress. 
 
Plants, in natural and cultivated ecosystems, are exposed to environmental 
stresses, biotic and abiotic stresses, along the processes involved in their development. 
Resistance to the latter can be qualitative or quantitative [39]. Qualitative resistance, 
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because of monogenic inheritance, has been successfully transferred to elite cultivars to 
improve resistance; whereas quantitative resistance is generally considered to be durable, 
no race-specific, and effective against multiple pathogens. Abiotic stresses result from 
inappropriate levels of environmental factors, such as drought, flood, extreme temperature, 
severe radiation, metal ion stress, nutrient limitation, and oxidative stress, while biotic 
stresses come from pathogens and pests.  
Advances in plant metabolomics can be applied to improve plant resistance to 
abiotic and biotic stresses, as once plant receptors are stimulated by stress signals, 
expression of stress responsive genes is activated and subsequently specialized metabolites 
(mainly some secondary metabolites) are biosynthesized to adapt to environmental 
stresses [40]. 
2.3.2. Metabolites production. A basic difference in the metabolites production in the plant 
and animal kingdoms is that in the former, metabolites are produced by their cellular 
biochemical machinery from carbon dioxide and inorganic nutrients, while in animals 
metabolites are produced from organic and inorganic nutrients in a set of complex 
processes involving glycolysis, oxidative decarboxylation, citric acid cycle or oxidative 
phosphorylation. 
2.3.3. Number of metabolites. Another big difference is the number of metabolites that 
exists in each kingdom —higher in plants—, which is a consequence of their very varied 
functions as a consequence of the defense necessities of the plants. The plant kingdom is 
routinely stated to contain between 100 000 and 1 million metabolites [41], with any given 
species thought to contain upwards of 5000 metabolites [42]. Although the core central 
metabolism of most plant species is largely comparable with that of no plant species, plants 
and fungi contain a vast wealth of specialized compounds that account for the vast majority 
of the diversity within their metabolomes. These specialized, secondary metabolites 
collectively act as an effective arsenal against the myriad of biotic and abiotic stresses to 
which they, as sessile organisms, may potentially be exposed during their lifespan. 
Measuring such a vast number of entities is right difficult; however, the problem is 
exacerbated by the fact that metabolites have highly diverse chemistry [43], a massive 
dynamic range [42], and are often compartmented at both the cellular and subcellular level 
[44]. 
On the contrary, once the first draft of the human metabolome —which can be 
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considered to be representative of the animal kingdom— has been completed, 
approximately 2500 metabolites have been cataloged, and 1200 drugs and 3500 food 
components have also been found in the human body [45]. In fact, it is difficult today to 
fully estimate the exact number of metabolites in our metabolome considering, for 
example, the vastly unknown metabolites arising from mammalian gut microflora 
metabolic cross-talks and so on. Presently, the coverage of the human metabolome is not 
well known, and similarly happens with plant metabolites, as only a few thousands of them 
have been measured, whereas between 100 000 and 1 million are estimated to be extant 
within the plant kingdom (Fig. 4). Even more, of the few thousand metabolites currently 
assigned either unambiguously or with a high level of confidence, the precise in vivo 
function of many is unknown, and even their spatial abundance is not always clearly 
understood [23]. 
 
Fig. 4. (A) Estimated number of metabolites in humans and plants. (B) Estimated number of 
metabolites measured so far. 
 
2.4. Other differences between plant and animal metabolomics 
Other differences between the two kingdoms that strongly affect the design and 
development of experiments to obtain information about them are the time, ethical 
considerations and price for development of the given population to be studied, the 
sampling and size of the sample, the necessity or no for quenching and for other 
preliminary steps, and sample preparation. After the analytical sample is obtained, the 
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other steps involved in the analytical process are common in dealing with the obtainment 
of analytical information, which, logically, require to be interpreted from the appropriate 
point of view or final aim of the study. All them are exposed and discussed in the next 
section. 
 
3. The analytical process as a function of plant or animal metabolomics 
approaches 
Metabolomic analysis consists of four experimental parts (Fig. 5), among which the 
two first clearly differ and depend on the kingdom to which the system on study belongs. 
Overally, preliminary operations, which include sampling and sample pretreatment, is the 
part with the highest differences between kingdoms, whereas sample preparation can be 
quite similar, most times, but dependent on the metabolomics strategy. Once the analytical 
sample (a liquid, but less commonly it can be a gas) is obtained, it is ready for being inserted 
into either the detector or high-resolution equipment for individual separation of the 
analytes, if required. In the latter case, the analytes are then sent to the on-line connected 
detector, which provides abundant data to be mined by the chemometric approaches that 
allow obtainment of the results to give appropriate response to the raised question. 
 
 
Fig. 5. Scheme of the steps involved in the analytical process. 
 
3.1. Sampling and sample pretreatment as a function of plant or animal 
metabolomics approaches 
The steps that precede sample preparation as such are those that mediate between 
the system under study and the sample ready for being subjected to sample preparation, 
which finally will produce the analytical sample. These previous or preliminary steps are 
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very different depending on the vegetal or animal nature of the system under study; 
therefore, they are considered separately. 
3.1.1. Presampling in plant metabolomic studies. A good experimental design in plant 
metabolomics heavily depends on the type of system to be studied, which commonly 
consists of greenhouses, growth chambers, or experimental fields.  
(a) In the case of a greenhouse or a growth chamber, the starting point of the experiment, 
must include, (i) the selection of appropriate growth conditions (e.g., photoperiod, relative 
humidity, temperature); (ii) a suitable number of biological replicates and controls; and 
(iii) the use of randomization practices throughout the entire experimental workflow 
[46,47]. It is also advisable to monitor environmental variations during the progress of the 
experiment, such as small differences in temperature or light intensity that might occur in 
the greenhouse or growth chamber; minor variations can greatly affect the biochemical 
status of the plant [48]. 
(b) In an experimental field the design involves, (i) selection of the part of the plant to be 
sampled, which most times is fruit from a given variety or from a number of selected 
varieties; (ii) the time for sampling (either a fixed time during maturation or growth and 
maturation evolution [49]); (iii) the sampling design that depends on the characteristics of 
the experimental field (e.g., a sampling methodology based on random rectangular 
coordinates [50]); (iv) the number of samples per coordinate point. A study on an 
experimental field requires repetition for several years to eliminate the characteristics of a 
given year (anomalous values of pluviometry, drought, cold period, etc.). 
3.1.2. Presampling step in animal metabolomic studies. Equivalent to plants presampling, 
in animal or in human studies this step consists of cohort selection, which can be composed 
only by people suffering a given health problem or by patients and healthy people 
(controls). Depending on the level of the planned study (preliminary or validation study) 
the number of participants can vary from 10–20 to several thousands. Also the number of 
samples per individual is a function of the longitudinal or transversal nature of the study. 
Ethical issues must be rigorously completed and the ethical committee of the involved 
hospital must accept the study. 
3.1.3. Sampling, quenching and molturation in plant metabolomic studies. There are 
several aspects to take into account regarding to the moment in which plants are sampled. 
The time of the day selected is very important, since the levels of plant metabolites (both 
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primary and secondary metabolites) vary throughout the day [51]. Strict control of the 
presampling conditions (both cultivation conditions and sampling regime —time of day, 
location on the plant, time from sampling to metabolic quenching, etc.) is essential for 
sample uniformity. Another point to consider is the part of the plant used, since the 
metabolite content varies throughout the plant. All organs should be separated when 
possible. Not only does the content vary from organ to organ, but even within the same 
organ different metabolites might be found. For example, there are large differences 
between young and old leaves, but even there is a difference between the veins and the rest 
of a leaf [52]. Sampling of plant materials requires special care because rapid metabolite 
changes, such as those due to enzymatic degradation or oxidation, could occur during the 
process and may affect the results drastically. For this reason, sampling (i.e., separation of 
the required material from the original plant) should be conducted very rapidly.  
Quenching consists of fast inactivation of enzymatic reactions in the sampled 
material, of particular importance to avoid fluctuations in the levels of fast turnover 
metabolites (e.g., glycolytic intermediates) [53]. Inactivation of the metabolism should be 
faster than metabolic changes occurring in the sample. The effectiveness of the quenching 
process is crucial, since the turnover rates of many primary metabolites are usually in the 
range of 1 mM/s —(taking into account that concentration of metabolites varies from a few 
molecules per cell, as in the case of certain signaling molecules, to mM concentrations for 
some primary metabolites (e.g., glucose)— [54]. 
The common strategies for quenching are based on rapid modification of sample 
conditions, usually pH or temperature. In modifying pH, quenching is achieved by instantly 
changing to extreme pH, either to high alkali (e.g., by adding KOH or NaOH) or to high 
acid pH (e.g., by adding perchloric, hydrochloric or trichloroacetic acid) [55]. In modifying 
temperature, quenching is mainly carried out by cooling at values usually lower than –20 
ºC, assuming that sample integrity is not endangered by the cold shock [56]. The most 
popular method is cold methanol quenching, which allows a rapid interruption of the 
metabolism in the sub-second time scale [57] and can be implemented in protocols 
destined to discriminate between intracellular and extracellular metabolites [57]. Freezing 
is the most used way of quenching as it helps to stabilize labile metabolites, but tissue 
excision and freezing need to be accomplished quickly to avoid induction of wounding 
responses. Rapid freeze methods include immersion into liquid nitrogen, liquid nitrogen–
cooled isopentane and freeze clamping. As freezing generally preserves protein structure, 
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care needs to be taken to avoid warming that may allow some enzyme activity to perturb 
metabolite pool composition. Freeze-drying (also known as lyophilization) can help to 
stabilize frozen samples, but may also cause a loss of some metabolites through irreversible 
binding to cell walls or membranes, and also result in the loss of volatile metabolites; 
nevertheless, lyophilization positively protects against enzyme activities and microbial 
decomposition during storage [58]. Care must be taken with lyophilized samples as they 
can still reabsorb atmospheric water and regain some enzyme activity. The influence of 
quenching (viz., lyophilization or dried under heated air) or the absence of this step (fresh 
sample) on citrus has been in-depth studied by the group in which the PhD student is 
integrated [59]. Metabolism has rarely been interrupted by a heating shock with a fast 
increase of temperature. One example can be the addition of ethanol at 90 ºC [54]. 
However, this method seems not to be a competitive option owing to potential degradation 
of thermolabile metabolites and increased cell permeability [60]. Apart from batch 
protocols, a variety of approaches for automated quenching have been reported [61,62]. 
These are based on on-line coupling of a fast sampling device to a bioreactor, where the 
metabolism is stopped. 
After quenching, plant tissues should be finely homogenized to obtain a 
homogeneous powder. This step is critical for plant tissues, in which cells are surrounded 
by a thick wall that must be breached before metabolite extraction. The most common 
procedures for plant-cell-wall breakage and homogenization use a mortar and pestle, ball 
mill, vibration mill, Ultra Turrax, ultrasonic probe or thermomixer. When possible, this 
step is performed under liquid nitrogen to prevent tissue defrosting. Finally, the powder 
must be divided into portions (samples) and stored at low temperatures until analysis. 
Plant growth metadata documentation and storage in databases is crucial, not only 
for the ongoing experiment but also for the data reanalysis and the possibility to perform 
data meta-analyses combining several experiments [63]. Storage conditions have to be 
controlled, as stability during sample storage is a key factor that is rarely taken into account. 
3.1.4. The overall sampled material, pretreatment and sampling in animal metabolomics 
studies. We restrict here the animal field to the clinical human field as it has received —and 
is receiving— the highest interest and research resources, and also because this has been 
the animal field to which part of the research in this PhD-Book has been focused. 
3.1.5. Types of biofluids and tissues in clinical metabolomics studies. Among clinical 
biofluids, blood —plasma or serum depending on allowing or blocking coagulation, 
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respectively— is the most commonly used in metabolomics studies, fact justified because 
its minimally invasive sampling, homogeneity as compared to urine, sweat, saliva, etc.; all 
them strongly influenced by the collected volume. Urine is also a common biofluid in 
metabolomic studies, while other less common biofluids used in this field are saliva, tears, 
exhaled breath condensate —see “recent contributions from the group”, in section 4 of this 
introduction—, and sweat, widely investigated by the PhD student (see Chapters VII-to-
XI). A key difference among them is the necessity for specialized personnel to obtain blood, 
and the only necessary consent by the donor in the case of the other biofluids. 
Whereas serum or plasma require containers with special characteristics, and to 
specify the time of the day when it is collected, urine is collected usually in bare 
polypropylene containers of the required volume, but the time of urine sampling must be 
planned depending of the target study: random samples, timed samples, 24-h samples, and 
even longer times for urine collection in dealing with pharmacokinetics studies [64].  
Tissues are less common samples because their invasive character; therefore, they 
are most times restricted to surgical interventions. 
Independent of the nature of the target biospecimen, the overall portion removed 
is subjected to some type of pretreatment: division into the appropriate containers to obtain 
plasma or serum in the case of blood; buffering, dilution or evaporation, centrifugation 
and/or deproteination in any biological fluid, before being divided into bare or special 
containers or vials. This last step could be considered properly as sampling. Then, the 
samples are, in general, subjected to low temperatures (usually –80 ºC) to quenching 
enzymatic processes, especially important in saliva, and to store them until use. 
3.1.6. Cell-sampling. Special mention deserves cell-sampling approaches that allow 
metabolites profiling, a promising field still in its infancy. Recent technological 
advancements —especially those made just in the past four years— have revealed that 
individual cells within the same population may differ dramatically, and these differences 
can have important consequences for health and disease. The rapid, dynamic responses a 
living cell has to its environment are better reflected in the metabolic transformations —
and the resulting patterns of small molecules— that keep the cell powered, cycling and 
communicating with others [65]. 
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3.2. Sample preparation 
This step, after which the sample is converted into the analytical sample —that is 
ready for being introduced into the analytical platform—, strongly depends on two key 
aspects: the type of sample and its physical state, and the metabolomics strategy that 
follows sample preparation. The procedure for sample preparation requires to be optimized 
by one of the chemometric approaches discussed in Section 3.6. 
Overall separation of the target metabolites from the matrix consists of an 
extraction step, the selection of which depends on the aim of the study: extractants and 
extraction technique must be carefully chosen to obtain the expected results. In dealing 
with solid samples, the solid–liquid extraction step (properly known as leaching or 
lixiviation) can consist of maceration, Soxhlet extraction, ultrasound-assisted extraction 
(USAE), microwave assisted extraction (MAE), supercritical fluid extraction (SFE) or 
superheated liquid extraction (SHLE), as the most used. Metabolites from liquids are 
mainly removed from the sample by liquid–liquid extraction (LLE), solid-phase extraction 
(SPE) or solid-phase microextraction (SPME). Volatile compounds are easily separated 
from the sample (either solid or liquid) by heating, mainly using a head-space (HS) device.  
Ideally, the extraction step aims at: (i) releasing given metabolites from the sample 
in an efficient manner; (ii) avoiding the presence of interferents that could difficult the 
analysis; (iii) making the extract compatible with the analytical equipment; and, (iv) 
concentrating trace metabolites before analysis, if necessary [66]. An example of the key 
influence of the characteristics of the extractant on the nature of the extracted metabolites 
is given in Chapter V of this PhD-Book, in dealing with aqueous enzymatic extracts of 
Agaricus bisporus. 
3.2.1. Sample preparation in plant metabolomics. Because most of the plant samples are 
solid, the most common procedure for removal of the metabolites from the sample matrix 
is solid–liquid extraction in any of its types. In the case of volatile metabolites such as 
essential oils, separation from the sample matrix is most times carried out by cold press, 
steam distillation or hydrodistillation, but also by HS or pervaporation. In dealing with 
juices, the sample is only subjected to centrifugation and/or filtration to give place to the 
analytical sample. 
Maceration or Soxhlet extraction have for many years been used to extract 
bioactive compounds from plant materials as a model for comparison and validation of 
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methods based on the use of auxiliary energies. These conventional approaches involve 
typical shortcomings (e.g., long development times, large amounts of extractants and 
potential and never checked degradation in the case of Soxhlet). USAE has been applied to 
obtain metabolites from plants using either an ultrasonic cleaning bath or a probe (each 
with its advantages and shortcomings [67]), always with drastic shortening of the 
extraction time from hours to minutes. Wide information on the functioning of ultrasonic 
devices and their positive and negative aspects can be found in Chapters I-to-III. 
Also MAE provides high yields in a short time as compared to traditional methods. 
Microwaves penetrate the sample and heat instantaneously individual polar components 
in the matrix, thus achieving extractions much faster than traditional heating methods that 
depend on the thermal conductivity of the sample [68]. However, microwaves irradiation 
can accelerate chemical reactions and degradation of thermolabile metabolites and also 
modify the chemical structures of some compounds like carotenoids [67]. A wider 
information on this subject can be found in a book chapter by the PhD student, included in 
the Book as Annex II. 
SFE, carried out most times by CO2 as extractant, was used to remove no polar 
compounds as essential oils from citrus [69]. In dealing with polar compounds, SFE 
requires the presence of a polar co-solvent such as ethanol, which complicates the step by 
increasing both costs and handling. Gases such as ethane have also been used as extractants 
in SFE of essential oils [70]. The cost of high purity CO2 makes its use prohibited for 
extraction of low price compounds, for which cold pressure extraction is preferred at large 
scale production. Nevertheless, the high selectivity of supercritical CO2 for extraction of 
terpenes has led to its use for deterpenation of essential oils [71] previously obtained by 
cold pressure extraction [72], because of the high commercial value of refined essential oils. 
SHLE involves heating of the extractant above its normal boiling point and keeping 
it in the liquid state by applying the necessary overpressure. Under these working 
conditions the extractants increase their ability to remove analytes and improve their 
diffusivity in the sample [73]. The most important factors in dealing with SHLE are 
temperature, type of extractant and extraction time. SHLE, used to obtain essential oils 
from different plants [74] and citrus bioactive compounds such as flavonoids [75], offers 
several advantages over other extraction techniques, namely: possibility of automation, low 
extractant volumes and decreased extraction time. Implementation of SHLE can be 
accomplished in the batch mode, in which the sample and extractant are kept into contact 
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for a preset time at constant temperature and pressure, or in the continuous mode in which 
the extractant flows through the sample in a continuous manner [76]. The main 
shortcoming of SHLE in any of its approaches is the working temperature, usually high, 
that can degrade thermolabile compounds. 
In general, degradation of metabolites by auxiliary energies has been understudied, 
as the research in this aspect has been mainly focused on the effect on a single metabolite 
or group of metabolites, as is the case with phenols [77]. The scant studies on this aspect 
have monitored degradation by decrease of the signal provided by the precursors. Based on 
the decrease the authors concluded that properties such as antioxidant activity and 
antiradical scavenging, among others, are deteriorated. In-depth studies on degradation 
products could show that not all degradation reactions are undesirable; in some cases these 
reactions yield compounds with better properties than their precursors. An example that 
supports this assertion is the decrease of glycosidic-conjugated flavonoids and increase of 
the corresponding aglycons in extracts from Citrus reticulata pomaces obtained by MAE 
[68], and extracts from Citrus unshiu pomaces treated with electron-beam irradiation, in 
which the antioxidant power increases from conjugated to free flavonoids [78]. Full 
understanding of the effect of auxiliary energies on metabolites treatment (either extraction 
or conservation) requires a simultaneous study of all factors involved in the step and their 
responses. The results from degradation studies should be based on a global profile of the 
components resulting from the given step and not only on a specific metabolite or response. 
3.2.2. Sample preparation in clinical metabolomics studies. Clinical metabolomics 
involves mainly liquid samples (serum or plasma, urine, saliva, tears, sweat, exhaled breath 
condensate, etc.), but there are also protocols for sample preparation from solids such as 
organ tissues (e.g., brain, liver and tumor tissues), feces or whole organisms (e.g., 
earthworms). The sample matrix (viz., the whole sample except the target analytes) takes 
extreme importance in metabolomics analysis because it influences the choice of sample 
preparation owing to its potential interference in the extraction and/or detection of the 
target compounds [79]. Regardless of the sample matrix, the different behavior of the target 
compounds and matrix components ultimately determine the choice of sample 
preparation. 
Depending on the metabolomics analytical strategy, sample preparation can be a 
very simple step or not. Some examples of sample preparation steps illustrate this 
assertion: (i) the analytical sample for urine analysis can be obtained by simple dilution, by 
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centrifugation or by filtration for cell removal. Bacterial growth inhibition or urease 
treatment (urea removal) can also provide the analytical sample from urine [80]. (ii) 
Plasma samples can need only anticoagulant selection and protein removal for being an 
analytical sample; but for targeted analysis, more commonly they require an SPE step that 
can be developed on-line with the high-resolution separation and detection steps [81], 
without real handling of the analytical sample. (iii) Serum samples can also need only 
protein removal, but commonly an SPE is mandatory. Also in this case, the on-line 
connection of this step (that can involve overall separation and concentration of the target 
metabolites) avoids sample handling and reduces drastically the sample volume [82]; 
aspect of great importance in clinical samples, mainly in cases of neonates, elderly people 
or patients in critical state. (iv) cerebrospinal fluid samples can need only protein removal 
for being an analytical sample, but frequently they require an SPE step. (v) Tissue samples 
must usually be subjected to complex sample pretreatment consisting of rinsing to remove 
blood, quenching, and homogenization, before being subjected to sample preparation, 
generally an SPE step, which can be followed by evaporation of the eluent and by 
reconstitution. Evaporation of the extractant or the eluent and reconstitution can also be 
mandatory for sample preparation in dealing with plasma or serum in the case of very 
diluted metabolites and/or necessity of change of the medium before entering in the 
detector or high-resolution separation equipment. 
The presence of standards (either conventional or isotopically labelled standards) 
is highly demanded to ensure reproducible and accurate results. The time for their addition 
closely depends on the different steps in which the sample is involved and selection of the 
proper moment is a matter of discussion, most times.  
 
3.3. Detection in the analytical process of metabolomics studies 
Once the analytical sample (e.g., an extract, an eluate, a reconstituted solution after 
evaporation of the solvent, a volatiles mixture) is obtained, the complexity of the next step 
depends on the required information to be mined from the prepared sample, which in turn 
establishes the analytical approach to be used. The metabolites to be determined in the 
analytical sample can be amino acids, lipids, etc., and they can come originally from a plant 
or animal sample. Therefore, despite the importance of the preliminary and sample 
preparation steps, detection is —with or without prior high-resolution separation— the step 
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that provides the analytical information to be then treated as required. The final aim of the 
study establishes the necessity or not of high-resolution separation and the type of detector, 
which can provide single or multi-information.  
There is a variety of analytical strategies to be used in metabolomics that not all are 
complex; therefore, the analyst must know what is the most appropriate in each situation 
and use each as required. From the simplest (unselective analysis) to the most complex 
(complete identification–quantitation) the necessary analytical platforms (and subsequent 
chemometric approaches, the subject of the next section) and applications are discussed 
below. 
Unselective analysis of an analytical sample refers to the total content of 
components capable of being related through a common characteristic. The simplest are 
total indexes (e.g., measurement of the absorbance of phenols contained in a vegetal extract 
at 280 nm or that of anthocyanins at 520 nm). A method that is not based on measurement 
of an intrinsic property of the target compounds is the Folin–Ciocalteu (F–C) method, often 
used for the determination of total phenols content. The F–C reagent forms colored 
products with the analytes (usually containing hydroxyl groups) with maximum 
absorbance at 765 nm. A calibration curve from a single reference standard as gallic acid 
[83] is used to interpolate in it the absorbance of the extracts. Also well known reagents 
such as 2,2-diphenyl-1-picrylhydrazyl (DPPH) or 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS) are used to determine the total scavenging capacity of an extract, 
while ferric ion reducing antioxidant power (FRAP) allows determining its antioxidant 
activity [84]. 
Individual quantitation of a metabolite or a small group of metabolites can provide, 
sometimes, the necessary information about the state or evolution of a given organism. This 
information is obtained by a relatively simple analytical platform constituted by a liquid or 
gas chromatograph coupled to a detector based on molecular absorption [either UV–visible 
detector or diode array detector (DAD)] or flame ionization detector (FID), respectively. 
This relatively simple analytical equipment requires standards to identify the target 
compounds based on the retention time, and also supported on the molecular spectrum in 
dealing with UV–visible detector or DAD. The absence of commercial standards makes 
difficult or hinders development of methods and thus the use of this approach [85]. 
Examples of its use are the individual separation of phenols, carotenoids and vitamin C in 
citrus carried out by C18 or UP-18 chromatographic columns in an LC coupled to a UV–
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visible detector [85]; and that of volatiles from essential oils, quantified in a simple manner 
by GC–FID with the help of available commercial standards [86]. 
More complex, common metabolomics studies require detectors with high 
sensitivity to detect metabolites at low concentrations, high-resolution power to identify 
them and wide dynamic range to detect them at variable concentrations in complex 
matrices. The most used types of detectors (MS and NMR) are described in the next 
subsection. 
3.3.1. MS detectors. MS fundamentals is the differential movement of ionized molecules 
through vacuum by administering an electrical field. A mass spectrometer consists of a 
sample inlet, an ion source, a mass analyzer, a detector and a system for data collection. 
The sample inlet let put the sample molecules inside the ion source, where they are ionized. 
The ion source produces gas-phase ions via an ionization technique, the mass analyzer 
separates the ions according to their mass-to-charge ratio (m/z), and the detector produces 
an electrical current from the incident ions that is proportional to their abundances, and 
constitutes the collected signal. 
Fig. 6 shows the main ionization sources and types of mass spectrometers, as well 
as the types of high-resolution separation approaches to which these detectors can be 
coupled. All them are discussed below.  
In dealing with ionization sources in MS, the most used, as summarizes Fig. 6, are 
electrospray ionization (ESI) for coupling to liquid chromatographs (LC–MS) and electron 
impact (EI) ionization when the coupled chromatograph is a GC (GC–MS). ESI is the most 
widely used for untargeted metabolomics studies, because it produces soft ionization (viz., 
ions are generated with little or without fragmentation, which can support the 
identification of unknown metabolites) and can ionize compounds within a wide range of 
polarity and mass. The produced ions are adducts with proton or other species present in 
the mobile phase. It is a very useful property to determine compounds such as acids, 
amines, proteins and peptides [87]; and, in general, this ionization source is useful to study 
polar volatile and no volatile compounds, thermally stable and no stable compounds, and 
polar compounds. An example of parameters optimization of this source for quantitation 
of amino acids can be found in Chapter VII of this Thesis-Book. 
In addition to the wide use of ESI, atmospheric pressure chemical ionization 
(APCI) and atmospheric pressure photoionization (APPI) have been used to receive the 
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eluate from LC, CE and supercritical fluid chromatography (SFC). APCI is of interest for 
ionization of carbohydrates, triglycerides, amines, esters, and phenols, and as 
complementary source of ESI, because it allows determining no polar compounds. APPI is 
a useful alternative to study compounds that are poorly ionized by ESI or APCI sources. EI, 
which consists of interaction of the gas molecules with kinetically activated electrons at an 
energy of 70 eV, and chemical ionization (CI) sources are frequently used to couple the 
mass detector to GC equipment. Both sources are complementary because EI allows 
obtaining structural information and CI molecular mass information, thus enhancing 
characterization. 
 
 
Fig. 6. High-resolution separation approaches, ionization sources and MS analyzers more used in 
metabolomics. 
 
Other interesting source is matrix-assisted laser desorption/ionization (MALDI), 
normally coupled to time-of-flight (TOF) equipment for protein analysis, and for lipidomics 
studies. Surface-enhanced laser desorption/ionization (SELDI) is a variation of MALDI 
widely used to identify new protein molecular biomarkers. MALDI can be used 
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independently or coupled to LC. Other ionization sources of MS used in metabolomics 
studies are direct analysis in real time (DART), inductively coupled plasma (ICP) and 
desorption electrospray ionization (DESI). Mass analyzers can be used either alone or 
combined with the same or different type of mass analyzers [hybrid instruments or tandem 
MS (MS/MS)]. Tandem MS and multiple-stage MS favor identification of a given molecule 
because the molecular ions and fragments from precursor ions can be detected. 
Concerning the characteristics of mass analyzers, the most remarkable are as 
follows: (a) mass accuracy of the measured m/z, related to the mass resolving power and 
stability of the instrument. (b) Mass resolving power or ability of an MS to provide a 
specified value of mass resolution (i.e., the instrument generates distinct signals for two 
ions with a small m/z difference). (c) Mass range or limits of m/z within which an MS can 
detect ions or operate to record a mass spectrum. (d) Transmission efficiency or ratio of the 
number of ions reaching the detector and the number of ions leaving the mass analyzer, 
related to the sensitivity of the mass spectrometer (i.e., the minimal concentration of a 
compound leading to a peak intensity greater than a specified signal-to-noise ratio). (e) 
Scan speed or rate at which the analyzer measures over a certain mass range. (f) Scan cycle 
time or the time required to obtain a mass spectrum, also known as duty cycle.  
The selection of a given MS detector depends on the type of metabolomics analysis 
to be performed, targeted or untargeted, as shows Fig. 6. Mass analyzers for untargeted 
metabolomics must provide the appropriate mass resolution power, mass range and mass 
accuracy. TOF, quadrupole time-of-flight (QTOF), Orbitrap, Q-Orbitrap and linear ion trap 
(LTQ)-Orbitrap are used in this context, and, among them, TOF and QTOF instruments are 
preferred because they provide data acquisition over a wide mass range with high mass 
accuracy and resolving power, whereas mass analyzers have to provide transmission 
efficiency, sensitivity, scan cycle time and scan speed to be used for targeted metabolomics 
—QqQ is the most useful instrument in this case. Other instruments such as single 
quadrupole (Q), ion trap (IT) and LTQ are used in both targeted and untargeted studies. 
MS has been used both to implement plant metabolomics strategies [88,89], and 
to develop and enhance clinical metabolomics assays in toxicology, endocrinology and 
biochemical genetics areas. 
The use of MS alone is called direct infusion mass spectrometry (DIMS). Its main 
disadvantages are the high-resolution mass analyzer requirement (more expensive 
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instrument) and ion suppression effects (more difficult identification and quantitation of 
low concentrated or difficult of ionizing metabolites). 
3.3.2. NMR detectors. NMR spectrometry is another prevailing technique in metabolomics 
thanks mainly to its resolution capabilities. Briefly, in NMR detectors, liquid or solid 
samples are placed inside a detection coil, and exposed to an external, static and 
homogeneous magnetic field referred to as Bo (z-axis). The magnetic moments in the 
sample align along Bo according to a Boltzmann distribution. According to quantum 
mechanics, magnetic moments can only align parallel or anti-parallel with respect to this 
external field, leading to a macroscopic magnetic moment M. After a short application of a 
high frequency B1 field orthogonal to Bo (B), the magnetization is aligned with the rotating 
B1 field. Detection of NMR signals can be only from atomic nucleuses possessing unpaired 
number of electrons (responsible for the resultant spin of these atoms, which align parallel 
or anti-parallel to the applied magnetic field), property termed as paramagnetism. In the 
absence of magnetic field, nucleuses are rotating with randomized trajectories, but if a 
suited magnetic field is applied these nucleuses are aligned with it. 
Most elements have at least one isotope with a magnetic spin number greater than 
zero, necessary for the NMR effect. In the case of biological samples, the two more common 
nucleuses, 1H and 13C, give place to the two most frequent NMR techniques, 1H-NMR and 
13C-NMR. The former is the most sensitive of them because of the natural presence of this 
nucleus. Thus, magnetization of hydrogen atoms experiencing a magnetic field of 14.1 T will 
rotate at 600 MHz aligned with the magnetic field. Such a spectrometer is called a 600 MHz 
detector. This is the reason why NMR spectrometers are usually classified in frequencies. 
With the same magnet, a 13C spin will process at about 150 MHz due to the natural presence 
of this nucleus (1.1%). Nowadays, there are available NMR magnets up to 1 GHz that 
operate at magnetic field strengths of 23.5 T and proton NMR frequency of 1000 MHz with 
tremendously high field stability. 
An NMR spectrum is composed by spectral amplitude plotted versus chemical 
shift. This method, called 1D-NMR, allows determining the composition of a sample only if 
there is no severe overlap of signals. A method called 2D-NMR is used to overcome this 
limitation. It consists of a sequence of B1 pulses under systematic variation of an inter-
pulse delay, leading to a 2Dmap where the amplitude is plotted as a function of two 
frequency dimensions. A cross-signal in this map indicates a pair of spins with a transfer of 
magnetization during the pulse sequence. This allows determining related signals of the 
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spectrum (such as signal corresponding to the same molecule). 2D-NMR spectrometry can 
encompass homonuclear and heteronuclear methods if the couplings are between the same 
or different nucleuses such 1H-1H and 1H-13C, as the most frequent couplings. 
The great advantages of NMR are the potential for high throughput fingerprinting, 
minimal requirements for sample preparation, and the no discriminating and no 
destructive nature of the technique. In fact, 1H-NMR spectra can be acquired rapidly in 3-
15 min with minimum sample preparation that usually just entails buffering and internal 
standard addition [90]. Furthermore, 1H-NMR has been largely used to unequivocally 
determine metabolite structures and, perhaps due to its no invasive nature, is more 
commonly used in mammalian systems than MS technologies. However, only medium-to-
high abundance metabolites will be detected with this approach and the identification of 
individual metabolites based on multivariate analysis of signals that cause sample 
clustering is difficult in complex mixtures. Indeed, the 1H-NMR spectrum of a complex 
sample is composed of several hundred resonances (with chemical shifts between 0-10 
ppm), which are estimated to arise from a hundred of more metabolites, resulting in a 
highly congested spectrum, given that each compound usually provide more than one 
signal each with a certain multiplicity. On the other hand, the reduced sensitivity of 13C-
NMR has practically limited its application to the study of metabolic fluxes in cells and 
tissues by suited fed with isotopically labeled metabolites, thus given place to fluxomics. 
Limitations of 1D-NMR have been partly overcome by the use of 2D-NMR and by 
ultrahigh-field NMR spectrometers, which allow increasing spectral dispersion and reduce 
strong coupling associated distortions, but highly increase the analysis time. They are used 
for global profiling analysis. 
It is generally accepted that sensitivity in 1H-NMR is lower than in MS. This 
depends on the magnetic field strength, with higher field magnets providing greater signal-
to-noise ratio. This ratio can be increased by increasing acquisition time, which means 
increased number of scans. On the other hand, integration can be directly carried out by 
comparison with an internal standard by simple integration. Although NMR can be coupled 
to LC and SPE columns to improve separation and sensitivity [91,92], it is unlikely that 
NMR will attain the sensitivity of MS. 
Despite the advantageous aspect of 2D-NMR spectra to spread overlapping 
resonances into a second dimension by the various alternatives to carry out 2D-
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measurements, the main limitation of these experiments is the high acquisition time 
required, typically within 16-20 h to achieve a comparable sensitivity to 1D spectra. 
Therefore, identification in complex mixtures is still more difficult than in MS and requires 
large user interpretation. This is the reason why the use of 2D-NMR for metabolomics is 
usually restricted to the characterization of compounds unidentified from the 1D spectra.  
Among the remarkable applications of 1H-NMR fingerprinting with multivariate 
analysis in plant metabolomics is the identification and classification of maize seeds 
obtained from transgenic plants into different classes according to changes in metabolites 
[93], a genetic study of strawberry fruit quality, a functional study of tomato transformants 
and a study of Arabidopsis thaliana phosphoenolpyruvate transformant metabolites [94]. 
NMR fingerprinting has been used for many years to authenticate foodstuffs, 
especially in the beverage industry and grape [95]. Using standards methods of 1H-NMR 
data collection, followed by principal components analysis (PCA) and partial least squares 
(PLS) methods, predictive modelling pinpointed the spectral areas responsible for a 
separation according to vintage. 
Even with the improved resolution of 2D-NMR approaches, complete 
characterization of complex mixtures such as plant extracts by NMR is often impossible. 
Hyphenating NMR to LC alleviates some of the problems by allowing NMR data to be 
collected on individual comments of a mixture, as in the screening LC–NMR profiles of 
crude lipophilic extracts of aquatic plants for potential algacides [96]. Nevertheless, the 
compounds of interest could not be completely identified from the LC–NMR analysis. The 
lack of enough sensitivity of on-flow LC–NMR for phytochemical analysis is overcoming by 
previous automated SPE peak trapping, which has been used to investigate the composition 
of an African medicinal plant, Kanahia ianiflora [97]. 
In the clinical field, and despite its relatively low sensitivity, targeting NMR 
analysis has been widely applied. In fact, quantitation of biomarkers related to diseases or 
human metabolism [98,99], including schizophrenia, multiple sclerosis, diabetes, organ 
rejection, and rheumatoid arthritis have already been published and exploited. 
Interestingly, NMR-based serum-lipoprotein quantitation is a mainstream clinical 
diagnostic tool, as also does in-vivo NMR analysis, probably the most outstanding 
application of NMR in metabolomics due to its use in diagnosis of diseases such as cancer. 
The in-vivo NMR “metabolite mapping” of tissues after biopsy or before local ablative 
 Introduction 
 
Page | 49  
procedures provides precise differentiation of cancer and benign tissue based on detection 
of given metabolites such as choline [100]. 
Clinical metabolomics fingerprinting by NMR has proved to be an excellent 
approach to discover metabolic changes associated with disease in humans [101]. 
Currently, clinical NMR-based metabolomics allows semi-automated 
identification and quantitation of metabolites with concentrations as low as 1 µM. This 
means that up to 20 different metabolites can be detected (in-vivo) in certain tissues and 
up to 100 metabolites (in-vitro) in certain biofluids. Given that the metabolome of many 
biofluids and tissues is of the order of thousands of metabolites [45], a major future 
challenge will be to find ways of increasing that number. In addition, provided that 
quantitative NMR metabolomics is carried out almost exclusively in aqueous conditions, it 
is not surprising that most of the quantifiable metabolites are water soluble, thus limiting 
considerably its applicability. In addition, no internal standard addition, apart from D2O 
(to serve as a frequency lock signal) and a chemical-shift reference standard [sodium 
trimethylsilylpropanesulfonate (DSS) or trimethylsilyl propionate (TPS)] are required. 
It is worth remarking the use of quantitative NMR for in-vivo applications. This 
approach was used for the first time to quantify brain metabolites [102] (glutamine, 
glutamate and gamma butyric acid) in patients suffering from epilepsy, which were proved 
to increase as compared to controls [103]. Also, precise quantitation of the major brain 
antioxidants (vitamin C and glutathione) at µM levels has been described, taking into 
accoung that altered antioxidant profiles in the brain have been linked to schizophrenia 
[104]. Analysis of N-acetyl aspartate, creatine, choline and myo-inositol concentrations in 
the spinal cord have shown significant differences from those found in the brain stem. This 
may have implications in the diagnosis of multiple sclerosis and the monitoring of spinal 
cord injuries, among other diseases [105]. 
3.3.3. Analytical platforms based on high-resolution separation approaches and MS 
detectors. Mass detectors have traditionally been connected to chromatographs and, in a 
lesser extent, to CE devices. Coupling of liquid chromatographs to NMR detectors is more 
recent and scanter. GC–MS allows profiling a wide range of metabolites with different 
physico-chemical properties such as amino acids, carbohydrates and organic acids, with a 
characteristic high reproducibility thanks to the ionization source normally used: EI [106]. 
The main disadvantage of this approach is its limitation to thermally stable metabolites 
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that are volatile and/or easy to convert into volatile products. Therefore, the study of 
thermolabile and/or no volatile metabolites such as sugar phosphates or large 
oligosaccharides is mainly afforded by LC–MS approaches [106]. 
Regarding the type of mass detector coupled to GC, a Q/MS (GC–Q/MS platform) 
provides sensitive, cheap and reliable analysis, but operates at slow scan rates and provides 
low mass accuracy. When the study deals with compounds identification or comparison 
among samples obtained in —or subjected to— different conditions, the most appropriate 
detector coupled to the separation equipment is TOF. GC–TOF/MS provides high mass 
accuracy, high duty cycles and fast acquisition times. In addition, it permits accurate 
deconvolution of overlapping peaks, which are common in plant extracts [107]. A 
complementary approach is GC–QTOF that provides MS/MS information on the structure 
of the target metabolites and their fragmentation pattern (precursor ion, product ions, loss 
of neutral mass, adducts formation), which permit identification supported on the 
appropriate databases. The evaluation of the metabolite profile by the mandatory 
chemometric approaches makes possible to evaluate the variances among samples, usually 
as compared with control samples (no treated samples). The necessity for mass standards, 
which depend on the given instrument and the ionization mode, together with the special 
training required for data interpretation, and the acquisition cost of these instruments 
make them prohibitive for low-medium budget laboratories. GC-QqQ has been recently 
applied in metabolomics, providing accurate quantitative metabolite data [108]. It can 
monitor simultaneously a large amount of MS/MS transitions, improving the sensitivity 
and selectivity of the analysis, thus enhancing the quantitative profiling of metabolites 
[108]. 
Recent applications of GC–MS platforms (particularly GC–TOF/MS [107], and 
GC–QqQ MS/MS [108]) prove their importance in plant metabolomics studies, despite the 
need for derivatization required most times for plant primary metabolites [85,86]. 
In dealing with LC–MS platforms (more recent than GC–MS platforms because of 
the shortcomings derived from the insertion of the eluate from the LC column and the 
necessity for evaporation of the eluant before ionization) their use has complemented (and 
in countless cases surpassed) that of GC–MS platforms. The demonstrated exceptional 
performance of LC–MS interfaces avoids derivatization (as compared with GC–MS), and 
offers a wide range of possibilities concerning columns and mobile phases both for polar 
and no polar compounds, in addition to the high sensitivity and selectivity of the detector, 
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mainly in the case of triple quadrupole instruments. This platform is very appropriate to 
profile a set of known metabolites or compound classes; that is, for target metabolomics 
analysis. As commented before, the most used ionization source in LC–MS is ESI.  
Concerning the different types of mass detectors coupled to LC, QTOF has been 
used for LC–MS analysis of plant and animal metabolomics, but also QqQ, IT, Q-Orbitrap 
have been coupled to LC for development of these studies. LC-QqQ is required for 
quantitative targeted analysis because it provides high sensitivity using the multiple 
reaction monitoring (MRM) mode, allowing quantitation of very low abundant metabolites 
[109]. The analysis of metabolites in human body fluids constitutes a challenge because of 
their chemical diversity and dynamic concentration range, to which LC–MS/MS faces by 
methods for quantitative analysis and profiling of complete metabolites classes in a biofluid 
over a broad dynamic concentration range. In fact, LC–MS/MS-based metabolomics 
approaches in clinical applications aims at both, the improvement of diagnostic sensitivity 
and specificity by profiling a metabolite class instead of determination of a single 
metabolite, and identification of new disease specific biomarkers [110]. 
Especial mention deserves the coupling of supercritical fluid chromatographs to 
MS detectors. Despite SFC is not a novel technique as it appeared at the beginning of the 
90’s in the last decade of the XX century together with SFE, the improvement in its different 
parts (particularly pumps) has propitiated its relatively recent use, and its coupling to MS 
detectors.  
Despite in SFC the mobile phase is a fluid, typically carbon dioxide that is 
maintained beyond its critical point, the addition of an organic solvent (usually 2–30% of 
methanol or ethanol) to increase its polarity leads to specific conditions referred to as 
subcritical. Significant improvements in both instrumentation and column technology have 
shaped SFC as very promising and competitive in high-throughput analysis due to the 
specific features of the supercritical/subcritical fluid allowing for better solubility and faster 
analyte transport without excessive backpressure generation. Higher linear velocities of the 
mobile phase can be used in SFC due to a less mass transfer resistance explained by the 
relatively lower mobile phase viscosity and higher analyte diffusivity [111,112]. 
Similarly to high-performance liquid chromatography (HPLC), SFC made a 
considerable step forward in bioanalysis upon the introduction of state-of-the-art 
dedicated or hybrid systems with adapted pumps and backpressure regulators [largely 
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inspired on developments achieved for ultra-high-performance liquid chromatography 
(UHPLC)], which are also compatible with modern LC stationary phases [111,112]. Ultra-
high performance supercritical fluid chromatography (UHPSFC) exhibits a high kinetic 
performance with a shifted optimum linear velocity towards higher values (3–5 fold) 
compared to UHPLC, allowing for ultra-fast analysis. This is an essential advantage in 
metabolomics studies, particularly considering the low solvents consumption [111,112].  
In a lesser proportion than to LC, MS has also been coupled to SFC, most times for 
lipidomics studies as this type of chromatography is very efficient for lipid class separation 
[113]. One of the most promising fields of SFC in the context of metabolomics is probably 
the analysis of isomers such as stereoisomers, diastereomers, and enantiomers. Also 
UHPSFC–MS platforms have shown their suitability for analysis of medium- and high-
polar metabolites with high-throughput metabolomics purposes [114]. 
CE–MS is still less used in metabolomics owing to poor reproducibility of 
migration times, absence of interfaces for CE–MS coupling that provide sensitive, robust 
and stable CE–MS setup and the scant versatility of these interfaces [115]. Neutral 
compounds can only be separated by specific methods based on addition of SDS, 
cyclodextrins or micelles formation; reagents incompatible with MS. Nevertheless, CE–MS 
allows enhancing metabolite coverage, specially of polar compounds. In fact, the 
metabolome fraction mapped by CE–MS is not usually covered by other platforms [115]. 
CE provides complementary information to hydrophilic interaction liquid chromatography 
(HILIC) and also better peak shape. In fact, CE is one of the most suited techniques for 
separation of phosphorylated metabolites, amino acids or metabolites from the Krebs cycle. 
Also, isomeric compounds such as citrate/isocitrate or leucine/isoleucine can be easily 
baseline separated. So, CE has been used for metabolomics studies of diseases such as 
migraine, schizophrenia, Huntington disease, cancer and chronic alcohol abuse [116,117] . 
The combination of some of these approaches, such as NMR, GC–MS and LC–MS, 
allows identification and quantitation of a big quantity of metabolites. A key example is the 
research from Wishart et al., who identified 3564 metabolites in human serum [118], by 
five metabolic profiling methods [NMR, GC─MS, lipid mediators by LC–ESI-MS/MS, 
lipidomics profiling via thin layer chromatography (TLC)/GC–FID-MS and direct fluid 
injection (DFI)-MS/MS] to experimentally characterize as much of the known serum 
metabolome as possible. NMR spectroscopy was able to identify and quantify 49 
compounds, GC–MS was able to identify 90 and quantify 33 compounds, lipid mediator 
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profiling (targeted ESI-MS/MS) identified and quantified 96 compounds, TLC/GC–FID-
MS identified and quantified 3381 compounds, while DFI MS/MS identified and quantified 
139 compounds. Some of these compounds were identified by several platforms.  
3.3.4. Chemical derivatization as an essential or additional sample preparation step to 
obtain the analytical sample for GC–MS or LC–MS. Derivatization of the target 
metabolites can be a mandatory step (as is the case of no volatile compounds to be inserted 
into a GC) or an additional step desirable to improve sensitivity and/or selectivity that can 
be used either in GC and LC. 
In dealing with GC separation, while some plant metabolites such as essential oils 
are highly suited to be injected into the chromatograph without derivatization, chemical 
derivatization is usually required to reduce the polarities of the functional groups, facilitate 
their separation and influence mass spectral properties. To reduce polarity, organic acids 
are esterified by reaction with diazomethane, but mainly by silylation [119] —
predominantly trimethylsilylation (TMS) or tert-butyldimethylsilylation (TBDMS). In 
addition, keto-(oxo-) groups are usually oximated to improve their GC properties and 
prevent enolization reactions that can introduce multiple products, thereby complicating 
the chromatograms. In high resolution chromatography, the syn- and anti- isomers of the 
oximes can sometimes partially separate giving rise to recognizable shoulders on the GC 
peaks. As the number of derivatized groups increases, there is the danger in MS detection 
that the molecular mass of the derivative is outside the mass range of the detector, typically 
m/z 650–1000, or is too high that the derivative will not pass through the GC column. In 
addition, the likelihood of sterically hindered groups can lead to the formation of multiple 
products, thereby complicating the chromatogram. TBDMS has been evaluated as the most 
comprehensive for metabolite profiling applications [120] and it has as further advantage 
the lower sensitivity of its derivatives to the hydrolytic effects of moisture than the 
corresponding TMS derivatives during the TMS process, which, in addition, are susceptible 
to artifact formation. The former give often mass spectra with abundant fragment ions (m/z 
M-57, where M is the molecular mass of the metabolite) from easy loss of the tert-butyl 
moiety, convenient for structural assignments of plant metabolites [121]. A disadvantage of 
TBDMS derivatives lies in the significant increase in molecular mass, particularly where 
multiple derivatizable groups are present in the molecule. In addition, problems of steric 
hindrance might lead to mixtures of fully and partially derivatized analytes. In the study of 
detailed metabolic processes, particularly where the intermediate compounds may be 
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reactive or unstable, the analyst should always be aware of such possibilities when 
interpreting the results. In case of any doubt, alternative derivatization procedures are 
generally available for specific functional groups [122]. 
Compared with GC–MS, a major advantage of LC–MS with atmospheric pressure 
ionization (API) has been the avoidance of a requirement to derivatize the target 
metabolites in the samples; therefore, the combined approach is, and has been for years, 
being applied in metabolomics profiling [123] with appropriate choices of column polarity 
and mobile phase compositions. As derivatization by definition induces chemical changes 
and is sometimes performed under harsh conditions with a consequent danger of artifact 
formation, to avoid this step when possible is advisable.  
Nevertheless, the literature contains many examples where derivatization can be 
advantageously employed to enhance the signals obtained from soft ionization MS 
approaches such as fast atom bombardment (FAB), thermospray, ESI, and MALDI. 
Analytes in the ESI region containing different functional groups can have diverse 
ionization properties, giving preferentially positive or negative ions depending on the 
mobile phase composition. For example, the ESI method in positive mode would work 
particularly well with positively charged (or easily chargeable) species (highly polar) so that 
a derivatization step that introduces such species to a wide variety of compounds would 
facilitate simultaneous measurement (profiling) of an increased number of compounds in 
one analysis. The same applies to negatively charged (or easily chargeable) species. 
Although atmospheric pressure LC–MS/MS is eminently suited to the profiling of 
polar compounds without such derivatization, applications of derivatization are increasing, 
usually for specific applications. For example, the clinically important groups of 
acylcarnitines and amino acids are commonly n-butylated prior to direct ESI-MS/MS 
analysis [124]. The IT MS/MS spectra of the butyl esters of acylcarnitines yield more 
fragment ions than the underivatized compounds giving more detailed mass spectral 
‘fingerprints’ and thereby increasing their utility for identification [125]. Interesting 
derivatives based on electrochemically-generated ions can enhance detection 
characteristics. Ferrocene-based electrochemically ionizable derivatives facilitate analysis 
of simple alcohols, sterols and phenols [126] and provide further structural information. 
Alcohols could be selectively detected at low levels in a complex fruit extract after ESI [127]. 
Fatty acids have been analyzed after ESI using alkyldimethylaminoethyl derivatives [128]. 
Polar derivatives have been applied to steroids, fatty alcohols and alcohol ethoxylate 
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surfactants in wastewater, carbonyl compounds, and drug impurities with improved 
detection [129,130]. In MALDI-MS, charged tris(2,4,6-trimethoxyphenyl)phosphonium 
(TMPP) derivatives were used for derivatization of peptide amino groups, yielding 
improved sequence information. Such derivatives have since been applied to amines and 
carboxylic acids, alcohols, aldehydes, and ketones, oligosaccharides, and carboxylic acids 
[131,132]. The chromatographic properties of the TMPP derivatives of amines have also 
been investigated, and a preliminary study has been carried out on the utility of TMPP 
derivatives for metabolic profiling [133]. Also, electron-capturing derivatives have shown 
to facilitate greatly the analysis of small molecules at attomole levels [134] with application 
to lipidomics [135]. 
The application of stable-isotope-labelled derivatives is having an enormous 
impact on protein analysis (isotope coded affinity tags, ICAT), a clear indication of the 
potential utility of chemical derivatization (tagging) in API MS. 
Derivatization has also been applied in the research that conform the major part of 
this PhD-Book for increasing the identification of Cannabis compounds by reducing the 
polarities of their functional groups before Cannabis extract analysis by GC–TOF/MS 
(Chapter VI) and also for increasing the identification of sweat compounds by GC–TOF/MS 
(Chapter VIII-to-X). 
 
3.4. Data treatment in metabolomics studies 
Chemometrics, a chemical discipline that uses mathematical, statistical, and other 
tools to design or select optimal measurement procedures and experiments, and to provide 
maximum relevant chemical information by analyzing chemical data [136], is essential for 
metabolomics development. This discipline covers from design of experiments, through 
data preprocessing and processing, to data analysis. It has been used as tool to design, 
process, visualize, explore and analyze metabolomics data. 
Data analysis strategies used in metabolomics are designed as a function of the 
approach selected, being different for targeted and untargeted analysis (Fig. 7). The huge 
amount of data generated in untargeted metabolomics analysis is evaluated by biostatistics 
and bioinformatics tools. 
The main difference between plant and clinical metabolomics analysis is that in the 
latter the chemometrics treatment of the data can be much more complex, tedious and slow 
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because of the number of samples that can involve. Although clinical metabolomics studies 
are frequently based on small sample sizes, representative, well-supported clinical 
epidemiological studies involve more than 1000 samples. As a way of example, a recent 
study on the association between serum 25-hydroxyvitamin D and mammographic density, 
and to assess whether this association differed according to women characteristics, 
involved more than 1400 premenopausal Spanish women [137]. 
 
 
Fig. 7. Workflow of data analysis strategies for untargeted and targeted analysis in metabolomics. 
 
3.4.1. Data treatment for untargeted metabolomics analysis. Untargeted metabolomics 
analysis consists of covering the maximum number of metabolites using analytical 
platforms. In this case, the optimization of experimental parameters to obtain the best 
working conditions for the determination of given metabolites is not required. So, general 
working conditions are used for untargeted metabolomics analysis. This step covers from 
data acquisition, through data pre-processing, data pre-treatment to statistical analysis. 
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Data pre-processing and data-pre-treatment are crucial quality results [138]. The former 
allows transformation of the raw data into clean data to process them by a data processing 
software. Some examples for MS data are: extraction of potential molecular features 
(potential metabolites), finding compounds by chromatogram deconvolution (for GC–MS 
data), alignment of the signals corresponding to the same metabolites, removal of 
redundant information and management of missing values. In this step, many factors such 
as adducts, peak shape, noise removal, etc. need to be considered. Once data pre-processing 
has finished, the data pre-treatment step (which consists of applying mathematical 
operations to facilitate comparison among samples) starts. To favor obtainment of 
information on the relevant biological variations, the experimental and instrumental 
variables effects should be reduced. For that, the dataset is pretreated to properly transform 
the data for analysis by using the following tools: 
- Normalization, which removes unwanted variation among samples allowing their 
quantitative comparison. Different normalization approaches as single or multiple 
internal/external addition, total area normalization or standard to logarithmic 
transformation can be applied to remove variations among samples. 
- Scaling, which consists of dividing each variable by a different factor for an equal 
treatment of all variables, regardless of their intensity. For example, the mean of each 
variable is one of the most used factors; while Z-transform can be used in case of combining 
data obtained from different platforms or methodologies [139]. 
The use of filters is required in untargeted analysis to reduce the number of 
potential molecular features and facilitate further statistical analysis. Only potential 
entities with high intensity, high significance with respect to a factor of interest, or entities 
that appear with high frequency in the samples batch would pass the filter. The types of 
filters to be used as required are as follows: 
- Filter by abundance, which consists of removing all potential molecular features below a 
certain abundance. 
- Filter by frequency, which consists of eliminating entities present below a certain 
percentage of samples from each group. 
- Fold change analysis, which consists of comparing the level of each potential molecular 
feature among the groups under study and retaining only the entities that show a preset 
change. 
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- Filter based on univariate hypothesis test, which consists of eliminating entities with a p-
value above 0.05 or 0.01. 
- Filter by Volcano plot, which is a combination of analysis of variance and fold change 
analysis. 
The large multivariate data sets generated by this type of metabolomics 
experiments constitute a great challenge from the point of view of statistical analysis. The 
outputs of a metabolomics data analysis may differ greatly depending on the purpose of the 
research. Untargeted metabolomics studies can be divided into two categories —those that 
aim at understanding biological processes and those that aim at discovering biomarkers 
[140]. In the first case, an extended set of compounds may be desirable when a biochemical 
network is under examination, while in the second case, very few highly dependable 
metabolites can suffice for diagnostic purposes. The second case has not been as widely 
applied in plant metabolomics studies as in the case of clinical metabolomics studies. 
i) Untargeted metabolomics analysis to understand biological processes. The study of the 
influence of a target factor in a batch of samples and the identification of the most affected 
molecular features can be performed by different strategies. Usual chemometric tools [141] 
such as PCA [142] are generally used for display and exploratory analysis purposes, 
whereas univariate statistical tests such as the Student’s t-test are used for identification of 
the relevant variables after exploratory analysis. 
- Exploratory analysis by unsupervised learning: unsupervised methods try to analyze a set 
of observations without measuring or observing any related result.  
No specified class label or response exists, so the data set is considered as a 
collection of analogous objects. Unsupervised learning employs procedures that try to 
discover the natural partitions of patterns to simplify the understanding of the relationship 
among the samples and to highlight the variables that are responsible for these 
relationships. By providing means for visualization, unsupervised learning aids in the 
discovery of unknown but meaningful categories of samples or variables that naturally fall 
together. The achievement of such approaches is, in general, evaluated subjectively by the 
interpretability and usefulness of the results with respect to a certain problem. 
PCA is a general no supervised approach, an orthogonal transformation of 
multivariate data first formulated by Pearson [143] generally employed as an exploratory 
analysis by extracting and displaying systematic variations and visualization tools to detect 
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trends and/or groups and outliers. PCA attempts to uncover hidden internal structures by 
constructing principal components describing the maximal variance of the data [144]. It is 
a very suitable tool for displaying purposes as it provides a low-dimension projection of the 
data by transformation into a new different coordinate system preserving as much of the 
relevant information as possible while discarding the noise. The basic concept relies on 
areas of signal variance in the data where underlying phenomena can be observed. This 
principle leads to a focus on a minor number of uncorrelated independent signals that 
explicate a great part of the total variance in a compact and insightful mode. Practically, 
PCA creates hyperplanes in the original space that are linear combinations of the original 
variables and delineates the data in a least squares view. The PCA scores and loadings plots 
inspections highlight the associations among the distribution of samples that may reveal 
grouping, trends or outliers and the corresponding variables. More successful data analyses 
can be achieved on the reduced dimensional space, such as clustering, pattern recognition 
or classification. Most of metabolomics studies comprises PCA as a first exploratory step 
[145,146]. 
- Classification by supervised multivariate analysis: supervised learning contemplates each 
object with respect to an observed response and includes regression and classification 
problems depending on the output type under consideration. The objective is to study the 
mapping from the first to the last. For that, this classification aims at generating general 
hypotheses based on a training set of examples that are defined by several variables and 
identified by known labels corresponding to the existing classes.  
Several approaches have been developed for that purpose, based either on statistics 
or on artificial intelligence. Within the diversity of supervised statistical approaches, the 
most employed is PLS, but they include also decision trees, artificial neural networks and 
support vector machines. This approach is useful where less observations (N) than 
measured variables (e.g., detected features, K) are available. PLS use has becomes popular 
because its ability to deal with many correlated and noisy variables creating megavariate 
data structures (K>>N) [147]. 
PLS forms a low dimensional sub-space based on linear combinations of the 
original X-variables and facilitates the use of the additional Y information by adjusting the 
model to capture the Y-related variation in X. A PLS-based classification thus has the 
property to construct data structures with an intrinsic prediction power, by maximizing the 
covariance between the data and the class assignment. The decomposition relies on latent 
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variables that are computed sequentially to offer a good correlation with the remaining 
unexplained fraction of Y. In a classification context, PLS discriminant analysis (PLS-DA) 
is done to sharpen the partition between groups of observations, in such as way that a 
maximum separation among classes is achieved. Then, the model can be analyzed to 
understand the variables that carry the class-separating information. PLS-DA was 
confirmed to be a powerful tool for classification of metabolomics data [148]. 
- Univariate hypothesis testing: the Student’s t-test, the one-way analysis of variance or the 
no parametric equivalents can be employed for the identification of statistical differences 
among samples of distinct classes. The predictive power of each variable is evaluated by 
finding statistically significant differences between the mean intensity values of a given 
signal, of which the calculated p-value is a straightforward indicator. Such procedures are 
comprehensible but their use is rather restricted in dealing with thousands of highly 
correlated variables. False positives (type I error) are possible to happen when performing 
multiple comparisons. Procedures such as the Bonferroni of the Benjamini correction have 
been implemented to address this issue [149]. Most of metabolomics dedicated software 
provides statistical hypothesis testing [150,151]. 
ii) Untargeted metabolomics analysis to discover biomarkers. Biomarker discovering 
must be made before deriving a definitive multivariate predictive model. Between 1 and 10 
biomarkers yield mathematically robust and useful models for clinical testing purposes. 
Normally, supervised machine learning algorithms (PLS), or multivariate regression 
models are used for modelling the discriminatory relationship between a binary dependent 
variable and one or more explanatory variables. 
Regarding the selection of potential biomarkers, iterative methodologies for 
biomarker panel development, such as the used in the PanelomiX bioinformatics tool or in 
the ROCCET on-line tool, are recommended. 
Biomarker panels are designed to discriminate with an optimal 
sensitivity/specificity, but in most cases the parameter used for measuring the clinical 
usefulness of a panel developed by PLS, for example, is the R2 (multiple correlation 
coefficient). R2 of the model and R2 of its cross-validation can be used as part of the 
biomarker choice process, but they do not provide enough transparency and are not a 
readily interpretable indication of the clinical usefulness of an assumed model. The ROC 
(receiver operating characteristic) curve analysis is a standard method for describing and 
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assessing the performance of medical diagnostic tests with binary classification [152]. 
Nonetheless, it is not used in plant metabolomics studies. 
ROC curves reflect the regularity with which the test produces true positives, true 
negatives, false positives and false negatives, which are collected into the proportion of 
actual positives that are correctly classified as positive (sensitivity) and the proportion of 
actual negatives that are correctly classified as negative (specificity). An example of ROC 
curves is shown in Fig. 8. 
 
Fig. 8. ROC curve representation including the curve described for an ideal test, and a test without 
predictive value [153]. 
 
Specificity and sensitivity can be considered as the probability of false positives (the 
negative result of the test from a subject that has an actual negative outcome) and true 
positives (the positive result of the test from a subject that has an actual positive outcome), 
respectively. These parameters can fluctuate depending on the biomarker decision 
boundary, so the ROC curve is a good mode to visualize how sensitivity and specificity are 
affected by this decided threshold. ROC curve is considered an objective and statistically 
valid method for biomarker performance evaluation [152]; a no parametric measure of 
biomarker utility. 
ROC curve generation and the area under the curve (AUC) —parameter that 
summarized the curve— can be generated by different informatics tools. AUC is interpreted 
as the probability that a diagnostic test or a classifier will rank a randomly chosen positive 
instance higher than a randomly chosen negative one. If a perfect classifier is obtained, the 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
Page | 62 
AUC value is 1, which mean that all positive samples are ranked before negatives ones. 
When AUC value is 0.5, the classifier does not present utility because it is equivalent to 
randomly classifying subjects as either positive or negative. Nevertheless, AUC may not be 
the most appropriate in some cases, where the partial AUC is more useful when only certain 
regions of the ROC space (high sensitivity or high specificity) are of particular interest 
[154]. 
3.4.2. Data treatment in targeted metabolomics analysis. The development of targeted 
metabolomics methods requires the optimization of experimental parameters for obtaining 
the best working conditions for the determination of the compound(s) of interest, through 
response surface or other designs [155,156]. The optimization designs can be classified into 
two main groups: i) univariate designs, in which a single factor is analyzed by the effect of 
its variation, while the rest of factors remain fixed. ii) multivariate designs, in which the 
interactions among different factors are studied [157]. Full factorial designs offer more 
information on interactions among factors, but the number of experiments multiplies 
substantially when many factors are analyzed.  As example, in two-level full factorial 
designs for k factors (2k), if k = 2, the required experiments are 4; if k = 4, the number of 
required experiments is 16; if k = 6, the number of experiments is 64, and so on. If more 
levels are analyzed, three level full factorial designs (3k) must be implemented, if k = 2, the 
number of required experiments is 9; if k = 4, the number of experiments is 81, etc. If the 
effect of many factors has to be analyzed, the use of fractional factorial models decreases 
the number of experiments and provide information about the factors that exert strong 
effect on the response. In this way, the number of factors to be analyzed in successive 
experiments is reduced [158]. Among the existing optimization methods, response surface 
is the most common, although the simplex method or the sequential method, where each 
new experiment is based on the results obtained in previous experiments, are used in some 
cases [159]. 
Concerning calibration curves and characterization of a method, simple statisticals 
such as regression or calculation is used to obtain the calibration curves for quantitation of 
the target metabolites and to characterize the analytical method (reproducibility and 
repeatability, among others) in target analysis. Then, after integration of the target 
metabolite area, pre-processing strategies as normalization and/or scaling can be applied. 
The objective of the former strategy is to remove the unwanted systematic bias in ion 
intensities among measurements, while keeping biological variation. In scaling, each 
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variable is divided by a different factor to treat all variables equally, regardless of their 
intensity. 
 
3.5. Identification of metabolites 
The identification of the key metabolites is a requirement in untargeted 
metabolomics analysis, because it is needed for biological or chemical interpretation of the 
results of metabolomics analysis. Owing to the chemical diversity of most metabolomes and 
the character of most metabolomics data, metabolites identification is intrinsically difficult. 
Identification of metabolites by MS requires a combination of high-resolution, 
accurate mass matching, MS/MS fragmentation data, and retention time comparisons 
between experimental data and pure standards or database, and libraries information 
[160]. When database searching results in multiple potential identifications for a particular 
mass, tandem mass spectra collected for each metabolite of interest can be compared to 
metabolite standards, libraries, or in silico fragmentation tools such as MetFrag for further 
narrow down identification assignments [161]. 
Pure standards of many compounds are not available, and also the cost of setting 
up large collections of standards is prohibitive. Publication and commercialization of 
electronic libraries from metabolomic analyses carried out by by GC–MS or LC–MS 
platforms reduce or minimize the problem. Retention times and characteristic ions of huge 
amounts of metabolites are listed in these libraries, each of which is specific to one type of 
column in LC, and to one type of derivatization and ionization (usually methoximation + 
trimethylsilylation and electron ionization) in the case of GC–MS libraries. The detected 
and no identified metabolites appear listed, together with their retention times and ion 
spectra as “mass spectral tags” or “events”. 
Some of the most used metabolites databases with identification purposes are 
METLIN [162], HMDB (Human Metabolome Database) [163], PubChem [164], MassBank 
[165], MMCD (Madison Metabolomics Consortium Database) [166], and LIPID MAPS 
[167], as the most important. Many plant metabolites, mainly secondary metabolites, are 
not present in these databases; therefore, given researchers create their own and specific 
databases for plant metabolomics studies. Some researchers on plant metabolomics have 
developed specific databases and software that allow integration of data from different 
omics. This is the case of the Sumner group, who has reported a tandem mass spectral 
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library of plant natural products by using pure standards and purified compounds [168]. 
The database involves plant secondary metabolites, with their retention times and tandem 
mass spectra obtained at six collision energies. 
 
3.6. Metabolic pathways interpretation 
After a set of metabolites of interest has been identified and quantified, two tools 
can be used to gain biological insight into the experimental results: (i) mapping and 
visualization of pathways, and (ii) statistical enrichment analysis of metabolite 
annotations. 
A first necessary step is the analysis of the metabolites set, the identification and 
interpretation of the metabolite data searching for the underlying biochemical mechanisms 
and their influence on phenotype and physiology of the target subject [169]. This means 
that the results provided by the applied metabolomics strategy need a secondary analysis 
to answer the initial question. A post-process of the metabolomics data is required for their 
biological interpretation (e.g., pathways or biological processes overrepresented in these 
genes), which can consist of extracting recurrent patterns or enriched ‘features’ such as 
metabolic pathways, physico-chemical features, associated diseases, etc., from the list of 
metabolites identified in the experiment. For large-scale experiments involving a huge 
number of compounds these features can be extracted by sophisticated and automatic 
tools. 
The software tools available for the biological and functional interpretation of 
metabolomics data are classified into two groups for complementary analysis. The first 
involves tools for mapping and visualization of a set of metabolites, thus allowing obtaining 
graphical plots of the metabolism, as metabolic pathways. The second group involves tools 
for the statistical analysis of metabolite annotations (enrichment analysis), and tools to 
perform metabolic modeling (or metabolic simulation). 
3.6.1. Pathway mapping and visualization. The interpretation of metabolic experiments 
requires to map and visualize the identified metabolites and associate them to metabolic 
pathways and other biological networks. The visualization allows that the identified 
metabolites can be considered in their metabolic context, assessing whether them are 
involved in a common biological pathway or are related in a given metabolic network. The 
complexity of the metabolism and the associated biological phenomena require automated 
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and interactive tools to locate and visualize a number of compounds in metabolic charts. 
Most of the existing tools are not specifically designed for metabolomics analysis but they 
can provide information on the location in the metabolism of a given set of metabolites. 
They have been classified in two groups: those provided by pathway databases [BioCyc-
Omics Viewer (http://biocyc.org), KEGG (http://www.genome.jp/kegg/pathway.html) and 
Reactome (http://www.reactome.org)]; and those developed by third-parties (independent 
laboratories) [iPath (http://pathways.embl.de), VANTED (http://vanted.ipk-
gatersleben.de), Metscape (http://metscape.ncibi.org)]. 
Other tools are focused on the integrated visualization of omics data such as 
ProMetra [170] (a web-based multi-omics pathway mapping and visualization tool), 
Paintomics [171] (a web-based tool that maps simultaneously quantitative data from both, 
transcriptomics or proteomics and metabolomics experiments in KEGG pathways), and 
Pathvisio, an application for the creation and edition of pathways, can also be used to map 
experimental data associated to both, gene/proteins and metabolites. There are two tools 
of interest to study plant metabolomes: KaPPA-View [172] and MapMan [173]. Other 
pathway analysis and visualization tools constitute a part of metabolomics data analysis 
software such as MetPA [174] (integrated in the MetaboAnalyst platform [175]), and Pathos 
[176] (integrated with MeltDB [177]). 
3.6.2. Enrichment analysis. Statistical values associated to gene functional annotations can 
be provided by several tools applied for enrichment analysis to transcriptomic and 
proteomic data. The annotations in a set of given genes can be compared with the 
corresponding annotations in a reference set, and those overrepresented in the given set be 
reported, according to a given statistical test. Then, the tools are used to ‘summarize’ a list 
of genes and elucidate the biological phenomenon behind it. Available software 
implementing similar approaches for the analysis of a list of metabolites are MSEA 
(http://www.msea.ca), MBRole (http://csbg.cnb.csic.es/mbrole), MPEA 
(http://ekhidna.biocenter.helsinki.fi/poxo/mpea/) and IMPaLA 
(http://impala.molgen.mpg.de). In this way, functional interpretation of metabolomic 
experiments on statistically significant pathways and on other biological annotations can 
be achieved. 
Types of analysis. Overrepresentation analysis (ORA) and set enrichment analysis 
(SEA) are two tools for enrichment analysis.  
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ORA allows development of a statistical test to check if a set of metabolites is 
enriched with a particular annotation as compared to a background set. The statistical test 
is applied to each annotation of the target set of metabolites for calculation of a p-value. 
ORA manages a given metabolite set and provided information on its underlined biological 
mechanisms and functional implications. Chi-square, Fisher’s exact test, binomial 
probability and hypergeometric distribution are some of the statistical tests used for 
analysis [178]). 
SEA uses a list of genes in the array sorted by a score (i.e., fold change of 
expression) to define a list of overexpressed or underexpressed genes, looking for 
annotations to be associated to extreme scores in a sort of ‘continuous’ way [179]. In its 
application the analysis of metabolite sets is performed by associating a quantitative 
measure to the concentration of each metabolite. The consistency of each annotation in the 
top and bottom of the list of metabolites sorted is evaluated by that quantitative value, 
which compared to a background distribution. 
 
3.7. Validation 
The correct biological interpretation of a specific metabolite difference in the 
untargeted approach depends on the reliability and suitability of the whole approach (from 
sampling to biomarker identification) [180]. Obtainment of consistent and reliable data 
from the analytical measurements is the key to avoid false positive and negative values. It 
means that validation of the analytical methods is needed to achieve the objective. 
For targeted metabolomics, validation of available guidelines is specifically focused 
on instrumental aspects. There are no guidelines available for untargeted metabolomics, so 
alternative ways to validate untargeted approaches are being used. Some available 
guidelines exist for analytical and bioanalytical aspects as the two industrial guidelines 
established by the United States Food and Drug Administration (FDA) [181,182], other two 
guidelines develop by ICH for method validation that were later merged in one (Q2-R1) 
[183], and one published by the International Union of Pure and Applied Chemistry, called 
“Harmonized Guidelines for Single-Laboratory Validation of Methods of Analysis”. This 
last guideline provides scant recommendations on procedures that should be used to 
confirm validation of analytical methods [184].  
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All these guidelines are mainly focused on seven (accuracy, precision, specificity, 
LOD, LOQ, linearity and range) parameters that should be controlled during validation of 
a bioanalytical method to get the searched purpose. 
3.7.1. Untargeted metabolomics and method validation. Guidelines for validating the 
analytical part in untargeted approaches do not exist. Most of the times the purpose of 
untargeted metabolomics is to discover statistically significant biomarkers doing unbiased 
differential analysis of the biggest amount of signals from biological samples, which will 
compare different conditions under study. Comparisons will be valid when the samples are 
studied under the same conditions and the method and the signal variation is related to the 
metabolites concentration. So, it is important to develop a method that includes all 
necessary steps prior to validation. 
Some alternative strategies to validate the analytical method have been used and 
are described below. 
Quality control samples (QCs). Some potential limitations should be controlled 
while developing and applying high-throughput techniques for the untargeted approach to 
eliminate bias owing to a gradual change in the performance of the system. These 
limitations can yield potential drifts in chromatographic and MS performance, thus 
affecting the repeatability and reproducibility of the method. To monitor the performance 
of the instruments, the order of the samples must randomized, and quality QCs should be 
included [185]. 
QCs are pools of samples prepared either from the target test samples, or a 
representative bulk control sample, and they should be assessed against preset criteria by 
which acceptance or rejection of the analytical run is decided. A number of injections 
should be made at the beginning and end of the analytical run, and repeated at regular 
intervals throughout the sequence run, with the aim of stabilizing the system. Other 
criterion suggested by the FDA for validation of bioanalytical methods consists of 
calculation of the relative standard deviation (RSD) of the molecular features existing in 
the QCs [186]. Values close to 30% RSD could be allowed for untargeted metabolomics 
analysis by LC–MS. Together with checking RSD in QCs, the linearity of diluted pools of 
QCs, matrix effects and recovery have been checked by some researchers [187]. 
Spiked standards. The use of the external standard method is frequent in the 
pharmaceutical industry to control the reliability of the methodology. This kind of 
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validation has been used by some researchers in untargeted analysis. As example, six 
xenobiotic standards were spiked to calculate the matrix effect and recovery in the 
validation of a quantitative method applied in nutritional plasma metabolomics [188]. 
Although spiking some chosen metabolites provides an approach to the general behavior 
of the method, the behavior cannot be supposed for all the compounds in the sample. 
Internal standards have also been used to check instrumental reproducibility [189]. 
Also conventional validation guidelines have been applied in some cases; 
nevertheless, not all them can be used for method validation. However, to target some of 
them from no targeted metabolites (considering different class/category, retention 
time/migration time, more or less abundant, some physico-chemical properties) should be 
acceptable to validate some methodologies.  
Statistical model validation. Either targeted or untargeted metabolomics analysis 
uses the tight clustering of QCs in the PCA model to check the quality of the instrumental 
platforms. By the poor or good clustering of QCs, an initial idea of the data could be got, 
and before making a PCA model the QCs can be excluded and later predicted on the same 
model. The clustering of the QCs after prediction considers the repeatability of the 
instrumental performances and established that the separations between the groups are 
not due to the instrumental variations but to the sample itself [190]. 
3.7.2 Chemometrics model validation. After validation of an analytical method, the 
chemometrics models must be validated. The prediction reliability is of primary concern in 
the evaluation of the performance of a given regression model. 
External validation is referred to as the validation of models by objects (samples), 
whose data were not used for model calculation. Objects excluded from the model fitting 
are known external test objects, and they should not be confused with test objects used for 
the internal validation of models. The main difference between the two sets is that the 
former is used only for validation purposes, while the latter also used for model calculation 
and optimization. External test objects should be arbitrarily selected from the pool of 
existing objects and they must be fully independent of the training set. 
Strategies based on cluster analysis, optimal design or sphere exclusion algorithms 
are applied to design an external test set that results enough representative of the whole set 
of data [191]. In this way, the test data lose their status of independence of training data. 
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4. Recent contributions of the FQM-227 research group to plant and 
clinical metabolomics 
The group in which the PhD student has developed her PhD is “Analytical 
platforms in metabolomics: clinical and agrifood areas", FQM-227, as a member of the PAI, 
and therefore of the University of Córdoba; and “GC-21 Metabolomics” as a member of the 
IMIBIC. The main research lines of this group are metabolomics (including lipidomics, 
nutritional metabolomics, search for clinical metabolomics biomarkers, plant 
metabolomics, and analytical omics platforms based on mass spectrometry), analytical 
green chemistry, exploitation of agrifood byproducts, automation and acceleration of 
sample preparation by microwaves, ultrasound or superheated liquids assistance. The wide 
experience of the group in the development, validation and application of metabolomics-
based analytical platforms is remarkable. 
Clinical metabolomics studies developed by the group in the last five years include 
a variety of samples, from no invasive and scarcely used human biofluids as sweat [192] or 
exhaled breath condensate [193] to common biofluids as urine [194] or blood [81]. All kind 
of research, from optimization studies [195] to creation of data treatment tools, has so far 
been developed by the group [196]. Among others, the group has developed optimization 
studies for metabolomics untargeted analysis of human sweat and exhaled breath 
condensate by LC–MS/MS [195] and GC–MS, respectively, both in high resolution mode 
[197]. After characterization of the target samples, discrimination of different groups of 
samples has been achieved. Thus, sweat has been the biosample involved in metabolomics 
studies for lung cancer screening [192]; exhaled breath condensate has been the sample for 
discrimination of either individuals with different smoking habits by GC–TOF/MS [198] or 
lung cancer patients from risk factor individuals [199]; and also for identification of 
metabolomics panels with potential for lung cancer screening [193]. Urine has allowed 
discriminating prostate cancer patients and negative biopsy controls [194]. 
Other clinical metabolomics studies have been focused on the complex pathways 
in which vitamin D is involved. After development of analytical methods to determine in 
200 µL of serum samples up to 8 vitamin D metabolites [82] —including the C3-epimer-
25-monohydroxyvitamin D3, which has required the use of two-dimensional LC coupled to 
an MS/MS detector [200]— the method thus developed has been massively applied to 
serum samples from cohorts constituted by breast cancer patients, and premenopausal 
women, among others [201,137]. The results from application of the method to massive 
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number of samples have allowed finding out the relation between 25-hydroxyvitamin D in 
serum and mammographic density in premenopausal Spanish women [137], among other 
findings. Other interesting recent studies developed by the group have involved 
endocannabinoids and analogous compounds, for which a method based on LC–MS/MS in 
MRM mode, and on a key serum-sample preparation step has been reported [202]; and the 
quantitative determination and confirmatory analysis of N-acetylneuraminic and N-
glycolylneuraminic acids in serum and urine by SPE on-line coupled to LC–MS/MS [203]. 
Regarding plant metabolomics, methods for sample preparation and analysis have 
been developed for a great variety of samples, involving traditional samples such as olive 
leaves and fruits, wine and vineyard material, but also samples of recent interest in the 
agrifood area both fruits and byproducts and also waste of them. Examples of these studies 
are the characterization of polar and no polar compounds in stevia leaves [204], wine lees 
[205] or Persian lime (Citrus latifolia) [50], and sample preparation for quantitation of 
families of compounds such as flavonoids in orange peel [206]. Characteristic of the group 
are the studies on the effect of auxiliary energies on the extraction of plant metabolites 
[207] or that of evolution of the composition of polar or no polar fractions components of 
a fruit during the grown period, performed by both LC–QTOF MS/MS and GC–TOF/MS 
platforms [49,207]. Other studies have been focused on compounds with healthy effects, 
as is the case with oleocanthal and oleacein in virgin olive oils, which were quantified by 
LC–MS/MS [208]. Also, the effect of these compounds in humans and animals has been 
considered, such as the decrease of the postprandial inflammatory response by reducing 
postprandial plasma lipopolysaccharide levels in metabolomic syndrome patients by olive 
oil phenolic compounds [209] or the inhibitory effects on liver carcinogenesis in rats by red 
and white wine lees [210]. Furthermore, the group has elucidated the metabolism of some 
pesticides such as imazamox in common plant and in plants with genetically modified 
resistance, such as Clearfield® wheat [211]. 
Finally, the group have also experience in acquisition and treatment of 
metabolomics data, as shown in the following publications: MSCombine: a tool for merging 
untargeted metabolomic data from high-resolution mass spectrometry in the positive and 
negative ionization modes [196], and in enhancing metabolomics detection and 
identification by LC−MS/MS untargeted analysis in combination with gas-phase 
fractionation [212]. 
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This section of the Thesis-Book briefly describes the different types of samples that 
have been the object of the research, the instruments and devices used during the 
experimental development of the Thesis, as well as the chemometrics tools and databases. 
In Chapters IV-to-XI a more detailed explanation of those that have been used in the 
research collected in each of them is included. 
 
1. Samples 
For the development of the research contained in Section B, three types of plant 
samples have been used; residues from the olive oil industry, such as olive (Olea europaea 
L.) leaves (Chapter IV), white button mushrooms (Agaricus bisporus) (Chapter V) and 
Cannabis sativa L. leaves and inflorescences (Chapter VI). 
For Sections C and D, only a type of biological samples has been used: human sweat 
(Chapters VII-to-XI). 
 
2. Sample preparation devices 
Discontinuous equipment for sample preparation has been used in both targeted 
and untargeted analysis. In general, sample preparation was based on agitation, 
centrifugation, dilution, extraction, precipitation of proteins and/or derivatization. The 
required steps depended on the metabolites of interest, sample nature and 
chromatographic separation (GC or LC) used. 
In plant metabolomics, obtaining of plant extracts required drying, chopping or 
grinding of the leaves, and subsequent extraction with a solvent or a mixture of them (see 
Chapters IV and VI). Methanol and water─methanol mixtures were the solvents used for 
polar compounds extraction, and hexane for no polar compounds. The extraction step was 
assisted by agitation (using a Vibromatic rocking mixer) (Chapter IV) or US (using an US 
bath at 37 kHz and 800 W) (Chapter VI). 
Mushroom extracts required homogenization, enzymatic digestion, centrifugation 
of the hydrolyzate and collection of the supernatant (mushroom extract) (see Chapter V). 
Fractionation of the extract required LLE with different polarity index extractants. In 
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Chapter IV, the olive leaf extract was subjected to US-assisted enzymatic hydrolysis 
(USAEH) of oleuropein to its aglycon, which required controlled conditions of enzyme 
amount, buffer pH, temperature (by a digital block heater) and optimized US conditions 
(US cycles, duty cycle, % amplitude and cycle time), for which an ultrasonic probe (20 kHz, 
400 W), equipped with a cylindrical titanium alloy probe microtip was used. 
In clinical metabolomics, simple protocols as dilution with an acid (Chapter XI) or 
dilution+clean-up by c-µSPE (Chapter VII) were used. In other cases, focused to coverage 
the sweat metabolome, protocols as deproteination (Chapter X) and LLE with different 
extractants (Chapter VIII) were used. Deproteination+acidification was used in Chapter 
IX. 
In the research involving GC, the sample preparation protocol required removal of 
water traces (dryness or freezing) and derivatization of the extract (using a ThermoMixer 
C to heat and mix). Methoxymation+silylation (Chapter VIII-to-X) or only silylation 
(Chapter VI) were the derivatization protocols used. 
 
3. Detectors and previous chromatographic separation systems 
The methods developed in the experimental part of this Thesis have been based on 
chromatographic separation by LC or GC, and subsequent detection by mass spectrometry. 
For untargeted analysis to obtain the metabolomics profile of plant extracts 
(Chapters V and VI) and human sweat (Chapters IX and XI), an Agilent 1200 Series LC 
system coupled to an Agilent 6540 UHD Accurate-Mass QTOF hybrid mass spectrometer 
equipped with dual electrospray ionization (ESI) was used, with detection in MS/MS mode. 
In all cases, the separation of the metabolites was based on C18 reverse-phase analytical 
columns (25 cm×0.46 cm i.d., 5 μm particle size in Chapter V; 25 cm×0.46 cm i.d., 3 µm 
particle size in Chapter VI; and 5 cm×0.46 cm i.d., 3 µm particle size in Chapters IX and 
XI), using water and methanol (Chapter V) or acetonitrile as mobile phases, and formic 
acid as ionization agent. 
Targeted analysis, used in Chapter IV and VII, was performed by an Agilent 1200 
Series LC system (consisting of a binary pump, a vacuum degasser, an autosampler and 
thermostated column compartment), and an Agilent 6460 triple quadrupole mass 
spectrometer equipped with a Jetstream® electrospray ionization (ESI). Chromatographic 
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separation was performed by C18 reverse-phase analytical columns (15 cm×0.46 cm i.d., 5 
µm particle size in Chapter IX; and 10 cm×0.46 cm i.d. 3 µm particle size in Chapter VII), 
using water and methanol or acetonitrile as mobile phases, and formic acid or ammonium 
formate as ionization agent. In all cases, the data were processed using a MassHunter 
Workstation Software for qualitative and quantitative analysis. 
Untargeted analyses of volatiles or easy to convert into volatile compounds were 
performed using always the same plaftform (Chapters VI and VIII-to-X): an Agilent 7890B 
Series GC system coupled to an Agilent 7200 UHD Accurate-Mass QTOF hybrid mass 
spectrometer equipped with electron impact source, using a fused silica DB-5MS-UI 30 
m×0.25 mm i.d,×0.25 μm film thickness capillary column from Agilent Technologies. 
 
4. Chemometrics tools 
According to the importance that chemometrics has acquired in metabolomics, in 
the research included in this Thesis-Book, chemometrics tools have been used both for the 
development and optimization of analytical methods and for the treatment of multivariate 
data. First of all, data processing was carried out with different software according to the 
objective and instrument used: 
i) Extraction and alignment of molecular entities in untargeted analysis provided 
by an LC–QTOF platform. A combination of Agilent softwares was used: Qualitative 
Workstation+Profinder or MassProfiler Professional. The first software allows extracting 
the entities taking into account adducts and isotopes, the second and third allow alignment 
of the potential entities. 
The Qualitative Workstation software was used to process the data obtained by LC–
QTOF in auto MS/MS mode. Treatment of raw data files started by extraction of potential 
molecular features with the suited algorithm included in the software. Background 
contribution was removed by subtraction of MFs linked to plasticizers, solvent impurities 
and other contaminants after analysis of a blank of each sample. Thus, ions with identical 
elution profiles and related m/z values (representing different adducts or isotopes of the 
same compound) were extracted as entities characterized by their retention times, intensity 
in the apex of the chromatographic peaks and accurate mass (Chapters V, VI, IX and XI). 
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The “Recursive Feature Extraction” algorithm from the Profinder software was 
used to extract and align potential molecular features in all injections. This algorithm 
initially deconvolutes chromatograms and aligns features across the selected sample files 
in terms of mass and retention time; then, it uses the mass and retention time of each 
feature for recursive targeted feature extraction. This two-step procedure reduces the 
number of both false negatives and false positives in feature extraction (Chapter XI). 
The “Batch Targeted Feature Extraction” algorithm from the Profinder software 
was used to extract and align peaks from all chromatograms that matched a database of the 
identified metabolites (Chapters VI and IX). 
The MassProfiler Professional was also used to align potential molecular features 
in all injections (Chapter V). 
ii) Extraction and alignment of molecular entities in untargeted analysis using the 
GC–TOF platform. The combination of three Agilent softwares was used: Unknown 
Analysis, Qualitative Workstation and Quantitative Workstation. The first allows unzipping 
all data files obtained by GC–TOF/MS in full scan mode; the second allows extracting the 
potential molecular entities from an untargeted analysis; the third software is used to re-
extract the entities in all samples (recursive analysis). 
The Qualitative Workstation software was used to process all data obtained by GC–
TOF/MS in full scan mode. Treatment of raw data files started by deconvolution of 
chromatograms to obtain a list of molecular features (MFs) considered as potential 
compounds defined by the m/z value and retention time (RT) of one representative ion for 
each chromatographic peak. The background spectrum was subtracted to the spectrum 
obtained from each sample before its deconvolution (Chapters VI and VIII-to-X). 
For recursive analysis, the Quantitative Analysis software was used to reintegrate 
all potential compounds found in all analyzed samples, using the corresponding 
characteristic quantifier and qualifiers (Chapters VI, VIII and IX). 
Once data pre-processing has finished, the data pre-treatment step (which consists 
of applying mathematical operations to favor comparison among samples) starts. 
Normalization of the data was performed by the Mass Profiler Professional, before 
the statistical analysis (Chapter VIII), and also by MetaboAnalyst (www.metaboanalyst.ca). 
The latter was used for normalization by sum (the quantitative response of a potential 
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metabolite is scaled by the sum of the quantitative responses of all potential metabolites 
detected in the samples), log transformation and scaling of the data set (Chapter XI). 
Regarding types of filters, filter by frequency was required in Chapter V. The Mass 
Profiler Professional software was used to reduce the molecular features number, based on 
frequency of occurrence by comparing repetitions of the same sample. 
Among the statistical analysis tools and softwares used in the studies of this Thesis-
Books the following are remarkable: 
- Statgraphics: software that allows performing different univariate and multi-
variate statistical analyses, as well as the design and evaluation of screening models and 
response surfaces. It was used for optimization of experimental parameters to obtain the 
best working conditions for the determination of the compound(s) of interest, through 
response surface. A multivariate design, a 15-run BBD, was used to optimize three 
interrelated US variables: X1 (duty cycle), X2 (amplitude) and X3 (cycle time) for the 
enzymatic hydrolysis of oleuropein (Chapter IV). Other multivariate design involving 3-
level 32 factorial designs including 9 experiments and 2 central points, which corresponded 
to star points used to model the surface, was used to evaluate the nozzle voltage and sheath 
temperature of the source for amino acids quantitation (Chapter VII). 
- MassProfiler Professional: software that allows application of different statistical 
analysis algorithms especially suitable for metabolomics analysis. It was used for statistical 
analyses in Chapters IV and VIII. 
- MetaboAnalyst: web tool that allows executing high performance analytical 
studies in metabolomics for the analysis and interpretation of metabolomics data. 
MetaboAnalyst was used for metabolomic data analysis, visualization and interpretation in 
Chapters VII and XI. 
- SPSS Statistics: software package used for interactive or batched statistical 
analysis. This base software includes descriptive statistics (cross tabulation, frequencies, 
descriptives, explore, descriptive ratio statistics), bivariate statistics (means, t-test, 
ANOVA, correlation, no parametric tests, Bayesian), linear regression and prediction to 
identify groups (factor analysis, cluster analysis and discriminant analysis). SPSS was used 
to performed the statistical analyses in Chapters V and IX, and PASW Statistics was used 
to statistically analyze the differences in the content of cannabinoids and terpenoids among 
different varieties of cultivars and cultivation modes (Chapter VI). 
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The evaluation of the predictability of metabolites or panels with potential as 
markers has been carried out through Random Forest graphs and ROC curves, which 
represent specificity versus sensitivity. The free online access tools ROCCET 
(http://www.roccet.ca/ROCCET/) and Metaboanalyst have been used to obtain them. In 
Chapter XI, the predictive capability of each metabolite by Random Forest Analysis was 
determined by MetaboAnalyst. 
Design of prediction models and creation of marker panels: in this case we have 
used the online tools ROCCET, MetaboAnalyst and the PanelomiX software, which allow 
creating marker panels and assess their prediction/discrimination ability. In Chapter XI, 
PanelomiX toolbox, supported on the iterative combination of biomarkers and thresholds, 
was used to combine iteratively biomarkers by selecting thresholds that provided optimal 
classification performance [1]. 
 
5. Identification of metabolites and databases 
Identification of the most relevant entities was supported on MS and MS/MS 
information, which was obtained by LC–QTOF MS/MS and analyzed using the 
MassHunter Qualitative Data Analysis v.7.0 program (Agilent Technologies, Inc. 2014), by 
comparison of the MS/MS spectra obtained with those stored in libraries generated by the 
research group [2], as well as in the public databases such as METLIN MS and MS/MS 
databases (http://metlin.scripps.edu); the Human Metabolome Database (HMDB) 
(http://www.hmdb.ca) and the Metfrag database (https://msbi.ipb-halle.de/MetFrag/) 
based on mass spectra of metabolites generated by in silico fragmentation (Chapters V, VI, 
IX and XI). In addition, standard solutions were used to confirm the presence of identified 
compounds (Chapter VI). 
The identification of the metabolites detected by GC–MS was firstly carried out by 
searching MS spectra in the NIST Mass Spectral Search v.11.0 (NIST, Washington, DC, 
USA). Only identifications with a match factor and a reverse match factor higher than 700 
were considered. Furthermore, the RI values included in the NIST database were used to 
support identifications. For this purpose, an RI calibration model was built by plotting the 
retention times (RT) obtained by analysis of the alkane standard mixture (C10 to C40 with 
an even number of carbons) with the chromatographic method used in this research and 
the RI values provided for each alkane by the NIST database. This equation was used to 
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estimate the RI value for each identified compound, which has to be less than 100 units 
different as compared with the theoretical value provided by the NIST. This database does 
not contain high resolution MS information as provided by the TOF detector. For this 
reason, a third step was included to validate identification of each compound by using high 
resolution MS. Thus, the molecular formula for the tentative ion [M]+ and the most intense 
fragments for each molecular feature (MF) should fit the NIST identification by setting a 
cut-off value in mass accuracy of 10 ppm (Chapters VI and VIII-to-X). 
Identification was also carried out by searching MS spectra on the Fiehn database 
[3]. Only identifications with a score higher than 70 were considered as valid. The RT 
included in the Fiehn database were also taken into account to support identifications with 
the requirement for acceptance of a difference between the experimental RT and the 
theoretical value provided by this database for each target compound below 0.50 min 
(Chapters IX and X).  
Additionally, multistandard solutions of terpenoids and cannabinoids were 
injected to confirm their identification in the Cannabis extracts (Chapter VI), and 
derivatized standards (glutamic acid, phenylalanine, proline, D-galactose, D-glucose, myo-
inositol, phosphate, p-hydroxybenzoic, fumaric, malic, succinic, caprylic, lauric and 
palmitic acids) were injected for confirmation of some amino acids, sugars, benzene 
derivatives, dicarboxylic and fatty acids in sweat (Chapters VIII-to-X). 
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Scientist training requires, as a starting step, an in depth study of the literature 
related to the planned research; then, a continuous updating during the development of 
target studies. The previous study of the related literature allows establishing the limits 
between what is done and what should be done to advance in or start a given research line. 
The continuous update is the way to keep the research in the front line.  
An added value to an in depth study of the bibliography on a certain topic can be 
obtained if the knowledge acquired is sufficient to be offered to potential readers in the 
form of either a revision or a book chapter. This has been the case with the training of the 
PhD student on sample preparation, one of the research guidelines of the team to which 
she belongs, and in which the use of ultrasound (US) is a hallmark. 
In this way, the effect of US on the extraction of food components has given place 
to a huge number of methods that clearly surpass the analytical features of conventional 
methods and even those of methods assisted by other energies, such as microwaves. 
Chapter I of this PhD book is in turn a chapter belonging to an online Reference Module in 
Food Sciences, published by Elsevier, in which typical and special US-assisted methods for 
extraction of food components are explained and discussed; then compared with other 
methods using different energy assistance or even dual energy assistance.  
Chapter II constituted a new step in the literature training of the PhD student as it 
is devoted to the use of US for sample preparation in the metabolomics field. Thus, the 
published review critically discusses the most abundant uses of US in the plant area to the 
detriment of the clinical area. Special emphasis is devoted to the almost total absence of 
studies on the potential degradation of given sample components caused by US, as only the 
efficiency of the favored step is outlined without taken into account the degradation that 
US energy can promote on key and/or unimportant compounds. 
The very controversial information in the bibliography related to the influence of 
US on biocatalysis has been the subject of an also controversial review that constitutes 
Chapter III. The scan attention paid to the frequency and power of the US device used, and 
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the absence of crucial data and metadata in most publications hinders to draw conclusions 
from the study of the existing bibliography. The assessment of this situation gave place to 
the development of the research in Chapter IV (Section B) as a starting point of the future 
wide investigation required to give enough light on the US–enzyme binomial. Rational use 
of US, either to accelerate or hinder enzymatic activity, will be the most useful result of 
these studies. 
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Ultrasound-assisted extraction of food 
components 
 
María del Mar Delgado-Povedano and María Dolores Luque de Castro 
 
Synopsis 
The growing use of ultrasound-assisted extraction (USAE) with foodstuffs is 
discussed. The chapter starts with a general overview on the ultrasound (US) basics and the 
features that assist in extraction, the extractants and US devices used. Representative 
examples of USAE methods used for the extraction of food components (e.g., antioxidants, 
volatiles, multielements, undesirable compounds) are critically discussed. Further USAE 
methods for foods based on the use of ionic liquids (ILs), a typical US property of favoring 
emulsification simultaneously with extraction ─both involving not only solids but also 
liquid samples─, development of USAE with either simultaneous derivatization or 
enzymatic catalysis are discussed. A comparison of USAE methods with other conventional 
or unconventional extraction methods with respect to the respective advantages and 
disadvantages is also covered. The exploitation of USAE at pilot scale and industrial scale 
is discussed with a view to a wide use of this technology at a scale greater than laboratory 
scale. Finally, the foreseeable and desirable future trends are considered. 
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1. Introduction 
Ultrasound (US), or sound of frequencies above the capabilities of human hearing, 
spans within the range from 20 kHz to several GHz, which can be divided into a power 
region and a diagnostic region. The low-frequency region is endowed with enough 
ultrasonic energy to produce cavitation, which is of great interest from the analytical point 
of view for sample preparation and from the industrial point of view to produce key effects 
on given steps of the production line. The cavitation phenomenon is highly dependent on 
the US frequency (a property that should be taken into account by the users), and it consists 
of three main components: thermal effects, shear forces, and free radical formation (the 
last only when applied in polar liquids). 
 
1.1. General aspects of ultrasound-assisted extraction 
The favorable effect of US on mass transfer between two phases in the same or 
different physical state has been widely demonstrated as did the number of chemical 
reactions accelerated/improved under ultrasonic influence (Luque de Castro and Priego-
Capote, 2006). Thus, US application allows to save energy, and also to be operated 
efficiently at moderate temperatures, which is beneficial for heat-sensitive compounds. 
When applied to the removal of given components from a solid sample (known as solid–
liquid extraction, leaching, or lixiviation), US gives place to phenomena that affect the raw 
material through effects such as fragmentation, erosion, detexturation, and also to an effect 
referred to as ultrasonocapillary effect or increase of depth and velocity of penetration of 
the extractant into channels and pores under given US conditions (Chemat et al., 2017). In 
dealing with plant cells or tissues, the US effect involves cell membrane destruction, thus 
causing morphological changes of the plant structure that can change its properties 
dramatically. An example of this behavior can be seen in Fig. 1, which shows 
photomicrographs of saffron before and after ultrasonication (Sereshti et al., 2014). The 
effect is enhanced by the simultaneous action of other types of treatments, as that provided 
by extractants under supercritical (SC) conditions. This is the case with the supercritical 
fluid extraction (SFE) with SC carbon dioxide of bioactive components from blackberry 
(Rubus sp.) industrial residues, which was enhanced by US application. Scanning electron 
microscopy (SEM) was used to analyze the blackberry bagasse subjected to SFE with and 
without US assistance, which showed that this treatment disturbs the cell walls, enhancing 
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the release of the extractable compounds. This can be seen in Fig. 2 showing the effect of 
SFE and USAE separately and combined (Pasquel Reátegui et al., 2014). These studies are 
of interest to explain the increased extraction efficiency (of phenols and anthocyanins in 
this case) when these types of materials are subjected to the combined treatment, and also 
to understand, from an economical viewpoint, the final state of the residue after extraction. 
 
                 
Fig. 1. Morphological photomicrograph of saffron: (A) before ultrasonication and (B) after 
ultrasonication. With permission of Elsevier, Sereshti, H., Heidari, R., Samadi, S., 2014. 
Determination of volatile components of saffron by optimized ultrasound-assisted extraction in 
tandem with dispersive liquid–liquid microextraction followed by gas chromatography–mass 
spectrometry. Food Chem. 143, 499–505. 
 
 
Fig. 2. Images obtained by SEM on the surface of blackberry bagasse particles under different 
conditions of extraction: (A) SFE without US at 50 ºC and 25 MPa; (B) SFE + US at 40 ºC, 15 MPa 
and a 200 W US power; (C) SFE + US at 50 ºC, 25 MPa and a 400 W US power. SEM, scanning 
electron microscopy; SFE, supercritical fluid extraction; US, ultrasound. With permission of Elsevier, 
Pasquel Reátegui, J.L., da Fonseca Machado, A.P., Barbero, G.F., Rezende, C.A., Martínez, J., 2014. 
Extraction of antioxidant compounds from blackberry (Rubus sp.) bagasse using supercritical CO2 
assisted by ultrasound. J. Supercrit. Fluids 94, 223–233. 
(A) (B) 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
Page | 108 
The lower operating temperature in USAE, as compared to microwave-assisted 
extraction (MAE), does not avoid the degradation effect of free radicals formed by polar 
extractants. While USAE can be a suitable technique for the extraction of thermally 
unstable compounds, one should not forget the potential effect of free radicals, which 
mainly affect to the compounds extracted at long US application times. The degradation 
effect is shown as a decrease of the extraction yield when increasing the extraction time if 
the process is monitored by an unselective detector (Sun et al., 2011). 
 
1.2. Extractants in ultrasound-assisted extraction 
The extractant features can influence USAE efficiency drastically, and its effect is 
highly dependent on the nature of both the matrix and analyte(s). Fig. 3 shows this effect 
on the extraction of phenols from pomegranate peel using extractants of different polarity. 
The behavior shown in the figure was expected, given the polar nature of the extracted 
components (Kaderides et al., 2015). 
 
 
Fig. 3. Effect of the extractant on the extraction yield of phenols from pomegranate. With permission 
of Elsevier, Kaderides, K., Goula, A.M., Adamopoulos, K.G., 2015. A process for turning pomegranate 
peels into a valuable food ingredient using ultrasound-assisted extraction and encapsulation. Innov. 
Food Sci. Emerg. Technol. 31, 204–215. 
 
The present trend of promoting green extractants has led to the use of oils for 
extraction. However, oils as extractants have a limited application as they can only be used 
to be enriched with the components from the solid that are able to be transferred to the 
lipids. Isolation of the transferred compounds is a very difficult task. Recently, USAE has 
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been used to transfer carotenoids from pomegranate to sunflower and soy oils (Goula et al., 
2017), thus improving the antioxidant capacity of the oils. Nevertheless, when dealing with 
oils, it is important to consider that US can drastically affect oil stability. This behavior was 
demonstrated by the authors in a study on oils’ stability in which stable extra-virgin olive 
oil showed severe rancidity after only a few hours of US application (Cañizares et al., 2004). 
The growing trend to the use of multivariate optimization designs (e.g., central 
composite rotary design, faced-centered cubic experimental design, completely 
randomized two-factorial design, Box–Behnken design), which reduces the number of 
experiments to be carried out in the optimization process, hides the behavior of each 
individual component when its value is changed. This negative aspect of multivariate 
optimization is absent in univariate optimization, which should be applied when possible. 
 
1.3. Ultrasound devices 
There are currently two main types of US equipment available in the market for 
analytical laboratories (plus a further type, plate transducers, which is not to be discussed 
in this article): ultrasonic cleaning baths and probes. The former (designed mainly for 
cleaning glassware and degassing) is omnipresent in any laboratory, because it is the most 
affordable and inexpensive US device available in the market. However, US cleaning baths 
have several major disadvantages due to the design of these baths (with transducer 
elements embedded in the tank walls). Ultrasonication is generally highly no uniform, 
which leads to problems with reproducibility of effects and performance. Furthermore, the 
transferred power into the tank declines over time, mainly due to a degradation of the 
transducer elements. Very often, users do not consider these aspects that can severely affect 
the results. In addition, not all US cleaning baths operate at the same frequency; a fact that 
can significantly affect the results, which is obviously a big problem when reproduction of 
previously reported results is attempted. 
US probes, also referred to as horns or sonotrodes, are not subjected to the 
disadvantages of ultrasonic cleaning baths. In addition, probes are endowed with the 
versatility of power and duty cycle programming as required, so they are better suited to 
facilitate analytical steps in laboratories than US cleaning baths. Besides, microtips can be 
coupled to the transducer to work at low-volume scale. 
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Sonoreactors are US devices that work in tank format, but are well designed to 
operate more uniformly and provide good reproducibility, provided sample location and 
setup are fixed; therefore, these are more appropriate for analytical purposes. A similar 
design to analytical sonoreactors is adopted for pilot- and industrial-scale reactors (Chemat 
et al., 2017). 
 
2. Typical ultrasound-assisted extraction of food components 
USAE methods are often grouped according to some common characteristics of the 
food (e.g., antioxidant capacity, volatility, designed for extraction of volatile compounds, 
or because some food contaminant requires to be determined). Their main characteristics 
are discussed below. 
 
2.1. Extraction of antioxidant compounds and other families of valuable 
compounds from plants/foods 
There is a growing trend to extract families of compounds with given characteristics 
from a raw material, which can be used as nutraceuticals or to enrich/supplement foods. 
The raw material can be a complete plant or a part of it (e.g., leaves, fruits, flowers, roots), 
a low value residue or waste. US is often an excellent treatment to accelerate extraction, 
improve the yield, and facilitate automation of the process. A plethora of USAE methods 
has been developed with the aim to obtain valuable plant components. 
In most of the published USAE methods the extracted compounds are not 
identified, but rather global parameters of the extract, such as the antioxidant activity, the 
radical scavenging activity, the reducing antioxidant power, the total phenols content, or 
the flavonoid content, are measured during optimization and as a final result of the method 
(Briones-Labarca et al., 2015). In most cases, common photometers for monitoring the 
given property of the extract are reported; therefore, degradation of the extract components 
under US application is only detected by a decrease of the measured absorbance. However, 
identification of the extracted components is essential when the aim is to use the extracts 
in food products to ensure that the degradation products are not toxic. Recent examples on 
this field are discussed below. 
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The term “bioactive compounds” is very broad and covers, for example, those 
compounds extracted by Tomšik et al. from Allium ursinum using an ethanol–water 
mixture under US application and optimizing the process by response surface methodology 
(RSM) (Tomšik et al., 2016). Photometric overall measurements of total phenols utilizing 
the Folin–Ciocalteu (F–C) method and gallic acid as general standard, flavonoids by the 
aluminum chloride colorimetric assay, and scavenging capacity by the DPPH radical 
scavenging assay were carried out, but none of the extracted compounds were identified. 
Numerous figures showed the extraction yield as a function of each of the two relevant 
variables, while a table of the ANOVA results highlighted the importance of solvent 
concentration, as the authors considered the concentration of ethanol in the extractant 
mixture. 
A further example was given by Wang et al. (2016) in the research on blueberries, 
cherries, and red pear peels attempting to achieve a high recovery of phenols and 
anthocyanins. The authors determined in the extracts the overall phenol content (F–C 
method), total monomeric anthocyanin content (differential pH method), total polymeric 
anthocyanins through percent polymeric color, and DPPH scavenging activity. Then, the 
extracts were injected into a liquid chromatograph (LC) for separation of the components 
and monitored at 540 nm by a photometric detector. Three of the anthocyanins in the 
extract were quantified by commercial standards, while those with no available standards 
were identified by bibliographic information and semiquantified by standards close to their 
chemical structure. Comparison of conventional extraction and USAE showed that 
different operating conditions must be implemented for maximizing extraction yield and 
anthocyanins composition of the extracts from the different fruits. 
An extraction method based on discontinuous application of US was investigated 
to achieve high extraction yield and antioxidant activity of the extract from pomegranate 
peel. The main aim was the extraction of ellagitannins, phenolic acids, and flavonoids, 
significantly concentrated in pomegranate peel, to which health contributing properties, 
such as anticarcinogenic, antimutagenic, antitumoral, antidiabetic, and antioxidant 
properties have been attributed (Kazemi et al., 2016). Two commercial standards of 
punicalagin and ellagic acid were used for identification and quantitation of these 
compounds, while other extract components were identified/semiquantified by 
bibliographic data. Enhanced extraction yield and shortening of the time were achieved 
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under the optimum conditions of the USAE method, considered by the authors as practical 
for large-scale industrial food production. 
In dealing with USAE of valuable compounds in orange peel, a method was 
developed in 2010 for overall determination of the phenolic content (F–C method), DPPH 
scavenging activity and ORAC tests in the extracts, and individual determination of 
naringin and hesperidin by a diode array detector (DAD) after LC separation (Khan et al., 
2010). A more recent study for USAE of the same raw material used LC–quadrupole time-
of-flight (QTOF) for identification of 8 coumarins, 4 polymethoxyflavones, 2 
flavonoidaglycons, 12 glucosylated flavonoids, and 7 further compounds not classifiable in 
the previous groups, thus providing useful information on the orange peel composition 
(Molina-Calle et al., 2015). 
In addition to USAE of antioxidant compounds from plants or foods, the USAE of 
water-soluble polysaccharides from dried and milled by-products generated from Agaricus 
bisporus production has recently been reported (Aguiló-Aguayo et al., 2017), and also 
extraction of hemicelluloses from grape pomace (Minjares-Fuentes et al., 2016), thus 
showing the wide field of little to unexplored applications of USAE in food processing. 
It is worth emphasizing that authors working with LCs coupled to photometric 
detectors use most times HPLC analysis to designate both individual separation and 
molecular absorption detection. 
 
2.2. Extraction of volatile compounds 
It is well known that US application favors removal of volatiles from liquids as US 
cleaning baths have for years been used for this purpose (e.g., for degasification of 
chromatographic mobile phases). Nevertheless, authors working on USAE of volatile 
components from saffron developed this step in an open atmosphere without protection 
for losses of both the target compounds, after transference to the liquid extractant, and the 
volatile medium (an ethanol–ethylacetate mixture). The authors stored the extract at 4 ºC 
in the absence of light until gas chromatography–mass spectrometry (GC–MS) analysis, by 
which they identified 40 saffron components (Jalali-Heravi et al., 2009). More recently, a 
methanol–acetonitrile mixture has been used for USAE of volatiles from the same matrix, 
followed by dispersive liquid–liquid microextraction (DLLME) to isolate and enrich the 
extract on the target compounds prior to GC separation and MS detection (Sereshti et al., 
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2014). No special operating conditions were used to avoid losses of the more volatile extract 
components, which could be the reason for the high detection and quantitation limits 
provided by the method (at the mg/L level) for the 27 identified compounds. 
 
2.3. Multielement ultrasound-assisted extraction 
Metal ions have been extracted by US assistance from food and beverages prior to 
determination by the proper atomic detector (Tadeo et al., 2010). US-assisted cloud point 
extraction/preconcentration of metal ions from selected foods and beverages was achieved 
before determination of antimony and tin by flame atomic absorption spectrometry (FAAS) 
(Altunay et al., 2016). A limit of detection for both Sb(III) and Sn(IV) of 0.03 mg/L and 
sensitivity enhancement factors of 114.5 and 110.6, respectively, show the usefulness of the 
method. 
A multivariate optimization was applied to the development of a US-assisted 
multielemental extraction procedure for analysis of target inorganic ions in bean samples 
by inductively coupled plasma optical emission spectrometry (ICP-OES). The procedure 
consisted of treatment of the powdered samples with an acid mixture, then subjected to US 
energy to extract the target ions of Ba, Ca, Cu, Fe, K, Mg, Mn, Sr, and Zn prior to 
introduction of the extract into the instrument (Carvalho Santos et al., 2009). 
 
2.4. Extraction of undesirable compounds in food 
A wide range of organic and inorganic contaminants is found in the environment 
as a consequence of diverse anthropogenic activities or natural processes. Their presence 
in the different environmental compartments may cause adverse effects on human health 
and animals, including cancer and/or disruption of the immune system. In addition, these 
compounds can persist in the environment and bioaccumulate along the food chain; 
therefore, their potential presence in foods requires to be investigated. The traditional 
sample preparation procedures previous to analysis have been widely substituted by those 
that are faster and more efficient based on US assistance. Thus, USAE methods for 
pesticides, polycyclic aromatic hydrocarbons, pharmaceuticals, heavy metals, among 
others, have been reported and reviewed (Tadeo et al., 2010). An interesting example of 
USAE is that of 19 Fusarium toxins from muscle, liver, kidney, and fat of swine, bovine, 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
Page | 114 
and sheep; muscle and liver of chicken; muscle and skin of fish, as well as milk and eggs. 
The extracts were then subjected to defatting with n-hexane and cleanup by solid-phase 
extraction (SPE) on BondElut Mycotoxin cartridges. All these steps provided an analytical 
sample to be injected into a reversed-phase LC coupled to an electrospray ionization triple 
quadrupole mass spectrometer for separation and detection/quantitation of the analytes. 
Despite the extraction step only required 15 min, the previous enzymatic hydrolysis step 
took 16 h. The latter could also be shortened by US assistance, as activation of hydrolytic 
enzymes has been widely demonstrated (Delgado-Povedano and Luque de Castro, 2015). 
 
3. Special ultrasound-assisted extraction methods for food 
components 
USAE methods with special characteristics, such as the use of ionic liquids (ILs) as 
extractants, formation of emulsions, development of derivatization reactions simultaneous 
with extraction or the use of biocatalyzed reactions, are the subject of this section. 
 
3.1. Ultrasound-assisted extraction using ionic liquids 
The boom of ILs proclaimed their advantages (namely, negligible vapor pressure, 
wide liquid range, good stability, tunable viscosity, good miscibility in water and organic 
solvents, good solubility and extractability for organic compounds, and suitability for 
energy dissipation (Du et al., 2007)), which were later moderated and gave them an also 
moderated position in analytical applications. ILs were used as promising extractants of 
plant components such as alkaloids, terpene lactones, phenols, and quinones (Maet et al., 
2011). An example of ILs use is the USAE of four biphenyl cyclooctene lignans from the 
fruit of Schisandra chinensis Baill. Seventeen types of ILs with different cations and anions 
were investigated, and a 0.8 M 1-lauryl-3-methylimidazolium bromide water solution was 
selected as extractant. After optimization of US parameters such as US power, time for US 
treatment, and solid–liquid ratio by an RSM, the extracts were compared with those 
obtained by conventional extraction, resulting in an efficiency increase of about 350%, and 
a shortening of the process time from 6 h to 30 min. Both the nature of the cation and anion 
that constituted the IL showed to be influential on the extraction process (Ma et al., 2011). 
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Task-specific Brönsted acidic imidazole ILs with two acidic sites have been 
designed primarily as an alternative to traditional mineral acids such as H2SO4 and HCl for 
catalytic applications (Wilkes, 2004), and as excellent extractants for preparation of 
natural products such as flavonoid glycosides (Yao et al., 2012) or phenolic acids (Liu et al., 
2016). Recently, a method based on 3-methyl-1-(4-sulfonylbutyl) imidazolium hydrogen-
sulfate as extractant and the synergistic effect of US and microwaves (MW) was used for 
the extraction of pectin from the albedo part of pomelo peels and the extracts compared 
with those obtained by conventional extraction with reference extractants. ANOVA 
application showed no significant differences in total carbohydrate content and degree of 
esterification (DE), while galacturonic acid content was significantly different for the pectin 
from each extractant. The differences revealed by images of atomic force microscopy (AFM) 
and SEM (Fig. 4) suggest changes of the physicochemical properties of pectin by the 
extractant that were not investigated using appropriate analytical instrumentation (Liu et 
al., 2017), an aspect of paramount importance before the use of the extracted compounds 
as food components. 
 
 
Fig. 4. AFM and SEM images of pectins. AFM images of pectin extracted with an aqueous solution 
of the selected IL (A), and a hydrochloric acid solution (B); SEM images of pectin extracted with an 
aqueous solution of the selected IL (C); and a hydrochloric acid solution (D). AFM, atomic force 
microscopy; IL, ionic liquid; SEM, scanning electron microscopy. With permission of Elsevier, Liu, 
Z., Qiao, L., Yang, F., Gu, H., Yang, L., 2017. Brönsted acidic ionic liquid based on ultrasound-
microwave synergistic extraction of pectin from pomelo peles. Int. J. Biol. Macromol. 94, 309–318. 
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3.2. Ultrasound-assisted emulsification/extraction 
The availability of US to form fine emulsions has been exploited in dealing with two 
main types of samples: 
(1) With solid samples and using two immiscible polar/no polar extractants for 
simultaneous removal of both polar and no polar sample components. The approach 
known as US-assisted emulsification–extraction (USAEE) is based on the use of two 
immiscible extractants, which, under US application, form an emulsion that allows close 
contact of both with the solid sample and a rapid mass transfer of the compounds 
extractable to one or the other liquid phase with the help of the cavitation phenomenon, 
also promoted by US. Thus, USAEE is an effective extraction approach for subsequent 
characterization of the metabolic profile of a given solid sample, as proven for the extraction 
of polar and no polar compounds from samples such as acorns, grape seeds, or alperujo 
(Mason, 1991). 
The excellent performance of USAEE with vegetable matrices led to the 
development of a method for extraction of as many components of orange peel as possible 
with a view on optimizing resources and shortening the extraction time. The method allows 
the simultaneous extraction of polar and no polar compounds by using an 80:20 (v/v) 
methanol–water mixture as polar extractant, and n-hexane as a no polar extractant. The 
US-assisted method facilitates both the formation of a stable emulsion between the two 
immiscible extractants and mass transfer from the solid sample to the liquid phases by a 
wide contact surface. Optimization of the USAEE by desirability conditions for both 
extracts led to analytical samples that were subjected to LC–QTOF MS/MS in positive and 
negative ionization modes and tentative identification of the most significant compounds 
present in each extract (a total of 51 compounds). Comparison of the USAEE extracts with 
those obtained by conventional extraction for polar and no polar compounds by principal 
component analysis showed that the polar extracts were similar in extraction efficiency, 
while the no polar ones showed clear differences. This behavior was attributed to the effect 
of US on lipids (Cañizares et al., 2004). 
(2) With liquid samples for liquid–liquid microextraction (LLME). In this case, a 
large volume of usually aqueous sample is put into contact with a very small volume of 
usually organic extractant that is finally emulsified with the sample under US application, 
thus giving place to UASE–LLME (Delgado-Povedano and Luque de Castro, 2013a). The 
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approach is useful for analytical purposes, but it is not suitable for automation, thus 
hindering its application in routine analysis, and in particular for larger-scale industrial 
applications (Delgado-Povedano and Luque de Castro, 2013a). 
 
3.3. Ultrasound-assisted extraction and in situ derivatization 
Ultrasound does not only affect heat and mass transfer, but can also induce 
chemical reactions, or at least enhance chemical reactions (i.e., similar to the 
improvements in mass transfer, US can also have a synergistic effect on chemical reactions 
and as a consequence to the “removal” of the target extracted species by conversion into a 
product). Cavitation is the main US effect that favors both reaction and extraction 
(Delgado-Povedano and Luque de Castro, 2013b). Derivatizing reactions (e.g., complex 
formation, ion-pair formation, depolymerization, redox, alkylation, esterification, 
addition, organics ethylation), oxidation (e.g., involving inorganics, organics, 
organometallics or to study oxidative stability), or hydrolysis (e.g., phenols, carbohydrates) 
are among the most used. Special care has to be taken to understand the influence of US on 
each step for an appropriate optimization of US variables. An example is found in the 
determination of phenols in virgin olive oil based on extraction of the target analytes into a 
basic aqueous medium containing the F–C reagent. In this case, only the hydrolysis 
reaction to form phenolate as previous step is favored by US, with no influence of this 
intervention on the derivatization reaction as such (Ruiz-Jiménez and Luque de Castro, 
2003). 
One example of the drastic reduction in time provided by a reaction assisted by US 
energy is a study reported on oil stability. The use of a probe and the appropriate 
optimization of the US variables have allowed Rancimat times of 129 h to be reduced to 50 
min; therefore, the overall time required for the determination of oil stability, even for 
highly stable virgin olive oils, is shorter than 1 h (Cañizares et al., 2004). The study also 
revealed that US is not a recommended type of energy to assist oil processes in which fat 
oxidation is not the target. 
When developed in a continuous approach, USAE and in situ derivatization can be 
coupled to other steps of the analytical process such as online filtration, cleanup–
preconcentration, individual separation, and detection (Delgado-Povedano and Luque de 
Castro, 2013b). 
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3.4. Ultrasound-assisted extraction and in situ enzymatic catalysis 
The effect of US on the enzymatic activity is a debatable matter that requires in 
depth studies involving the US frequency and the biocatalyst structure, among the most 
significant. Examples of the controversial effect of US on biocatalyst behavior are found in 
the review by Delgado-Povedano and Luque de Castro (2015). 
 
4. Comparison of ultrasound-assisted extraction methods with other 
methods using different energy assistance or dual energy assistance 
The most common and immediate step after development of a USAE is its 
comparison with conventional counterparts. USAE has shown to exhibit advantageous 
characteristics. Furthermore, USAE methods have been compared with extraction methods 
assisted by other intervention approaches, or even with methods simultaneously assisted 
by two different types of energy. 
 
4.1. Comparison of ultrasound-assisted extraction methods with conventional 
extraction methods 
The extracts of anthocyanins from different fruits obtained by both a conventional 
stirring method and a USAE method were compared on the basis of total phenol content, 
total monomeric anthocyanin content, DPPH scavenging activity, and the analysis by LC–
DAD using three commercial standards. The poor resolution of the analytical 
instrumentation hindered a critical comparison of the effect of the methods on the 
extracted components, and degradation was considered as “a decrease of extraction 
efficiency by increasing the time of US application” (Wang et al., 2016). 
Comparison of the efficiency in the extraction of total carbohydrates from Stevia 
rebaudiana Bertoni by conventional extraction and USAE showed an increase by a factor 
of 1.5, a lower processing temperature (68 vs. 100 ºC) and a drastic time reduction by using 
the latter method. The improvement in efficiency was explained by the mechanical action 
of the ultrasound on the cell walls that resulted in an increased accessibility and 
extractability of the target components; while a better quality of the extracts was attributed 
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to a better extractability of stevioside and rebaudioside A, the most desirable stevia 
components (Liu et al., 2010). 
The method proposed for USAE of carotenoids from pomegranate peel was 
compared with the conventional extraction method only in terms of efficiency and time 
required for extraction development, but the effects of US on the stability of the oils used 
as extractants were not taken into account (Kaderides et al., 2015). 
Comparison of Soxhlet extraction (SE) and USAE to remove vanillin from cured 
vanilla pods showed that polar extractants were the best in both cases and a temperature 
of 90–100 ºC in the former and ambient temperature in the latter provided almost similar 
efficiency for 8 and 1 h extraction, respectively. The effect of temperature and/or US on the 
target compounds or on the sample matrix were not studied (Jadhav et al., 2009). 
 
4.2. Simultaneous comparison of ultrasound-assisted extraction methods with 
several extraction methods 
The extraction of 26 characteristic components covering four structure types 
(flavonoids, terpene lactones, ginkgolic acids, and phenylpropanols) in ginkgo seeds by US, 
refluxing, percolation, or SE were compared to determine the best extraction procedure for 
the target compounds. USAE proved to be better than the percolation and Soxhlet methods 
in terms of efficiency. Refluxing and ultrasonication were found to provide comparable 
results, but refluxing was a more time-consuming procedure (Zhou et al., 2014). 
 
4.3. Comparison of extraction by ultrasound combined with a different 
intervention technique with other extraction methods 
The comparison of the extraction of oleuropein from olive leaves by USAE with 
reduced pressure, conventional extraction under atmospheric pressure, reduced-pressure 
boiling extraction, or USAE provided the highest efficiency and shortest extraction time for 
the first, which also produced the highest alteration of the leaf structure (Xie et al., 2015). 
Nevertheless, when a method to extract bioactive compounds from papaya seeds based on 
high hydrostatic pressure extraction was compared with USAE and conventional 
extraction, the first also showed to be the most effective (Briones-Labarca et al., 2015). 
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Superheated water extraction (SHWE) was assisted by US for removal of 
naphthoquinone pigments from purple gromwell, and the results thus obtained were 
compared with those provided by SFE with CO2 or by SE. The comparison showed that the 
extraction yield of naphthoquinone pigments by US–SHWE was the highest, up to 0.31%, 
while the yields achieved by SE and SFE were 0.21% and 0.19%, respectively; and the first 
also provided the extracts with less impurities and the best inhibitory effects on Escherichia 
coli and Staphylococcus aureus, followed by that with SE. However, the extracts obtained 
with SE showed the highest DPPH scavenging capacity and reducing activity (Yang et al., 
2013). 
The combined effect of sequential application of US and MW (US–MAE) on the 
yield and DE of pectin from pomelo peel using citric acid was recently investigated (Liew et 
al., 2016). Under the optimum working conditions (pH 1.80, 27.52 min ultrasonication 
followed by 6.40 min MW irradiation at 643.44 W), the yield and the DE of pectin obtained 
were 38.00% and 56.88%, respectively. Under the optimized US–MAE conditions, the 
pectin extracted by MW–USAE and by only USAE or MAE were studied and compared. The 
order of yield efficiency was US–MAE > MW–USAE > MAE > USAE. The pectin 
galacturonic acid content obtained by combined intervention techniques was always higher 
than that provided by a single technique, and the pectin gel from combined techniques 
exhibited a pseudoplastic behavior. The visual aspect in each case is shown in Fig. 5. 
 
Fig. 5. SEM micrograph of pectin extracted by (A) USAE; (B) MAE; (C) MW–USAE; and (D) US–
MAE at ×500 magnification, 100 mm. MAE, microwave-assisted extraction; MW, microwave; SEM, 
scanning electron microscopy; US, ultracound; USAE, ultrasound-assisted extraction. With 
permission of Elsevier, Liew, S.Q., Ngoh, G.C., Yusoff, R., Teoh, W.H., 2016. Sequential ultrasound-
microwave assisted acid extraction (UMAE) of pectin from pomelo peles. Int. J. Biol. Macromol. 93, 
426–435. 
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The influence of US on SFE to remove bioactive compounds from blackberry 
bagasse was also studied, and its effect (at 400 W, frequency not given) was significant at a 
pressure of 15 MPa, contributing to enhance the extraction kinetics and increase the global 
yield without compromising the quality of the extracts. The enhancement of mass transfer 
by US is caused by changes in the structure of the substrate, as can be observed by the image 
analyses in Fig. 2. Specifically, the increase of particles stuck onto the surface of blackberry 
bagasse contributed to reduce the barriers to both supercritical fluid and extractable 
compounds (Pasquel Reátegui et al., 2014). When compared with SE with ethanol as 
extractant, this provided higher yield, which is attributed to the higher polarity of ethanol 
as compared with CO2, even in the presence of water or ethanol as cosolvent. 
 
5. Scaling up laboratory methods for ultrasound-assisted extraction of 
food components 
The use of US in the food industry is not exclusive to extraction. In fact, there are a 
number of food processes that profit from this technology to shorten or improve certain 
applications and, in some cases, even facilitate phenomena that cannot be achieved by any 
other means. Some examples include but are not limited to filtration, defoaming, 
depolymerization, degassing/deaeration, cooking, cutting, demolding and extrusion, 
freezing and crystallization, drying, defrosting/thawing, brining, pickling and marinating, 
meat tenderization, separation (emulsion breaking), emulsification/homogenization. 
When considering US for extraction purposes, it is essential the laboratory 
development has to be exhaustive, particularly in identification of the extract components 
and in the potential degradation caused or favored by US energy. Only then upscaling to 
pilot scale and eventually industrial scale should be considered. The absence of degradation 
must also be assessed at the pilot plant and industrial scales. 
Residues or waste valorization has been the most prominent application of the 
USAE method over the last decade. Extracts rich in antioxidants, mainly phenol 
compounds (usually named as polyphenols, despite some of them are simple phenols as is 
the case with hydroxytyrosol, tyrosol, oleocanthal, etc.), have been obtained from apple 
pomace (Virot et al., 2010; Pingret et al., 2012), from chicory grounds (Pradal et al., 2016), 
olive leaves or olive oil pomace (Delgado-Povedano et al., 2017), and pomegranate peels 
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(Kaderides et al., 2015). Usually the residues are richer in antioxidants than the main 
product (cider or virgin olive oil, for example). 
Experiments at pilot plant scale have ratified the results obtained at laboratory 
scale (shortening of the extraction time, enhancement of the final yield, low operating 
temperature) (Cárcel et al., 2012). The final aim at the industrial scale of reaching the 
working conditions to obtain a given yield with minimal process duration and/or minimal 
energy consumption was in most cases achieved. 
 
 
Fig. 6. Industrial ultrasonic equipment (capacity: 50, 500, and 1000 L). With permission of Elsevier, 
Chemat, F., Huma, Z., Khan, M.K., 2011. Applications of ultrasound in food technology: processing, 
preservation and extraction. Ultrason. Sonochem. 18, 813–835. 
 
Despite the food industry being reluctant to apply new extraction technologies, 
such as USAE, a better understanding of US energy and assessment of the quality of the 
extracts thus obtained are displacing the old traditional systems in the industry for US-
assisted equipment, as shown in Fig. 6. 
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6. Future trends in ultrasound-assisted extraction of food components 
A desirable step in the development of an extraction method based on US 
assistance (as should be with any other type of technology intervention) is exhaustive 
identification of the extract components to detect any potential degradation. The nature of 
the degradation products is of paramount importance when the extracts are used to 
supplement foods or as nutraceuticals. Once the healthy nature of the extracts has been 
assessed, the US conditions (i.e., US frequency, power, and application time) to obtain the 
extracts must be maintained when the process is upscaled. 
A variable rarely taken into account by US users is frequency, the importance of 
which is often ignored in publications. To study different frequencies of US devices can be 
very useful to avoid degradation and/or obtain the pursued results. 
“Bioactive” is a catch word applied to a number of plant components that are 
presently extracted with US assistance (Kadam et al., 2015). Additional research is 
required, including upscale studies to facilitate the adoption of US in the bioactive 
compounds industries to enhance processing efficiency and capability after in-depth study 
of extractants, thermolability, and fragility against US action, particularly against free 
radicals formed in polar media. Usually, intermittent US application (short duty cycles) 
does not affect the molecular structures of the target compounds. 
While multivariate optimization designs are useful to reduce the number of 
experiments, univariate optimization of some parameters is of paramount importance to 
assess the effect changing process variables has on the target components (Sourki et al., 
2017). Multicriteria optimization and desirability criteria are of interest in USAE and 
should be promoted (Tomšik et al., 2016). 
A more in-depth knowledge of USAE at the laboratory scale is the necessary step 
to potentiate the interest in upscaling these methods, taking advantage of their positive 
aspects at industrial scale. 
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Ultrasound: A subexploited tool for sample 
preparation in metabolomics 
 
M.D. Luque de Castro, M.M. Delgado-Povedano 
 
Abstract 
Metabolomics, one of the most recently emerged “omics”, has taken advantage of 
ultrasound (US) to improve sample preparation (SP) steps. The metabolomics–US assisted 
SP step binomial has experienced a dissimilar development that has depended on the area 
(plant or animal) and the SP step. Thus, plant metabolomics and US assisted leaching has 
received the greater attention (encompassing subdisciplines such as metallomics, 
xenometabolomics and, mainly, lipidomics), but also liquid–liquid extraction and 
(bio)chemical reactions in metabolomics have taken advantage of US energy. Also clinical 
and animal samples have benefited from US assisted SP in metabolomics studies but in a 
lesser extension. The main effects of US have been shortening of the time required for the 
given step, and/or increase of its efficiency or availability for automation; nevertheless, 
attention paid to potential degradation caused by US has been scant or nil. Achievements 
and weak points of the metabolomics–US assisted SP step binomial are discussed and 
possible solutions to the present shortcomings are exposed. 
 
Keywords: ultrasound, sample preparation, metabolomics, metallomics, lipidomics, 
xenometabolomics. 
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1. Introduction 
Analytical methods typically consist of a number of steps (from sampling, to sample 
preparation, isolation of the target compounds if required, identification, quantitation and, 
finally data handling) each of them with its specific weight on the final results. A glance to 
the nature and goal of most sample preparation operations allows evaluation of the key 
influence of these steps on both the total time required to complete the analysis and the 
quality of the obtained results. However, it has only been in recent years when this step has 
risen to the prominent place that it holds at present within the analytical process [1,2]. 
The disciplines appeared in recent years under the umbrella of the common subfix 
“omics” started in 1986 with genomics [3], and reached its present completness in 2002 
with metabolomics, defined that year by O. Fiehn as “a comprehensive analysis in which all 
the metabolites of a biological system are identified and quantified” [4]. The general 
concept of metabolomics as “the omics of small molecules” leads to the subsequent 
definition as “the comprehensive analytical approach to study all low-molecular weight 
species (typically defined as <1000 or <1500 Da) present in a given biological system of 
interest”. Recently, Ryan et al. [5] seem to lean toward a definition that encompasses 
characterization and quantitation of all metabolites within a sample, but with the 
qualification that metabolomics considers both spatial resolution (due to cellular 
compartmentalization of metabolism) and temporal changes in response to environmental 
stimuli (the latter should be extended to xeno stimuli). 
The joint use of the information provided by two or more omics constitutes the 
systems biology approach [6]. 
Metabolomics analyses encompass different strategies, which depend on the 
information required from the system under study [7], namely: (a) target analysis [8], 
which aims at qualitative and quantitative study of one or, more frequently, a small group 
of chemically similar metabolites; (b) global metabolomics profiling [9], which allows 
detection of a broad range of metabolites by using a single analytical platform or a 
combination of complementary analytical platforms —based on GC–MS, LC–MS, capillary 
electrophoresis (CE)–MS or nuclear magnetic resonance (NMR)— to obtain a 
comprehensive profile of the metabolome; (c) metabolomics fingerprinting [10], a high 
throughput, fast methodology for analysis of biological samples that provides fingerprints 
for sample classification and screening; and, (d) metabolomics footprinting [11], which 
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aims at the study of metabolites in extracellular fluids, also known as exometabolome or 
secretome. Obviously, the complexity of sample preparation for each strategy is different 
increasing from (d) to (a). The most recent trend leans to simplification by establishing 
distinction only between targeted and untargeted analysis including profiling, which 
require quite different sampling and sample preparation approaches [12]. 
The physical state of the samples in metabolomics studies encompasses from solids 
—mainly in plant metabolomics, and sporadically in animal and clinical metabolomics— to 
gases —exhaled breath or aromas. Therefore, the operations to be developed prior to 
introduction of the analytical sample [13] either into high resolution separation equipment 
or into the detector are very varied and most of them can be accelerated/improved by 
auxiliary energies. 
Ultrasound (US) is an auxiliary energy in analytical chemistry the effects of which 
have been differently used in general [14] and poorly in omics in particular. Despite the 
traditional use of US probes to disrupt cells in proteomics studies [15], and its recent 
application to study thermal aggregation, gelation, foaming and emulsifying properties of 
egg white proteins [16], US does not participate of the massive use of microwaves (MW) in 
proteomics [17]. The dissimilar use of these energies in analytical applications in general is 
a consequence of several factors: 
(i) The use of cleaning US baths as analytical devices for which they have not been 
designed. 
(ii) The comparison of the performance of cleaning US baths with that of specific 
designed MW-assisted analytical devices (particularly for digestion or leaching), in 
which the supremacy of the latter was most times demonstrated. 
(iii) The nil importance given by the users to US frequency. Most US devices (including 
cleaning baths, probes and reactors) work within a small range of frequencies (viz. 
20–40 kHz) despite power frequencies encompass the range 20–100 kHz. Each 
device usually works at a fixed frequency. After application of US by a given device, 
the users conclude US produces a nil, small or medium effect; sometimes without 
specifying the frequency of the US device they used [18]. 
The unfear opinion on the role of US energy to help analytical steps in 
metabolomics calls for: (i) examples of typical metabolomics publications in which US has 
been used to favor one or several steps; (ii) critical discussion of US aspects that wether 
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have not been taken into account or have been misinterpreted by the authors; (iii) ways to 
improve and extend US applications in metabolomics, thus taken profit of this energy. 
 
2. Generalities on the use of US in metabolomics 
In the light of the research so far developed in the field of metabolomics, it is clear 
that US has been mainly used in target analysis (e.g., determination of estrogens in human 
urine [19], simultaneous determination of quinocetone and three of its synthesized desoxy 
metabolites in swine urine [20], or carbamate pesticides in environmental water samples 
[21]). Presently, this energy is starting to be used in other strategies, as global metabolomics 
profiling (e.g., metabolomic analysis of clinically relevant bacteria —Pseudomonas 
aeruginosa, Salmonella typhimurium, Escherichia coli, Yersinia pseudotuberculosis or 
Methicillin-Sensitive Staphylococcus aureus) [22], and metabolomic profiling of human 
saliva [23]), which highlight US subexploited utility. 
The fact that US application does not increase the temperature of the system is one 
of the reasons why this energy is a suitable option to work with thermally unstable 
metabolites present in a biological fluid, cell or organism under a given set of physiological 
conditions. Benzodiazepines in human plasma [24], vitamin C in dehydrated carrots [25] 
or β-carotene in Spirulina platensis [26] are examples of this behavior. US is also a suitable 
option when working with polar and no polar metabolites/samples, because US, in contrast 
to MW, does not require polarity of sample components to promote interaction with them. 
Nevertheless, US is not the panacea in dealing with auxiliary energies, as the formation of 
free radicals by the cavitation phenomenon in polar media can constitute a shortcoming for 
some given systems. 
As commented before, the most frequently used US devices are ultrasonic cleaning 
baths and probes (the use of ultrasonic reactors shyly starts at present). The former 
(designed for cleaning glassware and degassing) are the most widely used in metabolomics 
sample preparation, because they are the most affordable and cheapest ultrasonic 
laboratory devices available in the market. This is why US cleaning baths are used for 
analytical tasks which require more specifically designed US equipment. The main 
drawbacks of US cleaning baths, which are the sources of their irreproducibility, are the 
decline of power with time and the lack of uniformity in the transmission of US. Despite 
these unfavorable aspects, these devices have sometimes provided the best results for 
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leaching as compared with both Soxhlet and maceration methods, probably due to higher 
temperatures of the Soxhlet method and longer time required for maceration (up to 18 h) 
[27]. Nevertheless, a probe ultrasonic device, either immersed in the sample or in a water 
bath where the flask containing the sample is located, is the most desirable option [28]. 
In dealing with the approaches designed for US assisted sample preparation in 
metabolomics they have been either of the continuous or discontinuous type. The former 
approaches are endowed with the capacity for being coupled to equipment where 
subsequent steps of the analytical process are developed (sometimes, a US device has 
assisted several analytical steps by accelerating/improving them [29]). These approaches 
that undoubtedly increase automation of sample preparation have preceded liquid or gas 
chromatographs and even CE equipment [30]. The design of discontinuous approaches is 
simpler and allows applications difficult or impossible to carry out by those of the 
continuous type, as is the case with steps based on emulsification–extraction, either 
involving solid–liquid or liquid–liquid systems [31]. 
Two main aspects must be taken into account in dealing with the use of US in 
metabolomics so far: 
(i) Most authors working on target metabolomics both in plant and animal or clinical 
metabolomics do not consider their research within this omics; therefore, they use 
the terms antioxidants, phenols, bioactive compounds, lipids (individual or overall 
analysis), hormones, etc., but the word metabolite(s) does not appear in the 
publication. 
(ii) The general use of high power US is not accompanied by assessing no degradation 
effect of this type of energy, despite the claim “no degradation effect was detected” 
that in general refers to as “no degradation effect was visually observed”. 
The number of different steps in metabolomics sample preparation assisted by US 
forces to discuss them in the order they are included in the analytical process, starting with 
preliminary steps, solid samples and the different actions of US in them, and liquid 
samples, from liquid–liquid extraction (LLE) to derivatization without forgetting 
enzymatic reactions. 
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3. Preliminary US assisted steps in metabolomics 
The use of US to improve steps in metabolomics that precede the socalled sample 
preparation [14] has been very varied. 
US has been used to improve freezing and crystallization processes prior to 
evaluation of the viability of Lactobacillus plantarum subsp. plantarum by Kiani et al. 
[32]. This energy induced nucleation in the supercooled suspension of L. plantarum, thus 
maintaining highly viable bacteria cells in frozen products and reducing damage caused by 
freezing. Ultrasonication during nucleation or phase change of the freezing process holds 
promising as a tool to ensure viability of frozen suspended cells. 
Freezing–drying processes can also take advantage from US application that 
allowed supplying additional sublimation energy without sample heating in the case of red 
bell pepper [33]. Application of US led to temperature increase, which was reduced when 
this energy was applied as pulses (in this case, 10 s US application and 90 s recovery phase), 
which made possible freeze-drying at increased sublimation rates without causing sample 
heating during the 7 h required by the process. Application of US did not affect product 
quality of the lyophilized sample in terms of ascorbic acid content, bulk density, color, and 
rehydration characteristics. 
Also, the influence of US on the microstructure of tomate pulp, lycopene content 
and in vitro bioaccessibility has been studied [34]. US was responsible for loss of tomato 
cell integrity, as well as partial de-esterification of tomato pectins. In contrast, 
ultrasonicated tomato pulp had greater gel like properties than a no ultrasonicated sample. 
The authors deduced that the partially de-esterified pectin molecules gave rise to a new 
molecular organization leading to the formation of a stronger network with increased gel 
like properties. Such an effect on the tomato pulp structure resulted in a decrease in 
lycopene in vitro bioaccessibility of the ultrasonically treated tomato pulp. In this study, in 
which the authors always worked at a fixed frequency of 24 kHz and a temperature never 
exceeding 90 °C, undesirable effects such as loss of tomato cell integrity and decrease in 
the degree of pectin esterification could be avoided by using lower temperatures and, 
especially higher frequencies —with the concomitant effect of reduced cavitation. 
As commented before, US is not always the panacea, as this type of energy also 
caused undesirable effects, mainly owing to degradation. An example is the use of this 
energy to modify cell structure and mass transfer in potato tissue [35]. Cell disruption 
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caused by US (24 kHz) was limited to a thin tissue layer in direct vicinity to the sonicated 
surface, but mass transfer was influenced throughout the complete sample (a cylinder of 12 
mm diameter and 1 cm height). Hence, US affects mass transfer at overall tissue level. The 
authors used conductivity to measure cell injury as the amount of ions leaking from a 
treated tissue in relation to the total amount of present ions. Modification of sample 
metabolites by ultrasonication was not a matter of study in this research. On the contrary, 
Zuo et al. studied the damage on potato starch granules induced by US [36]. The treatment 
of granule suspensions by power US caused damage to the starch surface and, under certain 
working conditions, shattering of the granules. The extent of damage to starch granules 
dispersed in water was first only slightly dependent on sonication power, then increased 
markedly by increasing this variable up to a given power threshold. Frequencies higher 
than 20 kHz were not assayed; therefore, the unknown behavior of the sample under higher 
frequencies should be studied, as well as under different temperatures as the authors 
worked at constant temperature of 5 °C. 
On the other hand, Gamboa-Santos et al. have treated to use the degrading effect 
of US to favor desirable processes such as carrots blanching [25]. After assisting this 
process by US, the authors evaluated the content of vitamin C and sensory properties of the 
treated carrots. Fresh or dried carrots subjected to ultrasonication by a US probe (20 kHz, 
400 W directly applied to the sample for 10 or 15 min at temperatures of 60 or 70 °C, 
respectively) showed vitamin C retention values lower than 4%; whereas carrots blanched 
conventionally using water at 95 °C for 5 min, boiling water for 1 min or in an autoclave for 
2 min showed percents of vitamin C retention between 20.6 and 85.0. The main aim of this 
research was the use of a Headspace ChemSensor System (considered as an MS electronic 
nose) to obtain mass spectral fingerprints for sample classification. More in depth studies 
using different US frequencies would be of interest to know if negative effects such as 
vitamin C degradation can be avoided at higher values of this variable. 
Particular individual uses of US in metabolomics or proteomics leads to consider 
its potential joint application in systems biology to facilitate development of preliminary 
steps. Some of these individual uses in proteomics are commented below. 
US energy has demonstrated to enhance cholesterol removal ability of lactobacilli. 
US application (30 kHz, intensities of 20, 60 and 100 W and during 1, 2 and 3 min) 
influenced the properties of cellular membrane, increasing cellular viability immediately 
after treatment, except after treatment at 100 W and the longest application time (3 min), 
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owing to disruption of membrane lipid bilayer, cell lysis and membrane lipid peroxidation 
occurring under these conditions [37]. 
On the other hand, US has been used to treat whey protein coatings on frozen 
Atlantic salmon. Ultrasonication was applied at a fixed frequency of 35 kHz and three 
sonication times (1, 15 and 60 min). The drip loss after chilled storage, drip loss in thawing, 
cooking loss, thaw yield and yield were not affected by US as compared with salmon 
samples with untreated protein coatings. However, the authors observed decreases of the 
above parameters in samples from whey proteins sonicated 60 min in relation to those 
sonicated for 15 min. US application to the coatings delayed the lipid oxidation of salmon 
pieces in comparison with those coated with untreated proteins. In addition, US application 
increased whiteness of cooked samples and lightness, but did not modify the color of frozen 
and thawed fillets in comparison with untreated protein coated samples [38]. 
 
4. US assisted digestion in metabolomics 
Digestion is not a common treatment in metabolomics as most sample preparation 
steps in dealing with solid samples use leaching as the way to obtain a treated sample 
containing the target metabolites and with lower undesirable matrix components than 
those digested. In fact, digestion of any type of tissue has been mainly used to liberate 
metals; therefore, metabolomics subdisciplines such as ionomics or metallomics should be 
those taking benefits from US assisted digestion. 
An example of the positive effects of US for digestion as sample preparation in these 
metabolomics subdisciplines is the method reported by Cespón-Romero and Yebra-
Biurrun [39], who used US (applied by an ultrasonic bath for 3 min at room temperature) 
to accelerate urine sample digestion for subsequent determination of trace metals such as 
copper, iron, manganese and nickel. Urine volumes of few mL were mixed with HNO3 and 
digested under US application by immersion of the digestion unit into the US bath. It is 
remarkable that the authors do not specify the frequency and other characteristics of the 
US device they used. 
 
5. US assisted leaching in metabolomics 
Leaching or solid–liquid extraction is the sample preparation step in metabolomics  
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that has been more frequently improved, either enhanced and/or accelerated, by US 
energy. Batch and continuous approaches in meso and micro format have been used with 
these aims. Distinction is made between the plant and animal field, and the metabolomics 
subdiscipline to which the research belongs, if appropriate. 
 
5.1. US assisted plant leaching in metabolomics 
This is the area in which US has been more frequently applied to favor leaching of 
a wide number of metabolites, despite the word metabolite(s) does not appear in most of 
the publications on the subject, as commented previously. Lipids and other bioactive 
compounds such as antioxidants have received the highest attention. Examples of leaching 
prior to the determination of metals in living organisms are first discussed as they required 
the simplest analytical approaches. 
 
5.1.1. US assisted plant leaching in metallomics 
Metals in the plant kingdom can exist as constituents of the given plant (as is the 
case with copper in tomatoes); therefore, their study belongs to ionomics or metallomics, 
depending of the oxidation state in the target plant. Also the presence of the metal in the 
sample can be the result of exposition to contamination: in this case the study pertains to 
xenometabolomics. Examples in which US has been used in metallomics to facilitate 
leaching are as follows: 
A dynamic, automated US-assisted system as that shown in Fig. 1A was used to 
assist leaching of essential macronutrients (calcium and magnesium) and micronutrients 
(copper, iron and zinc) from animal feeds. The overall system consisted of: (i) a leaching 
chamber where the sample was located and through which a leaching carrier (10% aqueous 
HNO3) was circulated and the direction of which changed each 80 s, thus minimizing both 
dilution of the leachate and increased compactness of the sample in the chamber that could 
cause overpressure in the system; (ii) a programmable peristaltic pump; (iii) coils of enough 
length to keep the leaching carrier/leachate within the dynamic system during the go–back 
sequence; (iv) a US probe (duty cycle 0.8 s/s, output amplitude 80% of the nominal 
amplitude of the converter applied 20 kHz and power 400 W with the probe placed 1 mm 
from the top surface of the extraction cell); (v) a water bath at 40 °C in which the chamber 
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and the US probe were immersed for proper transmission of US. After leaching, the target 
metals were quantified by flame atomic absorption spectrometry (FAAS) [40]. 
 
 
 
Fig. 1. Experimental setups for dynamic USAL and determination of metals. (A) For macro and 
micro nutrients in animal feeds. (B) For cadmium in vegetables by slurry formation USAL, hydride 
generation, pervaporation and atomic absorption detection. FAAS, flame atomic absorption 
spectrometer; IV, injection valve; LC, leaching chamber; WB, thermostatic water bath. (With 
permission of Springer-Verlag and Elsevier, Refs. [40] and [41], respectively). 
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A more complex dynamic approach was used for determination of cadmium in 
olive leaves (Fig. 1B), because after leaching the target analyte by an 1 M HCl + 16% (m/v) 
H2O2 aqueous solution with the help of a US probe acting for 17 min (duty cycle 0.9 s/s and 
output amplitude 100%) at the maximum power of the US probe, generation of the 
corresponding hydride and pervaporation of the volatile product was carried out prior to 
determination by FAAS [41]. 
 
5.1.2. US assisted plant leaching in lipidomics 
US has been widely used to improve leaching of a wide number of metabolites as 
triglycerides and fatty acids thus constituting a key sample preparation step in lipidomics. 
Although most samples subjected to US assisted leaching (USAL) have been seeds, also 
flowers and plants have been the target of this step. In this context, USAL has been 
compared with other conventional techniques as Soxhlet extraction (SE) or supercritical 
fluid extraction (SFE) and in all instances USAL was found to shorten the leaching time for 
the same or similar target metabolites. 
A wide variety of lipids has taken advantage of USAL, as is the case of phospholipids 
(PL) from palm-pressed fiber. The leaching efficiency of PL increased by increasing the 
sonication time and decreased when the amplitude and cycle increased. Maximum PL 
leaching efficiency was achieved by 30 min sonication, 20% US amplitude and 0.2 (W/s) 
cycle with an 1:4 (g/mL) solid–liquid ratio using a US device working at 24 kHz. The 
authors deduced by SEM images that US caused disaggregation and rupture of the plant 
cell walls, thereby facilitating leaching of PL from the target fiber [42]. 
USAL for plant sample preparation in lipidomics has been compared with either 
traditional and no traditional leaching. An example of the former case is the extraction of 
grape seed oil, which required 30 min of USAL at 20 kHz, 150 W to obtain a 14% (w/w) 
yield, while a similar result by SE required 6 h. No significant differences were observed for 
the major fatty acids obtained by both methods [43]. 
When the leachates of fatty acids from quince seeds obtained by USAL were 
compared to those provided by SFE a similar lipid composition was obtained [44]. An 
exhaustive optimization of inter-related variables in both methods (viz., 30 min sonication 
time, 12 mL of n-hexane, 55 °C in USAE; and 353 bar of CO2 pressure, static extraction time 
for 10 min, dynamic extraction time for 60 min, 150 µL of methanol as modifier, at 35 °C 
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in SFE) allowed obtaining a maximum oil recovery of 19.5% by USAL, and 24.32% by SFE, 
mainly constituted in both cases by linoleic, palmitic, oleic, stearic and eicosanoic acids. 
The extracts from both methods were subject to transesterification and GC–MS analysis, 
which showed only slight or negligible differences in methyl esters profiles of the extracted 
oils. It is remarkable that better efficiency is obtained by SFE at the expenses of a longer, 
complicate and expensive process. In neither case the authors studied potential lipid 
degradation. 
On the contrary, the quality of oil from Jatropha curcas and Pongamia seeds (both 
of Indian origin) by different methods (USAL, SE and direct reflux) was studied by Kaul et 
al. who analyzed in all cases the triglycerides and fatty acids by HPLC–DAD and finally 
supported the results on the determination of the acid value of the obtained oil by the ASTM 
D-974/04 method [45]. Unfortunately, molecular absorption was not the most appropriate 
technique to identify degradation caused by the different working conditions of each 
method. Significant differences concerning the extraction time and acid value of the oil (mg 
KOH/g) were obtained, as US application shortened the time required for extraction from 
16 h (by conventional methods) to 3 min (by USAL), and allowed obtaining oils with acid 
value lower than by conventional methods. 
A number of methods have recently been developed to extract aromas or essential 
oils from different plants. An example was provided by Goula [46], who carried out USAL 
to obtain oil from pomegranate seeds, using n-hexane as leachant. The leaching yield of oil 
increased with the increase of leachant–solid ratio and US amplitude and decreased seed 
particle size, extraction temperature, and pulse duration/pulse interval ratio. Maximum 
extraction yield (about 60%) was achieved by a 20:1 extractant–solid ratio, 60% US 
amplitude, 0.2 mm particle size, extraction temperature of 20 °C and pulse duration/pulse 
interval ratio 5/15 using a US device working at 20 kHz. The yield thus achieved was higher 
than those reported by methods based on SE, SFE, normal stirring, microwave-assisted 
extraction (MAE) or cold pressing [47–49]. The authors explained the improved oil yields 
in terms of cavitational effects caused by application of high power US (130 W). 
Also USAL can precede hydrodistillation of essential oils as a way to accelerate and 
improve removal from the solid; then taking profit from the volatility of these compounds 
to obtain a purer composition by leaving in the leachate no volatile compounds. This was 
the case with USAL of caraway seeds by using 1.5 L of water and an ultrasonic reactor acting 
for 30 min at 25 kHz and 1 W/cm. Subsequent hydrodistillation yielded 1.72% of the target 
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oils, higher than no sonicated samples (with yield 1.68%) and in a shorter time (30 min vs. 
90 min). Identification of 21 components in the hydrodistillate by GC–MS showed no 
differences in composition between sonicated and no sonicated samples [50]. 
More appropriate for aromatic oils because of their volatility is the use of a closed, 
dynamic and automated US assisted system, as that shown in Fig. 1A for macro and 
micronutrients leaching [40]. The leachates obtained from laurel, rosemary, thyme, 
oregano and tuberose under the optimum working conditions in each case were subject to 
LLE coupled to either GC–flame ionization detection (GC–FID) or GC–MS for detection 
and identification of the extracted compounds, respectively. Only 10 min were required to 
obtain leaching efficiencies that greatly surpassed those provided by steam distillation or 
superheated liquid extraction (SHLE) for these oils, with higher quality of the extract. The 
leaching time of the proposed method was between 165 and 176 min (depending on the 
target raw material), shorter than steam distillation (more than 4 h) and between 31 and 
20 min shorter than SHLE [51]. 
A promising, innovative study reported by Araujo et al. [52] compared five leaching 
methods (viz., Chen, Folch, Hara and Radin, and Soxhlet methods, and the Bligh and Dyer 
method both conventional and US assisted) for lipids from Chlorella vulgaris to take 
advantage of the ability of this microalgae to grow rapidly, synthesize and accumulate large 
amounts of lipids (approximately 20–50% of dry weight). The authors also studied the 
addition of silica powder to evaluate the introduction of more shear stress to the system as 
to increase the disruption of cell walls, but the addition did not improve oil extraction. The 
Bligh and Dyer method assisted by US (40 kHz and 2.68 W/m) provided the highest 
extraction of oil from C. vulgaris (52.5% w/w), thus demonstrating the usefulness of this 
type of energy also in USAL from this matrix. 
 
5.1.3. US assisted leaching of plant no lipid metabolites 
The number of applications of US to favor leaching of metabolites different from 
lipids in dealing with plants drastically surpass other types of matrices, and, among 
metabolites, phenols and antioxidants in general have been the most frequent targets. The 
final use of the leachates establishes both the optimum features of the method and the 
analyses to be carried out. When the final aim of the research is to study global 
characteristics of the leachates such as total phenolic content (TPC), antioxidant capacity 
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or scavenging activity the toxicity of the leachant is not a limitation. One of the most used 
global methods for TPC is based on the Folin–Ciocalteu reagent, which has been applied to 
USAL leachates from different plants as apple pomace [53], arecanut [54], black 
chokeberry [55], olive leaves [56] or grapes [57]. In the last case, other general methods 
such as that for total amount of anthocyanins and total amount of tannic components have 
also been applied to the leachate. 
Total antioxidant activity (AOA) has most times been determined by the ferrous 
reducing antioxidant power assay (FRAP), as is the case of leachates from arecanut [54] or 
marjoram [58]; while a common method to determine the scavenging activity is based on 
2,2-diphenyl-1-picrylhydrazyl, applied to leachates from black chokeberry fruits [55]. 
In all overall studies, higher values of the given parameter were obtained when the 
leaching step was assisted by US as compared with traditional leaching methods. The 
authors attributed this behavior to a higher efficiency of the USAL step without checking 
possible degradation in the presence of power US that could yield products with higher 
values of the parameter under study. Research on this subject should involve, (i) 
appropriate analytical instrumentation to identify the compounds in the leachate, thus 
detecting potential degradation; (ii) use of higher US frequencies to avoid degradation if 
undesirable. 
A recent example of incipient, but not sufficient, use of present analytical 
equipment is the research by Ahmad-Qasem et al. on phenol composition of olive leaves 
[56]. The authors used a dynamic recirculating system for a strict control of the 
temperature and a calorimetric procedure to determine the effective ultrasonic power 
transferred into the medium for every condition tested, but they do not specify the 
frequency of the US device used. First, the kinetics of the leaching step was monitored in 
the leachates by global parameters such as AOA by the FRAP method, Trolox equivalent 
antioxidant capacity (TEAC), and the TPC by the Folin–Ciocalteu method; then, they 
separated and identified the main phenols in the leachates by comparing the retention 
times, UV spectra and MS/MS data obtained by LC–DAD/MS–MS with those from either 
authentic standards or data reported in the literature. Remarkable in this research is the 
fact that the leaching time was shortened from 24 h (conventional method) to 15 min 
without modification of the leachate characteristics. 
When the aim of the research was targeted metabolomics, a single compound or 
groups of compounds with common or different characteristics are quantified using 
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specific methods with or without prior identification depending on available both analytical 
equipment and standards. Such is the case with five isoflavones leachated from Iris 
tectorum Maxim [59], four acetophenones from Cynanchum bungei Decne [60], or eight 
ginsenosides from ginseng root [61]. Drastic reduction of the leaching time was highlighted 
in all instances, thus opening a door to potential implementation at an industrial scale. 
When a single leached compound is the aim of the research, a more in depth study 
of the steps involved in the overall method has been carried out. Such is the case with 
hesperidin from Citrus reticulata Penggan peel [62]. Several US frequencies (20, 60 and 
100 kHz) and four US powers (3.2, 8, 30, 56 W) were used to study potential degradation 
effects, which also were checked by subjecting a hesperidin standard to the leaching 
working conditions. Hesperidin yield under 60 kHz was the highest, but all three assayed 
frequencies provided yields that clearly surpassed that obtained by SE. No degradation of 
the target metabolite occurred by increasing the sonication time and methanol was the 
leachant providing the best efficiency; nevertheless, its use should be seriously considered 
before a potential application of the leachates for human or animal consumption. 
Also bioactive glycosides (i.e., crocins and picrocrocin) from Crocus sativus L. dry 
stigmas [63] have been leached using methanol as extractant and an ultrasonic probe under 
optimum conditions with a halved leaching time as compared to magnetic stirring 
according to ISO 3632-2. Degradation of crocins observed within the optimum time was 
rather low, the authors claimed, despite they used no appropriate analytical tools, but LC–
DAD, to support this assertion. 
Ionic liquids as leachants for USAL have been scarcely reported, but they have 
looked very promising for removal of three terpenoids indole alkaloids from Catharanthus 
roseus [64], using (1-allyl-3-methylimidazolium)Br. A soaking step prior to USAL 
increased diffusion of the leachant into the cellular structure, thus allowing improved 
solubilization of the metabolites. Compared with ME, USAL provided higher extraction 
efficiency (94.84±4.45% vs. 45.40±2.10%) and a significant shortening of leaching time 
(30 vs. 24 h). 
Simultaneous USAL of polar (phenols) and no polar (lipids) from plants was 
achieved by formation of an emulsion with two immiscible leachants (methanol–water as 
dispersed phase and n-hexane as continuous phase). US enhanced formation of methanol–
water microdroplets 1–15 µm in size, which act as solid–liquid microextractors spanning a 
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large surface area. The efficiency of this dual sample preparation approach was assessed by 
characterization of natural products of variable hardness including acorns, grape seeds, 
and alperujo, which provided quantitative leaching from acorns and alperujo in 9 min and 
in 20 min from grape seeds. Following leaching and separation of the two phases by 
centrifugation, the polar and no polar fractions were analyzed by HPLC–DAD and GC–MS, 
respectively. The method provided extraction efficiency similar to the Folch method 
(reference mild method for fat extraction, 4.5 h) in a shorter time, and extraction efficiency 
equal to or higher than the stirring-based method (reference method for phenol 
compounds extraction, 24 h) [65]. 
 
5.1.4. US assisted plant leaching in xenometabolomics 
Xenometabolomics is the metabolomics subdiscipline that deals with the study of 
no endogenous compounds (e.g., drugs and its metabolites, contaminants, dietary 
components, medicinal herbs, cosmetics) in a tissue or biofluid. Sample preparation in this 
omics has also taken profit from US, particularly in the plant field. Methods for haloacetic 
acids (HAAs) and metabolic pathways of either herbicides or others affected by them are 
examples of this assertion. 
HAAs, included into the category of “disinfection byproducts”, are mainly in water, 
but they also contaminate vegetables by irrigation. A continuous US assisted approach to 
favor extraction of nine HAAs from vegetables with in situ derivatization to methyl esters 
for subsequent analysis by GC–electron capture detection was developed by Álvarez-
Sánchez et al. [66]. Optimization of simultaneous leaching and derivatization enabled 
completion of both steps in 15 min. US assistance (20 kHz and 450 W) proved to enhance 
both linked steps, which resulted in a considerable shortening of the overall analysis time 
(i.e., 552.1 and 552.3 EPA methods require 1 and 2 h, respectively, only for derivatization, 
prior to analysis of these compounds in drinking water). 
Research on metabolomic pathways of herbicides with the help of US for sample 
preparation has been of great interest to the agronomical field. Thus, studies on the 
metabolism of glyphosate in different plants such as Lolium ssp [67], Clitoria ternatea and 
Neonotonia wightii [68], and Digitaria insularis [69] have been monitored through 
herbicide decrease and formation of the corresponding metabolites after leaching all them 
with the assistance of US and separation of the target compounds by capillary 
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electrophoresis for final photometric detection. USAL and introduction of the leachate into 
the analytical equipment by the electroinjection mode were the key to obtain clean 
electropherograms, which allowed quantitation through the corresponding calibration 
curves from commercial standards of the target compounds. 
Even more interesting are metabolomics studies on glufosinate [70] and imazamox 
[71] for whose metabolites there are not commercial standards. The metabolism of both 
herbicides in plants resistant and susceptible to these herbicides, which have also shown 
the influence of genetic modifications on the metabolic pathways of the herbicides, has 
recently been revealed. In both cases, acceleration of leaching was studied using MW or US, 
the former being less effective for removal of the target compounds and producing faster 
degradation of them; therefore, USAL was the advantageous selected approach. The aspect 
common to both studies was the absence of commercial standards of the corresponding 
metabolites, which forced to identify them by time-of-flight (TOF)/MS detection 
subsequent to LC separation. After characterization by this equipment, a simple method 
was proposed for semiquantitative determination of the metabolites based on LC–DAD and 
calibration curves from either the precursors or the commercial standard more similar to 
the given metabolite. 
Also belonging to the xenometabolomics field is the research by Alcaide-Molina et 
al., who studied the metabolites involved in the shikimate pathway (phenylalanine, 
tryptophan, tyrosine and shikimic acid) as biomarkers of the effect of glyphosate on 
Triticum aestivum exposed to this herbicide. The target metabolites were leached from 
wheat model plants with the help of US, which drastically reduced the time required for 
this step [72]. 
 
5.2. USAL of metabolites from animal and clinical samples 
US has so far been scarcely applied to enhance leaching of target metabolites from 
animal or human samples. Some examples that show the advantages of application of this 
type of auxiliary energy, and can promote its use, are as follows: 
A US device (40 kHz and 125 W) was used to accelerate leaching of bufadienolides 
such as bufalin, cinobufagin and resibufogenin from toad venom samples prior to 
individual separation–determination by HPLC–DAD. With this aim, 0.2 g of sample was 
mixed with 70:30 (v/v) methanol–water solution, then subjected to US (applied by an 
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ultrasonic bath for 20 min at 20 °C). A similar yield to that provided by USAL in 20 min 
required 6 h by SE, and 18 h by maceration [27]. 
 
6. US assisted steps in polymer matrices 
The special action of US on polymer structures deserves to be considered; 
nevertheless, the number and variety of applications and the sometimes doubtful 
relationship of these steps with metabolomics make convenient condensation of the 
information as listed in Table 1. A brief comment of the most salient aspects to offer readers 
an overview of the advantages, disadvantages and no studied or no clarified aspects of US 
assisted steps in dealing with polymers is below. 
The increased surface area of immobilized cellulase [73]; the favorable effect on 
glutarylation of sugarcane cellulose without catalyst requeriments and with an unclarified 
contribution of the presence of an ionic liquid [74]; the way by which the yield of 
polysaccharides from corn silk [75] or from pumkin [76] or that of lignans from Shisandran 
chinensis [77] is increased after exhaustive optimization by using the appropriate response 
surface design; the shortening of time and energy required for extraction of β-glucans from 
barley, of great interest for scaling up the process [78], all them show the accelerating effect 
of US, despite only in two of these studies [73,54] the effect of this energy on the structure 
of the target material has been analyzed. 
The assertion of Milic et al. on the influence of US only on washing and no on 
diffusion of extractable resinoid substances from the aerial parts of white lady’s bedstraw 
[79] deserves a more in depth research using both different US conditions, particularly 
frequency, and phenomenological models. Remarkable is the study on the effect of high 
power US to extract podophyllotoxin from Podophyllum peltatum. SEM analysis showed 
microscopic structure change on the tissue cells and increased pore volume and surface 
area after ultrasonic treatment, with a significant positive effect on the extraction yield 
[80]. Also the recent contribution by Yang et al. supports the drastic shortening of the 
process time required to extract baicalin and baicalein from Radix Scutellariae under the 
influence of US as compared with heat reflux extraction, with also a very significant 
reduction of temperature and solvent consumption; thus making the US assisted method 
very valuable for large scale implementation [81]. 
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Table 1. Use of US to accelerate or enhance changes in polymer matrices. 
Extracted 
compound 
US device 
Optimum working 
conditions 
Extraction yield Other features Ref. 
Free cellulose 
activity 
Immobilized 
cellulase activity 
5 US probes 
(18, 20, 24, 26 
and 29 kHz) 
24 kHz and 15 W  
for 10 min  
24 kHz and 60 W  
for 10 min 
Increased activity: 
18.17%  
Increased activity: 
24.67% 
Fluorescence,  
CD and SEM 
measurements  
of US effects 
73 
Glutarylation  
of sugarcane 
bagasse cellulose 
Cleaning bath 
40 kHz, 180 W,  
20–120 min,  
70–95 ºC,  
ionic liquid 
Substitution ranging 
from 0.22 to 1.20 
Without catalyst. 
Structural 
characterization of 
glutarylated cellulose 
by FT-IR, and 
CP/MAS 13C NMR 
74 
Polysaccharides 
from corn silk 
With digital 
time and 
temperature 
controller 
20 kHz, 250 W,  
17 min, 56 ºC,  
1:20 g/mL solid–
liquid(water) ratio 
6.06% 
Box–Behnken 
response surface 
design 
75 
Polysaccharides 
from pumpkin 
With 2 cm flat 
tip probe 
40 kHz, 70 W,  
25 min, 70 ºC,  
1:10 g/mL solid–
liquid (water) ratio 
16.04±0.53% 
Central composite 
rotatable response 
surface design 
76 
β-Glucans  
(>260 kDa)  
from barley 
Processor 
with a 22 mm 
probe 
24 kHz, 400 W,  
17 min, 55 ºC,  
80% amplitude,  
1% cycle, water 
66.1% 
Time and energy 
required vs stirred 
tank extraction:  
3 min vs 3 h and 170 
kJ/L vs 1460 kJ/L. 
Decrease of molecular 
weight with US 
application time. 
78 
Lignans from 
Schisandra 
chinensis seeds 
Crasher with 
digital timer, 
power and 
temperature 
controller 
40 kHz, 800 W,  
61 min, 25 ºC,  
1:20 g/mL solid–
liquid(19% ethanol, 
25% (NH4)2SO4,  
56% water) ratio 
13.10 mg/g 
schizandrin,  
1.87 mg/g 
schisantherin A  
and 1.84 mg/g 
deoxyschizandrin 
Use of 19% ethanol,  
25% (NH4)2SO4, 56% 
water instead of pure 
ethanol duplicated 
yield. 
77 
Resinoid from 
aerial parts of 
white lady’s 
bedstraw 
Cleaning bath 
40 kHz, 120 W,  
30 min, 40 ºC,  
50% aqueous ethanol 
25.1 g/100 g 
US influenced 
washing but not 
diffusion of ex- 
tractable substances. 
80 
Podophyllotoxin 
from rhizomes of 
Podophyllum 
peltatum 
Homogenizer 
connected to a 
sonotrode  
with 7 mm 
flat probe 
24 kHz, 35 W,  
10 min, 0.425–0.6 
mm particle size, 
water as the medium 
Brunauer–Emmett–
Teller surface area : 
1.1887 m2/g, 
Langmuir surface 
area: 1.8542 m2/g, 
cumulative volume of 
pores 0.003768 
cm3/g, average pore 
size 56.1844 Å 
SEM studies showed 
changes in 
microscopic structure. 
79 
Baicalin and 
baicalein from 
Radix 
Scutellariae 
Cleaning bath 
with 
temperature-
controller 
Common optimum 
values: 40 kHz, 180 
W, 20 min, 0.355 
mm particle size, 1:10 
g/mL solid–liquid 
ratio, 3 cycles, pulse 
US mode Baicalin: 60 
ºC, 40% ethanol 
Baicalein: 30 ºC with 
ethanol concen- 
trations of 50% (v/v) 
110.3167±4.1258 mg 
baicalin/100 g 
37.4254±1.7665 mg 
baicalein/100 g 
Drastic decrease of 
extraction time, 
temperature and 
solvent consumption 
as compared to the 
heat reflux method. 
81 
CD, circular dicroism; SEM, scanning electron microscopy; FT-IR, Fourier transform-infrared; CP/MAS 13C NMR, cross 
polarization/magic angle spinning 13C nuclear magnetic resonance. 
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7. US assisted liquid–liquid extraction 
Despite US application favors mass transfer between immiscible phases —provided 
the involved partitioning equilibrium facilitates the transfer [82]— drastically shortens the 
extraction time, and enhances sensitivity as a result of the favorable effect of sample–
extractant volumes ratio, few applications involving US, LLE and metabolomics appear in 
the bibliography on this subject. The high user involvement and the difficulty for 
automation could be the reasons for this situation. 
Most authors working on USALLE use volumes within the range from few mL to 
few µL (which can be justified only either for expensive reagents or when the required 
preconcentration factor demands less extractant volume according to the partitioning 
factor and sample volume). In metabolomics, USALLE has been used mainly in 
discontinuous approaches and at conventional and micro scale [83]. Examples of USALLE 
of metabolites from plant and animal or clinical origin are discussed below. 
 
7.1. US assisted liquid–liquid extraction of metabolites from plant origin samples 
The sensitivity and repeatability of USAELLE and solid phase extraction (SPE) 
have been compared for preparation of samples of five commercial wines with markedly 
different aromatic characteristics and a synthetic wine, prior to the analysis of up to 44 
volatile compounds. Many aroma compounds such as alcohols, esters and acids were 
common to all the samples, but some others no. The method providing higher recoveries 
was named as LLE-I (30 min sonication at 25 °C under a nitrogen atmosphere with diethyl 
ether-n-pentane mixture as extractant), which also allowed a greater number of aroma 
compounds to be extracted; while the SPE method presented higher repeatability. On the 
contrary the LLE-II method (15 min sonication at 25 °C with dichloromethane as 
extractant) was the least convenient for sample preparation prior to the analysis of the 
volatiles in the surveyed wines [84], thus showing the necessity for an exhaustive 
optimization of sample preparation. 
 
7.2. US assisted liquid–liquid extraction of metabolites from samples of animal 
and clinical origin 
Despite the also scant use of USALLE for metabolites from biological fluids, the  
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examples below show the potential of this technique also in this metabolomics area. It 
should be noted that the use of US accelerates the LLE step, but is does not avoid the need 
for previous steps mandatory to remove proteins and other high-molecular weight 
components of biofluids. 
Sample preparation of human urine prior to determination of three strogens (17β-
estradiol, estrone, and diethylstilbestrol) required protein precipitation by inorganic salts 
such as ZnSO4, MgSO4, and PbAc2 and subsequent centrifugation. Then, a US assisted 
cloud point extraction method was based on the induction of an organized micellar medium 
by using a no ionic biodegradable surfactant (Tergitol TMN-6) to extract the strogens using 
10% (v/v) of Tergitol TMN-6 solution and the help of a thermostated ultrasonic bath acting 
for 45 min at 35 kHz. Finally, the target metabolites were determined by HPLC–DAD [19]. 
A more interesting approach was used for sample preparation prior to the 
simultaneous determination of quinocetone and three of its desoxy metabolites in swine 
urine. US-assisted dispersive liquid–liquid microextraction was carried out using 
tetrachloromethane in acetone as extractant and an ultrasonic water bath for 3 min to form 
an emulsion with subsequent disruption by centrifugation. The target metabolites were 
both in the solid and the extract at the bottom of the test tube; therefore, the aqueous 
solution was discarded and the rest was used for analysis (after dissolving the remaining 
droplet and lipidic solid in acetonitrile) based on individual separation by HPLC and 
determination by a coupled variable wavelength detector [20]. 
A complex approach was used for determination of five phenols in human urine 
and blood samples, because prior to extraction of the target analytes by US assisted 
emulsification, microextraction and solidification of the floating organic droplet, a step to 
remove proteins and other high weight molecules was mandatory. It consisted of mixing 2 
mL of the target human fluid (serum or urine) with acetonitrile at 1:2 ratio, subsequent 
centrifugation for 3 min and adjustment of both the ionic strength and pH of the liquid 
phase [85]. A subsequent multi US-assisted step involving simultaneous US assisted 
emulsion formation and US assisted LLE —viz., the socalled US assisted emulsification LLE 
[31]— was developed by using 10 mL of the prepared sample and 40 µL of 2-dodecanol 
under application of US (40 kHz for 5 min at 45 °C). The micro droplet of the extract, 
solidified in an ice bath, was collected with a spatula and finally subjected to CE separation. 
These sample preparation methods require high user involvement but simple analytical 
tools. 
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8. US assisted (bio)chemical reactions in metabolomics 
In the light of the research so far developed in dealing with metabolomics studies 
in which reactions have been improved by US application, this energy has been mainly used 
to enhance hydrolysis of metabolites as sialic acids (SIAs) and enzymatic hydrolysis (using 
mainly β-glucuronidase) in clinical samples. 
 
8.1. US assisted hydrolysis reactions in metabolomics 
Hydrolysis of conjugated metabolites in clinical samples is a slow step drastically 
accelerated by US. Some examples support this assertion. 
A method for determination of SIAs shows how a US device can be used to assist 
different steps of the analytical process by the semiautomatic platform shown in Fig. 2. The 
method, applied to serum, urine, saliva and breast milk samples, consists of the following 
steps: hydrolysis of SIA conjugated derivatives, SPE and derivatization as sample 
preparation prior to insertion of the analytical sample into either a µLC–laser induced 
fluorescence detector or an LC–MS/MS triple quadrupole mass detector [86]. 
Deconjugation of SIAs was carried out by sample acidification and immersion of the flask 
containing the sample into a water bath at 40 °C, where ultrasonic energy under the optimal 
working conditions —0.5 s/s duty cycle, output amplitude 40% of the converter (180 W) 
and sonication time for 20 min— was applied. The released SIAs were then efficiently 
concentrated in a dynamic manner using a lab-on-valve module that allows automation of 
SPE for preconcentration and cleanup. In line with SPE derivatization of SIAs by DMB 
labelling was carried, thus shortening the time from 180 min, required by the conventional 
heating method, to 20 min when assisted by US. 
On the other hand, Álvarez-Sánchez et al. [23] optimized a sample preparation 
protocol to obtain a metabolite profile of human saliva by LC–TOF/MS in high accuracy 
mode. Acidic and mild basic hydrolysis conditions were tested for sonicated (50% of total 
output amplitude, 0.5 s/s duty cycle and 10 min US application) and no sonicated samples. 
US proved to enhance and accelerate hydrolysis with an associated effect of increased 
metabolite coverage. While US energy did not have any impact on the number of detected 
features in negative ionization mode, a considerably increase of detected features in both 
acidic and basic hydrolyses was found in positive mode. Thus, US-assisted hydrolysis led 
to 38 unique features in basic hydrolysis, in contrast to 16 entities obtained by hydrolysis 
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without US assistance. Amino acids, sugars, lipids antioxidants and other potentially 
interesting biomarkers such as polyamines, vitamin B3, and ethylphosphate were 
identified. This was the first time US was involved in saliva sample preparation. 
 
 
Fig. 2. Experimental scheme for sample preparation: (A) and (C) ultrasound-assisted hydrolysis 
and derivatization, respectively. Dashed line, no automated process; dotted line, exchangeable 
position of the probe for derivatization. (B) LOV system for SPE. Continuous line, automated 
process. DMB, derivatizing reagent; LC–MS/MS, liquid chromatograph with triple quad mass 
detector; µLC–LIF, microliquid chromatograph with laser induced fluorescence detector; SPE, solid 
phase extraction; SV, switching valve. (With permission of Elsevier, Ref. [86]). 
 
Also an overall method has been proposed for targeted quantitative analysis of 
aliphatic alcohols, triterpenes and phytosterols in human serum in which saponification 
and derivatization were accelerated by US assistance. The method started by protein 
precipitation; then, saponification consisted of addition to the deproteinated sample of 
methanol 2 M KOH and immersion of the reaction mixture vessel into a water bath at 20 
°C, where US —0.45 s/s duty cycle, 50% output amplitude of the converter— was applied 
for 10 min. After cooling at room temperature, the immiscible organic phase was separated 
by centrifugation and the unsaponifiable fraction was extracted with n-hexane and 
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pump
Waste
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Waste
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column
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sample
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subsequent treated with pyridine, BSTFA and TMCS, the mixture was shaken and then, 
subjected to US (50 s/s duty cycle, 40% output amplitude of the converter) for 10 min to 
accelerate the derivatization reaction prior to GC–MS analysis of the target metabolites. US 
allowed shortening of the sample preparation <35 min for the organic phase and <48 min 
for the unsaponificable phase. The total analysis time was 71 min, and 10 min extra time 
was necessary for re-establishing and equilibrating the initial conditions [87]. The 
advantage of using the same US probe to assist both steps, thus decreasing the time 
required by their development, should be counterbalanced by optimizing the US frequency, 
which could give better results to the detriment of simplicity of using a single US device, if 
the optimum values of this variable were different for each of the given steps. 
Sequential derivatization of esterified fatty acids (EFAs) and no esterified fatty 
acids (NEFAs) for independent GC–MS analysis of both fractions of metabolites can also 
be favored by US. Human serum from obese individuals was the sample subjected to the 
US assisted step under the optimum working conditions; first in a basic medium for EFAs, 
and then in an acidic medium for NEFAs. The time required for methylation was 5 and 15 
min, for EFAs and NEFAs, respectively, drastically shorter than for no sonicated samples 
[88]. 
 
8.2. US assisted enzymatic reactions in metabolomics 
US has so far been scarcely applied to enhance enzymatic reactions, despite the 
advantages involved in application of this type of auxiliary energy have been demonstrated. 
The analysis of female steroid hormones, which exist in urine as conjugated forms 
(mainly, glucuronides and sulfates), requires deconjugation by enzymatic hydrolysis 
(usually by β-glucuronidase with sulfatase activity). This slow step can be drastically 
accelerated by US energy in such as way that, under the optimum US conditions, it is 
completed within 30 min versus 12–18 h required for no ultrasonicated samples [89]. 
An interesting approach for sample preparation prior to determination of the 
sunscreen agent 2-ethylhexyl 4-(N,N-dimethylamino)benzoate (EDP) and its metabolites 
in human urine by automated on line SPE–LC–MS/MS with LC–TOF/MS confirmation 
was reported by León-González et al. [90]. Determination of both free and conjugated 
forms of the target metabolites required two urine aliquots, one of them in the absence of 
the biocatalyst and the other with addition of β-glucuronidase solution and subjected to US 
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energy for 50 min at 20 kHz, at 35% duty cycle and 50% output amplitude (converted 
applied power, 400 W)] to deconjugate any phase II EDP metabolites potentially existing 
in the urine. Similar sample preparation required the determination of EDP and its 
metabolites in human semen also by automated online SPE–LC–MS/MS [91]. 
Galesto et al. reported an in depth study on the enzymatic hydrolysis of anabolic 
androgenic steroids excreted to urine as glucuronide conjugates also improved by US 
energy [92]. The time required for hydrolysis catalyzed by β-glucuronidase from E. coli K12 
was shortened by a factor of six when US was applied. The authors concluded that US 
enhances β-glucuronidase enzymatic kinetics by increasing both initial velocity and 
maximum velocity and that the improvement caused by this energy is mainly due to both 
stabilization of the transition state and enhancement of the mass transfer processes. 
Assessment of these conclusions is a pending goal for the authors or other groups working 
in this area. 
 
9. Conclusions 
In the light of the research so far developed in the field of metabolomics, it is clear 
that the use of US for the steps involved in sample preparation and other preliminary steps 
should be promoted. It is remarkable that US application always shorten the time required 
for extraction of metabolites from h (by conventional methods) to min, which save energy 
and costs. 
It is worth to emphasizing that US energy also causes undesirable effects, mainly 
degradation, which should be widely studied with three main aims: (i) to know the nature 
of the degradation products, and thus the pathways through which degradation occurs; (ii) 
to prove the influence of the free radicals formed by influence of cavitation; (iii) to study 
the effect of US frequency on the degradation processes by the decrease of cavitation taking 
place by gradual change of this variable from power to high frequencies. Despite the 
benefits of automated frequency scanning demonstrated by Romdhane and Gourdan [93], 
later ratified by Vilkhu et al. [94], no subsequent studies in this direction have been 
developed nor appropriate equipment for their implementation has been commercialized. 
In fact, most of the authors work at fixed frequency (usually 20 or 40 kHz), they do not 
include the frequency within the characteristics of the US device, and do not develop 
studies on possible degradation or changes induced for US application. 
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It is also remarkable that US has been widely used to improve steps of a wide 
number of plant origin samples, but this energy has been scarcely applied to enhance steps 
of target metabolites from animal or human samples, possibly due to the fact that clinical 
personnel are unfamiliar with US. In addition, US has been used more in targeted than in 
untargeted analysis (despite the fact that the digestion assisted by US possibly degrades 
less than helped by heat —aspect that should be checked). USAL at different US frequencies 
could provide greater selectivity for compounds families and, therefore, be of great interest 
in targeted analysis. 
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A review on enzymes and ultrasound: A 
controversial but fruitful relationship 
 
M.M. Delgado-Povedano, M.D. Luque de Castro 
 
Abstract 
A critical review on the effect of ultrasound (US) on enzymes and their biocatalytic 
action is presented here. Discussion on the information users of US acquire before utilizing 
the different devices, and the importance they give to US frequency is constant along the 
review. The authors have gone into the different areas in which the US–enzyme binomial 
has been applied. The lack of enough information on the US–enzyme–working conditions 
under which each piece of research has been developed, and the necessity to provide 
complete information on the data and metadata to give enough light on each piece of 
research (and thus on the potential comparison of results from different studies) are 
critically exposed. With this aim, the study has been divided into the positive effect of US 
on enzymes to favor the production of metabolites, polymers or proteins; and the 
degradation, inhibition or activation of the biocatalyst under US application. Also the effect 
of US on enzymes production and the main fields of application of the US–enzyme binomial 
are discussed. 
 
Keywords: enzymes, ultrasound, metabolites, proteins, polymers, enzymatic 
activation/inhibition. 
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1. Introduction 
Ultrasound (US) is a type of no radiant energy (therefore, it is incorrect to express 
its application as “US irradiation”) each time more used by analytical chemists despite the 
knowledge some of them show about it has not grown at the same rhythm as its use. 
Cavitation, the most named phenomenon produced by US [1], is highly dependent on the 
frequency of US (property scantly considered by some of its users, even sometimes 
forgotten when US equipment is described). The cavitation phenomenon contributes to the 
US effect on enzymes through three main mechanisms, the effect of which is considered to 
act separately or combined, by either improving enzyme catalysis or degrading the 
biocatalyst. One of the effects is purely thermal, due to the enormous microzone 
temperatures achieved during cavitation. Other effect is due to free radicals generated by 
ultrasonolysis in either water or other polar liquids. The third effect is caused by the 
mechanical forces, shear forces, created by microstreaming and shock. 
Present literature regarding the time US is applied to enzymatic reactions can be 
categorized into two main groups: the first makes use of US sample preparation prior to 
the enzymatic step [2]. In this case, reduction in particle size and a consequent increase in 
the catalytic surface area are useful to reduce mass transfer limitations. The second 
approach involves the use of US throughout the enzymatic reaction. Here, the cavitation 
energy is thought to accelerate the reaction rate, yet the mechanism by which this occurs is 
unclear (perhaps by increasing the movement of liquid molecules, the substrate’s access to 
the active site is increased). The second approach has demonstrated either to accelerate 
enzymatic reactions or to inactivate the biocatalyst [2,3], but in the former case with a 
dependence of the enzymatic enhancement with the intensity of ultrasonication rather than 
with its frequency [4]. Apparently, cavitation promotes an increment in reaction rates 
rather than a change in the reaction constants. 
In old literature, authors working with US have attributed its action to different 
effects. This is the case with acceleration of enzymatic hydrolysis, which is mainly caused, 
in the Tuulmets and Paik’s opinion [5], by temperature gradients in the cavitation medium; 
while Vulfson et al. did not attribute to cavitation the effect of power US of 25 kHz 
(frequency no specified in the publication) on interesterification, which is also a hydrolytic 
reaction [6]. In dealing with enzyme degradation, the influence of moderate pressures on 
the system subjected to US is considered either to exert an enormous effect [7], or to cause 
little effect on enzyme degradation [8]. The main causes of controversial results can be 
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attributed to the different US frequencies, intensities and application conditions (no 
specified in the publication), and/or to the different types of enzymes on which US energy 
is applied and even to the different working conditions. 
This review article is mainly aimed at showing, (i) the different areas in which the 
US–enzyme binomial has been applied, (ii) the lack of enough information provided on the 
US–enzyme–working conditions under which each piece of research has been developed, 
and (iii) the necessity for providing complete information on the data and metadata to give 
enough light on each piece of research and thus, on the potential comparison of results 
from different studies. Advances in this field are closely related to the possibility of 
comparing the results obtained by different authors under different/similar but well-
known working conditions. Division of the review as a function of substrates instead of 
biocatalysts was decided both for a better interpretation of the influence of these 
components on the effects caused by the US–enzyme binomial and the importance of the 
products obtained as a result of the given process. 
 
2. Ultrasound frequency and power/intensity, ultrasonic devices and 
working modes 
This section deals with aspects that should be always included in any publication 
involving the use of US, but most times forgotten or scarcely explained. 
 
2.1. Types of ultrasonic devices 
Despite the well-known deficiencies of US cleaning baths when used for analytical 
tasks, for which they have not been designed [9], a number of researchers uses this device, 
omnipresent in analytical laboratories. The no reproducible performance of US cleaning 
baths and the decline of power with the working time are not taken into account by the 
authors, who do not consider these aspects affect the results. For example, these 
deficiencies are not reflected in the results obtained for arsenic speciation analysis in 
seafood when the sample, after US-assisted enzymatic hydrolysis, was subjected to solid-
phase extraction (SPE), HPLC separation and ICP–MS detection [10]. It is worth 
emphasizing the growing number of analytical chemists who use US probes or reactors 
designed for specific uses, as commented below. The inappropriate name of “instrument” 
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given by some authors to US probes [11] must be avoided as these devices never provide 
analytical information. 
 
2.2. Ultrasound frequency and power or intensity 
As the name implies, the frequency of US is beyond the sound frequency; 
nevertheless, the prefix “sono” and the adjective “acoustic” are used in dealing with US 
(e.g., sonochemistry is a term used in US application on chemistry). This error should be 
avoided as the US range encompasses from 20 kHz (human hearing reaches up to 16–18 
kHz) to GHz, with division between power US (20–100 kHz) within which cavitation is a 
predominant force, and diagnostic US (5 MHz–GHz) [9]. A “sonochemistry range” is 
considered to encompass from 20 kHz to 2 MHz, in which the zone within or close to MHz 
is considered as therapeutic. This last zone has been scarcely used by analytical chemists, 
but some pioneer research using it deserves to be pointed out: such is the case with the 
study, in 1975, on conformational changes produced by 880 kHz US on penicillin amidase 
(monitored by pH changes and assisted by a pH-Stat) [12]; or that developed in 1985 by 
Chetverikova et al. about the in vitro effect of US of the same frequency on different 
enzymes (kinases and dehydrogenases) as a way to detect if this primary US-biological 
interaction could be extrapolated at a higher level of organization complexity. They 
concluded the presence of minor effects that were not investigated using lower frequencies 
[13]. In vivo studies in rats developed about 15 years later on inhibition of enzymes of drug 
metabolism in the liver by US (then corrected by heparin), only included the intensity and 
duration of US application (2 W/cm2 for 1 min) [14]. A purely analytical study dealt with 
the effect of therapeutic US (815 kHz) on the hydrolysis reaction of sucrose catalyzed by 
invertase, in which significant enhancement of enzyme activity was obtained, especially at 
low sucrose concentration [15]. 
Apart from these few cases of specific use of US within the therapeutic range, most 
of the studies involving enzyme–US can be divided into six groups, in a growing order 
attending to the information provided on the characteristics of the US device used:  
(i) Without information. In some cases no information at all is given about the US 
device used. Maybe the lack of information on the US device and US variables was the 
reason why reproduction of the results obtained by ultrasonication of lipase from porcine 
pancreas (up to 83% enhancement) has been hindered for years [16].  
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(ii) With information on the model of the device. The scant information provided 
in a number of publications —data such as “a model Transsonic TI-H-5 ultrasonic bath 
from Elma (Singen, Germany), a model UTR200 cup horn sonoreactor (SR), and a model 
UP 50H (UP) ultrasonic cell disruptor, both from Dr. Hielscher (Teltow, Germany)” [17], a 
UP200 S Hielscher, 200 W ultrasound equipment operating at 23 kHz, and 20% to 100% 
of the total power [18], or “an ultrasonic bath (KH2200B, Herchuang Co., Kunshan, 
China)” [19]— should not be allowed as the only information about the devices used.  
(iii) With information only about US power and/or intensity applied. Information 
such as “US bath of 60 W” [20], “water bath supply 125 W and tank capacity 2.8 L” [21], 
“power of ultrasound irradiation (50, 100, and 120 W)” [22], or “ultrasonic-assisted 
enzymatic hydrolysis at speciﬁc ultrasound power (typically, 100 W) for a given time” [23], 
seem not to be the proper information a researcher needs when trying to reproduce an 
experiment.  
(iv) With information about frequency. Information on this US variable should be 
mandatory, but not sufficient, in any publication on the use of this type of energy [24], with 
welcome data about other variables, either related to US such as duty cycle [25] or physical 
variables that US action can modify, as temperature [26]. Especial care should be devoted 
to variable units, without confusion between US power (W) and US intensity (W/surface 
unit, usually cm2) [27]. 
(v) With enough information about the characteristics of commercial 
conventional US devices. Distinction should be made between devices providing single or 
multiple frequency of US. In the former case, the most common information is frequency 
and either, power or intensity for probes [28,29] or baths [30,31]. Additional information 
on the surface area of the US transducer (usually fitted at the bottom) is sometimes given 
in dealing with US baths [32]. A debatable concept is to attribute to probes a “focused” 
action, reflected even in the title [33]. In fact, there is not a guide for US in the probe; 
therefore, the effect is not focused, as is the case with wave-guides in some microwave 
devices [34]. It could be said that a US probe restricts its action zone with respect to a bath, 
but never focused US. In some research using both a bath and probe, information on 
frequency and power of the bath is given, but only the model in the case of the probe [35]. 
Information about both devices makes comparison easier for readers. 
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An odd frequency (423 kHz, far from the audio frequency) of the device named as 
“sonoreactor” has been profusely used for collaborative research between groups [36–38]. 
Multifrequency US devices encompass either narrow or wide range of frequencies. 
Examples of the former are a device that works at 18, 20, 24, 26, and 29 kHz, with different 
probes [39], and other working at 16 and 20 kHz [40]. Little or no differences were found 
in these cases for the different frequencies of US when working at the same power. Higher 
differences are found when the US range is wider, as is the case with an ultrasonic bath 
working at 40, 80 and 100 kHz, and powers of 100, 150 and 200 W, with the best effects 
on transesterification at 80 kHz and 150 W [41]: a US zone with chemical effects as opposite 
to the mechanical effects, the latter being the main effects of lower frequencies. Two baths, 
each endowed with two frequencies (28/40 and 50/100 kHz), have been used with 
optimum action on the biocatalyzed system at 40 kHz and intensity of 0.5 W/cm2 [42]. The 
different substrates, enzymes and expression of US variables make comparison of the 
different studies unfeasible. 
Performance comparison of probes versus baths working at different frequencies 
and powers can only be based on the results they provide when acting on a given enzyme–
substrate system [43,44]. 
(vi) With information about no conventional US devices. Application of heat and 
US under moderate pressure has been carried out by López et al. [7] using a device designed 
by the authors and called by them as a thermoresistometer [45]. Also a curved US 
transducer was devised by Oulahal et al. to standardize biofilm removal for hygiene testing 
in internal or curved food contact surfaces [46]. Other no conventional and no commercial 
transducers have been described elsewhere [9]. 
Mention apart deserves the discontinuous application of US that some authors 
designs as “pulse” and that should be designed as duty cycle. To express this parameter as 
percent is also incorrect as no information is given about how long each US application 
lasts. The correct way is as the number of times units of application per total units of the 
cycle (e.g., 5 s/9 s) or as a fraction of the unit of time that US application lasts (e.g., 0.5 
s/s). 
 
 
 Chapter III 
 
Page | 171  
3. Behavior of enzymes when subjected to US application 
 
3.1. The influence of the reaction medium on the effects of US on enzymes 
It is a proved fact that enzyme performance is greatly affected by the nature of the 
reaction medium [47]. This effect is enhanced in the presence of US, but it has not been 
studied and/or discussed in detail by researchers. Especial mention deserves the use of 
ionic liquids (ILs) in the reaction medium because their characteristics dramatically 
influence the US–enzyme behavior most times.  
The effect of ILs on the isomerization of glucose to fructose by glucose isomerase 
was investigated by Wang et al. [48] using 12 imidazolium ILs with different cations and 
anions in the presence and absence of different organic solvents. The authors demonstrated 
that the enzyme activity was greatly dependent on the properties of both the ILs and organic 
solvents. In most of the cases, higher enzyme activities were observed in ILs as compared 
with those in solvent free or organic solvent media. The enhancement of enzyme activity in 
ILs as compared to that in organic solvents might be caused by the highest capability of ILs 
to dissolve substrates (the glucose solubility in most ILs is much higher than in organic 
solvents), which enables the reaction to develop in homogeneous media [49]. The different 
reactivity patterns observed in different ILs (decreased by decreasing the length of the IL 
alkyl chain for the same anion: decreased hydrophobicity) is similar to that of the screened 
organic solvents, and in line with the literature: the enzymes usually exhibit good 
performance in hydrophobic solvents because hydrophilic solvents might disrupt the 
functional structure of enzyme by stripping off the essential water, whose function was to 
preserve the correct molecular conformation of the enzyme [50]. US application in these 
media plays a dual role: US decreases the high viscosity of the IL and increases interaction 
change between the substrate and the enzyme in the reaction medium [51]; but US would 
also inactivate the enzyme. The negative effect of cavitation on enzyme activity could be 
avoided or minimized by immobilizing the biocatalyst, the silica coating protecting from 
this effect. 
 
3.2. Behavior of free and immobilized enzymes under US application 
Most enzymes involved in the biocatalyst–US binomial have been hydrolytic 
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enzymes (particularly lipases, amylases or proteases), either as simple biocatalysts or in 
complex mixtures. Both in solution and immobilized enzymes are commercially available 
from Sigma–Aldrich, Novozymes and other suppliers, but also in-laboratory 
immobilization has been carried out, either individual or in mixture, as is the case with 
cellulose, pectinase and hemicellulose for which alginate was used as support and 
glutaraldehyde as the coupling agent [52]. 
Despite the action of US can significantly decrease the activation energy of 
enzymes, this type of energy can also alter the behavior of enzymes that respond differently 
to alterations of pH and temperature in the presence and absence of this type of energy, as 
is the case of α-amylase and amyloglucosidase [53]. While the different response to pH is 
not explained by the authors, the influence of temperature is explained by both an increase 
in activity by the increase in temperature in the presence of US, and the decrease of this 
effect by inactivation of the enzymes favored by US at temperatures higher than 50 ºC. 
Comparison of the impact of US on free and immobilized cellulase showed that the 
highest activity of the free biocatalyst was achieved when the sample was treated with 24 
kHz US at 15 W, for 10 min, under which the enzyme activity was increased by 18.17% over 
the control. Fluorescence and circular dichroism (CD) spectra revealed that the ultrasonic 
treatment had increased slightly the number of tryptophan on the cellulase surface, with 
partial deformation of the α-helix structure and an increase of random coil content in 
cellulase protein. The highest activity of immobilized cellulase was achieved when the 
sample was treated with 24 kHz US at 60 W for 10 min, under which the activity of the 
enzyme was increased by 24.67% over the control. Scanning electron microscopy (SEM) 
revealed that the ultrasonic treatment had increased the surface area of the immobilized 
cellulase [39]. 
Concerning reusability of immobilized enzymes, the increase in activity of 
commercially available lipase immobilized on beads of a macroporous acrylic resin when 
subjected to low intensity US was kept after being used up to 4 times [54], and even up to 
8 [55] or 10 times [56]. 
Also US can act on the support for enzyme immobilization improving its 
characteristics by controlling the morphology of mesoporous silica without additives. 
Discrete rod-like and string-of-beads like mesoporous SBA-15 can be achieved by US 
application (45 kHz, 400 W) without changing the composition of the synthesis system. 
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The smaller particles of SBA-15 showed to improve both lysozyme immobilization capacity 
and adsorption rate over conventional rope-like SBA-15 [57]. 
 
3.3. Influence of US variables on enzymes 
It is worth emphasizing that comparison of research developed with different US 
equipment acting on enzymes is not conclusive (especially when US is applied on different 
enzyme–substrate systems and in different media); nevertheless, a common behavior is 
inactivation of the enzyme in some proportion, an effect that increases by increasing power 
or intensity, but can be differently affected by US frequency. 
 
3.3.1. Influence of US frequency  
Comparison of different but close US frequencies (20-to-40 kHz) applied by the 
same US device to the same immobilized enzyme acting on the esterification of two 
different substrates, rutin and naringin, shows the same optimum value for frequency in 
both cases (25 kHz), but different optimum US power (200 and 150 W for rutin and 
naringin, respectively) [55]. On the contrary, comparison of the effect of different US 
frequencies by using different devices on the same enzymatic process does not provide 
conclusive results. This is the case with the use of a probe (50 W, 30 kHz) and a reactor 
(200 W, 24 kHz), both working at 50% amplitude, to accelerate proteins digestion. The use 
of cutting-edge analytical equipment (MALDI–TOF–MS) to analyze the digested sample 
provided as only conclusion that a dirtier digested sample was obtained by using the probe 
as a consequence of more direct US application [43]. 
 
3.3.2. Influence of US power 
A study on the use of a commercial lipase to produce diacylglycerol by hydrolysis 
of palm oil under US application (“ultrasound equipment” of 200 W at 23 kHz, and 20% to 
100% of the total power) showed that exposition of the reaction system to US led to enzyme 
inactivation and water evaporation [18]. On the contrary, when US was used to promote 
emulsification of the water–oil system before the hydrolysis reaction, thus avoiding contact 
between the probe and the enzyme, an increase of the reaction product was obtained in a 
shorter time, as shown in Fig. 1. A more recent study, also on hydrolysis of triglycerides at 
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different powers (45, 85, 125, 165 and 200 W) and duty cycles (20%, 40%, 66% and 80%, 
duration no expressed), and fixed frequency of 25 kHz of an ultrasonic bath, was carried 
out to know the influence of these variables on the reaction rate of dairy waste-water 
pretreatment. A linear increase of hydrolysis from 45 to 165 W was found and the highest 
hydrolysis of about 78% was obtained at 165 W at a time span of 40 min. At high power, a 
large number of bubbles was formed that collapsed violently. Concerning the duty cycle, 
the hydrolysis increased with the increase in duty cycle from 20% to 66%; then, it remained 
consistent at 80% duty cycle (not specified duration). The increase in the hydrolysis was 
explained by the fact that when the time of exposure to US increases bubble formation, 
implosion also increases, and the reaction rate as a result. Nevertheless, long US 
application times were not recommended owing to excessive heating, which denatured the 
enzyme and created problems to transducers [58]. 
 
 
Fig. 1. Free fatty acid content as a function of the reaction time. ■, Reaction assisted by US for the 
whole reaction time; ♦, two-step reaction (using US to promote emulsification before the reaction); 
▲, control reaction (without US assistance). (With permission of Elsevier, Ref. 18). 
 
The effect of US power on cellulase showed a high dependence of its activity on this 
US variable, which was more pronounced in the presence of a US reflector. Without a 
reflector at 40% amplitude of the probe (40 kHz, 500 W of maximum power), a 12% loss of 
enzyme activity was measured in a period of 65 min. By increasing the amplitude to 60 and 
80%, the decrease in enzyme activity became more significant, and after 65 min the enzyme 
possessed only 80 and 75% of the original activity, respectively. Despite the applied 
ultrasonication depressed the activity of cellulase, the outcome of the enzyme catalyzed 
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hydrolysis in the reaction model was always positive; therefore, the advantageous effects of 
ultrasonication on the heterogeneous cellulose–cellulase reaction always overcome the 
undesirable effect of US on enzyme modification [59]. 
 
3.3.3. Effect of US intensity 
A recent study deals with the effect of low intensity US application on the kinetic 
and thermodynamic parameters as well as on the molecular structure of cellulase. With this 
aim, the chemical reaction kinetics model, Arrhenius equation, Eyring transition state 
theory, Michaelis–Menten equation, ﬂuorescence spectrometry and CD spectroscopy were 
used. The maximum cellulase activity was observed at 17.33 W/cm2 intensity and ultrasonic 
treatment for 30 min, under which the enzyme activity was increased by about 25% over 
the untreated enzyme. After US treatment, the typical thermodynamic parameters were all 
reduced, as did the number of tryptophan on cellulase surface, and the molecular structure 
of cellulase changed favorably to provide more access to the active sites [60]. 
A previous study, developed more than 15 years ago and, therefore, with no cutting-
edge instrumentation for monitoring, was aimed at knowing the effects of 20 kHz US at 
different intensities (46, 92 and 138 W/cm2) on the catalytic activity and structure of the 
tetramer of wild-type human butyrylcholinesterase (BChE) from plasma and recombinant 
D70G mutant enzyme, working at constant temperature. The US effects were investigated 
using a neutral substrate (o-nitrophenylbutyrate), a positively charged substrate 
(butyrylthiocholine), and a negatively charged substrate (aspirin), and monitored by gel 
electrophoresis and photometric measurements of Vmax after US treatment. For both wild-
type and D70G biocatalysts, KM increased slightly for butyrylthiocholine and o-
nitrophenylbutyrate under US application, suggesting that the US effects were not due to 
the periodic variation of pressure but rather to shear forces that took off substrate from the 
peripheral site and altered diffusion to the active site. By contrast, affinity of the D70G 
mutant for aspirin slightly increased by increasing US power, suggesting that US-induced 
microstreaming unmasked peripheral residues involved in recognition and initial binding 
of the negatively charged substrate. Short US duty cycles induced a faint transient enzyme 
activation, but prolonged US application caused partial dissociation of the tetrameric 
enzyme and irreversible inactivation [8]. 
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3.3.4. A common use of US in biochemistry: cell disruption 
Cell disruption to extract enzymes is a common practice in biochemistry research, 
but the influence of the frequency of the US probe had not been comparatively studied. The 
results obtained from sludge ﬂocs using US probes working at 20 and 40 kHz at different 
intensities showed that the former frequency allows extraction of more types of enzymes 
than the latter. Under the optimum conditions, US can extract extracellular enzymes and a 
small part of intercellular enzymes, being US intensity a more influential variable than US 
duration [44]. 
 
4. Metabolites as substrates of US-assisted enzymatic catalysis 
The types of metabolites and enzymatic reactions that can be favorably influenced 
by US are numerous; therefore, the most outstanding processes involving these low-
molecular compounds are discussed in this section. 
 
4.1. US-assisted enzymatic hydrolysis 
The type of reaction more widely assisted by the US–enzyme binomial in dealing 
with metabolites is hydrolysis. The following subsections are devoted to representative 
types of metabolites the hydrolysis of which has been favored by the given binomial. 
 
4.1.1. Fats hydrolysis 
Hydrolysis is the main first reaction for production of free fatty acids that may then 
be esterified, interesterified, transesterified or converted into high-value fatty alcohols. As 
compared with conventional methods for oil hydrolysis, enzymatic hydrolysis can be 
performed under relatively milder and simpler process conditions, and enhanced by US 
energy, either in solvent-free media or in heterogeneous media. Free lipases from different 
strains and immobilized on different supports are commercially available for this task. A 
review on this subject has recently been published by Lerin et al. [61]. 
Comparative studies on lipase-catalyzed hydrolysis of soy oil in solvent-free 
systems were carried out in a shaking bath US bath (ultrasonic intensity 1.64 W/cm2 and 
frequency of 28 kHz). Under the optimum conditions, the overall enzymatic hydrolysis 
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assisted by US was 2 times higher than that assisted by shaking [31]. When the solvent-free 
US-assisted process of lipase-catalyzed hydrolysis of soy oil was compared with that taking 
place in a heterogeneous medium involving water, the latter was the most favorable 
situation as the US energy dispersed soy oil in water to obtain a larger interfacial area, 
which caused a higher initial rate of soy oil hydrolysis as compared with the solvent-free 
system [62]. 
Diacylglycerols (DAGs) are glycerol esters in which two hydroxyl groups are 
esterified with fatty acids that occur as natural components of glycerides in various fats and 
oils at levels up to 10% (w/w) [63]. The properties attributed to DAG oils as suppressors of 
serum levels of postprandial triglycerides [64], and as emulsifiers and stabilizers in foods, 
cosmetics and pharmaceutical industries have promoted their US-assisted production by 
enhancing the action of lipases, either in solution or immobilized. Solvent-free systems, 
with [35] and without the presence of surfactants [65], have been studied, mainly using 
commercially immobilized enzymes. Despite most of the studies on DAGs have involved 
the joint use of both immobilized enzymes and US, the previous application of this energy 
to promote emulsiﬁcation of a water/oil system before the hydrolysis reaction avoids 
contact between the probe and the enzymes and provides excellent results [18]. 
Degumming is the first step in the refining process of vegetable oils, which removes 
phospholipids and mucilaginous gums by phospholipases. Most of the reported studies 
have so far been focused on the degumming efficiency of phospholipase A, the action of 
which has intended to be accelerated by the presence of US [66]. Despite the increased 
acceleration caused by US, the well-known effect of this energy on oils oxidation [67] 
advisers against application of US on edible oils. 
An uncommon and recently developed reaction involving US–enzyme action was 
the enzymatic pre-hydrolysis of a synthetic dairy wastewater with around 2000 mg/L of fat 
content. Exhaustive optimization of parameters such as enzyme loading, temperature, US 
power, frequency, duty cycle and speed of agitation led to a maximum hydrolysis of 78% at 
0.2% (w/v) enzyme loading, 30 ºC temperature, 165 W of US power at 25 kHz and 66% 
duty cycle (with not information on cycle duration) [68]. 
 
4.1.2. Hydrolysis of glucuronide conjugates  
A number of liposoluble metabolites is excreted in urine after formation in the  
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organism of more hydrophilic glucuronide conjugates. The study of these metabolites 
makes mandatory a previous hydrolysis using β-glucuronidase, the biocatalysis of which is 
relatively slow. One of the first contributions to the use of US–enzyme in this field dealt 
with six female steroid hormones, found in woman urine as conjugated forms (mainly, 
glucuronides and sulfates). The free steroid forms of these metabolites were obtained by 
enzymatic hydrolysis using β-glucuronidase with sulfatase activity, and assisted by US 
energy (applied by a probe working at a frequency of 20 kHz, 225 W and 0.4 s/s duty cycle). 
A drastic shortening of the time required for this step as compared with conventional 
protocols (from 12–18 h to 30 min) was thus achieved [69]. Xenobiotics such as anabolic 
steroids in urine have also been deconjugated with the help of β-glucuronidase and a US 
probe in only 10 min. The different source of the enzyme, different metabolites and 
different US probe (no information but the commercial name was given) hinder 
comparison between the results in [69] and those obtained in this case [17]. A subsequent 
study on the same enzyme aimed at revealing the effect of US energy on the enzymatic 
hydrolysis kinetic parameters, as well as on the enzymatic activity of the biocatalyst was 
conducted using the compounds 4-nitrophenyl-β-D-glucuronide and 4-nitrophenol 
(product of the enzymatic reaction together with glucuronic acid). The experimental data 
suggested that the reaction follows the Michaelis–Menten kinetics and that US affects the 
initial reaction rate, which was higher when this energy was used and compared to the 
classical method of incubation at 55 ºC. Also the values of Vmax and kcat were higher for the 
ultrasonic assay, whilst the Michaelis–Menten constant obtained by the two methodologies 
showed similar values. Deactivation of the enzyme was also observed under US energy, 
which was found particularly evident for experimental conditions with excess of substrate. 
Key information on enzyme deactivation was not obtained because the simple analytical 
instrumentation used (HPLC–molecular absorption detector) [70]. 
The in vivo metabolism of a xenobiotic, a UV filter commonly used in sunscreen 
cosmetic products [2-ethylhexyl 4-(N,N-dimethylamino)benzoate (EDP)], was studied by 
targeting metabolomics analysis in human urine. The metabolomic study involved the use 
of urine from male and female volunteers before and after application of an EDP-
containing sunscreen cosmetic with and without enzymatic hydrolysis. The detected 
metabolites were subsequently confirmed by liquid chromatography–time-of-flight/mass 
spectrometry (LC–TOF/MS). The existence of phase II metabolism in the detoxification of 
EDP by effects of its lipophilic character was confirmed, but no importance was given to 
the US-assisted step that was developed following existing literature [71]. 
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4.2. The effect of US on no hydrolytic enzyme-catalyzed reactions 
Most of the slow biocatalyzed reactions that have been intended to be accelerated 
by US energy during more than 20 years have involved lipids, the products from which are 
applied on different fields (e.g., foods, cosmetics, pharmaceuticals, biofuel). The variety of 
the substrates and products in each field is so wide that general guides on the behavior of 
them when subjected to US energy have yet not been established. Some examples of 
progresses in some of these fields are discussed below. 
 
4.2.1. Enzymatic esterification assisted by US 
Esterifications constitute one of the most representative group of enzymatic-
assisted reactions the slowness of which has promoted the study of US application for 
acceleration. Interesterification of N-acetyl-phenylalanine ethyl ester catalyzed by 
subtilisin was developed for the first time in 1991, and substantial increase of the enzyme 
activity by US pretreatment was demonstrated [6]. The effect seemed to be dependent on 
US amplitude, the presence of water in the reaction medium and length of the chain of the 
alcohol involved. Subsequent studies on acylations and transacylations attributed the 
accelerating effect of US to the increase in temperature this energy causes, which also 
degrades the biocatalyst over a certain value. The increased pressure and active surface of 
the enzyme were also considered influential variables [16]. After more than 20 years, during 
which the research in this field has increased almost exponentially from 1-to-2 
publicationes/year before 2004 to more than 25 in 2014, the results obtained cannot allow 
general application of given working conditions. Therefore, each piece of research 
establishes the conditions for working on given systems, for given ranges of the influential 
variables and for given optimization designs, either uni- or multivariate approaches. 
An exhaustive study on the enzymatic acylation of troxerutin by alkaline protease 
from Bacillus subtilis with the assistance of US showed that, after optimization of several 
factors such as US application using different powers and frequencies (100, 150 and 200 
W, and 40, 80 and 100 kHz, respectively), US pretreatment of the enzyme for 8 h yielded 
conversion of troxerutin of 87.3% as compared with 56.3% of the stirring method. The 
acylation position in the series of mono-substituted products thus obtained was established 
by 1H NMR and 13C NMR, but no conclusions on the effects of US variables on the nature 
of the reaction products were obtained [41]. 
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Acidolysis (a two-step reaction in which TAGs are first hydrolyzed into 
diacylglycerols and monoacylglycerols, and then the new fatty acids are esterified into the 
glycerol skeleton to form new TAGs [72]) is a general enzymatic methodology more 
commonly employed than interesterification for the production of structured lipids, 
particularly of 1,3-dioleoyl-2-palmitoylglycerol (OPO), as their products are easily 
separated from the final reaction mixtures, thus decreasing separation costs [73]. The study 
recently carried out on three commercial lipases immobilized on different materials and 
with US assistance either during catalysis or as pretreatment step showed that under the 
optimum working conditions (US pretreatment for 6 min at 20 kHz, 115 W and 3 s/9 s duty 
cycle, 1:8 tripalmitin–oleic acid molar ratio, 12% enzyme dosage and 50 ºC temperature) 
the OPO yield was 51%. Fig. 2 shows the different behavior of the immobilized lipases (Fig. 
2A) and the increase of OPO with time both helped by conventional stirring and under US 
pretreatment (Fig. 2B). Reusability of the biocatalyst up to 10 times makes the process 
potentially adaptable to industrial scale after checking other US frequencies different from 
20 kHz [56]. 
 
       
Fig. 2. (A) Effect of reaction time on OPO content using different lipases. Reaction conditions: 50% 
US power, 6 s/3 s ultrasonic pulse mode, 6 min pretreatment time, 1:6 tripalmitin/oleic acid molar 
ratio, 8% enzyme dosage and 3 mL of hexane with molecular sieves 4A (50 mg/mL), 55 ºC. (B) 
Comparison between US pretreatment and conventional stirring method on the production of OPO. 
US reaction conditions: 50% US power, 3 s/9 s US pulse mode, 6 min pretreatment time, 1:8 
tripalmitin/oleic acid molar ratio, 12% enzyme dosage and 3 mL of hexane with molecular sieves 4A 
(50 mg/mL), 50 ºC. (With permission of Elsevier, Ref. 56). 
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Transesterification for production of 1-glyceryl benzoate from methyl benzoate 
under US application using a commercial immobilized lipase, Novozym 435, was optimized 
by a multivariate design (a full central composite rotable design) and the highest 
conversion, around 16%, was obtained at 65 ºC, 1:1 of methyl benzoate to glycerol molar 
ratio, 15 wt% of enzyme concentration, 3 mL of solvent and 40% ultrasonic power in 4 h of 
reaction [32]; nevertheless, the unique operating US frequency was 37 kHz and the 
maximum US power was 132 W, which could be not enough to obtain the attainable 
conversion by either higher or lower frequencies, under which higher conversions could be 
obtained. Similarly, the transesterification reaction for production of isoamyl butyrate from 
isoamyl alcohol and butyric acid using immobilized Novozym 435 and US assistance 
provided maximum conversion (96%) at 25 kHz frequency and 70 W US power, with 
shortening of the time required to 3 h vs 10 h in the absence of US [74]. 
Nevertheless, only two US frequencies (25 and 40 kHz) were studied and other 
variables such as US power, US application time, system temperature, etc., all them inter-
related, were studied by a univariate method. Therefore, the optimum values thus obtained 
(including reusability of the immobilized enzyme for 7 times) could be very different by 
applying a multivariate approach for optimization and a wider range of US frequencies. 
What it is clear in any case is that US favors the reactants–enzyme contact in solvent free 
systems that contribute to flavor production in a greener way. 
A recent example of research on transesterification is that of glycerol to glycerol 
carbonate (GlyC) from dimethyl carbonate also using commercial immobilized lipase 
(Novozym 435) and a US water bath using 20 and 40 kHz and 200 W. Evaluation of the 
effects of temperature, molar ratios of substrates, enzyme loading, duty cycle and US power 
on the conversion of glycerol to GlyC provided optimum conditions under which a 99.75% 
conversion and reduction of the reaction time from 14 to 10 h were achieved, with decay in 
both enzyme activity and product conversion with repeated use of the biocatalyst [75]. 
Some other organic reactions involving esterification aimed at obtaining a given 
product are more considered as synthesis of the pursued product than as the given organic 
reaction. Such is the case with the synthesis of flavonoid esters from unsaturated fatty acids 
to favor solubility of flavonoids such as rutin and naringin into lipophilic media that was 
catalyzed by Novozym 435 under US pretreatment. An ultrasonic frequency of 25 kHz, 
power of 200 W for rutin and 150 W for naringin and time of 1 h was determined to 
guarantee satisfactory degree of esteriﬁcation and lipase activity. Under the optimum 
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conditions, the overall esteriﬁcation reaction time using the ultrasonic pretreatment step 
was 24 h shorter than that of mechanical stirring process (48–72 h), without damaging the 
lipase activity [55]. Similarly, the US-accelerated enzymatic synthesis of caffeic acid 
phenethyl ester (CAPE) from caffeic acid and phenethyl alcohol was investigated using 
commercial immobilized Novozym 435. The results indicated that the reaction time, 
substrate molar ratio, and ultrasonic power signiﬁcantly affected percent molar conversion, 
whereas enzyme amount did not. A model for synthesis of CAPE was established based on 
ridge max analysis, the optimum condition for CAPE synthesis was predicted to be reaction 
time 9.6 h, substrate molar ratio 1:71, a 40 kHz frequency and US power of 2 W, yielding a 
molar conversion of 96.03±5.18%. Experiments performed under these optimal conditions 
yielded a molar conversion of 93.08±0.42% [76]. 
 
4.2.2. US-assisted catalyzed biodiesel production 
Despite the reactions involved in biodiesel (BD) production are common 
transesterification reactions, the restrictive requirements of the parameters to meet 
international standards for BD quality [77], and the achievements in this field by using US 
energy and enzymes make convenient a separate discussion of the subject. Chemical acid- 
and base-catalyzed, and enzyme-catalyzed BD production has been widely reported [78]. 
Acceleration of the former by US has been [79–82] and is at present [83,84] a matter of 
research. More recent is the contribution of US-assistance to biocatalyzed BD production 
that foreseeably will be place to abundant and fruitful research. After the first attempts by 
Yu et al. and Kumar et al. [47,80], the research by Feiten et al. has not reported useful 
information in this field. Following its previous experience, the group optimized typical 
parameters such as US power, temperature and type and reusability of the enzyme working 
at a single US frequency of 37 kHz and on only soybean oil as fat raw material. The group 
worked both in batch [54] and fed-batch regimes [85], but the produced BD did not reach 
the required international standard yield as the highest value they found was ~90% w/w vs 
the minimum allowed of 96.5%. The use of ethanol instead of methanol gave place to fatty 
acid ethyl esters considered at present an option better than methanol for making BD fully 
produced from renewable materials. Transesterification of waste cooking oil by dimethyl 
carbonate in solvent free system and in the presence of immobilized enzyme Novozyme 435 
was developed under three working conditions: with only stirring and under the action of 
US without and with stirring. Despite the last conditions provided the highest conversion 
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into fatty acid methyl esters (FAMEs) (86.61%) it was far from the minimum required by 
international standards [86]. A higher BD yield (96%) was achieved by the same authors 
after US application to the same immobilized biocatalyst (no specified support) but 
different raw materials (Nagchampa oil and methanol) in the presence of water, different 
US frequency, power and duty cycle; therefore, comparison of the results was impossible 
[87]. Titration was the only technique used for analysis in this case (viz., acid-base titration 
to know the amount of butyric acid produced by lipase hydrolysis, the amount of free fatty 
acids in the oil and the unreacted KOH); while HPLC–molecular absorption detection [86] 
and GC–FID [54] [85] were used in other cases; therefore, information on the reaction 
products was never obtained. Measurements of a crucial parameter as US power received 
by the sample under the experimental conditions were not performed in any of the studies 
[84]. 
 
5. Polymers as substrates of US-assisted enzymatic catalysis 
Polymers have been subjected to the combined application of US and enzymes 
mainly to facilitate solid–liquid extraction (more properly named as leaching or lixiviation) 
of metabolites, desirable or undesirable compounds, fractionation of the polymer into 
smaller polymers or monomers, etc. Some key examples of the process (named as US-
assisted enzymatic extraction or USAEE) are described below and others are summarized 
only discussing some outstanding aspects. 
A method for enzymatic extraction of high quantities of different fractions of 
polysaccharides from given vegetables requires the use of enzymes according to the types 
of target polysaccharides to be fractionated. In the case of polysaccharides in leaves in a 
Chinese medicinal plant, papain, pectase cellulose and α-amylase were required. The 
enzymes together with the use of US to favor their action were named by the authors as 
“ultrasound complex enzymes” or “UCE”, while the extracts were considered as “the 
extraction solutions”, obtained from a solid leaves-extractant system considered as “a 
mixture”, “extracted in an ultrasonic cleaner, using selected extraction temperature 
ultrasound time, ultrasound power and pH” (this last sentence containing all information 
about the characteristics of the US device used) and using a Box–Behnken design and 
statistical analysis for optimization. Then, the authors applied a number of analytical 
methods to obtain information about the nature of the obtained extracts: total 
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carbohydrate content, total protein and total uronic acid by photometric methods; 
composition in monosaccharides by FID detection after derivatization and individual 
separation by GC, the average molecular weight of the fractions by high-performance size-
exclusion chromatography  with refractive index detector and antioxidant activity assays 
(DPPH radical scavenging, superoxide radical scavenging, ferric-reducing antioxidant 
power), immunomodulatory activity assays (on animals and cells, in vitro lymphocyte 
proliferation and macrophage phagocytic, and natural killer cell activity). The authors 
justified the presence of each extracted fraction by the action of one or more of the enzymes 
in the UCE, and attributed the favorable effect of US on the characteristics of the extracts 
to the cavitation phenomenon (thus, the frequency of the US transducer should be within 
the power zone). In short, the research is a clear example of the necessity of 
interdisciplinarity to obtain really useful, well supported results from a wide study, and 
with the correct use of the terms [88]. 
Biocatalysis from cellulase, hemicellulase and pectinase are widely used in juice 
and wine processing to degrade cell walls and plant tissues for improvement juice yield [89] 
and shortening the maceration time while increasing the extraction yield [90]. The 
extraction yield is improved by combining US and enzymes, as in the case of grape and 
acerola juice [91,92]. A recent contribution in this area is the research on the effect of US 
frequency, enzyme concentration and maceration time as variables on the USAEE of 
mulberry must by using the response surface methodology. Both a tunable US probe and a 
US bath were used to ultrasonicate the samples at various times and frequencies according 
to the experimental design, at constant power of 60 W with duty cycle of 10 s/15 s. Total 
phenols, flavonoids and anthocyanins contents were monitored together with chromatic 
properties of the extracts, without other information about the extracted compounds and 
the potential degradation caused by US. Thus, the application of a Box–Behnken design 
and statistical analysis special software package does not allow achieving conclusions about 
the quality of the ultrasonicated extract as compared with a no ultrasonicated extract, of 
crucial importance in dealing with food [93]. 
Degumming is also the name given to an extraction process that modified the 
surface of natural ﬁbers such as silk by removing an amorphous matter as sericin that acts 
as gum binder from the main single protein known as fibroin, thus eliminating the harsh 
and stiff touch of the raw silk that hides the rich luster and whiteness of the commercial 
fiber. Traditional chemical degumming methods are highly contaminants, while the use of 
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enzymes overcomes this problem and the assistance of US to biocatalysis accelerates the 
process. A study on this matter developed in 2010 shows contradictory scientific rigor as 
the authors used for US application a cleaning US bath with an unknown frequency (which 
was not in the article or in the US cleaner catalog), but then, the effect of the US energy on 
the characteristics of the treated fiber was analyzed by SEM. Therefore, the exhaustive 
studies for comparison of the degumming process assisted by a surfactant, by US, by 
US+surfactant, and US+enzyme can be hardly reproduced; nevertheless, the results 
obtained by the US–enzyme binomial are promising as it seems to be effective and the joint 
action of US and the biocatalyst does not affect fribroin structure [21]. 
Bioethanol production from lignocellulosic biomass makes mandatory 
pretreatment to break up lignin structures and enhance enzymatic saccharification of 
cellulose. With sugarcane tops as raw material, US and a surfactant were used in the 
pretreatment for effective removal of hemicelluloses and lignin and improvement of the 
reducing sugar yield. Despite no information is given on the US device, the values of power 
and duty cycle were selected before applying an optimization design involving surfactant 
concentration, sonication time, biomass loading and incubation time as variables. The high 
yield of subsequent enzymatic hydrolysis obtained (0.661 g of reducing sugar/g of 
pretreated biomass) deserved a detailed study of the structural changes by comparing the 
native and pretreated biomass by SEM, XRD and FT-IR. The results of these analyses 
showed that, similarly to the results of previous studies, removal of some external fibers by 
destruction of the cellulose–hemicellulose lignin network generated a pretreated biomass 
more readily hydrolyzed, but the ultrasonication conditions did not hydrolyze the biomass 
[94]. As usual, the lack of information about the source and frequency of US hinder proper 
use of the results from this research. 
Studies in which US has been applied as sample preparation for subsequent 
biocatalysis have shown that the modification of the substrate structure facilitates 
enzymatic action. As examples, US-assisted pretreatments of lignocellulosic biomass from 
wood wastes [95], sugarcane bagasse [96,97] and kenaf powder [98] undergo a milling 
process of the lignocellulosic substrate due to shock waves generated by the cavitation 
collapse that increase the surface area thereby improving enzymatic saccharification. Study 
of the structural changes promoted by US carried out by SEM, X-ray diffraction (XRD) and 
FT-IR have been developed under not well specified US conditions (“40% amplitude, pulse 
59 s on and 59 s off”, without information of US frequency, power and intensity, and 
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involving an erroneous concept of pulse, that is the name the authors gave to duty cycle) 
and in the presence of surfactants. The pretreatment efficiency was measured through the 
reducing sugar yield after enzymatic saccharification of the pretreated sample. Scanning 
electron micrographs showed that US pretreatment induced physical changes in the 
biomass with a highly distorted structure and removal of some of the external fibers by 
destroying the cellulose–hemicelluloses lignin network. US does not hydrolyze the biomass 
to soluble sugars, but generate a pretreated biomass that is more readily hydrolyzed by 
increasing accessible surface area [94]. Identical observation was earlier reported for rice 
straw pretreated with an organosolvent [99]. Carbonyl bands also indicated removal of 
hemicelluloses and the X-ray diffraction profile showed an increase of the crystallinity 
index, which is also enhanced when surfactants are present in the media, and caused by an 
effective removal of amorphous components like lignin and hemicelluloses. A key aspect of 
US application prior to introduction of enzymes into the medium under study is that 
changes in the structural features of pretreated vs native samples facilitate subsequent 
enzyme biocatalysis and avoid the degrading effect this energy can exert on the given 
enzyme. 
Research on evaluation of pretreatment of sugarcane bagasse combining US and 
supercritical carbon dioxide (SC-CO2) in a sequential manner to enhance the enzymatic 
hydrolysis of pretreated bagasse has been developed by Benazzi et al. After multivariate 
optimization of the SC-CO2 pretreatment, the authors improved the amount of fermentable 
sugar of about 280% as compared with no treated bagasse, conducting to hydrolysis 
efficiencies of 74.2%. When this pretreatment was combined with previous US application 
the amount of fermentable sugar increased 16%. The authors supported the improvement 
provided by SC-CO2 on the agreement with previous results and on US cavitation [100]. 
Ring-opening polymerization of lactones and lactides had previously been achieved 
by chemical- and bio-catalysis helped by energies such as microwaves [101] or by 
supercritical fluids [102] in the presence of ILs [103]. The use of US in combination with 
enzymes has been applied to the Candida antarctica lipase B mediated ring opening 
polymerization of ε-caprolactone to poly-6-hydroxyhexanoate, also with the assistance of 
an IL (1-ethyl-3-methylimidazolium tetraﬂouroborate). The authors compared the method 
with and without US assistance and checked that in the former case monomer conversion 
increased by 63% and afforded a polymer product of a narrower molecular weight 
distribution and a higher degree of crystallinity. Under US application, the polydispersity 
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index of the product was ~1.44 compared to a value of ~2.55 for the product from the 
conventional reaction. The improvement was associated to US microstreaming that favored 
mass transfer of the monomer to the active site of the enzyme in a reaction mixture that 
became increasingly viscous with time and, therefore, increasingly limited mass transfer 
[104]. Despite data about the US device used (35 kHz and 320 W) appears in the article, no 
information about optimization nor values of the applied US variables are given. The 
authors analyzed the treated samples by FT-IR, 1H NMR, gel permeation chromatography, 
differential scanning calorimetry and thermogravimetric analysis, and evaluated the 
volumetric productivity and monomer conversion, but they did not compare the results 
they obtained with those provided by assistance from other energies [105]. 
One of the scant contributions in polymers treatment of US multifrequency devices 
is that developed by Oliver et al. for biodegradation of wheat chaff. The authors used a 
sequential two-steps US-assisted pretreatment of the sample (10 min each) at 40 and 270 
kHz, but they did not justify the selected frequencies, the US application time or the 
necessity for two sequential treatments to increase enzyme accessibility to the cellulose 
fibrils by disruption of the plant surface structure, as shown by changes in the 
microestructure. Then, they applied US (80 kHz) to the extract–enzyme system for 72 h 
with a duty cycle of 1 min/31 min and analyzed the resulting analytical sample by head 
space GC–MS to obtain the mass profile of volatiles. The scheme of the overall process 
includes a previous treatment with microwaves, which was not useful at all [106]. 
Studies on US treatment of sorghum slurry prior to liquefaction and 
sacchariﬁcation under optimized conditions provided an increased yield of glucose within 
10–25%, depending on time of US application and intensity (horn working at 20 kHz and 
750 W maximum power). The reason for the increase in the percentage of sacchariﬁcation 
was attributed to the availability of additional starch for hydrolysis due to US-assisted 
disruption of the protein matrix (surrounding starch granules) and the amylose–lipid 
complex [29]. 
US-assisted enzymatic extraction of arabinoxylan, the major dietary ﬁber 
component of wheat bran, has recently been reported [107]. Commercial enzymes (endo-
1,4-β-xylanase, α-amylase, protease, and amyloglucosidase) acted on the sample in a 
sequential manner under the action of US provided by a US bath equipped with two US 
transducers with frequencies 28/40 and 50/135 kHz. Despite the possibilities to study the 
influence of the different US frequencies on the different enzymes, the authors only applied 
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and validated an optimization design and presented the tables of data, three- and 
bidimensional plots with no mention to the effect of US on both solid raw material and 
enzymes. The analytical equipment involved in the research was quite similar to that used 
by Wu et al., who obtained the analytical information by a common photometer; therefore, 
information only concerned to overall common parameters and no to the effect of US 
assistance as a function of the values of its characteristic parameters [108]. It is clear that 
despite a multivariate design is useful for optimization, information on the effect caused by 
the auxiliary energy is mandatory to evaluate its usefulness. 
A recent comparison of the influence of US on the chemical and enzymatic 
hydrolysis of yam has been reported. The comparison was only based on the yield of 
fermentable sugars: the highest yield was obtained by the US-enzymatic process, followed 
by that enzymatic, then US–chemical and chemical [109]. This would be an excellent 
system to study the pathways followed by hydrolysis in each case for which the variables 
involved in the optimization designs provided scant or null information. 
 
6. Proteins as substrates of US-assisted enzymatic catalysis 
The subject of this section was widely covered by Bermejo et al. in 2004 in a review 
on enzymatic digestion and ultrasonication [110]; therefore, only some specific, recent 
contributions are discussed below. 
The analysis of protein-containing samples requires a pretreatment for 
deproteination, which is usually accomplished by acid treatment (trichloroacetic acid, 
TCA), organic solvents (methanol, acetonitrile) or heat. However, these treatments seem to 
be not very efficient to remove this interference, particularly when the analytical method 
uses a mass detector for identification and/or quantitation [111]. To overcome this problem, 
a US-assisted enzymatic hydrolysis method was developed to break the three dimensional 
structures of proteins and release bound tetracycline antibiotics (TCs). This step not only 
improved signiﬁcantly the recovery of TCs, but also shortened the pretreatment time from 
16 h to 6 min. By combining this new deproteination method and a solid phase extraction 
clean-up step, a suitable sample preparation was achieved for the analysis of TCs by LC–
MS/MS. The overall method provided recoveries in the range 89.1–102.4%, much higher 
than those obtained when acid deproteination was used (23.5–36.2%). Despite the 
“ultrasound-assisted enzymatic hydrolysis” of the proteins was even in the title, no 
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information is given about the US device used nor about its frequency, but only about the 
optimum US power (100 W), above which the efficiency of the process decreased. The 
drastic reduction of the time required for protein enzymatic digestion in the presence of US 
as compared with that necessary in the absence of this energy deserves an in depth study 
of US action, which clearly was not the aim of this research [23].  
Enzymatic hydrolysis by pepsin of seafood materials to liberate arsenic species 
(arsenite, As(III); arsenate, As(V); dimethylarsinic acid, DMA; and arsenobetaine, AsB) 
As(III), As(V), DMA and AsB) was performed with US assistance by a US water bath 
working at 35 kHz, thus shortening the digestion time from 12–14 h to 4–30 min. The 
digested thus obtained, after being subjected to a clean-up step, was injected into an LC for 
individual separation of the target analytes prior to atomization–detection by ICP– 
Orbitrap MS [10]. The authors used microwave-assisted digestion (MAD) as the standard 
method for comparison with the proposed method, and they obtained good results. 
Nevertheless, the authors did not justify why they used the US frequency of 35 kHz and not 
that at 17 kHz, also provided by the US water-bath; and why the times required for 
hydrolysis of the different arsenic species were also different. Similar studies have later 
been developed by the same authors for determination of iodinated amino acids in edible 
seaweed using in this case pancreatin as biocatalyst. Also similar was the comparison of the 
proposed US-assisted method with the MAD method as standard, but the US bath worked 
at 45 kHz as single frequency in this case. No explanation nor discussion was given about 
the difference in percent content of iodine between the two target iodinated species (50–
83% of the extractable iodine) and the total content that the authors attributed to no 
extractable iodinated species and/or minor un-extractable target amino acids [112]. 
A more complete study on the effects of US treatment during proteolysis on kinetic 
characterization of the hydrolysis of defatted wheat germ protein (DWGP), and on the 
inhibitory activity of the hydrolyzate of the angiotensin I-converting enzyme (ACE) has 
been developed [113]. Thus, the effects of US pretreatment on the release of peptides with 
ACE-inhibitory activity showed that the value of kA for DWGP hydrolysis under US 
application increased by about 22.2%, and KM decreased about 13.0%, compared with that 
obtained without US. The analysis of ACE-inhibitory activity indicated that US had less 
effect on the ACE-inhibitory activity during enzyme treatments than US pretreatment that 
caused a 21.0–40.7% increase in ACE-inhibitory activity of DWGP hydrolyzate. The studies 
on hydrophobicity, microstructure, and amino acid composition revealed that US 
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pretreatment could result in an increase of surface hydrophobicity of DWGP and loosening 
of protein tissue, which accelerate the release of hydrophobic amino acids during enzymatic 
hydrolysis, thus facilitating the enzymatic hydrolysis of DWGP; whereas US pretreatment 
could promote the release of ACE-inhibitory peptides from DWGP during enzymatic 
hydrolysis. The digested was subjected to RP-HPLC separation of the target amino acids 
previously derivatized for final fluorescence detection. A single frequency (20 kHz) was 
provided by the US probe working at a duty cycle of 2 s/4 s, but the applied power was 
provided as power output rather than fractions of the maximum power provided by the 
probe. Also, US pretreatment was the best option for subsequent treatment of peanut 
kernels with trypsin and α-chymotrypsin to increase the solubility of peanut protein and 
decrease the concentrations of allergenic proteins. No explanation was provided on the 
phenomena caused in the raw material by US pretreatment [114]. 
Studies on garlic have been carried out mainly by Chinese researchers, possibly as 
a consequence of being China the main producer of this edible plant. Studies by Peng et al. 
[115] showed that garlic powder treated by US and alcalase increased the ACE-inhibitory 
activity by 170.9% over the water extracts. This behavior led Huang et al. to evaluate the 
effects of US pretreatment on kinetic constants of garlic protein hydrolysis by alcalase [116]. 
The aims were to study the effects of optimal ultrasonic conditions on the kinetic constants 
of garlic enzymolysis, and determine the hydrolysis curves of garlic catalyzed by alcalase in 
solution, modeled by a simple empirical equation from which kinetic parameters can be 
deduced. The final aim of the Huang’s group was to provide the theoretical basis and 
technological support for better understanding and designing enzymatic hydrolysis of other 
ultrasonic pretreated materials. Nevertheless, they only worked at a fixed frequency of 20 
kHz, US power of 410 W duty cycle of 3 s/5 s and 8.2 initial pH in a countercurrent system, 
and determined the kinetic parameters from the data provided by a colorimetric method 
for determination of total phenols. With these data, and those from the traditional 
enzymolysis method, the kinetic parameters were calculated and compared. They 
confirmed the accelerating effects on the enzymatic action of US pretreatment of the 
substrate; in this way, the enzyme was not modified by this energy. 
 
7. Effects of US on enzymatic degradation 
Studies on acceleration of enzymatic catalysis by US have been mainly aimed at  
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obtaining a given product in a shorter time, as is the case with metabolites, amino 
acids or peptides, as the most outstanding examples. Nevertheless, research on the US-
enzyme binomial for degradation of undesirable compounds or materials also deserves 
discussion.  
Wastewater discharge from textile industries contains many types of dyes that are 
toxic organic pollutants. Low-frequency US has been used to degrade undesirable 
contaminants by effect of the cavitation phenomenon and the formation of free radicals. 
Also peroxidases have been used to catalyze the oxidation of a variety of contaminants using 
H2O2 as an electron acceptor. The combined action of US of 20 kHz frequency, peroxidases 
and high static pressure on dyes degradation has been studied with the following main 
conclusions: the interaction between US waves and enzyme is of physical nature; intense 
convection generated in the bulk liquid medium enhances the interactions between dyes 
and enzyme molecules and yields enhanced degradation; the oxidation power of 
horseradish peroxidase to degrade dyes is a function of the convection level in the medium; 
the highest synergism between US and enzymatic degradation of the dyes organic 
pollutants is achieved in the absence of cavitation phenomena, as US provides intense 
convection in the medium, and increases the probability and energy of interaction between 
the dyes and the enzyme [117]. Cavitation by itself contributes to dyes degradation through 
the OH radicals produced during transient collapse, but this effect works against the 
enzyme action by denaturation. High convection level in the medium obviates the need for 
external agents such as polyethylene glycol that would prevent deactivation of enzyme. 
The contaminant leather industry can also take advantage of the US–enzyme 
binomial for degradation in two preliminary steps of the whole process: acting on the 
untanned leather waste [30] or by converting the unhairing step into a clean step [26]. In 
both cases, US favors penetration of the enzyme through the skin. In the first case, the 
cementing substances known as ‘‘proteoglycans” or as ‘‘mucoids”, mainly composed of 
protein and polysaccharides, are degraded, and protein and saccharides are liberated into 
the enzyme bath [118] by the action of amylase and protease enzymes and that of US of 
frequency and intensity of 20 kHz and 2.2 W/cm2, respectively, with little effect on both 
the enzyme activities and on the physical and mechanical properties of the leather. No 
difference was detected on the use of two US frequencies, 20 and 40 kHz. On the other 
hand, fleshings and shavings from the tannery industry when treated with alkaline protease 
(less sensitive to US effects than neutral protease) and US of 40 kHz and 0.64 W/cm2 
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yielded a conversion ratio of the enzymatic hydrolysis of 84.1% as compared with the 57.6% 
obtained in the absence of US. The reason of this increased yield was ascribed to the dual 
effect of US by facilitating passage of the protease through the skin pores and promoting 
the breakdown of helical regions of collagen, which are difﬁcult to attack by proteases. 
An example of the potential of the degradation effects of combined US and enzymes 
to minimize contamination of aquatic ecosystems by pharmaceuticals is the recently 
reported method for degradation of cetirizine dihydrochloride, an antihistaminic drug. 
Using laccase and US (after optimization of parameters such as enzyme loading, 
temperature, US power and frequency, duty cycle, and speed of agitation) a maximum 
degradation of 91% was achieved in 7 h, while with the conventional stirring method the 
degradation was about 13% in 24 h. The pathway proposed for degradation of the target 
drug was confirmed by MS [25]. 
 
8. Inhibition/activation of enzyme effects by US 
Inhibition or activation of enzyme catalysis by US can be either a pursued effect or 
an undesirable effect. 
Enzyme inactivation is a requisite for stabilization of some materials, particularly 
foods. Although inactivation can be easily achieved by heat treatment, there are a number 
of cases where the high heat resistance of some enzymes makes heat treatments not a 
solution of the problem but a problem by itself, because heat can negatively modify some 
food properties such as flavor, color or nutritional value. The efficiencies of nano-
thermosonication (MTS) —a combination of heat, moderate pressure and ultrasound (50–
130 ºC, 0.2–0.3 MPa, 117 µm amplitude)— against the activity of two proteolytic enzymes 
and two lipolytic enzymes (porcine pancreatic lipase and phospholipase A, and α-
chymotrypsin and trypsin), which differ considerably in their heat resistance although they 
catalyze similar reactions, was studied, and very different results were obtained depending 
on the biocatalyst. Thus, whereas phospholipase A2 was almost insensitive to MTS 
treatments, α-chymotrypsin and porcine lipase MTS inactivation was much faster than heat 
inactivation. MTS is also able to impair the protection that several molecules offer to several 
enzymes against heat inactivation. As a result, MTS is also able to inactivate enzymes that 
are protected by such molecules at high temperatures. Molecular size and structure play 
also a role in the sensitivity to MTS; large and less globular enzymes being more sensitive 
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to MTS. Sensitivity to MTS is the result of a complex interaction of heat resistance, 
molecular structure and size, and treatment medium. Titrimetric, photometric and 
fluorimetric monitoring of the effects did not provide the required information for 
appropriate discussion about the mechanisms through which inactivation occurred in each 
case. No experiments in the absence of applied pressure and heat were developed [7]. Heat 
and MTS treatments were carried out in a TR-SC thermoresistometer [45]. 
A recent study has also combined US and pressure —high hydrostatic pressure 
(HHP)— on enzymes (polyphenolase, peroxidase and pectin methylesterase) for the 
production of safe and quality fruit juices in which phenols, ﬂavonoids and ﬂavonols should 
remain unaltered. Unfortunately, the analytical assays performed (determination of the 
residual activity of the enzymes after US–HHP treatment, determination of ascorbic acid 
content, total phenolics, flavonoids and flavonols, total antioxidant capacity and DPPH 
radical scavenging activity, color, pH, soluble solids and titratable acidity) were all 
unspecific assays that did not provide information on the products resulting from the 
application of US–HHP. The overall, indiscriminate information could hide degradation of 
the components of interest in the fruit juices, as some values of overall parameters even 
increased in the products as compared with that of the original compounds [119]. 
A research providing contradictory results that require a more in depth study with 
appropriate analytical instrumentation was the evaluation of the effects of US on the 
activity of α-amylase and amyloglucosidase by the results of a multivariate optimization 
design involving temperature and pH in the presence and absence of US, as they behaved 
differently to alterations of both variables. For temperatures up to 50 ºC the enzymes 
activities were always higher in the presence than in the absence of US, but above 60 ºC the 
activity in the absence of US was always higher. The activation energy of both enzymes in 
the presence of US was decreased considerably. The study of the influence of changes of 
physical and chemical variables on the structure of the enzymes (and thus on their 
inhibition or activation) was only evidenced, but not confirmed by using appropriate 
analytical equipment to support the experimental findings [53]. 
Because the growing use of fresh-cut vegetables, investigation about the combined 
effect on activity changes of polyphenol oxidases and peroxidase (as enzymes involved in 
the browning process) with US and ascorbic acid on fresh-cut apple during storage has been 
developed. The combined treatment inactivated monophenolase, diphenolase and 
peroxidase, whilst the individual treatment with US or ascorbic acid had inverse and 
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limited inhibitory effect on the enzymes. Photometric monitoring and conventional gel 
electrophoresis are not the most appropriate analytical tools to elucidate the changes the 
individual and combined application of energy and chemicals produced on the biocatalysts. 
Information about the type of US device used (only the frequency) does not help to a correct 
interpretation of the results [120]. 
Information about changes produced by US (40 kHz, 300 W at temperature in the 
range 0–4 ºC) on structures of α-amylase and other proteases as papain and pepsin has 
recently been reported. The effect of US on the activity of the enzymes has been investigated 
and the mechanisms involved have been explored. Conformational changes in enzymes 
structures, folding and binding properties were determined by CD; FT-IR was used for the 
estimation of their three-dimensional structures and fluorescence measurements as an 
effective indicator of tertiary structure transitions in proteins. It is worth clarifying that the 
fluorescence behavior of a protein is mainly attributed to its aromatic amino acid residues, 
especially the tryptophan residue; therefore, tryptophan fluorescence is considered reliable 
to determine the conformational changes of proteins caused by US [121]. Fig. 3 confirms 
that inhibition of enzyme activity by US was highly related to enzyme structure: after 60 
min of US application the activity of native amylase decreased from 627.76 to 107.61 U/mg 
(Fig. 3A); that of papain was reduced from 21.33 to 15.05 U/mg, while the activity of pepsin 
significantly increased from 46.46 to 53.22 U/mg (Fig. 3B). The activity change of these 
three enzymes seems to be mainly due to the variation of their secondary and tertiary 
structures. 
 
Fig. 3. Effect of US application on, (A) α-amylase activity, (B) papain and pepsin activity. (With 
permission of Elsevier, Ref. 121). 
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In short, low-frequency US mainly promotes inhibition of enzymatic activity, 
probably caused by cavitation and shear forces that should be investigated by proper 
analytical tools to provide information on the conformational changes produced in the 
biocatalysts as a function of their structure. Additionally, higher US frequencies should be 
applied to prove their influence that could be very different. 
 
9. US-assisted enzyme production and related processes 
US is a useful tool to assist different steps involved in enzyme production. Thus, 
enzyme production, extraction, purification, and immobilization can be improved by US 
application. 
Conventional production of ﬁbrinolytic enzymes in liquid–in suspension particle 
systems is favored by aeration and agitation that decreased oxygen depletion and increase 
mass transfer, respectively. Phenomena associated to low-frequency application were 
considered to provide a higher efficiency by favoring the production process. With this aim, 
a single US frequency of 25 kHz was used, while other variables such as US power and duty 
cycle, and application time were optimized using a multivariate approach [122]. 
Photometric monitoring of both the decline in glucose concentration and protease activity 
did not provide information on how US acts to promote an 1.48-fold increase in fibrinolytic 
enzyme yield as compared to no ultrasonicated fermentation. Therefore, more resolutive 
analytical equipment would be necessary to study the modification produced by US energy, 
which should be complemented by using different US frequencies for a better 
understanding of how US can better help to production of this enzyme. 
A more in depth study was also aimed at enhancing the production of a ﬁbrinolytic 
enzyme by US stimulation. Parameters such as US application at different growth phases, 
US power and duty cycle, US duration, and multiple US application were studied to 
enhance the yield of the ﬁbrinolytic enzyme by a univariate design despite variables inter-
relation. Under the optimum US conditions (25 kHz, 160 W, 20% duty cycle) applied for 5 
min the productivity of the target enzyme increased by 1.82-fold (from 110 to 201 U/mL) 
as compared with the no ultrasonicated control fermentation. Drop in glucose 
concentration from 0.41% to 0.12% w/v in ultrasonicated batches implies that US increases 
the cell permeability, improves substrate intake and progresses metabolism of microbial 
cell. SEM images before and after US stimulation clearly showed the impact of duty cycle 
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on decreasing biomass concentration. However, environmental scanning electron 
micrographs does not show any cell lysis at optimum US application [123]. 
While solid-state fermentation process for ligninolytic and hydrolytic enzymes 
production can hardly be assisted by US, this energy can be used to improve the efficiency 
of the subsequent step: enzyme extraction. With this aim, studies about the action of low-
frequency US (horn working at 20 kHz and 500 W) on the free enzymes (endoxylanase, 1,4-
β-D-glucosidase, 1,4-β-D-endoglucanase, polygalacturonase, lignin peroxidase, manganese 
peroxidase and laccase) were developed and no significant changes were detected. Then, 
the enzyme activities in the extracts obtained by conventional stirring and by US at different 
powers were compared and increases within 129–498% were achieved under 
ultrasonication as a function of the increased US power. Despite the simple analytical 
instrumentation used, the previous experiments on free enzymes confirmed their no 
degradation by US; therefore, the increased activity must be ascribed to more efficient 
extraction in the presence of US [124]. 
Comparison of the influence of US frequencies on cell disruption to extract 
enzymes (protease, α-amylase, α-glucosidase, and alkaline and acid phosphatases) from 
sludge ﬂocs showed that working at 20 kHz more amount and types of enzymes could be 
extracted than at 40 kHz or by the EDTA method. In addition, US intensity seemed to be 
more influential than duration of US application. Under the optimum extraction 
conditions, US could break the cells and extract both the extracellular and a small part of 
intercellular enzymes from sludge flocs. On the other hand, the Pearson correlation 
analysis between enzyme activities and cation contents revealed that the different types of 
enzymes had distinct cations binding characteristics [44]. 
Purification of ﬁbrinolytic enzyme extracts by three phase partitioning (TPP), 
which integrates concentration and purification, can also be assisted by US, giving place to 
UATPP. A three-phase system was formed by simultaneous addition of ammonium sulfate 
and t-butanol to crude broth. UATPP of a ﬁbrinolytic enzyme was studied by varying 
different process parameters such as ammonium sulfate saturation concentration, pH, 
broth-to-t-butanol ratio, temperature, and US frequency power and duty cycle. The 
optimized parameters yielded maximum purity of 16.15-fold of fibrinolytic enzyme with 
65% recovery. SDS PAGE analysis of partitioned enzyme shows partial purification with a 
molecular weight in the range of 55–70 kDa. Enhanced mass transfer of UATPP resulted in 
higher purity of fibrinolytic enzyme with reduced time of operation from 1 h to 5 min as 
 Chapter III 
 
Page | 197  
compared to conventional TPP. No big differences were found in the results provided by 
the two assayed US frequencies (25 and 40 kHz), but 25 kHz was slightly better [125]. 
The advantages of immobilized enzymes as compared with their in solution 
counterparts are well-know, but what is scantly known is that US can facilitate and improve 
the immobilization process. These beneficial effects have been demonstrated by 
immobilization of dextranase onto calcium alginate beads. Furthermore, the activity of the 
free and immobilized enzyme prepared with and without US treatment, as a function of pH, 
temperature, recyclability and enzyme kinetic parameters, was compared. The best 
characteristics of immobilization were achieved when the immobilized dextranase was 
prepared under US application at 25 kHz, 40 W for 15 min, under which the loading 
efﬁciency and the immobilization yield increased by 27.21% and 18.77%, respectively, as 
compared with the immobilized enzymes prepared in the absence of US. On the other hand, 
US-assisted immobilization showed Vmax and KM values higher than without US; therefore, 
the former immobilization method improved the catalytic kinetics activity of immobilized 
dextranase under the reaction conditions studied; method that also shows higher optimum 
pH and reaction temperature, activation energy, and thermal stability, as well as a higher 
recyclability [126]. The good results obtained make desirable research on other types of 
enzymes and supports, other US conditions (viz., a wide range of US frequencies, power, 
continuous vs. discontinuous US application, and, particularly, modifications on the 
enzyme structure and/or binding to the support that justify the favorable action of US on 
immobilization).  
 
10. Fields of application of the US-enzyme binomial 
Tables 1-to-4 intends to give an overview of the most outstanding fields of 
application of the binomial object of this review. In them, special emphasis has been given 
to recent contributions without forgetting salient no so recent studies. Common aspects of 
the four tables are the scant importance given to the US device (and the scant information 
the authors provide about it, as a result); the great importance given to the improvement 
US produces on the given process with no interest in the way US acts on the improvement; 
and the poor analytical instrumentation used, most times, to monitor the changes produced 
by US. 
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Table 2. Applications of the US–enzyme binomial in the environmental area. 
Target 
system 
Sample 
matrix 
Substrate 
or 
enzyme 
-Enzyme 
-Catalyzed 
reaction 
Type of US 
device/ 
features 
Analytical 
technique 
Comments Ref. 
Toxicants Seafood 
Proteins, 
organo-As 
compounds 
-Pepsin 
-Hydrolytic 
digestion 
Bath/ 
35 kHz 
HPLC–
ICP/MS 
Digestion 
shortening from 
12–24 h to 5 min 
[10] 
Cosmetics Urine 
Sunscreen 
agent 
-β-Glucu-
ronidase 
-Hydrolysis 
Probe/ 
20 kHz/ 
450 W 
HPLC–
TOF/MS, 
HPLC–
MS/MS 
Hydrolysis 
shortening from 
12 h to 50 min 
[71] 
Pollutans 
Organic 
solvents 
Recalcitrant 
dyes 
-Peroxidase 
-Oxidation 
Bath/35 
kHz/35 W 
Photometry 
US-assisted 
degradation 
[117] 
Pollutants Water Phenol 
-Peroxidase 
-Oxidation 
Bath/423 
kHz/5.5 W 
HPLC–UV 
Phenol 
degradation 
[37] 
Pollutants Synthetic Phenols 
-Peroxidase 
-Oxidation 
Bath/423 
kHz/5.5 W 
HPLC–UV 
Degradation of 
substituted 
phenols 
[36, 
38] 
Pollutants Wastewater 
Reductant 
compounds 
-Cellulase, 
endo-
glucanase, 
cellobio-
hydrolase 
-Hydrolysis 
Bath/ 
22.5 kHz 
Potenti- 
ometry (pH) 
Decrease chemical 
oxygen demand 
(COD) 
[139] 
Leather 
Untanned 
solid leather 
waste 
Proteins 
-Alkaline and 
neutral 
proteases 
-Proteolysis 
Bath/ 
40 kHz 
Photometry 
Impair collagen 
structure 
[30] 
Leather Skin Proteins 
-Neutral and 
alkaline 
proteases, 
amylase 
-Hydrolysis 
Probe/ 
20, 40 kHz/ 
2.2 W/cm2 
Photometry 
US improves 
enzymes diffusion 
through the skin, 
with little effect 
on activity 
[26] 
Sewage 
sludge 
Sludge flocs 
Cells/ 
Enzymes 
-Protease, 
phosphateses,  
α-amylase,  
α-glucosidase 
Baths/20, 
40 kHz 
Photometry 
US action: cell 
disruption, 
enzyme extraction 
[44] 
Fish Fish bile 
Endocrine-
disrupting 
compounds 
-β-Glucu- 
ronidase, 
β-gluco- 
sidase, 
sulfatase 
-Hydrolysis 
Probe/ 
20 kHz, 
70W 
Derivatiza-
tion+  
GC–MS 
Shortening of 
hydrolysis time 
from 16 h to  
20 min 
[33] 
Pollutants 
Dairy 
wastewater 
Fats 
-Lipase 
-Hydrolysis 
Bath/25, 40 
kHz/165 W 
Titration 
Shortening of 
reaction time 
[68] 
Pollutants 
Phosphate 
buffer 
Cetirizine 
dihydro-
chloride 
-Laccase 
-Oxidation 
Bath/25 
kHz/100 W 
HPLC–UV, 
LC–MS 
Shortening 
degradation time 
[25] 
Waste 
newspaper 
Delignified 
Newspaper, 
citrate 
Lignocellu-
lose 
-Cellulase 
-Hydrolysis 
Probe/ 
20 kHz/ 
120 W 
Photometry 
Decrease of 
hydrolysis time 
and enzyme 
loading. 
Improvement of 
yield of reducing 
sugars. 
[140] 
Biodiesel 
byproduct 
Tert-butyl 
alcohol 
Glycerol, 
dimethyl 
carbonate 
-Lipase 
-Transteri-
fication 
Bath/25, 40 
kHz/200 W 
GC–FID 
Shortening of 
processing time 
[75] 
 
 
 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
Page | 204 
 
Table 3. Applications of the US–enzyme binomial in the clinical area. 
Type of 
study 
Sample 
matrix 
Substrate 
or 
enzyme 
-Enzyme 
-Catalyzed 
reaction 
Type of US 
device/ 
features 
Analytical 
technique 
Comments Ref. 
US effect on 
enzymes 
Plasma 
o-Nitro-
phenyl-
butyrate, 
butyrylthi-
ocholine, 
aspirin 
-Butyryl-
cholines-
terase 
Probe/ 
20 kHz 
Gel electro-
phoresis, 
photometry 
Enzyme 
denaturation-
inactivation by US 
[8] 
Remedia 
tion of US 
effects 
Rat liver 
Microsomal, 
cytosolic 
liver 
fractions 
-Oxidases, 
cytochromo 
P450 
-Oxidation 
No data/2 
W/cm2 
Photometry 
Inhibition by US, 
correction by 
heparin 
[14] 
Activation, 
degradation 
Buffer 
Chymotryps
inogen, 
trypsinogen 
-Chymo-
trypsinogen, 
trypsinogen 
-Proteolysis 
Probe/ 
26.4 kHz/ 
26 W/cm2 
Photometry, 
HPLC–UV 
US minimizes 
effects of 
trombolysis 
[28] 
Wheat 
Protein 
hydrolyzate 
ACEa-
inhibitory 
activity 
-Alcalase 
-Hydrolysis 
Probe/ 
20 kHz/ 
40 W 
IEC–FLb, 
SEM 
US increases 
enzymatic 
hydrolysis and 
ACE-inhibitory 
activity 
[113] 
Dopant 
drugs 
Urine 
Anabolic 
steroids 
-β-Glucu-
ronidase 
-Hydrolysis 
Probe, 
reactor, 
bath (35, 
130 kHz) 
Derivati- 
zation+ 
GC–MS 
US-assisted 
enzymatic 
hydrolysis and 
derivatization 
[17] 
Dopping 
control 
Urine 
Anabolic 
androgenic 
steroids 
-β-Glucu-
ronidase 
-Hydrolysis 
Probe 
HLPC–UV-
visible 
Study of kinetics 
parameters 
[70] 
Health-care 
foods 
Epimedium 
leaves 
Polysaccha-
rides extract 
-Papain, 
pectase, 
cellulase  
α-amylase 
-Hydrolysis 
Bath/40 
kHz/300 W 
Ultrafiltra-
tion, 
chroma- 
tography- 
DEAE-
Sepharose, 
Photometry 
US provides 
extracts with 
higher antioxidant 
power 
[88] 
Implants 
materials 
ILs Monomers 
-Lipase 
-Polymeri-
zation 
Bath/35 
kHz/320 W 
NMR,  
GPC–RIc 
Ring opening 
polymerization of 
ε-caprolactone 
monomer 
[105] 
Ester 
synthesis 
ILs 
Caffeic acid 
and 
metanol 
-Lipases 
-Esterifica-
tion 
No data/ 15, 
20, 25, 30, 
35 kHz/ 
90, 120, 
150,180, 
210 W 
LC-DAD-
MS, HPLC–
UV-vis 
US shortens 
reaction time and 
increases synthesis 
yield 
[141] 
Enzyme 
purification 
Cells and 
fermenta- 
tive 
medium 
Azoalbumin 
-Fibrinolytic 
enzyme 
-Hydrolysis 
Bath/25, 40 
kHz /150W 
Photometry 
US-assisted three-
phase partitioning 
to increase % 
recovery of 
fibrinolytic 
enzyme. 
[125] 
Enzyme 
production 
Cells and 
fermenta- 
tive 
medium 
Azoalbumin 
-Fibrinolytic 
enzyme 
-Hydrolysis 
Bath/25 
kHz /160W 
Photometry, 
SEM 
US-assisted mass 
transfer on enzyme 
production 
[123] 
Enzyme 
production 
Cells and 
fermenta- 
tive 
medium 
Azoalbumin 
-Fibrinolytic 
enzyme 
-Hydrolysis 
Bath/25 
kHz/ 160W 
Photometry 
US-assisted mass 
transfer on in-
bioreactor enzyme 
production 
[122] 
aACE, angiotensin I-converting enzyme; bIEC–FL, ion-exchange chromatography–fluorescence detection; cGPC–RI, gel 
permeation chromatography–refractive index detector. 
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Table 1 is devoted to US–enzymes application in the food field, which is that has so 
far received more attention. In addition to the improved yields of products of great interest 
in processed foods by favoring enzyme activity (e.g., mono- and diacylglycerols, 
polysaccharides, fermentable sugars, esterified and transesterified products) improvement 
of fresh food quality by delay or avoidance of fruit browning deserves also be stressed. 
Table 2 summarized outstanding contributions to the environmental area in which 
a fast removal of the given pollutant is always desirable. Some of the applications of US–
enzymes in the environmental field deal with the acceleration of sample preparation 
methods for subsequent determination of toxicants [10] or cosmetics [70], which constitute 
valuable contributions from the point of view of contaminants analyses. 
Table 3 shows an overview of the varied applications of US–enzymes in the clinical 
field. Thus, from enzyme production and purification, through synthesis or extraction of 
compounds of clinical interest, to acceleration of sample preparation in dopping control, 
the effect of US on enzyme activation are of great interest; nevertheless, enzyme 
inactivation and/or degradation can even be more interesting. Remediation of US effects 
on living systems is also a matter of study for better understanding the damage US can exert 
on living materials. 
Last, but not the least, are industrial applications of US–enzymes, to which Table 
4 is devoted. In it, a trending topic as biofuel production is successfully assisted by the US–
enzyme binomial. Traditional problems in the textile industry are also overcome or 
minimized by the use of the binomial, as do in the pharmaceutical and cosmetics industries. 
 
11. Conclusions 
The following aspects can be pinpointed from the study of the research so far 
developed on US–enzyme uses: 
1. Especial care should be devoted to the nomenclature related to US and the way to 
express the variables and parameters involved in this type of energy. The metadata 
in this area can be of paramount importance when other scientists try to reproduce 
an experiment to work on the basis established by previous research as a way to 
advance in the knowledge. 
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2. The role of US frequencies on the effect caused by this energy as a function of 
matrix–analyte–enzyme has been poorly considered. The scant studies on this 
aspect allow evidencing an enormous field of possibilities, which should be solidly 
established. 
3. Analytical equipment different from photometers and titrimeters is mandatory to 
know the real effect of US on the given target. Despite techniques such CD, SEM, 
FT-IR are starting to be used, not enough information is obtained, most times, from 
the data they provide. 
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Section B encompasses the metabolomics research in the plant field developed by 
the PhD student. The three different topics addressed in this section open three interesting 
lines, which require further wide and in depth research. 
As a consequence of the information handled to write Chapter III, the research in 
Chapter IV open the door to the enormous and unknown potential of the US–enzyme 
binomial. The enzymatic hydrolysis of oleuropein in olive leaf extracts to oleuropein 
aglycon was studied using a multivariate design in which different hydrolases showed 
different behavior for different values of US variables (viz., duty cycle, amplitude, cycle 
time). The study of a key US variable (frequency) is a pending goal that requires the design 
of US devices that only differ in this variable and keep constant the others. Attempts to 
achieve these designs have been unsuccessful so far. 
Among the healthy properties of mushrooms, the recently described “in vitro” 
inhibition of the protease NS3 of hepatitis-C virus (HCV) by aqueous enzymatic extracts of 
the common edible mushroom Agaricus bisporus (A. bisporus) promoted interest in an 
untargeted study on the components of these extracts. Chapter V contains the results 
obtained by a liquid chromatography–tandem mass spectrometry (LC–QTOF MS/MS) 
platform working in high resolution mode: 55 out of 123 total metabolites tentatively 
investigated by combination of MS and MS/MS information were identified for the first 
time; a representative snapshot of the composition of the target extracts. 
The increased legal pharmacological uses of cannabis and the implementation of 
breeding programs with agronomical purposes have made mandatory a wide study of this 
plant by gas chromatography–time-of-flight/mass spectrometry (GC–TOF/MS) and LC–
QTOF MS/MS) in high resolution mode. The identified compounds in the extracts were 
169, as shows Chapter VI, and the difference in their concentrations as a function of the in 
field or in greenhouse cultivation open a door to a more rational grown of this plant as 
required. 
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Selective ultrasound-enhanced enzymatic 
hydrolysis of oleuropein to its aglycon in olive 
(Olea europaea L.) leaf extracts 
 
María del Mar Delgado-Povedano, Feliciano Priego-Capote, María Dolores 
Luque de Castro 
 
Abstract 
Hydrolysis of oleuropein, the main phenol in olive (Olea europaea L.) leaf extracts, 
to oleuropein aglycon and other subsequent products in the hydrolytic pathway can be 
catalyzed by different enzymes. Three of the most used hydrolases were assayed to catalyze 
the process, and β-glucosidase from Aspergillus niger was selected. Acceleration of the 
enzymatic hydrolysis by ultrasound (US) was studied using a Box-Behnken design (duty 
cycle, amplitude, cycle time) and an oleuropein standard, and the optimum US conditions 
for achieving maximum yield of oleuropein aglycon were 0.5 s/s duty cycle, 50% amplitude 
and 45 s cycle. The method was applied to obtain oleuropein aglycon from commercial and 
laboratory extracts from olive leaves, which may have a pharmacological use as deduced by 
its healthy properties. The kinetics of the US-assisted enzymatic hydrolysis was monitored 
by analysis of the target compounds using liquid chromatography–tandem mass 
spectrometry. 
 
Keywords: enzymatic hydrolysis, ultrasound, Olea europaea leaf extract, glucosidase, 
oleuropein, oleuropein aglycon. 
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1. Introduction 
Oleuropein and oleuropein aglycon, present in virgin olive oil (VOO), could be used 
as nutraceutical or as component of new functional foods (Van der Stelt et al., 2015). 
Oleuropein and its aglycon possess beneficial pharmacological properties such as 
cardioprotective (Manna et al., 2004), antioxidant (Andreadou et al., 2006), anti-
inflammatory (Khalatbary & Zarrinjoei, 2012), anti-cancer (Hamdi & Castellon, 2005), and 
neuroprotective effects (Bazoti, Bergquist, Markides & Tsarbopoulos, 2006), among the 
most important. 
The use of VOO as a source of oleuropein and/or oleuropein aglycon for 
preparation of functional foods is not recommended owing to the high price of VOO and 
relative low concentration of these minor components. An almost ideal raw material for 
extraction of these and other valuable compounds are olive leaves: a residue generated from 
olive pruning and VOO production. 
Olive leaves may account up to 5% of the weight of collected olives and are removed 
in the step of cleaning olive drupes in the oil mill prior to VOO production (Zoiopoulos, 
1983). By sum up the leaves from this step to those from pruning olive trees, the total 
amount of twigs and leaves residues may reach 12–30 kg/tree (Nefzaoui, Hellings & 
Vanbelle, 1983). There are almost 900 million olive trees over 10 million hectares 
worldwide, 98% of which in the Mediterranean countries (Sesli & Yegenoglu, 2009); 
therefore, the management of these residues should be properly exploited taking into 
account the high valuable compounds they contain (Xie, Huang, Zhang & Zhang, 2016), 
and the scant applications developed so far. The present main uses of olive leaves are 
animal feed, production of thermal energy, extraction of useful components (Joint 
Ministerial Decision, 2012), or composting (the last probably because the high C/N ratio of 
this residue) (Manios, 2004). 
The aglycon form of oleuropein is obtained by enzymatic hydrolysis of oleuropein, 
being β-glucosidase the key enzyme involved in the process, as shows Fig. S1, which also 
shows the possible subsequent evolution of oleuropein aglycon to hydroxytyrosol and/or 
decarboxymethyloleuropein aglycon depending on the working conditions. 
The different sources of β-glucosidase to catalyze the hydrolysis of oleuropein to 
obtain hydroxytyrosol and/or oleuropein aglycon have been almonds (Briante et al., 2000; 
Jemai, Bouaziz, Fki, Feki & Sayadi, 2008), Sulfolobus solfatarius (Briante et al., 2000; 
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Briante, La Cara, Febbraio, Patumi & Nucci, 2002; Briante, Patumi, Febbraio & Nucci, 
2004), or Aspergillus niger (Hamza & Sayadi, 2015; Khoufi, Hamza & Sayadi, 2011), which 
require intervals from 2 to 16 h to complete hydrolysis (Briante et al., 2004; Jemai et al., 
2008). Also hemicellulase, a glycolytic enzyme that decomposes hemicellulose of plant cell 
walls, has been proposed to hydrolyze oleuropein, to hydroxytyrosol in this case (De Faveri, 
Aliakbarian, Avogadro, Perego & Converti, 2008; Yuan, Wang, Ye, Tao & Zhang, 2015). 
Ultrasound (US) as modifier of enzyme activity has provided very controversial 
results (Delgado-Povedano & Luque de Castro, 2014). While oxidases seem to suffer 
deactivation under US application, an activity enhancement on hydrolytic enzymes is 
experienced in the case of sugarcane bagasse for the production of fermentable sugars, with 
yield of 0.26 g sugar/g dry sugarcane bagasse, around twice the value obtained without US 
assistance (Lunelli et al., 2014). Also in the enzymatic hydrolysis for extraction of luteolin 
and apigenin from celery, US-assistance provided yield increases of 26.1-fold and 32.2-fold, 
respectively, as compared with no ultrasonicated systems (Zhang, Zhou, Chen, Cao & Tan, 
2011). 
With these premises, and with the aim of developing a fast method for enzymatic 
hydrolysis of oleuropein to its aglycon with minimum production of more degraded 
products, the following steps were planned: (i) selection of the most suitable hydrolase 
among the three more frequently used in the literature; (ii) application of US to shorten the 
enzymatic hydrolysis step as much as possible; (iii) use of a Box-Behnken design (BBD) to 
optimize the US variables duty cycle, amplitude, and cycle time for maximum acceleration 
of the hydrolysis of an oleuropein standard; (iv) application of the method to different olive 
leaf extracts. 
 
2. Materials and methods 
 
2.1. Olive leaf samples 
Olive leaves collected from January to March 2015 from different cultivars located 
in the Denomination of Origin “Baena” in the South of Spain were used to obtain phenols 
extracts. 
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Commercial olive leaf extract powder enriched in oleuropein (40% oleuropein), 
from Ferrer HealthTech (Barcelona, Spain), was also used in this work for comparison with 
the behavior of fresh extracts. 
 
2.2. Chemicals and reagents 
Standards of oleuropein (purity ≥90%) and hydroxytyrosol (purity >98.0%) for 
quantitative analysis of these metabolites were from Extrasynthese (Genay, France). 
Standards of oleuropein aglycon, decarboxymethyl oleuropein aglycon, decarboxymethyl 
ligstroside aglycon and ligstroside aglycon were donated by P. Magiatis (Athens, Greece). 
The three tested enzymes (hemicellulase and β-glucosidase from A. niger, and β-
glucosidase from almonds, the characteristics of which are listed in Table S1) were all from 
Sigma–Aldrich (Madrid, Spain). MS (mass spectrometry) grade glacial acetic acid from 
Scharlab (Barcelona, Spain) and anhydrous sodium acetate from Panreac (Barcelona, 
Spain) were used to prepare buffers at different pHs. MS grade formic acid (FA) from 
Scharlab and methanol from Sigma–Aldrich were used to prepare the chromatographic 
mobile phases. Methanol was also used for sample preparation. Deionized water (18 
mΩ•cm) from a Millipore Milli-Q water purification system (Bedford, MA, USA) was used 
to prepare aqueous solutions. 
 
2.3. Extraction of oleuropein from olive leaves 
Olive leaves (1 g) were dried and chopped, and 30 mL of 4:1 (v/v) methanol–water 
was added to the chopped olive leaves and the heterogeneous system thus formed was kept 
under agitation for 24 h in a Vibromatic rocking mixer from JP Selecta S.A. (Barcelona, 
Spain) for transfer of the polar compounds to the liquid phase. Then, the system was 
centrifuged at 1500×g for 15 min, the extract was filtered through 0.2 μm filter and divided 
into 8 aliquots before evaporation to dryness in a Concentrator Plus speed-vac from 
Eppendorf (Hamburg, Germany). This approach has been widely validated in previous 
research and it is accepted as sample preparation strategy prior to quantitative analysis of 
oleuropein in olive leaves (Jemai et al., 2008). 
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2.4. Enzymatic hydrolysis 
The hydrolysis step catalyzed by each of the three enzymes under study was 
performed by locating 10 mg of oleuropein in each of three 12-mL glass bottles, and adding 
to them the same units (2.5 U/mg oleuropein substrate) of one of the enzymes and 10 mL 
of 0.05 M sodium acetate buffer. The amount of enzyme to be added depended on its 
activity: 21.6 mg of β-glucosidase from A. niger (1.2 U/mg), 3.5 mg of β-glucosidase from 
almonds (7.7 U/mg) and 16.7 mg of hemicellulase from A. niger (1.5 U/mg). The bottles 
were placed in a digital block heater, model SBH130D, from Stuart (Staffordshire, ST15 
OSA, UK) to maintain constant temperature during the enzymatic hydrolysis. The enzyme–
substrate ratio had been optimized in a previous study (Yuan et al., 2015), and other 
enzymatic conditions (the best temperature and pH) for each enzyme were those 
commercially recommended (37 ºC for both β-glucosidases and 40 ºC for hemicellulase, 
and pH 4.0 for β-glucosidase from A. niger, pH 5.0 for β-glucosidase from almonds and 
pH 4.5 for hemicellulase). 
Sampling at different enzymatic hydrolysis times (0, 0.5, 2, 4, 6, 8, 10 and 12 h) 
was performed. The samples were immediately frozen and stored at –20 ºC to stop the 
catalyzed reaction (Molinari & Silva, 1955), then analyzed to monitor the development of 
the reaction at each preset time. Also the evolution of the no catalyzed reaction was tested 
by developing the experiment in the absence of biocatalyst. 
The hydrolysis of oleuropein was calculated by the following expression: 
[(concentration of oleuropein in the sample before hydrolysis – concentration after 
hydrolysis)/concentration in the sample before hydrolysis] × 100. 
 
2.5. US-assisted enzymatic hydrolysis (USAEH) of oleuropein standard 
USAEH of oleuropein by β-glucosidase from A. niger was performed under the 
conditions described in section 2.4. The mixture was immersed in a water bath to maintain 
constant the temperature during hydrolysis. The ultrasonic probe —a Branson 450 digital 
sonifier (20 kHz, 400 W) with tunable amplitude, corresponding 100% of amplitude to 400 
W, and duty cycle, equipped with a cylindrical titanium alloy probe microtip (3 mm in 
diameter)— was dipped into the solution, with the microtip horn at a fixed distance from 
the bottom (2 mm) of the container without contacting it. The probe was totally immersed 
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into the solution to avoid formation of aerosol and foam that create dead zones where 
cavitation does not occur. A water-bath from Selecta (Barcelona, Spain) with a cooling 
system was used to maintain the temperature constant during USAEH. The US conditions 
were a 0.5 s/s duty cycle, 50% amplitude and 45 s cycle time. A 30 s off interval separated 
two consecutive US cycles. Sampling was performed after 0, 10, 15, 20, 25, 30, 45 and 60 
consecutive US cycles, and the samples were frozen (–20 ºC) until analysis. Also the 
evolution of the no catalyzed reaction (in the absence of biocatalyst) was monitored. 
 
2.6. USAEH of olive leaf extracts 
Hydrolysis of oleuropein in the commercial olive leaf extract was carried out by 
taking 25 mg of it (equivalent to 10 mg of oleuropein), putting it into contact with 10 mL of 
0.05 M sodium acetate buffer (pH 4) and the appropriate amount of the selected enzyme 
(2.5 U/mg oleuropein substrate). 
For hydrolysis of oleuropein in the extract prepared as described in Section 2.3, the 
solid residue generated after dryness of one of the aliquots was put into contact with 10 mL 
of 0.05 M sodium acetate buffer (pH 4) and the appropriate amount of the selected enzyme 
(2.5 U/mg oleuropein substrate). 
Both systems were subjected to US under the conditions described in section 2.5 
and the evolution of the reaction was monitored by analyzing the samples taken at preset 
number of consecutive US cycles. 
 
2.7. LC–MS/MS analysis 
An Agilent (Palo Alto, CA, USA) 1200 Series liquid chromatography (LC) system 
(consisting of a binary pump, a vacuum degasser, an autosampler and thermostated 
column compartment) was used for chromatographic separation, and an Agilent 6460 
triple quadrupole mass spectrometer equipped with a Jetstream® electrospray ionization 
(ESI) source was used for detection. The data were processed using a MassHunter 
Workstation Software for qualitative and quantitative analysis. 
The analytical column was a reverse phase 5 µm particle size, 150 mm×4.6 mm i.d. 
C18 Mediterranean Sea from Teknokroma (Barcelona, Spain), which was thermostated at 
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30 ºC. A pre-column, 40 mm×3.0 mm i.d., from Phenomenex (Torrance, CA, USA) was 
connected to the analytical column for protection. 
All samples were 1:500 diluted with 60:40 (v/v) methanol–water before analysis. 
The mobile phases were: 0.1% FA in water (phase A) and 0.1% FA in methanol (phase B). 
The LC pump worked at a constant flow rate of 0.8 mL/min with the following elution 
gradient: 20% phase B for 1 min, after which a linear gradient for 5 min was programmed 
up to 66% phase B. Then, a second gradient up to 100% B for 7 min was applied and, finally, 
100% B for 2 min. A post-time of 5 min was set to equilibrate the initial conditions for the 
next analysis. The injection volume was 10 µL and the injector needle was washed for 12 s 
between injections with 60% methanol to avoid cross contamination. 
MS detection was performed in the negative ESI mode at unit resolution in both 
quadrupoles. The Jetstream ESI source parameters, operating in the negative ionization 
mode, were as follows: nozzle and capillary voltage were set at 0.5 kV and 3 kV, respectively, 
N2 nebulizer was flowed at 50 psi, N2 drying gas flow rate and temperature were 10 L/min 
and 300 ºC, N2 sheat gas flow rate and temperature were 12 L/min and 360 ºC. The selected 
voltage for efficient filtration of precursor ions in the first quadrupole, collision energy to 
fragment the precursor ions by collision-induced dissociation to generate the product ions 
selected as quantitation and qualifier ions in the selected reaction monitoring (SRM) 
method for each analyte are shown in Table 1. The dwell time was fixed at 200 ms for each 
SRM transition. Identification and quantitation of the target compounds were performed 
using pure standards for all monitored compounds. All samples were injected in duplicate. 
 
Table 1. MS/MS parameters for qualitative and quantitative determination of the target compounds. 
Compound 
Fragmentor 
(V) 
Precursor 
ion (m/z) 
Collision 
energy 
(eV) 
Quantitation 
transition 
Product ion 
confirmation 
(m/z) 
Oleuropein 170 539.2 23 539.2 → 307.1 275.0 
Oleuropein aglycon 110 377.1 12 377.1 → 275.1 307.0 
Ligstroside aglycon 110 361.1 12 361.1 → 291.1 259.0 
Decarboxymethyl 
oleuropein aglycon 
110 319.1 12 319.1 → 59.0 123.0 
Decarboxymethyl 
ligstroside aglycon 
110 303.1 12 303.1 → 59.1 137.0 
Hydroxytyrosol 110 153.0 12 153.0 → 123.0 108.0 
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2.8. SRM-based quantitation 
Quantitative analysis of the target compounds in the olive leaf extracts was carried 
out using the peak area from the transition of each compound, which coincided with the 
chromatographic retention time of the standard. Calibration models were developed for 
each compound using multistandard solutions at seven concentrations that depended on 
the target analyte. All calibration points were obtained in duplicate injection to set the 
confidence intervals. The calibration ranges and regression coefficients are shown in Table 
2. As can be seen, the regression coefficients were above 0.998 for all analytes, and the 
upper limits for the calibration models depended on the target compound. The limits of 
detection (LOD) and quantitation (LOQ) of the method for each target compound were 
calculated as the concentration providing signals three and ten times, respectively, higher 
than the background noise in the elution window close to each peak. They were between 
0.1 ng/mL and 0.24 µg/mL for LODs and from 0.3 ng/mL to 0.75 µg/mL for LOQs. 
 
Table 2. Linear calibration ranges, calibration equations, regression coefficients and limits of 
quantitation for analysis of the target compounds. 
Compound 
Linear 
calibration 
range (µg/mL) 
Calibration 
equation 
Regression 
coefficient 
(R2) 
LOD 
(ng/mL) 
LOQ 
(ng/mL) 
Oleuropein 0.01–10 
y = 13034.31x 
+12.93 
0.9990 3.0 10.0 
Oleuropein aglycon 3·10–4–10 
y = 10678x 
+219.66 
0.9998 0.1 0.3 
Ligstroside aglycon 3·10–4–0.20 
y = 33044x 
+42.72 
0.9992 0.1 0.3 
Decarboxymethyl 
oleuropein aglycon 
3·10–4–1 
y = 10354x 
+34.21 
0.9997 0.1 0.3 
Decarboxymethyl 
ligstroside aglycon 
1.7·10-–3–5 
y = 4393.76x 
+166.14 
0.9998 0.5 1.7 
Hydroxytyrosol 3·10–4–1 
y = 44321x 
+72.46 
1.0000 0.1 0.3 
y: peak area; x: concentration as µg/mL. 
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3. Results and discussion 
 
3.1. Enzyme selection for hydrolysis of oleuropein 
The most used biocatalysts to hydrolyze oleuropein to oleuropein aglycon —viz., β-
glucosidase from almonds (Briante et al., 2000; Jemai et al., 2008), β-glucosidase from A. 
niger (Hamza et al., 2015; Khoufi et al., 2011), and hemicellulase from A niger (De Faveri 
et al., 2008; Yuan et al., 2015)— were assayed in this comparative study under the 
conditions recommended by the manufacturer. Fig. 1 shows that complete hydrolysis of 
oleuropein was achieved by β-glucosidase from A. niger and from almonds. The highest 
catalytic effect was provided by β-glucosidase from A. niger as complete hydrolysis was 
achieved within 2 h, while the same enzyme from almonds required 4 h for complete 
hydrolysis, and hemicellulase from A. niger provided a low catalytic efficiency that did not 
surpass 30%.  
 
 
Fig. 1. Enzymatic effect of different enzymes on the hydrolysis of an oleuropein standard (10 µg/mL) 
as compared with the no catalyzed reaction. 
 
These results are not in agreement with those in a previous work in which different 
enzymes were compared, and where hemicellulase gave the best catalytic behavior, but in 
which the hydrolysis was optimized to obtain hydroxytyrosol as the final product (Yuan et 
al., 2015). 
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In the present research, and for all the enzymes tested, the main product from 
hydrolysis of oleuropein was oleuropein aglycon, with small generation of other hydrolysis 
products depending on the target biocatalyst, as shows Fig. S2. Thus, decarboxymethyl 
oleuropein aglycon and hydroxytyrosol were also formed by β-glucosidase from A. niger 
(see Fig. S2A). Oleuropein aglycon increased from 0 to 2 h and then decreased linearly up 
to 12 h, while decarboxymethyl oleuropein aglycon and hydroxytyrosol slightly increased 
from 0 to 12 h, but the final amounts of them were 0.06 μg/mL and 0.04 μg/mL, 
respectively. When β-glucosidase from almonds was used the main hydrolysis product was 
oleuropein aglycon, which increased from 0 to 6 h and kept constant from 6 to 12 h. The 
other hydrolysis product was hydroxytyrosol, which increased slightly from 0 to 12 h, but 
the total amount formed did not surpass 0.04 μg/mL (Fig. S2B). When hemicellulase from 
A. niger was used the main hydrolysis products were oleuropein aglycon and 
hydroxytyrosol; both products increased from 0 to 12 h, but the total amounts formed were 
0.25 μg/mL and 0.01 μg/mL, respectively (Fig. S2C). 
With these results, β-glucosidase from A. niger was selected among the three 
enzymes tested for further studies since hydrolysis of oleuropein was complete within 2 h 
with not significant development of subsequent hydrolysis steps. It is worth mentioning 
that the hydrolysis of oleuropein in the absence of enzyme did not progress along the 12 h 
of the study (see Fig. S2D), thus proving the crucial role of the enzyme.  
 
3.2. Effect of temperature on the enzymatic hydrolysis 
The influence of temperature on the catalytic effect of β-glucosidase from A. niger 
in the hydrolysis of oleuropein was studied at the recommended temperature (37 ºC), and 
at lower (25 ºC) and upper (50 ºC) temperatures. As compared to the behavior at 37 ºC 
(complete hydrolysis within 2 h, see Fig. S2A) the hydrolysis of oleuropein at 25 ºC was 
complete after 8 h (see Fig. S3A). Therefore, the decrease of temperature also decreased 
the reaction kinetics as the hydrolysis pathway seemed to be the same because the 
coincidence of the hydrolysis product. On the other hand, the hydrolytic process was 
accelerated by increasing the temperature up to 50 ºC, and it was complete after 0.5 h (see 
Fig. S3B). However, in this case the hydrolysis progressed with formation of hydroxytyrosol 
as one of the main reaction products together with oleuropein aglycon (21% hydroxytyrosol, 
as compared with 3% formed after 12 h at 37 ºC). Additionally, other reaction products such 
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as decarboxymethyl ligstroside and decarboxymethyl oleuropein aglycon were detected 
when working at 50 ºC, with final amounts of 0.01 μg/mL for decarboxymethyl ligstroside 
aglycon and 0.01 μg/mL for decarboxymethyl oleuropein aglycon; therefore, a loss of 
selectivity occurred regarding the pursued oleuropein aglycon. 
 
3.3. Optimization of USAEH 
As acceleration of enzymatic hydrolysis by US is well documented (Delgado-
Povedano et al., 2014), the use of this energy to obtain the target aglycon in a time as short 
as possible without subsequent degradation was assayed by using a multivariate design and 
oleuropein standard. A 15-run BBD was used to optimize three interrelated US variables: 
X1 (duty cycle), X2 (amplitude) and X3 (cycle time). Table S2 shows the input parameters 
and experimental design levels used. Different combinations of these US parameters were 
investigated, as shows Table S3 where the values of the dependent variable (formation of 
oleuropein aglycon and hydrolysis of oleuropein expressed as the concentrations ratio 
between the former and the latter) are also shown. 
The oleuropein aglycon obtained at various levels of the three independent 
variables (X1, X2, and X3) was subjected to multiple regression to yield a second-order 
polynomial equation, as follows: 
Y = 2.70532 − 8.88722X1 − 10.3086X2 + 0.00486972X3 + 15.3162X1X2 + 0.0485667X1X3 
+ 0.0703792X2X3 + 7.97026X12 + 10.3218 X22 − 0.000410231X32  
where Y represents the ratio between the concentrations of oleuropein aglycon and 
oleuropein, and X1, X2 and X3 represent duty cycle, amplitude and cycle time, respectively. 
According to the regression model equations, the fitting coefficient of the three variables 
provided values of 10.3086 > 8.88722 > 0.00486972, thus implying that X1 (duty cycle) 
and X2 (amplitude) were the most influential US variables. 
The statistical parameters obtained from the analysis of variance are given in Table 
S4. The value of the determination coefficient (R2 = 0.9225) and the adjusted 
determination coefficient (Radj2 = 0.8877) also confirmed the statistical significance of the 
model. In conclusion, the model was found to be adequate for navigating the design. 
The p-value is used as a tool to check the significance of each coefficient, which in 
turn indicates the strength of the interaction among independent variables. It could be 
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observed that the coefficients of X1, X2, X3, X1X2 and X22 were highly significant (p<0.001); 
while the coefficient of X1X3, X32 was found non-significant (p>0.05). The X1, X2 and X3 
variables had a significant effect on US. For the X1X2 interaction, p<0.001 implies that the 
duty cycle was closely related to amplitude in the US-assisted process. 
The formation of oleuropein aglycon increased when the duty cycle was extended 
from 0.1 to 0.5 s/s, with the logical simultaneous decrease of oleuropein. The former also 
increased by increasing both the amplitude (from 10 to 50%) and the cycle time (from 15 to 
45 s). The optimal US conditions to achieve maximum amount of oleuropein aglycon were 
duty cycle 0.5 s/s, amplitude 50% and cycle time 45 s. The amount of oleuropein aglycon 
obtained under the optimum conditions and applying 10 US cycles was 73.27±0.72% (n = 
2). Values of the three interrelated variables higher than those within the BBD design were 
not tested because the temperature generated under these conditions was difficult to 
control when exceeding 37 °C, and could damage the microprobe and/or degrade the target 
aglycon. 
A kinetics study was made testing different US cycles to determine the time 
necessary for total hydrolysis of the oleuropein standard. Each sample was ultrasonicated 
under the optimum working conditions (50% amplitude, 0.5 s/s duty cycle and 45 s cycle) 
at different number of US cycles within 0−60. The hydrolysis efficiency was calculated as 
the ratio between the area of the chromatographic peak provided by oleuropein aglycon 
obtained by USAEH and that obtained under identical working conditions but in the 
absence of US. 
In addition to oleuropein aglycon, a small proportion of hydroxytyrosol was 
produced in the enzymatic hydrolysis of oleuropein in the presence of US. The formation 
of oleuropein aglycon increased from 0 to 10 cycles and decreased from 10 to 60 cycles, 
while hydroxytyrosol increased from 0 to 60 cycles, but the final amount of the latter was 
0.01 μg/mL. After 10 cycles, subsequent hydrolysis of oleuropein to the aglycon form did 
not compensate owing to degradation to the subsequent product. During all the process 
time, the total number of moles was preserved. 
An additional experiment to prove the effect of US on the enzymatic hydrolysis 
consisted of application of US under the optimum operational conditions in the absence of 
enzyme: no bond-breaking took place in the absence of enzyme as only oleuropein was 
found after the experiment. 
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Comparing the results obtained in the presence and absence of US, a drastic 
shortening of the time (from 2 h to 18.75 min with 15 US cycles) required for enzymatic 
hydrolysis of oleuropein was obtained with the help of US. 
 
3.4. USAEH of olive leaf extracts 
The usefulness of the proposed method was demonstrated by application to olive 
leaf extracts. The enzymatic hydrolysis with US assistance of oleuropein from a commercial 
extract from olive leaves yielded oleuropein aglycon and then hydroxytyrosol; but also 
decarboxymethyl oleuropein and ligstroside, present in the extracts in a smaller proportion 
due to the enrichment in oleuropein, were hydrolyzed to the corresponding aglycons. The 
hydrolysis yield of oleuropein was 90.8% after 10 US cycles, which produced 90% of 
oleuropein aglycon. The latter increased from 0 to 10 cycles and decreased very slowly from 
10 to 60 cycles (final concentration at 60 cycles 82%). Ligstroside aglycon increased from 
0 to 10 cycles and then decreased, its concentration being 0.03 μg/mL after 60 cycles. 
Decarboxymethyl oleuropein aglycon and hydroxytyrosol increased from 0 to 60 cycles and 
their concentrations were 0.026 and 0.031 μg/mL, respectively, after 60 cycles. Comparing 
the results with those obtained by hydrolysis of the oleuropein standard, it is clear that the 
sample matrix did not influence the results, as shows Fig. S4. 
When working with olive leaf extracts prepared as described in Section 2.3, the 
products were the same as from commercial extracts. The hydrolysis yield of oleuropein 
reached 95.7% at 10 US cycles, with formation of 94.9% of the aglycon form. Fig. 2 shows 
the oleuropein-aglycon/oleuropein ratio (expressed as concentration) obtained from the 
three type of samples: oleuropein standard, commercial olive leaf extract and no 
commercial olive leaf extract. These results show that the behavior of oleuropein and that 
of the oleuropein aglycon was always the same, independent of the sample from which they 
come. As can be seen in Fig. 2, high statistical differences were seen for 15 US cycles (p-
values<0.0055) in the three types of samples. 
 
4. Conclusions 
A USAEH method has been developed to obtain oleuropein aglycon from 
oleuropein in olive leaf extracts. β-Glucosidase from A. niger was selected among three 
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enzymes. A drastic shortening of the time required for complete hydrolysis was achieved as 
compared with a traditional method based on enzymatic incubation, which requires 2 h. 
Extraction of oleuropein from olive leaf extracts was carried out by agitation with a 
methanol–water mixture, while hydrolysis was carried out by β-glucosidase from A. niger 
and quantitation was by LC−MS/MS with multiple reaction monitoring. After multivariate 
optimization of the variables involved in the USAEH method, a kinetics study showed that 
the hydrolysis reaction of oleuropein was complete in only 18.75 min. 
 
 
Fig. 2. USAEH (0–15 cycles) of oleuropein from an analytical standard (10 µg/mL), a commercial 
olive leaf extract and a no commercial olive leaf extract. The comparison to confirm statistical 
differences was based on ANOVA. 1p-values were obtained by analysis of variance (ANOVA). **p-
value between 0.001 and 0.01. ***p-value < 0.001. 
 
The fast production of oleuropein aglycon thus achieved, together with the fast 
methods for the extraction of phenols from olive leaves based on US or microwaves 
assistance previously reported by the authors (Japón-Luján, Luque-Rodríguez & Luque de 
Castro, 2006a; Japón-Luján, Luque-Rodríguez & Luque de Castro, 2006b), open a door to 
the exploitation of the interesting pharmacological properties of this compound 
(Casamenti, Grossi, Rigacci, Pantano, Luccarini & Stefani, 2015; Corominas-Faja et al., 
2014; Grossi et al., 2013; Luccarini, Ed Dami, Grossi, Rigacci, Stefani & Casamenti, 2014), 
and its wide use for cosmetics, functional foods and nutraceuticals (Van der Stelt et al., 
2015). 
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Supplementary material 
 
Table S1. Specific information about the different enzymes. 
Enzyme pH 
Temperature 
(ºC) 
Enzyme activity 
(U/mg) 
Enzyme form 
β-Glucosidase from  
Aspergillus niger 
4.0 37 1.2 Powder 
β-Glucosidase from  
almonds 
5.0 37 7.7 
Lyophilized 
powder 
Hemicellulase from  
Aspergillus niger 
4.5 40 1.5 Powder 
 
Table S2. Independent variables and their levels of Box-Behnken design for the hydrolysis reaction. 
Independent variable Symbol 
Variable levels 
-1 0 1 
Duty cycle (s/s) X1 0.1 0.3 0.5 
Amplitude (%) X2 10 30 50 
Cycle time (s) X3 15 30 45 
 
Table S3. Box-Behnken experimental design and corresponding oleuropein peak area. 
No. 
X1  
duty cycle 
(s/s) 
X2 amplitude (%) 
X3  
cycle time (s) 
Y 
[oleuropein aglycon]/ 
[oleuropein] 
1 1 0 –1 0.87 
1 1 0 –1 0.88 
2 0 0 0 0.82 
2 0 0 0 0.82 
3 0 –1 1 0.83 
3 0 –1 1 0.84 
4 0 –1 –1 0.70 
4 0 –1 –1 0.70 
5 1 –1 0 0.87 
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5 1 –1 0 0.88 
6 0 0 0 0.79 
6 0 0 0 0.78 
7 –1 0 –1 0.82 
7 –1 0 –1 0.82 
8 –1 0 1 0.92 
8 –1 0 1 0.92 
9 0 1 –1 1.03 
9 0 1 –1 1.01 
10 –1 –1 0 0.90 
10 –1 –1 0 0.89 
11 –1 1 0 1.00 
11 –1 1 0 1.00 
12 0 1 1 2.01 
12 0 1 1 1.99 
13 1 0 1 1.55 
13 1 0 1 1.58 
14 1 1 0 3.46 
14 1 1 0 3.40 
15 0 0 0 0.85 
15 0 0 0 0.85 
 
Table S4. Variance analysis of items in the regression equation. 
Sources of 
variation 
Sum of squares df1 Mean square F value P value 
X1 duty 2.42565 1 2.42565 41.60 0.0000 
X2 am 4.29557 1 4.29557 73.67 0.0000 
X3 cycl 0.91465 1 0.91465 15.69 0.0008 
X1X2 3.00272 1 3.00272 51.50 0.0000 
X1X3 0.16983 1 0.16983 2.91 0.1042 
 
Continuation Table S3 
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X2X3 0.35663 1 0.35663 6.12 0.0230 
X12 0.75057 1 0.75057 12.87 0.0020 
X22 1.25881 1 1.25881 21.59 0.0002 
X32 0.06291 1 0.06291 1.08 0.3119 
R2 0.9225     
Radj2 0.8877     
1 degree of freedom. 
 
Fig. S1. Enzymatic hydrolysis of oleuropein. 
 
 
Fig. S2. (A) Hydrolysis of oleuropein to oleuropein aglycon and other minority products from an 
oleuropein standard (10 μg/mL) in the presence of β-glucosidase from Aspergillus niger. 
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Fig. S2. Hydrolysis of oleuropein to oleuropein aglycon and other minority products from an 
oleuropein standard (10 μg/mL) in the presence of β-glucosidase from almonds (B), hemicellulase 
from Aspergillus niger (C), and the no catalyzed reaction (D). 
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Fig. S3. Hydrolysis of oleuropein to oleuropein aglycon and other products from an oleuropein 
standard (10 μg/mL) in the presence of β-glucosidase from Aspergillus niger at 25 (A) and 50 ºC 
(B). 
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Fig. S4. USAEH (0–60 cycles) of oleuropein from an analytical standard (3.0 μg/mL) (A), and 
from an olive leaf extract (B). 
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Tentative identification of the composition of 
Agaricus bisporus aqueous enzymatic extracts 
with antiviral activity against HCV: A study by 
liquid chromatography–tandem mass 
spectrometry in high resolution mode 
 
María del Mar Delgado-Povedano, Verónica Sánchez de Medina , Juan 
Bautista, Feliciano Priego-Capote , María Dolores Luque de Castro 
 
Abstract 
Aqueous enzymatic extracts of edible mushroom Agaricus bisporus (AbAEE) have 
been studied as a key source of biological active compounds, among which those with 
antiviral activity against HCV are of special interest. Searching for a better knowledge of 
AbAEE, a new approach based on sequential fractionation with solvents of different 
polarity is here proposed to improve the tentative identification of AbAEE components by 
liquid chromatography–tandem mass spectrometry (LC–QTOF MS/MS) in high resolution 
mode. Fifty five out of one hundred twenty-three total metabolites tentatively identified by 
combination of MS and MS/MS information were identified for the first time. The 
identified compounds include amino acids, sugars, carboxylic, fatty and cinnamic acids, 
mono- and disaccharides, phospholipids and purines, as the most outstanding; thus 
demonstrating that fractionation based on sequential liquid–liquid extraction followed by 
LC–QTOF MS/MS is a suited option to obtain a wide, representative snapshot of AbAEE 
composition. 
Keywords: mushroom, Agaricus bisporus, aqueous enzymatic extracts, liquid 
chromatography–tandem mass spectrometry, antiviral activity, HCV. 
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1. Introduction 
Besides their unique flavor and sensory properties, mushrooms are endowed with 
excellent nutritional and healthy properties; therefore, mushrooms have been appreciated 
and consumed for thousands of years thanks to their nutritional value and health benefits. 
On a dry weight basis, mushrooms can be considered a good source of proteins, 
carbohydrates and dietary fiber (Barros, Baptista, Estevinho, & Ferreira, 2007), and of 
bioactive metabolites involved in health promotion and disease prevention (Bishop et al., 
2015). Currently, edible mushrooms and their extracts or fractions are considered good 
candidates to be included in healthy diets, as components of new functional foods or 
nutraceuticals. Concerning disease prevention, we recently described the “in vitro” 
inhibition of the protease NS3 of hepatitis-C virus (HCV) by aqueous enzymatic extracts of 
the common edible mushroom Agaricus bisporus (A. bisporus) (Gayego-Yerga & Bautista, 
2015). This fact suggests incorporation of these extracts to the diet as components of new 
functional foods or nutraceuticals for hepatitis-C prevention in people under risk of HCV 
infection. 
The use of these extracts as they are, as part of new functional foods or as 
nutraceuticals requires characterization of A. bisporus aqueous enzymatic extracts 
(AbAEE) as exhaustive as possible, in addition to complete safety. As far as we know, this 
characterization has not yet been carried out. In fact, the widest study on the chemical 
composition and biological properties of mushrooms and their extracts involved individual 
profiles of sugars (four sugars), fatty acids (twenty-three fatty acids), and tocopherols 
(three tocopherols) by using a gas chromatograph coupled to either a refractive index 
detector or a flame ionization detector (GC–FID), and by a liquid chromatograph coupled 
to a UV detector (LC–UV) (Barros, Venturini, Baptista, Estevinho, & Ferreira, 2008). Other 
compounds such as phenols, flavonoids, carotenoids or ascorbic acid have also been 
determined (Barros et al., 2008); however, the study did not include determination of 
compounds such as peptides, organic acids or 5´-nucleotides. Triterpenes from 
Ganoderma lucidum have been determined by liquid chromatography–mass spectrometry 
(LC–QTOF MS/MS) and NMR (Dudhgaonkar, Thyagarajan, & Sliva, 2009). A different 
study was aimed at determining the EC50 value of extracts from Boletus spp. to evaluate 
their potential antioxidant activity, also including the targeted identification of potential 
antioxidant metabolites involved in the 1,1-diphenyl-2-picrylhydrazyl oxidation assay using 
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LC–QTOF MS/MS (Yuswan et al., 2015). None of these studies on mushroom were targeted 
at overall identification. 
Concerning A. bisporus, one of the major cultivated mushrooms, and its extracts 
the main studies have been addressed to the determination of the total content of moisture, 
protein, fat, carbohydrate and ash (Maseko et al., 2013), carbohydrate composition; 
chemical characterization and speciation analysis of organic selenium compounds (Maseko 
et al., 2013); determination of the antioxidant activity of phenols or polysaccharides (Bao, 
Ochiai, & Ohshima, 2010; Thetsrimuang, Khammuang, & Sarnthima, 2011); analysis of 
amino acids and 5´-nucleotides (Liu, Huang et al., 2014), that of five organic acids by LC–
UV or organic acids by LC–UV (Valentaõ et al., 2005), that of no hallucinogenic indole 
compounds (Muszyńska, Sułkowska-Ziaja, Hałaszczuk, Krężałek, & Łojewsk, 2014), or the 
analysis of intact and purified lipid extracts from A. bisporus using 1D and 2D COSY proton 
NMR (Bonzom, Nicolaou, Zloh, Baldeo, & Gibbons, 1999). Other studies have involved 
identification of soluble sugars and polyols by LC equipped with an evaporative light 
scattering detector, free amino acids by LC–MS/MS, 5′-nucleotides by LC–UV at 254 nm, 
and organic acids by LC–UV at 210 nm (Pei et al., 2014). 
Therefore, the aim of the present study was the tentative identification of as many 
AbAEE components as possible by an appropriate sample preparation strategy for 
fractionation based on sequential liquid–liquid extraction (LLE) of AbAEE prior to LC–
QTOFMS/MS in high resolution mode to obtain the required analytical information, 
increasing knowledge for a safe use of these extracts as they are, as part of new functional 
foods, or as nutraceuticals. 
 
2. Materials and methods 
 
2.1. Samples and chemicals 
White button mushrooms (A. bisporus) were used as raw material after cultivation 
according to standard procedures in a pilot plant in the University of Seville (Spain). 
SensoLyte520 HCV Protease Assay Kit “Fluorimetric” and HCV NS3/4A protease were 
from AnaSpec (San Jose, CA, USA). 
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MS-grade ethyl acetate, dichloromethane and n-hexane from Sigma–Aldrich 
(Madrid, Spain) were used as extractants for LLE. MS-grade formic acid (FA) from 
Scharlab (Barcelona, Spain) was used as ionization agent. Methanol MS-grade from 
Sigma–Aldrich, and LC–grade from Scharlab were used to prepare the chromatographic 
mobile phases for LC–MS/MS and LC–diode array detector (DAD) analysis, respectively. 
Deionized water (18 mΩ•cm) from a Millipore Milli-Q water purification system (Bedford, 
MA, USA) was used to prepare the aqueous solutions. 
 
2.2. Extracts preparation 
AbAEE was obtained by an enzymatic procedure based on that described by 
Cremades et al. (2012). Briefly, after homogenization and enzymatic digestion, the 
hydrolyzate was centrifuged at 8000×g, resulting in a supernatant and a solid residue. The 
latter (insoluble material) was discharged, and the supernatant (raw extract) was collected 
and filtrate through a Vivaflow-50 crossflow cassette (Sartorius), equipped with a 50 kDa 
ultrafiltration membrane, using the ultrafiltrate (UF-50) as AbAEE for activity assays. 
 
2.3. Apparatus and instruments 
A 5 liter reactor with pH, temperature and agitation control was used for enzymatic 
treatment, and a Vivaflow-50 crossflow cassette (Sartorius) was the ultrafiltration device. 
A Synergy HT plate reader (BioTeK) was use for enzymatic activity measurements. A vortex 
shaker from IKA (Wilmington, NC, USA), a Digtor 21 centrifuge from Ortoalresa (Madrid, 
Spain) and a Concentrator Plus speed-vac from Eppendorf (Hamburg, Germany) were 
used. An Agilent 1100 Series LC system from Agilent Technologies (Waldbronn, Germany) 
coupled to a DAD was used. Control of the instrumental setup and data acquisition was 
performed by the HPLC ChemStation software from Agilent. 
An Agilent 1200 Series LC system coupled to an Agilent 6540 UHD Accurate-Mass 
QTOF hybrid mass spectrometer (Santa Clara, CA, USA) equipped with dual electrospray 
ionization (ESI) source for simultaneous spraying of a mass reference solution to calibrate 
continuously detected m/z ratios. The samples were thus monitored in high resolution 
mode. The Agilent MassHunter Workstation software was used to process the raw MS data, 
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including extraction of molecular features (MFs), generation of molecular formula, library 
searching and database searching. 
 
2.4. HCV NS3-protease assay 
HCV NS3-protease activity was fluorimetrically measured using the SensoLyte520 
HCV Protease Assay Kit (Fluorimetric) and a recombinant HCV NS3/4A protease 
(AnaSpec, San Jose, CA, USA). 0.1 mg/mL of mushroom extracts (crude and AgAEE), 
together with 0.2 ng of freshly diluted enzyme were added to each well of a 96-well black 
assay plate (BD Falcon). The reaction started by adding 25 μL of freshly diluted substrate 
(1:25 in assay buffer solution). After incubation at room temperature (28 ºC) for 15 min, 
the fluorescence intensity was measured at λex/λem 490/520 nm in a Synergy HT, BioTeK 
plate reader. Substrate–enzyme reaction with vehicle dimethyl sulfoxide (DMSO) or water 
was used as reference value (100% activity). Inhibition percentages were calculated as:  
% inhibition = 100% – (RFU0/RFUx) 100% (1) 
where RFU0 and RFUx are the fluorescence intensity of NS3 in the absence and presence of 
inhibitor, respectively. Quercetin (50 μM) and Telaprevir (TLP) (5μM) were used as 
positive inhibition controls. All analyses were performed in triplicate and the vehicle DMSO 
or water were considered as control (no inhibition, 100% of RFU). 
 
2.5. Sequential fractionation of AbAEE 
Fractionation of AbAEE was performed using sequential LLE with three 
extractants characterized by different polarity indices (pI), all of them immiscible with 
water, used in the following order: hexane (pI=0), dichloromethane (pI=3.1), and ethyl 
acetate (pI=4.4). For this purpose, 2 mL of AbAEE was diluted with 4 mL of deionized water 
and shaken for 1 min in the vortex before addition of 3 mL of hexane (first extractant) and 
shaken for 30 s in the vortex. The resulting two-phase system was centrifuged at 1500×g 
for 5 min for phase separation. The hexane phase was collected in a vial and the aqueous 
phase was shaken in the vortex with 3 mL of dichloromethane (second extractant) for 30 s.  
The liquid–liquid system was centrifuged at 1500×g for 5 min and the 
dichloromethane phase was collected in a vial. Finally, 3 mL of ethyl acetate (third 
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extractant) was added to the remaining aqueous phase and the system shaken for 30 s in 
the vortex. The two-phase system was centrifuged at 1500×g for 5 min and each of the 
phases was collected in a vial. The extraction sequence is shown in Fig S1. 
Then, 2 mL of each extract (hexane, dichloromethane and ethyl acetate extracts) 
was concentrated up to 0.5 mL in the speed-vac prior to analysis. 
 
2.6. LC–DAD analysis 
The analytical column was a 5 μm particle size, 250 mm×4.6 mm i.d. C18 Inertsil 
ODS-2 from GL Sciences Inc. (Torrance, CA, USA), and a C18 pre-column, 4 mm×3.0 mm 
i.d., from Phenomenex (Torrance, CA, USA) was used to protect the analytical column. The 
mobile phases were: 0.1% FA in water (phase A) and 0.1% FA in methanol (phase B). Three 
chromatographic gradients, at 0.8 mL/min constant flow rate, were used according to the 
polarity of the extracts. For no polar extracts (preconcentrated and no preconcentrated 
hexane extracts) the initial mobile phase was 96% A and 4% B, changed to 100% B along 
30 min, then maintained constant for 30 min more. For medium polar extracts 
(preconcentrated and no preconcentrated both dichloromethane and ethyl acetate extracts) 
the initial mobile phase was 96% A and 4% B, changed to 100% B along 30 min, then 
maintained for 12 min more. For high-polar analytical samples (1:2 diluted remaining 
aqueous phase and 1:10 diluted MAEE, in both cases diluted with water) the initial mobile 
phase was also 96% A and 4% B, changed to 75% A and 25% B between min 0 and 30, to 
100% B between min 30 and 40, then maintained for 2 min more. 
In all cases a 10 min post-time was set to equilibrate the initial conditions for the 
next analysis. The injection volume was 20 µL and the injector needle was washed for 5 
times between injections with 70% acetonitrile to avoid cross contamination. The 
chromatograms were acquired at 225, 250, 260, 280 and 320 nm (wavelengths of 
maximum absorption for most phenols). 
 
2.7. LC–QTOF MS/MS analysis 
Identification was carried out by LC–QTOFMS/MS analysis in high-resolution 
mode due to the complexity of mushroom extracts. The analytical samples were injected 
into the LC–QTOF system without additional preparation, except for the remaining 
 Chapter V 
 
Page | 261  
aqueous phase and the AbAEE, which were 1:10 and 1:30, respectively, diluted with water. 
The injection and separation conditions were identical to those for the LC–DAD analysis, 
except for the use of LC–MS grade solvents. 
The parameters of the ESI source, operating in negative and positive ionization 
modes, were as follows: the capillary and fragmentor voltage were set at ± 3.5 kV and 145 
V, respectively; N2 in the nebulizer was flowed at 40 psi; the flow rate and temperature of 
the N2 as drying gas were 10 L/min and 350 ºC, respectively. The instrument was calibrated 
and tuned according to the procedures recommended by the manufacturer. Data were 
collected in both centroid modes at a rate of 1 spectrum per second in the extended dynamic 
range mode (2 GHz). Accurate mass spectra in MS scan were acquired in the m/z range 
60–1100 and in MS/MS mode in the m/z range 31–1100. The instrument gave typical 
resolution 15,000 FWHM (Full Width at Half Maximum) at m/z 118.0862 and 30,000 
FWHM at m/z 922.0098. To assure the desired mass resolution, continuous internal 
calibration was performed during analyses by using the signals at m/z 121.0509 
(protonated purine) and m/z 922.0098 [protonatedhexakis(1H,1H,3H-tetrafluoro-
propoxy)phosphazine or HP-921] in the positive ion mode; while in the negative ion mode, 
ions with m/z 119.0362 (proton abstracted purine) and m/z 1033.9881 (TFA adduct of HP-
921) were used. 
The analytical samples were injected in auto MS/MS acquisition mode to obtain 
information from fragmentation of the target compounds. The maximum number of 
precursors selected per cycle was set at 2, with an exclusion window of 0.1 min after 2 
consecutive selections of the same precursor. Collision energy of 20 eV was used to obtain 
the maximum information from fragmentation. Two replicates of each analytical sample 
were analyzed. 
 
2.8. Data pretreatment 
MassHunter Workstation software (version B7.00 Qualitative Analysis, Agilent 
Technologies, Santa Clara, CA, USA) was used to process all data obtained by LC–QTOF in 
full scan MS mode. Treatment of raw data files started by extraction of potential MFs with 
the suited algorithm included in the software. For this purpose, the extraction algorithm 
considered all ions exceeding 800 counts for negative ionization mode and 1000 counts for 
positive ionization mode with a single charge state for the obtained chromatograms. These 
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cut-off values were established taking into account the chromatographic background noise. 
Additionally, the isotopic distribution to consider MFs as valid should be defined by two or 
more ions (with a peak spacing tolerance of 0.0025 m/z, plus 7.0 ppm in mass accuracy). 
Ions and adducts formation in the positive (+H, +Na) and negative ionization (−H, −2H, 
+HCOO, +Cl) modes, as well as neutral loss by dehydration, were included to identify 
features corresponding to the same potential metabolite. Thus, ions with identical elution 
profiles and related m/z values (representing different adducts or isotopes of the same 
compound) were extracted as entities characterized by their retention time (RT), intensity 
in the apex of the chromatographic peaks and accurate mass. In this way, raw data files 
were created in compound exchange format files (.cef files) for each sample and exported 
into the Mass Profiler Professional software package (version 13.0, Agilent Technologies, 
Santa Clara, CA, USA) for further processing. 
In the next step, the data were processed by alignment of RT and m/z values across 
the data matrix using a tolerance window of 0.6 min and 10 ppm mass accuracy, 
respectively. Stepwise reduction of the MFs number was based on frequency of occurrence 
by comparing repetitions of the same sample. 
Identification of the most relevant entities was supported on MS and MS/MS 
information and search in the METLIN MS and MS/MS databases 
(http://metlin.scripps.edu) and the Human Metabolome Database (HMDB, 3.6 version). 
 
2.9. Statistical analysis 
All inhibition experiments were conducted in triplicate. Statistical analysis was 
carried out using SPSS (version 16.0, Chicago, USA). The results were expressed as 
mean±standard deviation, and the significance was set at 95% confidence level. 
 
3. Results and discussion 
 
3.1. HCV protease NS3/NS4 inhibition 
In vitro inhibitory capacity of crude extract and AbAEE against the HCV 
recombinant protease NS3/NS4 was studied by a fluorimetric assay using the SensoLyte® 
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520 HCV Protease Assay Kit. This procedure provides an appropriate assay for high 
throughput screening of HCV NS3/4A protease inhibitors and for continuous quantitation 
of HCV NS3/4A protease activity using a 5-FAM/QXL™520 fluorescence resonance energy 
transfer (FRET) peptide. The sequence of this peptide is derived from the cleavage site of 
NS4A/NS4B. In the FRET peptide, the fluorescence of 5-FAM is quenched by QXL™520. 
Upon cleavage into two separate fragments by HCV NS3/4A protease (Scheme 1), the 
recovered fluorescence of 5-FAM can be monitored at λex/λem = 490/520 nm. Thanks to a 
higher fluorescence quantum yield and longer wavelength, the signal of 5-FAM is less 
interfered by the auto fluorescence of cell components and test compounds. The assay can 
detect as low as 1.56 ng/mL active HCV NS3/4A protease (Tong et al., 2005). 
 
 
Scheme 1. Proteolytic cleavage of 5-FAM/QXL™520 FRET peptide by HCV NS3/4A protease. 
 
Fig. 1 shows that VHC protease NS3/NS4 activity is 64.85% and 75.56% inhibited 
by A. bisporus raw extract (41.15 µg/mL) and AgAEE (20.73 µg/mL), respectively; while 
quercetin (50 µM = 15.122 µg/mL), and telaprevil (TPV, 5 µM = 3.40 µg/mL), a natural and 
a synthetic inhibitors of the VCH NS3 protease that inhibit 29.86 and 87.69%, respectively, 
the recombinant enzyme. These data show the significant inhibition of VCH protease by 
AgAEE; inhibition greater than that of quercetin 50 µM; but lower than that caused by the 
synthetic inhibitor TPV. However, it must be taken into account that while quercetin and 
TPV are pure products, AgAEE are complex mixtures of at least 123 different compounds 
(Table 1), as discussed below. Therefore, a significant increase of the inhibitory activity can 
be expected after extracts purification. Consequently, isolation and identification of the 
product or products responsible for the inhibition is of utmost importance. 
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Fig. 1. In vitro inhibition of recombinant protease NS3/NS4 of HCV by A. bisporus raw extract 
(AbRE), A. bisporus aqueous enzymatic extract (AbAEE), quercetin and telaprevir (TPV). 
 
Table 1. List of metabolites identified in the different fractions and AbAEE classified by families. RT 
is included, as well as the MS identification information (precursor and product ions) and error 
(expressed as ppm) of the precursor ion detected. In bold are metabolites identified for the first time 
in this research. 
Metabolite 
MS spectra 
experi- 
mental 
(m/z) 
MS spectra 
theoretical 
(m/z) 
Error 
(ppm) 
Adduct 
RT 
(min) 
Product ions 
(m/z) 
Extract 
Alkaloid derivative 
2-Methyl-
pyrrolidine 
86.0969 86.0970 1.2 [M+H]+ 7.90 
43.0539 
41.0390 
AbAEE1, Aq2 
Alkylamines 
Pantothenic 
acid 
220.1178 220.1186 3.6 [M+H]+ 20.02 
90.0556 
72.0443 
AbAEE, Aq 
Spermidine 146.1651 146.1658 4.8 [M+H]+ 2.53 
84.0811 
72.0809 
AbEE, Aq 
Pyrroline 
1-Pyrroline 70.0652 70.0657 7.1 [M+H]+ 4.28 
43.0542 
41.0385 
AbAEE, Aq 
Amino acids and derivatives 
2,5-Dihy-
drophenyl-
alanine 
168.1019 168.1025 3.6 [M+H]+ 6.78 
126.0551 
81.0707 
Dclo cc3, 
Dclo4, Et5,  
Et cc6 
2-Amino-
butyric acid 
102.0562 102.0554 −7.8 [M–H]– 3.92 102.0562 AbAEE, Aq 
3-Amino-2-
naphthoic 
acid 
188.0703 188.0712 4.8 [M+H]+ 22.23 
170.0594 
142.0651 
AbAEE, Aq 
3-Amino-3-
(4-hydroxy-
phenyl)-
propanoate 
180.0665 180.0660 −2.8 [M–H]– 27.28 
119.0495 
93.0340 
AbAEE, Aq 
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5-Amino 
pentanoate 
118.0864 118.0869 4.2 [M+H]+ 4.20 
74.0588 
58.0625 
AbAEE, Aq 
Acetyl-
carnitine 
204.1231 204.1237 2.9 [M+H]+ 4.04 
85.0288 
60.0809 
AbAEE, Aq 
Citrulline 176.1031 176.1036 2.8 [M+H]+ 3.92 
113.0708 
70.0650 
AbAEE, Aq 
Cyclo-
leucine 
130.0863 130.0869 4.6 [M+H]+ 5.52 
84.0809 
67.0540 
AbAEE, Aq 
Cystathionine 223.0746 223.0753 3.1 [M+H]+ 3.55 
134.0267 
88.0212 
AbAEE, Aq 
Ergothioneine 230.0957 230.0964 3.0 [M+H]+ 5.13 
127.0322 
60.0809 
AbAEE, Aq 
L-2-Amino-
adipic acid 
160.0616 160.0609 −4.4 [M–H]– 4.21 
116.0720 
98.0609 
AbAEE, Aq 
L-Agaritine 268.1292 268.1298 2.2 [M+H]+ 7.31 
84.0439 
77.0389 
AbAEE, Aq 
L-Arginine 173.1040 173.1038 −1.1 [M–H]– 3.44 
131.0823 
112.0868 
Aq 
L-Asparagine 133.0610 133.0614 3.0 [M+H]+ 3.70 
74.0233 
46.0283 
AbAEE, Aq 
L-Aspartic 
acid 
132.0302 132.0296 −4.5 [M–H]– 4.02 
88.0405 
71.0139 
AbAEE, Aq 
L-Carnitine 162.1124 162.1131 4.3 [M+H]+ 3.52 
103.0389 
60.0808 
AbAEE, Aq 
L-Glutamate 148.0602 148.0611 6.1 [M+H]+ 3.94 
85.0284 
56.0494 
AbAEE, Aq 
L-Glutamine 147.0761 147.0770 6.1 [M+H]+ 3.77 
84.0442 
56.0493 
AbAEE, Aq 
L-Isoleucine 132.1019 132.1025 4.5 [M+H]+ 7.40 
86.0967 
69.0699 
AbAEE, Aq 
LL-2,6-Di-
aminohep- 
tanedioate 
189.0886 189.0875 −5.8 [M–H]– 4.16 
84.0444 
74.0237 
AbAEE, Aq 
L-Leucine 132.1020 132.1025 3.8 [M+H]+ 7.87 
86.0967 
44.0492 
AbAEE, Aq 
L-Lysine 147.1129 147.1134 3.4 [M+H]+ 2.77 
84.0809 
56.0492 
Aq 
L-Methionine 150.0585 150.0590 3.3 [M+H]+ 5.80 
61.0105 
56.0496 
AbAEE, Aq 
L-Phenyl-
alanine 
166.0860 166.0869 5.4 [M+H]+ 14.21 
120.0804 
103.0544 
AbAEE, Aq 
L-Proline 116.0703 116.0712 7.8 [M+H]+ 4.28 
70.0652 
43.0539 
AbAEE, Aq 
L-Serine 104.0353 104.0347 −5.8 [M–H]– 3.75 
74.0243 
42.0356 
AbAEE, Aq 
L-Threonine 120.0651 120.0661 8.3 [M+H]+ 3.79 
74.0599 
56.0495 
AbAEE, Aq 
L-Tryptophan 205.0972 205.0978 2.9 [M+H]+ 22.30 
146.0600 
118.0649 
AbAEE, Aq 
L-Tyrosine 182.0806 182.0818 6.6 [M+H]+ 8.93 
136.0753 
91.0542 
AbAEE, Aq 
L-Valine 118.0863 118.0869 5.1 [M+H]+ 4.81 
72.0809 
55.0543 
AbAEE, Aq 
N2-Acetyl-
L-ornithine 
175.1078 175.1083 2.9 [M+H]+ 4.57 
116.0692 
70.0653 
AbAEE, Aq 
N6-Acetyl-
L-2,6-di-
aminohep-
tanedioate 
233.1134 233.1138 1.7 [M+H]+ 6.54 
87.0433 
84.0465 
AbAEE, Aq 
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N-Car-
bamylgluta-
mate 
189.0518 189.0511 −3.7 [M–H]– 7.46 
128.0347 
102.0560 
AbAEE, Aq 
Nε-Acetyl- 
L-lysine 
189.1230 189.1240 5.3 [M+H]+ 5.29 
126.0909 
84.0811 
AbAEE, Aq 
Ornithine 133.0973 133.0978 3.8 [M+H]+ 2.77 
116.0708 
70.0651 
Aq 
Pipecolic acid 130.0864 130.0869 3.8 [M+H]+ 5.15 
84.0810 
56.0493 
AbAEE, Aq 
Pyroglutamic 
acid 
128.0353 128.0347 −4.7 [M–H]– 9.09 
128.0352 
82.0294 
AbAEE, Aq 
Saccharopine 277.1393 277.1400 2.5 [M+H]+ 3.81 
130.0864 
84.0809 
AbAEE, Aq 
Anthranilic 
acid 
138.0546 138.0556 7.2 [M+H]+ 12.04 
120.0441 
92.0500 
Et cc 
Peptides 
Cyclo(L-
phe-L-pro) 
245.1286 245.1291 2.0 [M+H]+ 19.78 
120.0802 
70.0654 
Dclo, Dclo cc 
Oxidized 
glutathione 
611.1446 611.1441 −0.8 [M–H]– 9.52 
306.0762 
272.0886 
AbAEE, Aq 
γ-D-Glu- 
tamylglycine 
205.0822 205.0825 1.5 [M+H]+ 4.39 
142.0494 
84.0442 
AbAEE, Aq 
Quinoline derivative 
5,6-Di-
hydroxy-3-
methyl-2-
oxo-1,2,5,6-
tetrahydro-
quinoline 
194.0812 194.0818 3.1 [M+H]+ 11.41 
120.0455 
57.0332 
Et, Et cc 
Indoles 
Formyl indole 146.0596 146.0607 7.5 [M+H]+ 20.48 
118.0649 
91.0543 
Dclo, Dclo cc, 
Et cc 
5-Hydroxy-
indolepyru-
vate 
254.0224 254.0226 0.8 [M+Cl]– 9.51 
200.0353 
191.0350 
Et cc 
Indole- 
3-acetate 
174.0559 174.0554 −2.9 [M–H]– 18.88 
144.0439 
130.0656 
Dclo, Dclo cc 
Indole- 
3-carboxylic 
acid 
160.0403 160.0398 −3.1 [M–H]– 20.40 116.0502 Et cc 
Benzaldehyde 
4-Hydroxy-
benzaldehyde 
123.0444 123.0447 2.4 [M+H]+ 8.92 
95.0484 
77.0381 
AbAEE, Dclo 
cc, Aq 
Benzoic acid derivative 
Salicylic acid 137.0242 137.0238 −2.9 [M–H]– 17.07 
93.0342 
65.0396 
Et cc 
Carboxylic acids and derivatives 
2,2-Di-
methyl 
succinic 
acid 
145.0505 145.0500 −3.4 [M–H]– 25.65 
101.0602 
83.0504 
AbAEE, Aq 
3-Hydroxy-
3-methyl-
glutaric 
acid 
161.0454 161.0449 −3.1 [M–H]– 11.98 
59.0143 
57.0349 
AbAEE, Aq 
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Citric acid 191.0195 191.0191 −2.1 [M–H]– 9.73 
111.0093 
87.0089 
AbAEE, Aq 
Lactic acid 89.0246 89.0238 −9.0 [M–H]– 6.98 
43.0188 
41.0032 
AbAEE, Aq 
Malic acid 133.0142 133.0136 −4.5 [M–H]– 6.23 
72.9928 
71.0135 
AbAEE. Aq 
Succinic acid 117.0198 117.0187 −9.4 [M–H]– 10.19 
73.0297 
55.0194 
Aq 
Cinnamic acid derivative 
p-Coumaric 
acid 
165.0542 165.0552 6.1 [M+H]+ 19.57 
147.0442 
119.0493 
AbAEE, Et cc, 
Aq 
Disaccharides 
Cellobionic 
acid 
357.1043 357.1032 −3.1 [M–H]– 5.36 
113.0233 
89.0233 
AbAEE, Aq 
α-1,5-L-
Arabino-
biose 
281.0876 281.0872 −1.4 [M–H]– 8.44 
89.0244 
71.0132 
AbAEE, Aq 
Monosaccharides 
Sedohep-
tulose-7-
phosphate 
289.0332 289.0324 −2.8 [M–H]– 6.33 
96.9693 
78.9592 
AbAEE, Aq 
D-Glucosa-
mine 6-
phosphate 
258.0385 258.0378 −2.7 [M–H]– 5.92 
171.0060 
78.9615 
Aq 
D-Glucose 
6-phos- 
phate 
259.0226 259.0218 −3.1 [M–H]– 6.34 
96.9693 
78.9592 
AbAEE, Aq 
D-Mannitol 183.0862 183.0869 3.8 [M+H]+ 4.12 
69.0337 
57.0330 
AbAEE, Et, 
Aq 
D-Mannitol 
1-phosphate 
261.0379 261.0375 −1.5 [M–H]– 6.76 
96.9694 
78.9591 
AbAEE, Aq 
Sedoheptu-
lose 
209.0664 209.0661 −1.4 [M–H]– 4.83 
59.0128 
57.0335 
AbAEE, Aq 
α-D-Glucose 179.0556 179.0555 −0.6 [M–H]– 4.62 
71.0141 
59.0134 
AbAEE, Aq 
Sugar acids and derivatives 
Galactonic 
acid 
195.0511 195.0504 −3.6 [M–H]– 4.32 
75.0090 
59.0139 
AbAEE, Aq 
Glucuronic 
acid 
193.0349 193.0348 −0.5 [M–H]– 4.56 
75.0088 
59.0139 
AbAEE, Aq 
Glyceric 
acid 
105.0189 105.0187 −1.9 [M–H]– 4.90 
59.0143 
56.9850 
AbAEE, Aq 
2-Dehydro-
3-deoxy-L-
arabinonate 
147.0300 147.0293 −4.8 [M–H]– 8.06 
85.0284 
57.0335 
AbAEE, Aq 
Glycerol-2-
phosphate 
171.0066 171.0058 −4.7 [M–H]– 6.68 
96.9688 
78.9594 
AbAEE, Aq 
Xylonate 165.0402 165.0398 −2.4 [M–H]– 4.48 
75.0089 
59.0140 
AbAEE, Aq 
Fatty acids and conjugates 
2-Hydroxy-
palmitic acid 
271.2282 271.2272 −3.7 [M–H]– 29.23 
253.2157 
225.2225 
Hex cc7, Dclo, 
Dclo cc 
2-Hydroxy-
isocaproic 
acid 
131.0715 131.0707 −6.1 [M–H]– 38.15 
85.0660 
69.0340 
AbAEE, Aq 
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3-Hydroxy-
palmitic 
acid 
271.2281 271.2272 −3.3 [M–H]– 31.46 59.0162 Dclo cc 
3-Hydroxy-
myristic 
acid 
243.1969 243.1959 −4.1 [M–H]– 29.97 
243.1950 
59.0142 
Dclo cc 
3-Hydroxy-
capric acid 
187.1341 187.1333 −4.3 [M–H]– 26.38 
59.0138 
41.0031 
Dclo cc, Et, Et 
cc 
5,8-DiHODE 311.2229 311.2222 −2.2 [M–H]– 26.52 
167.1441 
127.0765 
Dclo cc, Et cc 
6,7-Epoxy-
stearic acid 
297.2438 297.2429 −3.0 [M–H]– 29.67 
297.2427 
185.1178 
Hex8, Hex cc, 
Dclo, Dclo cc 
9,10,13-
TriHOME 
329.2339 329.2327 −3.6 [M–H]– 25.40 
157.1223 
99.0804 
Et cc 
9,10-
Dihydroxy-
stearic acid 
315.2541 315.2534 −2.2 [M–H]– 27.89 
298.2502 
44.9971 
Dclo, Dclo cc, 
Et cc 
9,10-Epoxy-
18-hydroxy-
stereate 
313.2382 313.2378 −1.3 [M–H]– 27.32 
113.0961 
99.0804 
Dclo, Dclo cc, 
Et cc 
Oleic acid 281.2484 281.2480 −1.4 [M–H]– 34.20 281.2501 Hex cc 
ε-Capra-
mine 
132.1020 132.1025 3.8 [M+H]+ 4.54 
59.0724 
132.1018 
AbAEE, Aq 
Palmitic acid 255.2331 255.2323 −3.1 [M–H]– 34.10 255.2337 Hex cc, Et cc 
Palmitoleic 
acid 
253.2170 253.2167 −1.2 [M–H]– 32.56 253.2157 Hex cc 
Stearic acid 283.2646 283.2636 −3.5 [M–H]– 36.24 283.2638 
Hex, Hex cc, 
Dclo, Dclo cc, 
Et 
α-Licanic 
acid 
293.2089 293.2117 9.5 [M+H]+ 29.24 
116.0505 
45.0336 
Hex cc, Dclo, 
Dclo cc 
Fatty amides 
13-Docosena-
mide 
338.3418 338.3424 1.8 [M+H]+ 36.32 
83.0855 
57.0697 
Hex, Hex cc, 
Dclo, Dclo cc, 
Et, Et cc 
Oleamide 282.2793 282.2798 1.8 [M+H]+ 32.73 
71.0861 
57.0693 
Hex cc, Dclo, 
Dclo cc, Et 
Sphingolipids 
C16 
Sphinganine 
274.2739 274.2747 2.9 [M+H]+ 22.69 
256.2622 
106.0853 
Dclo, Dclo cc 
Sphinganine 302.3058 302.3060 0.7 [M+H]+ 24.34 
284.2943 
57.0692 
Dclo, Dclo cc 
Phospholipid and derivative 
Phospho-
choline 
184.0731 184.0739 4.3 [M+H]+ 4.04 
124.9997 
86.0967 
AbAEE, Aq 
Glycer 
ophospho-
choline 
258.1099 258.1107 3.1 [M+H]+ 4.14 
124.9996 
104.1070 
AbAEE, Aq 
Furan 
2-Furoic 
acid 
111.0088 111.0081 −6.3 [M–H]– 9.73 
67.0189 
39.0241 
AbAEE, Aq 
No metal oxoanionic compounds 
Phosphate 96.9694 96.9690 −4.1 [M–H]– 5.80 
96.9690 
78.9594 
AbAEE, Aq 
 
Continuation Table 1 
 Chapter V 
 
Page | 269  
 
Phosphite 78.9588 78.9584 −5.1 
[M–
2H]– 6.00 
78.9599 
62.9646 
AbAEE, Aq 
Phenol derivative 
p-Amino-
phenol 
110.0601 110.0607 5.5 [M+H]+ 3.37 
93.0336 
65.0387 
Dclo, Dclo cc, 
Et, Et cc, Aq 
Purine nucleoside derivative 
Xanthosine 283.0650 283.0678 9.9 [M–H]– 18.19 151.0260 AbAEE, Aq 
Purine nucleotides and derivatives 
3´-AMP 346.0559 346.0552 −2.0 [M–H]– 13.50 
211.0014 
78.9590 
AbAEE, Aq 
AMP 348.0702 348.0710 2.3 [M+H]+ 8.83 
136.0619 
97.0285 
AbAEE, Aq 
ADP 426.0220 426.0215 −1.2 [M–H]– 13.01 
158.9250 
78.9593 
AbAEE, Aq 
cGMP 344.0405 344.0395 −2.9 [M–H]– 21.66 
150.0421 
108.0203 
AbAEE, Aq 
GDP 442.0173 442.0164 −2.0 [M–H]– 17.73 
344.0402 
150.0421 
AbAEE, Aq 
GDP-
mannose 
604.0701 604.0693 −1.3 [M–H]– 15.48 
442.0177 
424.0057 
AbAEE, Aq 
GMP 364.0654 364.0659 1.4 [M+H]+ 12.53 
152.0567 
97.0289 
AbAEE, Aq 
N6-(1,2-
Dicarboxy-
ethyl)-AMP 
464.0814 464.0819 1.1 [M+H]+ 28.45 
252.0724 
234.0620 
AbAEE, Aq 
Purines and purine derivatives 
Adenine 134.0469 134.0466 −2.2 [M–H]– 4.78 
107.0360 
92.0248 
AbAEE, Dclo, 
Dclo cc, Et, Et 
cc, Aq 
Guanine 152.0568 152.0573 3.3 [M+H]+ 5.34 
135.0302 
110.0351 
AbAEE, Aq, 
Et 
Hypoxanthine 137.0454 137.0464 7.3 [M+H]+ 9.31 
119.0351 
110.0349 
AbAEE, Aq, 
Et, Et cc 
Uric acid 167.0210 167.0204 −3.6 [M–H]– 9.22 
124.0154 
41.9985 
AbAEE, Aq 
Xanthine 151.0260 151.0255 −3.3 [M–H]– 11.07 
108.0196 
41.9987 
AbAEE, Aq, 
Et, Et cc 
Pyrimidine nucleotides and derivatives 
UMP 323.0291 323.0280 −3.4 [M–H]– 12.30 
96.9691 
78.9592 
AbAEE, Aq 
cUMP 305.0183 305.0174 −3.0 [M–H]– 15.51 
111.0197 
41.9985 
AbAEE, Aq 
UDP-D-
xylose 
535.0374 535.0366 −1.5 [M–H]– 19.31 
323.0286 
78.9591 
AbAEE, Aq 
UDP-
glucose 
565.0479 565.0471 −1.4 [M–H]– 18.90 
384.9842 
323.0289 
AbAEE, Aq 
UDP-
glucuronic 
acid 
579.0271 579.0264 −1.2 [M–H]– 19.54 
402.9954 
323.0289 
AbAEE, Aq 
UDP-N-
acetylglucos
amine 
606.0744 606.0737 −1.2 [M–H]– 19.97 
384.9850 
282.0392 
AbAEE, Aq 
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Pyrimidine derivative 
Uracil 111.0199 111.0194 −4.5 [M–H]– 7.01 41.9988 
AbAEE, Et, Et 
cc 
Pyridine derivative 
Nicotinic acid 124.0394 124.0399 4.0 [M+H]+ 7.09 
80.0497 
78.0335 
AbAEE, Aq 
AbAEE, Agaricus bisporus aqueous enzymatic extract; Aq, remaining aqueous extract; Dclo cc, preconcentrated 
dichloromethane extract; Dclo, dichloromethane extract; Et, ethyl acetate extract; Et cc, preconcentrated ethyl 
acetate extract; Hex cc, preconcentrated hexane extract; Hex, hexane extract. 
 
3.2. Sequential fractionation of AbAEE 
AbAEE are complex mixtures that mainly contain polar compounds due to their 
aqueous character (Kalač, 2009), but also no polar compounds are present in it. This 
complex composition justifies the selection of extractants with different polarity for 
sequential isolation of compounds pertaining to different families in order to enhance the 
coverage of identified compounds. The fractionation efficiency was evaluated by LC–DAD. 
The same mobile phases with slight modifications of the chromatographic gradients were 
used in all instances to facilitate comparison. Fig. 2 shows the DAD chromatograms 
provided by the analysis of the different fractions. Thus, Fig. 2A corresponds to the hexane 
extract (chromatogram obtained at 280 nm), Fig. 2B to the dichloromethane extract (at 
260 nm), Fig. 2C to the ethyl acetate extract (at 260 nm), Fig. 2D to the remaining aqueous 
phase (at 260 nm), and Fig. 2E to the analysis of MAEE (at 260 nm). Comparison of the 
chromatograms A-to-E in Fig. 2 emphasizes: (i) the complementarity of the fractionation, 
as shows the retention time distribution of the peaks in the different chromatograms; (ii) 
the polar character of most of the metabolites, shown by the high number of peaks found 
in the aqueous fraction; and (iii) the high concentration of polar compounds, taking into 
account that the analysis of AbAEE and the aqueous remaining fraction were 1:10 and 1:2 
diluted, respectively; while the organic phases were four times concentrated prior to 
injection into the chromatograph. 
Tentative identification was only applied to compounds with high quality MS/MS 
spectra. This step was supported on mass accuracy for precursor ions and also for the most 
representative product ions by searching for them in the METLIN database. Most of the 
compounds were detected in both positive and negative ionization polarities, but only the 
mode reporting the best resolution was included. A mass accuracy error for the precursor 
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ions lower than 10 ppm was accepted. The analysis of all analytical samples by LC–QTOF 
MS/MS allowed tentative identification of 123 compounds, while analysis of AbAEE 
without fractionation reported 90 compounds.  
 
 
 
Fig. 2. LC–DAD chromatograms from the fractions of the (A) hexane extract (obtained at 280 nm); 
(B) dichloromethane extract (at 260 nm); and (C) ethyl acetate extract (at 260 nm). 
(A) 
(B) 
(C) 
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Fig. 2. LC–DAD chromatograms from the fraction of the (D) 1:2 diluted remaining aqueous phase 
(at 260 nm); and (E) that from the 1:10 diluted A. bisporus aqueous enzymatic extract (at 260 nm). 
 
This identification increase can be attributed to fractionation as it permits 
implementing dilution or preconcentration steps for the different fractions as required. 
Fig. 3 shows a Venn diagram in which all compounds identified in the four fractions 
(three organic phases plus the remaining aqueous phase) are compared with those 
identified in AbAEE. As can be seen, 90 compounds were common to all the samples, while 
33 compounds were only identified in some of the fractions and no in the AbAEE. The 
compounds only identified in the fractionated extracts were mainly no polar (14 fatty acids 
and derivatives, 2 fatty amides and 2 sphingolipids), but also 5 amino acids, 4 indols, 1 
peptide, 1 phenol derivative, 1 benzoic acid derivative, 1 carboxylic acid, 1 monosaccharide 
derivative and 1 quinoline derivative. Among the total 123 tentatively identified 
(D) 
(E) 
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compounds, 55 were identified for the first time in this fungus (43 in AbAEE and aqueous 
remaining phase and 12 in the organic fractions). 
 
Fig. 3. Venn diagram comparing the compounds identified in A. bisporus aqueous enzymatic extract 
(AbAEE) with the sum of those identified in the four fractions. 
 
Once the tentative identification was complete, the efficiency of fractionation was 
explained by Venn diagrams. Fig. 4 shows the Venn diagram involving the compounds 
identified in the analyzed fractions.  
 
 
Fig. 4. Venn diagram comparing the compounds identified in the hexane, dichloromethane, ethyl 
acetate extracts and those remaining in the aqueous phase. 
 
As can be seen, the number of compounds identified in the aqueous sample was 
clearly higher than in hexane, dichloromethane or ethyl acetate extracts. Thus, the analysis 
of the hexane extract allowed identification of 9 compounds, that of dichloromethane 21 
0 90 33 
AbAEE All fractions 
Remaining 
aqueous phase 
Hexane 
extract 
Dichloromethane 
extract 
Ethyl acetate 
extract 
87 
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1 
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compounds and that of ethyl acetate 24 compounds. The analysis of the remaining aqueous 
fraction allowed identifying 95 compounds. One fact to be emphasized is that some of the 
identified compounds were found in all analytical fractions, but most of them were 
exclusively identified in one of the fractions, thus confirming the complementarity achieved 
by the fractionation step. 
 
3.3. Comparison of the metabolites tentatively identified in the no polar fraction 
(hexane extract) and AbAEE 
The analysis of the hexane extract allowed identification of 9 compounds that 
included 4 fatty acids —palmitic (C16:0), stearic (C18:0), palmitoleic (C16:1), and oleic 
acids (C18:1)— and 5 fatty acid derivatives —2-hydroxypalmitic acid, 6,7-epoxystearic acid, 
α-licanic acid, oleamide and 13-docosenamide). None of them were among the 90 
compounds tentatively identified in the direct analysis of AbAEE (see Fig. 5A), which is 
explained by the 1:30 dilution of AbAEE and the 4:1 preconcentration of the hexane extract 
applied to fit the scale of the analytical response. 
The compounds tentatively identified in the hexane extract were fatty acids and 
conjugates, which represent an important source of energy and facilitate vitamins 
absorption. These compounds were previously described by Woldegiorgis et al. 
(Woldegiorgis, Abate, Haki, Ziegler, & Harvatine, 2015), who determined fatty acids in 
mushrooms by GC–FID, after methylation. Two main saturated fatty acids —viz., palmitic 
(C16:0) and stearic (C18:0)— were tentatively identified in hexane extracts, in agreement 
with the literature that reports C16:0 as one of the most abundant fatty acids in A. bisporus 
(Nasiri, Ghiassi Tarzi, Bassiri, Hoseini, & Aminafshar, 2013). Unsaturated fatty acids such 
as oleic (C18:1) and palmitoleic (C16:1) acids, with modulatory effects on inflammatory 
diseases, have also been found in the hexane extract of the target mushroom, in agreement 
with previous studies on Agaricus species (Nasiri et al., 2013), as did oleic acid, detected 
as amide derivative, in agreement with previous studies on mushroom (Hyun, Lee, Sung, 
Kim, & Choi, 2013). Other fatty amide tentatively identified in the hexane extract was 13-
docosenamide, previously identified in mushroom by Nosaka et al. (Nosaka & Miyazawa, 
2014). Other fatty acid derivatives detected in hexane extracts were the acids 2-
hydroxypalmitic, α-licanic and 6,7-epoxystearic, among which 2-hydroxypalmitic acid had 
previously been identified (Proštenik et al., 1978), while α-licanic acid and 6,7-epoxystearic 
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acid had not previously been identified in any mushroom specie —the former had been 
identified in flowering plants (e.g., in seeds of Chrysobalanaceae) (Prance, 2014). 
 
3.4. Comparison of the metabolites tentatively identified in the dichloromethane 
extract with those in either AbAEE or hexane extract 
The analysis of the dichloromethane extract allowed tentative identification of 21 
compounds versus 90 identified in AbAEE. Only 2 compounds (viz., adenine and 4-
hydroxybenzaldehyde) were common to both extracts; therefore, 19 compounds were 
exclusively identified in the dichloromethane extract and 88 in AbAEE. Ten fatty acids and 
derivatives such as hydroxy fatty acids and epoxy fatty acids, 2 fatty amides (oleamide and 
13-docosenamide), 2 sphinganines (C16 sphinganine and sphinganine), 2 indoles (indole-
3-acetate and formyl indole), 1 peptide, 1 amino acid, and 1 phenol were the compounds 
tentatively identified in the dichloromethane extract. Fig. 5B shows the Venn diagram that 
compares the detection coverage by analyses of AbAEE and dichloromethane extract. 
Only 6 out of the 21 compounds tentatively identified in the dichloromethane 
extract were also identified in the hexane extract. Four fatty acids and derivatives (stearic 
acid, α-licanic acid, 6,7-epoxystearic acid and 2-hydroxypalmitic acid), and 2 fatty amides 
(oleamide and 13-docosenamide) were the compounds common to both extracts. Among 
the 15 compounds identified in the dichloromethane extract, but no in the hexane extract, 
6 were fatty acids and derivatives, 2 sphinganines, 2 indoles, 1 peptide, 1 amino acid, 1 
phenol, 1 purine and 1 benzaldehyde. Hydroxy fatty acids are useful as starting materials 
for functional foods (Takeuchi et al., 2013); 3 of the identified hydroxy fatty acids were 3-
hydroxy fatty acids (3-hydroxypalmitic acid, 3-hydroxymyristic acid and 3-hydroxycapric 
acid), which are typical of Pseudomonads (Saddler, 1994). Other 3 of the hydroxy fatty 
acids identified in dichloromethane extracts (5,8-DiHODE, 9,10-dihydroxystearic acid and 
9,10-epoxy-18-hydroxystereate, 5,8-DiHODE and 9,10-dihydroxystearic acid) had 
previously been identified in mushroom (Kang et al., 2013; Morris, 1968); while the 9,10-
epoxy-18-hydroxystearate had not previously been identified in mushroom, but it did in 
barley (Chamarthi et al., 2014). Two sphingolipids (viz., sphinganine and C16 sphinganine) 
were identified in dichloromethane extracts, in agreement with the literature that reports 
up to 10 glucosylceramides in Maitake mushrooms (Sugawara, Aida, Duan, & Hirata, 
2010). Dietary sphingolipids have gained attention because their potential to protect 
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intestine from inflammation (Duan & Nilsson, 2009). Other metabolites identified in 
dichloromethane extracts were indoles (formyl indole and indole-3-acetate) (Arnold, 
Palfner, Schmidt, Kuhnt, & Becerra, 2012; Muszyńska, Sułkowska-Ziaja, & Ekiert, 2013a). 
No essential compounds such as adenine, cyclo(L-phe-L-pro), 2,5-dihydrophenylalanine, 
4-hydroxybenzaldehydeand p-aminophenol were also identified in dichloromethane 
extracts. Adenine, p-aminophenol (Weijn et al., 2013), and 4-hydroxybenzaldehyde had 
previously been identified in mushroom (Papaspyridi et al., 2012). p-Aminophenol is, 
together with other phenols, associated to browning, thus producing the most common 
postharvest changes in button mushrooms, which often result in economic losses (Weijn et 
al., 2013). 4-Hydroxybenzaldehyde is a phytotoxic substance with allelopathic activity 
found in endophytic fungi Aspergillus sp. (Ren-Yi et al., 2015); cycle(L-Phe-L-Pro) is one 
of the compounds with higher involvement in the antifungal activity of Lactobacillus 
plantarum FST 1.7 (Dalbello et al., 2007), isolated from the Pseudomonas aeruginosa 
PAO1 strain; finally, 2,5-dihydrophenylalanine is a multipotent no proteinogenic amino 
acid produced by various actinobacterias and gammaproteobacterias (Crawford, 
Mahlstedt, Malcolmson, Clardy, & Walsh, 2011), but never identified in mushroom. 
 
3.5. Comparison of the metabolites tentatively identified in ethyl acetate extract 
with those in AbAEE and the other less polar extracts 
The analysis of the ethyl acetate extract allowed identification of 24 compounds 
versus the 90 compounds in AbAEE. Only 7 compounds —5 bases (adenine, guanine, 
hypoxanthine, xanthine and uracil), 1 sugar (mannitol), and 1 cinnamic acid derivative (p-
coumaric acid)— were tentatively identified in both samples. Therefore, 17 compounds —
viz., 7 fatty acids and derivatives, including palmitic and stearic acid, 2 fatty amides 
(oleamide and 13-docosenamide), 3 indoles, 1 quinoline derivative, 2 amino acids, 1 phenol 
derivative and 1 benzoic acid derivative— were exclusively identified in the ethyl acetate 
extract and 83 in AbAEE. Fig. 5C shows the Venn diagram comparing the detection 
coverage in AbAEE analysis versus that of the ethyl acetate extract. 
Only 3 out of the 24 compounds identified in the ethyl acetate extract were also 
identified in the hexane and dichloromethane extracts. Stearic acid and 2 fatty amides 
(oleamide and 13-docosenamide) were the compounds common to the three extracts. 
Palmitic acid was also identified in hexane, while 8 out of the 24 compounds identified in 
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the ethyl acetate extract were also identified in the dichloromethane extract, but no in the 
hexane extract. Four fatty acids derivatives (3-hydroxycapric acid, 5,8-DiHODE, 9,10-
dihydroxystearic acid and 9,10-epoxy-18-hydroxystereate), formyl indole, 2,5-
dihydrophenylalanine, adenine, and p-aminophenol were the compounds common to 
dichloromethane and ethyl acetate extracts. Among the 12 compounds tentatively 
identified in ethyl acetate but no in hexane or dichloromethane were 3 purines, 2 indoles, 
1 pyrimidine derivative, 1 fatty acid derivative, 1 amino acid, 1 quinoline derivative, 1 
monosaccharide, 1 benzoic acid derivative, and 1 cinnamic acid derivative. Purine bases 
(hypoxanthine, xanthine and guanine), and a pyrimidine derivative (uracil) were found in 
the ethyl acetate extract, in agreement with the literature (Kaneko, Aoyagi, Fukuuchi, 
Inazawa, & Yamaoka, 2014; Papaspyridi et al., 2012). 
 
 
Fig. 5. Venn diagrams comparing the compounds identified in A. bisporus aqueous 
enzymatic extract (AbAEE) with those in the (A) hexane extract, (B) dichloromethane extract, (C) 
ethyl acetate extract and (D) remaining aqueous phase with those in AbAEE. 
 
Other compounds identified in ethyl acetate extracts were indoles (indole-3-
carboxylic acid (Qian et al., 2014), and 5-hydroxyindolepyruvate). While indole-3-
carboxylic acid is an aromatic compound produced by fungi (Qian et al., 2014) valuable by 
pharmaceutical and food industries, 5-hydroxyindolepyruvate had not previously been 
identified in mushroom. Phenolic compounds such as benzoic acid (salicylic) and cinnamic 
acid derivatives (p-coumaric), which focus much attention due to their antioxidant activity, 
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also were tentatively identified in ethyl acetate extracts. These compounds had previously 
been identified by both LC–MS/MS and spectrophotometric tests in wild growing edible 
mushrooms (Nowacka et al., 2014). D-Mannitol, found in ethyl acetate extracts, is 
considered as a taste-active component in mushroom sugars and polyols (Pei et al., 2014). 
9,10,13-TriHOME is a metabolite of linoleic acid (an essential fatty acid) that had 
previously been identified in plants as rice (Chang et al., 2012), but no in mushrooms. Other 
compounds no previously identified in mushroom were anthranilic acid and 5,6-dihydroxy-
3-methyl-2-oxo-1,2,5,6-tetrahydroquinoline. 
 
3.6. Comparison of the metabolites tentatively identified in the high polar fraction 
(remaining aqueous phase) with AbAEE and the other extracts 
The analysis of the aqueous phase remaining after the extraction sequence allowed 
identification of 95 compounds versus 90 in AbAEE. Among them, 89 were common to 
both samples because of their aqueous nature. The fact that even after the extraction 
sequence more metabolites were identified in the remaining aqueous phase than in AbAEE 
can be explained by the higher dilution of the latter (5 times more diluted). Comparison 
between these two samples showed that 6 compounds —three amino acids (ornithine, 
lysine and arginine), 1 dicarboxylic acid (succinic acid), 1 monosaccharide (D-glucosamine 
6-phosphate) and 1 phenol (p-aminophenol)— were exclusively identified in the remaining 
aqueous phase and 1 compound (uracil) was identified in AbAEE, but no in the remaining 
aqueous phase (this compound was also identified in the ethyl acetate extract). Fig. 5D 
shows the Venn diagram comparing the metabolite coverage in AbAEE and in the aqueous 
solution after the extraction sequence. As can be seen, fractionation favors coverage as a 
less diluted sample allows identification of some low concentrated compounds. The 
removal of no polar and medium polar compounds during fractionation avoids potential 
ionization suppression in the remained aqueous phase caused by these compounds. Only 2 
(adenine and p-aminophenol) out of the 95 compounds identified in the remaining aqueous 
phase were also identified in ethyl acetate and dichloromethane extracts. 4-
Hydroxybenzaldehyde was also identified in dichloromethane extract, while 5 out of the 95 
compounds identified in the remaining aqueous phase were also identified in the ethyl 
acetate extract but no in the dichloromethane extract. Three purines (guanine, xanthine, 
and hypoxanthine), mannitol and p-coumaric acid were the compounds common to the 
ethyl acetate extract and the remaining aqueous phase. 
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Among the 87 compounds identified in the remaining aqueous phase, but no in 
dichloromethane and ethyl acetate extract were 1 alkaloid derivative, 2 alkylamines, 1 
pyrroline, 37 amino acids and derivatives, 2 peptides, 6 carboxylic acids and derivatives, 6 
monosaccharides, 2 disaccharides, 6 sugar acids and derivatives, 1 purine derivative, 1 
purine nucleoside derivative, 8 purine nucleotides and derivatives, 6 pyrimidine 
nucleotides and derivatives, 1 pyridine derivative, 2 fatty acids and conjugates, 2 
phospholipids and derivatives, 1 furan and 2 no metal oxoanionic compounds. 
Amino acids constitute a family of compounds identified by combining positive and 
negative ionization modes in the remaining aqueous phase. Two classes of amino acids 
were detected in this study: proteinogenic and no proteinogenic amino acids. Among the 
former are essential and no essential amino acids. The identified essential amino acids 
include isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and 
valine, which had previously been identified in mushroom using different protocols 
(O’Gorman, Barry-Ryan, & Frias, 2012). No essential amino acids such as tyrosine, aspartic 
acid, arginine, glutamate, glutamine, proline, serine, and asparagine had also been 
previously identified in mushroom (Mdachi, Nkunya, Nyigo, & Urasa, 2004), as did no 
proteinogenic amino acids such as ornithine (Valentaõ et al., 2005), citrulline, 
cystathionine (Ming, Li, Huo, Wei, & Chen, 2014), pipecolic acid (Kiyoto et al., 2008), and 
2-aminobutyric acid (Dembitsky, Terent’ev, & Levitsky, 2010). Interesting amino acids 
such as ergothioneine and carnitine had also been previously found in mushroom (Kim et 
al., 2009; Weigand-Heller, Kris-Etherton, & Beelman, 2012). Ergothioneine (an amino 
acid characteristic of fungi that cannot be produced by human cells) is a natural antioxidant 
with potential applications as a food additive (Cremades et al., 2015; Weigand-Heller et al., 
2012;). 
Regarding carnitine, about 80% of this compound is delivered by food. Intake of 
products rich in L-carnitine is of particular interest for people who are on a slimming diet 
as this compound may reduce the body weight. Agaritine, saccharopine and pyroglutamic 
acid are other amino acids found in the remaining aqueous phase, in agreement with 
previous studies (Cho, Jang, Park, & Park, 2008; Lu, Zeng-Tao, Yi, Xiao-Yan, & Yin-Bing, 
2012; Tomoko, Hiroko, Yasuo, & Tatsuyuki, 1999); while other amino acids and derivatives 
such as 3-amino-2-naphthoic acid, 3-amino-3-(4-hydroxyphenyl)propanoate, 5-
aminopentanoate, acetylcarnitine, cycloleucine, 2-aminoadipic acid, LL-2,6-
diaminoheptanedioate, N2-acetyl-L-ornithine, N6-acetyl-L-2,6-diaminoheptanedioate, N-
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carbamylglutamate and Nε-acetyl-L-lysine had not been previously identified in 
mushroom. Dipeptides such as γ-D-glutamylglycine and oxidized glutathione had been 
previously identified in mushroom (Maity et al., 2014; Oka, Tsuji, Ogawa, & Sasaoka, 1981). 
Other family detected in the remaining aqueous phase was sugars, among which 
stand essential monosaccharides such as α-D-glucose and no essential such as D-glucose 
6-phosphate, D-glucosamine 6-phosphate, D-mannitol 1-phosphate, sedoheptulose-7-
phosphate or sedoheptulose; disaccharides such as cellobionic acid or α-1,5-L-
arabinobiose; and sugar acids and derivatives such as galactonic acid, glucuronic acid, 
glyceric acid, xylonate, glycerol-2-phosphate or 2-dehydro-3-deoxy-L-arabinonate. Among 
these compounds only two (glucose and sedoheptulose) had previously been described in 
mushroom (Muszyńska et al., 2013b). Other sugars such as glucuronic acid had not been 
previously found in free form, but mushroom polysaccharides are formed from these sugars 
(Wasser, 2002). Many of the sugars identified in the remaining aqueous phase had not 
previously found in mushroom because most authors only had measured the total amount 
of sugars (Barros et al., 2008). 
Lipids, which can be metabolized as a primary energy source, constitute other 
super class of compounds identified in the remaining aqueous phase. Two classes of lipids 
were detected in this study: fatty acids and conjugates, and phospholipids and derivatives. 
Among the identified fatty acids and conjugates are 2-hydroxyisocaproic acid and ε-
capramine, which had not previously been identified in mushroom. Phosphocholine and 
glycerophosphocholine were the only phospholipids detected in the remaining aqueous 
phase, but there are in the literature no reports about the presence of these compounds in 
mushroom. 
Carboxylic acids were identified in AbAEE by the negative ionization mode. A 
monocarboxylic acid (lactic acid) was identified in mushroom, in agreement with the 
literature that detected this compound by 1H nuclear magnetic resonance spectroscopy 
(Park et al., 2013). Dicarboxylic acids such as malic, succinic and 2,2-dymethyl succinic 
were also confirmed in this analytical sample (Barros, Pereira, & Ferreira, 2013). Among 
them, the last was the only compound that had not previously been found in mushroom. 
Citric acid was the only tricarboxylic acid detected in the remaining aqueous phase, in 
agreement with previous studies (Barros et al., 2013). A carboxylic acid derivative such as 
3-hydroxy-3-methyl-glutaric acid was also identified in the remaining aqueous phase, but 
this compound had not previously been found in mushrooms. 
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Metabolites involved in the degradation of purine nucleosides such as uric acid 
were also detected in AbAEE, but uric acid had not previously been identified in 
mushrooms. 
Nucleotides, widely used in all types of cells for energy transfer in metabolic 
processes, constitute other family of compounds identified in the remaining aqueous phase. 
Two classes of nucleotides were detected in this study: purines and pyrimidines. Among 
the identified purine nucleotides —monophosphatenucleotides (AMP) (Ranogajec, 
Beluhan, & Šmit, 2010), 3´-AMP, N6-(1,2-dicarboxyethyl)-AMP, GMP (Mizuno, 1995), 
cGMP and diphosphatenucleotides (ADP) and GDP (Cheng et al., 2012), GDP-mannose)—
, those no previously identified in mushroom are N6-(1,2-dicarboxyethyl)-AMP, cGMP and 
GDP-mannose. Six pyrimidine nucleotides and derivatives with uracil (UMP, 2,3-cUMP, 
UDP-D-xylose, UDP-glucose, UDP-glucuronic acid and UDP-N-acetylglucosamine) were 
also identified in the remaining aqueous phase, but only UMP had previously been 
identified in mushroom (Ranogajec et al., 2010). Xanthosine was the only purine 
nucleoside derivative found, and it had previously been identified in mushroom (Ranogajec 
et al., 2010). 
Alkylamines such as spermidine and pantothenic acid had also been previously 
identified in mushroom (Mukhopadhyay & Guha, 2015) —the latter is a water-soluble 
vitamin essential for humans (Zempleni, Suttie, Gregory III, & Stover, 2013). Other water-
soluble vitamin found in the remaining aqueous phase was nicotinic acid (Papaspyridi et 
al., 2012). 
The rest of the compounds detected in the remaining aqueous phase (2-
methylpyrrolidine, 1-pyrroline, 2-furoic acid, phosphate and phosphite) have been 
identified in mushroom for the first time. 
 
4. Conclusions 
The in vitro inhibitory activity of AgAEE against the HCV protease NS3 makes the 
former a potential nutraceutical suitable for use as it is or as component of new functional 
foods, that could be used for prevention of HCV infection. 
Fractionation based on LLE with different extractants has been used for drastic 
improvement of the tentative identification coverage of metabolites in AbAEE. The 
possibility of either dilution or preconcentration of the fractions decisively contributed to 
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improve coverage. Table 1 shows all the tentatively identified metabolites, where those 
identified for the first time are highlighted in bold. In short, 55 out of the 123 tentatively 
identified metabolites have been identified in AbAEE and extensively in the edible 
mushroom A. bisporous (WBM) for the first time. The results confirm that fractionation 
improves the characterization of the WBM (A. bisporus) metabolome as some of the 
metabolites identified for the first time have been found in organic fractions —which can 
be attributed to the preconcentration step. Nevertheless, most of them have been found in 
both the AbAEE and remaining aqueous fraction, which strongly support that LC–QTOF 
MS/MS is a good strategy to analyze this fungus extracts. 
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Supplementary material 
 
 
Fig. S1. Fractionation of A. bisporus aqueous enzymatic extract (AbAEE) by sequential liquid–liquid 
extraction with three extractants. 
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Untargeted characterization of extracts from 
Cannabis sativa L. cultivars by gas and liquid 
chromatography coupled to mass spectrometry 
in high resolution mode 
 
M.M. Delgado-Povedano, C. Sánchez-Carnerero Callado, F. Priego-Capote, C. 
Ferreiro-Vera 
 
Abstract 
Elucidation of Cannabis composition is required to evaluate the potential of this 
plant for pharmacological uses, but also for implementation in breeding programs with 
agronomical purposes. The aim of the present study was to develop a method for 
untargeted analysis of polar and no polar Cannabis extracts. For this purpose, extracts from 
17 cultivars of Cannabis sativa L. were analyzed by gas chromatography–time-of-
flight/mass spectrometry (GC–TOF/MS) and liquid chromatography quadrupole time-of-
flight tandem mass spectrometry (LC–QTOF MS/MS) in high resolution mode. One 
hundred sixty-nine compounds were identified in the extracts by searching MS and MS/MS 
information. Among identified families, there were mainly cannabinoids, terpenoids, lipids 
and flavonoids, but also some interesting compounds such as amino and organic acids, 
among others. Relative contents of terpenoids and cannabinoids in the same cultivars 
grown in greenhouse and field were compared. Compositional differences in the profile of 
terpenoids and cannabinoids between both types of grown conditions were found. 
Keywords: Cannabis sativa L. metabolome, gas chromatography–mass spectrometry, 
liquid chromatography–mass spectrometry, cannabinoids, terpenoids, Cannabis sativa L. 
varieties. 
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1. Introduction 
The Cannabaceae is a family of flowering plants that includes 10 genera and 117 
accepted species [1]. Among them, Cannabis has been the most widely studied because of 
its pharmacological and psychoactive properties. Cannabis is used in the treatment of 
disorders such as migraine, spastic and pain disorders, and glaucoma as ocular 
hypotensive. Countries such as Canada, Germany, Israel, the Netherlands and more than 
50% of the United States have fully authorized the medical application of herbal Cannabis 
[2]. The pharmacological properties of Cannabis have been traditionally ascribed to the 
presence of cannabinoids [3–5]. However, there are some evidences regarding the 
differential effects of Cannabis preparations as compared to only cannabinoids [6]. 
Most analytical studies on characterization of Cannabis plants were targeted at the 
detection of two chemical families: cannabinoids and terpenoids. Cannabinoids are a 
family of compounds produced from fatty acids and isoprenoids precursors that are specific 
of Cannabis. They are primarily found in the resin produced in the glandular trichomes of 
pistillate (female) inflorescences [7]. On the other hand, terpenoids are other family of 
isoprenoids compounds found in plants, which are responsible for protecting them from 
predators and attract pollinating insects for propagation. The variety of monoterpenes and 
sesquiterpenes contained in Cannabis resin contribute to the scent of flowers and to the 
unique flavor qualities of Cannabis products. [7]. Pharmacologically, they have been 
implicated in influencing the properties of the cannabinoids, possibly by an entourage 
effect [8]. 
The analysis of both chemical families has been addressed with different analytical 
platforms [9], mainly by a combination of gas chromatography and liquid chromatography 
coupled to mass spectrometry (GC–MS, LC–MS) [10–13]. Concerning cannabinoids, a 
recent method based on GC–tandem mass spectrometry (MS/MS) allowed detecting seven 
trialkylsilylated cannabinoids in Cannabis-type ruderalis plant tissues [14]. Derivatization 
is a frequent step prior to GC separation of cannabinoids. Thus, different derivatization 
agents have been tested for the fast determination of 9 cannabinoids by GC–MS [12].  
LC–MS/MS has also provided optimum response in cannabinoids analysis. A 
recent research allowed detecting 94 phytocannabinoids in 10 species by LC–MS/MS with 
electrospray ionization [15]. This method was used to profile the most commonly used 
Cannabis plants prescribed to patients in Israel. In other study, 6 cannabinoids 
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[cannabidiol (CBD), δ9‐tetrahydrocannabivarin (Δ9‐THCV), cannabigerol (CBG), 
cannabinol (CBN), δ9‐tetrahydrocannabinol (Δ9‐THC) and δ9‐tetrahydrocannabinolic 
acid (Δ9‐THCA)] from 30 strains of Cannabis sativa were determined by LC–MS [16]. 
Terpenoids are mainly analyzed by GC–flame ionization detection (GC–FID) or 
GC–MS based on their high volatility [17,18]. In a recent study, 16 terpenoids were 
identified by GC–MS and quantified by GC–FID [19]. Additionally, some studies have been 
focused on the combined analysis of terpenoids and cannabinoids. In one of them, 23 
terpenoids (both monoterpenoids and sesquiterpenoids), and 9 cannabinoids were 
quantitatively determined in 11 Cannabis varieties by GC–FID [20]. The evolution of 8 
major cannabinoids and 28 terpenes during the growth of Cannabis sativa plants for 22 
weeks was studied in another research by LC–diode array detection (HPLC–DAD) and GC–
FID, respectively [21]. 
In addition to cannabinoids and terpenoids, there are scant studies dealing with 
other compounds in Cannabis. Five phenolic compounds (quercetin, gallic acid, p-
coumaric acid, m-coumaric acid and cinnamic acid) were identified in Cannabis plants by 
LC–UV spectrophotometry [22]. 
The development of untargeted strategies for characterization of Cannabis plant 
material is so far limited. In a recent study, 9 amino acids, 6 sugars, 4 cannabinoids, 4 
carboxylic acids and choline were identified in chloroform and aqueous extracts of 
Cannabis sativa trichomes by nuclear magnetic resonance (NMR) spectroscopy [23]. Also, 
18 compounds such as pamine and tyramine derivatives, among others, were identified in 
hemp (Cannabis sativa L.) seeds by NMR [24]. LC–MS was the selected platform for 
identification of 8 compounds in Cannabis sativa L. leaves to evaluate the effect of UV-C 
radiation on their metabolites [25]. 
Clearly, more research on Cannabis composition is demanded to assess its 
potential for pharmacological use, but also to implement breeding programs with 
agronomical purposes. With these premises, the aim of the present study was to develop a 
method for untargeted metabolomics analysis of polar and no polar Cannabis extracts. For 
this purpose, two analytical platforms —gas chromatography–time-of-flight/mass 
spectrometry (GC–TOF/MS) and liquid chromatography quadrupole time-of-flight 
tandem mass spectrometry (LC–QTOF MS/MS)— were used to maximize the detection 
coverage. 
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2. Experimental 
 
2.1. Reagents and chemicals 
LC–MS grade methanol and n-hexane from Sigma–Aldrich (St. Louis, MO, USA) 
were used for standards preparation and sample treatment. LC–MS grade acetonitrile 
(ACN) from Thermo Fisher Scientific (Pittsburgh, PA, USA) and MS grade formic acid (FA) 
from Scharlab (Barcelona, Spain) were used to prepare the chromatographic mobile 
phases for LC–MS/MS analysis. Deionized water (18 mΩ · cm) from a Millipore Milli-Q 
water purification system (Bedford, MA, USA) was used to prepare the aqueous solutions. 
Pyridine, bis-(trimethylsilyl) fluoroacetamide (BSTFA) and trimethylchlorosilane 
(TMCS) from Sigma–Aldrich were the solvent and silylation agents in the derivatization 
step. MS-grade perfluorotri-n-butylamine (PFTBA) from Agilent Technologies (Santa 
Clara, CA, USA) was used for daily mass calibration. A standard mixture containing 10 
linear alkanes from C10 to C40 designed for performance tests in GC from Sigma–Aldrich 
was used to establish the retention index (RI) calibration model. Standards of kaempferol, 
kaempferol-7-glucoside, vitexin, vitexin-2-rhamnoside, quercetin, quercetin-3-
galactoside, luteolin-6-glucoside (homoorientin), diosmetin, apigenin, rutin, naringenin, 
luteolin, naringin, procyanidins A2, B1 and B2, maltose, sucrose, lactose, glucose, stearic 
acid and pyroglutamic acid from Sigma–Aldrich and Extrasynthese (Lyon, France) were 
used to confirm the identification of flavonoids, sugars and other compounds in the 
extracts. 
Standards of cannabidivarin (CBDV), Δ9-THCV, CBD, cannabicyclol (CBL), 
cannabidivarinic acid (CBDVA), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), 
cannabichromene (CBC), δ8-tetrahydrocannabinol (Δ8‐THC), Δ9‐THC, CBG, CBN and 
THCA from Cerilliant (Darmstadt, Germany) were used to confirm the identification of 
cannabinoids. Finally, standards of  α-pinene, (-)-β-pinene, (-)-camphene, sabinene, β-
myrcene, α–phellandrene, 3-carene, p-cymene, limonene, eucalyptol, trans-β-ocimene, β-
ocimene, γ-terpinene, linalool, (+)-fenchol, (+)-camphor, isopulegol, (-)-borneol, menthol, 
α-terpineol, dihydrocarveol, nerol, citronellol, R-(+)-pulegone, cis-citral, geraniol, trans-
citral, longipinene, β-elemene, cedrene, trans-(-)-caryophyllene, aromadendrene, 
valencene, cis-nerolidol, farnesene, caryophyllene oxide, guaiol, β-eudesmol, α-bisabolol, 
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trans-trans-farnesol, cis-phytol and trans-phytol from Sigma–Aldrich were used to 
confirm the identification of terpenoids. 
 
2.2. Instruments and apparatus 
An Agilent 1200 Series LC system coupled to an Agilent 6540 UHD Accurate-
Mass QTOF hybrid mass spectrometer was used for LC–MS/MS analysis. This approach 
was equipped with a dual electrospray ionization (ESI) source (Santa Clara, CA, USA) for 
simultaneous spraying of a mass reference solution to calibrate continuously 
detected m/z ratios.  
Complementarily, an Agilent 7890A Series GC system coupled to an Agilent 7200 
UHD Accurate-Mass QTOF hybrid mass spectrometer equipped with electron impact (EI) 
source was also used for analysis.  
Both instrumental configurations were controlled through MassHunter GC–QTOF 
and LC–QTOF acquisition softwares (version B.06 and B.07, respectively, from Agilent 
Technologies). 
 
2.3. Samples and preparation of extracts  
Samples formed by leaves and inflorescences collected from 17 cultivars of 
Cannabis plants (3 biological replicates) were supplied by Phytoplant Research S.L., which 
is authorized by the Spanish Agency of Medicines and Medical Devices (AEMPS). Some of 
these plants are asexually propagated medicinal varieties registered by the company in the 
Community Plant Variety Office (CPVO) (http://cpvo.europa.eu/en) and identified with 
denomination proposals and application numbers: ‘Aida’, 50012; ‘Beatriz’, 50014; ‘Divina’, 
50045; ‘Juani’, 50011; ‘Magda’, 50011; ‘Mati’, 50015; ‘Moniek’, 50008; ‘Octavia’, 50016; 
‘Pilar’, 50009; ‘Sara’, 50007 and ‘Theresa’, 50009; while other genotypes and hybrids, 
obtained as a result of an internal breeding program, and modern industrial hemp varieties 
were also analyzed. Table 1 lists the cultivars selected for this study, the growing conditions 
and locations. Five cultivars were only grown indoor with photosynthetic active radiation 
(PAR) light exposition according to the legislation due to their high THC concentration. 
Other cultivars were grown in high tunnels in field or in high technology greenhouses. 
Irrigation doses, plant densities and sowing times were applied to each cultivar to maximize 
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the agronomic performance. Four cultivars (namely, ‘Aida’, ‘Juani’, ‘Pilar’ and ‘Theresa’) 
were grown in field and in greenhouse. They were used to evaluate the influence of the 
growing conditions on the composition of extracts. 
 
Table 1. List of the cultivars and growing conditions. 
Code Cultivar Growing conditions 
Theresa SCAI-6 Theresa Greenhouse 
Theresa IFAPA 2016 Theresa Field 
Pilar flores SCAI-6 Pilar Greenhouse 
Pilar IFAPA 2016 Pilar Field 
Aida SCAI-5 Aida Greenhouse 
Aida IFAPA 2016 Aida Field 
Sara IFAPA 2016 Sara Field 
Juani SCAI-5 Juani Greenhouse 
Juani IFAPA 2016 Juani Field 
Octavia IFAPA 2016 Octavia Field 
Mati (flor + hoja) Mati Indoor 
Beatriz (flor + hoja) Beatriz Indoor 
Magda 34/2 flor estándar Magda Indoor 
Moniek flor standariz Moniek Indoor 
Divina Divina Indoor 
H6 IFAPA 2016 H6 Field 
H7 IFAPA 2016 H7 Field 
Ermes (Appendino) 2017 Ermes Field 
Carma (Appendino) 2017 Carma Field 
Carmagnola (Appendino) 2017 Carmagnola Field 
Futura (Appendino) 2017 Futura Field 
 
Samples of the selected plant material were processed using the same protocol. A 
30 cm part of each plant containing leaves and at least one female inflorescence was 
collected to get around 30 g of fresh vegetal material. Plant samples were oven dried at 40 
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ºC  (J. P. Selecta model Conterm 2000210, Barcelona, Spain) for 72 h, and the stems and 
seeds of more than 2 mm in size were removed.  
Powdered plant materials (100 mg) were extracted with 5 mL of n-hexane or 
methanol for GC or LC analysis, respectively, placed in an ultrasound bath at 37 kHz and 
800 W, for 20 min, and centrifuged for 5 min at 2121×g. Then, the supernatants were 
collected and stored at –80 ºC until analysis. 
 
2.4. Sample preparation 
Different dilutions of the raw methanol and hexane extracts were tested prior to 
analysis. For derivatization, 300 µL of each 1:1000 diluted hexane extract was evaporated 
to dryness, reconstituted by 270 µL of BSTFA + TMCS (98:2 v/v) + 30 µL of pyridine, and 
maintained at 37 ºC for 1 h. Finally, the derivatized mixture was located in a new glass 
insert for analysis. 
 
2.5. LC–QTOF MS/MS analysis 
LC separation and QTOF detection were used for analysis of the methanol extracts. 
Chromatographic separation was performed using a C18 reverse-phase analytical column 
(Mediterranean, 25 cm×0.46 cm i.d., 3 µm particle size) from Teknokroma (Barcelona, 
Spain), which was thermostated at 34 ºC. The mobile phases were water with 5% ACN 
(phase A) and ACN with 5% water (phase B) both with 0.1% FA as ionization agent. The LC 
pump was programmed at a flow rate of 0.7 mL/min with the following elution gradient: 
4% phase B as initial mobile phase was kept constant since min 0 to 1; then, the percentage 
of phase B was increased from 4 to 20% since min 1 to 5, from 20 to 70% of phase B since 
min 5 to 10, from 70 to 90% of phase B since min 10 to 20, from 90 to 100% of phase B 
since min 20 to 32 and finally 100% phase B was kept constant since min 32 to 42. A post-
time of 10 min was set to equilibrate the initial conditions for the next analysis. The 
injection volume was 5 µL and the injector needle was washed between injections with 80% 
methanol for 10 s. The parameters of the electrospray ionization source, operating in 
negative and positive ionization modes, were as follows: the capillary and fragmentor 
voltage were set at ±3.5 kV and 175 V, respectively; N2 in the nebulizer flowed at 40 psi; the 
flow rate and temperature of the N2 as drying gas were 10 L/min and 325 ºC, respectively. 
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The instrument was calibrated and tuned according to procedures recommended by the 
manufacturer. MS and MS/MS data were collected in both polarities using the centroid 
mode at a rate of 2.4 spectra/s. Accurate mass spectra in MS scan and MS/MS mode were 
acquired in the m/z range 60–1100. The instrument gave typical resolution 15000 FWHM 
(full width at half maximum) at m/z 118.0862 and 30000 FWHM at m/z 922.0098. To 
ensure the desired mass accuracy of recorded ions, continuous internal calibration was 
performed during analyses by using the signals at m/z 121.0509 (protonated purine) and 
m/z 922.0098 [protonated hexakis (1H,1H,3Htetrafluoropropoxy) phosphazine or HP-
921] in the positive ionization mode, while in negative ionization mode ions with m/z 
119.0362 (proton abstracted purine) and m/z 966.0007 (formate adduct of HP-921) were 
used. The samples were injected in auto MS/MS acquisition mode to obtain information 
on the product ion of the most relevant compounds. The number of precursors selected per 
cycle was set at 2, with an exclusion window of 0.1 min after two consecutive selections of 
the same precursor. Two collision energies (20 and 40 eV) were used to obtain the 
fragmentation information for each entity. Three replicates of each analytical sample were 
analyzed to improve the quality of the results.  
 
2.6. GC–TOF/MS analysis 
The hexane extracts were analyzed by GC–TOF/MS by setting the ionization 
voltage at 70 eV. Chromatographic separation was carried out with a fused silica DB-5MS-
UI 30 m×0.25 mm i.d.×0.25 μm film thickness capillary column. The GC oven temperature 
program started at 50 °C with several consecutive temperature ramps: from 2 ºC/min to 
104 ºC (27 min held), from 20 ºC/min to 120 ºC (0.8 min held), from 4 ºC/min to 160 ºC 
(10 min held), from 25 ºC/min to 232 ºC (2.9 min held), from 1.5 ºC/min to 242 ºC (6.7 
min held), from 2 ºC/min to 250 ºC (4 min held), from 25 ºC/min to 300 ºC (2 min held), 
temperature that was kept constant for 10 min. A post-run time was programmed for 4 min 
up to 310 ºC to assure complete elution of the injected sample. One μL of sample was 
injected by splitless injection mode at 250 °C using ultrapure grade helium as carrier gas at 
1 mL/min. The transfer line, ion source and quadrupole temperatures were set at 305, 305 
and 200 °C, respectively. A solvent delay of 3 min was used to prevent damage of the ion 
source filament. The TOF detector was operated at 7 spectra/s in the mass range m/z 50–
750 and the resolution was 7500 (full width half maximum, FWHM) at m/z 501.9706. Daily 
mass calibration was performed with PFTBA. All samples were injected in triplicate. 
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In addition, the described method was adapted for the analysis of the derivatized 
solutions using pulse divided injection (1:10 split ratio) of one μL of the given solution at 
250 °C, and changing the solvent delay of the original method to 5.5 min to avoid filament 
damage.  
 
2.7. LC–QTOF MS/MS data processing and statistical analysis 
MassHunter Workstation software (version B7.00 Qualitative Analysis, Agilent 
Technologies, Santa Clara, CA, USA) was used to process the data obtained by LC–QTOF 
in auto MS/MS mode. Treatment of raw data files started by extraction of potential 
molecular features (MFs) with the suited algorithm included in the software. For this 
purpose, the extraction algorithm considered all ions with maximum charge state of 2 
exceeding 400 and 500 counts for negative and positive ionization modes, respectively. 
These cut-off values were established taking into account the chromatographic background 
noise. Additionally, the isotopic distribution to consider MFs as valid should be defined by 
two or more ions (with a peak spacing tolerance of m/z 0.0025, plus 7.0 ppm in mass 
accuracy). In the search criteria for MFs, ions and adducts formation in the positive (+ H, 
+ Na) and negative (− H, + HCOO, + Cl) ionization modes, as well as neutral loss by 
dehydration were included to identify features corresponding to the same potential 
metabolite. Background contribution was removed by subtraction of MFs linked to 
plasticizers, solvent impurities and other contaminants after analysis of a blank of pure 
methanol. 
Identification of the compounds was supported on MS and MS/MS information 
and search in the METLIN MS and MS/MS databases (http://metlin.scripps.edu), the 
Human Metabolome Database (HMDB, 4.0 version), the Metfrag database 
(https://msbi.ipb-halle.de/MetFrag/) based on mass spectra of metabolites generated by 
in silico fragmentation, and on a metabolites library generated in previous research [26] 
using in all cases the MFs obtained in the present research. In addition, standard solutions 
were used to confirm the presence of identified compounds. 
In a next step, the “Batch Targeted Feature Extraction” algorithm from the 
MassHunter Workstation software (version B8.00 Profinder, Agilent Technologies, Santa 
Clara, CA, USA) was used to extract and align peaks, from all chromatograms, that matched 
a database of the identified metabolites. The isotopic distribution for a valid feature had to 
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be defined by two or more ions, with a peak spacing tolerance of 0.0025 m/z, plus 7.0 ppm. 
The features were aligned by using a tolerance window of 0.30 min and a mass accuracy of 
10 ppm for retention times (RTs) and m/z values, respectively, across all data files. Each 
extracted ion chromatogram was individually examined, and potentially incorrect 
assignments and integrations were manually verified. A table with the peak area of all 
identified compounds in the different samples was thus obtained.  
 
2.8. GC–TOF/MS data processing and statistical analysis 
Unknown Analysis software (version 7.0, Agilent Technologies, Santa Clara, CA, 
USA) was used to process the data files obtained by GC–TOF/MS in full scan mode. Then, 
MassHunter Workstation software (version B7.00 Qualitative Analysis, Agilent 
Technologies, Santa Clara, CA, USA) was used to treat all data files. Treatment of raw data 
files started by deconvolution of chromatograms to obtain a list of MFs considered as 
potential compounds defined by the m/z value of one representative ion for each 
chromatographic peak and its RT. For this purpose, the deconvolution algorithm was 
applied to each sample by considering all ions, the accuracy error at 50 ppm and the 
window size factor at 200 units. The background spectrum was subtracted to the spectrum 
obtained from each sample before its deconvolution. 
Tentative identification of compounds was firstly performed by searching MS 
spectra in the NIST11 database. Only identifications with a match factor and a reverse 
match factor higher than 700 were considered. The RI values included in the National 
Institute of Standards and Technology (NIST) database also supported identifications. For 
this purpose, an RI calibration model for each method was built by plotting the RT obtained 
by analysis of the alkane standard mixture (C10 to C40 with an even number of carbons) 
with the chromatographic method used in this research and the RI values provided for each 
alkane by the NIST database. The equations thus obtained were used to experimentally 
estimate the RI value for each identified compound, which must be less than 100 units 
different from the theoretical value provided by the NIST. This database does not contain 
high resolution MS information as provided by the TOF detector; therefore, a third step 
was included to validate identification of each compound by high resolution MS. Thus, the 
molecular formula for the tentative ion [M]+ and the most intense fragments for each MF 
should fit the NIST identification by setting a cut-off value in mass accuracy of 10 ppm. 
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Background contribution was removed by subtraction of MFs linked to plasticizers, solvent 
impurities and other contaminants after analysis of a blank of pure hexane. 
In addition, the multistandard solutions of terpenoids and cannabinoids were 
injected to confirm their identification in the extracts. 
Finally, the MassHunter Workstation software (version 7.0, Quantitative Analysis, 
Agilent Technologies, Santa Clara, CA, USA) was used to reintegrate all metabolites found 
in all analyzed samples, using the corresponding characteristic quantifier and qualifiers. A 
table with the peak area of all identified compounds in the different samples was obtained 
and combined with those from LC–MS/MS data. 
PASW Statistics 18 (version 18.0.0) was used to statistically analyze the differences 
in the content of cannabinoids and terpenoids among different varieties of cultivars and 
cultivation. 
 
3. Results and discussion 
 
3.1. Identification of compounds in Cannabis 
Polar extracts of Cannabis were analyzed by LC–QTOF MS/MS, while no polar 
extracts were characterized by GC–TOF/MS. 1:40 (v/v) dilution factor was the most 
suitable for analysis of polar extracts in positive ionization mode, while 1:100 (v/v) was 
selected for negative polarity. In the case of no polar extracts, 1:50 (v/v) dilution factor was 
the most suitable for direct analysis by GC–TOF/MS, while 1:1000 (v/v) was adopted for 
analysis after derivatization. Supplementary Figs. 1 and 2 show the total ion 
chromatograms (TICs) provided by LC–MS/MS analysis in the two ionization modes and 
GC–MS, for the derivatized and underivatized extracts.  
Tentative identification of MFs using MS and MS/MS data in high resolution mode 
led to a total number of 169 compounds with an accuracy error below 8.4 ppm. The 
identified compounds and the main parameters that support the identification are listed in 
Supplementary Tables 1-to-3. Most of the compounds were identified in the no polar 
extract, with special emphasis on neutral cannabinoids, terpenoids and lipids. On the other 
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hand, most of the compounds detected in the polar extract were cannabinoids and 
terpenoids, but, in addition, a high number of flavonoids were exclusively identified in the 
polar extract. Other minor families were also detected in Cannabis extracts, hydrocarbons 
and benzenoids in no polar extracts and carbohydrates in polar extracts. 
Compounds reporting the most intense chromatographic peaks both in the polar 
and no polar extracts of Cannabis were mainly cannabinoids. Some terpenoids such as 
limonene, trans-(-)-caryophyllene, caryophyllene, β-myrcene and α-pinene were also 
detected with high intensity in the no polar extracts, in agreement with a previous study 
[27]. Additionally, some long-chain fatty acids such as C16:0 and C18:0 also provided high 
intense peaks in the derivatized extracts. 
The chemical distribution of identified compounds was as follows: 22 
cannabinoids, 70 terpenoids, 31 lipids, 16 flavonoids, 6 amino acids, 5 organic acids, 4 
benzenoids, 4 organic oxygen compounds, 3 hydrocarbons, 3 carbohydrates, 2 
organoheterocyclic compounds, 2 organonitrogen compounds and 1 alkaloid. Among them, 
134 metabolites were identified in the no polar extracts by GC‒TOF/MS, while 46 
compounds were identified in the polar extracts by LC‒QTOF MS/MS. Eleven of the 
cannabinoids identified by LC‒QTOF MS/MS in the polar extracts where also identified in 
the no polar extracts by GC‒TOF/MS. Supplementary Tables 1 and 2 show the list of the 
134 compounds identified in the no polar extracts, which included mainly cannabinoids 
(20), terpenoids (69) and lipids (27). Most of these compounds (100), especially 
cannabinoids and terpenoids, were identified in the diluted underivatized extracts; while 
other 39 compounds (mainly lipids and organic acids) were identified in the derivatized 
extracts. Five of these 39 compounds were identified in both extracts. The identification of 
11 cannabinoids (CBDV, Δ9-THCV, CBD, CBC, Δ8‐THC, Δ9‐THC, CBG, CBN, CBL, CBDVA 
and THCA) and 28 terpenes was confirmed with standards. 
Complementarily, compounds identified in the polar extracts by LC‒QTOF MS/MS 
included 16 flavonoids, 13 cannabinoids, 6 amino acids, 4 lipids, 2 carbohydrates, 1 
alkaloid, 1 indole, 1 organonitrogen compound, 1 terpenoid and 1 urea derivative. 
Supplementary Table 3 shows the parameters supporting these identifications. Most of 
them, especially flavonoids and acid cannabinoids, were better identified in negative 
polarity, while neutral cannabinoids could be easily identified in both polarities. On the 
other hand, most amino acids and a miscellaneous group of compounds including one 
glycerophospholipid, one choline derivative, one alkaloid, one indole and one urea 
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derivative were identified in positive ionization. In this case, the identification of 13 
cannabinoids, 9 flavonoids and carbohydrates (CBDVA, CBDV, CBDA, CBG, CBGA, CBD, 
THCV, CBN, Δ8-THC, Δ9-THC, CBC, CBL, THCA, apigenin, quercetin, quercetin 3-
galactoside, kaempferol-7-glucoside, luteolin-6-C-glucoside, diosmetin, vitexin, vitexin-2-
rhamnoside, procyanidin B2, maltose and sucrose) was confirmed with standards. The rest 
of the compounds (22) were tentatively identified by the above-named metabolomics 
libraries. 
 
3.2. Cannabinoids 
Phytocannabinoids are synthesized in Cannabis in secretory cells inside glandular 
trichomes, which are more concentrated in unfertilized female flowers prior to senescence 
[28,29]. Geranyl pyrophosphate, formed via the deoxyxylulose pathway in Cannabis [30], 
is a precursor of phytocannabinoids (Fig. 1). 
The 22 cannabinoids identified in the extracts from Cannabis, classified into the 
main families of phytocannabinoids [31], include: 1) CBG type, 2) CBC type, 3) CBD type, 
4) (-)-Δ9-trans-THC type, 5) (-)-Δ8-trans- THC type, 6) CBL type, 7) cannabielsoin (CBE) 
type, 8) CBN type, 9) cannabinodiol type, 10) cannabitriol type, and 11) miscellaneous type. 
Only the last two families did not report any identified compound.  
The cannabinoids identified by analysis of no polar extracts were neutral 
cannabinoids, while two acid cannabinoids were identified after derivatization. Eighteen 
neutral cannabinoids were identified in the diluted underivatized extracts. The most 
concentrated neutral cannabinoids CBC, CBD, CBDV, CBG, CBN, ∆8-THC, ∆9-THC and 
∆9-THCV were confirmed with standards. Other cannabinoids such as cannabinerol, CBE, 
CBL, cannabigerovarin (CBGV), isomers of CBC, an isomer of ∆8-THC, an isomer of ∆9-
THCV and isomers of ∆9-THC were tentatively identified.  
Seven cannabinoids were identified after silylation. Five of them were neutral 
cannabinoids (CBDV, CBD, CBL, ∆9-THC and CBN), which were also previously identified 
without derivatization; while THCA and CBDVA were acid cannabinoids additionally 
identified in no polar extracts. All of them were confirmed with standards. 
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Supplementary Fig. 3 shows the MS spectra obtained after direct analysis of the 
cannabinoid standards by GC–MS: CBDV (A), ∆9-THCV (B), CBD (C), CBC (D), ∆8-THC 
(E), ∆9-THC (F), CBG (G) and CBN (H). Among them, only CBDV and ∆9-THCV reported 
the product ion at m/z 203.1079 as representative fragment. Other cannabinoids such as 
CBD, CBC, ∆8-THC, ∆9-THC gave the product ion at m/z 231.1397 as the largest fragment, 
also present in the MS spectrum of CBG. The fragment at m/z 299.2022 was the top 
product ion in ∆9-THC, while ions at m/z 295.1707 and 193.1238 were the representative 
fragments for CBN and CBG, respectively.  
Some minor fragments characteristic for cannabinoids were detected at m/z 
174.0678, 193.1217, 231.1397 and 271.1692 (Supplementary Fig. 3). In fact, m/z 174.0678, 
231.1397 and 271.6920 were found in CBDV, ∆9-THCV, CBD, CBC, CBG, ∆8-THC and ∆9-
THC. The fragment at m/z 193.1238 was found in CBD, ∆8-THC, ∆9-THC, CBG and CBN. 
Supplementary Fig. 4 shows the MS spectra of ten tentatively identified 
cannabinoids [an isomer of ∆9-THCV (cannabinoid 1), an isomer of CBC (cannabinoid 2), 
CBGV (cannabinoid 3), CBL (cannabinoid 4), an isomer of ∆8-THC (cannabinoid 5), 
isomers of ∆9-THC (cannabinoids 6 and 9), CBE (cannabinoid 7), isomer of CBC 
(cannabinoid 8), and cannabinerol (cannabinoid 10)].  
The cannabinoids identified in polar extracts by LC–MS/MS were neutral (9) and 
acid (4) cannabinoids. All of them were confirmed with standards (CBDV, CBG, CBD, 
THCV, CBN, Δ8-THC, Δ9-THC, CBC, CBL, CBDVA, CBDA, CBGA and THCA). Acid 
cannabinoids were identified by LC–MS/MS in negative ionization mode as [M−H]−. Also, 
two neutral cannabinoids, such as CBL and CBN, were better identified by LC–MS/MS in 
negative ionization mode, while the rest (7) were better identified using positive ionization 
mode. However, all of them were detected in both polarities, except THCV. 
Also, all of them were previously identified by GC–MS, except CBDA and CBGA. 
CBDA is the precursor of CBD, which gave the most intense peak. It is remarkable that 
other cannabinoids were also detected by LC–MS/MS in the chromatographic retention 
interval 19 to 37 min. Cannabinoids fragmentation pattern is quite similar; therefore, 
identification of cannabinoids based only on MS/MS information is not a reliable process. 
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3.3. Terpenoids 
Terpenoids constituted the second major family of identified compounds in 
Cannabis samples. It is remarkable that volatile terpenoids provide the characteristic 
aroma to Cannabis [8]. Terpenoids are formed also in secretory cells inside glandular 
trichomes that are much more concentrated in unfertilized female flowers prior to 
senescence [28,29]. Geranyl pyrophosphate is synthesized in Cannabis as a precursor via 
the deoxyxylulose pathway [30], being the precursor of phytocannabinoids and terpenoids 
(Fig. 1). Geranyl pyrophosphate may form monoterpenoids such as limonene, among 
others, in secretory cell plastids, or couple with isopentenyl pyrophosphate in the 
cytoplasm to form farnesyl pyrophosphate, precursor of sesquiterpenoids. This explains 
the fact that most identified terpenoids were monoterpenoids and sesquiterpenoids (20 
and 65%, respectively). In addition, two diterpenoids and three triterpenoids were 
tentatively identified. 
The identified monoterpenoids included three acyclic monoterpenes (cis-β-
ocimene, trans-β-ocimene and β-myrcene), five monocyclic monoterpenes (p-cymene, α-
phellandrene, β-terpinene, γ-terpinene and limonene), two monocyclic monoterpene 
alcohols (menthol and α-terpineol), three bicyclic monoterpenes (α-pinene, β-pinene and 
camphene), two bicyclic monoterpene alcohols (borneol and fenchol) and one bicyclic 
monoterpene ether (eucalyptol). 
One of the diterpenoids identified, an acyclic diterpene alcohol, was trans-phytol, 
which is present in Cannabis extracts as a breakdown product of chlorophyll and 
tocopherol. It is an aromatic compound used widely in cosmetics as ingredient of many 
fragrances [32], and studied in medicine due to its antioxidant activity [33]. The other 
diterpenoid identified was carnosol, a phenolic diterpene, which was the only terpenoid 
identified by LC–QTOF MS/MS in negative ionization mode due to the presence of 
hydroxyl groups. 
Identified sesquiterpenoids included one acyclic sesquiterpene (farnesene), two 
acyclic sesquiterpene alcohols (cis-nerolidol and trans-trans-farnesol), five monocyclic 
sesquiterpenes (β-elemene, α-curcumene, β-curcumene, β-sesquiphellandrene and α-
humulene), one monocyclic sesquiterpene ether (caryophyllene oxide), one monocyclic 
sesquiterpene alcohol (α-bisabolol), sixteen bicyclic sesquiterpenes (two caryophyllene 
isomers, cis- and trans-α-bergamotene, β- and γ-selinene, β- and γ-guaiene, two guaia-
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1(10),11-diene isomers, selina-3,7(11)diene, cedrene, valencene and trans-caryophyllene, 
among others), three bicyclic sesquiterpene alcohols (guaiol, β-eudesmol and γ-eudesmol), 
seven tricyclic sesquiterpenes (two cedrane isomers, di-epi-α-cedrene, a longipinene 
isomer, (-)-aristolene, aromadendrene and cis-thujopsene) and two tricyclic sesquiterpene 
ethers. Furthermore, one triterpene (squalene) and two triterpene alcohols (α-amyrin and 
β-amyrin) were identified in the extracts. 
Most terpenoids were identified in no polar extracts by GC–TOF/MS, except for 
carnosol. The identification of terpenoids is a challenging task favored by comparison of 
their RTs with those provided by standards due to the similarity of MS spectra. Terpenes 
show representative common fragments due to the structure formed by isoprene units. 
Some examples of the most characteristic fragments are shown in Supplementary Fig 5. 
Thus, most terpenes yield fragments at m/z values of 51.0235 [C4H3]+, 65.0391 [C5H5]+, 
69.0704 [C5H9]+, 77.0391 [C6H5]+, 79.0548 [C6H7]+, 91.0548 [C7H7]+, 93.0704 [C7H9]+, 
107.0861 [C8H11]+, 121.1017 [C9H13]+. Most sesquiterpenes produce fragments at m/z values 
of 147.1174 [C11H15]+, 161.1330 [C12H17]+, 175.1487[C13H19]+ and 189.1643 [C14H21]+.  
Complementarily, some terpenoids present characteristic fragments that contain 
the ether oxygen or the hydroxyl group. Some examples of these fragments, shown in 
Supplementary Fig. 5, are found at m/z values 57.0334 [C3H5O]+ for fenchol, 59.0497 
[C3H7O]+ for β-eudesmol, guaiol, α-terpineol and eucalyptol, 71.0497 [C4H7O]+ for trans-
phytol, menthol and α-terpineol, 85.0653 [C5H9O]+ for menthol and α-terpineol, 111.0810 
[C7H11O]+ for eucalyptol and fenchol, 113.0966 [C7H13O]+ for menthol, 125.0966 [C8H13O]+ 
for eucalyptol and 139.1123 [C9H15O]+ for α-terpineol, eucalyptol and fenchol, 205.1582 
[C14H21O]+  for caryophyllene oxide and 207.1749 [C14H23O]+ for cis-nerolidol. 
Fig. 2 clearly shows that monoterpenoids reported the highest intensity signals in 
hexanoic extracts, then sesquiterpenoids and, finally, tri- and diterpenoids. Among them, 
limonene (monocyclic monoterpene) was the terpenoid that provided the highest 
chromatographic peak, which can be explained by its role as precursor of monoterpenoids. 
Two caryophyllene isomers (the most common sesquiterpene [34]), β-myrcene and α-
pinene were other terpenoids found at relatively high concentration. 
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Fig. 2. Bars diagram comparing the peak areas of the identified terpenoids identified in Cannabis 
extracts by GC–TOF/MS, classified by subfamilies. 
 
3.4. Other families of compounds identified in Cannabis 
In addition to cannabinoids and terpenoids, other chemical families of compounds 
were tentatively identified in Cannabis. They included lipids, flavonoids, amino acids, 
organic acids, benzenoids, organic oxygen compounds, carbohydrates, hydrocarbons, 
organoheterocyclic compounds, organonitrogen compounds and an alkaloid. 
Fig. 3 plots the Venn diagram that compares the number of metabolites identified 
using each of the two analytical platforms involved in this study. A total of 169 metabolites 
were detected by combination of the two platforms, with GC–MS reporting the highest 
detection coverage (~80% of the identified compounds). GC–MS was preferred to identify 
terpenoids, cannabinoids, lipids, benzene derivatives, hydrocarbons, organic acids and 
organic oxygen compounds; while LC–MS/MS allowed identification of flavonoids and 
amino acids, but it was also capable of covering compounds such as cannabinoids, 
carbohydrates and lipids, among others.  
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Fig. 3. Venn diagram comparing the number of compounds identified in Cannabis extracts by GC–
TOF/MS and LC–QTOF MS/MS, classified by families. 
 
Fig. 4 plots the bar diagram that compares the metabolites identified in Cannabis 
polar extracts using LC–MS/MS in negative and positive ionization modes, and also those 
identified in no polar extracts using GC–MS with and without previous derivatization. 
Some families such as lipids, flavonoids and carbohydrates provided a better response in 
negative ionization mode, while others as amino acids were better detected in positive 
mode, and cannabinoids in both ionization modes. Regarding families detected by GC–MS, 
lipids and organic acids provided a better response after derivatization of the extracts, while 
cannabinoids, terpenoids, benzenoids, organic oxygen compounds and hydrocarbons were 
better detected by direct analysis of the extracts. 
Lipids are other key group of metabolites tentatively identified in Cannabis, 
representing 15% of all metabolites. They included mainly fatty acids, fatty acid derivatives 
such as hydroxy fatty acids, methyl-branched fatty acids, fatty acid esters, 
monoacylglycerols and steroids. Among them, more than 60% of identified lipids were fatty 
acids and derivatives. Fatty acids detected in Cannabis were mostly saturated, from 
medium to long-chains [caprylic acid, (C8:0), pelargonic acid (C9:0), lauric acid (C12:0), 
myristic acid (C14:0), pentadecylic acid (C15:0), palmitic (C16:0) margaric acid (C17:0), 
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stearic acid (C18:0) and arachidic acid (C20:0)]. Only five unsaturated fatty acids [oleic 
acid (C18:1 cis-9), its isomer, linoleic acid (C18:2), pinolenic (C18:3) and α-linolenic (C18:3) 
acids] were found. Some of them, such as oleic, arachidic and stearic acids, had been 
previously identified as the most abundant fatty acids in Cannabis seeds oil [34,35].  
 
 
Fig. 4. Bars diagram comparing the number of compounds identified in Cannabis extracts by GC–
TOF/MS, GC–TOF/MS after derivatization, LC–QTOF MS/MS in positive and negative ionization 
modes, classified by families. 
 
Medium-chain dicarboxylic acids such as adipic and azelaic acids were also 
identified. Concerning fatty acid derivatives, 2 methyl-branched fatty acids (methylsuccinic 
and methylmaleic acids), a hydroxy fatty acid (ricinoleic acid), three fatty acid esters, two 
methyl esters from C16:0 and C18:0 and mono(2-ethylhexyl) adipate, and the fatty acid 
amide from C18:1 (oleamide) were also found in no polar extracts. Finally, other important 
compounds such as two steroids (4,14-dimethyl-9,19-cycloergost-24(28)-en-3-ol and 17β-
hydroxyandrost-4-ene-3,11-dione propionate), tocopherol (vitamin E) and 
glycerophosphocholine (GPC) were reported.  
Flavonoids are other key group of compounds identified in Cannabis. About 20 
flavonoids have been reported to be present in the Cannabis plant as aglycons or as 
conjugated O-glycosides or C-glycosides [36–39]. The exact structure of most of the 
glycosides has not been determined because of the uncertainty of the exact linkage and/or 
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the number of sugar moieties. Paris et al. reported the detection of two flavonoids in the 
extracts of pollen grains from Cannabis sativa, which provided, upon acid hydrolysis, two 
genins identified as apigenin and luteolin, indicating the presence of the respective O-
glycosides in the pollen [38].  
Typical compounds such as quercetin and luteolin, and two of its glycosylated 
derivatives (quercetin-3-galactoside and homoorientin), two glycosylated derivatives of 
kaempferol (kaempferol-7-O-glucoside and kaempferol-rutinoside), one O-methylated 
flavone (diosmetin), one trihydroxyflavone (apigenin) and three of its glycosylated 
derivatives (vitexin, apigenin-7-O-glucoside and vitexin-2-rhamnoside), other glycosylated 
flavone (baicalin) and four flavanols (two procyanidins B and two procyanidins C) were 
tentatively identified. Some of them, as vitexin, were previously reported in low-THC 
Cannabis cultivars [34]. 
Flavonoids fragmentation patterns are very similar. Nevertheless, identification is 
possible by comparison of their retention times with those of the corresponding standards. 
For this reason, most flavonoids were identified injecting their individual standards, and 
the rest were tentatively identified by the commented libraries. 
Amino acids were identified in the methanolic extracts of Cannabis using LC‒
QTOF MS/MS. Two essential amino acids (phenylalanine and tryptophan), two 
conditionally essential amino acids (arginine and proline), one no essential amino acid 
(glutamic acid) and one no proteinogenic amino acid (betaine) were found. 
Metabolites of vitamins from the B complex (choline and trigonelline, previously 
identified in Cannabis [34]) and 4-formyl indole were tentatively identified in positive 
ionization mode by LC–QTOF MS/MS, while ethylamine and 2,5-dimethylimidazole were 
tentatively identified by GC–TOF/MS in the derivatized extracts. Ethylamine had been also 
previously identified in Cannabis extracts [34]. 
 
3.5. Comparison of cannabinoids and terpenoids in plants grown in greenhouse 
vs. field cultivation 
Cannabis plants can exhibit wide variation in the quantity and type of 
cannabinoids and terpenoids they produce depending on the cultivar and growing 
conditions. The cultivation of plants in greenhouse (semiclosed environment) or in field 
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can influence many biochemical processes, including those involved in the formation of 
cannabinoids and terpenoids. 
The cannabinoid and terpenoid profiles of female flowers collected from four 
different cultivars (‘Theresa’, ‘Pilar’, ‘Aida’ and ‘Juani’) grown in field in 2016 were 
compared with those provided by the same cultivars in greenhouse (Fig. 5 and 
Supplementary Fig. 6). The growing conditions (greenhouse or field) affected more 
significantly to cannabinoids as compared to terpenoids in all four cultivars. 
Hexane extracts from ‘Pilar’ and ‘Theresa’ cultivars grown in greenhouse (Fig. 5A 
and C) and field (Fig. 5B and D) presented similar relative content of cannabinoids with 
predominance of CBD (>90% and >70%, respectively). Then, particular differences were 
found for each cultivar, which could be explained by the cultivation type. Thus, the content 
of CBG, CBC, cannabinerol and an isomer of Δ9-THCV in ‘Pilar’ plants cultivated in 
greenhouse was higher (0.49%, 4.41% 0.04% and 0.0029%, respectively) than in plants 
cultivated in field (0.09%, 2.01% 0.00% and 0.0002%, respectively). On the other hand, 
the content of CBGV, CBN, CBDV and an isomer of CBC in plants cultivated in greenhouse 
(0.07%, 0.16%, 0.30% and 0.06, respectively) was lower than in field (0.16%, 0.32%, 0.51% 
and 0.16%, respectively). 
Concerning ‘Theresa’ cultivar, CBC, CBDV and ∆9-THC were high concentrated in 
both types of cultivation. The main difference found in the two extracts affected to ∆9-
THCV, CBDV and an isomer of CBC that were found in plants grown in greenhouse at lower 
concentration (0.19%, 17.22% and 0.06%, respectively) than in field (0.26%, 21.56% and 
0.08%, respectively). 
‘Aida’ and ‘Juani’ cultivars grown in greenhouse (Fig. 5E and G) and field (Fig. 5F 
and H) were characterized by high content of CBG (>55% and >60%, respectively). Other 
dominant cannabinoids in the two cultivars were CBD, CBC and cannabinerol. The main 
difference between the two types of cultivation for ‘Aida’ cultivar affected to one isomer of 
CBC, found at higher concentration in plants cultivated in greenhouse (0.28%) as 
compared to those cultivated in field (0.11%). 
Concerning CBGV, CBL, CBDV and ∆9-THC, they were at higher level in ‘Aida’ 
plants cultivated in field (0.23%, 0.51%, 0.40% and 0.43%, respectively) as compared to 
those grown in greenhouse (0.11%, 0.00%, 0.20% and 0.28%, respectively). 
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In the case of ‘Juani’ cultivar, the content of CBGV and one isomer of CBC in plants 
grown in greenhouse (0.61% and 1.67%, respectively) was higher than in plants cultivated 
in field (0.44% and 0.31%, respectively).  
The terpenoids profile was also compared in the same four cultivars grown in 
greenhouse and field. High concentration of limonene was found in ‘Pilar’ (>70%) and 
‘Juani’ (>30%) extracts. Limonene, α-pinene, β-myrcene, (-)-β-pinene, trans-
caryophyllene and borneol were among the most concentrated terpenoids in all studied 
cultivars. 
In general, the content of terpenoids was higher in extracts from plants grown in 
greenhouse than those cultivated in field. However, the content of caryophyllene and 
bergamotene isomers, caryophyllene oxide, squalene and β-amyrin was lower in cultivars 
grown in greenhouse. The content of α-pinene was higher in “Juani” cultivar grown in field. 
Other minor terpenoids such as β-myrcene, cedrane isomers, farnesene, α-curcumene, cis-
thujopsene, β-guaiene, camphene, valencene, aristolene and selinene isomers were more 
concentrated in cultivars grown in field. 
 
4. Conclusions 
Untargeted metabolomics analysis of polar and no polar extracts from 21 Cannabis 
sativa L. cultivars has been carried out. Two analytical platforms, GC–TOF/MS and LC–
QTOF MS/MS, were used to maximize the detection coverage. The first one was used to 
analyze the polar extracts and the second for no polar extracts, either with or without 
previous silylation of the target compounds. Forty-six compounds were identified in polar 
extracts and 134 compounds in no polar extracts, being 11 cannabinoids identified by both 
platforms. Among the identified families, mainly cannabinoids, terpenoids, lipids and 
flavonoids, but also some interesting compounds such as amino and organic acids as the 
most remarkable were found. Compositional differences were found in the profile of 
terpenoids and cannabinoids between extracts of plants cultivated in field and greenhouse. 
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Supplementary Fig. 6. Ring plots comparing the peak area of terpenoids identified in extracts of 
four varieties [‘Pilar’ (A and B), ‘Theresa’ (C and D), ‘Aida’ (E and F), and ‘Juani’ (G and H)] of 
female Cannabis flowers, all cultivated in both field and greenhouse. 
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This section encompasses the research dealing with the first steps of the analytical 
process required by a new clinical sample as sweat: sampling —taking advantage of the 
multiple forms and situations by which this biofluid can be sampled— and sample 
preparation —mandatory step to obtain the analytical sample as required for introduction 
in the target equipment. 
Sweat sampling after moderate exercise provided samples from different parts of 
the body, the composition of which was compared with that of sweat obtained by passive 
sampling and using different sweat induction procedures. Different sample preparation 
strategies including derivatization were assayed to obtain a representative snapshot of 
sweat metabolome, mainly of no polar metabolites as corresponds to the use of GC–MS. 
Chapter VIII contains this research. 
Sampling dry sweat constitutes a novelty; therefore, different solid supports 
impregnated with different solvents were used as samplers and the composition of the 
collected samples was compared among them, and also with the composition of fresh sweat. 
All the samples were analyzed by a dual approach: GC–MS and LC–MS/MS, and the results 
allowed concluding that dry sweat is better for analysis of low polar metabolites and fresh 
sweat is more suited for polar compounds, as shows Chapter IX. 
Amino acids, as key metabolites in the diagnosis and treatment of several diseases, 
are determined in common biofluids. Quantitative determination of these compounds in 
sweat have required optimization of the sample preparation step that can consist either of 
simple dilution or centrifugal solid-phase microextraction, depending on the 
concentrations of metabolites, prior to introduction into a liquid chromatograph connected 
to a triple quad mass detector, as shown in Chapter VII. 
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analysis of amino acids in human sweat by 
liquid chromatography–tandem mass 
spectrometry 
 
M.M. Delgado-Povedano, M. Calderón-Santiago, F. Priego-Capote, M.D. Luque 
de Castro 
Abstract 
The determination of physiological levels of amino acids is important for clinicians 
to aid in the diagnosis and treatment of several diseases and nutritional status of 
individuals. Amino acids are frequently determined in typical biofluids such as blood 
(serum or plasma) and urine; however, there are less common biofluids with other different 
concentration profiles of amino acids that could be of interest. One of these biofluids is 
sweat that can be obtained in a no invasive manner and is characterized by low 
compositional complexity. The analysis of amino acids in human sweat requires the 
development of sample preparation strategies according to the sample matrix and small 
collected volume. The influence of sample preparation on the quantitative analysis of 
amino acids in sweat by LC–MS/MS has been assessed through a comparison between two 
strategies: dilution of sweat and centrifugal solid-phase microextraction (c-SPµE). In both 
cases, several dilution factors were assayed for in-depth knowledge of the matrix effects, 
and the use of c-SPµE provided the best results in terms of accuracy. The behavior of the 
different amino acids was a function of the dilution factor, thus providing a pattern for 
sample preparation according to the amino acids to be determined. The concentration of 
amino acids in sweat ranges between 6.20 ng/mL (for homocysteine) and 259.77 µg/mL 
(for serine) with precision, expressed as relative standard deviation, within 1.1–21.4%. 
Keywords: sweat, amino acid, sample preparation, biomarker, liquid chromatography, 
mass spectrometry. 
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1. Introduction 
Amino acids, the basic units of proteins, play a key role in the metabolic processes 
of living organisms. They are the building blocks of peptides and proteins, act as cell 
signaling molecules, regulate gene expression and critical metabolic pathways, and are key 
precursors for the synthesis of hormones and low-molecular weight nitrogenous molecules 
[1]. 
Determination of physiological levels of amino acids is important to aid in the 
diagnosis and treatment of hereditary diseases, kidney and liver diseases and neuropathies, 
but also to evaluate the nutritional status of individuals [1]. Thus, hyperhomocysteinemia 
has been established as potential biomarkers for neurodegenerative diseases, such as 
Alzheimer's disease, vascular dementia, cognitive impairment or stroke [2]. Also, the levels 
of tyrosine, phenylalanine and tryptophan in gastric juice have allowed detection of gastric 
malignancies [3], or the analysis of branched chain amino acids to discriminate between 
individuals with and without cardiometabolic risk factors [4]. 
Derivatization of amino acids has been a common practice prior to their 
photometric or fluorimetric detection, as most of them do not absorb UV–vis radiation [5]. 
Among derivatization reagents, o-phthaldialdehyde (OPA), phenylisothiocyanate (PITC), 
1-dimethylaminonaphthalene-5-sulphonyl chloride (Dansyl-Cl), 1-fluoro-2,4-dinitro-
benzene (FDNB) and ninhydrin have been widely used to improve the sensitivity and 
selectivity for the determination of amino acids [6]. Despite the popularity of these 
reagents, they suffer from different drawbacks; thus, the instability of OPA derivatives 
causes irreproducibility in no automated derivatization; Dansyl-Cl based protocols must be 
developed in the absence of light; FDNB undergoes decomposition in methanol–water 
solution when exposed to daylight, and PITC is highly toxic [6]. Additionally, derivatization 
always involves time consuming protocols. 
Concerning clinical samples, blood (plasma and serum) and urine have 
traditionally been used to measure physiological levels of amino acids since both biofluids 
provide a complete profile of endogenous amino acids [7–9]. For this reason, few methods 
have been developed to determine these compounds in other clinical samples such as 
cerebrospinal fluid [10], gastric fluids or sweat, and even less, hair or mammalian tissue 
[11]. Among these other samples, sweat is especially interesting as it is obtained by no 
invasive sampling, a key aspect in dealing with people such as hemophiliacs, neonates or 
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elderly individuals, from whom obtaining blood samples is difficult. Additionally, sweat is 
a biofluid characterized by a simple matrix composition and, therefore, the probability of 
interferences from other components is lower than in conventional biofluids [12]. Studies 
developed by automated analyzers have revealed that the composition of free amino acids 
in sweat is different from that in other biofluids [13], thus increasing the interest of this 
sample for quantitative analysis of amino acids for development of diagnostic tools. 
Methods based on automated analyzers have detected up to 26 amino acids in human 
sweat, which allows confirming this biofluid as suitable for complete profile of amino acids 
[13]. 
To the authors’ knowledge, no analytical methods based on LC–MS/MS have been 
proposed for determination of amino acids in sweat. The objective of this research was to 
evaluate the influence of sample preparation on quantitative analysis of amino acids in 
sweat by LC–MS/MS with selected reaction monitoring (SRM) detection mode. For this 
purpose, two sample preparation approaches were selected: sample dilution to check the 
influence of matrix effects, and centrifugal solid-phase microextraction (c-SPµE), 
compatible with the low sample volumes and able to study the clean-up effect. Different 
sample dilution factors were tested to study the influence of sample composition on the 
quantitative determination of amino acids. 
 
2. Materials and methods 
 
2.1. Chemicals and reagents 
A multistandard solution of amino acids from Sigma–Aldrich (Madrid, Spain) with 
an individual concentration for each analyte of 0.5 mM±4% in 0.2 N lithium citrate buffer 
(pH 2.2) with 2% of thiodiglycol and 0.1% of phenol was used to optimize both the 
chromatographic separation and detection. The multistandard solution contained L-
alanine, L-arginine, L-aspartic acid, (±)-carnitine hydrochloride, L-citrulline, L-cysteine, 
L-glutamic acid, DL-homocysteine, L-isoleucine, L-leucine, DL-lysine, L-methionine, L-
ornithine monohydrochloride, D-phenylalanine, DL-proline, L-serine, DL-taurine, L-
threonine, L-tyrosine and DL-valine. Additionally, glycine from Merck (Darmstadt, 
Germany), creatinine and D-tryptophan from Fluka (Madrid, Spain) and L-histidine from 
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Panreac (Barcelona, Spain) were acquired. A working solution containing 10 µg/mL of each 
amino acid was prepared in 0.1 M formic acid (FA). All the above solutions were stored at 
−20 °C until use. 
LC–MS grade acetonitrile (ACN) and ammonium formate, ammonium acetate, 
ammonia, acetic acid and FA from Scharlab (Barcelona, Spain) were used to prepare the 
chromatographic mobile phases. Deionized water (18 mΩ·cm) from a Millipore Milli-Q 
water purification system was used to prepare all aqueous solutions. 36.5% (v/v) 
hydrochloric acid employed for sample preparation was from Panreac. 
 
2.2. Instruments and apparatus 
The analyses were performed by RP-LC with MS/MS detection. Chromatographic 
separation was carried out with an Agilent (Palo Alto, CA, USA) 1200 Series LC system 
(consisting of a binary pump, a vacuum degasser, an autosampler and a thermostated 
column compartment). Detection was carried out by an Agilent 6460 triple quadrupole 
mass spectrometer equipped with a Jetstream®electrospray ionization (ESI) source. The 
data were processed using a MassHunter Workstation Software for qualitative and 
quantitative analysis. 
The analytical columns were a 3 µm particle size, 100 mm×4.6 mm i.d. C18 
Mediterranean Sea from Teknokroma (Barcelona, Spain) and a 3 µm particle size, 100 
mm×4.6 mm i.d. Luna hydrophilic interaction chromatography (HILIC) column from 
Phenomenex (Torrance, CA, USA). Pre-columns, 40 mm×3.0 mm i.d., from Phenomenex 
were connected to the analytical columns for protection. 
A Sorvall Legend Micro 21 microcentrifuge with a standard rotor for 24 tubes with 
equalized g-forces for reproducibility was used for c-µSPE. 
 
2.3. Sweat sampling and storage 
The Macroduct® Sweat Analysis System (Wescor, Utah, USA) (Fig. 1) used for 
sampling consists of a Webster sweat inducer and a Macroduct sweat collector (US Patent 
4,542,751). Pilogel®discs (US Patent 4,383,529) (Wescor, Utah, USA) that consist of gel 
reservoir of pilocarpinium ions were used in the iontophoretic stimulation of sweat 
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excretion. The sweat inducer provides a current intensity of 1.5 mA for 5 min through two 
Pilogel discs as electrodes located on the forearm. Previously, the skin was cleaned with 
ethanol and then with distilled water. The Macroduct device collected sweat for 15 min, 
which was transferred to plastic microEppendorf tubes and stored at –80 °C until analysis. 
A total sweat volume of ca. 50 µL was collected per individual. 
Sweat samples for development and characterization of the method were kindly 
donated by healthy volunteers at Reina Sofía University Hospital (Córdoba, Spain). Pools 
of the biofluid used for optimization of the method were prepared by mixing aliquots from 
all the donors. A number of 14 sweat samples from 8 female and 6 male volunteers were 
used for quantitative profiling analysis of amino acids. All subjects gave their informed 
consent for sweat sampling. No restrictions about diet or age were taken into account.  All 
steps from sweat sampling to analysis were performed in compliance with the guidelines 
dictated by the World Medical Association Declaration of Helsinki of 2004. The study was 
approved by the ethical committee of the Reina Sofia University Hospital. 
 
 
Fig. 1. Macroduct sweat collector. 
 
2.4. Sample preparation 
Two different sample preparation protocols were compared in this research. 
Firstly, aliquots of the sweat pool were 1:1, 1:4, 1:10, 1:20 or 1:50 diluted with 0.1 M FA in 
water. Then, they were either no spiked or spiked with multistandard solutions at two 
concentrations per amino acid (50 and 250 ng/mL) and vortexed for homogenization. 
These samples were analyzed without sample preparation. Secondly, sweat clean-up by c-
µSPE using strong cation Micro SpinColumnTM systems (Harvard Apparatus, MA, USA) 
was applied by following the protocol recommended by the manufacturer for this sorbent 
material. The protocol used with strong cation Micro SpinColumnTM was as follows: 
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insertion of 150 µL of water and wait for 10 min for solvation, followed by 150 µL of 50% 
(v/v) ACN–water for sorbent conditioning, 150 µL of 1% (v/v) FA–water for sorbent 
equilibration, 75 µL of sample (sweat pool aliquots 1:1, 1:4, 1:10, 1:20, 1:50 and 1:100 diluted 
with 0.1 M FA), 150 µL of 20% (v/v) ACN–water to wash out potential interferents and, 
finally, 150 µL of 5% (v/v) ammonia–water for elution of the retained compounds. 
Centrifugation for 120 s at 1000×g was applied after each step, except for elution, which 
required centrifugation for 240 s at 1000×g to complete this step. 
 
2.5. LC–MS/MS analysis 
A C18 reverse-phase analytical column thermostated at 25 °C was used for 
chromatographic separation. The mobile phases were water (phase A) and 90% (v/v) ACN–
water (phase B) both with 5 mM ammonium formate as ionization agent. The LC pump was 
programmed with a flow rate of 0.5 mL/min with the following elution gradient: from 2% 
phase B as initial mobile phase to 5% phase B in 5 min and from 5 to 60% of phase B in 20 
min. A post-time of 10 min was set to equilibrate the initial conditions for the next analysis. 
The injection volume was 5 µL and the injector needle was washed for 12 s between 
injections with 80% methanol to avoid cross contamination. 
MS detection was performed in positive ESI mode at unit resolution in both 
quadrupoles. The Jetstream ESI source parameters, operating in positive ionization mode, 
were as follows: nozzle and capillary voltage were set at 0.9 kV and 1 kV, respectively, N2 
nebulizer was flowed at 60 psi, N2 drying gas flow rate and temperature were 11 L/min and 
200 ºC, N2 sheath gas flow rate and temperature were 12 L/min and 400 °C. Detection was 
carried out by tandem mass spectrometry using the SRM mode. For this purpose, the dwell 
time was set between 15 and 246.50 ms depending on the transition.  
 
2.6. SRM-based quantitation 
Quantitative analysis of amino acids in sweat was carried out using the peak area 
obtained for the transition of each analyte, which coincided with the chromatographic 
retention time of the multistandard solution. Calibration models were developed for each 
analyte using multistandard solutions at nine concentration levels that depended on the 
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analyte. Five of the calibration points were injected in triplicate to set the confidence 
intervals. 
 
3. Results and discussion 
 
3.1. Optimization of MS/MS by SRM 
Numerous LC–MS/MS methods have been proposed for quantitative analysis of 
amino acids either using direct analysis or after derivatization to improve sensitivity and 
selectivity [7,14–18]. The recent advances in both MS instrumentation and sample 
preparation have allowed developing MS/MS SRM methods with similar or even lower 
detection limits than those taking benefits after derivatization [19]. For this reason, a 
strategy without derivatization was adopted for this research. 
Optimization of the voltage in the first quadrupole, collision energy and 
quantitation transition for each amino acid was automatically carried out by direct infusion 
of standard solutions of the target amino acids at a common concentration of 2 µg/mL. 
Both positive and negative ionization modes were tested, and the highest sensitivity for all 
amino acids was achieved by using the positive mode. The most abundant ions of all amino 
acids under the optimum conditions were selected as precursor ions. As Table 1 shows, the 
m/z values fit the [M+H]+ ion in all instances, except for cysteine, which corresponded to 
the cystine dimer [2M+H]+. 
Isolation and fragmentation of the different amino acids were studied using Q1 
voltages from 40 to 200 V and collision energies from 0 to 40 eV. Table 1 lists the results 
of this study. The Q1 voltage ranged from 50 V for glycine to 140 V for threonine and 
histidine. On the other hand, the collision energy varied from 5 eV for leucine, glycine and 
serine up to 30 eV for cysteine and ornithine. In most cases, the product ions were formed 
by decarboxylation to produce the corresponding immonium ions by loss of 45 Da. In the 
particular case of lysine, the decarboxylated ion was not stable and tended to loss ammonia 
with subsequent formation of a product ion at m/z 84. The fragmentation pathways for the 
rest of amino acids involved intramolecular neutral losses or cleavage of the side-chain. 
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Table 1. Optimization of the MS/MS step for qualitative and quantitative determination of amino 
acids. 
Compound 
Retention 
time 
(min) 
Quantitation transition 
Precursor ion→ product ion 
(m/z) → (m/z) 
Q1 
voltage1 
(V) 
Collision 
energy 
(eV) 
Glutamic acid 1.9 148 → 84 80 10 
Aspartic acid 1.9 134.0 → 87.9 120 10 
Glycine 2.2 76.0 → 30.1 50 5 
Serine 2.2 106.2 → 60.2 60 5 
Taurine 2.2 126.0 → 107.8 100 10 
Threonine 2.3 119.7 → 74.0 140 10 
Alanine 2.3 90.0 → 44.0 80 20 
Citrulline 2.4 176.3 → 69.8 80 10 
Cysteine 2.5 241.1 → 152.0 80 30 
Proline 2.6 116.0 → 70.1 80 10 
Ornithine 2.7 133.0 → 70.0 80 30 
Lysine 2.8 147.0 → 84.0 80 10 
Valine 2.9 118.1 → 72.0 62 9 
Homocysteine 2.9 136.1 → 90.0 68 9 
Carnitine 3.0 162.0 → 60.0 120 20 
Arginine 3.1 175.0 → 70.1 80 10 
Methionine 3.5 149.9 → 103.8 100 10 
Creatinine 3.7 114.0 → 86.0 100 10 
Leucine/isoleucine 3.9 132.1 → 86.0 60 10 
Histidine 4.2 155.9 → 110.0 140 10 
Tyrosine 5.1 181.6 → 136.0 80 10 
Phenylalanine 8.6 165.9 → 119.9 80 10 
Tryptophan 12.8 205.0 → 187.9 80 10 
1Voltage for filtration of precursor ions. 
 
The study of the parameters involved in the ESI was carried out by testing different 
ionization agents, particularly, acetic acid, ammonium acetate, ammonium formate or FA. 
The highest responses were obtained with 5 mM ammonium formate giving a pH of 6.0, at 
which most amino acids have a neutral net charge. Concerning the ESI, variables such as 
capillary voltage, sheath gas flow, drying gas flow, gas temperature and nebulizer pressure 
were studied by a univariate design. The nozzle voltage and sheath temperature were 
evaluated by a multivariate design involving a 3-level 32 factorial design including 9 
experiments and 2 central points, which corresponded to star points used to model the 
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surface. The experiments were carried out by injection of the multistandard solution 
containing the target amino acids at 1 mg/L. The peak area of the precursor ions from the 
target amino acids was monitored as response variable. The studied ranges for the nozzle 
voltage and sheath temperature were 0–600 V and 200–400 ºC, respectively. A positive 
effect was observed by increasing the sheath temperature, which cannot be tested at values 
higher than 400 ºC; therefore, it was fixed at this value. The effect of increased nozzle 
voltage on the signal intensity of the precursor ions was positive, so the range studied for 
the nozzle voltage was raised up to 2000 V. As no significant improvement of the peak areas 
was observed between 900 and 2000 V, the nozzle voltage was set at 900 V to avoid source 
overexertion. The studied ranges for capillary voltage, sheath gas flow, drying gas flow, gas 
temperature and nebulizer pressure were 500–6000 V, 8–12 L/min, 8–12 L/min, 150–350 
ºC, and 30–60 psi, respectively. The effect of the sheath gas flow, drying gas flow and 
nebulizer pressure on the signal intensity corresponding to the target ions was positive. The 
sheath gas flow and nebulizer pressure were set at 12 L/min and 60 psi, respectively, and 
the drying gas flow was established at 11 L/min. The optimized values for capillary voltage 
and gas temperature were 1000 V and 200 ºC, respectively. 
 
3.2. Optimization of the chromatographic separation step 
The commercial multistandard solution containing most of the target amino acids 
was used to optimize the chromatographic conditions. Two types of columns based on 
different principles were compared for separation of the target analytes: the HILIC column 
and the C18 column specified under Section 2. 
Different chromatographic gradients were tested by using both analytical columns. 
In the case of HILIC, different gradients based on ACN–water mixtures were evaluated, 
and the best separation was achieved with a gradient from 90% ACN in water acidified with 
0.1% (v/v) acetic acid (phase A) to 40% (v/v) ACN–water with 5 mM ammonium acetate 
(phase B). The optimum gradient was as follows: phase A for 5 min, after which a linear 
gradient for 18 min was programmed up to 80 phase B. Then, a second ramp up to 100% B 
for 5 min was applied. On the other hand, combinations of water and ACN using 5 mM 
ammonium formate as ionizing agent were assayed in reverse-phase chromatography with 
the C18 column. The best results were obtained with 5 mM of ammonium formate in 100% 
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water (phase A) and 90% (v/v) ACN–water solutions (phase B) with the gradient described 
under Section 2. 
The pH of the mobile phases strongly affected the chromatographic separation in 
both chromatographic modes. Thus, pHs between 3.2 and 7.0 were evaluated, being pHs 
5.5 and 6.0 the best to achieve a suited analytes–chromatographic sorbent interaction in 
HILIC and RP chromatography, respectively; while pHs out of the 5.0–7.0 range led to 
irreproducible results owing to inefficient retention. Fig. 2 shows the chromatographic 
profile obtained with the two columns and ten representative amino acids eluting within 
the chromatographic gradient.  
Fig. 2. Retention times and peak widths of the target compounds obtained by the HILIC column as 
compared to those provided by the C18RP column (for details, see text). 
 
As can be seen, a better separation was obtained using the HILIC column since all 
the amino acids were eluted within the 10–20 min interval, as compared to RP 
chromatography in which elution was completed within the 2.0–8.6 min interval, except 
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for tryptophan that eluted at 12.8 min. However, the best resolution, expressed as the width 
of the chromatographic peaks, was obtained by the C18 column since the HILIC column 
provided wider peaks. This criterion relates a better resolution with a better sensitivity, 
which justified selection of the C18 column. Because leucine and isoleucine were not 
properly separated owing to their isomeric character, they were quantified together. 
Supplementary Fig. 1 shows the SRM chromatograms from a multistandard solution and 
using the two chromatographic methods. 
 
3.3. Calibration models 
The calibration curve for each analyte was run by using the peak areas of the 
selected transition obtained at different dilutions (with 0.1 M FA in water) of the stock 
solution containing all the amino acids. The linear dynamic ranges and regression 
coefficients are shown in Table 2, with values for the latter above 0.98 for all analytes, and 
upper limit for calibration dependent on the target compound. Thus, some amino acids 
fitted linearly up to concentrations ca. 1.25 μg/mL, while others only reached 25 ng/mL.  
The limits of detection (LOD) and quantitation (LOQ) of the method for each 
amino acid were calculated as the concentration providing signals three and ten times, 
respectively, higher than the background noise at elution times close to each peak; and they 
were between 0.08–1.50 ng/mL and 0.25–5 ng/mL, respectively, for all analytes. The 
individual values in all cases are shown in Table 3. 
Once the calibration models were obtained, the influence of the two sample 
preparation alternatives, dilution and c-SPµE, on the quantitative determination of amino 
acids in sweat was tested. 
 
3.4. Dilution of sweat as sample preparation step prior to quantitative analysis 
of amino acids 
Dilution of sweat by using 0.1 M FA in water was evaluated for analysis of amino 
acids without any other sample preparation step. For this purpose, the dilution factors 1:1, 
1:4, 1:10, 1:20 and 1:50 were tested to know the influence of matrix effects on the accuracy 
of the method. Three sweat aliquots of the prepared pool were diluted in the FA aqueous 
medium at each dilution factor. One of them was directly used for quantitative analysis of 
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the amino acids in sweat, while the other two aliquots were spiked with all target amino 
acids at 50 or 250 ng/mL. Each aliquot was analyzed in triplicate.  
 
Table 2. Linear calibration ranges, calibration equations and regression coefficients for the target 
amino acids. 
Compound Calibration curve 
Linear calibration range 
(ng/mL) 
Regression coefficient 
Glutamic acid y = 164.6x+2785 0.25–625 0.9930 
Aspartic acid y = 10.09x+39.47 0.25–50 0.9800 
Glycine y = 14.04x+102.6 0.25–50 0.9830 
Serine y = 92.07x+908.6 0.25–50 0.9980 
Taurine y = 0.59x+10.09 5–250 0.9970 
Threonine y = 0.677x+47.66 0.25–625 0.9800 
Alanine y = 57.96x+277.1 0.25–50 0.9910 
Citrulline y = 185.53x+844.86 0.25–50 0.9864 
Cysteine y = 9.9656x+4.2383 0.25–50 0.9973 
Proline y = 1382x+5380 0.25–50 0.9920 
Ornithine y = 167.6x+2440 0.25–250 0.9860 
Lysine y = 416.8x+556.2 0.25–25 0.9900 
Valine y = 103x+482.9 0.25–1250 0.9940 
Homocysteine y = 2.983x+6.392 2.5–50 0.9932 
Carnitine y = 1636.5x+589.37 0.25–50 0.9984 
Arginine y = 246.44x+1814.1 0.25–50 0.9863 
Methionine y = 24.55x+138.1 0.25–625 0.9970 
Creatinine y = 187.3x+110.4 0.25–25 0.9890 
Leucine/isoleucine y = 642.5x+782.9 0.25–50 0.9970 
Histidine y = 62.79x+10718 0.25–1250 0.9870 
Tyrosine y = 98.269x+795.33 0.25–250 0.9908 
Phenylalanine y = 343.5x+3028.2 0.25–1250 0.9988 
Tryptophan y = 89.19x+696.67 0.25–625 0.9984 
y: peak area; x: concentration as ng/mL. 
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Table 3. Limits of detection and quantitation for the target amino acids. 
Compound 
LOD 
(ng/mL) 
LOQ 
(ng/mL) 
Glutamic acid 0.08 0.25 
Aspartic acid 0.08 0.25 
Glycine 0.08 0.25 
Serine 0.08 0.25 
Taurine 1.50 5.00 
Threonine 0.08 0.25 
Alanine 0.08 0.25 
Citrulline 0.08 0.25 
Cysteine 0.08 0.25 
Proline 0.08 0.25 
Ornithine 0.08 0.25 
Lysine 0.08 0.25 
Valine 0.08 0.25 
Homocysteine 0.75 2.50 
Carnitine 0.08 0.25 
Arginine 0.08 0.25 
Methionine 0.08 0.25 
Creatinine 0.08 0.25 
Leucine/isoleucine 0.08 0.25 
Histidine 0.08 0.25 
Tyrosine 0.08 0.25 
Phenylalanine 0.08 0.25 
Tryptophan 0.08 0.25 
 
The accuracy values, estimated as mean percentage of the three analyses per 
aliquot, are listed in Table 4 for each spiked concentration. Only values within the 75–125% 
range are included in Table 4, assuming a maximum variability of 25% for the analysis of 
amino acids in sweat. The best accuracy values at the two spiked concentrations were 
provided by the 1:20 and 1:50 dilution factors. Thus, 9 and 11 amino acids out of 23 were 
properly quantified (assuming 25% variability in accuracy terms) by the 1:20 and 1:50 
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dilution factors, respectively, at the spiked level of 50 ng/mL. Nevertheless, when the 
spiked concentration was 250 ng/mL the number of properly quantified amino acids 
decreased to 6 and 8 for dilution factors 1:20 and 1:50, respectively. 
Only 10 out of the 23 amino acids reported values within the preset interval for the 
two spiked concentrations at one among the five assayed dilution factors. The low accuracy 
for the rest of amino acids (viz., cysteine, homocysteine, aspartic acid, ornithine, taurine, 
threonine, valine, lysine, methionine, tyrosine, phenylalanine and leucine/isoleucine) 
could be attributed to significant matrix effects, which are not suppressed by sample 
dilution. Despite quantitative analysis of the complete set of amino acid is not possible by 
direct injection into the chromatograph of diluted sweat, several dilution factors should be 
applied to maximize the number of amino acids to be quantified. Taking into account the 
matrix effects, other sample preparation protocol based on c-SPµE was tested to minimize 
or suppress them. 
 
3.5. Sample preparation based on c-SPµE prior to quantitative analysis of amino 
acids in sweat 
Centrifugal SPµE was assayed as sample preparation step to overcome sweat 
matrix effects. As amino acids can be positively or negatively charged depending on the pH 
of the solution, strong ionic sorbents should be an appropriate material for selective 
retention of the analytes. Two types of strong sorbents were tested: cation and anion resins. 
Preliminary experiments revealed that retention of amino acids on the cationic 
sorbent was more efficient than on the anionic, since the sorbent–analyte interaction is 
stronger in 0.1 M HCl medium (solution used for retention of amino acids in the cationic 
resin) than in 5% (v/v) ammonia in water (used for retention of amino acids in the anionic 
resin). For this reason, the strong cationic sorbent was selected for evaluation of c-SPµE in 
the analysis of amino acids in sweat. Supplementary Fig. 2 shows a chromatogram from 
sweat spiked with 50 ng/mL of each amino acid by using c-SPµE as sample preparation 
strategy. 
As in the previous study, different dilution factors were tested to know their 
influence of sweat matrix effects. Initially, no spiked aliquots (three per experimental 
condition) of sweat were 1:1, 1:4, 1:10, 1:20, 1:50 and 1:100 (v/v) diluted with 0.1 M HCl in 
water.  
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Table 4. Accuracy estimated in the analysis of diluted sweat. Recovery values are expressed as 
percent for each amino acid as a function of the dilution factor and the spiked concentration. Values 
below 75% or above 125% are not shown. 
 Dilution 
 1:1 1:4 1:10 1:20 1:50 
Compound\spiked 
concentration 
(ng/mL) 
50 250 50 250 50 250 50 250 50 250 
Glutamic acid – – – – 
83.8
±4.3 
– 
114.3
±8.5 
93.1±
2.2 
– 
94.8
±3.2 
Aspartic acid – – – – – – – 
105.8
±2.4 
– – 
Taurine – – – – – – – – 
84.5±
9.4 
– 
Serine 
103.8
±5.4 
101.7
±4.1 
97.1±
2.0 
86.9
±1.8 
104.0
±6.0 
116.2±
5.3 
107.2
±3.4 
102.4
±2.2 
116.9
±7.2 
97.3±
5.8 
Glycine 
93.2±
5.9 
90.5±
4.6 
81.9±
2.1 
– 
75.6±
2.1 
– 
79.7±
1.8 
– 
80.8±
2.5 
– 
Threonine – – – – – – 
116.9
±20.0 
– 
83.8±
3.5 
– 
Alanine 
89.4±
5.8 
87.0±
6.5 
94.3±
6.5 
– 
85.1±
11.8 
– – 
116.9
±5.5 
– 
122.6
±4.7 
Citrulline – – 
107.7
±60.9 
– 
121.4
±563 
121.1±
35.3 
99.5±
11.8 
– 
79.4±
4.0 
– 
Cysteine – – – – – – – – – – 
Proline 
95.7±
17.8 
93.6±
14.8 
85.8±
4.6 
– 
81.6±
3.8 
– 
94.8±
1.0 
– 
111.8±
10.0 
– 
Ornithine – – – – – 
80.5±
253.6 
– – – – 
Lysine – – – – – – 
105.4
±0.6 
– 
106.2
±9.7 
– 
Homocysteine – – – – – – – – – – 
Valine – – – – – – – – 
76.4±
6.9 
– 
Carnitine – – 
89.5±
79.5 
76.5±
13.0 
– – – – – – 
Arginine – – – – 
98.0
±7.7 
– 
112.3
±4.9 
– 
113.6
±8.6 
112.3
±2.9 
Methionine – – – – – – – – 
119.2
±20.1 
– 
Creatinine – – 
89.0±
31.8 
81.8
±31.2 
84.0
±4.6 
– – – – – 
Leucine/isoleucine – – – – – 
82.6±
9.0 
– – – – 
Histidine 
94.0±
49.3 
88.8±
40.0 
– – – – 
124.2
±5.9 
119.0
±8.9 
109.6
±12.5 
104.5
±0.6 
Tyrosine – – – – – – – 
78.8
±6.3 
– 
103.3
±4.7 
Phenylalanine – – – – – – – – – 
95.6±
2.9 
Tryptophan – – 
92.4±
1.9 
– 
79.1±
14.7 
– – – – 
110.5
±7.6 
 
For most of the amino acids the dilution factors providing the maximum 
concentrations were 1:20 and 1:50 (v/v) (exceptionally, cysteine was optimally quantified 
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at 1:100 dilution factor; arginine, histidine, homocysteine and aspartic acid at 1:10 dilution 
factor; and glutamic acid at 1:4 dilution factor). Attending to the behavior of the majority 
of the amino acids, two dilution factors, 1:20 and 1:50, were selected to estimate the 
accuracy of the method by using c-SPµE by spiking sweat aliquots with the target analytes 
at 50 and 250 ng/mL. The aliquots were then subjected to SPE and analyzed by LC–
MS/MS, and the accuracy values obtained were listed in Table 5 after discarding values of 
variability above 20% (viz., out of the range from 80–120%). 
For the 1:20 dilution factor, 13 amino acids provided accuracy values within the 
established limits at both concentration levels, while other five amino acids fulfilled the 
accuracy restriction only at 50 ng/mL. Despite of the fact that 1:20 was not the optimum 
dilution factor for alanine, citrulline, cysteine, aspartic acid, proline, lysine, valine, 
carnitine, methionine, phenylalanine, tryptophan and leucine/isoleucine, acceptable 
accuracy values were obtained for all them at both concentration levels.  
Concerning the 1:50 dilution factor, only 7 amino acids provided acceptable 
accuracy values at both spiked concentrations, while other 6 amino acids led to acceptable 
accuracy values at one spiked level. One amino acid, tyrosine, that did not provide accuracy 
values within the preset interval at 1:20 dilution factor was properly quantified at 1:50 
dilution. 
It can be summarized that amino acids such as cysteine, aspartic acid, lysine, 
valine, methionine, leucine/isoleucine, tyrosine and phenylalanine at the two spiked levels, 
and taurine and threonine at one spiked level that were not determined accurately by direct 
analysis of diluted sweat provided good accuracy values by c-SPµE. Therefore, the 
implementation of c-SPµE allowed reducing or suppressing matrix effects of sweat and 
made possible to obtain better accuracy values. This behavior is explained by the double 
clean-up effect of the c-SPµE procedure: in the sample loading by no retention of 
interferents, and in the washing step by removal of interferents by a suited washing solvent 
composition.  On the other hand, other amino acids such as homocysteine and ornithine 
did not provide acceptable accuracy by any of the two sample preparation strategies, which 
could be explained by losses in the different steps of the SPE protocol. 
Table 5 also contains information on the precision of the method since each 
accuracy value was estimated by three sweat aliquots. As can be seen, the repeatability, 
estimated as relative standard deviation, ranged from 1.1 to 21.4% and from 0.5 to 15.1% 
for 1:20 and 1:50 dilution factors, respectively. 
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Table 5. Accuracy estimated in the study of centrifugal SPµE for 1:20 and 1:50 diluted sweat. 
Recovery values are expressed as percent for each amino acid as a function of the dilution factor and 
the spiked concentration. Values below 80% or above 120% are not shown. 
 Dilution 
 1:20 1:50 
Compound\spiked 
concentration  
(ng/mL) 
50 250 50 250 
Glutamic acid 96.5±4.7 100.1±4.3 91,88±7,18 107,86±2,88 
Aspartic acid 97.1±5.2 98.3±11.1 – – 
Taurine 120.7±15.7 – 112,22±11,26 – 
Serine 99.9±4.1 89.2±7.6 104,13±0,45 88,53±1,38 
Glycine 86.6±3.9 – 94,31±3,32 – 
Threonine – – – 111,67±15,07 
Alanine 93.6±11.2 90.9±7.6 85,23±5,27 86,51±8,91 
Citrulline 84.0±2.4 98.0±2.4 112,34±4,39 – 
Cysteine 107.4±4.6 87.1±8.8 – – 
Proline 100.7±5.1 112.7±0.8 117,65±6,68 – 
Ornithine – – – – 
Lysine 85.3±2.4 89.78±0.9 114,19±2,84 115,95±8,47 
Homocysteine – – – – 
Valine 109.1±10.3 111.2±21.4 – – 
Carnitine 96.7±1.1 116.8±1.6 – – 
Arginine – – – – 
Methionine 102.1±5.9 104.9±5.6 – 89,69±5,27 
Creatinine 93.9±2.0 – – – 
Leucine/isoleucine 93.4±9.8 98.0±6.4 93,80±10,86 105,62±4,07 
Histidine – – – – 
Tyrosine 82.6±15.5 – 82,81±4,99 85,52±8,97 
Phenylalanine 86.2±5.8 93.7±6.8 102,71±1,86 94,44±3,48 
Tryptophan – 119.0±9.4 – – 
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3.6. Analysis of women and men sweat samples 
The method based on c-SPµE and dilution was used to analyze sweat samples of 
female and male volunteers. After analysis of all samples, the concentration of each amino 
acid in sweat was calculated. Fig. 3 shows the average concentration of each amino acid in 
8 sweat samples from women (Fig. 3A) and in 6 sweat samples from men (Fig. 3B). These 
results show that the average concentration of all amino acids in sweat was higher in 
women than in men. Concerning the profile of amino acids, the most concentrated amino 
acids in male and female individuals were serine, histidine, glycine, alanine, glutamic acid 
and valine. Additionally, aspartic acid was also found at higher concentrations in female 
than in male volunteers. It is also worth mentioning that the variability in concentrations 
of amino acids was particularly low, except for arginine that reported a high variability in 
the studied individuals. 
 
 
Fig. 3. Quantitative profiling of amino acids in 8 sweat samples from women (A) and in 6 sweat 
samples from men (B). 
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4. Conclusions 
The search for biofluids complementary to blood (serum or plasma) and urine is 
one of the present trends in clinical metabolomics analysis. In this research, the potential 
of sweat for quantitative profiling of amino acids has been evaluated with an in-depth study 
of sample preparation approaches, being c-SPµE the preferred option in terms of accuracy. 
The developed research has provided the following conclusions: (i) sweat can be an 
excellent sample for quantitative profiling analysis of amino acids in clinical studies, which 
is of interest taking into account the biomarker role of amino acids; (ii) the 
chromatographic resolution in the separation of amino acids is better with a C18 analytical 
column than with a HILIC phase; (iii) the small volume of sweat collected per individual 
makes mandatory the use of microformat sample preparation approaches, being c-µSPE an 
excellent option; (iv) dilution of sweat is mandatory to decrease matrix effects and make 
possible absolute quantitation of amino acids; (v) amino acids behave differently; 
therefore, compromise solutions are necessary for their determination in a single analysis. 
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Metabolomics analysis of human sweat 
collected after moderate exercise 
M.M. Delgado-Povedano, M. Calderón-Santiago, M.D. Luque de Castro, F. 
Priego-Capote 
Abstract 
Sweat is a promising biofluid scarcely used in clinical analysis despite its no 
invasive sampling. A more frequent clinical use of sweat requires to know its whole 
composition, especially concerning to no polar compounds, and the development of 
analytical strategies for its characterization. The aim of the present study was to compare 
different sample preparation strategies to maximize the detection of metabolites in sweat 
from humans collected after practicing moderate exercise. Special emphasis was put on no 
polar compounds as they have received scant attention in previous studies dealing with this 
biofluid. Sample preparation by liquid–liquid extraction (LLE) using extractants with 
different polarity index was compared to deproteination. Then, derivatization by 
methoxymation with subsequent silylation was compared to direct analysis of sweat 
extracts to check the influence of derivatization on the subsequent determination of volatile 
organic compounds (VOCs). A number of 135 compounds were tentatively identified by 
combining spectral and retention time information after analysis by gas chromatography 
coupled to mass spectrometry in high resolution mode (GC–TOF/MS). Lipids, VOCs, 
benzenoids and other interesting metabolites such as alkaloids and ethanolamines were 
identified. Among the tested protocols, methyoxiamination plus silylation after LLE with 
dichloromethane was the best option to obtain a representative snapshot of sweat 
metabolome collected from different body parts after moderate exercise. Passive and active 
sweat pools from a cohort of volunteers (n=6) were compared to detect compositional 
differences which can be explained by the sampling process and sweating induction. As 
most of the identified compounds are metabolites involved in key biochemical pathways, 
this study opens new opportunities to extend the applicability of human sweat as a source 
of metabolite biomarkers of pathologies or specific processes such as dehydration or 
nutritional unbalance. 
Keywords: metabolomics, active sweat, passive sweat, exercise, gas chromatography–
mass spectrometry, sample preparation. 
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1. Introduction 
Sweat is mainly composed by water (99%), electrolytes, small molecules (e.g., 
amines, carboxylic acids, amino acids), complex biomolecules such as proteins and 
antimicrobial peptides, and xenobiotics such as drugs, cosmetics, and ethanol, among 
others [1]. Due to the aqueous nature of sweat, the majority of the compounds identified in 
this biofluid are polar, but also no polar or intermediate polarity compounds have been 
identified in this biofluid. For example, in 1974 Förström et al. detected prostaglandins in 
sweat [2]. Fatty acids have also been detected in sweat by GC–MS and by GC coupled to 
Fourier transform infrared spectroscopy (GC–FTIR) [3]. Thus, sweat analysis showed the 
presence of several C6–C10 straight chains, branched, and unsaturated acids [3], but also 
conventional acids such as lauric, myristic, palmitic, oleic and stearic acids were detected 
[4]. Moreover, short-chain fatty acids have been determined in feet sweat after either 
Soxhlet extraction with diethyl ether [5] or headspace solid-phase microextraction [6] with 
subsequent GC–MS analysis in both cases. 
Characterization studies of sweat by nuclear magnetic resonance (NMR) have 
revealed that the main constituents of human sweat are compounds involved in primary 
and secondary biological functions [7]. Polar compounds such as amino acids, amines, 
sugars, lactate, glycerol, ethanol, formate, acetaldehyde, urea, inositol and compounds 
involved in the citric acid cycle (e.g., pyruvate, fumarate or aconitate) were mainly detected. 
However, NMR analysis only allowed detection of some characteristic groups of lipids. This 
fact could be explained by the low concentration of lipids in the collected samples (< 0.01 
mM) and the low resolution of 1H-NMR to discriminate among lipid families. In fact, only 
some signals corresponding to -CH2- and -CH3 groups were detected [7,8]. Other 
characterization study of sweat by LC–QTOF MS/MS confirmed that most of human sweat 
components are involved in key biochemical pathways [9]. Among them, the main families 
of detected metabolites were polar compounds such as amino acids, metabolites involved 
in purine nucleosides degradation, dicarboxylic acids, sugars, nutrients and exogenous 
compounds. On the contrary, only 4 no polar compounds (3 fatty acids and 1 sphingolipid) 
were detected [9]. A recent study on human sweat analysis by GC–TOF/MS in high 
resolution mode allowed the identification of 66 compounds, most of them also polar 
compounds (18 amino acids, 12 carboxylic acids, 12 sugars and 4 benzene derivatives), and 
only 14 no polar lipids were detected [10]. 
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All these previous studies had in common the collection of the known as passive 
sweat —that collected from individuals at rest—, although two different sampling strategies 
were used. In two studies based on MS, passive sweat was collected by the commercial 
Macroduct device, which is clinically used for the diagnostic of some diseases such as cystic 
fibrosis [11]. In the study based on NMR analysis, sweat was collected by special tools 
designed by the authors, which included glass rollers with dull surfaces and holders for 
sample collection when the sweat quantity was limited, and special pipettes with reverse 
capillaries for sweat drop collection in the case of profuse sweat secretion [7]. 
The sampling devices employed could explain the differences in sweat 
composition, and the lack of no polar compounds [7]. Sweating is usually stimulated by 
heat or chemical induction (for instance, using pilocarpine), but also by exercise practice at 
different intensity levels [12]. The first two protocols, based on temperature increase or 
chemical stimulation, allow collection of passive sweat, while that collected after exercise 
practice provides the known as active sweat, which can set differences at compositional 
level as compared to passive sweat. 
Recently, sensors to evaluate nutritional unbalance, dehydration and clinical 
biomarkers in sweat have been developed. As an example, a real-time colorimetric sensor 
that detects dehydratation, normal condition and over-hydratation within minutes has 
recently been designed for hydratation balance [13]. As the analysis is carried out in sweat, 
it is no invasive and makes possible real-time feedback [13]. Other example is a 
mechanically flexible and fully integrated sensor array for multiplexed in situ perspiration 
analysis that has allowed the simultaneous and selective screening of a panel of biomarkers 
in sweat. This sensor measures sweat metabolites (such as glucose and lactate) and 
electrolytes (such as sodium and potassium ions), as well as the skin temperature (to 
calibrate the sensors response). The portable system is used to evaluate the response of 
humans engaged in prolonged indoor and outdoor physical activities, and to make real-
time assessment of the physiological state of the individuals. This platform enables a wide 
range of personalized diagnostic and physiological monitoring applications [14]. 
The aim of the present study was to optimize a method for untargeted 
metabolomics analysis of active sweat, with special emphasis on no polar compounds, 
considering that lipids have been scarcely detected in active sweat probably owing to both 
their low concentration and the sampling strategy. Active sweat will be compared to passive 
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sweat to evaluate compositional differences associated to the stimulated perspiration 
process. 
 
2. Experimental 
 
2.1. Reagents 
Optima™ LC–MS grade acetonitrile from Thermo Fisher Scientific (Pittsburgh, 
PA, USA), LC–MS grade methanol, GC grade dichloromethane, and Trace SELECT® grade 
ethyl acetate and n-hexane from Sigma–Aldrich (St. Louis, MO, USA) were used for sample 
preparation. Deionized water (18 mΩ•cm) from a Millipore Milli-Q water purification 
system (Bedford, MA, USA) was used for standards preparation. Pyridine and 
methoxyamine hydrochloride from Sigma–Aldrich were used as solvent and reagent, 
respectively, for methoxymation. Bis-(trimethylsilyl) fluoroacetamide (BSTFA) and 
trimethylchlorosilane (TMCS) from Sigma–Aldrich were used as silylation agents in the 
derivatization step. MS-grade perfluorotri-n-butylamine (PFTBA) from Agilent 
Technologies (Santa Clara, CA, USA) was used for daily mass calibration in GC–TOF/MS. 
A standard mixture containing ten linear alkanes from C10 to C40 designed for 
performance tests in GC from Sigma–Aldrich was used to establish the retention index (RI) 
calibration model. HPLC–grade n-hexane and acetone from Scharlab (Barcelona, Spain) 
were used for washing the injection syringe. Standards of D-galactose, D-glucose and myo-
inositol from Sigma–Aldrich were used to confirm sugars identification. 
 
2.2. Instruments and apparatus 
A vortex shaker from IKA (Wilmington, NC, USA) was used to promote 
deproteination or liquid–liquid extraction (LLE). A Legend Micro 21R microcentrifuge 
from Thermo Fisher Scientific was used to centrifuge and separate the immiscible phases. 
A Concentrator plusTM from Eppendorf (Hamburg, Germany) with three application modes 
(aqueous, alcohol or high vapor pressure) was used to evaporate the extracts and the 
deproteinated sample before derivatization. A ThermoMixer C from Eppendorf was used 
to heat and mix solutions involved in the derivatization steps. An Agilent 7890A Series GC 
system coupled to an Agilent 7200 UHD Accurate-Mass QTOF hybrid mass spectrometer 
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equipped with electron impact (EI) source was used for analysis. The analytical sample was 
thus monitored in high resolution mode. MassHunter GC–QTOF Acquisition software 
(version B.07, Agilent Technologies) was used to control data acquisition and set the 
parameters for optimum operation. 
 
2.3. Sweat collection 
Active sweat was sampled from three different body areas (forehead, chest and 
back) by using a micropipette (from 20 to 200 µL) from Kartell (Noviglio, Italy) after 30 
min of moderate exercise. Previously, the skin area was cleaned with ethanol and then with 
distilled water. The use of deodorants, perfumes and cosmetics was excluded at least one 
day prior to sweat collection. The sweat was transferred to plastic microEppendorf tubes 
and stored at –80 ºC until analysis. A total sweat volume of at least 100 µL was collected 
per individual and body area.  
Passive sweat was sampled by using the Macroduct® Sweat Analysis System 
(Wescor, Utah, USA) from donors at rest, as described by Delgado-Povedano et al. [10]. A 
total sweat volume of at least 70 µL was collected per individual from the forearm. 
Sweat samples for development and characterization of the method were kindly 
donated by 6 healthy volunteers (4 men and 2 women) at Reina Sofía University Hospital 
(Córdoba, Spain). All subjects gave their informed consent for sweat sampling. No 
restrictions about diet or age were considered. All steps from sweat sampling to analysis 
were carried out in accordance with the ethical principles of the World Medical Association 
(Helsinki Declaration, 2004). 
 
2.4. Sample treatment 
Active and passive sweat pools were prepared by taking 70 µL of sweat from each 
participant. Then, different experimental strategies were tested with aliquots of both pools 
to select that providing maximum metabolite coverage:  
(i) Protocol 1: Liquid–liquid extraction (LLE) with different extractants and direct 
analysis of the extracts. Three organic solvents (hexane, dichloromethane and 
ethyl acetate) were evaluated as extractants. In all cases, a 12.5 μL aliquot of 
sample was vortexed with 75 μL of extractant in a glass insert at room 
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temperature for 5 min and centrifuged for 5 min at 10000×g. To assure the 
absence of water in the extract to be injected in the GC–MS system, the vial was 
subjected to −20 ºC to freeze the aqueous fraction; then, the organic phase was 
transferred to a new glass insert for analysis.  
(ii) Protocol 2: LLE and methoxymation+sylilation prior to analysis. After LLE 
followed by centrifugation as in protocol 1, the organic phase was isolated and 
located into a new glass insert for evaporation to dryness. Then, the solid residue 
was reconstituted with 10 µL of 40 mg/mL methoxyamine hydrochloride in 
pyridine. After adding the methoxymation agents, the mixture was shaken and 
maintained at 30 °C for 90 min. Then, 45 μL of 100:1 (v/v) BSTFA–TMCS 
mixture was added for silylation and the system was shaken for 30 s and 
maintained at 37 °C for 30 min prior to GC–MS analysis.  
(iii) Protocol 3: Deproteination with methanol–acetonitrile before 
methoxymation+silylation prior to analysis. With this aim, a 12.5 µL aliquot was 
vortexed with 75 µL of 70:30 (v:v) methanol–acetonitrile in a glass insert at room 
temperature for 5 min, then centrifuged for 5 min at 10000×g. The liquid phase 
was isolated and located into a new glass insert, evaporated to dryness before 
methoxymation plus silylation and analysis as described in Protocol 2.  
 
2.5. GC–TOF/MS analysis  
GC–TOF/MS analyses were performed following the method proposed by 
Delgado-Povedano et al. [10] by using a fused silica DB-5MS-UI 30 m×0.25 mm i.d.×0.25 
μm film thickness capillary column. All samples were analyzed in duplicate. 
 
2.6. Identification of metabolites 
Identification was carried out by searching MS spectra in theNIST11 and Fiehn 
databases [15] based on the criteria described by Delgado-Povedano et al. [10]. The match 
factor, reverse match factor and RI values in NIST database supported identifications. Fig. 
S1 shows the RI calibration graph and the equation fitting the model, both obtained as in 
Ref. [10]. Identification of sugars (D-galactose, D-glucose and myo-inositol) was confirmed 
by analysis of standards derivatized by the described protocol. 
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2.7. Data processing and statistical analysis 
Unknown Analysis software (version 7.0, Agilent Technologies, Santa Clara, CA, 
USA) was used to process all data files obtained by GC–TOF/MS in full scan mode. Then, 
MassHunter Workstation software (version B7.00 Qualitative Analysis, Agilent 
Technologies, Santa Clara, CA, USA) was used to treat all data files. Treatment of raw data 
files started by deconvolution of chromatograms to obtain a list of molecular features (MFs) 
considered as potential compounds defined by the m/z value and retention time (RT) of 
one representative ion for each chromatographic peak. For this purpose, the deconvolution 
algorithm was applied to each sample by considering all ions, the accuracy error at 50 ppm 
and the window size factor at 200 units. Finally, the MFs from data pretreatment were 
exported (.cef file) for recursive analysis. For this purpose, the Quantitative Analysis 
software (version 7.0, Agilent Technologies, Santa Clara, CA, USA) was used to reintegrate 
all potential compounds found in all analyzed samples. The resulting table was exported in 
comma separated value format (.csv file) into the Mass Profiler Professional software 
package (version 2.0, Agilent Technologies, Santa Clara, CA, USA) for statistical analysis. 
 
3. Results and discussion 
 
3.1. Liquid–liquid extraction of active sweat with no polar solvents and influence 
of derivatization on the detection coverage 
Sweat samples are not ready for direct analysis by GC–MS because of the aqueous 
nature of this excreted biofluid. Therefore, a sample preparation step is required to define 
suited protocols for the analysis and characterization of sweat composition. Deproteination 
with a methanol–acetonitrile mixture has previously been proposed as the best approach 
for untargeted analysis of low-molecular weight compounds in sweat sampled by a passive 
protocol [10]. However, no especial attention was paid to the scant no polar metabolites 
identified by MS.  
The research proposed here is intended to characterize active sweat produced after 
a moderate exercise session. Special attention was paid to no polar compounds, but without 
losing the capability of detecting polar and mid-polar compounds. For this purpose, three 
different extractants covering a mid-polar/no polar range —ethyl acetate (polarity index PI 
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4.4), dichloromethane (PI 3.1) and hexane (PI 0.0)— were selected to evaluate their 
extraction performance. Sweat aliquots of the pool were 1:6 extracted with each solvent and 
the resulting extracts were subjected to the derivatization protocol, consisting of 
methoxymation and silylation steps, prior to GC–TOF/MS analysis. Fig. S2 shows the base 
peak chromatograms (BPCs) provided by analysis of the derivatized extracts obtained with 
the three extractants, which clearly revealed the dichloromethane extract as that providing 
a higher number of chromatographic peaks with the highest sensitivity. Fig. 1A shows the 
Venn diagram comparing the number of compounds tentatively identified in the 
derivatized extracts. Identification of each compound in a given extract was validated if its 
peak area was above 10% of the sum of its peak areas reported in the three extracts. As can 
be seen, the number of identified compounds was clearly higher in the dichloromethane 
extract, which agrees with the results obtained by Delgado-Povedano et al., who compared 
dichloromethane and ethyl acetate for characterization of passive sweat [10]. The list of 
identified compounds in the three analytical samples is shown in Table 1. The analysis of 
sweat subjected to LLE with dichloromethane allowed the tentative identification of 121 
compounds as compared to ethyl acetate and hexane with 87 and 43 compounds, 
respectively. One fact to be emphasized is that 98 and 86% of the compounds identified in 
the ethyl acetate and hexane extracts, respectively, were also detected in the 
dichloromethane extract.  
 
                 
Fig. 1 (A) Venn diagram comparing the number of compounds tentatively identified in ethyl acetate, 
dichloromethane and hexane derivatized extracts of active sweat. (Identification of each compound 
in a given extract was validated if its peak area was above 10% of the sum of its peak areas reported 
in the three extracts). 
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Table 1. Compounds tentatively identified by GC–TOF/MS in ethyl acetate, dichloromethane and 
hexane extracts of active sweat after derivatization. 
Compounda 
RT 
(min) 
Formula Family 
LLE + derivatization 
Ethyl 
acetate 
Dichloro-
methane 
Hexane 
Nicotine 10.89 C10H14N2 Alkaloids    
Cotinine 15.01 C10H12N2O Alkaloids    
Caffeine 16.52 C8H10N4O2 Alkaloids    
Ethanolamine 9.36 C2H7NO Alkanolamines    
Diethanolamine 
9.60 
C4H11NO2 Alkanolamines 
   
11.67    
Triethanolamine 13.99 C6H15NO3 Alkanolamines    
Valine 
6.75 
C5H11NO2 Amino acids 
   
8.62    
Alanine 6.94 C3H7NO2 Amino acids    
Glycine 
7.24 
C2H5NO2 Amino acids 
   
9.92    
Leucine 7.77 C6H13NO2 Amino acids    
Isoleucine 
8.10 
C6H13NO2 Amino acids 
   
9.73    
Serine 
9.24 
C3H7NO3 Amino acids 
   
10.64    
Proline 9.81 C5H9NO2 Amino acids    
Threonine 10.98 C4H9NO3 Amino acids    
Sarcosine 11.19 C3H7NO2 Amino acids    
Aspartic acid 
11.51 
C4H7NO4 
Amino acids 
 
 
  
12.71 Amino acids    
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Aminomalonic acid 12.08 C3H5NO4 Amino acids    
Pyroglutamic acid 
12.48 
C5H7NO3 
Amino acids    
12.74 Amino acids    
γ-Aminobutyric acid 12.85 C4H9NO2 Amino acids    
α-Aminoadipic acid 13.05 C6H11NO4 Amino acids    
2-Aminoheptanedioic acid 13.70 C7H13NO4 Amino acids    
Ornithine 
13.86 
C5H12N2O2 Amino acids 
   
16.10    
Glutamic acid 13.91 C5H9NO4 Amino acids    
Phenylalanine 14.01 C9H11NO2 Amino acids    
Asparagine 14.49 C4H8N2O3 Amino acids    
Lysine 
14.92 
C6H14N2O2 Amino acids 
   
17.19    
Glutamine 15.63 C5H10N2O3 Amino acids    
Citrulline 
16.18 
C6H13N3O3 Amino acids 
   
18.97    
Histidine 17.16 C6H9N3O2 Amino acids    
Tyrosine 17.36 C9H11NO3 Amino acids    
Tryptophan 
19.57 
C11H12N2O2 Amino acids 
   
19.78    
19.89    
19.96    
Indane 6.05 C9H10 
Benzene 
derivatives    
Benzoic acid 9.14 C7H6O2 
Benzene 
derivatives (acids)    
4-Acetyloxybenzoic acid 14.50 C9H8O4 
Benzene 
derivatives (acids)    
4-Hydroxyphenyllactic acid 16.95 C9H10O4 
Benzene 
derivatives (acids)    
α-Keto-4-hydroxyben- 
zenepropanoic acid 
17.04 C9H8O4 
Benzene 
derivatives (acids)    

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β-Ethenylbenzeneethanol 6.05 C10H12O 
Benzene 
derivatives 
(alcohols) 
   
Cathecol 10.08 C6H6O2 
Benzene 
derivatives 
(alcohols) 
   
3-Methylcathecol 11.06 C7H8O2 
Benzene 
derivatives 
(alcohols) 
   
2,4-Ditertbutylphenol 12.63 C14H22O 
Benzene 
derivatives 
(alcohols) 
   
Pyrogallol 13.70 C6H6O3 
Benzene 
derivatives 
(alcohols) 
   
Triclosan 19.14 C12H7Cl3O2 
Benzene 
derivatives 
(clorinated) 
   
Carbamate 8.40 CH3NO2 Carbamic acids    
Trehalose 24.09 C12H22O11 
Carbohydrates 
(disaccharides)    
Erythrulose 14.56 C4H8O4 
Carbohydrates 
(monosaccharides)    
Sorbitol 16.48 C6H12O5 
Carbohydrates 
(monosaccharides)    
Galactose 
16.83 
C6H12O6 
Carbohydrates 
(monosaccharides) 
   
17.06    
Glucose 
16.90 
C6H12O6 
Carbohydrates 
(monosaccharides) 
   
17.10    
Glyceric acid 10.22 C3H6O4 
Carbohydrates 
(sugar acids)    
Threonic acid 12.96 C4H8O5 
Carbohydrates 
(sugar acids)    
Gluconic acid 17.92 C6H12O7 
Carbohydrates 
(sugar acids)    
Glycerol 9.43 C3H8O3 
Carbohydrates 
(sugar alcohols)    
Erythritol 12.53 C4H10O4 
Carbohydrates 
(sugar alcohols)    
Mannitol 17.29 C6H14O6 
Carbohydrates 
(sugar alcohols)    
Inositol 18.19 
C6H12O6 
Carbohydrates 
(sugar alcohols) 
   
myo-Inositol 18.80    
2,3-Butanediol 5.82 C4H10O2 
Other alcohols and 
polyols    
Propylene glycol 5.98 C3H8O2 
Other alcohols and 
polyols    
1,3-Butanediol 6.61 C4H10O2 
Other alcohols and 
polyols    

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
Pinacol 7.75 C6H14O2 
Other alcohols and 
polyols    
1,2-Butanediol 8.05 C4H10O2 
Other alcohols and 
polyols    
Diethylene glycol 9.04 C4H10O3 
Other alcohols and 
polyols    
1-Methylene- 
3-methylbutane-1,3-diol 
9.19 C6H12O2 
Other alcohols and 
polyols    
2-(2-Butoxyethoxy)ethanol 10.37 C8H18O3 
Other alcohols and 
polyols    
1,1,1-Tris(hydroxy-
methyl)propane 
11.06 C6H14O3 
Other alcohols and 
polyols  

 
 
Succinic acid 10.04 C4H6O4 Dicarboxylic acids    
Itaconic acid 10.41 C5H6O4 Dicarboxylic acids    
Citraconic acid 10.50 C5H6O4 Dicarboxylic acids    
Fumaric acid 10.54 C4H4O4 Dicarboxylic acids    
Glutaric acid 11.27 C5H8O4 Dicarboxylic acids    
Malic acid 12.30 C4H6O5 Dicarboxylic acids    
Adipic acid 12.56 C6H10O4 Dicarboxylic acids    
Azelaic acid 15.91 C9H16O4 Dicarboxylic acids    
Aconitic acid 15.35 C6H6O6 Tricarboxylic acids    
Pyruvic acid 6.10 C3H4O3 
Carboxylic acids 
(keto acids)    
α-Ketoglutaric acid 13.38 C5H6O5 
Carboxylic acids 
(keto acids)    
Lactic acid 
5.79 
C3H6O3 
Carboxylic acids 
(hydroxy acids) 
   
6.25    
Glycolic acid 6.51 C2H4O3 
Carboxylic acids 
(hydroxy acids)    
Caproic acid 6.51 C6H12O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
   
Caprylic acid 9.36 C8H16O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
   
Pelargonic acid 10.69 C9H18O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
   
Capric acid 11.97 C10H20O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
   
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Lauric acid 14.33 C12H24O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
   
Tridecylic acid 15.43 C13H26O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Mirystoleic acid 16.25 C14H26O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Myristic acid 16.48 C14H28O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Pentadecylic acid 17.48 C15H30O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Palmitic acid 18.44 C16H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  
Palmitoleic acid 18.19 C16H30O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
10-Heptadecenoic acid 19.12 C17H32O 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Margaric acid 19.36 C17H34O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Arachidonic acid 19.83 C20H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Linoleic acid 19.83 C18H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Oleic acid 20.01 C18H34O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Stearic acid 20.24 C18H36O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  
Arachidic acid 21.90 C20H40O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
   
Lignoceric acid 24.88 C24H48O2 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
   
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Hexacosanoic acid 26.41 C26H52O2 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
   
Dipropylacetic acid 9.36 C8H16O2 
Lipids (methyl-
branched fatty 
acids) 
   
2-Hydroxybutyric acid 7.25 C4H8O3 
Lipids (hydroxy 
fatty acids)    
3-Hydroxybutyric acid 7.81 C4H8O3 
Lipids (hydroxy 
fatty acids)    
3-Hydroxyisovaleric acid 7.85 C5H10O3 
Lipids (hydroxy 
fatty acids)    
2-Hydroxyisocaproic acid 8.91 C6H12O3 
Lipids (hydroxy 
fatty acids)    
5-Hydroxy-n-valeric acid 10.29 C5H10O 
Lipids (hydroxy 
fatty acids)    
Erucylamide 24.51 C22H43NO 
Lipids (fatty 
amides)    
Mono(2-ethylhexyl)adipate 21.50 C14H26O4 
Lipids (fatty acid 
esters)    
1-Monoisobutyroylglycerol 12.08 C7H14O4 
Lipids 
(acylglycerides)    
2-Monopalmitoylglycerol 22.76 C19H38O4 
Lipids 
(acylglycerides)    
1-Monopalmitoylglycerol 23.02 C19H38O4 
Lipids 
(acylglycerides)    
2-Monostearoylglycerol 24.20 C21H42O4 
Lipids 
(acylglycerides)    
1-Monostearoylglycerol 24.45 C21H42O4 
Lipids 
(acylglycerides)    
1-Monoarachidoylglycerol 25.86 C23H46O4 
Lipids 
(acylglycerides)    
Dehydroabietic acid 21.54 C20H28O2 
Lipids (prenol 
lipids-diterpenes)    
Squalene 24.76 C30H50 
Lipids (prenol 
lipids-triterpenes)    
Hedione 14.35 C13H22O3 
Lipids (lineolic 
acids and 
derivatives-
jasmonic acids) 
   
Cholesta-3,5-diene 25.47 C27H44 
Lipids (steroids 
and steroids 
derivatives) 
   
1-Dodecanol 13.35 C12H26O 
Lipids (fatty 
alcohols)    
1-Tetradecanol 15.58 C14H30O 
Lipids (fatty 
alcohols)    
1-Hexadecanol 17.62 C16H34O 
Lipids (fatty 
alcohols)    
1-Octadecanol 19.47 C18H38O 
Lipids (fatty 
alcohols)    
Phosphate 9.42 PO43- 
No metal 
oxoanionic 
compounds 
   

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2-Furoic acid 7.46 C5H4O3 
Organoheterocyclic 
compounds    
Uracil 10.34 C4H4N2O2 
Organoheterocyclic 
compounds    
Uridine 15.12 C9H12N2O6 
Organoheterocyclic 
compounds    
Urocanic acid 15.63 C6H6N2O2 
Organoheterocyclic 
compounds    
Xanthine 18.13 C5H4N4O2 
Organoheterocyclic 
compounds    
Uric acid 18.89 C5H4N4O3 
Organoheterocyclic 
compounds    
Urea 
8.10 
CH4N2O Ureas 
   
9.00    
Borate 9.64 BO33- Exogenous    
Methylparaben 12.46 C8H8O3 Exogenous    
a Identification of each compound in a given extract was validated if its peak area was above 10% of the sum of its 
peak areas reported in the three extracts. 
 
On the other hand, the hexane extract allowed identifying less than 31% of the 
sweat components found in the dichloromethane extract, while the ethyl acetate extract 
covered approximately 70% of them. Dichloromethane and ethyl acetate provided very 
close compositions, but the former allowed detecting no polar compounds with higher 
sensitivity. This is clear in the heat map shown in Fig. 1B that compares the three 
extractants. As can be seen, only few compounds were quantitatively extracted with hexane 
or ethyl acetate as compared to dichloromethane. Attending to these results, 
dichloromethane would be recommended as solvent to extract no polar and also polar 
compounds from sweat. 
The inclusion of a generic derivatization procedure such as methoxymation 
followed by silylation enables to enhance the detection of no volatile components. On the 
other hand, VOCs could be detected by direct GC–MS analysis. This approach was used by 
Zeng et al. in 1991 for the first time for the identification of VOCs in human sweat [3]. At 
present, it is well known that sweat may contain both a wide variety of no volatile 
compounds but also VOCs. With these premises, all sweat extracts (ethyl acetate, 
dichloromethane and hexane extracts) were also directly analyzed without derivatization. 
Fig. S3 shows the BPCs provided by direct analysis of the three extracts. As can be seen, the 
Continuation Table 1 
 Chapter VIII 
 
Page | 417  
chromatographic profiles provided by the derivatized extracts clearly reported more peaks 
than the underivatized extracts, but also the sensitivity was enhanced when derivatization 
was implemented. This result was especially remarkable for the dichloromethane extract 
as compared to ethyl acetate and hexane extracts. 
Fig. 2 compares the number of identified compounds in the dichloromethane 
extract with and without derivatization. Identification of each compound in a given extract 
was validated if its peak area was above 10% of the sum of its peak areas reported in the 
three extracts. Direct analysis only made possible to identify 14 compounds, 7 of them 
(isobutylparaben, propylparaben, triclosan, phenylethyl alcohol, α,α-dimethylbenzene-
methanol, erucylamide and 1-undecyne) exclusively identified by direct analysis of the 
extract.  
The same identification results were obtained for ethyl acetate and hexane samples 
since derivatization of the extract clearly led to higher identification rates than direct 
analysis. Therefore, methoxymation plus sylilation after LLE with dichloromethane seems 
to be the suited sample preparation approach for sweat analysis by GC–TOF/MS. 
 
 
Fig. 2. Venn diagram comparing the number of compounds tentatively identified in 
dichloromethane extracts of active sweat after derivatization and direct analysis. (Identification of 
each compound in a given extract was validated if its peak area was above 10% of the sum of its peak 
areas reported in the three extracts). 
 
3.2. Comparison of liquid–liquid extraction and deproteination for untargeted 
analysis of active sweat 
After knowing the chemical diversity of compounds found in sweat after LLE, the 
performance of a deproteination protocol using methanol‒acetonitrile was tested. Sweat 
7 7 115 
LLE dichloromethane 
(direct analysis) 
(14) 
LLE dichloromethane + 
derivatization 
(122) 
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aliquots were 1:6 mixed with a 70:30 (v/v) methanol‒acetonitrile mixture. The same 
derivatization protocol was used to enhance identification as previously assayed. Fig. 3 
shows the Venn diagram comparing the number of compounds tentatively identified in 
dichloromethane extract and deproteinated sweat. 
 
            
Fig. 3. Venn diagram comparing the number of compounds tentatively identified in 
dichloromethane extract and in active sweat deproteinated with methanol–acetonitrile. 
Derivatization was applied to both extracts. (Identification of each compound in a given extract was 
validated if its peak area was above 10% of the sum of its peak areas reported in the three extracts). 
 
The criterion used to validate identifications was adopted here. The list of the 
compounds identified in these two analytical samples is shown in Table 2. The analysis of 
sweat subjected to deproteination reported 116 compounds, a number very close to that 
obtained after LLE. One fact to be emphasized is that 98% of the compounds detected by 
deproteination of sweat were also detected in the dichloromethane extracts. Three of the 
compounds detected only in dichloromethane extracts fit three main unsaturated fatty 
acids: C18:1 ω-9, C18:2 ω-6 and C20:4 ω-6. 
Concerning the sensitivity of the approach, only 32% of the compounds commonly 
detected in the analytical samples obtained by both sample preparation protocols reported 
a lower sensitivity in the dichloromethane extract as compared to the deproteined sample. 
Most of these compounds were amino acids, mainly essential amino acids such as valine, 
lysine, histidine and tryptophan. Fig. 4 shows the heat map that compares the relative 
concentrations of compounds detected using the two protocols. As can be seen, 
methoxymation plus silylation after LLE with dichloromethane seems to be the suited 
8 114 2 
LLE dichloromethane 
+ derivatization 
(122) 
Deproteination  
+ derivatization  
(116) 
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sample preparation approach for analysis by GC–TOF/MS of active sweat after moderate 
exercise. 
 
Table 2. Compounds tentatively identified by GC–TOF/MS in dichloromethane extract of active 
sweat and deproteinated sweat, after derivatization in both cases. 
Compounda 
RT 
(min) 
Formula Family 
Deproteination 
+ 
derivatization 
LLE dichloro-
methane 
+ 
derivatization 
Cotinine 15.01 C10H12N2O Alkaloids  
Caffeine 16.52 C8H10N4O2 Alkaloids  
Ethanolamine 9.36 C2H7NO Alkanolamines  
Diethanolamine 
9.60 
C4H11NO2 Alkanolamines 
 
11.67  
Triethanolamine 13.99 C6H15NO3 Alkanolamines  
Valine 
6.75 
C5H11NO2 Amino acids 
 
8.62  
Alanine 6.94 C3H7NO2 Amino acids  
Glycine 
7.24 
C2H5NO2 Amino acids 
 
9.92  
Leucine 7.77 C6H13NO2 Amino acids  
Isoleucine 
8.10 
C6H13NO2 Amino acids 
 
9.73  
Serine 
9.24 
C3H7NO3 Amino acids 
 
10.64  
Proline 9.81 C5H9NO2 Amino acids  
Threonine 10.98 C4H9NO3 Amino acids  
Sarcosine 11.19 C3H7NO2 Amino acids  
Aspartic acid 12.71 C4H7NO4 Amino acids   
Aminomalonic acid 12.08 C3H5NO4 Amino acids  

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
Pyroglutamic acid 
12.48 
C5H7NO3 
Amino acids  
12.74 Amino acids  
γ-Aminobutyric acid 12.85 C4H9NO2 Amino acids  
α-Aminoadipic acid 13.05 C6H11NO4 Amino acids  
2-Aminoheptanedioic 
acid 
13.70 C7H13NO4 Amino acids  
Ornithine 
13.86 
C5H12N2O2 Amino acids 
 
16.10  
Glutamic acid 13.91 C5H9NO4 Amino acids  
Phenylalanine 14.01 C9H11NO2 Amino acids  
Asparagine 14.49 C4H8N2O3 Amino acids  
Lysine 
14.92 
C6H14N2O2 Amino acids 
 
17.19  
Glutamine 15.63 C5H10N2O3 Amino acids  
Citrulline 
16.18 
C6H13N3O3 Amino acids 
 
18.97  
Histidine 17.16 C6H9N3O2 Amino acids  
Tyrosine 17.36 C9H11NO3 Amino acids  
Tryptophan 
19.57 
C11H12N2O2 Amino acids 
 
19.78  
19.89  
19.96  
Indane 6.05 C9H10 
Benzene 
derivatives  
Benzoic acid 9.14 C7H6O2 
Benzene 
derivatives (acids)  
4-Acetyloxybenzoic acid 14.50 C9H8O4 
Benzene 
derivatives (acids)  
4-Hydroxyphenyllactic 
acid 
16.95 C9H10O4 
Benzene 
derivatives (acids)  
α-Keto- 
4-hydroxybenzenepro-
panoic acid 
17.04 C9H8O4 
Benzene 
derivatives (acids)  

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
β-Ethenylben-
zeneethanol 
6.05 C10H12O 
Benzene 
derivatives 
(alcohols) 
 
Cathecol 10.08 C6H6O2 
Benzene 
derivatives 
(alcohols) 
 
2,4-Ditertbutylphenol 12.63 C14H22O 
Benzene 
derivatives 
(alcohols) 
 
Pyrogallol 13.70 C6H6O3 
Benzene 
derivatives 
(alcohols) 
 
Carbamate 8.40 CH3NO2 Carbamic acids  
Trehalose 24.09 C12H22O11 
Carbohydrates 
(disaccharides)  
Erythrulose 14.56 C4H8O4 
Carbohydrates 
(monosaccharides)  
Sorbitol 16.48 C6H12O5 
Carbohydrates 
(monosaccharides)  
Galactose 
16.83 
C6H12O6 
Carbohydrates 
(monosaccharides) 
 
17.06  
Glucose 
16.90 
C6H12O6 
Carbohydrates 
(monosaccharides) 
 
17.10  
Glyceric acid 10.22 C3H6O4 
Carbohydrates 
(sugar acids)  
Threonic acid 12.96 C4H8O5 
Carbohydrates 
(sugar acids)  
Gluconic acid 17.92 C6H12O7 
Carbohydrates 
(sugar acids)  
Glycerol 9.43 C3H8O3 
Carbohydrates 
(sugar alcohols)  
Erythritol 12.53 C4H10O4 
Carbohydrates 
(sugar alcohols)  
Mannitol 17.29 C6H14O6 
Carbohydrates 
(sugar alcohols)  
Inositol 18.19 
C6H12O6 
Carbohydrates 
(sugar alcohols) 
 
myo-Inositol 18.80  
2,3-Butanediol 5.82 C4H10O2 
Other alcohols and 
polyols  
Propylene glycol 5.98 C3H8O2 
Other alcohols and 
polyols  
1,3-Butanediol 6.61 C4H10O2 
Other alcohols and 
polyols  
Pinacol 7.75 C6H14O2 
Other alcohols and 
polyols  
1,2-Butanediol 8.05 C4H10O2 
Other alcohols and 
polyols  
Diethylene glycol 9.04 C4H10O3 
Other alcohols and 
polyols  

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
1-Methylene- 
3-methylbutane-1,3-diol 
9.19 C6H12O2 
Other alcohols and 
polyols  
2-(2-Butoxy-
ethoxy)ethanol 
10.37 C8H18O3 
Other alcohols and 
polyols  
Succinic acid 10.04 C4H6O4 Dicarboxylic acids  
Itaconic acid 10.41 C5H6O4 Dicarboxylic acids  
Citraconic acid 10.50 C5H6O4 Dicarboxylic acids  
Fumaric acid 10.54 C4H4O4 Dicarboxylic acids  
Glutaric acid 11.27 C5H8O4 Dicarboxylic acids  
Malic acid 12.30 C4H6O5 Dicarboxylic acids  
Adipic acid 12.56 C6H10O4 Dicarboxylic acids  
Azelaic acid 15.91 C9H16O4 Dicarboxylic acids  
Aconitic acid 15.35 C6H6O6 Tricarboxylic acids  
Pyruvic acid 6.10 C3H4O3 
Carboxylic acids 
(keto acids)  
α-Ketoglutaric acid 13.38 C5H6O5 
Carboxylic acids 
(keto acids)  
Lactic acid 6.25 C3H6O3 
Carboxylic acids 
(hydroxy acids)   
Glycolic acid 6.51 C2H4O3 
Carboxylic acids 
(hydroxy acids)  
Caproic acid 6.51 C6H12O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
 
Caprylic acid 9.36 C8H16O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
 
Pelargonic acid 10.69 C9H18O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
 
Capric acid 11.97 C10H20O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
 
Lauric acid 14.33 C12H24O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
 
Tridecylic acid 15.43 C13H26O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Mirystoleic acid 16.25 C14H26O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 

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
Myristic acid 16.48 C14H28O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Pentadecylic acid 17.48 C15H30O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Palmitic acid 18.44 C16H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  
Palmitoleic acid 18.19 C16H30O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
10-Heptadecenoic acid 19.12 C17H32O 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Margaric acid 19.36 C17H34O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Arachidonic acid 19.83 C20H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Linoleic acid 19.83 C18H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Oleic acid 20.01 C18H34O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Stearic acid 20.24 C18H36O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  
Arachidic acid 21.90 C20H40O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
 
Lignoceric acid 24.88 C24H48O2 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
 
Hexacosanoic acid 26.41 C26H52O2 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
 
Dipropylacetic acid 9.36 C8H16O2 
Lipids (methyl-
branched fatty 
acids) 
 
2-Hydroxybutyric acid 7.25 C4H8O3 
Lipids (hydroxy 
fatty acids)  
3-Hydroxybutyric acid 7.81 C4H8O3 
Lipids (hydroxy 
fatty acids)  

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
3-Hydroxyisovaleric acid 7.85 C5H10O3 
Lipids (hydroxy 
fatty acids)  
5-Hydroxy-n-valeric acid 10.29 C5H10O3 
Lipids (hydroxy 
fatty acids)  
Erucylamide 24.51 C22H43NO 
Lipids (fatty 
amides)  
Mono(2-ethylhexyl)- 
adipate 
21.50 C14H26O4 
Lipids (fatty acid 
esters)  
1-Monoisobutyroyl-
glycerol 
12.08 C7H14O4 
Lipids 
(acylglycerides)  
2-Monopalmitoylglycerol 22.76 C19H38O4 
Lipids 
(acylglycerides)  
1-Monopalmitoylglycerol 23.02 C19H38O4 
Lipids 
(acylglycerides)  
2-Monostearoylglycerol 24.20 C21H42O4 
Lipids 
(acylglycerides)  
1-Monostearoylglycerol 24.45 C21H42O4 
Lipids 
(acylglycerides)  
1-Monoarachidoyl-
glycerol 
25.86 C23H46O4 
Lipids 
(acylglycerides)  
Dehydroabietic acid 21.54 C20H28O2 
Lipids (prenol 
lipids-diterpenes)  
Squalene 24.76 C30H50 
Lipids (prenol 
lipids-triterpenes)  
Hedione 14.35 C13H22O3 
Lipids (lineolic 
acids and 
derivatives-
jasmonic acids) 
 
Cholesta-3,5-diene 25.47 C27H44 
Lipids (steroids 
and steroids 
derivatives) 
 
1-Dodecanol 13.35 C12H26O 
Lipids (fatty 
alcohols)  
1-Tetradecanol 15.58 C14H30O 
Lipids (fatty 
alcohols)  
1-Hexadecanol 17.62 C16H34O 
Lipids (fatty 
alcohols)  
1-Octadecanol 19.47 C18H38O 
Lipids (fatty 
alcohols)  
Phosphate 9.42 PO43- 
No metal 
oxoanionic 
compounds 
 
2-Furoic acid 7.46 C5H4O3 
Organoheterocyclic 
compounds  
Uracil 10.34 C4H4N2O2 
Organoheterocyclic 
compounds  
Uridine 15.12 C9H12N2O6 
Organoheterocyclic 
compounds  
Urocanic acid 15.63 C6H6N2O2 
Organoheterocyclic 
compounds  
Xanthine 18.13 C5H4N4O2 
Organoheterocyclic 
compounds  
Uric acid 18.89 C5H4N4O3 
Organoheterocyclic 
compounds  

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
Urea 
8.10 
CH4N2O Ureas 
 
9.00  
Borate 9.64 BO33- Exogenous   
Methylparaben 12.46 C8H8O3 Exogenous  
a Identification of each compound in a given extract was validated if its peak area was above 10% of the sum of its 
peak areas reported in the two analytical samples. 
 
3.3. Identification of compounds in active sweat  
Tentatively identified compounds covered a wide diversity of chemical families 
such as lipids, benzene derivatives, amino acids, carboxylic acids, organoheterocyclic 
compounds, alkaloids and carbohydrates, among others. This wide variety of compounds, 
particularly no polar compounds, would increase the interest of sweat for clinical studies, 
particularly for identification of biomarkers. Table 3 lists the identified compounds 
classified per chemical family. Identification parameters are detailed for each compound. 
As can be seen, lipids constitute the most abundant group of identified compounds; very 
different from previous characterization studies dealing with sweat [7,9]. The detection of 
lipids as a major metabolite class in human sweat samples confirms previous reports 
detailing the occurrence of lipids in eccrine sweat despite the aqueous nature of this sample 
[4]. Futhermore, the epidermis is a very active site of lipids synthesis. In the present study 
20 fatty acids and conjugates, 8 fatty acid derivatives, 6 acylglycerides, 5 fatty alcohols, 2 
prenol lipids, 1 steroid and one jasmonic acid derivative were identified in sweat. Fatty acids 
are secreted by apocrine glands and are required for the normal barrier function. 
Furthermore, the concentration of some fatty acids, especially C2-C11 fatty acids, have been 
correlated to microbial biotransformation [16]. Fatty acids detected in sweat were mostly 
saturated, ranging from short- to very long-chain fatty acids: caproic acid (C6:0), caprylic 
acid, (C8:0), pelargonic acid (C9:0), capric acid (C10:0), lauric acid (C12:0), tridecanoic 
acid (C13:0), myristic acid (C14:0), pentadecanoic acid (C15:0), palmitic acid (C16:0), 
margaric acid (C17:0), stearic acid (C18:0), arachidic acid (C20:0), lignoceric acid (C24:0) 
and hexacosanoic acid (C26:0).  
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Monounsaturated fatty acids (MUFAs) such as myristoleic acid (C14:1 ω-5), 
palmitoleic acid (C16:1 ω-7), 10-heptadecenoic acid (C17:1 ω-7) and oleic acid (C18:1 ω-9), 
and polyunsaturated fatty acids (PUFAs) such as linoleic acid (C18:2 ω-6) and arachidonic 
acid (C20:4 ω-6) were identified in sweat. Among them, C18:0 and C20:0, together with 
C18:1 ω-9 and C18:2 ω-6 constituted around 75% of all free fatty acids in sweat, in 
agreement with the results provided by Korea et al. [17]. 
Fatty acid derivatives detected in active sweat were mainly hydroxy fatty acids, 
which are present in human dermis and epidermis [18]: 2-hydroxy fatty acids (2-
hydroxybutyric and 2-hydroxyisocaproic acids), 3-hydroxy fatty acids (3-hydroxybutyric 
and 3-hydroxyisovaleric acids) and a 5-hydroxy fatty acid (5-hydroxy-n-valeric acid). Other 
identified fatty acid derivatives were a fatty acid ester —mono(2-ethylhexyl)adipate—, a 
methyl-branched fatty acid (dipropylacetic acid) and a jasmonic acid derivative (hedione), 
which had not been previously detected in sweat. Only one fatty amide, erucylamide, was 
identified in sweat sampled after moderate active exercise. This compound had previously 
been studied because of its potential as antimicrobial agent [19].  
Concerning acylglycerides, glycerol ester isomers from C16:0, C18:0 and C20:0 (1-
monopalmitoylglycerol, 2-monopalmitoylglycerol, 1-monostearoylglycerol, 2-monoste-
aroylglycerol and 1-monoarachidoylglycerol) were detected in sweat, as well as the 
monoacylglycerol from isobutyric acid (1-monoisobutyroylglycerol). Some monoglycerides 
such as 1-monopalmitoylglycerol and 1-monostearoylglycerol had been previously 
identified in sweat [10]. Other fatty acid derivatives detected in sweat were fatty alcohols, 
mostly saturated (1-docecanol, 1-tetradecanol, 1-hexadecanol, 1-octadecanol), but also an 
unsaturated fatty alcohol (3-nonen-1-ol). Regarding unsaponifiable lipids, only one steroid 
(cholesta-3,5-diene), and two prenol lipids such as dehydroabietic acid (diterpene) and 
squalene (triterpene) were identified. Squalene, involved in the synthesis of cholesterol 
[20], had been previously identified in sweat [10]. 
Amino acids are other key group of metabolites identified in sweat, including 
essential (8) and no essential (9) amino acids, but also a few no proteinogenic amino acids 
(8). These last compounds play key roles as intermediates in metabolic pathways. Thus, 
aminoadipic and aminomalonic acids, citrulline, pyroglutamic acid and sarcosine play roles 
as intermediates in the formation of lysine, alanine, arginine, glutamic acid and glycine, 
while ornithine is involved in the urea cycle (urea was also detected). A neurotransmitter 
—γ-aminobutyric acid (GABA)— and 2-aminoheptanedioic acid were also detected. Most 
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of these amino acids or derivatives had previously been identified in sweat using different 
protocols [8,9]. 
 
Table 3. Compounds identified by GC–TOF/MS in active sweat classified by the chemical family. 
Compound 
RT 
(min) 
Formula 
CAS 
ID 
Formula 
(derivatiza- 
tion) 
Fragments Family 
Nicotine 10.89 C10H14N2 54-11-5 C10H14N2 
133.0759 
119.0611 
84.0808 
Alkaloids 
Cotinine 15.01 C10H12N2O 
486-
56-6 
C10H12N2O 
176.0938 
118.0640 
98.0599 
Alkaloids 
Caffeine 16.52 C8H10N4O2 
58-08-
2 
C8H10N4O2 
194.0798 
109.0624 
67.0301 
Alkaloids 
Ethanolamine 9.36 C2H7NO 
141-
43-5 
C11H31NOSi3 
174.1133 
131.0884 
117.0735 
Alkanolamines 
Diethanolamine 
9.60 
C4H11NO2 
111-42-
2 
C10H27NO2Si2 
146.0987 
130.0682 
59.0310 
Alkanolamines 
11.67 C13H35NO2Si3 
218.1395 
130.0682 
56.0497 
Triethanolamine 13.99 C6H15NO3 
102-
71-6 
C15H39NO3Si3 
262.1655 
117.0714 
59.0307 
Alkanolamines 
Valine 
6.75 
C5H11NO2 
72-18-
4 
C8H19NO2Si 
146.0648 
72.0814 
55.0547 
Amino acids 
8.62 C11H27NO2Si2 
246.1324 
218.1110 
203.0809 
Alanine 6.94 C3H7NO2 
56-41-
7 
C9H23NO2Si2 
218.1013 
190.1067 
116.0885 
Amino acids 
Glycine 
7.24 
C2H5NO2 
56-40-
6 
C8H21NO2Si2 
204.0876 
176.0914 
102.0735 
Amino acids 
9.92 C11H29NO2Si3 
276.1248 
248.1303 
174.1125 
Leucine 7.77 C6H13NO2 
61-90-
5 
C9H21NO2Si 
86.0964 
75.0271 
44.0497 
Amino acids 
Isoleucine 
8.10 
C6H13NO2 
73-32-
5 
C9H21NO2Si 
170.0994 
86.0963 
75.0271 
Amino acids 
9.73 C12H29NO2Si2 
260.1489 
232.1535 
158.1357 
Serine 
9.24 
C3H7NO3 
302-
84-1 
C9H23NO3Si2 
234.0954 
206.0477 
193.0507 
Amino acids 
10.64 C12H31NO3Si3 
218.1033 
204.1283 
188.0924 
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Proline 9.81 C5H9NO2 
609-
36-9 
C11H25NO2Si2 
216.1224 
170.0620 
142.1043 
Amino acids 
Threonine 10.98 C4H9NO3 
72-19-
5 
C13H33NO3Si3 
291.1513 
218.1342 
117.0734 
Amino acids 
Sarcosine 11.19 C3H7NO2 
107-
97-1 
C9H23NO2Si2 
190.1074 
147.0659 
116.0888 
Amino acids 
Aspartic acid 
11.51 
C4H7NO4 
617-
45-8 
C10H23NO4Si2 
262.0921 
172.0462 
160.0787 
Amino acids 
12.71 C13H31NO4Si3 
232.1202 
218.1042 
100.0587 
Amino acids 
Aminomalonic acid 12.08 C3H5NO4 
1068-
84-4 
C12H29NO4Si3 
320.1163 
292.1216 
218.1028 
Amino acids 
Pyroglutamic acid 
12.48 
C5H7NO3 
149-
87-1 
C8H15NO3Si 
106.0635 
84.0445 
56.0497 
Amino acids 
12.74 C11H23NO3Si2 
156.0863 
93.5422 
84.0436 
Amino acids 
γ-Aminobutyric acid 12.85 C4H9NO2 
56-12-
2 
C13H33NO2Si3 
304.1577 
174.1127 
100.0217 
Amino acids 
α-Aminoadipic acid 13.05 C6H11NO4 
1118-
90-7 
C15H35NO4Si3 
334.1635 
260.1497 
100.0218 
Amino acids 
2-Aminoheptanedioic acid 13.70 C7H13NO4 
627-
76-9 
C16H37NO4Si3 
274.1660 
218.1033 
73.0470 
Amino acids 
Ornithine 
13.86 
C5H12N2O2 
70-26-
8 
C14H36N2O2Si3 
348.2070 
142.1039 
115.0789 
Amino acids 
16.10 C17H44N2O2Si4 
420.2496 
147.1142 
142.1060 
Glutamic acid 13.91 C5H9NO4 
56-86-
9 
C14H33NO4Si3 
348.1465  
246.1333 
230.1019 
Amino acids 
Phenylalanine 14.01 C9H11NO2 
63-91-
2 
C15H27NO2Si2 
294.1339 
218.1021 
192.1194 
Amino acids 
Asparagine 14.49 C4H8N2O3 
70-47-
3 
C13H32N2O3Si3 
231.1341 
188.0919 
116.0842 
Amino acids 
Lysine 
14.92 
C6H14N2O2 
56-87-
1 
C15H38N2O2Si3 
362.2214 
230.1162 
156.1187 
Amino acids 
17.19 C18H46N2O2Si4 
317.2265 
174.1133 
156.1207 
Glutamine 15.63 C5H10N2O3 
56-85-
9 
C14H34N2O3Si3 
245.1492 
156.0844 
75.0262 
Amino acids 
Citrulline 16.18 C6H13N3O3 
372-
75-8 
C18H45N3O3Si4 
157.1156 
142.1040 
100.0217 
Amino acids 
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 18.97   C15H37N3O3Si3 
391.2138 
100.0218 
70.0656 
 
Histidine 17.16 C6H9N3O2 
71-00-
1 
C15H33N3O2Si3 
254.1512 
182.1105 
154.0933 
Amino acids 
Tyrosine 17.36 C9H11NO3 
60-18-
4 
C18H35NO3Si3 
382.1682 
354.1731 
280.1538 
Amino acids 
Tryptophan 
19.57 
C11H12N2O2 
73-22-
3 
C14H20N2O2Si 
159.0916 
130.0660 
75.0263 
Amino acids 
19.78 C17H28N2O2Si2 
218.1024 
130.0645 
73.0464 
19.89 C17H28N2O2Si2 
202.1046 
130.0644 
45.0153 
19.96 C20H36N2O2Si3 
291.1496 
218.1023 
202.1045 
Indane 6.05 C9H10 
496-
11-7 
C9H10 
117.0694 
91.0538 
63.0146 
Benzene 
derivatives 
Benzoic acid 9.14 C7H6O2 
65-85-
0 
C10H14O2Si 
194.0739 
179.0515 
105.0325 
Benzene 
derivatives (acids) 
4-Acetyloxybenzoic acid 14.50 C9H8O4 
2345-
34-8 
C12H16O4Si 
210.0714 
195.0488 
135.0284 
Benzene 
derivatives (acids) 
4-Hydroxyphenyllactic 
acid 
16.95 C9H10O4 
306-
23-0 
C18H34O4Si3 
308.1252 
293.1031 
179.0884 
Benzene 
derivatives (acids) 
α-Keto-4-hydroxyben-
zenepropanoic acid 
17.04 C9H8O4  C16H27NO4Si2 
338.1240 
277.1320 
190.0689 
Benzene 
derivatives (acids) 
β-Ethenylben-zeneethanol 6.05 C10H12O 
6052-
63-7 
C10H12O 
117.0691 
91.0534 
51.0118 
Benzene 
derivatives 
(alcohols) 
α,α-Dimethylben-
zenemethanol 
6.76 C9H12O 
617-
94-7 
C9H12O 
121.0645 
103.0529 
43.0178 
Benzene 
derivatives 
(alcohols) 
Phenylethyl alcohol 7.19 C8H10O 
60-12-
8 
C8H10O 
91.0541 
65.0384 
51.0213 
Benzene 
derivatives 
(alcohols) 
Cathecol 10.08 C6H6O2 
120-
80-9 
C12H22O2Si2 
254.1156 
151.0219 
73.0471 
Benzene 
derivatives 
(alcohols) 
3-Methylcathecol 11.06 C7H8O2 
488-
17-5 
C13H24O2Si2 
268.1312 
253.1061 
180.0609 
Benzene 
derivatives 
(alcohols) 
2,4-Ditertbutylphenol 12.63 C14H22O 
96-76-
4 
C14H22O 
206.1074 
191.1430 
163.1114 
Benzene 
derivatives 
(alcohols) 
Pyrogallol 13.70 C6H6O3 
87-66-
1 
C15H30O3Si3 
342.1490 
239.0553 
211.0599 
Benzene 
derivatives 
(alcohols) 
Triclosan 19.14 C12H7Cl3O2 
3380-
34-5 
C12H7Cl3O2 
252.9851 
218.0133 
145.9683 
Benzene 
derivatives 
(clorinated) 
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Isobutylparaben 13.01 C11H14O3 
4247-
02-3 
C11H14O3 
138.0311 
121.0284 
93.0358 
Benzene 
derivatives (esters) 
Carbamate 8.40 CH3NO2 
463-
77-4 
C10H27NO2Si3 
147.0659 
131.0359 
100.0217 
Carbamic acids 
Trehalose 24.09 C12H22O11 
6138-
23-4 
C36H86O11Si8 
361.1689 
243.1224 
191.0900 
Carbohydrates 
(disaccharides) 
Erythrulose 14.56 C4H8O4 
496-
55-9 
C16H41NO4Si4 
320.1512 
117.0641 
103.0472 
Carbohydrates 
(monosaccharides) 
Sorbitol 16.48 C6H12O5 
154-
58-5 
C18H44O5Si4 
259.1165 
217.1061 
191.0894 
Carbohydrates 
(monosaccharides) 
Galactose 
16.83 
C6H12O6 
59-23-
4 
C21H52O6Si5 
305.1384 
265.1097 
204.0998 Carbohydrates 
(monosaccharides) 
17.06 C22H55NO6Si5 
319.1559 
205.1053 
160.0764 
Glucose 
16.90 
C6H12O6 
50-99-
7 
C21H52O6Si5 
305.1388 
265.1093 
204.0998 Carbohydrates 
(monosaccharides) 
17.10 C22H55NO6Si5 
319.1563 
205.1065 
160.0784 
Glyceric acid 10.22 C3H6O4 
473-
81-4 
C12H30O4Si3 
307.1189 
292.1329 
189.0760 
Carbohydrates 
(sugar acids) 
Threonic acid 12.96 C4H8O5 
20246-
26-8 
C16H40O5Si4 
292.1326 
220.0931 
205.1057 
Carbohydrates 
(sugar acids) 
Gluconic acid 17.92 C6H12O7 
526-
95-4 
C24H60O7Si6 
333.1387 
292.1350 
117.0371 
Carbohydrates 
(sugar acids) 
Glycerol 9.43 C3H8O3 
56-81-
5 
C12H32O3Si3 
293.1401 
218.1127 
205.1071 
Carbohydrates 
(sugar alcohols) 
Erythritol 12.53 C4H10O4 
149-
32-6 
C16H42O4Si4 
217.1075 
205.1066 
117.0432 
Carbohydrates 
(sugar alcohols) 
Mannitol 17.29 C6H14O6 
69-65-
8 
C24H62O6Si6 
319.1590 
277.1472 
217.1086 
Carbohydrates 
(sugar alcohols) 
Inositol 18.19 
C6H12O6 
488-
59-5 
C24H60O6Si6 
612.2920 
305.1403 
217.1059 Carbohydrates 
(sugar alcohols) 
myo-Inositol 18.80 
87-89-
8 
C24H60O6Si6 
612.2926 
305.1405 
217.1060 
2,3-Butanediol 5.82 C4H10O2 
513-
85-9 
C10H26O2Si2 
147.0653 
133.0181 
117.0720 
Other alcohols and 
polyols 
Propylene glycol 5.98 C3H8O2 
57-55-
6 
C9H24O2Si2 
147.0662 
117.0726 
73.0469 
Other alcohols and 
polyols 
1,3-Butanediol 6.61 C4H10O2 
107-
88-0 
C10H26O2Si2 
191.0911 
117.0721 
59.0310 
Other alcohols and 
polyols 
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Pinacol 7.75 C6H14O2 
76-09-
5 
C12H30O2Si2 
131.0881 
115.0561 
73.0464 
Other alcohols and 
polyols 
1,2-Butanediol 8.05 C4H10O2 
584-
03-2 
C10H26O2Si2 
131.0882 
117.0714 
73.0469 
Other alcohols and 
polyols 
Diethylene glycol 9.04 C4H10O3 
111-46-
6 
C10H26O3Si2 
147.0658 
117.0716 
101.0409 
Other alcohols and 
polyols 
1-Methylene- 
3-methylbutane-1,3-diol 
9.19 C6H12O2  C12H28O2Si2 
147.0655 
131.0886 
45.0155 
Other alcohols and 
polyols 
2-(2-Butoxy-
ethoxy)ethanol 
10.37 C8H18O3 
112-
34-5 
C11H26O3Si 
117.0713 
101.0416 
85.0643 
Other alcohols and 
polyols 
1,1,1-Tris(hydroxy-
methyl)propane 
11.06 C6H14O3 
77-99-
6 
C15H38O3Si3 
191.0913 
157.1036 
129.0712 
Other alcohols and 
polyols 
Succinic acid 10.04 C4H6O4 
110-15-
6 
C10H22O4Si2 
247.0818 
147.0668 
75.0264 
Dicarboxylic acids 
Itaconic acid 10.41 C5H6O4 
97-65-
4 
C11H22O4Si2 
259.0812 
215.0913 
147.0655 
Dicarboxylic acids 
Citraconic acid 10.50 C5H6O4 
498-
23-7 
C11H22O4Si2 
259.0818 
184.0558 
97.0460 
Dicarboxylic acids 
Fumaric acid 10.54 C4H4O4 
110-17-
8 
C10H20O4Si2 
245.0665 
217.0707 
147.0656 
Dicarboxylic acids 
Glutaric acid 11.27 C5H8O4 
110-
94-1 
C11H24O4Si2 
261.0968 
233.1024 
129.0438 
Dicarboxylic acids 
Malic acid 12.30 C4H6O5 
617-
48-1 
C13H30O5Si3 
265.1114 
233.1022 
101.0408 
Dicarboxylic acids 
Adipic acid 12.56 C6H10O4 
124-
04-9 
C12H26O4Si2 
172.0903 
141.0731 
111.0439 
Dicarboxylic acids 
Azelaic acid 15.91 C9H16O4 
123-
99-9 
C15H32O4Si2 
317.1576 
217.1069 
117.0382 
Dicarboxylic acids 
Aconitic acid 15.35 C6H6O6 
499-
12-7 
C15H30O6Si3 
375.1119 
229.1073 
211.0436 
Tricarboxylic acids 
Pyruvic acid 6.10 C3H4O3 
127-17-
3 
C7H15NO3Si 
174.0582 
158.0625 
130.0646 
Carboxylic acids 
(keto acids) 
α-Ketoglutaric acid 13.38 C5H6O5 
328-
50-7 
C7H12O4 
129.0548 
100.0518 
59.0491 
Carboxylic acids 
(keto acids) 
Lactic acid 
5.79 
C3H6O3 
50-21-
5 
C6H14O3Si 
119.0543 
101.0416 
75.0272 Carboxylic acids 
(hydroxy acids) 
6.25 C9H22O3Si2 
191.0952 
117.0823 
45.0187 
Glycolic acid 6.51 C2H4O3 79-14-1 C8H20O3Si2 
147.0658 
133.0432 
66.0211 
Carboxylic acids 
(hydroxy acids) 
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1-Undecyne 7.03 C11H20 
2243-
98-3 
C11H20 
109.0990 
95.0845 
81.0689 
Hydrocarbons 
Caproic acid 6.51 C6H12O2 
142-
62-1 
C9H20O2Si 
173.0995 
117.0375 
75.0266 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
Caprylic acid 9.36 C8H16O2 
124-
07-2 
C11H24O2Si 
201.1304 
117.0450 
75.0262 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
Pelargonic acid 10.69 C9H18O2 
112-
05-0 
C12H26O2Si 
215.1465 
129.0367 
117.0370 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
Capric acid 11.97 C10H20O2 
334-
48-5 
C13H28O2Si 
229.1619 
129.0371 
75.0261 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
Lauric acid 14.33 C12H24O2 
143-
07-7 
C15H32O2Si 
257.1934 
117.0369 
75.0263 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
Tridecylic acid 15.43 C13H26O2 
638-
53-9 
C16H34O2Si 
271.2093 
117.0376 
75.0266 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Mirystoleic acid 16.25 C14H26O2 
544-
64-9 
C17H34O2Si 
283.2080 
145.0690 
129.0370 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Myristic acid 16.48 C14H28O2 
544-
63-8 
C17H36O2Si 
285.2251 
145.0681 
117.0370 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Pentadecylic acid 17.48 C15H30O2 
1002-
84-2 
C18H38O2Si 
299.2406 
129.0372 
117.0377 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Palmitic acid 
17.59 
C16H32O2 
57-10-
3 
C16H32O2 
227.1997 
129.0891 
73.0279 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 18.44 C19H40O2Si 
313.2541 
269.1921 
145.0674 
Palmitoleic acid 18.19 C16H30O2 
373-
49-9 
C19H38O2Si 
311.2403 
129.0370 
185.0990 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
10-Heptadecenoic acid 19.12 C17H32O 
29743-
97-3 
C20H40O2Si 
325.2551 
250.2277 
185.0997 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Margaric acid 19.36 C17H34O2 
506-
12-7 
C20H42O2Si 
327.2710 
145.0682 
117.0365 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Arachidonic acid 19.83 C20H32O2 
506-
32-1 
C23H40O2Si 
129.0432 
117.0382 
55.0541 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
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Linoleic acid 19.83 C18H32O2 
60-33-
3 
C21H40O2Si 
262.2289 
117.0403 
67.0535 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Oleic acid 20.01 C18H34O2 
112-
80-1 
C21H42O2Si 
339.2723 
145.0679 
117.0369 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Stearic acid 
19.51 
C18H36O2 57-11-4 
C18H36O2 
284.2706 
129.0908 
73.0281 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 20.24 C21H44O2Si 
341.2854 
129.0360 
117.0360 
Arachidic acid 21.90 C20H40O2 
506-
30-9 
C23H48O2Si 
369.3185 
145.0698 
129.0380 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
Lignoceric acid 24.88 C24H48O2 
557-
59-5 
C27H56O2Si 
425.3817 
129.0387 
117.0379 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
Hexacosanoic acid 26.41 C26H52O2 
506-
46-7 
C29H60O2Si 
453.4126 
129.0377 
117.0369 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
Dipropylacetic acid 9.36 C8H16O2 
99-66-
1 
C11H24O2Si 
201.1305 
174.1128 
117.0435 
Lipids (methyl-
branched fatty 
acids) 
2-Hydroxybutyric acid 7.25 C4H8O3 
565-
70-8 
C10H24O3Si2 
147.0659 
131.0886 
73.0470 
Lipids (hydroxy 
fatty acids) 
3-Hydroxybutyric acid 7.81 C4H8O3 
300-
85-6 
C10H24O3Si2 
233.1021 
191.0913 
117.0713 
Lipids (hydroxy 
fatty acids) 
3-Hydroxyisovaleric acid 7.85 C5H10O3 
17407-
56-6 
C11H26O3Si2 
147.0650 
131.0876 
115.0560 
Lipids (hydroxy 
fatty acids) 
2-Hydroxyisocaproic acid 8.91 C6H12O3 
498-
36-2 
C12H28O3Si2 
177.0744 
159.1194 
103.0548 
Lipids (hydroxy 
fatty acids) 
5-Hydroxy-n-valeric acid 10.29 C5H10O3 
13392-
69-3 
C11H26O3Si2 
247.1180 
231.0882 
147.0658 
Lipids (hydroxy 
fatty acids) 
Erucylamide 24.51 C22H43NO 
112-
84-5 
C22H43NO 
337.3338 
126.0916 
72.0440 
Lipids (fatty 
amides) 
Mono(2-ethylhexyl)-
adipate 
21.50 C14H26O4 
4337-
65-9 
C14H26O4 
129.0549 
111.0440 
83.0487 
Lipids (fatty acid 
esters) 
1-Monoisobu-
tyroylglycerol 
12.08 C7H14O4  C13H30O4Si2 
203.1091 
117.0407 
59.0310 
Lipids 
(acylglycerides) 
2-Monopalmito-ylglycerol 22.76 C19H38O4 
23470-
00-0 
C25H54O4Si2 
313.2552 
191.0010 
147.0655 
Lipids 
(acylglycerides) 
1-Monopalmitoylglycerol 23.02 C19H38O4 
26657-
96-5 
C25H54O4Si2 
371.2961 
239.2359 
203.0900 
Lipids 
(acylglycerides) 
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2-Monostearoylglycerol 24.20 C21H42O4 
621-
61-4 
C27H58O4Si2 
341.2863 
218.1136 
191.0851 
Lipids 
(acylglycerides) 
1-Monostearoylglycerol 24.45 C21H42O4 
123-
94-4 
C27H58O4Si2 
399.3293 
341.2868 
267.2691 
Lipids 
(acylglycerides) 
1-Monoarachi- 
doylglycerol 
25.86 C23H46O4 
50906-
68-8 
C29H62O4Si2 
427.3606 
411.4017 
295.2997 
Lipids 
(acylglycerides) 
Dehydroabietic acid 21.54 C20H28O2 
740-
19-8 
C23H36O2Si 
357.2222 
239.1791 
197.1315 
Lipids (prenol 
lipids-diterpenes) 
Squalene 24.76 C30H50 
111-02-
4 
C30H50 
410.3907 
121.0994 
81.0686 
Lipids (prenol 
lipids-triterpenes) 
Hedione 14.35 C13H22O3 
24851-
98-7 
C13H22O3 
226.1566 
97.0623 
83.0479 
Lipids (lineolic 
acids and 
derivatives-
jasmonic acids) 
Cholesta-3,5-diene 25.47 C27H44 
747-
90-0 
C27H44 
368.3437 
247.2412 
147.1141 
Lipids (steroids 
and steroids 
derivatives) 
3-Nonen-1-ol 7.03 C9H18O 
10340-
23-5 
C9H18O 
95.0848 
81.0694 
67.0540 
Lipids (fatty 
alcohols) 
1-Dodecanol 13.35 C12H26O 
112-53-
8 
C15H34OSi 
243.2136 
129.0699 
97.1002 
Lipids (fatty 
alcohols) 
1-Tetradecanol 15.58 C14H30O 
112-72-
1 
C17H38OSi 
271.2444 
111.1161 
97.1007 
Lipids (fatty 
alcohols) 
1-Hexadecanol 17.62 C16H34O 
36653-
82-4 
C19H42OSi 
299.2764 
97.1001 
55.0538 
Lipids (fatty 
alcohols) 
1-Octadecanol 19.47 C18H38O 
112-
92-5 
C21H46OSi 
327.3084 
241.1977 
97.1007 
Lipids (fatty 
alcohols) 
Phosphate 9.42 PO43- 
7664-
38-2 
C9H27O4PSi3 
299.0712 
211.0008 
133.0156 
No metal 
oxoanionic 
compounds 
2-Furoic acid 7.46 C5H4O3 
88-14-
2 
C8H12O3Si 
169.0314 
125.0416 
95.0193 
Organoheterocyclic 
compounds 
Uracil 10.34 C4H4N2O2 
66-22-
8 
C10H20N2O2Si2 
241.0818 
99.0350 
45.0157 
Organoheterocyclic 
compounds 
Uridine 15.12 C9H12N2O6 
58-96-
8 
C18H36N2O6Si3 
259.1164 
217.1063 
103.0487 
Organoheterocyclic 
compounds 
Urocanic acid 15.63 C6H6N2O2 
7699-
35-6 
C12H22N2O2Si2 
267.0975 
193.0784 
120.0308 
Organoheterocyclic 
compounds 
Xanthine 18.13 C5H4N4O2 
69-89-
6 
C14H28N4O2Si3 
353.1281 
294.1324 
238.0843 
Organoheterocyclic 
compounds 
Uric acid 18.89 C5H4N4O3 
69-93-
2 
C17H36N4O3Si4 
456.1680 
441.1635 
73.0467 
Organoheterocyclic 
compounds 
Urea 8.10 CH4N2O 
57-13-
6 
C10H28N2OSi3 
276.1501 
261.1273 
245.0959 
Ureas 
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 9.00   C7H20N2OSi2 
189.0879 
171.0775 
147.0663 
 
Borate 9.64 BO33- 
10043-
35-3 
C9H27BO3Si3 
263.1140 
221.0861 
175.0447 
Exogenous 
Methylparaben 
11.92 
C8H8O3 
99-76-
3 
C8H8O3 
152.0470 
121.0292 
93.0337 
Exogenous 
12.46 C11H16O3Si 
224.0863 
209.0622 
193.0666 
Propylparaben 12.84 C10H12O3 
94-13-
3 
C10H12O3 
138.0314 
121.0290 
93.0337 
Exogenous 
 
Other no polar chemical family found in sweat was that of aromatic 
homomonocyclic compounds, mainly benzene derivatives. It is worth mentioning among 
them benzene acid derivatives such as benzoic acid, 4-acetyloxybenzoic acid, 4-
hydroxyphenyllactic acid and α-keto-4-hydroxybenzenepropanoic acid, a benzene ester 
derivative (isobutylparaben), and benzene alcohol derivatives such as β-
ethenylbenzeneethanol, α,α-dimethylbenzenemethanol, phenylethyl alcohol, cathecol, 3-
methylcathecol, 2,4-ditertbutylphenol and pyrogallol. Other benzene derivatives detected 
in sweat were triclosan (clorinated derivative) and indane. It is remarkable the presence of 
exogenous compounds such as triclosan and parabens from cosmetics. For example, 
triclosan is present in shampoos, deodorants and toothpastes, as it has shown effectiveness 
in reducing and controlling bacterial contamination on the hands [21]; while parabens are 
commonly used as preservatives in cosmetics [22].  
Short carboxylic acids, which are also representative of crucial biochemical 
pathways [23], were other group of metabolites detected in sweat. It is worth mentioning 
the presence in this group of compounds related to the Krebs’ cycle as aconitic acid, 
succinic, α-ketoglutaric, fumaric, pyruvic and malic acids. Compounds produced in the 
body during the metabolism of some amino acids such as lysine and tryptophan are glutaric 
acid and other dicarboxylic acids such as itaconic, citraconic, adipic and azelaic acids, which 
were also identified in sweat. Carboxylic acid derivatives identified were hydroxy acids such 
as lactic and glycolic acids. Some dicarboxylic acids such as azelaic acid had previously been 
identified in sweat [9]. 
Identified sugars included monosaccharides (erythrulose, sorbitol, galactose and 
glucose), a disaccharide (trehalose), sugar alcohols (glycerol, erythritol, mannitol and 
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inositol) and sugar acids (glyceric, threonic and gluconic acids), some of them previously 
identified in sweat, such as glucose and inositol [7]. Other identified alcohols and polyols 
were propylene glycol, diethylene glycol, 1,2-butanediol, 1,3-butanediol, 2,3-butanediol, 
pinacol, 1-methylene-3-methylbutane-1,3-diol, 2-(2-butoxyethoxy)ethanol and 1,1,1-
tris(hydroxymethyl)propane. 
Organo heterocyclic compounds detected in sweat were uracil, uridine (uracil 
nucleoside), uric acid (product of metabolic breakdown of purine nucleotides), urocanic 
acid (intermediate in the catabolism of histidine), xanthine (an intermediate in the 
degradation of adenosine monophosphate to uric acid) and 2-furoic acid (a metabolite that 
appears in urine after exposition to furfural and is also naturally present in coffee). Also 
phosphate was identified in sweat.  
Other identified families were alkaloids and alkanoamines. Identified alkaloids 
were mainly stimulants such as caffeine and nicotine. Furthermore, cotinine, the 
predominant metabolite of nicotine, was detected in sweat. Regarding alkanolamines, 
ethanolamine, diethanolamine and triethanolamine were also found. 
 
3.4. Comparison of active sweat collected after moderate exercise and passive 
sweat 
In this study, active sweat collected after moderate exercise was compared with 
passive sweat from the same volunteers collected after induction by pilocarpine. In the first 
case, sweat was collected from three different parts of the body to increase the sampling 
representativeness. For passive sampling, sweat was only collected from the arm because 
the Macroduct system limits the sampling area. 
A previous study confirmed deproteination as the preferred sample preparation 
strategy for analysis of passive sweat collected with the Macroduct system [10]. This result 
was validated here by testing the different sample preparation approaches evaluated in this 
research. Therefore, the protocols that have provided better results in each of the cases, 
LLE with dichoromethane for active sweat after moderate exercise and deproteination for 
passive sweat were qualitatively and semiquantitatively compared. The two pools of sweat 
(active and passive) were analyzed in triplicate. In both cases, derivatization was carried 
out prior to GC–MS analysis. Fig. 5 shows the Venn diagram comparing the number of 
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compounds tentatively identified in the dichloromethane extract of active sweat and the 
deproteinated passive sweat collected by pilocarpine induction. The list of identified 
compounds in these analytical samples is shown in Table S1. The analysis of active sweat 
allowed detection of 118 compounds, while that of passive sweat provided 87. One fact to 
be emphasized is that 92% of the compounds detected in passive sweat were also detected 
in active sweat. Most of the compounds exclusively detected in active sweat were identified 
as lipids (42%), most of them long and very long-chain fatty acids, amino acids (15%) and 
sugars (15%), among others. 
 
 
Fig. 5. Venn diagram comparing the number of compounds tentatively identified in dichloromethane 
extract of active sweat and deproteinated passive sweat collected after pilocarpine induction. 
(Identification of each compound in a given extract was validated if its peak area was above 10% of 
the sum of its peak areas reported in the three extracts). 
 
A heat map was built to compare qualitative and quantitatively compositional 
differences between active and passive sweat. The resulting heat map, illustrated in Fig. 6, 
shows metabolomic differences between sweat collected after exercise and that collected 
after chemical induction.  
Concerning the family of compounds, benzenoids exhibited a similar concentration 
range in the two protocols, except for methylparaben, which was more concentrated in 
passive sweat because the Macroduct discs used for sweating induction contain this 
compound. Carboxylic acids such as dicarboxylic acids, keto acids and hydroxy acids also 
exhibited a similar concentration in sweat collected by the two protocols. Also 
organoheterocyclic compounds and essential amino acids were found in the two pools at 
similar concentration.  
 
38 80 7 
LLE dichloromethane + 
derivatization (active) 
(118) 
Deproteination + 
derivatization (passive) 
(87) 
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The most significant differences were found in alcohols, carbohydrates, lipids and 
no proteinogenic amino acids, as shown in Table S1, which reports higher concentration in 
sweat after moderate exercise. 
These metabolic differences can be explained by the stimulation of perspiration 
since active sweat involves the response to the practice of the moderate exercise and, 
therefore, sweat collected under these conditions should reflect a new metabolic state. 
Thus, alcohols such as diols (1,2-butanediol, 1,3-butanediol, 2,3-butanediol and pinacol) 
and glycols (diethylene and propylene glycol) were clearly found at higher concentration in 
active sweat as compared to passive sweat —see Fig. 7A. 
 
 
Fig. 7. The box-and-whisker plots of three families of metabolites found at different relative 
concentrations in active sweat and passive sweat. The bottom and top of the boxes represent the 25th 
and 75th percentile, respectively. The top and bottom bars represent the entire stretch of the data 
points for the subjects, except the extreme points, which are indicated with circles (o). The hyphen 
indicates the median value. The y axis represents the normalized peak area of the metabolites. 
 
Carbohydrates, particularly monosaccharides and sugar alcohols, were specially 
excreted in sweat after practicing moderate exercise. Glucose levels in sweat have been 
correlated to blood glucose as a no invasive proposal to control glycaemia in diabetic 
patients [24]. However, the levels of glucose in sweat as well as those of other metabolites 
such as lactic acid or gluconic acid can provide information about the response of the 
energetic metabolism to exercise. Concentration differences for carbohydrates commonly 
 Chapter VIII 
 
Page | 441  
detected in the two pools are clear in Fig. 7B. Fatty acids and squalene also gave an enriched 
concentration profile in active sweat as compared to passive sweat, in which most fatty 
acids were detected at lower concentrations. Only stearic acid and caproic acid presented 
higher levels in passive sweat —see Fig. 7C. The difference in no polar compounds is one of 
the most representative changes found in sweat collected after the two stimulation 
protocols.  
No proteinogenic amino acids were other family of metabolites found at higher 
concentration in active sweat, which could be explained by an activation of the synthesis 
and metabolism of amino acids in individuals after practicing exercise, but also could be 
associated to the contribution of the skin microbiota [25]. 
Other compounds such as α-keto-4-hydroxybenzenepropanoic acid, mono(2-
ethyhexyl)adipate and 5-hydroxy-n-valeric acid exhibited higher concentration in sweat 
collected after induction with pilocarpine. However, no special trends were observed for 
any family of compounds as occurred with active sweat. Finally, it is worth mentioning that 
passive sweat was only sampled from the arm of volunteers, which is a limitation of the 
Macroduct device, while active sweat was collected from three different areas of the body 
(forehead, chest and back). Therefore, the sampling of different parts of the body can 
increase representativeness based on results provided by other studies that have reported 
differences in sweat composition according to the sampling area [7,26]  
 
4. Conclusions 
Sample preparation for untargeted analysis of active sweat collected after moderate 
exercise has been evaluated by testing LLE with different extractants, protein precipitation 
and derivatization prior to GC–MS analysis. Among the tested protocols, LLE with 
dichloromethane with subsequent methoxymation plus silylation was the best option to 
obtain a representative snapshot of active sweat due to the detection of no polar 
compounds, scarcely detected in previous studies developed with passive sweat. 
Compositional differences in passive and active sweat collected from the same volunteers 
were found, offering the latter an enriched concentration of some important families of 
compounds such as fatty acids, alcohols, carbohydrates and no proteinogenic amino acids. 
The differences in concentration can be explained by the sampling protocol since sweat is 
stimulated in a different manner prior to collection of active and passive sweat. 
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Additionally, the sampling location was not the same due to operational restrictions of the 
Macroduct device. 
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[2] L. Főrstrőm, M.E. Goldyne, R.K. Winkelmann, Work in progress: prostaglandin activity in human eccrine 
sweat, Prostaglandins 7 (1974) 459–464. 
[3] X. Zeng, J.J. Leyden, H.J. Lawley, K. Sawano, I. Nohara, G. Preti, Analysis of characteristic odors from 
human male axillae, J. Chem. Ecol. 17 (1991) 1469–1492. 
[4] Y. Nunome, T. Tsuda, K. Kitagawa, Determination of fatty acids in human sweat during fasting using GC/MS, 
Anal. Sci. 26 (2010) 917–919. 
[5] F. Kanda, E. Yagi, M. Fukuda, K. Nakajima, T. Ohta, O. Nakata, Elucidation of chemical compounds 
responsible for foot malodour, Brit. J. Dermatol. 122 (1990) 771–776. 
[6] A. Caroprese, S. Gabbanini, C. Beltramini, E. Lucchi, L. Valgimigli, HS-SPME–GC–MS analysis of body odor 
to test the efficacy of foot deodorant formulations, Skin Res. Technol. 15 (2009) 503–510.  
[7] V.P. Kutyshenko, M. Molchanov, P. Beskaravayny, V.N. Uversky, M.A. Timchenko, Analyzing and mapping 
sweat metabolomics by high resolution NMR spectroscopy, PLoS ONE 6 (2011) e28824, 
http://dx.doi.org/10.1371/journal.pone.0028824. 
[8] M. Harker, H. Coulson, I. Fairweather, D. Taylor, C.A. Daykin, Study of metabolite composition of eccrine 
sweat from healthy male and female human subjects by 1H NMR spectroscopy, Metabolomics 2 (2006) 
105–112. 
 Chapter VIII 
 
Page | 443  
[9] M. Calderón-Santiago, F. Priego-Capote, B. Jurado-Gámez, M.D. Luque de Castro, Optimization study for 
metabolomics analysis of human sweat by liquid chromatography–tandem mass spectrometry in high 
resolution mode, J. Chromatogr. A 1333 (2014) 70–78. 
[10] M.M. Delgado-Povedano, M. Calderón-Santiago, F. Priego-Capote, M.D. Luque de Castro, Development of a 
method for enhancing metabolomics coverage of human sweat by gas chromatography–mass spectrometry 
in high resolution mode, Anal. Chim. Acta 905 (2016) 115–125. 
[11] J.T.B. Collie, R.J. Massie, O.A.H. Jones, V.A. LeGrys, R.F. Greaves, Sixty-five years since the New York heat 
wave: advances in sweat testing for cystic fibrosis, Pediatr. Pulm. 49 (2014) 106–117. 
[12] A. Mena-Bravo, M.D. Luque de Castro, Sweat: a sample with limited present applications and promising 
future in metabolomics, J. Pharm. Biomed. Anal. 90 (2014) 139–147. 
[13] Y. Zhou, H. Han, H.P.P. Naw, A.V. Lammy, C.H. Goh, S. Boujday, T.W.J. Steele, Real-time colorimetric 
hydration sensor for sport activities, Mater. Des. 90 (2016) 1181–1185. 
[14] W. Gao, S. Emaminejad, H.Y.Y. Nyein, S. Challa, K. Chen, A. Peck, H.M. Fahad, H. Ota, H. Shiraki, D. Kiriya, 
D.H. Lien, G.A. Brooks, R.W. Davis, A. Javey, Fully integrated wearable sensor arrays for multiplexed in 
situ perspiration analysis, Nature 529 (2016) 509–514. 
[15] T. Kind, G. Wohlgemuth, D.Y. Lee, Y. Lu, M. Palazoglu, S. Shahbaz, O. Fiehn, FiehnLib: mass spectral and 
retention index libraries for metabolomics based on quadrupole and time-of-flight gas 
chromatography/mass spectrometry, Anal. Chem. 81 (2009) 10038–10048. 
[16] R. Kanďár, P. Drábková, L. Andrlová, A. Kostelník, A. Cegan, Determination of selected fatty acids in dried 
sweat spot using gas chromatography with flame ionization detection, J. Sep. Sci. 39 (2016) 4377–4383. 
[17] M.J Choi, J. Ha, S. Yoo, S.W. Park, Study on individual characterization of sweat components, Anal. Sci. 
Technol. 20 (2007) 434–441. 
[18] A.C. Kendall, M. Kiezel-Tsugunova, L.C. Brownbridge, J.L. Harwood, A. Nicolaou, Lipid functions in skin: 
differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture 
model, Biochim. Biophys. Acta 1859 (2017) 1679–1689.  
[19] J.J. Kabara, D.M. Swieczkowski, A.J. Conley, J.P. Truant, Fatty acids and derivatives as antimicrobial 
agents, Antimicrob. Agents Chemother. 2 (1972) 23–28. 
[20] K. Saito, Y. Shirasago, T. Suzuki, H. Aizaki, K. Hanada, T. Wakita, M. Nishijima, M. Fukasawa, Targeting 
cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy 
against hepatitis C virus, J. Virol. 89 (2015) 2220–2232. 
[21] K. Jayaseelan, K.S. Lakshmi, Central composite design to develop a robust RP-TLC/densitometry method for 
quantification of triclosan in cosmetic preparations, Marmara Pharm. J. 21 (2017) nº 3. 
[22] P. Rocío-Bautista, C. Martínez-Benito, V. Pino, J. Pasán, J.H. Ayala, C. Ruiz-Pérez, A.M. Afonso, The metal–
organic framework HKUST-1 as efficient sorbent in a vortex-assisted dispersive micro solid-phase extraction 
of parabens from environmental waters, cosmetic creams, and human urine, Talanta 139 (2015) 13–20. 
[23] J. Tan, C. McKenzie, M. Potamitis, A.N. Thorburn, C.R. Mackay, L. Macia, Chapter three – The role of short-
chain fatty acids in health and disease, Adv. Immunol. 121 (2014) 91–119. 
[24] J. Moyer, D. Wilson, I. Finkelshtein, B. Wong, R. Potts, Correlation between sweat glucose and blood glucose 
in subjects with diabetes, Diabetes Technol. Ther. 14 (2012) 398–402. 
[25] G. Sharon, N. Garg, J. Debelius, R. Knight, P.C. Dorrestein, S.K. Mazmanian, Specialized metabolites from 
the microbiome in health and disease, Cell Metab. 20 (2014) 719–730. 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
 
Page | 444 
[26] K. Hooton, L. Li, Non-occlusive sweat collection combined with chemical isotope labeling LC–MS for human 
sweat metabolomics and mapping the sweat metabolomes at different skin locations, Anal. Chem. DOI: 
10.1021/acs.analchem.7b01988 
 Chapter VIII 
 
Page | 445  
Supplementary material 
 
Table S1. Compounds identified by GC–TOF/MS in dichloromethane extract of active and 
depreoteinated sweat collected after chemical induction (passive) after derivatization in both cases. 
Compound 
RT 
(min) 
Formula Family 
LLE dichloro-
methane 
+ 
derivatization 
(active sweat) 
Deproteination 
+ 
derivatization 
(passive sweat) 
p-
Valuea 
Cotinine 15.01 C10H12N2O Alkaloids   0.0017** 
Caffeine 16.52 C8H10N4O2 Alkaloids   0.0006** 
Ethanolamine 9.36 C2H7NO Alkanolamines   0.0013** 
Diethanolamine 
9.60 
C4H11NO2 Alkanolamines 
 
0.0000** 
11.67  
Triethanolamine 13.99 C6H15NO3 Alkanolamines   0.0001** 
Valine 
6.75 
C5H11NO2 Amino acids 
 
0.0355* 
8.62  
Alanine 6.94 C3H7NO2 Amino acids   0.1288 
Glycine 
7.24 
C2H5NO2 Amino acids 
 
0.6787 
9.92  
Leucine 7.77 C6H13NO2 Amino acids   0.0598 
Isoleucine 
8.10 
C6H13NO2 Amino acids 
 
0.0883 
9.73  
Serine 
9.24 
C3H7NO3 Amino acids 
 
0.0165* 
10.64  
Proline 9.81 C5H9NO2 Amino acids   0.3035 
Threonine 10.98 C4H9NO3 Amino acids   0.0026** 
Sarcosine 11.19 C3H7NO2 Amino acids   0.0000** 
Aspartic acid 12.71 C4H7NO4 Amino acids   0.0010** 
Aminomalonic 
acid 
12.08 C3H5NO4 Amino acids   0.0013** 
Pyroglutamic 
acid 
12.48 
C5H7NO3 
Amino acids  
0.0126* 
12.74 Amino acids  
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γ-Aminobutyric 
acid 
12.85 C4H9NO2 Amino acids   0.0010** 
α-Aminoadipic 
acid 
13.05 C6H11NO4 Amino acids   0.5767 
2-Aminohep- 
tanedioic acid 
13.70 C7H13NO4 Amino acids   0.0001** 
Ornithine 
13.86 
C5H12N2O2 Amino acids 
 
0.0003** 
16.10  
Glutamic acid 13.91 C5H9NO4 Amino acids   0.0011** 
Phenylalanine 14.01 C9H11NO2 Amino acids   0.0003** 
Asparagine 14.49 C4H8N2O3 Amino acids   0.2935 
Lysine 
14.92 
C6H14N2O2 Amino acids 
 
0.0011** 
17.19  
Glutamine 15.63 C5H10N2O3 Amino acids   0.8569 
Citrulline 
16.18 
C6H13N3O3 Amino acids 
  0.0000** 
18.97   0.1118 
Histidine 17.16 C6H9N3O2 Amino acids   0.0255* 
Tyrosine 17.36 C9H11NO3 Amino acids   0.0009** 
Tryptophan 
19.57 
C11H12N2-
O2 
Amino acids 
 
0.0795 
19.78  
19.89  
19.96  
Indane 6.05 C9H10 
Benzene 
derivatives 
  0.5058 
Benzoic acid 9.14 C7H6O2 
Benzene 
derivatives (acids) 
  0.0438* 
4-Acetyloxyben-
zoic acid 
14.50 C9H8O4 
Benzene 
derivatives (acids) 
  2 10–5** 
4-Hydroxy-
phenyllactic acid 
16.95 C9H10O4 
Benzene 
derivatives (acids) 
  0.0003** 
α-Keto-4- 
hydroxyben- 
zenepropanoic 
acid 
17.04 C9H8O4 
Benzene 
derivatives (acids) 
  0.0000** 
β-Ethenylben-
zeneethanol 
6.05 C10H12O 
Benzene 
derivatives 
(alcohols) 
  0.2490 
Cathecol 10.08 C6H6O2 
Benzene 
derivatives 
(alcohols) 
  0.8819 
2,4-Ditert-
butylphenol 
12.63 C14H22O 
Benzene 
derivatives 
(alcohols) 
  0.8381 
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Pyrogallol 13.70 C6H6O3 
Benzene 
derivatives 
(alcohols) 
  0.0045** 
Carbamate 8.40 CH3NO2 Carbamic acids   0.0000** 
Trehalose 24.09 C12H22O11 
Carbohydrates 
(disaccharides) 
  0.0002** 
Erythrulose 14.56 C4H8O4 
Carbohydrates 
(monosacchari-
des) 
  0.0001** 
Sorbitol 16.48 C6H12O5 
Carbohydrates 
(monosacchari-
des) 
  0.0001** 
Galactose 
16.83 
C6H12O6 
Carbohydrates 
(monosacchari-
des) 
 
0.0005** 
17.06  
Glucose 
16.90 
C6H12O6 
Carbohydrates 
(monosacchari-
des) 
 
0.0017** 
17.10  
Glyceric acid 10.22 C3H6O4 
Carbohydrates 
(sugar acids) 
  0.0017** 
Threonic acid 12.96 C4H8O5 
Carbohydrates 
(sugar acids) 
  0.0003** 
Gluconic acid 17.92 C6H12O7 
Carbohydrates 
(sugar acids) 
  0.0001** 
Glycerol 9.43 C3H8O3 
Carbohydrates 
(sugar alcohols) 
  0.9214 
Erythritol 12.53 C4H10O4 
Carbohydrates 
(sugar alcohols) 
  0.0033** 
Mannitol 17.29 C6H14O6 
Carbohydrates 
(sugar alcohols) 
  0.0002** 
Inositol 18.19 
C6H12O6 
Carbohydrates 
(sugar alcohols) 
  0.0005** 
myo-Inositol 18.80   0.0002** 
2,3-Butanediol 5.82 C4H10O2 
Other alcohols 
and polyols 
  0.0020** 
Propylene glycol 5.98 C3H8O2 
Other alcohols 
and polyols 
  0.0018** 
1,3-Butanediol 6.61 C4H10O2 
Other alcohols 
and polyols 
  4 ּ 10-–5** 
Pinacol 7.75 C6H14O2 
Other alcohols 
and polyols 
  0.1656 
1,2-Butanediol 8.05 C4H10O2 
Other alcohols 
and polyols 
  0.0000** 
Diethylene glycol 9.04 C4H10O3 
Other alcohols 
and polyols 
  0.0039** 
1-Methylene- 
3-methylbutane-
1,3-diol 
9.19 C6H12O2 
Other alcohols 
and polyols 
  0.0000** 
2-(2-Butoxy-
ethoxy)ethanol 
10.37 C8H18O3 
Other alcohols 
and polyols 
  0.1599 
Succinic acid 10.04 C4H6O4 Dicarboxylic acids   0.3953 
Itaconic acid 10.41 C5H6O4 Dicarboxylic acids   0.0000** 
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Citraconic acid 10.50 C5H6O4 Dicarboxylic acids   0.1334 
Fumaric acid 10.54 C4H4O4 Dicarboxylic acids   0.3023 
Glutaric acid 11.27 C5H8O4 Dicarboxylic acids   0.6470 
Malic acid 12.30 C4H6O5 Dicarboxylic acids   0.0038** 
Adipic acid 12.56 C6H10O4 Dicarboxylic acids   0.0574 
Azelaic acid 15.91 C9H16O4 Dicarboxylic acids   0.0000** 
Aconitic acid 15.35 C6H6O6 Tricarboxylic acids   0.0000** 
Pyruvic acid 6.10 C3H4O3 
Carboxylic acids 
(keto acids) 
  0.0009** 
α-Ketoglutaric 
acid 
13.38 C5H6O5 
Carboxylic acids 
(keto acids) 
  0.0091** 
Lactic acid 6.25 C3H6O3 
Carboxylic acids 
(hydroxy acids) 
  3 ּ 10–7** 
Glycolic acid 6.51 C2H4O3 
Carboxylic acids 
(hydroxy acids) 
  0.0139* 
Caproic acid 6.51 C6H12O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
  0.0930 
Caprylic acid 9.36 C8H16O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
  0.1043 
Pelargonic acid 10.69 C9H18O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
  0.1104 
Capric acid 11.97 C10H20O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
  0.1791 
Lauric acid 14.33 C12H24O2 
Lipids (fatty acids 
and conjugates-
medium chain 
fatty acids) 
  0.0032** 
Tridecylic acid 15.43 C13H26O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0009** 
Mirystoleic acid 16.25 C14H26O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0000** 
Myristic acid 16.48 C14H28O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0001** 
Pentadecylic acid 17.48 C15H30O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0001** 
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Palmitic acid 18.44 C16H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0095** 
Palmitoleic acid 18.19 C16H30O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0001** 
10-Heptade- 
cenoic acid 
19.12 C17H32O 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0000** 
Margaric acid 19.36 C17H34O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0024** 
Arachidonic acid 19.83 C20H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0000** 
Linoleic acid 19.83 C18H32O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0000** 
Oleic acid 20.01 C18H34O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.0051** 
Stearic acid 20.24 C18H36O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.2156 
Arachidic acid 21.90 C20H40O2 
Lipids (fatty acids 
and conjugates-
long chain fatty 
acids) 
  0.1478 
Lignoceric acid 24.88 C24H48O2 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
  0.0016** 
Hexacosanoic 
acid 
26.41 C26H52O2 
Lipids (fatty acids 
and conjugates-
very long chain 
fatty acids) 
  0.0015** 
Dipropylacetic 
acid 
9.36 C8H16O2 
Lipids (methyl-
branched fatty 
acids) 
  0.0013** 
2-Hydroxy-
butyric acid 
7.25 C4H8O3 
Lipids (hydroxy 
fatty acids) 
  0.0009** 
3-Hydroxy-
butyric acid 
7.81 C4H8O3 
Lipids (hydroxy 
fatty acids) 
  0.9700 
3-Hydroxy-
isovaleric acid 
7.85 C5H10O3 
Lipids (hydroxy 
fatty acids) 
  0.0137* 
5-Hydroxy- 
n-valeric acid 
10.29 C5H10O3 
Lipids (hydroxy 
fatty acids) 
  0.0557 
Erucylamide 24.51 C22H43NO 
Lipids (fatty 
amides) 
  0.0119* 
Mono(2-
ethylhexyl)-
adipate 
21.50 C14H26O4 
Lipids (fatty acid 
esters) 
  0.0244* 
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1-Monoiso-
butyroylglycerol 
12.08 C7H14O4 
Lipids 
(acylglycerides) 
  0.0012** 
2-Monopalmito-
ylglycerol 
22.76 C19H38O4 
Lipids 
(acylglycerides) 
  0.3886 
1-Monopalmito-
ylglycerol 
23.02 C19H38O4 
Lipids 
(acylglycerides) 
  0.0057** 
2-Mono-
stearoylglycerol 
24.20 C21H42O4 
Lipids 
(acylglycerides) 
  0.0162* 
1-Monos 
tearoylglycerol 
24.45 C21H42O4 
Lipids 
(acylglycerides) 
  0.0050** 
1-Monoarachi-
doylglycerol 
25.86 C23H46O4 
Lipids 
(acylglycerides) 
  0.0012** 
Dehydroabietic 
acid 
21.54 C20H28O2 
Lipids (prenol 
lipids-diterpenes) 
  0.3188 
Squalene 24.76 C30H50 
Lipids (prenol 
lipids-triterpenes) 
  0.0002** 
Hedione 14.35 C13H22O3 
Lipids (lineolic 
acids and 
derivatives-
jasmonic acids) 
  0.0441* 
Cholesta- 
3,5-diene 
25.47 C27H44 
Lipids (steroids 
and steroids 
derivatives) 
  0.0000** 
1-Dodecanol 13.35 C12H26O 
Lipids (fatty 
alcohols) 
  0.0005** 
1-Tetradecanol 15.58 C14H30O 
Lipids (fatty 
alcohols) 
  0.0006** 
1-Hexadecanol 17.62 C16H34O 
Lipids (fatty 
alcohols) 
  0.1957 
1-Octadecanol 19.47 C18H38O 
Lipids (fatty 
alcohols) 
  0.0002** 
Phosphate 9.42 PO43- 
No metal 
oxoanionic 
compounds 
  0.0023* 
2-Furoic acid 7.46 C5H4O3 
Organoheterocy-
clic compounds 
  0.1325 
Uracil 10.34 C4H4N2O2 
Organoheterocy-
clic compounds 
  0.8341 
Uridine 15.12 C9H12N2O6 
Organoheterocy-
clic compounds 
  0.0130* 
Urocanic acid 15.63 C6H6N2O2 
Organoheterocy-
clic compounds 
  0.0040** 
Xanthine 18.13 C5H4N4O2 Alkaloids   0.0000** 
Uric acid 18.89 C5H4N4O3 
Organoheterocy-
clic compounds 
  0.9858 
Urea 
8.10 
CH4N2O Ureas 
 
0.0000** 
9.00  
Borate 9.64 BO33- Exogenous   0.0000** 
Methylparaben 12.46 C8H8O3 Exogenous   4 ּ 10-5** 
Pilocarpine 18.65 
C11H16N2 
O2 
Exogenous   0.0000** 
a An unpaired t-test statistical analysis was used to evaluate the significance of the compounds identified in 
dichloromethane extract of active and depreoteinated sweat collected after chemical induction to discriminate;     
* p-Value between 0.01 and 0.05; ** p-Value < 0.01. 
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Fig. S1. RI calibration line obtained by analysis of the alkane standard mixture. 
 
 
 
 
Fig. S2. Base peak chromatograms provided by analysis of the derivatized extracts of active sweat 
obtained with three extractants, ethyl acetate (red), dichloromethane (green) and hexane (blue). 
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Fig. S3. Base peak chromatograms provided by direct analysis of the extracts of active sweat obtained 
with three extractants, ethyl acetate (red), dichloromethane (green) and hexane (blue). 
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Dry sweat as sample for metabolomics analysis 
 
M.M. Delgado-Povedano, L.S. Castillo-Peinado, M. Calderón-Santiago, M.D. 
Luque de Castro, F. Priego-Capote 
Abstract 
Sweat is gaining popularity in clinical metabolomics as this biofluid is no invasively 
sampled and its composition is modified by several pathologies. There is a lack of 
standardized strategies for collection of human sweat. Most studies have been carried out 
with fresh sweat collected after stimulation. A promising and simple alternative is sampling 
dry sweat by a solid support impregnated with a suited solvent. This research was aimed at 
comparing the metabolomics coverage provided by dry sweat collected by two solid 
supports (gauzes and filter papers) impregnated with different solvents. The dissolved dry 
sweat was analyzed by a dual approach: gas chromatography–mass spectrometry (GC–MS) 
and liquid chromatography–tandem mass spectrometry (LC–MS/MS). Among the tested 
sampling strategies, filter paper impregnated with 1:1 (v/v) ethanol‒phosphate buffer 
resulted the combination providing the highest metabolomics coverage (tentative 
identification of 175 compounds). Dry and fresh sweat were compared by using pools from 
the same individuals to evaluate compositional differences. Families of metabolites such as 
carnitines, sphingolipids and N-acyl-amino acids, among others, were exclusively 
identified in dry sweat. Comparison of both samples allowed concluding that dry sweat is 
better for analysis of low polar metabolites and fresh sweat is more suited for polar 
compounds. As most of the identified metabolites are involved in key biochemical 
pathways, this study opens interesting possibilities to the use of dry sweat as a source of 
metabolite markers for specific disorders. Sampling of dry sweat could provide a 
standardized approach for collection of this biofluid, thus overcoming the variability 
limitations of fresh sweat. 
Keywords: dry sweat metabolome, metabolomics analysis, sampling protocol, gas 
chromatography, liquid chromatography, mass spectrometry. 
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1. Introduction 
Sweat is a biofluid produced by eccrine and procrine glands located in the 
epidermis [1]. This slightly acidic biofluid (pH range 4.0–7.0) is composed mainly of water 
(99%) containing electrolytes, small molecules, proteins, peptides, metal ions, and 
xenobiotics, among others. These substances are stored in the sweat glands, secreted and, 
finally, transported to the epidermis surface [1]. Sweat excretion is affected by several 
factors such as ambient temperature, relative humidity, area of the body skin, hormonal 
imbalances, overactive thyroid gland and the sympathetic nervous system, and certain 
foods and medications [2]. Sweating is also naturally increased by nervousness, exercise, 
stress and nausea. With sampling purposes, sweating must be stimulated by physical 
exercise or at rest, usually by heat or iontophoretic induction with chemicals such as 
pilocarpine, to obtain enough volume of this biofluid for analysis [3]. 
Sweat collection is a step to which scant attention has been paid, despite the 
collection format seems to be responsible for uncontrolled variability sources in the 
analysis of this biofluid. Most sweat analyses have been carried using fresh sweat [3–6], 
which has been used as such or treated after a drying process [7,8]. Fresh sweat can be 
collected by occlusive or no occlusive covering devices. In the former case, sweat has been 
mainly sampled on a bandage of filter paper, cotton, gauze or towel [9], and frequently 
associated to sweat suppression or skin irritation. Additionally, this sampling is typically 
lengthened to hours [10]. Other alternative involved the use of hydrogel micropatches as 
sampling device of skin excretions [11–13]. Hydrogel micropatches have been used to 
profile skin metabolites with identification of eight compounds [11], to monitor two drugs 
on skin surface [14] and to screen psoriasis-related skin metabolites [12]. Despite these 
limitations, novel wearable digital devices based on an adhesive radio-frequency sensor 
bandage (patch) have been reported. These devices can establish a close contact with 
human skin, a distinct advantage for chronological monitoring of biomarkers in sweat [15–
19]. As an example, a commercial radio-frequency identification chip has been adapted 
with minimum changes to allow sensing Na+ in sweat by potentiometric measurements and 
surface temperature. All these measurements are read by an Android smartphone app with 
96% accuracy at 50 mM Na+ [16]. 
On the other hand, devices for no occlusive sampling of fresh sweat are typically 
based on capillarity or condensation, the latter involving an adhesive layer on a thin 
transparent film, which is in contact with a rectangular absorbent pad for sweat collection 
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[9]. A comprehensive study has been recently published, in which sweat was collected over 
24-h periods using a no occlusive patch adhered to different skin zones [20]. The authors 
used differential chemical isotope labeling (CIL) and liquid chromatography‒mass 
spectrometry (LC–MS) to map the metabolomic profile of the samples, which resulted in 
the tentative identification of 84 metabolites by using MS/MS information [20]. 
Concerning capillarity collection, Kutyshenko et al. developed a device with special pipettes 
and reverse capillaries for collection of small sweat volumes [4]. Commercial devices for 
capillarity collection of sweat such as the Macroduct®, based on iontophoresis with 
pilocarpine, are widely used for diagnostic of cystic fibrosis [21]. 
Most of the wide variety of fresh sweat samplers require to wear the device during 
the sweating process, which is tedious. For this reason, novel procedures for sweat 
collection are desirable. One alternative is collection of dry sweat, a concept that should not 
be confused with those applications based on sampling of fresh sweat, then dried for 
analysis. One example of this is the study developed by Sikirzhytski et al., who dried fresh 
sweat on a microscopy slide prior to obtaining Raman spectra dominated by the 
contribution of lactic acid, urea and amino acids [7]. In one other application, fresh sweat 
was spotted onto collection paper containing butylated hydroxytoluene for solvent 
evaporation prior to determination of fatty acids by gas chromatography with flame 
ionization detection (GC–FID) [8]. 
A particular case specific for volatile organic compounds is the use of 
divinylbenzene/carboxen/polydimethylsiloxane ‘Stableflex’ fibers. The fiber came in 
contact with the skin for 30 min through a glass funnel. After collecting the volatiles, the 
SPME fiber was inserted into the injector of the GC–MS to desorb them [22]. 
Dry sweat can be collected after sweating stimulation by using a solid support to 
transfer sweat components from the skin. This protocol could be proposed to standardize 
the sampling process due to its simplicity [8]. For this purpose, the necessity for a well-
established protocol for collection of dry sweat seems to be essential to characterize its 
composition. The aim of the present study was to compare different supports–solvents for 
sampling dry sweat by compositional analysis using untargeted approaches based on gas 
chromatography–time of flight/mass spectrometry (GC–TOF/MS) and liquid 
chromatography‒quadrupole time of flight tandem mass spectrometry (LC–QTOF 
MS/MS). Fresh sweat was also analyzed to evaluate the detection coverage of metabolites 
in the different collection formats. 
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2. Experimental section 
 
2.1. Reagents 
Reagent grade ethanol from Scharlab (Barcelona, Spain), anhydrous potassium 
hydrogen phosphate from Panreac (Barcelona, Spain) and Optima™ LC–MS grade acetic 
acid from Thermo Fisher Scientific (Pittsburgh, PA, USA) were used for dissolution of dry 
sweat components. 
Optima™ LC–MS grade formic acid (FA) and acetonitrile (ACN) from Thermo 
Fisher Scientific, and LC–MS grade methanol and GC grade dichloromethane from Sigma–
Aldrich (St. Louis, MO, USA) were used for sample preparation. FA and ACN were also 
used to prepare the chromatographic mobile phases for LC–MS/MS analysis. Deionized 
water (18 mΩ·cm) from a Millipore Milli-Q water purification system (Bedford, MA, USA) 
was used to prepare the aqueous chromatographic mobile phases and all other aqueous 
solutions. 
Pyridine and methoxyamine hydrochloride from Sigma–Aldrich were used as 
solvent and reagent, respectively, for methoxymation. Bis-(trimethylsilyl) fluoroacetamide 
(BSTFA) and trimethylchlorosilane (TMCS) from Sigma–Aldrich were used as silylation 
agents in the derivatization step. MS-grade perfluorotri-n-butylamine (PFTBA) from 
Agilent Technologies (Santa Clara, CA, USA) was used for daily mass calibration. A 
standard mixture containing ten linear alkanes from C10 to C40 designed for performance 
tests in GC from Sigma–Aldrich was used to establish the retention index (RI) calibration 
model. LC–grade n-hexane and acetone from Scharlab were used for washing the injection 
syringe. Standards of D-galactose, D-glucose and myo-inositol from Sigma–Aldrich were 
used to prepare standards for confirmation of sugars identification. 
 
2.2. Instruments and apparatus 
A vortex shaker from IKA (Wilmington, NC, USA), a Legend Micro 21R 
microcentrifuge from Thermo Fisher Scientific, a Concentrator plusTM from Eppendorf 
(Hamburg, Germany), and a ThermoMixer C, also from Eppendorf, were used in different 
steps of sample preparation. 
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An Agilent 1200 Series LC system coupled to an Agilent 6540 UHD Accurate-Mass 
QTOF hybrid mass spectrometer equipped with a dual electrospray ionization (ESI) source 
was used. This ESI device enables to spray simultaneously a mass reference solution that 
calibrates continuously detected m/z ratios. 
An Agilent 7890A Series GC system coupled to an Agilent 7200 UHD Accurate-
Mass QTOF hybrid mass spectrometer equipped with electron impact (EI) source was also 
used for analysis. MassHunter LC–QTOF Acquisition software (version B.08, Agilent 
Technologies) and MassHunter GC–QTOF Acquisition software (version B.07, Agilent 
Technologies) were used to control data acquisition and set the parameters for optimum 
operation. The analytical samples were monitored in high resolution mode both in LC–
MS/MS and GC–MS analyses. 
 
2.3. Sweat collection 
Sweat samples were kindly donated by six healthy volunteers (3 men and 3 women) 
—all of them gave informed consent for sweat sampling. No restrictions about diet or age 
were considered. The use of deodorants, perfumes and cosmetics was excluded at least one 
day prior to sweat collection. The sampled skin area was cleaned with ethanol and distilled 
water before sweat stimulation. Sweat samples were collected from a given area of the back 
of about 100 cm2. Previously, the donors were subjected to a moderate exercise session 
walking for 30 min at around 35 ºC ambient temperature.  
Fresh and dry sweat were sampled simultaneously from similar back areas on each 
volunteer. Fresh sweat was collected directly from the skin by a glass Pasteur pipette with 
a latex bulb (supplied by Scharlab), then transferred to plastic micro Eppendorf tubes and 
stored at –80 °C until sample preparation. A total sweat volume of at least 100 µL was 
collected per sampling. On the other hand, dry sweat was collected after sweating 
stimulation by a gauze (10 cm×10 cm) from Difasan (Barcelona, Spain) or an ashless filter 
paper (10 cm×10 cm) from Filalbet (Barcelona, Spain), which were previously humidified 
with 250 µL of ethanol, pH 7 phosphate buffer solution (PBS) or an 1:1 (v/v) ethanol–PBS 
mixture. The wet supports were gently rubbed on the selected skin area, transferred to 
Falcon plastic tubes and stored at –80 °C until sample preparation. Sampling did not cause 
skin irritation during the process or on subsequent days. 
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2.4. Sample treatment 
Different experimental protocols were used for treatment of fresh and dry sweat 
samples before LC‒MS/MS and GC‒MS analysis. 
 
2.4.1 Sample treatment for fresh sweat 
For LC‒MS/MS analysis one aliquot of fresh sweat (100 μL) was deproteinized by 
vortexing with 100 μL of 50:50 methanol–ACN in a glass insert for 5 min at room 
temperature; then kept on ice for 5 min and centrifuged for 5 min at 10000×g. The liquid 
phase was isolated and located into a new glass insert, evaporated to dryness and 
reconstituted by 25 μL of 0.1% FA in water, as previously optimized Calderón-Santiago et 
al. [6]. 
For GC‒MS analysis fresh sweat samples were deproteinized, evaporated to 
dryness and reconstituted by 25 μL of 0.1% FA in water. Then, 25 μL of each reconstituted 
sample was vortexed with 150 μL of dichloromethane in a glass insert at room temperature 
for 5 min and centrifuged for 5 min at 10000×g. Then, the organic phase was isolated and 
located into a new glass insert, evaporated to dryness and reconstituted by 20 μL of 40 
mg/mL methoxyamine hydrochloride in pyridine. After adding the methoxymation 
solution, the mixture was shaken and maintained at 30 °C for 90 min. For subsequent 
silylation, 90 μL of a 100:1 BSTFA–TMCS mixture was added, shaken for 30 s and 
maintained at 37 °C for 30 min. All samples were cooled at room temperature until analysis. 
This sample preparation protocol was used in a previous study prior to analyzing sweat 
collected after moderate exercise [23]. 
 
2.4.2 Sample treatment for dry sweat 
Humid gauzes or filter papers with dry sweat were vortexed for 5 min with 750 µL 
of the same solvent used for wetting it, and then centrifuged for 5 min at 10000×g. The 
liquid phase was filtered through a 0.45 µm pore size membrane filter from Agilent 
Technologies, located into a new glass vial, and evaporated to dryness. Aliquots for LC–
MS/MS analysis were reconstituted with 25 μL of 0.1% FA in 50:50 water‒methanol. On 
the other hand, aliquots for GC–MS analysis were reconstituted with 25 μL of 0.1% FA in 
water. Then, 25 μL of the reconstituted samples was vortexed with 150 μL of 
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dichloromethane in a glass insert at room temperature for 5 min and centrifuged for 5 min 
at 10000×g. The organic phase was isolated and located into a new glass insert, evaporated 
to dryness and reconstituted by 20 μL of 40 mg/mL methoxyamine hydrochloride in 
pyridine. After adding the methoxymation solution, the mixture was shaken and 
maintained at 30 °C for 90 min. Subsequent silylation involved addition of 90 μL of a 100:1 
BSTFA–TMCS mixture, shaking for 30 s and keeping at 37 °C for 30 min. All samples were 
cooled at room temperature for subsequent analysis. Contamination from gauze and/or 
filter paper was discarded by analysis of water introduced in them as blank, which was 
subjected to the same protocols. In all cases, the samples were prepared in triplicate. 
 
2.5. LC–QTOF MS/MS analysis 
LC separation and QTOF detection were used for analysis of dry and fresh sweat 
samples. Chromatographic separation was performed using a C18 reverse-phase analytical 
column (Mediterranean, 50 mm×4.6 mm i.d., 3 µm particle size) from Teknokroma 
(Barcelona, Spain), which was thermostated at 25 ºC. The mobile phases were water (phase 
A) and ACN (phase B) both with 0.1% FA as ionization agent. The LC pump was 
programmed at a flow rate of 0.8 mL/min with the following elution gradient: 3% phase B 
as initial mobile phase was kept constant from min 0 to 1; then, the percentage of phase B 
was increased from 3 to 80% from min 1 to 10.5, and finally from 80 to 100% of phase B 
from min 10.5 to 11.5. A post-time of 5 min was set to equilibrate the initial conditions for 
the next analysis. The injection volume was 3 µL and the injector needle was washed ten 
times between injections with 70% methanol. Furthermore, the needle seat back was 
flushed for 15 s at a flow rate of 4 mL/min with 70% methanol to avoid cross-contamination. 
The parameters of the ESI source, operating in negative and positive ionization modes, 
were as follows: the capillary and fragmentor voltage were set at ± 3.5 kV and 175 V, 
respectively; N2 in the nebulizer flowed at 40 psi; the flow rate and temperature of the N2 
as drying gas were 8 L/min and 350 ºC, respectively. The instrument was calibrated and 
tuned according to procedures recommended by the manufacturer. MS and MS/MS data 
were collected in both polarities separately using the centroid mode at a rate of 1 
spectrum/s in the extended dynamic range mode (2 GHz). Accurate mass spectra in MS 
scan and MS/MS mode were acquired within the m/z range 60–1100. The instrument gave 
typical resolution 15000 FWHM (full width at half maximum) at m/z 118.0862 and 30000 
FWHM at m/z 922.0098. To assure the desired mass accuracy of recorded ions, continuous 
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internal calibration was performed during analyses by using the signals at m/z 121.0509 
(protonated purine) and m/z 922.0098 [protonated hexakis (1H,1H,3Htetrafluoro-
propoxy) phosphazine or HP-921] in the positive ionization mode; while in negative 
ionization mode ions with m/z 119.0362 (proton abstracted purine) and m/z 966.0007 
(formate adduct of HP-921) were used. The samples were injected in auto-MS/MS 
acquisition mode to obtain information on the product ion of the relevant compounds. The 
number of precursors selected per cycle was set at 2, with an exclusion window of 0.3 min 
after two consecutive selections of the same precursor. The collision energy 20 eV was used 
to obtain the fragmentation information for each entity. At least three replicates of each 
analytical sample were analyzed to improve the quality of the results.  
 
2.6. GC–TOF/MS analysis 
GC–TOF/MS analyses were performed by EI ionization mode at 70 eV and 
controlled by MassHunter Acquisition B.06. Chromatographic separation was carried out 
with a fused silica DB-5MS-UI 30 m×0.25 mm i.d×0.25 μm film thickness capillary 
column. The GC oven temperature program started at 60 °C (1 min held), followed by a 
temperature ramp of 10 °C/min to final 300 °C (2 min held). A post-run time was 
programmed for 4 min up to 310 ºC to assure complete elution of the injected sample. One 
μL of sample was injected using pulsed split injection (1:10 split ratio) at 250 °C (the data 
in the Fiehn library were obtained with this injection mode, and the sensitivity of the 
proposed method is enough for using this injection mode). Ultrapure grade helium was 
used as carrier gas at 0.9 mL/min. The transfer line, ion source and quadrupole 
temperatures were set at 280, 300 and 200 °C, respectively. A solvent delay of 5.50 min 
was used to prevent damage of the ion source filament. The TOF detector was operated at 
5 spectra/s in the mass range m/z 40–750 and the resolution was 8500 FWHM at m/z 
501.9706. Daily mass calibration was performed with PFTBA. 
 
2.7. LC–QTOF MS/MS data processing and statistical analysis  
Details including extraction of molecular features (MFs), tentative identification 
and integration of all peaks are provided as Supplementary material. 
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2.8. GC–TOF/MS data processing and statistical analysis 
Details including deconvolution of chromatograms to obtain a list of MFs, tentative 
identification of compounds by the National Institute of Standards and Technology (NIST) 
database (supported on MS spectrum and retention index, Supplementary Fig. 1) and Fiehn 
database [24], and integration of all metabolites found are provided as Supplementary 
material. 
 
3. Results and discussion 
 
3.1. Influence of impregnation solvent on the collection of dry sweat 
Gauze and filter paper were selected as supports for collection of dry sweat thanks 
to their simplicity and low price. A requirement is that they should be humidified with a 
solvent to solubilize dry sweat components from the skin. In this study, ethanol, PBS and 
1:1 (v/v) ethanol–PBS were compared. Ethanol and PBS are characterized by medium and 
high polarity, respectively, while ethanol–PBS allows testing the effect of an intermediate 
polarity solvent. Additionally, the three solvents present low-toxicity and miscibility with 
water. Dry sweat samples from the six volunteers were collected on gauze and papers using 
independently the three solutions (6 volunteers 2 supports  3 solvents), and treated as 
detailed in Section 2.4. The analytical samples thus obtained were analyzed in triplicate by 
GC–TOF/MS and LC–QTOF MS/MS. Supplementary Fig. 2 shows the base peak 
chromatograms (BPCs) provided by analysis of sweat samples collected on filter paper (A) 
and gauze (B) using the two platforms. The number of chromatographic peaks increased 
when the ethanol‒PBS mixture impregnated the two solid supports as compared to the use 
of ethanol or PBS independently. This increase in detection capability was then estimated 
as the number of tentatively identified metabolites in dry sweat by combination of GC‒MS 
and LC‒MS/MS analyses. The result is illustrated in the Venn diagrams of Fig. 1. 
Sweat samples collected by filter paper impregnated with ethanol‒PBS enabled the 
tentative identification of 156 compounds, while collection with the gauze using the same 
solvent composition led to the identification of 163 compounds. Both collection devices 
behaved similarly in terms of identified compounds. Samples in ethanol or PBS led to the 
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identification of around 83‒91% of the sweat components detected in ethanol‒PBS mixture 
using both paper and gauze as supports. 
 
 
Fig. 1. Venn diagrams comparing the number of compounds tentatively identified by GC‒TOF/MS 
and LC‒QTOF MS/MS in dry sweat collected by the two supports and the three impregnation 
solutions. 
 
The ethanol‒PBS solution also offered the best performance in quantitative terms. 
The detection capability for ethanol‒PBS solution was calculated for each pair ethanol‒
PBS/ethanol and ethanol‒PBS/PBS by using the following expressions: 
Detection capability (%) =  
𝑃𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 𝑓𝑜𝑟 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑋 𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 𝑖𝑛 𝑒𝑡ℎ𝑎𝑛𝑜𝑙‒PBS 
𝑃𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 𝑓𝑜𝑟 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑋 𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 𝑖𝑛 𝑒𝑡ℎ𝑎𝑛𝑜𝑙
 ×  100  
and detection capability (%) = 
𝑃𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 𝑓𝑜𝑟 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑋 𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 𝑖𝑛 𝑒𝑡ℎ𝑎𝑛𝑜𝑙‒PBS 
𝑃𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 𝑓𝑜𝑟 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑋 𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 𝑖𝑛 𝑃𝐵𝑆
 ×  100 
Fig. 2 (A and B) shows the bar diagrams by plotting the number of compounds 
identified as a function of the detection capability using paper as support. As can be seen, 
most compounds reported a detection capability above 100% when ethanol‒PBS was used 
as solution mixture. However, 16% of the metabolites —mainly lipids such as fatty acyls and 
glycerolipids— were detected with a higher efficiency when ethanol was used as solvent. On 
the other hand, 23% of compounds (mainly carboxylic acids such as hydroxy acids) were 
more efficiently detected in the PBS buffer.  
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Complementarily, Fig. 2 (C and D) shows the bars diagrams with the results of the 
detection capability for gauze. Again, most compounds were more properly detected by 
using the ethanol‒PBS solution. In this case, 20% of the metabolites identified when 
ethanol‒PBS was used as solvent —mainly lipids such as fatty alcohols, long-chain fatty 
acids, sphingolipids and monoacylglycerols— were detected with higher efficiency when 
ethanol was used as solvent. 
On the other hand, 17% of compounds (mainly benzenoids such as benzoic acid 
derivatives, proteinogenic amino acids and organoheterocyclic compounds such as indoles) 
were better detected with the buffer as compared to the ethanol‒PBS mixture. According 
to these results, ethanol‒PBS was the solvent providing the most complete coverage at 
qualitative and quantitative levels when this solution impregnated either gauze or filter 
paper. Further experiments were carried out with ethanol‒PBS as suited solvent. 
 
3.2. Comparison of the solid support for dry sweat sampling 
The comparison between gauze and filter paper impregnated with ethanol‒PBS 
was carried out by the Venn diagram illustrated in Fig. 3.  
 
 
Fig. 3. Venn diagram and bar graph comparing the number and peak areas, respectively, of 
compounds tentatively identified in dry sweat collected on filter paper and gauze both impregnated 
with 1:1 (v/v) ethanol‒PBS. 
 Chapter IX 
 
Page | 469  
Nineteen metabolites were only identified by using gauze as support. They were 
particularly lipids —viz, fatty alcohols (C14:0 and C16:0) and medium-chain fatty acids 
(C6:0 and C8:0). On the other hand, 12 metabolites were only identified in impregnated 
filter paper. They included long-chain fatty acids —C20:0, C20:4 (n-6) and C18:2 (n-6)—, 
and monoacylglycerols (C12:0, C14:0 and C16:0) (Table 1). 
 
Table 1. Compounds classified by chemical families, and tentatively identified by LC–QTOF MS/MS 
and GC–TOF/MS in dry sweat collected by gauze or filter paper impregnated with 1:1 (v/v) ethanol–
PBS. 
Identification Compound name 
RT 
(min) 
Dry sweat 
(gauze) 
Dry sweat  
(filter paper) 
 Benzenoids   
LC─MS/MS Anthranilic acid 1.91  
LC─MS/MS 4-Hydroxybenzaldehyde 2.04  
LC─MS/MS 2-Phenylacetamide 2.04  
LC─MS/MS 3,4-Dihydroxybenzoic acid 4.95  
LC─MS/MS Hydroxyphenyllactic acid 5.14  
LC─MS/MS Chlorogenic acid 5.48  
LC─MS/MS Benzoic acid 5.82  
LC─MS/MS 4-Acetoxyphenol 5.83  
LC─MS/MS Hydroquinone 6.01  
GC─MS ß-Ethenylbenzeneethanol 6.10  
LC─MS/MS 3-Phenyllactic acid 6.58  
LC─MS/MS Phenylacetic acid 6.98  
LC─MS/MS Salicylic acid 7.83  
GC─MS Methylparaben 12.52  
GC─MS 2,4,6-Trimethylbenzoic acid 12.54  
GC─MS Isovanillin 13.04  
GC─MS 2-Phenyllactic acid 13.56  
GC─MS 4-Methoxybenzoic acid 15.67  
GC─MS Octocrylene 23.67  
 Carbohydrates   
LC─MS/MS Sorbitol 0.85  
LC─MS/MS Sucrose 0.92  
GC─MS Glyceric acid 10.26  
GC─MS Erythritol 12.56  

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
GC─MS Threonic acid 13.00  
GC─MS Galactose 17.00  
GC─MS Glucose 17.04  
GC─MS Mannitol 17.33  
GC─MS Gluconic acid 17.97  
GC─MS Trehalose 24.18  
 Amino acids   
LC─MS/MS Arginine 0.85  
LC─MS/MS Citrulline 0.86  
LC─MS/MS Betaine 0.87  
LC─MS/MS N-Acetylhistidine 0.92  
LC─MS/MS 
1-Aminocyclopropane-1-
carboxylic acid 
1.36  
LC─MS/MS Isoleucine 1.59  
LC─MS/MS Tyrosine 2.04  
LC─MS/MS Phenylalanine 3.67  
LC─MS/MS Tryptophan 4.83  
LC─MS/MS N-Acetylvaline 4.98  
GC─MS Alanine 6.97  
LC─MS/MS 
Methyl  
N-(α-methylbutyryl)glycine 
7.13  
GC─MS 2-Aminobutyric acid 8.03  
GC─MS Valine 8.66  
GC─MS Proline 9.86  
GC─MS Glycine 9.96  
GC─MS Serine 10.68  
GC─MS Threonine 11.02  
GC─MS Sarcosine 11.25  
GC─MS Hydroxyproline 11.98  
GC─MS Aminomalonic acid 12.13  
GC─MS Pyroglutamic acid 12.80  
GC─MS α-Aminoadipic acid 13.10  
GC─MS 2-Aminoheptanedioic acid 13.74  
GC─MS Ornithine 13.91  
GC─MS Glutamic acid 13.96  
GC─MS Asparagine 14.53  
GC─MS Histidine 17.22  
GC─MS Lysine 17.24  

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
 
Carboxylic acids and 
derivatives 
  
LC─MS/MS Citric acid 1.51  
LC─MS/MS 2,2-Dimethylsuccinic acid 4.86  
GC─MS Lactic acid 6.29  
GC─MS Pyruvic acid 6.73  
GC─MS 2-Hydroxybutyric acid 7.32  
GC─MS Oxalic acid 7.43  
GC─MS 3-Hydroxypropionic acid 7.62  
GC─MS 3-Hydroxybutyric acid 7.85  
GC─MS Carbamate 8.43  
GC─MS Hydroxycarbamic acid 9.02  
GC─MS Succinic acid 10.09  
GC─MS Fumaric acid 10.59  
GC─MS 3,4-Dihydroxybutanoic acid 11.63  
GC─MS Malic acid 12.35  
GC─MS 2-Oxoglutaric acid 13.43  
GC─MS Aconitic acid 15.42  
GC─MS Tributyl acetylcitrate 20.35  
 Flavonoid   
LC─MS/MS Rutin 6.22  
 Lipids   
LC─MS/MS 2-Hexyldecanoic acid 0.89  
LC─MS/MS Stearic acid 0.89  
LC─MS/MS Propionylcarnitine 1.88  
LC─MS/MS Dexpanthenol 4.30  
LC─MS/MS 2-Hydroxyisovaleric acid 4.61  
LC─MS/MS 2-Methylbutyroylcarnitine 4.99  
GC─MS Caproic acid 6.55  
GC─MS 3-Nonen-1-ol 7.14  
LC─MS/MS 3-Hydroxycaprylic acid 7.63  
LC─MS/MS Hexadecasphinganine 8.08  
LC─MS/MS 3-Ketosphingosine 8.23  
LC─MS/MS Phytosphingosine 8.76  
LC─MS/MS Sphinganine 8.82  
GC─MS 2-Hydroxyisocaproic acid 8.92  
LC─MS/MS Sphingosine 9.04  

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
LC─MS/MS C75 9.15  
LC─MS/MS Myristoylcarnitine 9.32  
GC─MS Caprylic acid 9.41  
LC─MS/MS NN-Dimethylsphing-4-enine 9.81  
LC─MS/MS Palmitoylcarnitine 10.12  
GC─MS 5-Hydroxy-N-valeric acid 10.34  
LC─MS/MS 
1-Palmitoyl-
lysophosphatidylcholine 
(LysoPC(16:0)) 
11.34  
GC─MS 1-Monoisobutyrylglycerol 12.13  
GC─MS Adipic acid 12.62  
GC─MS 1-Dodecanol 13.40  
GC─MS Lauric acid 14.39  
GC─MS Tridecylic acid 15.49  
GC─MS 1-Tetradecanol 15.64  
GC─MS Myristoleic acid 16.31  
GC─MS Myristic acid 16.54  
GC─MS Pentadecanoic acid 17.55  
GC─MS 1-Hexadecanol 17.67  
GC─MS Hexadecanoic acid, ethyl ester 18.03  
GC─MS Palmitoleic acid 18.27  
GC─MS 10-Heptadecenoic acid 19.19  
GC─MS Arachidonic acid 19.89  
GC─MS Linoleic acid 19.90  
GC─MS 1-Monolaurylglycerol 19.92  
GC─MS Oleic acid 20.08  
GC─MS 1-Monomyristylglycerol 21.56  
GC─MS Arachidic acid 21.97  
GC─MS 2-Monopalmitoylglycerol 22.83  
GC─MS 2-Monostearylglycerol 24.27  
GC─MS 1-Monostearylglycerol 24.51  
GC─MS 13-Docosenamide 24.59  
GC─MS Squalene 24.84  
GC─MS Cholesta-3,5-diene 25.55  
GC─MS Hexacosanoic acid 26.51  
 
Nucleosides, nucleotides, 
and analogues 
  
LC─MS/MS Hypoxanthine 1.82  

Continuation Table 1 
 Chapter IX 
 
Page | 473  

LC─MS/MS Inosine 3.64  
LC─MS/MS Guanosine 3.65  
LC─MS/MS Guanine 3.66  
LC─MS/MS Theophylline 4.95  
LC─MS/MS Caffeine 5.50  
GC─MS Thymine 11.24  
GC─MS Uric acid 18.94  
 
Organic nitrogen 
compounds 
  
LC─MS/MS Spermine 0.75  
LC─MS/MS Choline 0.84  
LC─MS/MS Octylamine 4.70  
GC─MS 2-Hydroxyethanamine 5.84  
LC─MS/MS Aminopentol 8.17  
LC─MS/MS Hexaldecylamine 8.81  
GC─MS Urea 9.18  
GC─MS Ethanolamine 9.40  
LC─MS/MS Octadecylamine 9.62  
LC─MS/MS N,N'-Dicyclohexylurea 9.84  
LC─MS/MS Cetrimonium 10.27  
GC─MS Diethanolamine 11.71  
GC─MS 
1,3,5-Trihydroxy-tert-
butylamine 
12.62  
GC─MS Triethanolamine 14.04  
 
Organic oxygen 
compounds 
  
GC─MS 2,3-Butanediol 5.85  
GC─MS 1,2-Butanediol 8.08  
GC─MS 4-Methyl-1,2-dihydroxypentane 8.83  
GC─MS Diethylene glycol 9.08  
GC─MS Glycerol 9.48  
GC─MS 2-(2-Butoxyethoxy)ethanol 10.43  
GC─MS 
1,1,1-Tris(hydroxyme-
thyl)propane 
11.12  
GC─MS Pinitol 16.25  
GC─MS myo-Inositol 18.84  
 Organic phosphoric acid   
GC─MS Ethyl phosphoric acid 8.78  
 
Organoheterocyclic 
compounds 
  

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
LC─MS/MS Melamine 0.87  
LC─MS/MS Urocanic acid 1.34  
LC─MS/MS Nicotine 1.34  
LC─MS/MS Nicotinic acid 1.36  
LC─MS/MS Niacinamide 1.41  
LC─MS/MS 2-Pyrimidine acetic acid 1.63  
LC─MS/MS Indole-3-acetamide 2.42  
LC─MS/MS 4-Formyl indole 4.83  
LC─MS/MS 3-Amino-2-naphthoic acid 5.87  
GC─MS Indane 6.10  
LC─MS/MS 
2-Methyl-3-hydroxy-
ethylenepyran-4-one 
7.64  
LC─MS/MS Embelin 10.04  
GC─MS 3-Amino-2-piperidone 11.98  
GC─MS Alloxanoic acid 12.48  
GC─MS Cyanuric acid 13.79  
GC─MS Gluconic acid δ-lactone 16.83  
 Oxoanionic compounds   
LC─MS/MS Pyrophosphate 1.07  
GC─MS Phosphite (3:1) 7.06  
GC─MS Borate 9.68  
 
It worth noting that the gauze used in this study was composed by hydrophilic 
healing material and a small quantity of nylon (polar tissue). Therefore, the gauze favored 
the dissolution of medium-chain fatty alcohols and fatty acids since the hydrophilic 
character of the polar head region of these compounds allowed setting interaction with the 
solid support. Concerning the filter paper, it was made of cotton linters pulp and high purity 
cellulose (above 95%) subjected to a rigorous washing with acids and water. Cellulose does 
not interact favorably with polar solvents such as water because its polymeric structure is 
based on strong intramolecular hydrogen bonds. Thus, filter paper favors dissolution of low 
polar compounds such as long-chain fatty acids and monoacylglycerols, characterized by 
an ester group and two alcohol groups, less polar than medium-chain fatty acids. 
In addition to lipids, most families of compounds —e.g., benzenoids (benzoic acid 
derivatives), carbohydrates (mainly sugar acids and sugar alcohols), hydroxy acids, amino 
acids, and organic nitrogen compounds (alkylamines and alkanolamines)— provided a 
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better response in the samples obtained using filter paper, except di- and tricarboxylic acids 
that were better detected in gauze, as shown in Fig. 3. Green bars are defined by the peak 
area of the compounds tentatively identified in dry sweat collected by gauze. Purple bars 
are defined by the peak area of the compounds identified in dry sweat collected by filter 
paper from the same six volunteers. In both cases, three replicates were performed. In fact, 
significant differences were found in lipids (p-value=0.000), amino acids (p-value=0.002), 
organic nitrogen compounds (p-value=0.002), carbohydrates (p-value=0.002), 
benzenoids (p-value=0.015) and other carboxylic acids (p-value=0.012) when the 
quantitative responses reported in dry sweat collected on the two supports were compared 
(Supplementary Table 1). Other families such as organic oxygen compounds (mainly diols) 
and organoheterocyclic compounds (a great diversity of compounds such as azines, indoles 
and pyridine derivatives, among others) behaved similarly in both supports. The 
methodological variability estimated as relative standard deviation of individual 
compounds ranged from 0.0 to 11.7% and from 0.0 to 17.7% for paper and gauze, 
respectively. 
Supplementary Fig. 3 shows the BPCs from GC‒MS and LC‒MS obtained by 
analysis of dry sweat sampled on filter paper or gauze containing the same solvent mixture. 
Comparison of the BPCs shows that GC‒MS, and LC‒MS in negative ionization mode 
provided more and higher peaks at the beginning of the chromatogram, while LC‒MS in 
positive ionization mode provided chromatograms with a higher number of peaks in overall 
terms along the chromatogram. Peaks identified at the beginning of the GC‒MS 
chromatograms were mainly amino acids and hydroxy acids, while those identified in the 
middle part were sugars, other amino acids, long-chain fatty acids, alkanolamines and 
alcohols; the compounds identified at the end of the chromatograms were mainly lipids. 
LC‒MS in negative ionization mode provided identification of compounds such as 
carbohydrates and fatty acyls at the beginning of the chromatogram. LC‒MS in positive 
ionization presented peaks corresponding to compounds such as aromatic amino acids and 
nucleotides and analogues also stood out in the mid-part of the chromatogram, while lipids, 
mainly sphingolipids, acyl carnitines and alkylamines were identified at the end of the 
chromatogram (Supplementary Fig. 3). More polar compounds such as amino acids and 
organoheterocyclic compounds were tentatively identified at the first part of the 
chromatogram. Finally, it is worth mentioning the presence of one high-intensity peak 
detected by LC‒MS in positive ionization of dry sweat collected with the gauze. This peak, 
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identified as an interferent (caprolactam), that also appears in gauze blanks. It is a key 
molecule in the synthesis of nylon. 
 
3.3. Metabolome differences between dry and fresh sweat 
Metabolomics analysis of fresh sweat had previously been addressed by three 
analytical platforms, namely, NMR, LC–MS/MS and GC–MS [4–6,25]. On the other hand, 
no comprehensive studies dealing with dry sweat metabolome composition had been 
carried out. As previously mentioned, most studies on dry sweat are referred to the 
collection of fresh sweat that was dried prior to analysis [7,8]. For this reason, a 
comparative study dealing with the analysis of dry and fresh sweat was carried out in this 
research by combined LC–MS/MS and GC–MS analyses. Supplementary Fig. 4 shows the 
BPCs obtained by analysis of both samples collected in similar body areas. Dry sweat 
reported more chromatographic peaks and with higher intensity than those detected in 
fresh sweat. However, the analysis of dry sweat led to the identification of 156 metabolites, 
while 172 were identified in fresh sweat. 
 
 
Fig. 4. Venn diagram and bar graph comparing the number and peak areas, respectively, of 
compounds tentatively identified in dry sweat collected on filter paper impregnated with 1:1 (v/v) 
ethanol‒PBS and fresh sweat. 
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Fig. 4 shows that 133 metabolites were common to both samples, as listed in Table 
2. Among the 23 compounds identified exclusively in dry sweat, 10 were lipids such as 
sphingolipids, monoacylglycerols and fatty acyls; 7 were benzenoids such as benzoic acid 
derivatives; and 4 were organic nitrogenated compounds such as alkylamines. It is well-
known that when sweat is excreted to the skin surface, it interacts with the stratum 
corneum, the outermost layer of the epidermis consisting of dead cells (corneocytes). These 
cells are embedded in a lipid matrix of ceramides, cholesterol, and fatty acids [20]. 
Fresh sweat provided exclusively the tentative identification of polar compounds, 
mainly diols and carboxylic acids, and also of some no polar compounds, mainly fatty acids 
and derivatives. 
 
Table 2. Compounds, classified by chemical families, tentatively identified by GC–TOF/MS and LC–
QTOF MS/MS in dry sweat collected by filter paper impregnated with 1:1 (v/v) ethanol–PBS and in 
fresh sweat. 
Identification Compound name 
RT 
(min) 
Dry sweat  
(filter paper) 
Fresh sweat 
 Benzenoids   
LC─MS/MS Anthranilic acid 1.91  
LC─MS/MS 4-Hydroxybenzaldehyde 2.04  
LC─MS/MS 2-Phenylacetamide 2.04  
LC─MS/MS 3,4-Dihydroxybenzoic acid 4.95  
LC─MS/MS Hydroxyphenyllactic acid 5.14  
LC─MS/MS Chlorogenic Acid 5.48  
LC─MS/MS Benzoic acid 5.82  
LC─MS/MS 4-Acetoxyphenol 5.83  
LC─MS/MS Hydroquinone 6.01  
GC─MS β-Ethenylbenzeneethanol 6.10  
LC─MS/MS 3-Phenyllactic acid 6.58  
LC─MS/MS Phenylacetic acid 6.98  
LC─MS/MS Salicylic acid 7.83  
LC─MS/MS Ketoprofen 9.69  
GC─MS Chlorphentermine 10.16  
GC─MS 3,4-Dimethylbenzoic acid 12.49  
GC─MS Methylparaben 12.52  
GC─MS 2,4,6-Trimethylbenzoic acid 12.54  

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
GC─MS Isovanillin 13.04  
GC─MS 2-Phenyllactic acid 13.56  
GC─MS 4-Methoxybenzoic acid 15.67  
GC─MS Octocrylene 23.67  
 Carbohydrates   
LC─MS/MS Sorbitol 0.85  
LC─MS/MS Sucrose 0.92  
GC─MS Glyceric acid 10.26  
GC─MS Erythritol 12.56  
GC─MS Threonic acid 13.00  
GC─MS Galactose 17.00  
GC─MS Glucose 17.04  
GC─MS Mannitol 17.33  
GC─MS Gluconic acid 17.97  
GC─MS Trehalose 24.18  
 Amino acids   
LC─MS/MS Arginine 0.85  
LC─MS/MS Citrulline 0.86  
LC─MS/MS Betaine 0.87  
LC─MS/MS N-Acetylhistidine 0.92  
LC─MS/MS 
1-Aminocyclopropane- 
1-carboxylic acid 
1.36  
LC─MS/MS Isoleucine 1.59  
LC─MS/MS Tyrosine 2.04  
LC─MS/MS Phenylalanine 3.67  
LC─MS/MS Tryptophan 4.83  
LC─MS/MS N-Acetylvaline 4.98  
GC─MS Alanine 6.97  
LC─MS/MS 
Methyl  
N-(α-methylbutyryl)glycine 
7.13  
GC─MS 2-Aminobutyric acid 8.03  
GC─MS Valine 8.66  
GC─MS Proline 9.86  
GC─MS Glycine 9.96  
GC─MS Serine 10.68  
GC─MS Threonine 11.02  
GC─MS Sarcosine 11.25  
GC─MS Hydroxyproline 11.98  

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
GC─MS Aminomalonic acid 12.13  
GC─MS Aspartic acid 12.77  
GC─MS Pyroglutamic acid 12.80  
GC─MS α-Aminoadipic acid 13.10  
GC─MS 2-Aminoheptanedioic acid 13.74  
GC─MS Ornithine 13.91  
GC─MS Glutamic acid 13.96  
GC─MS Asparagine 14.53  
GC─MS Histidine 17.22  
GC─MS Lysine 17.24  
 
Carboxylic acids and 
derivatives 
  
LC─MS/MS Citric acid 1.51  
LC─MS/MS 2,2-Dimethylsuccinic acid 4.86  
GC─MS Lactic acid 6.29  
GC─MS Pyruvic acid 6.73  
GC─MS 2-Hydroxybutyric acid 7.32  
GC─MS Oxalic acid 7.43  
GC─MS 3-Hydroxypropionic acid 7.62  
GC─MS 3-Hydroxybutyric acid 7.85  
GC─MS Carbamate 8.43  
GC─MS Hydroxycarbamic acid 9.02  
GC─MS Succinic acid 10.09  
GC─MS Fumaric acid 10.59  
GC─MS Glutaric acid 11.33  
GC─MS 3,4-Dihydroxybutanoic acid 11.63  
GC─MS Malic acid 12.35  
GC─MS 2-Oxoglutaric acid 13.43  
GC─MS Aconitic acid 15.42  
GC─MS Tributyl acetylcitrate 20.35  
 Flavonoid   
LC─MS/MS Rutin 6.22  
 Lipids   
LC─MS/MS Stearic acid 0.89  
LC─MS/MS 2-Hexyldecanoic acid 0.89  
LC─MS/MS Propionylcarnitine 1.88  
LC─MS/MS Dexpanthenol 4.30  

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
LC─MS/MS 2-Hydroxyisovaleric acid 4.61  
LC─MS/MS 2-Methylbutyroylcarnitine 4.99  
GC─MS Caproic acid 6.55  
GC─MS 3-Nonen-1-ol 7.14  
LC─MS/MS 3-Hydroxycaprylic acid 7.63  
LC─MS/MS Hexadecasphinganine 8.08  
LC─MS/MS 3-Ketosphingosine 8.23  
GC─MS 3-Hydroxyisovaleric acid 8.59  
LC─MS/MS Phytosphingosine 8.76  
LC─MS/MS Sphinganine 8.82  
GC─MS 2-Hydroxyisocaproic acid 8.92  
LC─MS/MS Sphingosine 9.04  
LC─MS/MS C75 9.15  
LC─MS/MS Myristoylcarnitine 9.32  
GC─MS Caprylic acid 9.41  
LC─MS/MS NN-Dimethylsphing-4-enine 9.81  
LC─MS/MS Palmitoylcarnitine 10.12  
GC─MS 5-Hydroxy-N-valeric acid 10.34  
GC─MS Nonanoic acid 10.75  
LC─MS/MS 
1-Palmitoyllysophos-
phatidylcholine (LysoPC(16:0)) 
11.34  
GC─MS Capric acid 12.03  
GC─MS 1-Monoisobutyrylglycerol 12.13  
GC─MS Adipic acid 12.62  
GC─MS 1-Dodecanol 13.40  
GC─MS Lauric acid 14.39  
GC─MS Tridecylic acid 15.49  
GC─MS 1-Tetradecanol 15.64  
GC─MS Azelaic acid 15.97  
GC─MS Myristoleic acid 16.31  
GC─MS Myristic acid 16.54  
GC─MS Pentadecanoic acid 17.55  
GC─MS 1-Hexadecanol 17.67  
GC─MS Hexadecanoic acid, ethyl ester 18.03  
GC─MS Palmitoleic acid 18.27  
GC─MS Palmitic acid 18.51  
GC─MS 10-Heptadecenoic acid 19.19  

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
GC─MS Margaric acid 19.43  
GC─MS 1-Octadecanol 19.53  
GC─MS Arachidonic acid 19.89  
GC─MS Linoleic acid 19.90  
GC─MS 1-Monolaurylglycerol 19.92  
GC─MS Oleic acid 20.08  
GC─MS 1-Monomyristylglycerol 21.56  
GC─MS Dehydroabietic acid 21.62  
GC─MS Oleamide 21.76  
GC─MS Arachidic acid 21.97  
GC─MS 2-Monopalmitoylglycerol 22.83  
GC─MS 1-Monopalmitoylglycerol 23.09  
GC─MS Docosanoic acid 23.52  
GC─MS 2-Monostearylglycerol 24.27  
GC─MS 1-Monostearylglycerol 24.51  
GC─MS 13-Docosenamide 24.59  
GC─MS Squalene 24.84  
GC─MS Cholesta-3,5-diene 25.55  
GC─MS Hexacosanoic acid 26.51  
 
Nucleosides, nucleotides, 
and analogues 
  
LC─MS/MS Hypoxanthine 1.82  
LC─MS/MS Inosine 3.64  
LC─MS/MS Guanosine 3.65  
LC─MS/MS Guanine 3.66  
LC─MS/MS Guanidylic acid 4.06  
LC─MS/MS Theophylline 4.95  
LC─MS/MS Caffeine 5.50  
GC─MS Thymine 11.24  
GC─MS Uric acid 18.94  
 
Organic nitrogen 
compounds 
  
LC─MS/MS Choline 0.84  
LC─MS/MS Octylamine 4.70  
GC─MS 2-Hydroxyethanamine 5.84  
LC─MS/MS Aminopentol 8.17  
LC─MS/MS Hexaldecylamine 8.81  
GC─MS Urea 9.18  

Continuation Table 2 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
 
Page | 482 

GC─MS Ethanolamine 9.40  
LC─MS/MS Octadecylamine 9.62  
LC─MS/MS N,N'-Dicyclohexylurea 9.84  
LC─MS/MS Cetrimonium 10.27  
GC─MS Diethanolamine 11.71  
GC─MS 
1,3,5-Trihydroxy- 
tert-butylamine 
12.62  
GC─MS Triethanolamine 14.04  
 Organic oxygen compounds   
GC─MS 2,3-Butanediol 5.85  
GC─MS Acetonyldimethylcarbinol 6.02  
GC─MS 2-Methyl-1,3-propanediol 6.63  
GC─MS 1,3-Butanediol 6.64  
GC─MS Pinacol 7.78  
GC─MS 4-Methyl-1,2-dihydroxypentane 8.83  
GC─MS Diethylene glycol 9.08  
GC─MS Glycerol 9.48  
GC─MS 2-(2-Butoxyethoxy)ethanol 10.43  
GC─MS 
1,1,1-Tris(hydroxy-
methyl)propane 
11.12  
GC─MS 
2,4,7,9-Tetramethyl- 
5-decyne-4,7-diol 
13.31  
GC─MS Pinitol 16.25  
GC─MS myo-Inositol 18.84  
 Organic phosphoric acid   
GC─MS Ethyl phosphoric acid 8.78  
 
Organoheterocyclic 
compounds 
  
LC─MS/MS Melamine 0.87  
LC─MS/MS Urocanic acid 1.34  
LC─MS/MS Nicotine 1.34  
LC─MS/MS Nicotinic acid 1.36  
LC─MS/MS Niacinamide 1.41  
LC─MS/MS 2-Pyrimidine acetic acid 1.63  
LC─MS/MS Indole-3-acetamide 2.42  
LC─MS/MS 4-Formyl indole 4.83  
LC─MS/MS 3-Amino-2-naphthoic acid 5.87  
GC─MS Indane 6.10  
GC─MS 2-Furoic acid 7.50  

Continuation Table 2 
 Chapter IX 
 
Page | 483  

LC─MS/MS 
2-Methyl-3-hydroxy 
ethylenepyran-4-one 
7.64  
LC─MS/MS Embelin 10.04  
GC─MS 3-Amino-2-piperidone 11.98  
GC─MS Alloxanoic acid 12.48  
GC─MS Cyanuric acid 13.79  
GC─MS Gluconic acid δ-lactone 16.83  
 Oxoanionic compounds   
LC─MS/MS Pyrophosphate 1.07  
GC─MS Borate 9.68  
 
The comparison of the detection coverage provided by both samples allowed 
concluding that dry sweat is better for analysis of low polar metabolites and fresh sweat is 
more suited for polar compounds (Fig. 4). In fact, significant differences were found in the 
case of amino acids (p-value=0.000), nucleotides and analogues (p-value=0.002), organic 
oxygen compounds (alcohols) (p-value=0.000) and organoheterocyclic compounds (a 
diverse group constituted mainly by azines, indoles and pyridine derivatives) (p-
value=0.001), but also in the case of benzenoids (benzaldehydes, benzoic acid derivatives 
and phenylpropanoic acids) (p-value=0.032), carboxylic acids (p-value=0.027) and lipids 
(p-value=0.031) in the comparison between fresh and dry sweat (Supplementary Table 2). 
Furthermore, the methodological variability, estimated as relative standard deviation of 
individual compounds, ranged from 0.0 to 11.7% and from 0.1 to 26.9% for dry and fresh 
sweat, respectively, which means that the protocol for collection of fresh sweat is less 
reproducible than that for sampling dry sweat. The solid support and the impregnation 
solvent play a key role favoring the dissolution of particular families of metabolites. It is 
remarkable that fresh sweat contained 85% of the metabolites detected in dry sweat 
collected by filter paper. 
 
3.4. GC‒MS vs LC‒MS/MS for analysis of dry sweat 
The combination of the two platforms allowed identification of 156 metabolites in 
dry sweat, with a detection coverage above 45 and 60% for LC‒MS/MS and GC‒MS, 
respectively. 
Continuation Table 2 
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Fig. 5 plots the Venn diagram that compares metabolites identified in dry sweat 
using both platforms. GC–MS resulted to be specially suited to detect lipids, and high polar 
compounds such as carbohydrates, carboxylic acids and amino acids. This approach 
allowed exclusively detecting organic oxygen compounds such as the polyols detected in 
dry sweat (Fig. 5). Bars are defined by the number of compounds tentatively identified in 
dry sweat from the six volunteers by GC–MS (purple) and LC–MS/MS (orange). 
 
 
Fig. 5. Venn diagram comparing the number of compounds tentatively identified by GC‒TOF/MS 
and LC‒QTOF MS/MS (in both ionization modes) in dry sweat collected on filter paper impregnated 
with 1:1 (v/v) ethanol‒PBS, classified by families in the bar graph. 
 
On the other hand, LC‒MS/MS was capable of covering a higher number of amino 
acids, nucleotides and analogues, organic nitrogen compounds such as alkylamines and 
alkanolamines, benzenoids (mainly benzoic acid derivatives), and organoheterocyclic 
compounds (mainly pyridine derivatives). These families were easily identified in positive 
ionization mode, except benzenoids, which reported higher sensitivity when working in 
negative mode. In fact, comparing the relative abundance (%) of the families identified in 
dry sweat by LC‒MS/MS in positive and negative ionization modes, it is remarkable that 
the former mode was the best as it covers a high percentage of polar lipids (such as 
carnitines and sphingolipids), organic nitrogen compounds (such as monoalkylamines) 
and organoheterocyclic compounds (such as pyridine derivatives). The positive ionization 
was also useful to detect xanthines and amino acids in sweat, while the negative polarity 
was better for covering nucleotides, carbohydrates, some carboxylic acids and benzenoids 
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such as benzoic acids, and also for detecting hydroxy fatty acids in dry sweat 
(Supplementary Fig. 5). 
Supplementary Table 3 lists the tentatively identified metabolites in dry sweat by 
LC–MS, classified according to their chemical family. Among the identified lipids, it is 
remarkable the presence of sphingosines, acylcarnitines and a glycerophospholipid. 
Regarding benzenoids and organoheterocyclic metabolites, pyridine derivatives 
(niacinamide and nicotinic acid), indoles, azines and other organoheterocyclic compounds 
(embelin, 3-amino-2-naphthoic acid and 2-methyl-3-hydroxyethylenepyran-4-one), and 
benzenoids such as benzoic acid derivatives and phenylpropanoic acids were identified for 
the first time in sweat. Moreover, alkylamines, aminopentol and N,N'-dicyclohexylurea 
detected in dry sweat had not been previously identified. Other metabolites detected in dry 
sweat were sugars, nucleotides, amino acids, N-acyl amino acids (methyl N-(a-
methylbutyryl)glycine, N-acetylhistidine and N-acetylvaline), 2,2-dimethyl succinic acid, 
rutin, guanosine, guanine, hypoxanthine and pyrophosphate. Although N-acetylamino 
acids had not been previously identified in sweat, similar metabolites as N-acetyl-aspartate 
and N-acetyl-serine had been identified in fresh sweat by NMR and MS, respectively [4,26].  
Complementarily, Supplementary Table 4 lists the tentatively identified 
metabolites in dry sweat by GC–MS, classified according to their chemical family. Some 
lipids such as 1-monoisobutyrylglycerol, 1-monolaurylglycerol, hexadecanoic acid ethyl 
ester and 13-docosenamide identified in dry sweat had not been previously identified in 
fresh sweat. Also, polar compounds such as amino acids, carboxylic acids (aconitic acid and 
2-oxoglutaric acid), hydroxy acids (3-hydroxybutyric and 3-hydroxypropionic acids), 
sugars (trehalose, gluconic acid, erythritol and mannitol) were identified in dry sweat. 
These compounds, but amino acids, had not been previously identified in fresh sweat 
[23,27,28]. Other metabolites detected in dry sweat for the first time were benzenoids (such 
as isovanillin, 2,4,6-trimethylbenzoic acid, 4-methoxybenzoic acid, phenyllactic acid, ß-
ethenylbenzeneethanol and octorylene), alcohols (pinitol and 4-methyl-1,2-
dihydroxypentane), organoheterocyclic compounds (cyanuric acid, melamine and 
alloxanoic acid), alkanolamines (2-hydroxyethanamine and 1,3,5-trihydroxy-tert-
butylamine), and uric acid and thymine. 
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4. Conclusions and perspectives 
Sampling approaches for collection of dry sweat have been evaluated to propose a 
standardized protocol alternative to fresh sweat sampling. The use of paper impregnated 
with 1:1 (v/v) ethanol‒PBS led to the best results in terms of detection coverage by using a 
combined approach based on GC–MS and LC–MS/MS analysis. A total 175 compounds 
were tentatively identified in dry sweat. The comparison between dry and fresh sweat 
revealed that the former provided an improvement in the detection of low-polar 
compounds, while fresh sweat was more suited for detection of polar metabolites. 
Nevertheless, particular families such as carnitines, sphingolipids and N-acyl-amino acids 
of essential amino acids were detected in dry sweat and have not been reported in fresh 
sweat. Considering the variability sources affecting the sampling of fresh sweat, collection 
of dry sweat can be proposed as a standardized approach to use this biofluid in 
metabolomics studies. 
 
Acknowledgments 
The Spanish Ministerio de Economía y Competitividad (MINECO) is thanked for 
financial support through the project CTQ2015-68813-R, which is co-funded by European 
Regional Development Fund/European Social Fund (“Investing in your future”). M.M. 
Delgado-Povedano thanks the Ministerio de Educación, Cultura y Deporte (MECD) for an 
FPU scholarship (FPU14/03068) and the members of the research group for their 
participation in the donation of some sweat samples. CIBER de Fragilidad y 
Envejecimiento Saludable (CIBERfes) is an initiative of ISCIII, Spain. 
 
References 
[1] K. Sato, W. H. Kang, K. Saga, K. T. Sato, Biology of sweat glands and their disorders. I. Normal sweat gland 
function, J. Am. Acad. Dermatol. 20 (1989) 537‒563. 
[2] A. Mena-Bravo, M.D. Luque de Castro, Sweat: a sample with limited present applications and promising 
future in metabolomics, J. Pharm. Biomed. Anal. 90 (2014) 139‒147. 
[3] S.L. Souza, G. Graça, A. Oliva, Characterization of sweat induced with pilocarpine, physical exercise, and 
collected passively by metabolomic analysis, Skin Res. Technol. 24 (2018) 187–195. 
[4] V.P. Kutyshenko, M. Molchanov, P. Beskaravayny, V.N. Uversky, M.A. Timchenko, Analyzing and mapping 
sweat metabolomics by high-resolution NMR spectroscopy, Plos One 6 (2011) e28824. 
 Chapter IX 
 
Page | 487  
[5] M. Harker, H. Coulson, I. Fairweather, D. Taylor, C.A. Daykin, Study of metabolite composition of eccrine 
sweat from healthy male and female human subjects by 1H NMR spectroscopy, Metabolomics 2 (2006) 105‒
112. 
[6] M. Calderón-Santiago, F. Priego-Capote, B. Jurado-Gámez, M.D. Luque de Castro, Optimization study for 
metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high 
resolution mode, J. Chromatogr. A 1333 (2014) 70‒78. 
[7] V. Sikirzhytski, A. Sikirzhytskaya, I.K. Lednev, Multidimensional Raman spectroscopic signature of sweat 
and its potential application to forensic body fluid identification, Anal. Chim. Acta 718 (2012) 78–83.  
[8] R. Kanďár, P. Drábková, L. Andrlová, A. Kostelník, A. Čegan, Determination of selected fatty acids in dried 
sweat spot using gas chromatography with flame ionization detection, J. Sep. Sci. 39 (2016) 4377‒4383. 
[9] K. Pascal, N. Samyn, Chapter 13 Unconventional samples and alternative matrices, Handbook of Analytical 
Separation, 2 (2000) 459‒488. 
[10] L.B. Baker, Sweating rate and sweat sodium concentration in athletes: A review of methodology and 
intra/interindividual variability, Sports Med. 47(Suppl 1) (2017) 111–128. 
[11] E.P. Dutkiewicz, J.-D. Lin, T.-W. Tseng, Y.-S. Wang, P.L. Urban, Hydrogel micropatches for sampling and 
profiling skin metabolites, Anal. Chem. 86 (2014) 2337–2344. 
[12] E.P. Dutkiewicz, K.T. Hsieh, Y.S. Wang, H.Y. Chiu, P.L. Urban, Hydrogel micropatch and mass spectrometry-
assisted screening for psoriasis-related skin metabolites, Clin. Chem. 62 (2016) 1120–1128. 
[13] E.P. Dutkiewicz, H.-Y. Chiu, P.L. Urban, Probing skin for metabolites and topical drugs with hydrogel 
micropatches, Anal. Chem. 89 (2017) 2664–2670. 
[14] E.P. Dutkiewicz, H.Y. Chiu, P.L. Urban, Micropatch-arrayed pads for non-invasive spatial and temporal 
profiling of topical drugs on skin surface, J. Mass Spectrom. 50 (2015) 1321–1325. 
[15] J. Heikenfeld, Bioanalytical devices: technological leap for sweat sensing, Nature 529 (2016) 475–476. 
[16] D.P. Rose, M.E. Ratterman, D.K. Griffin, L. Hou, N. Kelley-Loughnane, R.R. Naik, J.A. Hagen, I. Papautsky, 
J.C. Heikenfeld, Adhesive RFID sensor patch for monitoring of sweat electrolytes, IEEE Trans. Biomed. Eng. 
62 (2015) 1457–1465. 
[17] J. Choi, R. Ghaffari, L.B. Baker, J.A. Rogers, Skin-interfaced systems for sweat collection and analytics, Sci. 
Adv. 4 (2018) eaar3921. DOI: 10.1126/sciadv.aar3921. 
[18] M. Bariya, H.Y. Yin Nyein, A. Javey, Wearable sweat sensors, Nature Electronics 1 (2018) 160–171. 
[19] A. Koh, D. Kang, Y. Xue, S. Lee, R.M. Pielak, J. Kim, T. Hwang, S. Min, A. Banks, P. Bastien, M.C. Manco, L. 
Wang, K.R. Ammann, K.I. Jang, P. Won, S. Han, R. Ghaffari, U. Paik, M.J. Slepian, G. Balooch, et al. A soft, 
wearable microfluidic device for the capture, storage, and colorimetric sensing of sweat, Sci. Transl. Med. 8 
(2016) 366ra165. 
[20] K. Hooton, L. Li, Nonocclusive sweat collection combined with chemical isotope labeling LC–MS for human 
sweat metabolomics and mapping the sweat metabolomes at different skin locations, Anal. Chem. 89 (2017) 
7847–7851. 
[21] J.V. Pagaduan, M. Ali, M. Dowlin, L. Suo, T. Ward, F. Ruiz, S. Devaraj, Revisiting sweat chloride test results 
based on recent guidelines for diagnosis of cystic fibrosis, Pract. Lab. Med. 10 (2018) 34–37. 
[22] M. Gallagher, C.J. Wysocki, J.J. Leyden, A.I. Spielman, X. Sun, G. Preti, Analyses of volatile organic 
compounds from human skin, Br. J. Dermatol. 159 (2008) 780–791. 
[23] M.M. Delgado-Povedano, M. Calderón-Santiago, M.D. Luque de Castro, F. Priego-Capote, Metabolomics 
analysis of human sweat collected after moderate exercise, Talanta 177 (2018) 47‒65. 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
 
Page | 488 
[24] T. Kind, G. Wohlgemuth, D.Y. Lee, Y. Lu, M. Palazoglu, S. Shahbaz, O. Fiehn, FiehnLib: Mass spectral and 
retention index libraries for metabolomics based on quadrupole and time-of-flight gas 
chromatography/mass spectrometry, Anal. Chem. 81 (2009) 10038‒10048. 
[25] M.M. Delgado-Povedano, M. Calderón-Santiago, F. Priego-Capote, M.D. Luque de Castro, Development of a 
method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry 
in high resolution mode, Anal. Chim. Acta 905 (2016) 115‒125. 
[26] S.W. Harshman, R.L. Pitsch, Z.K. Smith, M.L. O’Connor, B.A. Geier, A.V. Qualley, N.M. Schaeublin, M.V. 
Fischer, J.J. Eckerle, A.J. Strang, J.A. Martin, The proteomic and metabolomic characterization of exercise-
induced sweat for human performance monitoring: A pilot investigation, PLoS ONE 13 (2018) e0203133. 
https://doi.org/10.1371/journal.pone.0203133 
[27] M.M. Delgado-Povedano, M. Calderón-Santiago, F. Priego-Capote, M.D. Luque de Castro, Study of sample 
preparation for quantitative analysis of amino acids in human sweat by liquid chromatography–tandem mass 
spectrometry, Talanta 146 (2016) 310‒317. 
[28] R.H. Dunstan, D.L. Sparkes, B.J. Dascombe, C.J. Stevens, G.R. Murphy, M.M. Macdonald, J. Gottfries, C.G. 
Gottfries, T.K. Roberts, Sex differences in amino acids lost via sweating could lead to differential 
susceptibilities to disturbances in nitrogen balance and collagen turnover, Amino Acids 49 (2017) 1337–1345. 
 Chapter IX 
 
Page | 489  
Supplementary material 
 
Supplementary Table 1. Kruskal-Wallis statistical analysis to evaluate significant differences in 
the dissolution levels of the tentatively identified compounds (classified by chemical families) in dry 
sweat collected by filter paper or gauze impregnated with 1:1 (v/v) ethanol–PBS. 
Family p-Valuea 
Benzenoids 0.015* 
Carbohydrates 0.002** 
Amino acids 0.002** 
Other carboxylic acids 0.012* 
Flavonoid 0.905 
Lipids 0.000** 
Nucleotides and analogues 0.153 
Organic nitrogen compounds 0.002** 
Organic oxygen compounds 0.280 
Organic phosphoric acid 0.000** 
Organoheterocyclic compounds 0.410 
Oxoanionic compounds 0.011* 
a p-Values were obtained by Kruskal-Wallis test comparing areas of the compounds in dry sweat collected on gauze 
or paper impregnated with the solvent mixture; * p-Value between 0.01 and 0.05; ** p-Value < 0.01. 
 
Supplementary Table 2. Kruskal-Wallis statistical analysis to evaluate the significance differences 
in the levels of the tentatively identified compounds (classified by chemical families) in dry sweat 
collected by filter paper impregnated with 1:1 (v/v) ethanol–PBS and in fresh sweat. 
Family p-Valuea 
Benzenoids 0.032* 
Carbohydrates 0.270 
Amino acids 0.000** 
Other carboxylic acids 0.027* 
Flavonoid 0.711 
Lipids 0.031* 
Nucleotides and analogues 0.002** 
Organic nitrogen compounds 0.131 
Organic oxygen compounds 0.000** 
Organoheterocyclic compounds 0.001** 
Oxoanionic compounds 0.712 
a p-Values were obtained by Kruskal-Wallis test comparing areas of the compounds in dry sweat collected by paper 
impregnated with the solvent mixture and in fresh sweat; * p-value between 0.01 and 0.05; ** p-value < 0.01.  
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Supplementary Fig. 1. RI calibration line of the alkane standard mixture. 
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Supplementary Fig. 5. Circle graphs comparing the percentage of compounds tentatively 
identified by LC–MS/MS of each chemical family in dry sweat collected on filter paper impregnated 
with 1:1 (v/v) ethanol‒PBS in positive (A) and negative (B) ionization modes. 
 
LC–QTOF MS/MS data processing and statistical analysis 
MassHunter Workstation software (version B7.00 Qualitative Analysis, Agilent 
Technologies) was used to process all data obtained by LC–QTOF in MS/MS mode. 
Treatment of raw data files started by extraction of potential MFs with the suited algorithm 
included in the software. For this purpose, the extraction algorithm considered all ions with 
single charge state exceeding 500 and 600 counts for negative and positive polarities, 
respectively. These cut-off values were established taking into account the 
chromatographic background noise. Additionally, the isotopic distribution to consider MFs 
as valid should be defined by two or more ions (with a peak spacing tolerance of m/z 
0.0025, plus 7.0 ppm in mass accuracy). Ions and adducts formation in the positive (+H, 
+Na, +K) and negative ionization (−H, +HCOO, +Cl) modes, as well as the neutral loss by 
dehydration were included to identify features corresponding to the same potential 
metabolite. Background contribution was removed by subtraction of MFs linked to 
plasticizers, solvent impurities and other contaminants after analysis of a blank for each 
sample (gauze and filter paper with water, and deionized water) under identical 
operational conditions for each sample treatment. 
Identification of the compounds was supported on MS and MS/MS information 
and search in the METLIN MS and MS/MS databases (http://metlin.scripps.edu) and the 
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Human Metabolome Database (HMDB, 4.0 version), using in all cases the MFs obtained in 
the previous step. 
In the next step, the “Batch Targeted Feature Extraction” algorithm from the 
MassHunter Workstation software (version B6.00 Profinder, Agilent Technologies) was 
used to extract and align peaks in all injections that matched a database of all identified 
metabolites. The isotopic distribution for a valid feature had to be defined by two or more 
ions —with a peak spacing tolerance of 0.0025 m/z, plus 7.0 ppm. The features were 
aligned by using a tolerance window of 0.30 min and a mass accuracy of 10 ppm for 
retention times (RTs) and m/z values across all data files, respectively. Each extracted ion 
chromatogram was individually examined, and potentially incorrect assignments and 
integrations were manually verified. The resulting table with the peak area of all identified 
compounds in the different samples was exported in comma separated value format (.csv 
file). 
 
GC–TOF/MS data processing and statistical analysis 
Unknown Analysis software (version B.07.00, Agilent Technologies) was used to 
process all data files obtained by GC–TOF/MS in full scan mode. Then, MassHunter 
Workstation software (version B7.00 Qualitative Analysis, Agilent Technologies) was used 
to treat all data files. Treatment of raw data files started by deconvolution of 
chromatograms to obtain a list of MFs considered as potential compounds defined by the 
m/z value of one representative ion for each chromatographic peak and its RT. For this 
purpose, the deconvolution algorithm was applied to each sample by considering all ions, 
the accuracy error at 50 ppm and the window size factor at 200 units. Background spectra 
were subtracted to spectra obtained from each sample before its deconvolution. 
Tentative identification of compounds was firstly performed by searching MS 
spectra in the NIST (version 2.0) database. Only identifications with a match factor and a 
reverse match factor higher than 700 were considered. The RI values included in the NIST 
database also supported identifications. For this purpose, an RI calibration model was built 
by plotting the RTs obtained by analysis of the alkane standard mixture (C10 to C40 with 
an even number of carbons) with the chromatographic method used in this research and 
the RI values provided for each alkane by the NIST database. Figure S-1 shows the RI 
calibration graph and the equation fitting the model. This equation was used to 
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experimentally estimate the RI value for each identified compound, which must be less 
than 100 units different as compared with the theoretical value provided by the NIST. This 
database does not contain high resolution MS information as provided by the TOF detector. 
For this reason, a third step was included to validate identification of each compound by 
using high resolution MS. Thus, the molecular formula for the tentative ion [M]+ and the 
most intense fragments for each MF should fit the NIST identification by setting a cut-off 
value in mass accuracy of 10 ppm. Identification was also carried out by searching MS 
spectra on the Fiehn database [19]. Only identifications with a score higher than 70 were 
considered as valid. The RTs included in the Fiehn database were also considered to 
support identifications with the requirement for acceptance of a difference between the 
experimental RT and the theoretical value provided by this database for each target 
compound below 0.50 min. Additionally, derivatized standards (D-galactose, D-glucose 
and myo-inositol) were injected for confirmation of some sugars. 
Background contribution was removed by subtraction of MFs linked to plasticizers, 
solvent impurities and other contaminants after analysis of a blank for each sample (gauze 
and filter paper with water, and deionized water) under identical operational conditions 
for each sample treatment procedure used. Finally, the MassHunter Workstation software 
(version 7.0, Quantitative Analysis, Agilent Technologies) was used to reintegrate all 
metabolites found in all analyzed samples, using the corresponding characteristic 
quantifier and qualifiers. The resulting table was exported in comma separated value 
format (.csv file). 
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In addition to establishing procedures for sampling and sample preparation for the 
different types of sweat samples, a research was addressed to enhancing the metabolomics 
coverage of sweat as much as possible. As Chapter X shows, this aim was achieved by a gas 
chromatography–time of flight/mass spectrometry (GC–TOF/MS) platform in high 
resolution mode, which provided information for tentative identification of 66 compounds, 
including amino acids, dicarboxylic acids and other interesting metabolites such as myo-
inositol or urocanic acid. 
A key contribution of the sweat-metabolomics binomial was the proposal of panels 
of biomarkers for lung cancer detection, which constitutes Chapter XI. The use of the 
PanelomiX tool allowed obtaining two panels of sweat metabolites in which both false 
negatives and false positives were reduced in such a way that 95% was the level reached for 
both specificity and sensitivity. 
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Development of a method for enhancing 
metabolomics coverage of human sweat by gas 
chromatography–mass spectrometry in high 
resolution mode 
 
M.M. Delgado-Povedano, M. Calderón-Santiago, F. Priego-Capote, M.D. Luque 
de Castro 
Abstract 
Sweat has recently gained popularity as clinical sample in metabolomics analysis 
as it is a no invasively sampled biofluid the composition of which could be modified by 
certain pathologies, as is the case with cystic fibrosis that increases chloride levels in sweat. 
However, the whole composition of sweat is still unknown and there is a lack of analytical 
strategies for sweat analysis. The aim of the present study was to develop and validate a 
method for metabolomic analysis of human sweat by gas chromatography–time of 
flight/mass spectrometry (GC–TOF/MS) in high resolution mode. Thus, different sample 
preparation strategies were compared to check their effect on the profile of sweat 
metabolites. Sixty-six compounds were tentatively identified by the obtained MS 
information. Amino acids, dicarboxylic acids and other interesting metabolites such as 
myo-inositol and urocanic acid were identified. Among the tested protocols, 
methoxymation plus silylation after deproteination was the most suited option to obtain a 
representative snapshot of sweat metabolome. The intra-day repeatability of the method 
ranged from 0.60 to 16.99% and the inter-day repeatability from 2.75 to 31.25%. As most 
of the identified metabolites are involved in key biochemical pathways, this study opens 
new possibilities to the use of sweat as a source of metabolite biomarkers of specific 
disorders. 
Keywords: Metabolomics, global profiling, human sweat, gas chromatography–mass 
spectrometry, human sweat metabolome, sample preparation. 
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1. Introduction 
The most common biofluids in metabolomics analysis applied to clinical and 
nutritional studies are blood (serum or plasma) and urine [1]. Nowadays, alternative 
biofluids such as sweat [2], tears [3], saliva [4] or exhaled breath [5], with a less complex 
composition, are gaining popularity as they can be easily obtained in a no invasive manner 
[2,6]. Among them, sweat is a biofluid produced by the eccrine and apocrine sweat glands 
located in the epidermis. The primary function of sweating is thermoregulation to control 
body temperature by evaporative cooling. In addition, sweat is a defense mechanism of 
skin, the excretion fluid of chemosignals such as androstadienone —which acts as hormonal 
stimuli in females—, and waste of metabolites such as uric acid [7]. Sweat is mainly 
composed by water (99%) containing electrolytes, small molecules as amines, carboxylic 
acids and amino acids, more complex biomolecules such as proteins and antimicrobial 
peptides, and xenobiotics such as drugs, cosmetics, and ethanol, among others [8]. Except 
for the case of proteins [9], most sweat components are small molecules resulting from 
metabolic pathways; therefore, their study pertains to the metabolomics field. Diseases can 
change sweat composition either by altering the concentration of common components or 
reporting new components that, in any case, could act as tentative biomarkers of the given 
disease. Therefore, the varied composition of sweat supports its clinical interest to be 
potentially exploited for diagnostic. 
The scant traditional use of sweat as clinical sample is explained by both the lack 
of studies to relate sweat composition with pathological states, and the absence of 
reproducible sweat collectors. In fact, few clinical tests use sweat as sample. One of them, 
already well implemented, is cystic fibrosis diagnosis in new-borns, based on the 
determination of chloride in sweat [10,11]. Recently, a new indicator test (Neuropad) has 
been developed to detect diabetes in foot sweat [12], since recent studies have found a 
credible biomarker that shows a strong correlation between sweat glucose and blood 
glucose, providing sweat is properly obtained to prevent contamination of the skin surface 
from other sources of glucose [13]. Thus, the advances both in sweat collection devices and 
sensitive analytical techniques increased the interest on sweat testing of drugs over the past 
few years [14–18]. Indeed, sweat is, together with urine, the preferred sample for doping 
control, each biofluid with its advantages and limitations. Sweat allows a no invasive 
sampling for continuous monitoring of drugs exposure as the samples can be collected for 
a programmed period with minimal disturbance for the sampled individual. Sweat 
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sampling can be performed with the aid of sweat wipes as liquid perspiration or over time 
using sweat patches [19,20]. The experience gained in sweat collection procedures for the 
analysis of xenobiotics could help to implement this biofluid in clinical diagnostics [12,21]. 
No invasive sampling, avoidance of infections risk to patients who need daily analysis, and 
absence of requirements in terms of health personnel care are the main benefits from sweat 
as clinical sample. 
The main limitations of sweat as clinical sample are the difficulty to produce 
enough sweat for analysis, the variability in secretion among individuals [22,23], and the 
problems associated to sample representativeness and presence of interferents. Despite the 
scant studies on the clinical perspectives of sweat, the potential of this biofluid in omics 
disciplines has been pointed out. In proteomics, a current research has revealed that sweat 
proteome is rather different from serum proteome [9]. Therefore, human sweat could be 
considered an additional source of unique disease-related biomolecules —in fact, 
differential abundances of selected proteins have been found in sweat from schizophrenia 
patients and control individuals [9]. This preliminary test should be validated to prove the 
applicability of human sweat in the diagnostic of schizophrenia. In the metabolomics field, 
a recent study on the composition of human sweat by high-resolution NMR spectroscopy 
has revealed that the main constituents found in human sweat from healthy people are 
compounds involved in primary and secondary biological functions [24]. Among them, 
amino acids, sugars, lactate, glycerol, and compounds involved in the citric acid cycle (e.g., 
pyruvate, fumarate or aconitate) have been detected. NMR is especially suited to 
metabolomics profiling of human sweat as this is a relatively no complex biofluid. Other 
recent study of sweat was carried out by liquid chromatography–quadrupole time of flight–
tandem mass spectrometry (LC–QTOF MS/MS) in high resolution mode, which has 
confirmed that most of human sweat components are involved in key biochemical pathways 
[2]. Forty-one compounds were identified by MS/MS. Among them, amino acids, 
dicarboxylic acids and other interesting metabolites were detected. Other study of 
untargeted analysis of sweat by LC–QTOF MS/MS revealed metabolomic discrimination 
between subjects with and without lung cancer [25]. A recent study of sweat was carried 
out by Fourier-transform ion cyclotron resonance mass spectrometry, in which only eight 
compounds were identified by MS/MS [20]. 
More research on sweat composition is demanded to assess the potential of this 
biofluid for clinical diagnostic as, at present, only NMR and LC–MS have been used for 
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sweat characterization. So, the aim of the present study was to develop and validate a 
method for analysis of human sweat by GC–TOF/MS. The use of this approach is desirable 
because it allows studying a wide variety of compounds. Furthermore, human sweat is 
composed by volatile and no volatile compounds, and GC–TOF/MS allows detecting both 
types of compounds after applying wellknown derivatization reactions for the latter. 
Different sample preparation strategies were compared to check their influence on the 
profile of the detected metabolites. Identification of metabolites by GC–TOF/MS was 
carried out to obtain a snapshot of the composition of sweat metabolome. 
 
2. Experimental 
 
2.1. Reagents 
TraceSELECT® grade acetonitrile, dichloromethane, ethyl acetate, methanol and 
n-hexane from Sigma–Aldrich (St. Louis, MO, USA) were used for standards and sample 
preparation. Deionized water (18 mΩ cm) from a Millipore Milli-Q water purification 
system (Bedford, MA, USA) was used for standards preparation. Pyridine from Merck 
(Darmstadt, Germany) and methoxyamine hydrochloride from Sigma–Aldrich were used 
as solvent and reagent, respectively, for methoxymation. Bis-(trimethylsilyl) 
fluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) from Sigma–Aldrich were 
used as silylation agents in the second derivatization step. MS-grade perfluorotri-n-
butylamine (PFTBA) from Agilent Technologies (Santa Clara, CA, USA) was used for daily 
mass calibration. A standard mixture containing ten linear alkanes from C10 to C40 
designed for performance tests in GC from Sigma–Aldrich was used to establish the 
retention index (RI) calibration model. Standards of glutamic acid, phenylalanine, proline, 
D-galactose, D-glucose, myo-inositol, phosphate, p-hydroxybenzoic, fumaric, malic, 
succinic, caprylic, lauric and palmitic acids from Sigma–Aldrich were used to confirm 
identification of amino acids, benzene derivatives, dicarboxylic acids, fatty acids and 
sugars. UV–grade n-hexane and acetone from Scharlab (Barcelona, Spain) were used for 
washing the injection syringe. 
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2.2. Instruments and apparatus 
An IKA® vortex shaker from IKA (Wilmington, NC, USA) was used to promote 
deproteination or liquid–liquid extraction (LLE). A Concentrator plusTM from Eppendorf 
(Hamburg, Germany) with three operation modes (vacuum concentrator, centrifuge or 
dessicator) and three application modes (aqueous, alcohol or high vapor pressure) was 
used to centrifuge and evaporate the analytical sample before derivatization. A block heater 
from Stuart Equipment (Staffordshire, ST15 OSA, UK) was used in the derivatization step. 
An Agilent 7890A Series GC system coupled to an Agilent 7200 UHD Accurate-
Mass QTOF hybrid mass spectrometer equipped with electron impact (EI) source (Santa 
Clara, CA, USA) was used for analysis. The analytical sample was thus monitored in high 
resolution mode. MassHunter GC–QTOF Acquisition software (version B.06, Agilent 
Technologies) was used to control data acquisition and set the parameters for optimum 
operation. 
 
2.3. Sample production and collection 
The Macroduct® Sweat Analysis System (Wescor, Utah, USA) used for sampling 
consists of a Webster sweat inducer and a Macroduct sweat collector (US Patent 4,542,751). 
Pilogel®discs (US Patent 4,383,529) (Wescor, Utah, USA) consisting of a gel reservoir of 
pilocarpinium ions were used in the iontophoretic stimulation of sweat excretion. The 
sweat inducer provides a current intensity of 1.50 mA for 5 min through two Pilogel discs 
as electrodes located on the forearm. Previously, the skin was cleaned with ethanol and 
then with distilled water. The Macroduct device collected sweat for 15 min, which was 
transferred to plastic microEppendorf tubes and stored at –80 ºC until analysis. A total 
sweat volume of at least 70 µL was collected per individual. 
Sweat samples for development and characterization of the method were kindly 
donated by healthy volunteers at Reina Sofía University Hospital (Córdoba, Spain). Pools 
of the biofluid used for optimization of the method were prepared by mixing aliquots from 
six healthy volunteers (2 men and 4 women). All subjects gave their informed consent for 
sweat sampling. No restrictions about diet or age were taken into account. All steps from 
sweat sampling to analysis were carried out in accordance with the ethical principles of 
human medical research (World Medical Association, Helsinki Declaration, 2004). The 
study was approved by the ethical committee of the Reina Sofia University Hospital. 
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2.4. Sample treatment 
A pool was prepared taking 70 µL of samples from each participant. Then, three 
experimental strategies were tested to select that providing maximum metabolite coverage. 
(i) Deproteination with methanol–acetonitrile before methoxymation plus silylation. With 
this aim, a 25 µL aliquot was vortexed with 150 µL of 70:30 methanol–acetonitrile in a glass 
insert at room temperature for 5 min, then centrifuged for 5 min at 10000×g. The liquid 
phase was isolated and located into a new glass insert, evaporated to dryness and 
reconstituted by 20 µL of 40 mg/mL methoxyamine hydrochloride in pyridine. After 
adding the methoxymation agents, the mixture was shaken and maintained at 30 °C for 90 
min. Then, for silylation, 90 μL of an 100:1 BSTFA–TMCS mixture was added, shaken for 
30 s and maintained at 37 °C for 30 min. (ii) Extraction with dichloromethane before 
methoxymation and silylation. With this aim, a 25 µL aliquot was vortexed with 150 µL of 
dicloromethane in a glass insert at room temperature for 5 min and centrifuged for 5 min 
at 10000×g. Then, the organic phase was isolated and located into a new glass insert for 
evaporation to dryness before methoxymation plus silylation. (iii) Extraction with ethyl 
acetate before methoxymation plus silylation. In this case, a 25 µL aliquot was vortexed 
with 150 µL of ethyl acetate in a glass insert at room temperature for 5 min and centrifuged 
for 5 min. Then, the organic phase was isolated and located into a new glass insert for 
evaporation to dryness before methoxymation plus silylation. All samples were cooled at 
room temperature for subsequent analysis. 
The samples thus prepared were analyzed directly and also after 1:5 dilution with 
hexane to cover both concentrated and diluted metabolites. 
 
2.5. GC–TOF/MS analysis 
GC–TOF/MS analyses were performed by EI ionization mode at 70 eV and 
controlled by MassHunter Acquisition B.06. Chromatographic separation was carried out 
with a fused silica DB-5MS-UI 30 m×0.25 mm i.d.×0.25 μm film thickness capillary 
column from Agilent Technologies. The GC oven temperature program started at 60 °C (1 
min held), followed by a temperature ramp of 10 °C/min to final 300 °C (2 min held). A 
post-run time was programmed for 4 min up to 310 ºC to assure complete elution of the 
injected sample. One μL of sample was injected using pulsed split injection (1:10 split ratio) 
at 250 °C (the data in the Fiehn library are obtained with this injection mode, and the 
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sensitivity of the proposed method is enough for using this injection mode). Ultrapure 
grade helium was used as carrier gas at 1 mL/min. The transfer line, ion source and 
quadrupole temperatures were set at 280, 300 and 200 °C, respectively. A solvent delay of 
5.50 min was used to prevent damage of the ion source filament. The TOF detector was 
operated at 5 spectra/s in the mass range m/z 40–750 and the resolution was 8500 (full 
width half maximum, FWHM) at m/z 501.9706. Daily mass calibration was performed with 
PFTBA. 
 
2.6. Identification of metabolites 
Identification was firstly carried out by searching MS spectra in the NIST11 
database. Only identifications with a match factor and a reverse match factor higher than 
700 were considered. Furthermore, the RI values included in the NIST database were used 
to support identifications. For this purpose, an RI calibration model was built by plotting 
the retention times (RT) obtained by analysis of the alkane standard mixture (C10 to C40 
with an even number of carbons) with the chromatographic method used in this research 
and the RI values provided for each alkane by the NIST database. This equation was used 
to estimate the RI value for each identified compound, which has to be less than 100 units 
different as compared with the theoretical value provided by the NIST. This database does 
not contain high resolution MS information as provided by the TOF detector. For this 
reason, a third step was included to validate identification of each compound by using high 
resolution MS. Thus, the molecular formula for the tentative ion [M]+ and the most intense 
fragments for each molecular feature (MF) should fit the NIST identification by setting a 
cut-off value in mass accuracy of 10 ppm. 
Identification was also carried out by searching MS spectra on the Fiehn database 
[26]. Only identifications with a score higher than 70 were considered as valid. The RT 
included in the Fiehn database were also taken into account to support identifications with 
the requirement for acceptance of a difference between the experimental RT and the 
theoretical value provided by this database for each target compound below 0.50 min. 
Additionally, derivatized standards (glutamic acid, phenylalanine, proline, D-
galactose, D-glucose, myo-inositol, phosphate, p-hydroxybenzoic, fumaric, malic, succinic, 
caprylic, lauric and palmitic acids) were injected for confirmation of some amino acids, 
sugars, benzene derivatives, dicarboxylic and fatty acids. 
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2.7. Data processing and statistical analysis 
Unknown Analysis software (version 7.0, Agilent Technologies, Santa Clara, CA, 
USA) was used to unzip all data files obtained by GC–TOF/MS in full scan mode. Then, 
MassHunter Workstation software (version B7.00 Qualitative Analysis, Agilent 
Technologies, Santa Clara, CA, USA) was used to process all data obtained by GC–TOF/MS 
in full scan mode. Treatment of raw data files started by deconvolution of chromatograms 
to obtain a list of MFs considered as potential compounds defined by the m/z value of one 
representative ion for each chromatographic peak and its RT. For this purpose, the 
deconvolution algorithm was applied to each sample by considering all ions exceeding 1500 
counts for the absolute height parameter, the accuracy error at 50 ppm and the window size 
factor at 150 units. The list of MFs obtained for each analysis was exported as data files in 
compound exchange format (.cef files). Tentative identification of compounds was 
performed by searching each mass spectrum in the NIST 11 and Fiehn databases using the 
RI or RT value, respectively. 
 
3. Results and discussion 
Sweat samples are not ready for direct analysis by GC–MS; therefore, a sample 
preparation step is demanded to define suited protocols to cover the maximum number of 
metabolites to characterize sweat composition in a single analysis. 
 
3.1. Optimization of sample preparation 
 
3.1.1. Sample clean-up 
Deproteination and liquid–liquid extraction (LLE) can be good sample preparation 
strategies for cleaning sweat sample prior to GC–MS analysis thanks to their efficiency. 
Thus, taking into account the chemical diversity of compounds present in sweat, the 
performance of two different extractants (ethyl acetate and dichloromethane) and a 
deproteination protocol using methanol‒acetonitrile were compared. Both extractants 
have different polarity and they are water immiscible, which seemed to be desirable for 
further comparison of the obtained extracts. In LLE, aliquots of the sweat pool were 1:6 
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extracted with each solvent and the resulting extracts analyzed by GC–TOF/MS. The same 
ratio was used for deproteination, in which a 70:30 (v/v) methanol‒acetonitrile mixture 
was added to sweat pool aliquots. In the three cases the same generic derivatization 
protocol that encompasses methoxymation plus silylation was used prior to injection. 
Supplementary Fig. 1 shows the base peak chromatograms (BPCs) provided by analysis of 
each extract as well as for the deproteinized sample. Some signals ascribed to column 
bleeding were detected in the chromatograms, but they were easily identified and discarded 
prior to comparison among extracts and the deproteinized sample. 
Fig. 1A shows the Venn diagram comparing the compounds tentatively identified 
in the extracts and the deproteinized sample. The compounds list is shown in 
Supplementary Table 1. As can be seen, deproteination enabled the detection of 62 
compounds, while only 24 and 28 of them were extracted with ethyl acetate and 
dichloromethane, respectively. As all the compounds detected in the extracts were also 
found in the deproteinized sample, deproteination was concluded as the most adequate 
strategy for sweat preparation prior to untargeted GC–MS analysis. The low extraction 
efficiency of LLE was ascribed to the wide variety of sweat components, which makes 
impossible to find an extractant with capability to isolate compounds pertaining to different 
chemical families. In fact, the extracts contained less than 50% of the sweat components 
detected with deproteination, and only in some cases the extraction was quantitatively 
efficient as compared to deproteination.  
 
 
Fig. 1. (A) Venn diagram comparing the number of compounds identified in sweat extracts (ethyl 
acetate and dichloromethane) as well as in sweat deproteneized with methanol–acetonitrile. 
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Fig. 1. (B) Histogram representing the number of metabolites detected in ethyl acetate and 
dichloromethane extracts taking as 100% those obtained by deproteination. 
 
Only nonanoic acid presented a lower area in deproteinized samples as compared 
to the two extracts, while the rest of metabolites were not efficiently extracted, as can be 
seen in Fig. 1B. Three metabolites —hexanoic, glycolic and oxalic acids— were extracted by 
dichloromethane with an efficiency higher than 90% as compared to the protein 
precipitation protocol, while only hexanoic acid and phenol were efficiently isolated with 
ethyl acetate as compared to the area obtained by the protein precipitation protocol. 
 
3.1.2. Derivatization 
As mentioned above, a standard derivatization procedure consisting of a 
methoxymation followed by silylation was selected as a first approach. This is the most 
common derivatization protocol used in metabolomic studies based on GC–MS, in which 
the methoxymation step is sometimes avoided to simplify the protocol, since the decisive 
step for increasing volatility and enhance metabolite detection is silylation. On the other 
hand, methoxymation involves the replacement of the oxygen in a carbonyl group 
(aldehyde or ketone) by methoxyamine, thus protecting these carbonyl groups from 
silylation to assure metabolite identification. However, not all aldehyde or ketone groups 
are protectable; in fact, carbonyl groups adjacent to heteroatoms, such as nitrogen or 
oxygen, are not electropositive enough to become target of nucleophilic attack by the 
methoxyamine reagent. Therefore, the methoxymation step does not alter some kind of 
metabolites, thus being optional or unnecessary in some cases. The removal of this step not 
only reduces the derivatization time, but also gives more stability to the final products. With 
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these premises, derivatization protocols with and without methoxymation before silylation 
were tested. Fig. 2 shows the Venn diagram comparing the compounds identified in both 
cases, which are listed in Supplementary Table 2. As can be seen, the removal of the 
methoxymation step reduces the number of identified metabolites from 62 to 58, which is 
the result of the loss of 8 metabolites no identified without methoxymation, and the 
appearance of 4 new metabolites only detected without methoxymation. Three of the 
identified sugars (galactose, glucose and maltose) were detected with and without 
methoxymation, giving different peaks after each derivatization protocol. Going deeper 
into the chemical structure of the identified metabolites, more than a half (57%) of the 
compounds with aldehyde or keto groups were wrongly identified when the methoximation 
step was not carried out. Therefore, methoxymation plus sylilation after deproteination 
with methanol‒acetonitrile seems to be the suited sample preparation approach for sweat 
analysis by GC–TOF/MS. 
 
 
Fig. 2. Venn diagram comparing the number of compounds identified in sweat after deproteination 
following a derivatization step with and without methoxymation prior to silylation.  
 
3.2. Identification of sweat compounds detected by GC–TOF/MS 
A total of 66 compounds were identified in sweat (including fatty acids, amino 
acids, dicarboxylic acids, sugars and benzene derivatives, among others) using the tested 
protocols. This wide variety of compounds supports the interest of this biofluid in clinical 
analysis. Table 1 lists the identified compounds classified according to their chemical 
family. 
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Table 1. Compounds identified in sweat by GC–TOF/MS, classified by the chemical family. 
Compound 
RT 
(min) 
Formula CAS ID 
Formula 
(derivatizati
on product) 
Fragments 
(derivatization product) 
Family 
Phenol 6.22 C6H6O 108-95-2 C9H14OSi 
166.0801 – [C9H14OSi]+ 
151.0565 – [C8H11OSi]+ 
135.0257 – [C7H7OSi]+ 
Benzene 
derivatives 
(alcohols) 
Benzoic acid 9.17 C7H6O2 65-85-0 C10H14O2Si 
194.0739 – [C10H14O2Si]+ 
179.0515 – [C9H11O2Si]+ 
105.0325 – [C7H5O]+ 
Benzene 
derivatives 
(acids) 
4-Hy-
droxybenzoic 
acid 
14.10 C7H6O3 99-96-7 C13H22O3Si2 
282.1083 – [C13H22O3Si2]+ 
267.0863 – [C12H19O3Si2]+ 
223.0965 – [C11H19OSi2]+ 
Benzene 
derivatives 
(acids) 
Isopropyl 4-
hydroxyben-
zoate 
14.55 C10H12O3 4191-73-5 C13H20O3Si 
252.1168 – [C13H20O3Si]+ 
237.0935 – [C12H17O3Si]+ 
210.0706 – [C10H14O3Si]+ 
Benzene 
derivatives 
(esters) 
Glycerol 9.52 C3H8O3 56-81-5 C12H32O3Si3 
293.1401 – [C11H29O3Si3]+ 
218.1127 – [C9H22O2Si2]+ 
205.1071 – [C8H21O2Si2]+ 
Carbohy- 
drates (sugar 
alcohols) 
Glyceric acid 10.30 C3H6O4 473-81-4 C12H30O4Si3 
307.1189 – [C11H27O4Si3]+ 
292.1329 – [C11H28O3Si3]+ 
189.0760 – [C7H17O2Si2]+ 
Carbohy- 
drates (sugar 
acids) 
Threonic acid 13.04 C4H8O5 
7306-96-
9 
C16H40O5Si4 
292.1326 – [C15H24O2Si2]+ 
220.0931 – [C8H20O3Si2]+ 
205.1057 – [C12H17OSi]+ 
Carbohy- 
drates (sugar 
acids) 
Erythrulose 14.63 C4H8O4 496-55-9 C16H41NO4Si4 
320.1512 – [C16H26NO2Si2]+ 
117.0641 – [C4H11NOSi]+ 
103.0472 – [C3H9NOSi]+ 
Carbohy- 
drates 
(monosac-
charides) 
1,5-Anhydro-
D-sorbitol 
16.53 C6H12O5 154-58-5 C18H44O5Si4 
259.1165 – [C16H33O2Si]+ 
217.1061 – [C10H17O5]+ 
191.0894 – [C11H15OSi]+ 
Carbohy- 
drates 
(monosac-
charides) 
Sorbose 16.72 C6H12O6 
3615-56-
3 
C22H55NO6 
Si5 
307.1560 – [C12H31O3Si3]+ 
277.1447 – [C15H25OSi2]+ 
217.1060 – [C9H21O2Si2]+ 
Carbohy- 
drates 
(monosac-
charides) 
Psicose 16.82 C6H12O6 551-68-8 
C22H55NO6 
Si5 
307.1560 – [C12H31O3Si3]+ 
277.1447 – [C15H25OSi2]+ 
217.1060 – [C9H21O2Si2]+ 
Carbohy- 
drates 
(monosac-
charides) 
Galactose 
16.91 
C6H12O6 
3646-73-
9 
C21H52O6Si5 
305.1384– [C16H25O2Si2]+ 
265.1097– [C10H21O6Si]+ 
204.0998– [C8H20O2Si2]+ 
Carbohy 
drates 
(monosac-
charides) 17.19 
C22H55NO6 
Si5 
319.1559 – [C17H27O2Si2]+ 
205.1053 – [C12H17OSi]+ 
160.0764 – [C6H14NO2Si]+ 
Methyl  
β-D-galacto- 
pyranoside 
16.95 C7H14O6 
3396-99-
4 
C19H46O6Si4 
217.1068 – [C9H21O2Si2]+ 
204.0998 – [C8H20O2Si2]+ 
191.0914 – [C7H9O2Si2]+ 
Carbohy- 
drates 
(monosac-
charides) 
Glucose 
16.98 
C6H12O6 50-99-7 
C22H55NO6 
Si5 
319.1563 – [C13H31O3Si3]+ 
205.1065 – [C8H21O2Si2]+ 
160.0784 – [C6H14NO2Si]+ 
Carbohy- 
drates 
(monosac-
charides) 17.78 C21H52O6Si5 
435.1960 – [C21H39O2Si4]+ 
305.1449 – [C11H33Si5]+ 
204.1752 – [C10H28Si2]+ 
Myo-Inositol 18.89 C6H12O6 87-89-8 C24H60O6Si6 
612.2926 – [C24H60O6Si6]+ 
305.1403 – [C12H29O3Si3]+ 
217.1059 – [C9H21O2Si2]+ 
Carbohy- 
drates (sugar 
alcohols) 
 
 Chapter X 
 
Page | 535  
Continuation Table 1 
Maltose 
23.61 
C12H22O11 69-79-4 
C36H86O11Si8 
243.1212 – [C15H19OSi]+ 
204.0994 – [C8H20O2Si2]+ 
191.0887 – [C11H15OSi]+ 
Carbohy- 
drates (disac-
charides) 
24.19 
C37H89NO11 
Si8 
480.2422 – [C23H42NO4Si3]+ 
361.1666 – [C15H33O4Si3]+ 
319.1558 – [C17H27O2Si2]+ 
24.35 C36H86O11Si8 
361.1681 – [C15H33O4Si3]+ 
204.0995 – [C8H20O2Si2]+ 
191.0887 – [C11H15OSi]+ 
Alanine 7.00 C3H7NO2 56-41-7 C9H23NO2Si2 
218.1013 – [C8H20NO2Si2]+ 
190.1067 – [C7H20NOSi2]+ 
116.0885 – [C5H14NSi]+ 
Amino acids 
Valine 8.70 C5H11NO2 72-18-4 C11H27NO2Si2 
246.1324 – [C10H24NO2Si2]+ 
218.1110 – [C9H22O2Si2]+ 
203.0809 – [C7H17NO2Si2]+ 
Amino acids 
Leucine 9.50 C6H13NO2 61-90-5 C12H29NO2Si2 
260.1489 – [C11H26NO2Si2]+ 
232.1535 – [C10H26NOSi2]+ 
158.1357 – [C8H20NSi]+ 
Amino acids 
Isoleucine 9.80 C6H13NO2 73-32-5 C12H29NO2Si2 
260.1489 – [C11H26NO2Si2]+ 
232.1535 – [C10H26NOSi2]+ 
158.1357 – [C8H20NSi]+ 
Amino acids 
Proline 9.87 C5H9NO2 609-36-9 C11H25NO2Si2 
216.1224 – [C9H22NOSi2]+ 
170.0620 – [C7H12NO2Si]+ 
142.1043 – [C7H16NSi]+ 
Amino acids 
Glycine 
7.28 
C2H5NO2 56-40-6 
C8H21NO2Si2 
204.0876 – [C7H18NO2Si2]+ 
176.0914 – [C6H18NOSi2]+ 
102.0735 – [C4H12NSi]+ 
Amino acids 
9.99 C11H29NO2Si3 
276.1248 – [C10H26NO2Si3]+ 
248.1303 – [C9H26NOSi3]+ 
174.1125 – [C7H20NSi2]+ 
Serine 
9.28 
C3H7NO3 302-84-1 
C9H23NO3Si2 
234.0954 – [C8H20NOSi2]+ 
206.0477 – [C9H12NOSi2]+ 
193.0507 – [C9H13OSi2]+ 
Amino acids 
10.71 C12H31NO3Si3 
218.1033 – [C8H20NO2Si2]+ 
204.1283 – [C8H22NOSi2]+ 
188.0924 – [C7H18NOSi2]+ 
Aspartic acid 11.25 C4H7NO4 617-45-8 
C10H23NO4 
Si2 
262.0921 – [C9H20NO4Si2]+ 
172.0462 – [C6H10NO3Si]+ 
160.0787 – [C6H14NO2Si]+ 
Amino acids 
Aminomalo-
nic acid 
12.14 C3H5NO4 
1068-84-
4 
C12H29NO4 
Si3 
320.1163 – [C11H26NO4Si3]+ 
292.1216 – [C10H26NO3Si3]+ 
218.1028 – [C8H20NO2Si2]+ 
Amino acids 
Ornithine 
13.93 
C5H12N2O2 70-26-8 
C14H36N2O2 
Si3 
348.2070 – 
[C14H36N2O2Si3]+ 
142.1039 – [C7H16NSi]+ 
115.0789 – [C5H13NSi]+ 
Amino acids 
15.48 
C14H36N2O2 
Si3 
348.2058 – 
[C14H36N2O2Si3]+ 
258.1329 – [C11H24NO2Si2]+ 
244.1166 – [C14H18NOSi]+ 
Glutamic acid 13.98 C5H9NO4 56-86-0 C14H33NO4Si3 
348.1465 – [C13H30NO4Si3]+ 
246.1333 – [C10H24NO2Si2]+ 
230.1019 – [C9H20NO2Si2]+ 
Amino acids 
Phenylala-
nine 
14.07 C9H11NO2 63-91-2 C15H27NO2Si2 
294.1339 – [C14H24NO2Si2]+ 
218.1021 – [C8H20NO2Si2]+ 
192.1194 – [C11H18NSi]+ 
Amino acids 
Lysine 14.99 C6H14N2O2 657-27-2 
C15H38N2O2 
Si3 
362.2214 – [C15H38N2O2Si3]+ 
230.1162 – [C10H22NOSi2]+ 
156.1187 – [C8H18NSi]+ 
Amino acids 
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Tyrosine 
16.90 
C9H11NO3 60-18-4 
C15H27NO3 
Si2 
310.1272 – [C14H24NO3Si2]+ 
208.1133 – [C15H14N]+ 
179.0877 – [C10H15OSi]+ 
Amino acids 
17.42 C18H35NO3Si3 
382.1682 – [C17H32NO3Si3]+ 
354.1731 – [C16H32NO2Si3]+ 
280.1538 – [C14H26NOSi2]+ 
Histidine 17.21 C6H9N3O2 71-00-1 
C15H33N3O2 
Si3 
254.1495 – [C11H24N3Si2]+ 
218.1029 – [C12H14N2O2]+ 
154.0918 – [C7H14N2Si]+ 
Amino acids 
Urocanic acid 18.02 C6H6N2O2 104-98-3 
C12H22N2O2 
Si2 
282.1204 – 
([C12H18NO2Si2]+NH4)+ 
267.0975 – 
([C11H15NO2Si2]+NH4)+ 
193.0784 – [C9H13N2OSi]+ 
Amino acids 
Tryptophan 19.92 C11H12N2O2 73-22-3 
C17H28N2O2 
Si2 
231.1277 – [C10H23O2Si2]+ 
219.1112 – [C12H15N2O2]+ 
202.1044 – 
([C12H12Si]+NH4)+ 
Amino acids 
Oxalic acid 7.43 C2H2O4 144-62-7 C8H18O4Si2 
219.0480 – [C7H15O4Si2]+ 
190.0831 – [C7H18O2Si2]+ 
131.0346 – [C4H11OSi2]+ 
Dicarboxylic 
acids 
Succinic acid 10.09 C4H6O4 110-15-6 C10H22O4Si2 
262.1050 – [C10H22O4Si2]+ 
247.0809 – [C9H19O4Si2]+ 
203.0590 – [C7H15O3Si2]+ 
Dicarboxylic 
acids 
Fumaric acid 10.59 C4H4O4 110-17-8 C10H20O4Si2 
245.0659 – [C9H17O4Si2]+ 
217.0707 – [C8H17O3Si2]+ 
143.0518 – [C6H11O2Si]+ 
Dicarboxylic 
acids 
Methyl-
enesuccinic 
acid 
11.77 C5H6O4 97-65-4 C11H22O4Si2 
259.0835 – [C10H19O4Si2]+ 
215.0912 – [C9H19O2Si2]+ 
185.0626 – [C8H13O3Si]+ 
Dicarboxylic 
acids 
Malic acid 12.37 C4H6O5 617-48-1 C13H30O5Si3 
245.0660 – [C9H17O4Si2]+ 
233.1022 – [C9H21O3Si2]+ 
217.0713 – [C8H17O3Si2]+ 
Dicarboxylic 
acids 
Azelaic acid 15.97 C9H16O4 123-99-9 C15H32O4Si2 
317.1575 – [C14H29O4Si2]+ 
217.1069 – [C9H21O2Si2]+ 
204.1015 – [C8H20O2Si2]+ 
Dicarboxylic 
acids 
Citric acid 16.17 C6H8O7 77-92-9 C18H40O7Si4 
465.1600 – [C17H37O7Si4]+ 
347.1146 – [C13H27O5Si3]+ 
273.0960 – [C11H21O4Si2]+ 
Tricarboxylic 
acids 
Lactic acid 6.32 C3H6O3 79-33-4 C9H22O3Si2 
233.1064 – [C9H21O3Si2]+ 
219.0923 – [C8H19O3Si2]+ 
203.0604 – [C7H15O3Si2]+ 
Carboxylic 
acids 
(hydroxy 
acids) 
Glycolic acid 6.58 C2H4O3 79-14-1 C8H20O3Si2 
205.0698 – [C7H17O3Si2]+ 
177.0744 – [C6H17O2Si2]+ 
161.0308 – [C6H17OSi2]+ 
Carboxylic 
acids 
(hydroxy 
acids) 
Diethyl 
tartrate 
14.07 C8H14O6 87-91-2 C14H30O6Si2 
335.1385 – [C13H27O6Si2]+ 
248.1131 – [C10H20O5Si]+ 
204.1232 – [C9H20O3Si]+ 
Carboxylic 
acids 
(hydroxy 
acids) 
2-Deoxy- 
D-erythro-
pentopyra-
nose 
14.07 C5H10O4 
113890-
34-9 
C14H34O4Si3 
260.0766 – [C9H20O3Si3]+ 
245.0894 – [C9H21O2Si3]+ 
217.0760 – [C8H17O3Si2]+ 
Carboxylic 
acids 
(hydroxy 
acids) 
Pyruvic acid 6.14 C3H4O3 127-17-3 C7H15NO3Si 
189.0811 – [C7H15NO3Si]+ 
174.0583 – [C6H12NO3Si]+ 
158.0625 – [C6H12NO2Si]+ 
Carboxylic 
acids (keto 
acids) 
Urea 8.16 CON2H4 57-13-6 
C10H28N2O 
Si3 
261.1255 – [C9H25N2OSi3]+ 
245.0944 – [C8H21N2OSi3]+ 
130.0493 – [C4H12NSi2]+ 
Amino acid 
derivative 
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 9.01   C7H20N2OSi2 
204.1110 – [C7H20N2OSi2]+ 
189.0885 – [C6H17N2OSi2]+ 
171.0781 – [C6H15N2Si2]+ 
 
3-Amino-2-
piperidone 
11,98 C5H10N2O 
42538-
31-8 
C11H26N2OSi2 
258.1551 – [C11H26N2OSi2]+ 
243.1327 – [C10H23N2OSi2]+ 
203.1135 – [C8H21NOSi2]+ 
Piperidines 
Sulfate 7.85 SO42- 
7757-82-
6 
C6H18O4SSi2 
227.0233 – [C5H15O4SSi2]+ 
210.9973 – [C4H11O4SSi2]+ 
138.9514 – [CH3O4SSi]+ 
Non-metal 
oxoanionic 
compounds 
Phosphate 9.47 PO43- 
7778-53-
2 
C9H27O4PSi3 
314.0950 – [C9H27O4PSi3]+ 
299.0722 – [C8H24O4PSi3]+ 
283.0427 – [C7H20O4PSi3]+ 
Non-metal 
oxoanionic 
compounds 
Caproic acid 6.56 C6H12O2 142-62-1 C9H20O2Si 
173.0995 – [C8H17O2Si]+ 
159.0829 – [C7H15O2Si]+ 
131.0492 – [C9H7O]+ 
Lipids (fatty 
acids and 
conjugates) 
Caprylic acid 9.41 C8H16O2 124-07-2 C11H24O2Si 
216.1495 – [C11H24O2Si]+ 
201.1293 – [C10H21O2Si]+ 
129.0384 – [C5H9O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Pelargonic 
acid 
10.75 C9H18O2 112-05-0 C12H26O2Si 
215.1465 – [C11H23O2Si]+ 
145.0670 – [C6H13O2Si]+ 
117.0370 – [C4H9O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Capric acid 12.03 C10H20O2 334-48-5 C13H28O2Si 
229.1604 – [C12H25O2Si]+ 
129.0375 – [C5H9O2Si]+ 
117.0366 – [C4H9O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Lauric acid 14.38 C12H24O2 143-07-7 C15H32O2Si 
272.2159 – [C15H32O2Si]+ 
257.1921 – [C14H29O2Si]+ 
145.0665 – [C6H13O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Palmitic acid 18.49 C16H32O2 57-10-3 C19H40O2Si 
328.2762 – [C19H40O2Si]+ 
313.2541 – [C18H37O2Si]+ 
285.2229 – [C16H33O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Pentade- 
canoic acid 
17.53 C15H30O2 
1002-84-
2 
C18H38O2Si 
314.2593 – [C18H38O2Si]+ 
299.2386 – [C17H35O2Si]+ 
271.2087 – [C15H31O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Stearic acid 20.29 C18H36O2 57-11-4 C21H44O2Si 
356.3080 – [C21H44O2Si]+ 
341.2854 – [C20H41O2Si]+ 
313.2534 – [C18H37O2Si]+ 
Lipids (fatty 
acids and 
conjugates) 
Eicosapen-
taenoic acid 
23.44 C20H30O2 
10417-94-
4 
C26H46O2Si 
361.1667 – [C23H25O2Si]+ 
169.0675 – [C8H13O2Si]+ 
129.0670 – [C10H9]+ 
Lipids (fatty 
acids and 
conjugates) 
2-Hydroxy-
butyric acid 
7.35 C4H8O3 600-15-7 C10H24O3Si2 
233.1028 – [C9H21O3Si2]+ 
205.1068 – [C8H21O2Si2]+ 
190.0834 – [C7H18O2Si2]+ 
Lipids 
(hydroxy 
fatty acids) 
2-Ethyl-
caproic acid 
7.95 C8H16O2 
205-743-
6 
C11H24O2Si 
201.1300 – [C10H21O2Si]+ 
160.0904 – [C7H16O2Si]+ 
145.0673 – [C6H13O2Si]+ 
Lipids (ethyl 
fatty acids) 
1-Mono-
palmitin 
23.07 C19H38O4 542-44-9 C25H54O4Si2 
459.3341 – [C24H51O4Si2]+ 
371.2978 – [C21H43O3Si]+ 
313.2553 – [C18H37O2Si]+ 
Lipids 
(glycerides) 
1-Mono-
stearin 
24.49 C21H42O4 123-94-4 C27H58O4Si2 
487.3626 – [C26H55O4Si2]+ 
399.3283 – [C23H47O3Si]+ 
341.2852 – [C20H41O2Si]+ 
Lipids 
(glycerides) 
Squalene 24.79 C30H50 111-02-4 C30H50 
367.3350 – [C27H43]+ 
81.0691 – [C6H9]+ 
69.0691 – [C5H9]+ 
Lipids 
(prenol 
lipids) 
Borate 9.73 BO33- 
10043-
35-3 
C9H27BO3Si3 
262.1146 – [C8H24BO3Si3]+ 
224.0792 – [C8H18BOSi3]+ 
217.0791 – [C6H19BO2Si3]+ 
Exogenous 
Triethanol-
amine 
14.05 C6H15NO3 102-71-6 C15H39NO3Si3 
350.2005 – [C14H36NO3Si3]+ 
262.1647 – [C11H28NO2Si2]+ 
218.1022 – [C8H20NO2Si2]+ 
Exogenous 
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Pilocarpine 18.67 C11H16N2O2 92-13-7 C11H16N2O2 
208.1193 – [C11H16N2O2]+ 
109.0750 – [C6H9N2]+ 
95.0598 – [C5H7N2]+ 
Exogenous 
 
As can be seen, amino acids constitute the most abundant group of identified 
compounds. In fact, seven essential amino acids (isoleucine, leucine, lysine, phenylalanine, 
tryptophan, valine and histidine), seven no essential amino acids (alanine, proline, 
glutamic acid, glycine, serine, tyrosine and aspartic acid), and one no proteinogenic amino 
acid that plays a role in the urea cycle (ornithine) have been identified in sweat. All these 
amino acids had previously been identified in sweat using different protocols [2,21,27]. 
Intermediates in amino acids formation such as aminomalonic acid (alanine precursor) 
and urocanic acid (glutamic acid precursor), and an amino acid derivative as urea were 
identified in sweat. Among them, urocanic acid and urea had previously been identified in 
this biofluid [2,21]. 
Lipids are other key group of metabolites identified in sweat, including mainly fatty 
acids, a few conjugates and also a triterpene as squalene, the main component of sebum 
[27]. Fatty acids detected in sweat were mostly unsaturated, ranging from short to long-
chains: caproic acid (C6:0), caprylic acid, (C8:0), pelargonic acid (C9:0), capric acid 
(C10:0), lauric acid (C12:0), pentadecanoic (C15:0), palmitic (C16:0) and stearic acid 
(C18:0). Only one unsaturated fatty acid —eicosapentaenoic acid (C20:5)— was identified 
in the analytical sample, where oleic acid [28] was not detected, in spite of being the most 
concentrated fatty acid in humans. All these compounds had previously been found in 
sweat [29,30]. Concerning the detected fatty acid derivatives, glycerol ester derivatives 
from C16:0 and C18:0 had also previously been identified in sweat [2], as well as the 
derivatives ethylcaproic acid [31] and hydroxybutyric acid [32]. 
Other family of metabolites detected in sweat was that of short carboxylic acids, 
which are also representative of crucial biochemical pathways that could be related to 
pathologies and/or dysfunctions [33]. It is worth mentioning the presence in this group of 
compounds related to the Krebs’ cycle as succinic, oxalic, fumaric, citric, pyruvic and malic 
acids, compounds that had already been detected in this analytical sample [2,21]. Identified 
sugars included monosaccharides, a disaccharide, sugar alcohols and sugar acids, most of 
them previously identified in sweat [2,13,21]. 
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Finally, other compounds not previously detected in sweat have been identified in 
this study. That is the case with benzene derivatives and no metal oxoanionic acids, and 
some exogenous compounds. All compounds no previously identified in sweat are listed in 
Supplementary Table 3. 
Elucidation of sweat metabolome had previously been done using two different 
analytical platforms (NMR and LC–MS), but not by GC–MS. Fig. 3 plots the Venn diagram 
that compares the metabolites identified using each platform, which are listed in 
Supplementary Table 4.  
 
 
Fig. 3. Venn diagram comparing the number of compounds identified in sweat by NMR, LC–QTOF 
MS/MS and GC–TOF/MS. 
 
As can be seen, a total of 103 metabolites can be detected by combination of the 
three platforms, being GC–MS the only one capable of detecting more than 60% of them. 
In fact, GC–MS is the most adequate platform to determine lipids, carbohydrates, benzene 
derivatives and carboxylic acids, being also useful to determine a high percent of the amino 
acids detected in sweat. On the other hand, NMR is capable of covering a higher number of 
amino acids, as well as small molecules such as ethanol, acetaldehyde or propanediol. 
Concerning LC–MS, this platform is also capable of covering a high percentage of amino 
acids, and it is the best to determine amino acid derivatives and exogenous compounds 
such as caffeine or theophylline. 
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3.3. Validation of the GC–TOF/MS method 
First of all, the precision of the analytical method was evaluated by analyzing a 
sweat pool twice for 5 consecutive days to calculate intra-day and inter-day variability. As 
can be seen in Table 2, within-day variability, expressed as relative standard deviation 
(RSD), ranged from 0.60 to 16.99% and between-days variability, also expressed as RSD, 
ranged from 2.75 to 31.25%. 
 
Table 2. Precision study for analysis of sweat metabolites estimated as percent of relative standard 
deviation. The study was based on 2 chromatographic injections per day on 5 consecutive days. 
Compound RT (min) Intra-day repeatability (%) Inter-day repeatability (%) 
Pyruvic acid 6.14 4.29 5.82 
Phenol 6.22 2.42 6.61 
Caproic acid 6.56 16.99 17.86 
Glycolic acid 6.58 8.96 12.98 
Alanine 7.00 5.57 25.82 
2-Hydroxybutyric acid 7.35 8.86 13.36 
Oxalic acid 7.43 10.29 19.45 
Sulfate 7.85 6.71 30.55 
Urea 9.01 0.73 2.75 
Benzoic acid 9.17 2.01 6.31 
Caprylic acid 9.41 2.43 3.85 
Phosphate 9.47 2.85 14.71 
Glycerol 9.52 1.48 7.05 
Isoleucine 9.80 1.92 12.12 
Proline 9.87 4.04 24.57 
Glycine 9.99 2.40 14.76 
Succinic acid 10.09 0.83 7.05 
Fumaric acid 10.59 2.33 7.62 
Pelargonic acid 10.75 7.22 17.83 
3-Amino-2-piperidone 11.98 2.87 10.07 
Capric acid 12.02 5.21 7.14 
Aminomalonic acid 12.14 3.29 11.91 
Malic acid 12.37 2.20 6.32 
Threonic acid 13.04 6.25 8.27 
Ornithine 13.93 8.68 17.56 
Glutamic acid 13.98 2.40 8.84 
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Phenylalanine 14.07 5.86 10.33 
4-Hydroxybenzoic acid 14.10 1.56 7.61 
Lauric acid 14.38 4.48 11.84 
Erythrulose 14.63 11.50 31.25 
Lysine 14.99 6.72 7.33 
Azelaic acid 15.97 13.40 9.92 
Citric acid 16.17 3.17 10.92 
1,5-Anhydro-D-sorbitol 16.53 3.99 10.04 
Sorbose 16.72 3.77 3.13 
Psicose 16.82 9.40 15.46 
Tyrosine 16.90 3.26 10.67 
Galactose 16.91 3.29 6.33 
Glucose 16.98 3.09 5.48 
Urocanic acid 18.02 13.87 18.97 
Palmitic acid 18.49 1.72 6.13 
Pilocarpine 18.67 7.25 12.45 
Myo-Inositol 18.89 3.01 6.77 
Stearic acid 20.29 0.60 4.91 
1-Monopalmitin 23.07 12.39 9.75 
Maltose 24.19 4.97 5.06 
1-Monostearin 24.49 9.70 11.87 
 
On the other hand, based on the identified compounds, a panel of standards was 
selected to characterize the proposed methodology in terms of calibration, sensitivity and 
recovery. The panel consisted of twelve compounds (three lipids, three amino acids, three 
dicarboxylic acids, one sugar, one benzene derivative and phosphate), which covered a 
broad range of chemical classes potentially occurring in sweat. These compounds have also 
been used to confirm the identified compounds by GC–TOF/MS analysis of individual 
standard solutions of the panel compounds subjected to the same preparation protocol as 
the sweat samples. 
Two calibration models were built for each compound using water and sweat as 
matrix. In both cases, a multistandard solution was added at six concentration levels, 
covering in both cases a calibration range from 0.50 to 30 µg/mL. Four of the calibration 
points were injected in triplicate to set the confidence intervals.  
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Table 3. Characteristics of the developed method: linear calibration ranges, calibration equations, 
regression coefficients, limit of detection (LOD) and quantitation (LOQ), and estimated recovery for 
analysis of sweat samples spiked with panel compounds at two levels. Recovery is expressed as 
percent of each detected compound as compared to the spiked concentration. 
Compound Family 
Calibration 
curve 
Regres
-sion 
coeffi-
cient 
LOD 
(µg/ 
mL) 
Calibration 
range 
(µg/mL) 
Recovery (%) 
LOQ 
Maxi-
mum 
At low 
concen- 
tration 
levela 
At high 
concen-
tration 
levelb 
4-Hydroxyben-
zoic acid 
Benzene 
derivatives 
(acids) 
y=(1107198 
±26908)x 
+788179±219589 
0.9935 0.15 0.50 20.80 82.56 94.69 
Galactose 
Carbohydrates 
(monosac- 
charides) 
y=(382616 
±5564)x 
+270953±53556 
0.9961 0.15 0.50 20.40 101.44 99.06 
Proline Amino acids 
y=(685169 
±19624)x 
+3147769±16013 
0.9911 0.30 1.00 24.40 86.77 100.06 
Glutamic acid Amino acids 
y=(221487 
±6331)x 
+2177124±53657 
0.9919 0.30 1.00 29.00 110.60 102.65 
Phenylalanine Amino acids 
y=(158972 
±6778)x 
+1331622±54498 
0.9910 0.15 0.50 26.30 93.21 100.55 
Succinic acid 
Dicarboxylic 
acids 
y=(696478 
±12786)x 
+1460309±10708 
0.9966 0.15 0.50 21.50 99.52 98.13 
Fumaric acid 
Dicarboxylic 
acids 
y=(517269± 
7427)x 
+612626±60610 
0.9977 0.15 0.50 21.20 99.49 98.62 
Malic acid 
Dicarboxylic 
acids 
y=(845505 
±14714)x 
+1131042±117369 
0.9964 0.15 0.50 21.20 97.65 98.56 
Phosphate 
Non-metal 
oxoanionic 
compounds 
y=(492755 
±15821)x 
+3842416±12008 
0.9939 0.15 0.50 28.10 101.95 98.79 
Caprylic acid 
Lipids (fatty 
acids and 
conjugates) 
y=(714498 
±24940)x 
+371500±52906 
0.9915 0.15 0.50 5.50 99.97 95.84 
Lauric acid 
Lipids (fatty 
acids and 
conjugates) 
y=(375777 
±7827)x 
+401578±63873 
0.9953 0.15 0.50 21.10 108.79 100.90 
Palmitic acid 
Lipids (fatty 
acids and 
conjugates) 
y=(166917± 
3322)x 
+160127±29388 
0.9964 0.15 0.50 21.00 94.99 100.60 
a The concentration selected for recovery estimation at low level was 5 µg/mL, except for caprylic acid, for which 
it was 1 µg/mL; b The concentration selected for recovery estimation at high level was 20 µg/mL, except for caprylic 
acid, for which it was 5 µg/mL. 
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Although the regression coefficient was similar for both calibration curves, the 
slope was at least 1.60 times higher in the curve obtained with sweat. Thus, the matrix effect 
leads to an increased sensitivity. Due to this matrix effect, the characterization of the 
method was done using the calibration curve in sweat and quantitation was performed by 
standard addition. The linear dynamic ranges and regression coefficients are shown in 
Table 3. 
As can be seen, regression coefficients were above 0.99 for all analytes and the 
linear range depended on the target compound. Thus, some compounds fitted linearly up 
to concentrations ca. 29 μg/mL, while others only reached 5.50 µg/mL. 
The sensitivity of the method was evaluated by estimation of the lowest limit of 
detection (LLOD) and that of quantitation (LLOQ), both determined by injecting in-series 
dilutions of the multistandard to obtain signals 3 and 10 times, respectively, the 
background noise (average noise value obtained for blank injections). LOD and LOQ were 
between 0.15–0.30 µg/mL and 0.50–1 µg/mL, respectively, for all compounds and they are 
also shown in Table 3. 
Finally, recovery of the deproteination step was estimated by analysis of spiked 
sweat samples at two concentrations (5 and 20 µg/mL for all metabolites except for caprylic 
acid, which was spiked at 1 and 5 µg/mL because of its linear range only reach to 5.50 
µg/mL), selected to cover the linear dynamic range. Recovery values, expressed as percent 
of the spiked concentration, are listed in Table 3. As can be seen, acceptable accuracy values 
were obtained for all analytes near the two extremes of the linear dynamic range, with 
variability values between 82 and 111%. 
Although a quite straightforward sample preparation (protein precipitation 
followed by derivatization) was used, satisfactory validation results in terms of precision, 
recovery, and linearity have been achieved with some exceptions. 
 
4. Conclusions 
Sample preparation for untargeted sweat analysis has been optimized, considering 
both the clean-up and derivatization steps. Although sweat is gaining popularity in 
metabolomics studies, its metabolome has not been completely elucidated yet. Thus, the 
optimization of a new analytical platform as GC–MS for sweat study has revealed the 
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presence of metabolites that can be of interest for the study of different pathologies. Among 
the tested protocols, sweat deproteination with subsequent methoxymation plus silylation 
was the best option to obtain a representative snapshot of sweat metabolome. GC–TOF/MS 
appears to be the best strategy to analyze this biofluid in terms of metabolome coverage as 
compared to previous studies using NMR and LC–MS.  It is worthy to distinguishing the 
ability of GC–MS to detect sugars, lipids and carboxylic acids, families that with previous 
platforms seem to have insignificant presence, but they constitute around 20% of the whole 
entities detected by GC–MS. These three groups, together with amino acids that involve 
30% of the identified compounds, are the four most important families in sweat. 
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Supplementary material 
 
Supplementary Table 1. Sweat compounds identified by GC–TOF/MS in each experiment. 
Compound 
RT 
(min) 
Formula Family Deproteination 
LLE 
Dichloro- 
methane 
Ethyl 
acetate 
Phenol 6.22 C6H6O 
Benzene derivatives 
(alcohols)   
Benzoic acid 9.17 C7H6O2 
Benzene derivatives 
(acids)   
4-Hydroxybenzoic 
acid 
14.10 C7H6O3 
Benzene derivatives 
(acids)    
Isopropyl  
4-hydroxybenzoate 
14.55 C10H12O3 
Benzene derivatives 
(esters)   
Glycerol 9.52 C3H8O3 
Carbohydrates 
(sugar alcohols)   
Glyceric acid 10.30 C3H6O4 
Carbohydrates 
(sugar acids)    
Threonic acid 13.04 C4H8O5 
Carbohydrates 
(sugar acids)    
Erythrulose 14.63 C4H8O4 
Carbohydrates 
(monosaccharides)    
1,5-Anhydro- 
D-sorbitol 
16.53 C6H12O5 
Carbohydrates 
(monosaccharides)    
Sorbose 16.72 C6H12O6 
Carbohydrates 
(monosaccharides)    
Psicose 16.82 C6H12O6 
Carbohydrates 
(monosaccharides)   
Galactose 16.91 C6H12O6 
Carbohydrates 
(monosaccharides)   
Glucose 16.98 C6H12O6 
Carbohydrates 
(monosaccharides)    
Myo-Inositol 18.89 C6H12O6 
Carbohydrates 
(sugar alcohols)    
Maltose 24.19 C12H22O11 
Carbohydrates 
(disaccharides)   
Alanine 7.00 C3H7NO2 Amino acids    
Valine 8.70 C5H11NO2 Amino acids    
Leucine 9.50 C6H13NO2 Amino acids    
Isoleucine 9.80 C6H13NO2 Amino acids    
Proline 9.87 C5H9NO2 Amino acids    
Glycine 9.99 C2H5NO2 Amino acids    
Serine 10.71 C3H7NO3 Amino acids    
Aspartic acid 11.24 C4H7NO4 Amino acids    
Aminomalonic acid 12.14 C3H5NO4 Amino acids    
Ornithine 13.93 C5H12N2O2 Amino acids    
Glutamic acid 13.98 C5H9NO4 Amino acids    
Phenylalanine 14.07 C9H11NO2 Amino acids    
Lysine 14.99 C6H14N2O2 Amino acids    
Tyrosine 16.90 C9H11NO3 Amino acids    

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Urocanic acid 18.02 C6H6N2O2 Amino acids   
Oxalic acid 7.43 C2H2O4 Dicarboxylic acids    
Succinic acid 10.09 C4H6O4 Dicarboxylic acids    
Fumaric acid 10.59 C4H4O4 Dicarboxylic acids    
Methylenesuccinic 
acid 
11,77 C5H6O4 Dicarboxylic acids    
Malic acid 12.37 C4H6O5 Dicarboxylic acids    
Azelaic acid 15.97 C9H16O4 Dicarboxylic acids    
Citric acid 16.17 C6H8O7 Tricarboxylic acids    
Lactic acid 6.32 C3H6O3 
Carboxylic acids 
(hydroxy acids)   
Glycolic acid 6.58 C2H4O3 
Carboxylic acids 
(hydroxy acids)    
2-Deoxy-D-erythro-
pentopyranose 
14.07 C5H10O4 
Carboxylic acids 
(hydroxy acids)    
Pyruvic acid 6.14 C3H4O3 
Carboxylic acids 
(keto acids)    
Urea 9.01 CON2H4 Ureas   
3-Amino- 
2-piperidone 
11.98 C5H10N2O Piperidines    
Sulfate 7.85 SO42- 
Non-metal 
oxoanionic 
compounds 
  
Phosphate 9.47 PO43- 
Non-metal 
oxoanionic 
compounds 
   
Caproic acid 6.56 C6H12O2 
Lipids (fatty acids 
and conjugates)   
Caprylic acid 9.41 C8H16O2 
Lipids (fatty acids 
and conjugates)   
Pelargonic acid 10.75 C9H18O2 
Lipids (fatty acids 
and conjugates)   
Capric acid 12,03 C10H20O2 
Lipids (fatty acids 
and conjugates)   
Lauric acid 14,38 C12H24O2 
Lipids (fatty acids 
and conjugates)   
Palmitic acid 18.49 C16H32O2 
Lipids (fatty acids 
and conjugates)   
Pentadecanoic acid 17.53 C15H30O2 
Lipids (fatty acids 
and conjugates)    
Stearic acid 20.29 C18H36O2 
Lipids (fatty acids 
and conjugates)   
Eicosapentaenoic 
acid 
23.44 C20H30O2 
Lipids (fatty acids 
and conjugates)    
2-Hydroxybutyric 
acid 
7.35 C4H8O3 
Lipids (hydroxy fatty 
acids)    
2-Ethylcaproic acid 7.95 C8H16O2 
Lipids (ethyl fatty 
acids)   
1-Monopalmitin 23.07 C19H38O4 Lipids (glycerides)   
1-Monostearin 24.49 C21H42O4 Lipids (glycerides)   
Squalene 24.79 C30H50 
Lipids (prenol 
lipids)    
Borate 9.73 BO33- Exogenous    
Triethanolamine 14.05 C6H15NO3 Exogenous   
Pilocarpine 18.67 C11H16N2O2 Exogenous   
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Supplementary Table 2. Sweat compounds identified after derivatization with methoxymation 
plus silylation or only by silylation prior to GC–TOF/MS. 
Compound RT (min) Formula Family 
Methoxymation 
+ 
silylation 
Silylation 
Phenol 6.22 C6H6O 
Benzene 
derivatives 
(alcohols) 
 
Benzoic acid 9.17 C7H6O2 
Benzene 
derivatives (acids)  
4-Hydroxybenzoic acid 14.10 C7H6O3 
Benzene 
derivatives (acids)  
Isopropyl  
4-hydroxybenzoate 
14.54 C10H12O3 
Benzene 
derivatives (esters)  
Glycerol 9.52 C3H8O3 
Carbohydrates 
(sugar alcohols)  
Glyceric acid 10.30 C3H6O4 
Carbohydrates 
(sugar acids)  
Threonic acid 13.04 C4H8O5 
Carbohydrates 
(sugar acids)  
Erythrulose 14.63 C4H8O4 
Carbohydrates 
(monosaccharides)  
1,5-Anhydro-D-sorbitol 16.53 C6H12O5 
Carbohydrates 
(monosaccharides)  
Sorbose 16.72 C6H12O6 
Carbohydrates 
(monosaccharides)   
Psicose 16.82 C6H12O6 
Carbohydrates 
(monosaccharides)  
Galactose 16.91 C6H12O6 
Carbohydrates 
(monosaccharides)  
Methyl  
β-D-galactopyranoside 
16.95 C7H14O6 
Carbohydrates 
(monosaccharides)  
Glucose 16.98 C6H12O6 
Carbohydrates 
(monosaccharides)  
Myo-Inositol 18.89 C6H12O6 
Carbohydrates 
(sugar alcohols)  
Maltose 24.19 C12H22O11 
Carbohydrates 
(disaccharides)  
Alanine 7.00 C3H7NO2 Amino acids  
Valine 8.70 C5H11NO2 Amino acids  
Leucine 9.50 C6H13NO2 Amino acids  
Isoleucine 9.80 C6H13NO2 Amino acids  

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Proline 9.87 C5H9NO2 Amino acids  
Glycine 9.99 C2H5NO2 Amino acids  
Serine 10.71 C3H7NO3 Amino acids  
Aspartic acid 11.25 C4H7NO4 Amino acids  
Aminomalonic acid 12.14 C3H5NO4 Amino acids  
Ornithine 13.93 C5H12N2O2 Amino acids  
Glutamic acid 13.98 C5H9NO4 Amino acids  
Phenylalanine 14.07 C9H11NO2 Amino acids   
Lysine 14.99 C6H14N2O2 Amino acids  
Tyrosine 16.90 C9H11NO3 Amino acids  
Histidine 17.21 C6H9N3O2 Amino acids  
Urocanic acid 18.02 C6H6N2O2 Amino acids  
Tryptophan 19.92 C11H12N2O2 Amino acids  
Oxalic acid 7.43 C2H2O4 Dicarboxylic acids  
Succinic acid 10.09 C4H6O4 Dicarboxylic acids  
Fumaric acid 10.59 C4H4O4 Dicarboxylic acids  
Methylenesuccinic acid 11,77 C5H6O4 Dicarboxylic acids  
Malic acid 12.37 C4H6O5 Dicarboxylic acids  
Azelaic acid 15.97 C9H16O4 Dicarboxylic acids  
Citric acid 16.17 C6H8O7 Tricarboxylic acids  
Lactic acid 6.32 C3H6O3 
Carboxylic acids 
(hydroxy acids)  
Glycolic acid 6.58 C2H4O3 
Carboxylic acids 
(hydroxy acids)  
Diethyl tartrate 14.07 C8H14O6 
Carboxylic acids 
(hydroxy acids)  

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2-Deoxy-D-erythro-
pentopyranose 
14.07 C5H10O4 
Carboxylic acids 
(hydroxy acids)  
Pyruvic acid 6.14 C3H4O3 
Carboxylic acids 
(keto acids)   
Urea 9.01 CON2H4 Ureas  
3-Amino-2-piperidone 11.98 C5H10N2O Piperidines  
Sulfate 7.85 SO42- 
Non-metal 
oxoanionic 
compounds 
 
Phosphate 9.47 PO43- 
Non-metal 
oxoanionic 
compounds 
 
Caproic acid 6.56 C6H12O2 
Lipids (fatty acids 
and conjugates)  
Caprylic acid 9.41 C8H16O2 
Lipids (fatty acids 
and conjugates)  
Pelargonic acid 10.75 C9H18O2 
Lipids (fatty acids 
and conjugates)  
Capric acid 12.03 C10H20O2 
Lipids (fatty acids 
and conjugates)  
Lauric acid 14,38 C12H24O2 
Lipids (fatty acids 
and conjugates)  
Palmitic acid 18.49 C16H32O2 
Lipids (fatty acids 
and conjugates)  
Pentadecanoic acid 17.53 C15H30O2 
Lipids (fatty acids 
and conjugates)  
Stearic acid 20.29 C18H36O2 
Lipids (fatty acids 
and conjugates)  
Eicosapentaenoic acid 23.44 C20H30O2 
Lipids (fatty acids 
and conjugates)  
2-Hydroxybutyric acid 7.35 C4H8O3 
Lipids (hydroxy 
fatty acids)  
2-Ethylcaproic acid 7.95 C8H16O2 
Lipids (ethyl fatty 
acids)  
1-Monopalmitin 23.07 C19H38O4 Lipids (glycerides)  
1-Monostearin 24.49 C21H42O4 Lipids (glycerides)  
Squalene 24.79 C30H50 
Lipids (prenol 
lipids)   
Borate 9.73 BO33- Exogenous  
Triethanolamine 14.05 C6H15NO3 Exogenous   
Pilocarpine 18.67 C11H16N2O2 Exogenous  
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Supplementary Table 3. Compounds no previously identified in sweat.* 
Compound RT (min) Formula Family 
Phenol 6.22 C6H6O 
Benzene derivatives 
(alcohols) 
Benzoic acid 9.17 C7H6O2 
Benzene derivatives 
(acids) 
4-Hydroxybenzoic acid 14.10 C7H6O3 
Benzene derivatives 
(acids) 
Isopropyl  
4-hydroxybenzoate 
14.54 C10H12O3 
Benzene derivatives 
(esters) 
Glyceric acid 10.30 C3H6O4 
Carbohydrates  
(sugar acids) 
Threonic acid 13.04 C4H8O5 
Carbohydrates  
(sugar acids) 
Erythrulose 14.63 C4H8O4 
Carbohydrates 
(monosaccharides) 
1,5-Anhydro-D-sorbitol 16.53 C6H12O5 
Carbohydrates 
(monosaccharides) 
Sorbose 16.72 C6H12O6 
Carbohydrates 
(monosaccharides) 
Psicose 16.82 C6H12O6 
Carbohydrates 
(monosaccharides) 
Galactose 16.91 C6H12O6 
Carbohydrates 
(monosaccharides) 
Methyl  
β-D-galactopyranoside 
16.95 C7H14O6 
Carbohydrates 
(monosaccharides) 
Maltose 24.19 C12H22O11 
Carbohydrates 
(disaccharides) 
Aminomalonic acid 12.14 C3H5NO4 Amino acids 
Methylenesuccinic acid 11,77 C5H6O4 Dicarboxylic acids 
Glycolic acid 6.58 C2H4O3 
Carboxylic acids (hydroxy 
acids) 
Diethyl tartrate 14.07 C8H14O6 
Carboxylic acids (hydroxy 
acids) 
2-Deoxy-D-erythro-
pentopyranose 
14.07 C5H10O4 
Carboxylic acids (hydroxy 
acids) 
3-Amino-2-piperidone 11.98 C5H10N2O Piperidines 
Sulfate 7.85 S O42- 
No metal oxoanionic 
compounds 
Phosphate 9.47 PO43- 
No metal oxoanionic 
compounds 
Borate 9.73 BO33- Exogenous 
Triethanolamine 14.05 C6H15NO3 Exogenous 
*As far as the authors know. 
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Supplementary Table 4. Sweat compounds identified by NMR, LC–QTOF MS/MS and GC–
TOF/MS. 
Compound Family NMR LC–MS GC‒MS 
Benzoic acid Benzene derivatives   
4-Hydroxybenzoic acid Benzene derivatives   
Isopropyl 4-hydroxybenzoate Benzene derivatives   
Phenol Benzene derivatives   
1,5-Anhydro-D-sorbitol Carbohydrates   
Erythrulose Carbohydrates   
Galactose Carbohydrates   
Glucose Carbohydrates   
Glyceric acid Carbohydrates   
Glycerol Carbohydrates   
Inositol Carbohydrates   
Maltose Carbohydrates   
Maltotriose Carbohydrates   
Methyl β-D-galactopyranoside Carbohydrates   
Psicose Carbohydrates   
Sorbose Carbohydrates   
Sucrose Carbohydrates   
Tetrasaccharide Carbohydrates   
Threonic acid Carbohydrates   
Alanine Amino acids   
Aminomalonic acid Amino acids   
Arginine Amino acids   
Aspartic acid Amino acids   
Citrulline Amino acids   
Cysteine Amino acids   
Glutamic acid Amino acids   
Glutamine Amino acids   
Glycine Amino acids   
Histidine Amino acids   
Isoleucine Amino acids   
Leucine Amino acids   
Lysine Amino acids   

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Continuation Supplementary Table 4
Methionine Amino acids   
Ornithine Amino acids   
Phenylalanine Amino acids   
Proline Amino acids   
Serine Amino acids   
Threonine Amino acids   
Tryptophan Amino acids   
Tyrosine Amino acids   
Valine Amino acids   
Carnitine Amino acid derivatives   
N- acetyl - aspartate Amino acid derivatives   
Prolylhydroxyproline Amino acid derivatives   
Pyroglutamic acid Amino acid derivatives   
Taurine Amino acid derivatives   
Tyramine Amino acid derivatives   
Urea Amino acid derivatives   
Urocanic acid Amino acid derivatives   
2-Deoxy-D-erythro-pentopyranose Carboxylic acids   
Azelaic acid Carboxylic acids   
Cis-aconitate Carboxylic acids   
Citric acid Carboxylic acids   
Diethyl tartrate Carboxylic acids   
Formate Carboxylic acids   
Fumaric acid Carboxylic acids   
Glycolic acid Carboxylic acids   
Lactic acid Carboxylic acids   
Malic acid Carboxylic acids   
Methylenesuccinic acid Carboxylic acids   
Oxalic acid Carboxylic acids   
Pyruvic acid Carboxylic acids   
Sebacic acid Carboxylic acids   
Suberic acid Carboxylic acids   
Succinic acid Carboxylic acids   
Acetoacetate Carboxylic acid derivatives   
Choline Nutrients   

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Coumaric acid Nutrients   
Inosine Purine derivatives   
Uric acid Purine derivatives   
3-Amino-2-piperidone Piperidines   
Phosphate No metal oxoanionic compounds   
Sulfate No metal oxoanionic compounds   
1-Monopalmitin Lipids   
1-Monostearin Lipids   
2-Ethylcaproic acid Lipids   
2-Hydroxybutyric acid Lipids   
C16 sphinganine Lipids   
Capric acid Lipids   
Caproic acid Lipids   
Caprylic acid Lipids   
Eicosapentaenoic acid Lipids   
Lauric acid Lipids   
MG(22:2) Lipids   
Palmitic acid Lipids   
Pelargonic acid Lipids   
Pentadecanoic acid Lipids   
Squalene Lipids   
Stearic acid Lipids   
Dimethylamine Amines   
Methylamine Amines   
Ammonium cation Ammonium   
1,2-Propanediol Exogenous   
Acetaldehyde Exogenous   
Borate Exogenous   
Caffeine Exogenous   
Ethanol Exogenous   
Methylparaben Exogenous   
Pilocarpic acid Exogenous   
Pilocarpine Exogenous   
Propylparaben Exogenous   
Theophylline Exogenous   
Triethanolamine Exogenous   
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Recent advances in human sweat metabolomics 
for lung cancer screening 
María del Mar Delgado-Povedano, Mónica Calderón-Santiago, Feliciano 
Priego-Capote, Bernabé Jurado-Gámez, María Dolores Luque de Castro 
Abstract 
Introduction Lung cancer is the leading cause of cancer related mortality owing to the advanced 
stage it is usually detected because the available diagnostic tests are expensive and invasive; 
therefore, they cannot be used for general screening. 
Objectives To increase robustness of previous biomarker panels — based on metabolites in sweat 
samples— proposed by the authors, new samples were collected within different intervals (4 
months and two years), analyzed at different times (2012 and 2014, respectively) by different 
analysts to discriminate lung cancer patients and smokers at risk factor.  
Methods Sweat analysis was carried out by LC–MS/MS with minimum sample preparation and 
the generated analytical data were then integrated to minimize variability in statistical analysis.  
Results Panels with capability to discriminate lung cancer patients from smokers at risk factor 
were obtained taken into account the variability between both cohorts as a consequence of the 
different intervals for samples collection, the times at which the analyses were carried out and 
the influence of the analyst. Two panels of metabolites using the PanelomiX tool allow reducing 
false negatives (95% specificity) and false positives (95% sensitivity). The first panel (96.9% 
specificity and 83.8% sensitivity) is composed by monoglyceride MG(22:2), muconic, suberic 
and urocanic acids, and a tetrahexose; the second panel (81.2% specificity and 97.3% sensitivity) 
is composed by the monoglyceride MG(22:2), muconic, nonanedioic and urocanic acids, and a 
tetrahexose.  
Conclusion The study has allowed obtaining a prediction model more robust than that obtained 
in the previous study from the authors. 
Keywords: lung cancer, human sweat, biomarker panel, metabolomics, liquid 
chromatography, mass spectrometry. 
New strategies on sample preparation and on platforms development 
for targeted and untargeted metabolomics analysis 
Page | 562 
1. Introduction 
Lung cancer is the leading cause of cancer deaths in the United Kingdom (Cancer 
Research UK 2012), Europe (Ferlay et al., 2008) and the United States (Jemal et al., 2010). 
According to the American Cancer Society, lung cancer causes more deaths than the sum 
of the three most common cancers (colon, breast and prostate) (World Health 
Organization, 2012). Despite the advances in diagnostic, surgery, and chemotherapy, the 
last 30 years has seen little improvement in the overall five-year survival rate for lung 
cancer, with only 15% of patients living for at least five years after initial diagnosis (Jemal 
et al., 2010). These relatively poor survival rates are mainly the result of the late detection 
of a malignancy for which available diagnostic tests are invasive and cannot be used for 
general screening. 
Presently, no invasive techniques for cancer screening are the subject of wide 
clinical research. The current techniques to diagnostic lung cancer are mainly based on 
chest X-rays and sputum cytology, which have not contributed to reduce cancer mortality 
(Yu et al., 2008). Recently, the use of techniques such as low-dose computed tomography 
has decreased mortality rate around 20% in comparison with chest X-ray radiography 
(Aberle et al., 2011). Nevertheless, the main limitation of the present methods to diagnose 
lung cancer is ascribed to the high number of abnormalities potentially mimicking lung 
cancer (false positives) and the difficulty to apply diagnostic tools to the target population 
because of the high costs. This makes the 5 years survival rate very low owing to the 
advanced stage at which lung cancer is most times diagnosed. 
The above limitations have led to active research in omics disciplines with two main 
purposes: to understand the development and biology of lung cancer and to identify 
potential biomarkers to detect initial stages in the development of the disease (Khadir and 
Tiss, 2013). Metabolomics has developed promising tools for disease diagnosis by 
biomarker discovery and characterization of biological pathways. Recent research has 
focused on metabolomics profiling for biomarkers discovery using different biological 
samples (tissue, urine, exhaled breath condensate or plasma) (Armitage and Barbas, 2014). 
The low complexity of sweat matrix is an advantage to search for biomarkers in the 
study of diseases because other pathological conditions could interfere less than in more 
complex samples. Furthermore, sweat can be obtained easily in a no invasive manner 
(Calderón-Santiago et al., 2014). Several studies have demonstrated the suitability of sweat 
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profiling for monitoring human health. For example, sweat has been used for over 50 years 
in the diagnostics of cystic fibrosis (Mishra et al., 2007; Seia et al., 2009). Furthermore, a 
recent study used human sweat as clinical sample to develop a screening tool for lung 
cancer (Calderón-Santiago et al., 2015). The prediction model based on a panel of 
metabolites that included amino acids, sugars, and some lipids was built to discriminate 
patients with lung cancer from a risk factor control group. This panel, composed by five 
metabolites, provided 80% specificity and 79% sensitivity. These preliminary results, 
obtained with a unique cohort, emphasized the necessity of new studies to validate the 
obtained results and reduce the proportion of individuals that would be subjected to 
confirmatory tests. 
The aim of the present study was to combine the data generated by analysis of sweat 
from individuals pertaining to two independent cohorts that were collected within different 
time intervals and analyzed at different times by different analysts. A crucial task was to 
minimize the variability between the two cohorts to make possible the integration of the 
data provided by analysis of both batches. Statistical analysis of the integrated data set was 
targeted at finding robust panels with capability to discriminate patients with lung cancer 
from smokers as risk factor individuals. These panels attempt to reduce the probability of 
false negatives and false positives, which is of crucial interest for diagnostic purposes. 
 
2. Materials and methods 
 
2.1. Chemicals and reagents 
MS-grade formic acid (FA) and acetonitrile (ACN) from Scharlab (Barcelona, 
Spain) were used to prepare the chromatographic mobile phases for LC–MS/MS analysis. 
FA was also used for sample preparation. Deionized water (18 mΩ • cm) from a Millipore 
Milli-Q water purification system (Bedford, MA, USA) was used to prepare the aqueous 
chromatographic phases and for sample preparation. 
 
2.2. Apparatus and instruments 
A vortex shaker from IKA (Wilmington, NC, USA) was used to shake and 
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homogenize the analytical samples, and an Agilent 1200 Series LC system (consisting of a 
binary pump, a vacuum degasser, an autosampler, and a thermostated column 
compartment) coupled to an Agilent 6540 UHD Accurate-Mass QTOF hybrid mass 
spectrometer equipped with a dual electrospray ionization (ESI) source (Santa Clara, CA, 
USA) was used to analyze them. The chromatographic eluate was monitored in high-
resolution mode. 
 
2.3. Cohorts selected for the study 
A first cohort of thirty-five patients recruited by the Respiratory Medicine 
Department of the Reina Sofía Hospital (Córdoba, Spain) from March to August 2012 and 
a second cohort composed by thirty-four patients recruited by the same Department from 
November 2012 to October 2014 constituted the target of the study. Sixteen patients of the 
first cohort and twenty-one patients of the second were diagnosed with lung cancer after 
clinical tests based on bronchoscopy, fine needle biopsy, or thorascopy. Nineteen patients 
of the first cohort and thirteen patients of the second were classified as risk factor 
individuals owing to smoking habit. 
In both cohorts the existence of other severe pulmonary diseases (interstitial 
pneumonitis, pneumonia, tuberculosis, etc.) was excluded by bronchoscopy and/or 
computed tomography scanning. The exclusion criteria were (1) coexistence of 
extrapulmonary neoplasia during the last 5 years or chemotherapy for other different 
neoplasias, and (2) severe organ disease with negative influence on prognostic or with 
influence on the application of the target protocol, including congestive heart failure, 
chronic liver disease (functional stage MELD >12), and chronic kidney disease stage 5 with 
substitutive treatment (hemodialysis or peritoneal dialysis).  
The study was approved by the ethical committee of the Reina Sofia University 
Hospital. The individuals selected for this study were previously informed to obtain 
complete consent. All steps from sweat extraction to analysis were performed in 
compliance with the guidelines dictated by the World Medical Association Declaration of 
Helsinki of 2004. It should be emphasized that sweat collection was performed before 
finishing the clinical study, which means that patients were not subjected to cytostatic 
treatment. Therefore, medication was exclusively restricted to control the symptoms by 
analgesics (paracetamol or ibuprofen), cough suppressants (codeine), and similar drugs. 
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Apart from that, both control individuals and patients were taking common treatments 
related to diseases associated to the age interval (statins, antihypertensives, analgesics, 
etc.). 
The main characteristics —age, sex, body mass index (BMI), and smoked pack-
years— of the cohorts are shown in Table 1. Dependence of these characteristics among 
them and the risk factor group was checked by χ2 test for sex, and analysis of variance 
(ANOVA) with 95% confidence level for the rest of parameters but age was evaluated by 
Kruskal-Wallis test as this parameter did not fit a normal distribution according to the 
Skewness and Kurtosis criteria for normality (p-values are also shown in Table 1).  
 
Table 1. Main characteristics of the two cohorts under study including age, sex, body mass index 
(BMI), and smoked pack-years. 
Characteristics 
Cohort 1 (n = 35) Cohort 2 (n = 34) 
Lung 
cancer 
patients 
(n=16) 
Risk factor 
individuals 
(n=19) 
p-
Valueb 
Lung 
cancer 
patients 
(n=21) 
Risk factor 
individuals 
(n=13) 
p-
Valueb 
Age, (year) 65 (46–87) 56 (38–77) 0.024 62 (49–75) 60 (46–73) 0.384 
Sex, (male %) 81 89 0.489 81 85 0.785 
Pack-yearsa 52 (20–100) 36 (10–80) 0.030 49 (0–100) 39 (15–70) 0.209 
BMI, (kg/m2) 
27.0 (17.6–
33.6) 
28.2 (23.5–
36.3) 
0.407 
26.0 (19.3–
35.5) 
29.0 (21.3–
36.9) 
0.126 
All data are expressed as percent or mean (range); a Cigarettes consumption is considered as pack-years (average 
cigarettes smoked per day/20)×(years of smoking); b p-Values were obtained by Chi Squares test for the sex and 
by analysis of variance (ANOVA) for the rest of parameters —the no parametric version (Kruskal-Wallis) was 
applied in the case of age, since this factor does not fit normal distribution. 
 
The first cohort revealed high significance for age (p-value 0.024) —lung cancer 
patients were older than risk factor individuals—, and for pack-years parameter (p-value 
0.030). On the other hand, no significant factors were found in the second cohort. 
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The present accepted guidelines for pathological and staging diagnosis of lung 
cancer were used (Sánchez de Cos et al., 2011). The most frequent diagnostic was squamous 
cell carcinoma (n=18 patients, 48.7%), followed by adenocarcinome (11 patients, 29.7%), 
bronchogenic carcinoma (2 patients, 5.4%), and synchronous bronchial cancer (1 patient, 
2.7%). Five patients were diagnosed with no small cell lung cancer without histological 
classification. Concerning stages, nine cases were diagnosed as stage IA, four as stage IB, 
two as stage IIB, twelve as stage IIIA, four as stage IIIB, and six as stage IV. The number of 
patients for each diagnostic and stage did not enable inclusion of this variability source in 
the study. 
 
2.4. Sweat sampling and storage 
The Macroduct® Sweat Analysis System (Wescor, Utah, USA) used for sampling 
consists of a Webster sweat inducer and a Macroduct sweat collector (US Patent 4,542,751). 
Pilogel®discs (US Patent 4,383,529) (Wescor, Utah, USA), which consist of a gel reservoir 
of pilocarpinium ions, were used in the iontophoretic stimulation of sweat excretion. The 
sweat inducer provides a current intensity of 1.5 mA for 5 min through two Pilogel discs as 
electrodes located on the forearm. Previously, the skin was cleaned with ethanol and then 
with distilled water. The Macroduct device collected sweat for 15 min, which was 
transferred to plastic microEppendorf tubes and stored at –80 ºC until analysis. A total 
sweat volume of ca. 50 µL was collected per individual. 
 
2.5. Sample treatment 
Sweat samples (10 μL) were 1:2 (v/v) diluted with 0.1% FA in water. The mixture 
was vortexed for homogenezation for 1 min and placed in the LC autosampler for 
subsequent analysis. All samples were prepared in duplicate. 
 
2.6 LC–QTOF MS/MS analysis 
Chromatographic separation was performed using a C18 reverse-phase analytical 
column (Mediterranean, 50 mm×0.46 mm i.d., 3 μm particle size) from Teknokroma 
(Barcelona, Spain), which was thermostated at 25 °C. The mobile phases were water (phase 
A) and ACN (phase B) both with 0.1 % FA as ionization agent. The LC pump was 
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programmed with a flow rate of 0.8 mL/min with the following elution gradient: 3 % phase 
B as initial mobile phase was kept constant from min 0 to 1; then, the percentage of phase 
B was increased from 3 to 80% min 1 to 10.5, and finally from 80 to 100% of phase B from 
min 10.5 to 11.5. A post-time of 5 min was set to equilibrate the initial conditions for the 
next analysis. The injection volume was 3 μL and the injector needle was washed ten times 
between injections with 70% methanol. Furthermore, the needle seat back was flushed for 
15 s at a flow rate of 4 mL/min with 70% methanol to avoid cross-contamination. The 
parameters of the electrospray ionization source, operating in negative and positive 
ionization modes, were as follows: the capillary and fragmentor voltage were set at ±3.5 kV 
and 175 V, respectively; N2 in the nebulizer flowed at 40 psi; the flow rate and temperature 
of the N2 as drying gas were 8 L/min and 350 °C, respectively. The instrument was 
calibrated and tuned according to procedures recommended by the manufacturer. MS and 
MS/MS data were collected in both polarities using the centroid mode at a rate of 1 
spectrum/s in the extended dynamic range mode (2 GHz). Accurate mass spectra in MS 
scan and MS/MS mode were acquired in the m/z range 60–1100. The instrument gave 
typical resolution 15,000 FWHM (full width at half maximum) at m/z 118.0862 and 30,000 
FWHM at m/z 922.0098. To assure the desired mass accuracy of recorded ions, continuous 
internal calibration was performed during analyses by using the signals at m/z 121.0509 
(protonated purine) and m/z 922.0098 [protonated hexakis (1H,1H,3Htetrafluoro-
propoxy) phosphazine or HP-921] in the positive ionization mode, while in negative 
ionization mode ions with m/z 119.0362 (proton abstracted purine) and m/z 966.0007 
(formate adduct of HP-921) were used. The samples were injected in auto MS/MS 
acquisition mode with a preferred list of precursor ions to obtain the product ion 
information of metabolites with significant difference between the groups under study (two 
replicates per sample). Supplementary Table 1 shows the list of metabolites with significant 
difference between the groups under study including the retention time and m/z values for 
precursor and product ions as well as the error in precursor ion detection expressed as ppm. 
The number of precursors selected per cycle was set at 2, with an exclusion window of 0.3 
min after two consecutive selections of the same precursor. The collision energy 20 eV was 
used to obtain the fragmentation information for each entity. 
 
2.7. Data processing and statistical analysis 
The MassHunter Workstation software package (Qualitative Analysis (version  
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B.07.00) and Profinder (version B.06.00), Agilent Technologies, Santa Clara, CA, USA) was 
used for processing the raw data files obtained by LC–QTOF in auto MS/MS acquisition 
mode. The recursive feature extraction algorithm in the software MassHunter Profinder 
was used to extract and align potential molecular features in all injections. This algorithm 
initially deconvolutes chromatograms and aligns features across the selected sample files 
in terms of mass and retention time; then, it uses the mass and retention time of each 
feature for recursive targeted feature extraction. This two-step procedure reduces the 
number of both false negatives and false positives in feature extraction. The target 
parameters for feature extraction included a threshold of 500 counts and a maximum 
charge state of one. In addition, the isotopic distribution for a valid feature had to be 
defined by two or more ions, with a peak spacing tolerance of 0.0025 m/z, plus 10.0 ppm. 
Adduct formation in the positive (+H, +Na) and negative ionization mode (−H, +HCOO) 
was also used to identify features of the same molecule. The features were aligned by using 
a tolerance window of 0.50 min and a mass accuracy of 10 ppm for retention times and m/z 
values across all data files, respectively. Identification of the metabolites detected in the 
two groups under study (Supplementary Table 1) was done using MS and MS/MS 
information and searching in the METLIN MS and MS/MS database (URL: 
http://metlin.scripps.edu) and Human Metabolome Database (URL: 
http://www.hmdb.ca/) (version 3.5). The average area of the two injections of these 
metabolites was calculated for each of them. MetaboAnalyst (www.metaboanalyst.ca) 
(version 3.0) was used for metabolomic data analysis, visualization and interpretation, and 
also for normalization by sum (the quantitative response of a potential metabolite is scaled 
by the sum of the quantitative responses of all potential metabolites detected in the 
samples), log transformation and scaling of the data set. The scaling procedure was carried 
out with the weighted mean and standard deviation. Both parameters were calculated 
taking into account the two classes under study: risk factor controls and lung cancer 
patients. The predictive capability of each metabolite by Random Forest Analysis was also 
determined by MetaboAnalyst. Finally, PanelomiX toolbox, supported on the iterative 
combination of biomarkers and thresholds, was used to combine iteratively biomarkers by 
selecting thresholds that provide optimal classification performance (Robin et al., 2013). 
Cross-validation was performed by including the scaling process in it. For this purpose, 
10% of the samples were excluded from the complete set. After that, data treatment was 
applied from scaling to panels generation. It is worth mentioning that scaling was carried 
out as previously described using the weighted mean and standard deviation for each 
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independent class. Then, the resulting panel was validated using the excluded samples. 
Previously, the excluded samples were scaled with the mean and standard deviation values 
obtained from the corresponding batch used to generate the panels. The process was 
repeated 10 times, which means that all samples were used for validation. 
 
3. Results and discussion 
 
3.1. Inter- and intra-batch variability 
As mentioned before, the first cohort was sampled from March 2012 to August 2012 
and the samples were analyzed in 2012 by analyst 1 (Calderón-Santiago et al., 2015). Two 
years later, the second cohort was sampled from November 2012 to October 2014 and 
analyzed by analyst 2. In the first study, the relative standard deviation (RSD) for MS 
signals of metabolites identified in sweat in both positive and negative ionization modes 
was below 20%; indicative of a representative data set. In the present research, the data 
were generated from two independent batches. Supplementary Fig. 1 shows the bars 
diagram comparing the mean quantitative response and RSD obtained for each metabolite 
identified in the samples pertaining to each cohort and, thus, analyzed by different analysts. 
The sensitivity obtained from the data provided by analysis of the second batch was clearly 
better, except for trisaccharide phosphate, trihexose and tetrahexose, eluted in the first part 
of the chromatogram, and sharing a similar chemical structure. On the other hand, most of 
the compounds detected in positive ionization mode presented lower RSD for the analyst 
2, while compounds detected in negative ionization mode presented lower variability for 
the analyst 1. In an attempt to evaluate the intra-batch variability, the RSD for the sum of 
the quantitative responses of all compounds detected in the duplicate analysis of each 
individual was calculated. The sum of all compounds provides evidences of the whole 
variability between replicates and also establishes the suitability of this parameter for 
normalization. Inter-replicate variability was between 0.002 and 18.4% for the first batch, 
and from 0.40 to 10.4% for the second batch. The mean variability, also expressed as RSD, 
was quite similar in both batches (4.4 and 5.8% for the first and second batch, respectively). 
Despite both batches provided similar RSD, differences for specific compounds were 
identified. Thus, it was mandatory to identify and minimize variability sources that could 
be associated to the experimental plan (sampling period, analysis time and analyst). Several 
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research groups have emphasized the capability of autoscaling and range scaling 
normalizations to preprocess data from metabolomics experiments without modification 
of the biological variability (Van den Berg et al., 2006). Taking into account differences in 
sensitivity between both batches, the variability in terms of RSD for each identified 
metabolite, and also the differences in the number of samples between batches, a scaling 
procedure similar to autoscaling but based on weighted average and weighted standard 
deviation was used as preprocessing strategy (since now called weighted scaling). Thus, the 
weighted scaling consists of the independent calculation of the mean and standard 
deviation for controls and lung cancer patients, and the use of the average of means and 
standard deviations for the scaling procedure. This strategy, applied after normalization by 
sum and logarithmic transformation, allows rendering each variable on the same scale. All 
variables in the data set presented a normal distribution with this approach. PCA can detect 
systematic no biologically related or undesired bias defined as batch effects, which are 
recognized as frequent misguide of biological interpretations. To detect variability sources, 
an unsupervised principal component analysis (PCA) was firstly carried out using the 
combined data set that was subjected to normalization by sum, log transformation and 
weighted scaling. The PCA scores plot in Fig. 1A shows that variability among batches is 
high enough for a clear discrimination between the two cohorts by using the two first 
components: principal component 1 (PC1) explains 33.8%, and principal component 2 
(PC2) explains 21%. 
No discrimination was observed under these conditions according to the diagnostic 
between lung cancer patients and risk factor individuals (Fig. 1B). As the main variability 
source between batches was ascribed to sensitivity differences between both batches, 
normalization by sum, log transformation and weighted scaling were separately applied to 
the two data sets obtained by analysis of both batches, and then, the two resulting data sets 
were combined. The PCA scores plot obtained in this case (Fig. 1C) did not provide 
discrimination between cohorts 1 and 2, and what is more relevant, allowed detecting a 
slight discrimination between lung cancer and control individuals according to the second 
component (Fig. 1D). In this case the variability explained by PC1 and PC2 was similar to 
that observed in the previous PCA. With these premises, the separated application of 
normalization, transformation and weighted scaling prior to combination of both data sets 
was crucial to remove the contribution of external variability sources associated to each 
cohort. 
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Fig. 1. Two-dimensional PCA score plots after scaling of the complete data set to detect 
discrimination patterns according to the cohort (A) and the diagnostic of lung cancer (B). Two-
dimensional PCA score plots after separate scaling of the two data sets to detect discrimination 
patterns according to the cohort (C) and the diagnostic of lung cancer (D). 
 
3.2. Selection of metabolites with high predictive capability 
Random Forest Analysis was used to rank tentative identified metabolites 
according to their importance, evaluated by measuring the increase of the unbiased 
estimation of the classification error (Xia et al., 2009). Since metabolites are ranked by 
their statistical significance for discrimination of individuals between the two groups under 
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study, this classification can provide evidences on the tentative metabolites characterized 
by a high prediction capability and, therefore, the most probable to be combined in a panel 
of markers to discriminate the two classes. 
 
 
Fig. 2. Random Forest Analysis of significant metabolites found in human sweat to discriminate lung 
cancer patients and risk factor individuals. 
 
Fig. 2 shows the first 14 metabolites ranked by their contributions to classification 
accuracy. As can be seen, tetrahexose, MG(22:2), nonanedioic acid, urocanic acid and 
suberic acid presented the highest probability to appear in a panel to discriminate lung 
cancer patients and control individuals, while the only two compounds excluded from the 
classification were two dipeptides, GluVal and GluLeu that reported, together with the 
trihexose and citrulline, mean accuracy values below zero. Taking into account the 
significance of the metabolites, a Kruskal-Wallis test was applied to the fourteen 
compounds detected in each batch and in both batches together. As can be seen in Table 2, 
among the seven significant metabolites found in the first batch (Calderón-Santiago et al., 
2015), only one is significant in the second batch, but when the two batches are taken 
together, only one metabolite is excluded from the list of significant metabolites (the 
trihexose). Therefore, the inclusion of the second batch did not alter the changes in 
metabolite composition between lung cancer and risk factor individuals. Supplementary 
Fig. 2 shows the box-and-whisker plots for the 12 metabolites after exclusion of the two 
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dipeptides with higher classification capability according to Random Forest Analysis. Half 
of the compounds presented higher quantitative response in lung cancer patients than in 
control individuals. This is the case with tetrahexose, urocanic acid, sulfonic lipid, 
trisaccharide phosphate, muconic acid, phenylalanine, tryptophan, citrulline and 
trihexose. The rest of compounds presented higher relative concentration in control 
individuals than in lung cancer patients. 
 
Table 2. Kruskal-Wallis statistical analysis to evaluate the significance of the fourteen metabolites 
selected after the Random Forest test to discriminate between lung cancer patients and risk factor 
individuals. 
Marker 
p-Value 
1st Batch 2nd Batch 1st + 2nd Batches 
Urocanic acid 0.0018** 0.3436 0.0023** 
Tetrahexose 0.0020** 0.0597 0.0003** 
Trisaccharide phosphate 0.0033** 0.5060 0.0080** 
Nonanedioic acid 0.0111* 0.0292* 0.0005** 
MG(22:2) 0.0150* 0.4410 0.0152* 
Suberic acid 0.0200* 0.0962 0.0025** 
Trihexose 0.0343* 0.4410 0.2376 
Histidine 0.1613 0.3259 0.0531 
Phenylalanine 0.1715 0.0074** 0.3290 
Taurine 0.1823 0.7267 0.4839 
Citrulline 0.2858 0.5288 0.1770 
Sulfonic lipid 0.3011 0.0548 0.0249* 
Tryptophan 0.6353 0.8614 0.8436 
Muconic acid 0.7811 0.1584 0.2523 
* p-Value between 0.01 and 0.05; ** p-Value < 0.01. 
 
3.3. Development of panels with prediction capability for lung cancer 
The development of panels for discrimination between lung cancer patients and 
risk factor individuals was addressed by using PanelomiX as computational toolbox. This 
tool iteratively combines significant variables and thresholds to find panels of potential 
biomarkers with good prediction/discrimination parameters in terms of sensitivity and 
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specificity. As mentioned above, the most important aspect in a prediction model for lung 
cancer is to reduce the probability of false negatives, while the probability of false positives 
is not so critical as the disease could be confirmed by other tests. Nevertheless, the 
development of discrimination models targeted at reducing false positives would also be 
useful as screening strategy to minimize the number of patients subjected to invasive 
confirmatory tests. In this research, the configuration of panels was supported on two 
statistical criteria: at least 95% sensitivity or specificity, which resulted in two panels of 
biomarkers. The panel with at least 95% specificity should allow decreasing considerably 
false negative rate. On the other hand, a biomarker panel with at least 95% sensitivity 
should allow a significant decrease of false positive rate. PanelomiX was applied to the two 
whole cohorts together (which were previously auto scaled separately, then joined and 
normalized) to define panels of five biomarkers with the best classification parameters. 
Metabolites listed in Supplementary Table 1, from both positive and negative ionization 
modes, were considered as the set of variables, excluding GluVal, GluLeu, trihexose and 
citrulline, the four compounds with less probability of taking part in a prediction panel 
according to Random Forest Analysis. Cross-validation was included in the development 
of panels for internal validation, which reported information on the model stability. The 
classification capability of the panels was assessed by threshold sensitivity and specificity 
and the value of the partial area under the curve (pAUC), calculated taking the range of 
specificity or sensitivity from 95 to 100%. Furthermore, a cross-validation including the 
scaling procedure was also applied to the optimum panels to assure the correctness of data 
pretreatment. The best panel providing specificity above 95% was obtained by combination 
of five metabolites: the monoglyceride MG(22:2), suberic, muconic and urocanic acids, and 
a tetrahexose. The parameters that characterized this panel were 96.9% specificity, 83.8% 
sensitivity and the pAUC was 1.6%. This panel would allow diagnosing individuals with 
lung cancer with a low false positive rate. Fig. 3A shows the receiver operating characteristic 
(ROC) curve obtained from this panel that included four metabolites present in the top-5 
compounds ranked by Random Forest Analysis and that for nonanedioic acid, which was 
the marker with the highest predictive capability in terms of specificity. The parameters 
provided by nonanedioic acid were 93.8% of specificity, 45.9% of sensitivity and a pAUC of 
1.7%. The specificity of this marker was similar to that provided by the panel, but the 
sensitivity and pAUC are improved when considering a group of compounds.  
 
 Chapter XI 
 
Page | 575  
 
Fig. 3. ROC curves obtained from the panel with at least 95% specificity (black) and that of 
nonanedioic acid (grey) as the best individual marker in terms of specificity (A) and ROC curves from 
the panel with at least 95% sensitivity (black) and that of MG(22:2) (grey) as the best predictive 
marker in terms of sensitivity (B). 
 
Curiously, although nonanedioic acid showed the third best accuracy response in 
the Random Forest ranking, and was the metabolite providing the best specificity, it was 
not included in the panel. This panel reported a positive response when any 4 of the 5 
markers (suberic acid, muconic acid, tetrahexose, urocanic acid and MG(22:2)) fulfilled the 
conditions imposed in the panel. As an example, the quantitative response of suberic acid 
for a positive response (lung cancer detection) should be below 34.7% of the total variability 
scale defined by the highest and the lowest quantitative responses for this metabolite in the 
two cohorts. By analogy, the MG(22:2) must be below 78.8% of the total variability scale, 
while the levels of urocanic acid, muconic acid and tetrahexose should be above 53.0, 38.2 
and 19.3%, respectively (Table 3). 
Fig. 4A shows the box-and-whisker plots of the five metabolites that constitute the 
panel with at least 95% specificity with a distribution of quantitative responses detected for 
all individuals. The dashed lines pinpoint the quantitative response imposed by the panel 
for a positive response. As can be seen, the threshold stablished for MG(22:2) allowed 
classifying correctly 100% of controls.  
 
A B
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Table 3. Panels of biomarkers with at least 95% of either specificity or sensitivity. 
Panel 1 (>95% specificity) 
 
Panel 2 (>95% sensitivity) 
Urocanic acid > 53.00% Urocanic acid > 50.31% 
Muconic acid > 38.23% Muconic acid > 43.59% 
Suberic acid < 34.71% Nonanedioic acid < 45.53% 
MG (22:2) < 78.79% MG (22:2) < 78.79% 
Tetrahexose > 19.31% Tetrahexose > 91.55% 
Both panels provide a positive response when 3 of the 5 biomarkers of each panel give a quantitative response 
below or above the corresponding threshold. 
 
 
Fig. 4. The box-and-whisker plots of the five metabolites that constitute the panel with at least 95% 
specificity (A), and with at least 95% specificity (B) with distribution of quantitative responses for all 
individuals. The y axis represents the normalized concentration of the metabolites expressed at 
percentage according to the samples with the highest and the lowest quantitative response. The 
dashed lines pinpoint the quantitative response of each marker to provide a positive response. 
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Similar specificity was obtained for urocanic acid and tetrahexose, 94.6%, followed 
by muconic acid that classified correctly 75.7% of controls. On the other hand, suberic acid 
gave the best performance for lung cancer patients, classifying correctly 96.8% of them. It 
is worth mentioning that this panel included three of the compounds contained in that 
obtained by Calderon-Santiago et al. using only the first batch. The prediction parameters, 
sensitivity and specificity, were clearly higher than those reported in the first study. Thus, 
the first panel provided 80 and 79% for specificity and sensitivity, respectively; while the 
new panel proposed here increased especially the specificity that reached 96.9%. The 
inclusion of the second batch improved significantly the capability of the panel to identify 
individuals without the disease and, therefore, they would be excluded from the application 
of a confirmatory test. 
On the other hand, the best panel providing sensitivity above 95% was obtained 
only by replacement of one of the metabolites included in the previous panel, suberic acid 
by nonanedioic acid. It is worth emphasizing that suberic acid was included in the panel of 
three markers obtained by Calderon-Santiago et al. maximizing specificity, while 
nonanedioic was obtained in that targeted at maximizing sensitivity. Fig. 3B shows the ROC 
curve obtained for this second panel together with that obtained for MG(22:2), which 
provided the highest individual prediction capability in terms of sensitivity. The parameters 
obtained for this panel were 81.2% specificity, 97.3% sensitivity, and a pAUC of 1.6%. In 
this case also four of the markers included in the panel were part of the top-five metabolites 
in the Random Forest ranking. MG(22:2) presented 31.2% specificity, 100.0% sensitivity, 
and a pAUC of 1.6%, being the second best accuracy value in the Random Forest ranking. 
This panel contained also three of the metabolites included in the panel obtained in the 
study published in 2015. With the inclusion of the second batch, the new proposed panel 
allowed increasing the sensitivity up to 97.3%, which means that the number of cases 
affected by the pathology would be identified with a high detection rate. 
This panel was positive when any 3 of the 5 biomarkers (urocanic, nonanedioic and 
muconic acids, tetrahexose and MG(22:2)) gave a positive response. For this purpose, the 
quantitative response of MG(22:2) and nonanedioic acid must be lower than 78.8 and 
45.5% of the total variability scale defined by the highest and the lowest quantitative 
responses observed for this metabolite in the two cohorts, respectively. Similarly, the 
quantitative responses of muconic and urocanic acids, and tetrahexose must be higher than 
43.6, 50.3, 91.5%, respectively (Table 3). Fig. 4B shows the box-and-whisker plots of the 
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five metabolites that constitute the panel with at least 95% sensitivity and the cut-off values 
imposed by the panel. As can be seen, tetrahexose classified correctly 100% of lung cancer 
patients, followed by nonanedioic acid with 75% of good performance for lung cancer 
patients. On the other hand, MG(22:2) classified properly 100% of risk factor individuals, 
followed by urocanic acid with 97.3% specificity and nonanedioic and muconic acids, both 
classifying correctly around 62% of controls.  
As stated above, a cross-validation process including the scaling procedure was 
executed for both optimized panels as described above. For the panel optimizing specificity 
(composed by tetrahexose, MG(22:2) and suberic, muconic and urocanic acids), the new 
panels generated with only 90% of the samples gave from 81.8 to 96.9% sensitivity and 
from 82.8 to 96.9% specificity. Furthermore, the 10% of the samples excluded gave 62.3% 
sensitivity and 70.8% specificity. Similarly, for the panel optimizing sensitivity (including 
MG(22:2), tetrahexose and muconic, urocanic and nonanedioic acids), a sensitivity from 
96.9 to 100% and a specificity from 72.4 to 79.3% were obtained for the 10 panels generated 
with only 90% of the samples. Then, a sensitivity and specificity of 86 and 51% was obtained 
when testing the panels in the samples excluded in the panel generation process. 
 
3.4. Biological interpretation of significant metabolites included in the panels 
Regarding the markers included in the panels, it is worth emphasizing the presence 
of short chain dicarboxylic acids such as muconic, suberic or nonanedioic acids. The last is 
a peroxidative lipid breakdown product, the levels of which appeared in a recent work to be 
lowered in blood samples from lung cancer patients as compared to smokers (Miyamoto et 
al., 2015). In sweat, nonanedioic acid was found in lung cancer patients at lower 
concentration than in risk factor individuals. Nonanedioic acid is supposed to be linked to 
signaling functions or a reflection of a lowered use of oxidative pathways of lipid 
metabolism in tumors (Miyamoto et al., 2015). The levels of suberic acid and nonanedioic 
acid in urine have been previously proposed as potential markers to discriminate patients 
with cervical cancer (malignant tumor) and patients with uterine myoma (benign tumor) 
(Kim et al., 1998). Suberic acid was found at lower concentration in cervical cancer patients 
whereas nonanedioic acid was found at higher concentration in cervical cancer patients 
(Kim et al., 1998). On the other hand, the level of muconic acid has been previously related 
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to the exposure to benzene (Zhang et al., 2011) —for example, in smokers (Wiwanitkit et 
al., 2005)— a factor already linked to cancer development (Snyder, 2012). 
Other metabolite included in the panels was urocanic acid, a degradation product 
from histidine. The levels of several amino acids in plasma, including histidine, together 
with the levels of other compounds such as lipoproteins, glucose, lactate, pyruvate, citrate, 
formate, acetate, and methanol have also been previously proposed for discrimination lung 
cancer patients and healthy subjects (Rocha et al., 2011). Additionally, some amino acids 
in urine have been identified as potential biomarkers for lung cancer, which revealed active 
amino acid and nucleoside metabolism as well as protein degradation in lung cancer 
patients (An et al., 2010). Urocanic acid, the product of histidine degradation, is a UV filter 
found in human skin that protects this from UV damage, but has also been linked to the 
onset of skin cancer and to photoimmunosuppresion (Tuna et al., 2014). Some studies 
suggested that urocanic acid can modulate the production of immunosuppressive 
molecules from keratinocytes, nerves and mast cells (Hart et al., 2002; Kaneko et al., 2008; 
Khalil et al., 2001). 
Urocanic acid had been previously used to build a panel, together with other nine 
compounds (proline betaine, pyridylacetic acid, 1-methylguanine, uric acid, methyl-
xanthine, tryptophan, theophylline, and carnitine C8:1) for detection of uterine cervix 
cancer using urine as sample. The panel provided an AUC of 0.997, with a sensitivity of 
92.9% and a specificity of 95.6% (Chen et al., 2013). 
Other component of the panels was the monoglyceride (MG) of an omega-6 fatty 
acid —docosadienoic acid—, which is involved in a critical biochemical pathway as is the 
metabolism of essential fatty acids (Simonsen et al., 1998; Simopoulos, 2002; Simopoulos, 
2008). The levels of some MGs have been demonstrated to be altered in tumor tissues 
(Yang et al., 2015). Finally, another metabolite involved in the panels was a carbohydrate, 
particularly a tetrahexose. The presence of these compounds is related to amylases, 
enzymes present in most human biofluids, including sweat, and whose composition and 
action has shown to be altered in tumor tissues (Takeuchi et al., 1981). 
As stated above, this research employed a first cohort that was already used to find 
a tentative panel of markers for lung cancer diagnosis. When this panel was compared with 
panels obtained using two cohorts in the present research, the panel that maximizes 
specificity and sensitivity differs in two metabolites with the panel obtained with only one 
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batch. The two panels obtained in the present research contains 4 compounds in common: 
MG(22:2), tetrahexose and urocanic and muconic acids, from which the two first 
compounds were present in the previous research. It is worth emphasizing that these two 
compounds are the two best compounds according to their accuracy in the Random Forest 
test. Nonanedioic and suberic acids, compounds exclusive for the panels maximizing 
sensitivity and specificity, respectively, were also present in the panel obtained only with 
the first batch. The novel presence of urocanic and muconic acids, as well as the exclusion 
of trihexose, can be attributed to the inclusion of the new cohort, which not only included 
samples analyzed at different times, but also implies slightly different percentage of 
histological types and stages.  
These preliminary results emphasize the necessity of a large-scale study to validate 
the proposed panels and obtain great robustness. The use of these panels would tentatively 
reduce the proportion of individuals to be subjected to confirmatory tests and to detect lung 
cancer in less advanced stages. However, the efficiency of the panels should be 
demonstrated with the inclusion of new batches. 
 
4. Conclusions 
A strategy to remove instrumental variability between batches has been proposed 
and satisfactorily applied to the two cohorts employed in the present research. The use of 
batches of samples collected and analyzed with a shift time of two years and by different 
analysts would allow to obtain a prediction model more robust than that obtained using the 
first batch. Two panels of metabolites including amino acids, short chain dicarboxylic acids, 
sugars and some lipids have been built to discriminate patients with lung cancer from a 
control group with risk factor. The best panel providing specificity above 95% was formed 
by five metabolites, the monoglyceride MG(22:2), muconic, urocanic and suberic acids, and 
a tetrahexose. This panel provided 96.9% specificity and 83.8% sensitivity. On the other 
hand, the best panel providing sensitivity above 95% was formed by four of the metabolites 
included in the previous panel, so only suberic acid was replaced by nonanedioic acid. This 
panel provided 81.2% specificity and 97.3% sensitivity. 
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Supplementary material 
 
Supplementary Table 1. Metabolites found in sweat at significantly different concentrations 
between the groups under study including the retention time and m/z values for precursor and 
product ions as well as the error in precursor ion detection expressed as ppm. 
Negative ionization mode 
 
Compound 
name 
HMDB ID 
RT 
(min) 
Precursor ion 
(m/z) 
Δppm 
Product ions 
(m/z) 
1 Citrulline HMDB00904 0.8 174.0883 0.6 
131.0818 
44.9974 
72.0078 
2 
Trisaccharide 
phosphate 
 1.0 601.1371 1.7 
547.0835 
96.9696 
161.0440 
259.0221 
3 Phenylalanine HMDB00159 4.1 164.0718 0 
147.0445 
103.0549 
91.0549 
72.0094 
4 Nonanedioic acid HMDB00784 7.1 187.0969 3.7 
125.0962 
187.0954 
97.0645 
57.0335 
5 Sulfonic lipid  8.4 577.1470 1.6 
170.0046 
391.1109 
497.1911 
6 Trihexose  0.8 549.1672 0 
503.1598 
341.1085 
179.0553 
89.0241 
7 Histidine HMDB00177 0.8 154.0619 2 
137.0358 
93.0457 
80.0385 
67.0307 
8 Taurine HMDB00251 0.8 124.0073 0.8 79.9567 
9 Urocanic acid HMDB00301 1.4 137.0357 0 
93.0445 
66.0349 
65.0206 
50.0050 
10 Muconic acid HMDB06331 7.7 123.0089 5 
53.0033 
95.0139 
68.9982 
11 Suberic acid HMDB00893 6.6 173.0824 2.9 
111.0809 
83.0503 
57.0349 
12 MG(22:2) HMDB11581 8.9 431.3127 3.6 89.0247 
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Positive ionization mode 
 
Compound 
name 
HMDB ID 
RT 
(min) 
Precursor ion 
(m/z) 
Δppm 
Product ions 
(m/z) 
1 Tryptophan HMDB00929 4.7 205.0971 0.5 
188.0699 
146.0593 
118.0647 
2 Tetrahexose  0.8 689.2113 0.3 
145.0488 
127.0385 
85.0283 
487.1640 
3 GluVal HMDB59717 4.6 229.118 3.9 
183.1104 
118.0852 
72.0809 
102.0550 
4 γ-GluLeu HMDB29153 4.6 261.1439 2 
244.1169 
132.1014 
86.0968 
84.0443 
 
 
 
 
Supplementary Fig. 1. Mean relative standard deviation (RSD) obtained for each metabolite 
considering the replicates analyzed per sample by analyst 1 and 2. 
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Supplementary Fig. 2. The box-and-whisker plots of the metabolites with accuracy 
above 0 for the comparison between lung cancer patients and risk factor individuals. The bottom and 
top of the boxes represent the 25th and 75th percentile, respectively. The top and bottom bars 
represent the entire stretch of the data points for the subjects, except the extreme points, which are 
indicated with circles (o). The hyphen indicates the median value. The y axis represents the 
normalized relative concentration of the metabolites.  
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The present rules in the University of Córdoba concerning the model of Thesis-
Book in the format in which the articles as such (either published or close to be published) 
are included in the book, make mandatory to include a joint discussion of the obtained 
results. 
The research in this Thesis-Book, based on sample preparation and on platforms 
development for both plant and animal metabolomics analysis, including US as auxiliary 
energy to favor analytical steps, has been divided into four sections as a function of the 
pursued objectives. Thus, Section A, constituted by Chapters I-to-III, contains critical 
reviews and discussion on the state-of-art of the US as auxiliary energy on sample 
preparation steps, with special emphasis on: (i) US devices, (ii) USAE of food/plant 
components, (iii) US-assisted steps in metabolomics, and (iv) behavior of enzymes when 
subjected to US application. Also, a large discussion on the effect of US on enzyme-
catalyzed reactions when metabolites act as substrates is a part of this section. 
The experimental research that constitutes Sections B deals with the appropriate 
sample preparation and design of the analytical platform to favor by US the enzymatic 
hydrolysis of oleuropein in olive (Olea europaea L.) leaf extracts to oleuropein aglycon, a 
compound that may have a pharmacological use (Chapter IV); and to elucidate the 
metabolome by untargeted analysis of extracts of two different plants with clinical 
applications: edible mushroom Agaricus bisporus (A. bisporus) aqueous enzymatic 
extracts with antiviral activity against HCV (Chapter V), and Cannabis sativa L. extracts 
(Chapter VI). 
The experimental research that constitutes Sections C and D deals with the 
appropriate sample preparation and design of the analytical platforms to elucidate the 
metabolome of human sweat by GC–MS (Chapter X), after comparing different sampling 
strategies (Chapters VIII and IX). It also deals with the appropriate sample preparation and 
design of the analytical platform to obtain robust panels of metabolites for screening of 
lung cancer using human sweat as sample (Chapter XI) and to quantify in this biofluid 
amino acids, biomarkers of lung cancer (Chapter VII), both by LC–MS/MS. 
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Section A. Bibliographical studies 
To start with, and during the development of this PhD Thesis, bibliographical 
studies were a continuous and key task to focus the research on the current needs in the 
given area. Thus, the growing application of USAE to plant/food components, the use of 
US to improve sample preparation steps in metabolomics and the effect of this auxiliary 
energy on enzymes and their biocatalytic action have been critically revised and discussed. 
 
Chapter I of this Thesis-Book is devoted to critical review of the increased 
application of USAE to foodstuffs. A general overview on the US basics and its features that 
assist in extraction, the extractants and US devices used are covered. As described in this 
chapter, the low-frequency region of US is endowed with appropriate energy to produce 
cavitation, highly dependent on frequency and of great interest for most of the sample 
preparation steps. US favors mass transfer between two phases in the same or different 
physical state, accelerating and/or improving physical phenomena and chemical reactions 
[1]. In dealing with plant tissues, US application implicates cell membrane destruction, 
causing morphological changes of the plant structure, and possibly with drastic change of 
its properties. Regarding extractants, their features influence considerably USAE 
efficiency, which is also highly dependent on the nature of both the matrix and analyte. Two 
main types of US equipment, ultrasonic cleaning baths and probes, have been considered 
in this chapter. The disadvantages of baths as compared with US probes (e.g., no uniform 
ultrasonication with reproducibility problems or declination of the transferred power into 
the tank over time), the versatility of power and duty cycle programming as required, which 
with probes are endowed, make these better suited to facilitate analytical steps in 
laboratories than US cleaning baths. 
Characteristic examples of USAE methods used for food components extraction 
(e.g., antioxidants, volatiles, multielements, undesirable compounds) are critically debated 
in this chapter. As commented in it, US accelerates extraction, improves extraction yield, 
and facilitates automation; favorable aspects that have been exploited to extract families of 
compounds with specified characteristics from a raw material, to be used as nutraceuticals. 
One common aspect of most of the USAE methods in the literature is monitoring of the 
extraction process exclusively by global parameters of the extract such as antioxidant 
activity, total phenols content, etc. [2]; while degradation of the extract components under 
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US application is only detected by a decrease of the measured absorbance by a photometer. 
What is emphasized in Chapter I on this subject is the necessity of identification of the 
extract components, particularly when the extracts are devoted to the food industry, where 
the nature of the degradation products should be well known. Other aspect critically 
discussed refers to volatiles extraction, which can be favored by US: it is known that this 
energy helps to remove a gas from a liquid, as used to obtain mobile chromatographic 
phases free from air. Nevertheless, when the gas phase is the target, especial care must be 
adopted, which was not the case in the extraction of volatiles from saffron, developed in an 
open atmosphere without protection for losses of both the target compounds, which are 
transfer to a liquid, and the volatile medium (an ethanol–ethylacetate mixture) [3]. Metal 
ions have been extracted from food by US assistance prior to determination by the proper 
atomic detector [4,5]. Also fast and efficient extractions of undesirable compounds from 
foods have been helped by US [4]. 
Methods based on the use of both ionic liquids (ILs) and USAE have been applied 
by taken advantage of a typical US property of favoring emulsification simultaneously with 
extraction ─both involving not only solids but also liquid samples─; and also development 
of USAE with either simultaneous derivatization or enzymatic catalysis are discussed in 
Chapter I. An example on the use of ILs is the USAE of four biphenyl cyclooctene lignans 
from the fruit of Schisandra chinensis Baill. After optimization of US power, time for US 
treatment, and solid–liquid ratio by response surface methodology, the extracts were 
compared with those obtained by conventional extraction, resulting in an efficiency 
increase of about 350%, and a shortening of the process time from 6 h to 30 min [6]. 
Lignans concentration was monitored by an HPLC–UV-detector at 220 nm. 
US-assisted emulsification–extraction (USAEE) has been used with two main types 
of samples: (i) With solid samples and using two immiscible polar/no polar extractants for 
simultaneous removal of both polar and no polar sample components, as the formation of 
an emulsion allows a rapid mass transfer of the compounds extractable to one or the other 
liquid phase under US application. (ii) With liquid samples for liquid–liquid 
microextraction, for which a large volume of usually aqueous sample is put into contact 
with a very small volume of organic extractant that is emulsified with the sample under US 
application.  
A very drastic reduction in time required for a reaction assisted by US energy is the 
result of a study on oil stability reported by the UCO research team that deserves be 
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discussed. The use of a probe and the appropriate optimization of the US variables allowed 
Rancimat times of 129 h to be shortened to 50 min; therefore, the overall time required for 
the determination of oil stability is shorter than 1 h [7]. On the other hand, the debatable 
effect of US on the enzymatic activity requires in depth studies involving the US frequency 
and the biocatalyst structure, as shown in the review by Delgado-Povedano and Luque de 
Castro [8] that promoted the study on the enzymatic hydrolysis of oleuropein to its aglycon 
form assisted by US, which is the matter of Chapter IV of this Thesis-Book. 
The advantages and disadvantages of USAE methods have also been compared in 
this chapter with those of other conventional or unconventional extraction methods as the 
case of Soxhlet extraction (SE) and USAE to remove vanillin from cured vanilla pods that 
allowed to short the extraction time from 8 to 1 h [9]. USAE also proved to be better than 
percolation and Soxhlet methods in terms of efficiency to extract 26 characteristic 
components in ginkgo seeds [10]. Also, the combined effect of sequential application of US 
and MW (US–MAE) on the yield and degree of esterification of pectin from pomelo peel 
using citric acid [11] has been checked and the order of yield efficiency was US–MAE > 
MW–USAE > MAE > USAE. The pectin galacturonic acid obtained by combined extraction 
techniques exhibited a pseudoplastic behavior, and the yield was always higher than that 
provided by a single technique. 
The exploitation of USAE at industrial and pilot scale is also considered, but 
pointing out that the use of US in the food industry is not exclusive of extraction, as 
filtration, defoaming, depolymerization, degassing/deaeration, cooking, cutting, 
demolding and extrusion, freezing and crystallization, drying, defrosting/thawing, brining, 
pickling and marinating, meat tenderization, separation (emulsion breaking), and 
emulsification/homogenization have also been favored by this type of energy. When 
considering US for extraction purposes, an exhaustive development at the laboratory scale 
is mandatory, particularly for identification of the extract components, with an especial 
emphasis on the potential degradation products caused or favored by US energy. Also 
residues or waste valorization has been a remarkable application of USAE over the last 
decade [12,13].  
The in-depth study of the literature on USAE allowed concluding with the following 
foreseeable and desirable future trends: (i) to develop USAE methods with exhaustive 
identification of the extract components to detect any potential degradation; (ii) to pay 
attention to US frequency, because to test different frequencies of US devices can be very 
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useful to avoid degradation and/or obtain the pursued results; (iii) to carry out additional 
research, including upscale studies, to facilitate the adoption of US in the bioactive 
compounds industries —thus enhancing processing efficiency and capability after in-depth 
study of extractants, thermolability, and fragility against US action, particularly against free 
radicals formed in polar media; (iv) to apply multivariate optimization designs to reduce 
the number of experiments, but also use univariate optimization of some parameters, of 
paramount importance to assess the effect that changing process variables has on the target 
components; (v) to get a more in-depth knowledge of USAE at the laboratory scale to 
potentiate the interest in upscaling methods, thus taking advantage of their positive aspects 
at industrial scale. 
 
Metabolomics has also taken advantage of US to improve sample preparation (SP) 
steps, as shows Chapter II. The operations to be developed prior to introduction of the 
analytical sample either into high-resolution separation equipment or into the detector in 
metabolomics are very varied, and most of them can be accelerated/improved by US [1].  
As shown in the literature on the subject, US has been mainly used in targeted 
metabolomics analysis (e.g., determination of estrogens in human urine [14]), but US has 
begun to be used in other strategies, as global metabolomics profiling (e.g., metabolomic 
profiling of human saliva [15]), which highlight US subexploited utility. 
The research on the US–metabolomics binomial reported in this chapter reveals its 
dissimilar development depending on the area (plant or animal) and the sample 
preparation step. Plant metabolomics and US assisted leaching (USAL) has received the 
greatest attention (encompassing subdisciplines such as metallomics, xenometabolomics 
and, mainly, lipidomics), but also liquid–liquid extraction (LLE) and (bio)chemical 
reactions in metabolomics have taken advantage of US energy. Among plant metabolites, 
lipids and other bioactive compounds such as antioxidants have received the highest 
attention, but also leaching prior to the determination of metals in plants has been 
performed [16]. Regarding lipids, US has been widely used to improve leaching of a wide 
number of metabolites as triglycerides and fatty acids, thus constituting a key tool for 
sample preparation steps in lipidomics [17,18]. Although most samples subjected to USAL 
have been seeds [19], also flowers and other plant parts have been the target of this step. 
USAL has also been compared with other conventional techniques as SE [19] or 
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supercritical fluid extraction, and in all instances USAL was found to shorten the leaching 
time for the same or similar target metabolites [19,20]. The number of applications of US 
to favor leaching of metabolites different from lipids in dealing with plants drastically 
surpass other types of matrices, and, among metabolites, phenols and antioxidants in 
general have been the most frequent targets. The final use of the leachates establishes both 
the optimum features of the method and the analyses to be carried out. One of the most 
used global methods for determination of the total phenolic content is based on the Folin–
Ciocalteu reagent, which has been applied to USAL leachates from different plants as apple 
pomace, arecanut, black chokeberry, olive leaves or grapes. In the last case, other general 
methods such as those for total amount of anthocyanins and total amount of tannic 
components have also been applied to the leachate. In all overall studies, higher values of 
the given parameter were obtained when the leaching step was assisted by US as compared 
with traditional leaching methods. This behavior was attributed to a higher efficiency of the 
USAL step without checking possible degradation in the presence of power US that could 
yield products with higher values of the parameter under study. Research on this subject 
should involve, (i) appropriate analytical instrumentation to identify the compounds in the 
leachate thus detecting potential degradation; (ii) use of higher US frequencies to avoid 
degradation, if undesirable. 
When the aim of the research was targeted metabolomics [21,22], drastic reduction 
of the leaching time was highlighted in all instances, thus opening a door to potential 
implementation at an industrial scale. 
When a single leached metabolite is the aim of the research, a first study should 
involve the behavior of the target compound when subjected to US action under the 
possible working conditions. This was the case with the use of several US frequencies (20, 
60 and 100 kHz) and four US powers (3.2, 8, 30, 56 W) to study their potential degradation 
effects on a hesperidin standard prior to be leached from Citrus reticulata Penggan peel 
[23]. 
Ionic liquids as leachants for USAL have been scarcely reported, but they seemed 
to be very promising for removal of three terpenoids indole alkaloids from Catharanthus 
roseus [24], using (1-allyl-3-methylimidazolium) Br. 
Sample preparation in plant xenometabolomics has also taken profit from US, as 
is the case of USAL of herbicides from resistant and susceptible plants for subsequent study 
of the metabolic pathways in each case [25,26]. 
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Clinical and animal samples have also benefited from US-assisted sample 
preparation in metabolomics studies but in a lesser extension, despite that examples as the 
following show the advantages of application of this type of auxiliary energy, and should 
promote its use. A US device (40 kHz and 125 W) has been used to accelerate leaching of 
bufadienolides such as bufalin, cinobufagin and resibufogenin from toad venom samples 
prior to individual separation–determination by HPLC–DAD. A yield similar to that 
provided by USAL in 20 min required 6 h by SE, and 18 h by maceration [27]. 
Despite US application favors mass transfer between immiscible phases drastically 
shortening the extraction time, and enhancing sensitivity as a result of the favorable effect 
of sample–extractant volumes ratio, few applications involving US, LLE and metabolomics 
appear in the literature. Maybe this situation is due to the fact that, despite the use of US 
accelerates the LLE step, it does not avoid the need for previous steps mandatory to remove 
proteins and other high-molecular weight components of biofluids [28]. 
Regarding US and (bio)chemical reactions in clinical metabolomics, US has been 
used to enhance hydrolysis of metabolites as sialic acids, and enzymatic hydrolysis (using 
mainly β-glucuronidase), with drastic acceleration of this slow step [15]; nevertheless, few 
applications of US in this field have been reported [29]. 
The main effects of US on metabolomics clinical sample preparation have been 
shortening of the time required for the given step, and/or increase of its efficiency or 
availability for automation; nevertheless, as in other areas, the attention paid to potential 
degradation caused and other effects caused by US has been scant or nil. Therefore, the 
undesirable action of US energy in dealing with clinical samples should be widely studied 
with three main aims: (i) to know the nature of the degradation products, and thus the 
pathways through which degradation occurs; (ii) to prove the influence of the free radicals 
formed by influence of cavitation; (iii) to study the effect of US frequency on the 
degradation processes by the decrease of cavitation taking place by gradual change of this 
variable from power to high frequencies.  
In short, while US has been widely used to improve steps of a wide number of plant 
origin samples, this energy has been scarcely applied to enhance steps of target metabolites 
from animal or human samples, possibly owing to the fact that clinical personnel are 
unfamiliar with US. Also, US has been used more in clinical targeted than in untargeted 
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analysis. USAL at different US frequencies could provide greater selectivity for metabolites 
families; thus being in the clinical field of similar interest as in the plant field. 
 
The last chapter of this section (Chapter III) was a critical review on the effect of 
US on enzymes and their biocatalytic action. This review is mainly aimed at showing: (i) 
the different areas in which the US–enzyme binomial has been applied; (ii) the lack of 
enough information provided on the US–enzyme-working conditions under which each 
piece of research has been developed; and (iii) the necessity for providing complete 
information on the data and metadata to give enough light on each piece of research and 
thus, on the potential comparison of results from different studies. Advances in this field 
are closely related to the possibility of comparing the results obtained by different authors 
under different/similar but well-known working conditions. 
The controversial results found in it can be attributed mainly to the different US 
frequencies, intensities and conditions applied (no specified in the publications), and/or to 
the different types of enzymes on which US energy is applied and even to the different 
working conditions. In fact, the no reproducible performance of US cleaning baths and the 
decline of power with the working time are not taken into account by the authors, who do 
not consider these aspects affect the results [30]. It is worth emphasizing the growing 
number of analytical chemists who use US probes or reactors designed for specific uses. 
Most of the studies involving enzyme–US can be divided into six groups, in a 
growing order attending to the information provided on the characteristics of the US device 
used: (i) without information; (ii) with information on the model of the device; (iii) with 
information only about US power and/or intensity applied; (iv) with information about 
frequency; (v) with enough information about the characteristics of commercial 
conventional US devices; and (vi) with information about no conventional US devices. The 
needed information is frequency and either, power or intensity for probes or baths. 
Additional information on the surface area of the US transducer (usually fitted at the 
bottom) is sometimes given in dealing with US baths. In some research using both a bath 
and probe, information on frequency and power of the bath is given, but only the model in 
the case of the probe [31]. 
Regarding the behavior of enzymes when subjected to US application, it is a proved 
fact that enzyme performance is greatly affected by the nature of the reaction medium [32]. 
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This effect is enhanced in the presence of US, but it has not been studied and/or discussed 
in detail by researchers. Special mention deserves the use of ionic liquids (ILs) in the 
reaction medium because their characteristics dramatically influence the US–enzyme 
behavior most times. 
Most enzymes involved in the biocatalyst–US binomial have been hydrolytic 
enzymes (particularly lipases, amylases or proteases), either immobilized or in solution. It 
is worth emphasizing that comparison of research developed with different US equipment 
acting on enzymes has not been conclusive so far (especially when US is applied on different 
enzyme–substrate systems and in different media); nevertheless, a common behavior is 
inactivation of the enzyme in some proportion; an effect that increases by increasing power 
or intensity, but can be differently affected by US frequency. 
The type of reaction more widely assisted by the US–enzyme binomial in dealing 
with metabolites is hydrolysis. As compared with conventional methods for oil hydrolysis, 
enzymatic hydrolysis can be performed under relatively milder and simpler process 
conditions, and enhanced by US energy [33]. 
From the point of view of the reaction components, division as a function of the 
substrates involved instead of biocatalysts is more appropriate for a better interpretation 
of the influence of these components on the effects caused by the US–enzyme binomial. 
Most of the slow biocatalyzed reactions that have been intended to be accelerated by US 
energy during more than 20 years have involved lipids, the products from which are applied 
on different fields (e.g., foods, cosmetics, pharmaceuticals, biofuel). The variety of the 
substrates and products in each field is so wide that general guides on the behavior of them 
when subjected to US energy have not been established yet. Esterifications constitute one 
of the most representative groups of enzymatic-assisted reactions the slowness of which 
has promoted the study of US application for acceleration [34]. The effect seems to be 
dependent on US amplitude, the presence of water in the reaction medium and length of 
the chain of the alcohol involved. Studies on acylations and transacylations attributed the 
accelerating effect of US to the increase in temperature this energy causes, which also 
degrades the biocatalyst over a certain value. The increased pressure and active surface of 
the enzyme were also considered influential variables [35]. After more than 20 years, the 
results obtained cannot allow general application of given working conditions. Therefore, 
each piece of research establishes the conditions for working on given systems, for given 
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ranges of the influential variables and for given optimization designs, either uni- or 
multivariate approaches. 
More recent is the contribution of US-assistance to biocatalyzed biodiesel (BD) 
production that foreseeably will be place to abundant and fruitful research. A higher BD 
yield (96%) was obtained after US application to the immobilized Novozyme 435 (using 
Nagchampa oil and methanol as raw materials in the presence of water) different US 
frequency, power and duty cycle; therefore, comparison of the results was impossible [36]. 
Polymers have been subjected to the combined application of US and enzymes 
mainly to facilitate leaching of metabolites, desirable or undesirable compounds, 
fractionation of the polymer into smaller polymers or monomers, etc [37,38]. 
Proteins as substrates of US-assisted enzymatic catalysis was widely covered by 
Bermejo et al. in 2004 in a review on enzymatic digestion and ultrasonication [39]. 
Furthermore, the degradation, inhibition or activation of the biocatalyst under US 
application, also the effect of US on enzymes production and the main fields of application 
of the US–enzyme binomial are covered in the review that constitutes this chapter. An 
example of the potential of the degradation effects of combined US and enzymes to 
minimize contamination of aquatic ecosystems by pharmaceuticals consisted of 
degradation of an antihistaminic drug. Using laccase and US (after optimization of 
parameters such as enzyme loading, temperature, US power and frequency, duty cycle, and 
speed of agitation) a maximum degradation of 91% was achieved in 7 h, while with the 
conventional stirring method the degradation was about 13% in 24 h. The pathway 
proposed for degradation of the target drug was confirmed by MS [40]. 
Inhibition or activation of enzyme catalysis by US can be either a pursued effect or 
an undesirable effect [41]. In short, low-frequency US mainly promotes inhibition of 
enzymatic activity, probably caused by cavitation and shear forces that should be 
investigated by proper analytical tools to provide information on the conformational 
changes produced in the biocatalysts as a function of their structure. Additionally, higher 
US frequencies should be applied to prove their influence that could be very different. 
Moreover, US is a useful tool to assist different steps involved in enzyme 
production. Thus, enzyme production, extraction, purification, and immobilization can be 
improved by US application [42]. 
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In dealing with the fields of application of the US-enzyme binomial, food (to 
improve yields of products of great interest in processed foods), environmental (to 
accelerate sample preparation methods for subsequent determination of toxicants), clinical 
(from enzyme production and purification, through synthesis or extraction of compounds 
of clinical interest, to acceleration of sample preparation in dopping control) and industrial 
(to assist biofuel production, among others)  are the general areas of application. 
The nomenclature related to US and the way to express the variables and 
parameters involved in US energy deserve to be carefully revised. The metadata in this area 
can be of paramount importance when other scientists try to work on the basis established 
by previous research as a way to advance in the knowledge. Also, the role of US frequencies 
on the effect caused by this energy as a function of matrix–analyte–enzyme has been poorly 
considered. The scant studies on this aspect allow evidencing an enormous field of 
possibilities, which should be solidly established. Finally, analytical equipment different 
from photometers and titrimeters is mandatory to know the real effect of US on the given 
target. Despite techniques such CD, SEM, FT-IR are starting to be used, no enough 
information can be obtained, most times, from the provided data. 
As a consequence of the information discused in Chapter III, the research in Chapter 
IV was developed to open a new door to the huge and indefinite potential of the US–enzyme 
binomial. The enzymatic hydrolysis of oleuropein in olive leaf extracts to its aglycon was 
studied by different hydrolases, which exhibited different behavior and a multivariate 
design for studying the different values of US variables (viz., amplitude, duty cycle, cycle 
time). The study of a key US variable (frequency) is a pending goal that requires the design 
of US devices that only differ in this variable and keep constant the others. Attempts to 
achieve these designs have been unsuccessful so far. 
 
Section B. Plant metabolomics 
To contribute to plant metabolomics by opening new key research lines was the 
specific objective of Section B. The hydrolysis of oleuropein to its aglycon in olive leaf 
extracts accelerated by different hydrolases and US action constitutes the matter of Chapter 
IV, which opens the door to the complex enzymes–US world in this section. The 
characterization of edible mushroom A. bisporus aqueous enzymatic extracts with antiviral 
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activity against HCV, and Cannabis sativa L. extracts constitutes the matter of Chapter V 
and VI, respectively. 
Oleuropein and oleuropein aglycon, present in olive tree materials and virgin olive 
oil (VOO), respectively, could be used as nutraceuticals or as components of new functional 
foods [43] thanks to their beneficial pharmacological properties [44,45]. The use of VOO 
as a source of oleuropein and/or oleuropein aglycon for preparation of functional foods is 
not recommended owing to the high price of VOO and relatively low concentration of these 
minor components. But olive leaves, which are generated as residue from olive pruning and 
VOO production (12–30 kg of twigs and leaf residues/tree [46]) are almost an ideal raw 
material to extract these compounds, and also other highly valuable compounds they 
contain [47]; all them scantly exploited so far [48]. 
The content of Chapter IV (on the hydrolysis of oleuropein to its aglycon in olive 
leaf extracts accelerated by different hydrolases and US energy) constitutes an attempt of 
shading some light on the very controversial results found in the literature on this subject 
and discussed in Chapter III [8]. With this purpose, a fast US-assisted enzymatic hydrolysis 
(USAEH) method to obtain oleuropein aglycon from olive (Olea europaea L.) leaf extracts 
with minimum production of more degraded products was developed in this chapter. A 
drastic shortening of the time required for complete hydrolysis was achieved as compared 
with the traditional method based on enzymatic incubation, from 2 h to less than 20 min. 
The enzyme used in both cases was β-glucosidase from Aspergillus niger (A. niger) and the 
optimum US conditions for achieving maximum yield of oleuropein aglycon were 0.5 s/s 
duty cycle, 50% amplitude and 45 s cycle, optimized by a Box-Behnken design, and 10 US 
cycles (in 18.75 min) at 20 kHz. The method developed using oleuropein standard also 
allowed to obtain oleuropein aglycon from commercial and laboratory extracts from olive 
leaves, which may have a pharmacological use because of its healthy properties. A previous 
extraction of oleuropein from olive leaf extracts was carried out by agitation with a 
methanol–water mixture, while hydrolysis was carried out by β-glucosidase from A. niger, 
and monitoring of degradation and quantitation was achieved by LC–MS/MS with multiple 
reaction monitoring. The hydrolysis yield of oleuropein was 90.8% after 10 US cycles, 
which produced 90% of oleuropein aglycon for commercial olive leaves extracts. The 
hydrolysis yield of oleuropein reached 95.7% at 10 US cycles, with formation of 94.9% of 
the aglycon form for laboratory olive leaf extracts. 
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The fast production of oleuropein aglycon thus achieved open a door to the 
exploitation of the interesting pharmacological properties of this compound [49,50], and 
its wide use for cosmetics, functional foods and nutraceuticals [43]. 
 
Other good candidates to be included in healthy diets as components of new 
functional foods or nutraceuticals are edible mushrooms and their extracts or fractions of 
them. Concerning disease prevention, we recently described the “in vitro” inhibition of the 
protease NS3 of hepatitis-C virus (HCV) by aqueous enzymatic extracts of the common 
edible mushroom Agaricus bisporus (A. bisporus) [51]. This fact suggests incorporation of 
these extracts to the diet as components of new functional foods or nutraceuticals for 
hepatitis-C prevention in people under risk of HCV infection. The use of these extracts as 
they are, as a part of new functional foods or as nutraceuticals, requires characterization of 
A. bisporus aqueous enzymatic extracts (AbAEE) as exhaustive as possible, with especial 
emphasis on checking their safety. As far as we know, this characterization had not been 
carried out. For this reason, the research in Chapter V was developed. A liquid 
chromatography–tandem mass spectrometry (LC–QTOF MS/MS) platform was used to 
obtain, for the first time, the data for tentative identification of 55 out of 123 total 
metabolites by combination of MS and MS/MS information on aqueous enzymatic extracts 
of the common edible mushroom A. bisporus, which had shown inhibition of the protease 
NS3 of HCV. The tentative identification of as many AbAEE components as possible was 
performed after an appropriate sample preparation strategy for fractionation based on 
sequential LLE of AbAEE with solvents of different polarity. The LC–QTOF MS/MS was 
used in high-resolution mode to obtain the required analytical information, which provided 
the necessary knowledge for a safe use of the extracts as they are; a very promising fact for 
HCV patients.  
Among the new identified compounds there are amino acids, sugars, carboxylic, 
fatty and cinnamic acids, mono- and disaccharides, phospholipids, and purines as the most 
outstanding, thus demonstrating that fractionation based on sequential LLE followed by 
LC–QTOF MS/MS is a suitable option to obtain a wide, representative snapshot of AbAEE 
composition. 
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Another plant, in this case Cannabis, is the most widely cultivated, produced, 
trafficked and consumed drug worldwide, with approximately 183 million consumers in 
2016 [52]. Since 1990 the crop of hemp has been introduced or reintroduced in several 
countries to obtain fibre and grains [53]. It is being explored increasingly for medicinal 
applications and therapies, particularly one of its main cannabinoids, CBD [54]. In fact, 
Cannabis is used in the treatment of disorders such as migraine, spastic and pain disorders, 
and glaucoma as ocular hypotensive. Moreover, cannabinoids have been useful as 
antiemetic [55]. Countries such as Canada, Germany, Israel, the Netherlands and more 
than 50% of the United States have fully authorized the medical application of herbal 
Cannabis [56]. 
Most analytical studies on characterization of Cannabis plants were targeted at the 
detection of two chemical families: cannabinoids and terpenoids. The analysis of both 
families has been addressed with different analytical platforms [57], mainly by a 
combination of gas chromatographs or liquid chromatographs to mass spectrometers (GC–
MS, LC–MS) [58,59]. Also, GC coupled to a flame ionization detector (GC–FID) has been 
recommended in cases such as the analysis of Cannabis and its products by the United 
Nations [60]. There are scant studies dealing with compounds in Cannabis sativa other 
than cannabinoids and terpenoids [61,62]. 
Considering the interest on the study of Cannabis sativa for the scientific 
community in fields such as the pharmacological, biomedical, and agronomical (to name 
just a few), clearly, more research on Cannabis composition is demanded to assess its 
potential for pharmacological use, but also to implement breeding programs with 
agronomical purposes. In this line, the research in Chapter VI may constitute a key advance 
in identification of components of this controversial plant. A total of 169 compounds 
(cannabinoids, terpenoids, lipids, flavonoids, amino and organic acids, among others) were 
identified in polar and no polar extracts from 17 cultivars of Cannabis sativa L. using the 
data obtained by gas chromatography–time-of-flight/mass spectrometry (GC–TOF/MS) 
and LC–QTOF MS/MS platforms. A number of commercial standards of cannabinoids, and 
terpenoids allowed confirming their identification. Relative contents of secondary 
metabolites (terpenoids and cannabinoids) in the same cultivars grown in greenhouse and 
in field were compared, and the found compositional differences between both types of 
grown conditions open a door for a more rational cultivation of this plant as a function of 
its use. 
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The results of these studies revealed the suitability of both LC–QTOF MS/MS and 
GC–MS for characterization of polar/low-polar compounds from plant samples and 
provided the clues for identification of their metabolites. 
 
Sections C and D share as common denominator a relatively new clinical sample: 
sweat. For this reason, both sections have been discussed together. First, key contributions 
of the sweat–clinical metabolomics binomial were the proposal of panels of biomarkers for 
lung cancer detection and the quantitative determination of amino acids in sweat. Second, 
a method to enhance the metabolomics coverage of human sweat by GC–MS was 
developed. Finally, the first steps of the analytical process required by this new clinical 
sample are discussed: sampling —taking advantage of the multiple forms and situations by 
which this biofluid can be sampled— and sample preparation —mandatory step to obtain 
the analytical sample as required for introduction in the target analytical platform. 
 
Sections C and D. Sweat and metabolomics: Sampling and sample 
preparation, and clinical applications 
Sweat is mainly composed by water, but it contains several minor components 
including electrolytes, ammonia, urea, small molecules such as carboxylic acids and amino 
acids as well as more complex biomolecules such as proteolytic enzymes and antimicrobial 
peptides, among others [63]. The varied composition, which can be modified by certain 
pathologies, and the no invasive sampling of this biofluid have gained clinical interest as a 
potential tool for diagnostics and biomarker monitoring. As a previous step to the use of 
this biofluid in the clinical field, metabolomics has been used as a tool to obtain a snapshot 
of the composition of sweat metabolome. A method developed for analysis of human sweat 
by LC–QTOF MS/MS allowed identifying 41 compounds, mainly amino acids, being the 
most abundant compounds in this sample [64]. From this research developed by the group 
of the PhD student, two research lines emerged. 
The first line consisted of using the platform previously proposed [65] to develop a 
more robust predictive model for lung cancer screening (Chapter XI) and a method for 
quantitation of amino acids as potential biomarkers of lung cancer in the target biofluid 
(Chapter VII) by LC─MS/MS. The second line consisted of developing a GC─MS platform 
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to elucidate sweat metabolome (Chapter X), then used to test different sample preparation 
protocols and samplings (Chapters VIII and XI). 
The active research on omics disciplines had been previously focused on 
understanding the development and biology of lung cancer and identifying potential 
biomarkers to detect initial stages in the development of the disease [66]. Metabolomics 
had provided new technical approaches to enhance the capability of this discipline on 
biomarker discovery for diagnosis of different types of cancer. The potential of both sweat 
as biofluid and metabolomics for implementation in the diagnostic of lung cancer had been 
demonstrated in a previous study developed by the group of the PhD student [65]. Human 
sweat had been used as clinical sample to develop a tool for lung cancer screening. A 
prediction model based on a panel of sweat metabolites (80% specificity and 79% 
sensitivity), including amino acids, sugars, and some lipids, was built to discriminate 
patients with lung cancer from a control group with risk factor. These preliminary results, 
obtained with a unique cohort, emphasized the necessity of new studies, as that in Chapter 
XI, to validate the obtained results and reduce the proportion of individuals that would be 
subjected to confirmatory tests. 
Chapter XI proposes a prediction model for lung cancer detection more robust than 
that obtained in the previous study. The prediction model was based on two panels of sweat 
metabolites in which both false negatives and false positives were reduced in such a way 
that 95% was the level reached for both specificity and sensitivity. The best panel providing 
specificity above 95% was formed by five metabolites: the monoglyceride MG(22:2), 
muconic, urocanic and suberic acids, and a tetrahexose. This panel provided 96.9% 
specificity and 83.8% sensitivity. On the other hand, the best panel providing sensitivity 
above 95% was composed of the metabolites included in the previous panel, in which 
suberic acid was replaced by nonanedioic acid (the previous panel provided 81.2% 
specificity and 97.3% sensitivity). The robustness of the previous biomarker panel by 
Calderón-Santiago et al. [65] was increased in Chapter XI, using new samples collected 
within different times (4 months and 2 years) and analyzed at different times (2012 and 
2014, respectively) by different analysts, and always with the aim of discriminating lung 
cancer patients from smokers at risk factor. 
Among 16 sweat metabolites used to discriminate lung cancer patients from control 
individuals, 5 of them were amino acids [65]. The composition of free amino acids in sweat 
is different from that in other biofluids, according to studies developed by automated 
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analyzers [67], thus increasing the interest in this sample for quantitative analysis of amino 
acids for diagnosis purposes. Also, methods based on automated analyzers had detected up 
to 26 amino acids in human sweat, which allow confirming this biofluid as suitable for 
complete profile of amino acids [67]. However, derivatization of amino acids, a common 
practice prior to their photometric or fluorimetric detection [68], suffers from different 
drawbacks, and dramatically enlarges sample preparation protocols [69]. Chapter VII 
affords the development of a method to quantify 23 amino acids in human sweat by LC–
MS/MS. Matrix effects decreased by both dilution of sweat and clean-up effect provided by 
centrifugal solid-phase microextraction (c-SPµE). Amino acids behave differently among 
them; therefore, compromise solutions were necessary for their determination in a single 
analysis. The concentration of amino acids in sweat ranges between 6.20 ng/mL (for 
homocysteine) and 259.77 µg/mL (for serine). 
In this way, Chapters XI and VII open the door to the use of no common samples 
as sweat in clinical studies for diagnosis of diseases as lung cancer. 
The second line of the research on sweat–metabolomics was based on improving 
the detection coverage for identification of metabolites in this biofluid. Considering that 
more research on sweat composition is demanded to assess the potential of this biofluid for 
clinical diagnostic, and that before Chapter X only NMR [70] and LC–MS [64] had been 
used for sweat characterization, sweat metabolome including volatile and easy to convert 
into volatile compounds needed to be elucidated. Chapter X contains the development and 
validation of a method for analysis of human sweat by GC–TOF/MS in high resolution 
mode, which allowed studying a wide variety of these compounds. GC–TOF/MS allowed 
detecting both volatile and no volatile compounds from human sweat after applying sweat 
deproteination and well-known derivatization reactions. It provided information for 
tentative identification of 66 compounds, including amino acids, dicarboxylic acids and 
other interesting metabolites such as myo-inositol or urocanic acid. GC–TOF/MS appears 
to be the best strategy to analyze this biofluid, in terms of metabolome coverage, as 
compared to previous studies using NMR and LC–MS. It is worthy to distinguishing the 
ability of GC–MS to detect sugars, lipids and carboxylic acids, families that with previous 
platforms seemed to have insignificant presence, but they constitute around 20% of the 
whole entities detected by GC–MS. These three groups, together with amino acids, which 
constitute 30% of the identified compounds, are the four most remarkable families in 
sweat. The excellent characteristics of the developed method and the identification of 
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metabolites involved in key biochemical pathways emphasized the necessity of new studies, 
as those in Chapters VIII and IX, to set the pattern of the type of sample to be obtained 
depending on the metabolites of interest (polar, no polar or medium polarity compounds). 
Among 66 compounds identified in Chapter X only 14 no polar compounds were 
detected, because most of them were of polar nature. Similar results had been found using 
NMR [71] and LC–MS [64]. Regarding no polar compounds, NMR analysis only allowed 
detection of some characteristic groups of lipids. This fact could be explained by the low 
concentration of lipids in the collected samples (<0.01 mM) and the low resolution of 1H-
NMR to discriminate lipid families. The developed LC–QTOF MS/MS analysis confirmed 
that the main families of detected metabolites were polar compounds, and only 4 no polar 
compounds (3 fatty acids and 1 sphingolipid) were detected [64]. 
All the studies discussed above had in common the collection of the known as 
passive sweat —that collected from individuals at rest. The sampling devices employed 
could explain the differences in sweat composition, and the lack of no polar compounds 
[71]. Sweating is usually stimulated by heat and/or chemical induction (for instance, using 
pilocarpine), but also by exercise practice at different intensity levels [72]. The first two 
protocols, based on temperature increase or chemical stimulation, allow collection of 
passive sweat, while that collected after exercise practice provides the known as active 
sweat, which can set differences at compositional level as compared to passive sweat. 
Considering that sampling processes for this scantly known clinical sample in the 
above commented studies were based on passive sweat and that lipids had been scarcely 
detected in this sample, a method for active sweat analysis, with special emphasis on no 
polar compounds, was developed in Chapter VIII. A GC–TOF/MS platform allowed the 
tentative identification of 135 compounds. Lipids, VOCs, benzenoids and other interesting 
metabolites such as alkaloids and ethanolamines were identified among them more than 
40 lipids. Sample preparation to obtain a representative snapshot of active sweat 
metabolome consisted of methoximation plus silylation after LLE with dichloromethane. 
Compositional differences in passive and active sweat collected from the same volunteers 
were found, the latter presenting an enriched concentration of some key families of 
compounds such as fatty acids, alcohols, carbohydrates and no proteinogenic amino acids. 
The differences in concentration can be explained by the sampling protocol since sweat is 
stimulated in a different manner prior to collection of active or passive sweat. 
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Focusing again on sampling, all previous studies had in common the collection of 
the known as passive sweat but also that it was always collected as fresh sweat, and used as 
such [64,70,71,73]. In most of the wide variety of fresh sweat samplers it is mandatory to 
wear the device for sweat production, which is a tedious process. For this reason, novel 
procedures for sweat collection are desirable. One alternative is collection of dry sweat, a 
concept that should not be confused with applications based on sampling of fresh sweat, 
then dried for analysis. This protocol was proposed to standardize the sampling process 
due to its simplicity [74]. In Chapter IX, a solid support as filter paper impregnated with 
1:1 (v/v) ethanol‒phosphate buffer to collect sweat components from the skin was proposed 
as a standardized protocol alternative to fresh sweat sampling. The collected dry sweat 
allowed tentative identification of 175 compounds by using a combined approach based on 
GC–MS and LC–MS/MS analysis. The comparison between dry and fresh sweat revealed 
that the former provides an improvement in the detection of low-polar compounds, while 
fresh sweat is more suited for detection of polar metabolites. In addition, particular families 
such as carnitines, sphingolipids and N-acyl-amino acids never reported in fresh sweat 
were detected in dry sweat. Considering the variability sources affecting the sampling of 
fresh sweat, collection of dry sweat can be proposed as a standardized sample from this 
biofluid for its use in metabolomics and future clinical studies. 
In short, Chapter X open the door to the use of a GC–MS platform for sweat 
samples analysis in clinical studies and Chapters VIII and IX to select the type of sweat 
sample to be obtained depending on the metabolites of interest. 
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La investigación realizada y que ha dado lugar a esta Memoria de Tesis ha 
permitido extraer las siguientes conclusiones: 
La extensa búsqueda bibliográfica, que ha propiciado las publicaciones que 
constituyen los Capítulos del I al III, permite una evaluación crítica del estado actual de los 
métodos basados en USAE para obtener componentes de plantas/alimentos y de los 
controvertidos efectos de los US en las enzimas y en su acción biocatalítica, pero también 
proporciona pautas para planificar investigación en metabolómica de plantas asistida por 
US. 
La investigación experimental contenida en esta Memoria de Tesis se orientó al 
análisis metabolómico, tanto dirigido como global, en las áreas vegetal y animal. La 
diversidad de los estudios desarrollados incluye el efecto de la preparación de la muestra 
en la cobertura conseguida en la detección y el efecto favorable de los US en las reacciones 
enzimáticas. La variedad de los estudios realizados también abarca el efecto del muestreo 
y la preparación de la muestra en la eficacia de la detección de componentes del sudor, así 
como el estudio de los cambios en los perfiles de los metabolitos en el sudor humano 
recogido después de estimulación mediante diferentes procedimientos. 
Las conclusiones más destacables de la investigación en metabolómica en el área 
vegetal son: 
Capítulo IV: 
 El método basado en USAEH para la obtención de la aglicona de la oleuropeína a 
partir oleuropeína de extractos de hojas de olivo, que requiere menos de 20 min 
para la hidrólisis completa, lo que permite una comparación favorable con el 
método tradicional basado en incubación enzimática, que requiere 2 h.  
Capítulo V: 
 El fraccionamiento basado en extracción líquido–líquido secuencial con 
extractantes de diferente polaridad mejora drásticamente la cobertura de la 
identificación tentativa de metabolitos en los extractos enzimáticos acuosos del 
A. bisporus (123 metabolitos tentativamente identificados). 
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Capítulo VI: 
 Se han identificado 169 compuestos (cannabinoides, terpenoides, lípidos, 
flavonoides, aminoácidos y ácidos orgánicos, entre los más destacables) en 
extractos polares y no polares, obtenidos con la asistencia de US, de 17 cultivos 
de Cannabis sativa L. Las plataformas GC–TOF/MS y LC–QTOF MS/MS 
maximizan la cobertura conseguida en la detección de componentes del 
Cannabis, consiguiéndose identificar 46 compuestos en los extractos polares y 
134 en los no polares. 
En cuanto al efecto del muestreo y de la preparación de la muestra en la detección 
de metabolitos en sudor humano (Sección C), el uso de análisis dirigido y no dirigido 
permitió obtener las siguientes conclusiones: 
Capítulo VII: 
 El sudor es una muestra excelente para el análisis cuantitativo del perfil de 
aminoácidos en estudios clínicos, lo que resulta de interés teniendo en cuenta el 
papel biomarcador de estos compuestos. La dilución+c-SPµE ha demostrado ser 
decisiva para disminuir el efecto matriz del sudor humano y hacer así posible la 
cuantificación de aminoácidos mediante LC–MS/MS. 
Capítulo VIII: 
 El sudor activo, con respecto al sudor pasivo, está enriquecido en algunas familias 
de compuestos claves, tales como ácidos grasos, alcoholes, carbohidratos y 
aminoácidos no proteinogénicos. La LLE con diclorometano y posterior 
metoximación más sililación es la mejor opción entre los protocolos ensayados 
para obtener mediante GC–MS una instantánea representativa de los 
compuestos no polares del sudor activo. 
Capítulo IX: 
 El muestreo de sudor seco es una alternativa para la estandarización de la 
recogida de sudor. El papel impregnado con etanol–PBS en proporción 1:1 (v/v) 
proporciona los mejores resultados en términos de cobertura de la detección 
utilizando un análisis combinado mediante las plataformas GC–MS y LC–
MS/MS. Se han detectado en sudor seco familias tales como carnitinas, 
esfingolípidos y N-acil-aminoácidos, que no se han encontrado en sudor fresco. 
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Los hallazgos más destacables en la mejora en cobertura metabolómica del sudor 
para estudios clínicos han sido los siguientes: 
Capítulo X: 
 La optimización de una nueva plataforma basada en GC–MS para el análisis de 
sudor revela la presencia de metabolitos que pueden ser de interés para el estudio 
de diferentes patologías. Es destacable la capacidad de la plataforma para 
detectar azúcares, lípidos y ácidos carboxílicos, familias cuya presencia había 
resultado insignificante cuando se utilizaron plataformas basadas en RMN o en 
LC–MS. 
Capítulo XI: 
 El diseño de dos paneles de cinco metabolitos que incluyen aminoácidos, ácidos 
dicarboxílicos de cadena corta, azúcares y algunos lípidos permite discriminar 
pacientes con cáncer de pulmón del grupo de control con factor de riesgo. Este 
nuevo modelo de predicción es más robusto que el obtenido previamente por 
nuestro grupo, ya que se construyó con dos tandas de muestras recogidas y 
analizadas con una diferencia de tiempo de dos años y por diferentes analistas.  
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The following are the conclusions from the research that constitutes this PhD-
Book: 
The in-depth bibliographic search (Chapters I-to-III) allows a critical evaluation of 
the state-of-the-art of USAE methods to obtain components from plants/foods, and the 
controversial effects of US on enzymes and their biocatalytic action, but also provides 
guidelines to plan the research on plants through metabolomics helped by US. 
The experimental research in this Thesis-Book was focused on the use of both 
targeted and untargeted metabolomics analysis for plant and animal studies. The diversity 
of the developed studies includes the effect of sample preparation on detection coverage, 
and the favorable US effect on enzymatic reactions. The variety of the developed studies 
also covers the effect of both sampling and sample preparation on the efficient detection of 
sweat components, and the study of the changes in the metabolite profiles of human sweat 
collected after different sweat stimulation procedures. 
The most outstanding conclusions from the research devoted to studying the 
metabolomics in the plant field are: 
Chapter IV: 
 The USAEH method to obtain oleuropein aglycon from oleuropein in olive leaf 
extracts requires less than 20 min for complete hydrolysis, which compares 
favorably with the traditional method based on enzymatic incubation, for which 
2 h are necessary. 
Chapter V: 
 Fractionation based on sequential liquid–liquid extraction with extractants of 
different polarity drastically improves the tentative identification coverage of 
metabolites in A. bisporus aqueous enzymatic extracts (123 tentatively identified 
metabolites). 
Chapter VI: 
 A total of 169 compounds (cannabinoids, terpenoids, lipids, flavonoids, amino 
and organic acids, among others) have been identified in polar and no polar 
extracts obtained by US assistance from 17 cultivars of Cannabis sativa L. GC–
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TOF/MS and LC–QTOF MS/MS maximize the detection coverage of Cannabis 
components, so 46 compounds were identified in polar extracts and 134 
compounds in no polar extracts. 
Concerning the effect of sampling and sample preparation on the detection of 
metabolites from human sweat (Section C), untargeted and targeted analysis allowed 
reaching the following conclusions: 
Chapter VII: 
 Sweat is an excellent sample for quantitative profiling analysis of amino acids in 
clinical studies, which is of interest taking into account the biomarker role of 
these compounds. Dilution+c-SPµE has proved to be mandatory to decrease the 
matrix effect of human sweat thus making possible absolute quantitation of 
amino acids by LC–MS/MS. 
Chapter VIII: 
 Active sweat is enriched in some key families of compounds such as fatty acids, 
alcohols, carbohydrates and no proteinogenic amino acids as compared with 
passive sweat. LLE with dichloromethane with subsequent methoxymation plus 
silylation is the best option among the tested protocols to obtain a representative 
snapshot by GC–MS of active sweat due to the detection of no polar compounds. 
Chapter IX: 
 Dry sweat sampling is an alternative to standardize sweat collection. Paper 
impregnated with 1:1 (v/v) ethanol‒PBS provides the best results in terms of 
detection coverage by using a combined approach based on GC–MS and LC–
MS/MS analysis. Particular families such as carnitines, sphingolipids and N-acyl-
amino acids detected in dry sweat have not been reported in fresh sweat. 
The most remarkable findings on enhancement of metabolomics coverage of sweat 
for clinical studies are the following: 
Chapter X: 
 The optimization of a new GC–MS platform for sweat analysis reveals the 
presence of metabolites that can be of interest for the study of different 
pathologies. It is worthy to remarking the ability of GC–MS to detect sugars, 
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lipids and carboxylic acids, families that with previous platforms (NMR and LC–
MS) seemed to have insignificant presence. 
Chapter XI: 
 Two panels of five metabolites including amino acids, short chain dicarboxylic 
acids, sugars and some lipids allow discriminating patients with lung cancer from 
a control group with risk factor. This new prediction model is more robust than 
that obtained previously by our group since it was built with two batches of 
samples collected and analyzed with a shift time of two years and by different 
analysts.  
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Análisis cuantitativo del perfil de aminoácidos en sudor humano mediante 
cromatografía líquida–espectrometría de masas de triple cuadrupolo 
 
Introducción 
El sudor constituye una muestra escasamente utilizada en análisis clínico, a pesar de la 
facilidad de su obtención y el carácter no invasivo de su muestreo. Entre los usos 
destacables de este fluido biológico se encuentra su aplicación a la diagnosis de la fibrosis 
quística [1], el control de la relación hidro-electrolítica durante el ejercicio humano [2,3] y 
la detección de la presencia de sustancias tóxicas en el organismo [4,5]. La metabolómica, 
la más reciente de las grandes ómicas, está adquiriendo un gran desarrollo en su vertiente 
clínica, especialmente en la búsqueda de biomarcadores de enfermedades, por lo que 
constituye una disciplina prometedora en el uso del sudor para esta búsqueda.  
En un estudio reciente desarrollado en nuestro Grupo de Investigación, se utilizó el sudor 
como muestra para la discriminación metabolómica entre sujetos con y sin cáncer de 
pulmón (CP) mediante un perfil global obtenido con un equipo de cromatografía líquida–
tiempo de vuelo/espectrometría de masas (LC–TOF/MS). El tratamiento quimiométrico 
de los datos obtenidos permitió obtener un panel de biomarcadores de CP compuesto por 
tres metabolitos y caracterizado por 100% de especificidad y el 81% de sensibilidad [6–8]. 
Estos resultados hicieron deseable el desarrollo de la siguiente investigación, que ha 
constituido el trabajo fin de máster de la autora y el comienzo de su Tesis Doctoral. 
 
Objetivos 
El objetivo genérico de la investigación fue desarrollar una plataforma analítica robusta 
y validada para obtener perfiles cuantitativos de metabolitos en sudor. 
Los objetivos concretos fueron: 
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Objetivo 1: Optimizar un método muy sensible y selectivo basado en LC–MS/MS en modo 
de monitorización de reacciones seleccionadas (SRM) para el análisis confirmatorio y 
cuantitativo de aminoácidos en sudor humano. 
Objetivo 2: Proponer diferentes formas de preparación de la muestra de sudor (dilución, 
extracción en fase sólida automatizada, microextracción en fase sólida) para minimizar o 
evitar el efecto matriz del sudor en la determinación de los metabolitos problema. 
Objetivo 3. Caracterizar el método total (resultado de combinar la etapa de preparación de 
la muestra con la de detección) evaluando sus propiedades analíticas. Esta caracterización 
soporta el uso del sudor como muestra analítica para obtener un perfil de aminoácidos 
teniendo en cuenta el número de patologías en las que está implicado el metabolismo de 
estos compuestos. 
 
Materiales y métodos 
El perfil de analitos estuvo compuesto por todos los aminoácidos proteinogénicos además 
de otros tales como carnitina, citrulina, taurina, y creatinina, que fueron seleccionados por 
su importancia biológica. 
Para el análisis de estos aminoácidos se utilizó la cromatografía líquida (LC) con detección 
mediante espectrometría de masas (MS/MS) usando un espectrómetro de triple 
cuadrupolo (QqQ) Agilent 6460 equipado con una fuente de ionización por electrospray 
(ESI) Jetstream®. Los datos se procesaron mediante un software Workstation MassHunter 
para el análisis cualitativo y cuantitativo. 
Las muestras de sudor para el desarrollo y caracterización del método se tomaron de 
voluntarias sanas en el Hospital Reina Sofía, provocando la sudoración mediante un 
inductor de sudor Webster. El sudor se recogió en un colector Macroduct. 
Para la preparación de la muestra se compararon dos protocolos: Uno de dilución de la 
muestra y otro de extracción en fase sólida (SPE). En el primero, se preparó un pool de 
sudor con todas las muestras y se tomaron alícuotas, que se utilizaron tal cual o 
enriquecidas a dos concentraciones (50 y 250 ng/mL) con un multipatrón de los 
aminoácidos en medio acuoso 0.1 M en ácido fórmico (AF). En el segundo, las alícuotas se 
diluyeron con HCl 0.1M y se sometieron a microSPE (en formato centrífugo). 
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Para la separación cromatográfica se utilizó una columna analítica C18 en fase reversa 
termostatizada a 25 °C. Las fases móviles fueron agua y acetonitrilo–agua 90:10, ambos 
con formiato amónico 5 mM como agente ionizante. La bomba del LC se programó a 0.5 
mL/min en modo gradiente.  
La detección se llevó a cabo en ionización positiva en modo SRM con una resolución m/z 
de 1. Para la cuantificación de los aminoácidos en el sudor se utilizó el área del pico obtenido 
para la transición de cada analito, que coincidió con el tiempo de retención cromatográfico 
proporcionado por la disolución multipatrón. Los modelos de calibración para cada analito 
se desarrollaron usando disoluciones multipatrón a diferentes concentraciones mediante 
la dilución de la disolución madre con 0.1 M FA en agua. 
 
Principales aportaciones 
Se optimizó la preparación de la muestra (tanto la dilución necesaria para evitar el efecto 
matriz como el tipo de cartucho para la SPE), la separación cromatográfica (la columna, el 
tipo de gradiente y el pH), la ionización (parámetros de la fuente), el método SRM (el voltaje 
del Q1 y la energía de colisión) y la transición para la cuantificación de los aminoácidos. 
Se evaluó el potencial del sudor para la obtención del perfil cuantitativo de aminoácidos 
mediante un estudio exhaustivo de la preparación de la muestra, en el que se demostró que 
el SPE en el formato centrífugo era la opción que proporcionaba unas mejores 
características analíticas del método global. 
El pequeño volumen de sudor muestreado en cada individuo hace imprescindible el uso de 
microformatos para la preparación de la muestra, como es el caso de las microcolumnas de 
tipo centrífugo utilizadas en esta investigación. 
La dilución del sudor es necesaria para disminuir el efecto matriz y conseguir así la 
cuantificación absoluta de los aminoácidos. 
Los modelos de calibración obtenidos son buenos, con coeficientes de regresión superiores 
a 0.98 para todos los analitos, excepto para la cisteína, que fue del 0.97. Los límites de 
detección y de cuantificación obtenidos están entre los pg/mL y los ng/mL.  
Los aminoácidos se comportan de forma diferente entre sí; por tanto, se han de adoptar 
soluciones de compromiso cuando se realiza su determinación en un solo análisis. 
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El sudor puede ser una muestra excelente para la obtención del perfil cuantitativo de 
aminoácidos en estudios clínicos; lo que es de interés si se tiene en cuenta el papel que 
tienen estos compuestos como biomarcadores. 
 
Investigación prevista 
-Estudio en sudor de los perfiles de otras familias de metabolitos potenciales 
biomarcadores. 
-Validación de los métodos mediante aplicación a muestras de sudor de pacientes de CP, 
de otras patologías y a individuos sanos. Aplicación a una población amplia en diferentes 
grados de desarrollo de CP. 
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Abbreviations 
A. bisporus, Agaricus bisporus; A. niger, Aspergillus niger; AbAEE, 
Agaricus bisporus aqueous enzymatic extracts; AbRE, Agaricus bisporus raw 
extracts; ABTS, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); ACE, 
angiotensin I-converting enzyme; ACN, acetonitrile; AOA, total antioxidant 
activity; APCI, atmospheric pressure chemical ionization; API, atmospheric 
pressure ionization; APPI, atmospheric pressure photoionization; AUC, area 
under the curve; BBD, Box-Behnken design; BD, biodiesel; BPC, base peak 
chromatogram; BSTFA, bis-(trimethylsilyl)-fluoroacetamide; CAPE, caffeic acid 
phenethyl ester; CBC, cannabichromene; CBD, cannabidiol; CBDA, cannabidiolic 
acid; CBDV, cannabidivarin; CBDVA, cannabidivarinic acid; CBE, cannabielsoin; 
CBG, cannabigerol; CBGA, cannabigerolic acid; CBGV, cannabigerovarin; CBL, 
cannabicyclol; CBN, cannabinol; CD, circular dichroism; CE, capillary 
electrophoresis; CI, chemical ionization; CIL, chemical isotope labeling; c-SPµE, 
centrifugal solid-phase microextraction; DAD, diode array detector; DAG, 
diacylglycerol; Dansyl-Cl,1-dimethylaminonaphthalene-5-sulphonyl chloride; 
DART, direct analysis in real time; DE, degree of esterification; DESI, desorption 
electrospray ionization; DFI, direct fluid injection; DIMS, direct infusion mass 
spectrometry; DLLME, dispersive liquid–liquid microextraction; DMB, 1,2-
diamino-4,5-methylene dioxybenzene; DPPH, 2,2-diphenyl-1-picrylhydrazyl; DSS, 
sodium trimethylsilylpropanesulfonate; DW, dried weight; DWGP, defatted 
wheat germ protein; EAE, enzyme assisted extraction method; EDP, 2-ethylhexyl 
4-(N,N-dimethylamino)benzoate; EFA, esterified fatty acid; EI, electron impact; ES, 
external standard; ESI, electrospray ionization; FA, formic acid; FAAS, flame 
atomic absorption spectrometry; FAB, fast atom bombardment; FAME, fatty acid 
methyl ester; F–C, Folin–Ciocalteu; FDA, Food and Drug Administration; FDNB, 
1-fluoro-2,4-dinitrobenzene; FID, flame ionization detection; FRAP, ferrous 
reducing antioxidant power; FT–IR, Fourier transform infrared analysis; FWHM, 
full width at half maximum; GABA, γ-aminobutyric acid; GC, gas 
chromatography; GC–FID, gas chromatography–flame ionization detector; GC–
FTIR, gas chromatography–Fourier transform infrared spectroscopy; GC–MS, 
gas chromatography–mass spectrometry; GC–MS/MS, gas chromatography–
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tandem mass spectrometry; GC–TOF/MS, gas chromatography–time-of-flight/ 
mass spectrometry; GHz, gigahertz; GlyC, glycerol carbonate; HCV, hepatitis-C 
virus; HHP, high hydrostatic pressure; HMDB, Human Metabolome Database; 
1H-NMR, proton nuclear magnetic resonance; HPLC, high performance liquid 
chromatography; HPLC–DAD, high pressure liquid chromatography–diode array 
detection; HS, head-space; ICAT, isotope coded affinity tags; ICP, inductively 
coupled plasma; ICP-OES, inductively coupled plasma optical emission 
spectrometry; IL, ionic liquid; IT, ion trap; kA, apparent breakdown rate constant; 
kHz, kilohertz; KM, Michaelis-Menten constant; LC, liquid chromatography; LC–
MS, liquid chromatography–mass spectrometry; LC–MS/MS, liquid chromatog-
raphy–tandem mass spectrometry; LC–QTOF MS/MS, liquid chromatography 
quadrupole time-of-flight tandem mass spectrometry; LC–UV, liquid chromato-
graph coupled to a UV detector; LIF, laser induced fluorescence; LLE, liquid–liquid 
extraction; LLME, liquid–liquid microextraction; LOD, limit of detection; LOQ, 
limit of quantitation; LTQ, linear trap quadrupole; MAD, microwave-assisted 
digestion; MAE, microwave-assisted extraction; MALDI, matrix-assisted laser 
desorption/ionization; MALDI-TOF-MS, matrix-assisted laser desorption/ioni-
zation time-of-flight mass spectrometry; MF, molecular feature; MG, 
monoglyceride; MHz, megahertz; MMCD, Madison Metabolomics Consortium 
Database; MPP, Mass Profiler Professional; MRM, multiple reaction monitoring; 
MS, mass spectrometry; MS/MS, tandem mass spectrometry; MTS, nano-
thermosonication; MW, microwave(s); NEFA, no esterified fatty acid; NIST, 
National Institute of Standards and Technology; NMR, nuclear magnetic 
resonance; OPA, o-phthaldialdehyde; OPO, 1,3-dioleoyl-2-palmitoylglycerol; 
ORA, overrepresentation analysis; ORAC, oxygen radical absorption capacity; 
PAHs, polycyclic aromatic hydrocarbons; PAR, photosynthetically active 
radiation; pAUC, partial area under the curve; PBS, phosphate buffer solution; 
PC1, principal component 1; PC2, principal component 2; PCA, principal 
component analysis; PFTBA, perfluorotri-n-butylamine; pI, polarity index; PITC, 
phenylisothiocyanate; PL, phospholipid; PLS, partial least squares; PLS-DA, PLS 
discriminant analysis; Q, single quadrupole; QCs, quality control sample; QqQ, 
triple quadrupole; QTOF, quadrupole time-of-flight; RI, retention index; ROC, 
receiver operating characteristic; RP, reversed-phase; RP-HPLC, reverse phase 
 Abbreviations 
 
Page | 717  
 
high-performance liquid chromatography; RSD, relative standard deviation; 
RSM, response surface methodology; RT, retention time; SC, supercritical; SC-
CO2, supercritical carbon dioxide; SDS PAGE, sodium dodecyl sulphate-
polyacrylamide gel electrophoresis; SE, Soxhlet extraction; SEA, set enrichment 
analysis; SELDI, surface-enhanced laser desorption/ionization; SEM, scanning 
electron microscopy; SFC, supercritical fluid chromatography; SFE, supercritical 
fluid extraction; SHLE, superheated liquid extraction; SHWE, superheated water 
extraction; SP, sample preparation; SPE, solid-phase extraction; SPME, solid-
phase microextraction; SRM, selected reaction monitoring; TBDMS, tert-
butyldimethylsilylation; TC, tetracycline; TEAC, Trolox equivalent antioxidant 
capacity; TIC, total ion chromatogram; TLC, thin layer chromatography; TMCS, 
trimethylchlorosilane; TMPP, tris(2,4,6-trimethoxyphenyl)phosphonium; TMS, 
trimethylsilylation; TOF, time of flight; TPC, total phenolic content; TPP, three 
phase partitioning; TPS, trimethylsilyl propionate; UATPP, ultrasound assisted 
three phase partitioning; UHPLC, ultra-high-performance liquid 
chromatography; UHPSFC, ultrahigh performance supercritical fluid 
chromatography; US, ultrasound; USAE, ultrasound-assisted extraction; USAEE, 
US-assisted emulsification–extraction; USAEH, ultrasound-assisted enzymatic 
hydrolysis; USAL, ultrasound assisted leaching; USALLE, US assisted liquid–liquid 
extraction; UV, ultraviolet; VOC, volatile organic compound; VOO, virgin olive oil; 
W, watt; XRD, X-ray diffraction; Δ8‐THC, δ8-tetrahydrocannabinol; Δ9‐THC, 
δ9‐tetrahydrocannabinol; Δ9‐THCA, δ9‐tetrahydrocannabinolic acid; Δ9-THCV, 
δ9‐tetrahydrocannabivarin. 
 
  
 
 
  
 
 

